data_1id8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1id8 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.613 ' HZ1' ' HG1' ' A' ' 5' ' ' THR . 0.1 OUTLIER -76.27 133.76 39.98 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -81.25 89.57 6.05 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 111.023 -2.808 . . . . 0.0 107.335 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.613 ' HG1' ' HZ1' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -174.36 120.2 0.25 Allowed 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.12 112.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 p -98.98 113.6 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.678 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -125.2 154.04 42.17 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.911 1.382 . . . . 0.0 109.762 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.25 -154.32 25.12 Favored Glycine 0 C--N 1.361 1.963 0 CA-C-N 111.931 -2.395 . . . . 0.0 112.689 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.704 14.9 p 88.28 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 131.095 3.758 . . . . 0.0 115.398 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.271 1.2 tt 67.03 148.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.173 2.189 . . . . 0.0 109.22 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.956 0 CA-C-N 112.267 -2.242 . . . . 0.0 110.763 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 125.883 2.754 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER 43.13 44.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 1 CA-C-N 106.659 -4.791 . . . . 0.0 109.539 -178.473 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.68 -24.07 64.47 Favored 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 114.679 -2.809 . . . . 0.0 103.602 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.23 -15.99 64.02 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.901 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.265 0.7 OUTLIER -69.72 -26.3 64.26 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 117.969 -1.492 . . . . 0.0 108.241 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -20.17 65.34 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 113.161 -1.836 . . . . 0.0 108.814 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -58.62 -46.27 87.43 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -29.66 69.45 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 112.121 -2.309 . . . . 0.0 112.133 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.69 10.88 19.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.068 -2.333 . . . . 0.0 108.55 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -8.81 2.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.91 31.49 76.33 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.75 -175.21 2.91 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 113.006 -1.597 . . . . 0.0 108.328 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -108.71 154.64 21.74 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 112.287 -2.233 . . . . 0.0 106.777 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 27' ' ' PHE . 78.5 t -99.94 135.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 CA-C-N 111.781 -2.463 . . . . 0.0 108.83 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.36 54.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 111.418 -2.628 . . . . 0.0 107.005 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.8 126.43 30.37 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.84 -65.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.86 -116.82 0.73 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.394 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.12 23.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.323 -1.438 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.85 167.91 10.46 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.9 t -123.61 66.53 1.02 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 111.37 -2.65 . . . . 0.0 104.166 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.9 m -77.75 102.77 7.32 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -88.16 -85.9 0.18 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 113.06 -1.882 . . . . 0.0 107.38 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.19 -11.25 56.85 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 124.94 1.4 . . . . 0.0 110.926 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -89.21 -45.62 9.41 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.68 3.18 48.84 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.683 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 -29.03 7.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -73.05 -27.9 62.01 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.71 2.86 54.19 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.39 -9.13 48.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.24 -36.91 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -62.0 -69.07 0.27 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.192 -2.276 . . . . 0.0 110.195 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . 0.279 6.4 p -78.34 -32.43 49.15 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 123.783 0.677 . . . . 0.0 109.685 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 81.15 61.09 0.02 OUTLIER 'General case' 0 C--N 1.349 0.552 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.8 118.27 3.03 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.851 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -83.31 -49.35 9.47 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -142.83 161.2 38.71 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 125.426 1.704 . . . . 0.0 106.78 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.28 137.2 54.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 111.139 -2.755 . . . . 0.0 105.295 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.95 112.28 14.5 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.62 142.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.207 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -114.39 63.61 0.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 p -168.67 148.62 4.44 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 70.59 0.74 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 111.61 -2.541 . . . . 0.0 104.341 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 72.22 87.3 0.11 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-N 110.413 -3.085 . . . . 0.0 106.818 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.28 33.52 0.51 Allowed Glycine 0 CA--C 1.535 1.32 0 CA-C-N 109.833 -3.349 . . . . 0.0 106.61 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.78 -14.65 0.54 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 111.259 -2.471 . . . . 0.0 108.476 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.76 -162.78 54.55 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 122.53 1.072 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.2 3.27 27.99 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 111.79 -2.205 . . . . 0.0 108.055 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mm -73.15 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.85 -24.6 65.28 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.843 1.339 . . . . 0.0 108.813 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 21.9 t -62.91 -72.13 0.14 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -90.17 33.09 0.89 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.313 1.008 . . . . 0.0 109.33 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.74 -47.61 2.47 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.82 -20.82 23.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 112.047 -2.076 . . . . 0.0 107.89 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 75' ' ' ARG . 5.5 mmt85 -74.84 -31.85 61.76 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.05 -23.79 47.97 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.057 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.95 -16.11 59.45 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.96 0.787 . . . . 0.0 109.183 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.4 m -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 123.868 1.794 . . . . 0.0 107.229 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.38 -1.51 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 108.692 -3.867 . . . . 0.0 108.667 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.83 -53.46 6.47 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.73 48.76 5.32 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 111.024 -2.807 . . . . 0.0 107.101 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.06 -47.14 0.01 OUTLIER Glycine 0 C--N 1.347 1.166 0 CA-C-N 112.268 -2.242 . . . . 0.0 108.357 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.46 124.51 35.03 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 124.61 33.9 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.918 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.29 65.59 0.03 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 112.825 -1.988 . . . . 0.0 109.32 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.4 tt -105.54 11.32 8.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 112.097 -2.052 . . . . 0.0 108.139 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.51 114.26 20.43 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.11 101.88 4.25 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -99.87 90.96 4.61 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.81 96.52 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 108.89 -3.777 . . . . 0.0 111.323 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.0 124.12 34.56 Favored Glycine 0 CA--C 1.537 1.417 1 CA-C-N 107.433 -4.439 . . . . 0.0 112.69 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.37 -80.84 0.94 Allowed Glycine 0 C--N 1.352 1.441 0 CA-C-N 112.549 -1.825 . . . . 0.0 109.143 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 25.44 94.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.431 3.492 . . . . 0.0 110.823 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 69.91 123.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.511 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.63 169.9 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 112.343 -2.208 . . . . 0.0 107.318 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.42 61.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.648 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.03 148.03 9.74 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.275 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.47 105.12 0.36 Allowed 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 87.14 -58.94 0.04 OUTLIER 'General case' 0 C--N 1.357 0.899 0 O-C-N 125.915 2.01 . . . . 0.0 106.753 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -86.17 101.21 12.8 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -106.86 160.91 24.61 Favored Pre-proline 0 C--N 1.351 0.64 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.23 -158.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.61 1.54 . . . . 0.0 108.631 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.78 -23.45 67.25 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.592 -2.094 . . . . 0.0 108.771 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.81 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.735 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.746 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.3 29.42 1.26 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.911 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -82.54 -41.18 19.96 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -80.46 -32.67 37.16 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.117 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -90.32 14.81 11.82 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.081 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -90.35 -38.77 13.12 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.23 75.05 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 112.63 -2.077 . . . . 0.0 106.99 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtp -77.63 -62.58 1.62 Allowed 'General case' 0 C--N 1.355 0.81 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.79 34.41 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.547 2.498 . . . . 0.0 117.261 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -4.76 58.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.27 132.67 51.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.403 HH21 HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.31 171.87 7.2 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.13 152.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.188 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -99.74 117.74 63.07 Favored Pre-proline 0 C--N 1.36 1.05 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.82 147.95 90.31 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.417 2.078 . . . . 0.0 107.99 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.47 115.97 3.65 Favored 'Trans proline' 0 C--N 1.365 1.42 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.1 32.09 1.75 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.547 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.07 -166.37 1.57 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.771 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.263 3.2 p -143.2 170.68 8.19 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.489 -176.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.57 -4.61 13.68 Favored 'Trans proline' 0 C--N 1.37 1.666 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.83 -25.75 61.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.771 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -79.4 -17.53 54.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.668 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 129' ' ' ASP . 5.6 p -83.96 -16.77 42.91 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 118.498 -1.281 . . . . 0.0 109.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.18 -32.92 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.06 -1.23 52.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.236 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.7 t0 -61.32 -65.32 0.71 Allowed 'General case' 0 C--N 1.365 1.264 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.444 ' SD ' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -90.1 9.26 28.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 111.995 -2.366 . . . . 0.0 110.657 -176.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -88.66 -34.19 17.33 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 116.884 -1.927 . . . . 0.0 108.281 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.97 -43.45 10.54 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 124.256 0.973 . . . . 0.0 110.503 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.403 HG23 HH21 ' A' ' 115' ' ' ARG . 44.5 t -66.48 -31.15 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.682 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.09 -33.83 16.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.563 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.066 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 130.82 36.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 123.38 1.562 . . . . 0.0 107.049 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -81.69 95.69 7.3 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 109.952 -3.295 . . . . 0.0 107.886 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.36 109.28 0.01 OUTLIER 'General case' 0 C--N 1.35 0.608 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.21 117.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -98.95 133.42 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 111.55 -2.568 . . . . 0.0 108.301 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -125.2 143.71 50.81 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.976 1.422 . . . . 0.0 107.63 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.29 170.4 42.95 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.443 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.711 11.7 p 99.63 -130.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 130.893 3.677 . . . . 0.0 116.526 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.09 102.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 127.401 2.281 . . . . 0.0 107.618 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.871 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.211 -179.185 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 125.583 2.611 . . . . 0.0 108.077 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp 56.4 15.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 1 CA-C-N 105.725 -5.216 . . . . 0.0 112.049 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.89 -40.07 48.72 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 116.512 -2.075 . . . . 0.0 106.059 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.62 -1.25 37.22 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.787 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -82.32 -34.2 28.67 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 1.2 t -66.57 -29.26 69.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.124 -1.853 . . . . 0.0 110.438 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -42.68 93.01 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.901 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -29.18 64.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.648 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -98.01 15.41 24.17 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.606 -2.543 . . . . 0.0 109.72 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.03 2.91 1.77 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.37 67.87 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.793 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -99.76 156.18 17.24 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 112.603 -1.798 . . . . 0.0 106.169 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.26 140.8 34.65 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 111.327 -2.669 . . . . 0.0 105.85 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 p -99.88 137.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 112.145 -2.298 . . . . 0.0 107.457 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.74 63.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.652 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -81.71 120.92 25.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.436 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.95 -79.47 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.8 -158.38 22.65 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.062 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.37 59.76 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.661 1.219 . . . . 0.0 110.117 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 tp -165.63 124.59 1.66 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 t -96.25 84.72 3.81 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.68 122.98 27.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.404 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.81 -94.63 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.23 -2.259 . . . . 0.0 108.745 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.46 -17.25 19.37 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.813 1.645 . . . . 0.0 111.735 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.92 -48.88 8.3 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.85 0.51 50.65 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 116.58 -2.048 . . . . 0.0 109.001 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 -27.88 7.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.23 -29.03 57.39 Favored 'General case' 0 C--N 1.365 1.27 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.95 6.96 46.79 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -20.93 22.54 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.19 -38.26 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.22 -68.65 0.27 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 112.337 -2.21 . . . . 0.0 110.332 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -64.97 0.95 Allowed 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? 129.69 47.36 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 O-C-N 126.912 2.632 . . . . 0.0 106.933 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.73 108.36 0.73 Allowed 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.67 -82.64 0.2 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.267 -2.242 . . . . 0.0 104.972 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -89.57 142.08 28.0 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.45 144.66 36.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.5 m -134.68 129.31 34.6 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 112.433 -2.167 . . . . 0.0 106.686 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.5 t -99.96 137.04 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 110.042 -3.254 . . . . 0.0 103.451 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -123.14 89.56 3.13 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 10.0 t -165.77 -172.62 2.43 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.555 ' H ' ' HG ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -133.05 42.68 3.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 179.06 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.587 ' HH ' ' HG ' ' A' ' 71' ' ' CYS . 0.1 OUTLIER 81.29 96.02 0.05 OUTLIER 'General case' 0 C--N 1.356 0.873 0 CA-C-N 112.779 -2.01 . . . . 0.0 106.205 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.33 19.85 0.11 Allowed Glycine 0 CA--C 1.538 1.515 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.689 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -109.4 -0.81 18.81 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 160.18 13.18 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -81.56 6.87 13.61 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.455 -1.373 . . . . 0.0 108.263 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -48.2 16.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.31 -25.14 62.29 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.587 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 52.7 t -67.46 -57.88 5.75 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.15 25.55 2.14 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 124.879 1.362 . . . . 0.0 109.295 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -104.63 -32.72 4.08 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.264 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.41 -26.71 24.6 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.5 mmt85 -73.03 -33.38 65.7 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.69 -19.93 47.79 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.659 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -76.42 -20.33 57.19 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 66.5 m -90.15 -43.22 10.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 123.698 1.713 . . . . 0.0 107.434 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.45 1.09 17.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 108.932 -3.758 . . . . 0.0 108.478 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.89 -54.69 5.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.08 39.37 7.81 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 110.686 -2.961 . . . . 0.0 107.114 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -49.22 0.04 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.43 120.28 27.6 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 122.0 28.59 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.13 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.6 81.73 0.04 OUTLIER Glycine 0 C--N 1.348 1.211 0 CA-C-N 112.339 -2.21 . . . . 0.0 109.995 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -111.78 38.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -145.48 114.17 6.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 98.76 3.5 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 90.84 4.62 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.42 93.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 110.294 -3.139 . . . . 0.0 109.696 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.43 118.43 7.84 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 110.181 -3.19 . . . . 0.0 113.912 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.9 -45.1 2.89 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 111.915 -2.143 . . . . 0.0 113.778 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -46.12 129.77 10.04 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 127.743 2.417 . . . . 0.0 107.184 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 60.33 72.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -161.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.312 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.279 17.2 m 61.46 118.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 127.831 2.453 . . . . 0.0 109.482 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 160.07 7.1 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.181 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -152.07 109.57 3.6 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 98.29 -53.01 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -92.73 75.86 4.95 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -83.85 159.92 59.39 Favored Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 112.652 -2.067 . . . . 0.0 105.808 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.34 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.684 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.29 -21.2 64.79 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.724 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.87 -68.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.82 0 O-C-N 124.477 1.111 . . . . 0.0 111.282 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.18 27.41 1.64 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 117.986 -1.486 . . . . 0.0 108.967 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -80.51 -41.25 24.59 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -80.52 -31.87 37.01 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.468 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.3 15.11 12.67 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.42 -40.41 12.07 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.2 78.66 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.316 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 37.6 mtp -77.56 -61.45 1.99 Allowed 'General case' 0 C--N 1.354 0.791 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.52 27.13 0.09 OUTLIER Glycine 0 C--N 1.353 1.493 0 CA-C-N 112.177 -2.283 . . . . 0.0 118.085 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.05 -2.7 58.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.22 128.75 53.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 102.937 -2.986 . . . . 0.0 102.937 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.5 t -140.01 151.66 21.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.63 148.06 34.22 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 102.95 -2.982 . . . . 0.0 102.95 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -70.39 155.75 63.18 Favored 'Trans proline' 0 C--N 1.364 1.356 0 N-CA-C 106.017 -2.339 . . . . 0.0 106.017 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -75.93 118.11 4.92 Favored 'Trans proline' 0 C--N 1.365 1.441 0 N-CA-C 105.08 -2.7 . . . . 0.0 105.08 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.46 56.56 5.03 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.186 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.67 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 13.8 t -88.35 179.1 6.4 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 125.151 2.405 . . . . 0.0 107.501 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.708 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.331 21.4 p -75.87 170.68 14.73 Favored Pre-proline 0 N--CA 1.431 -1.4 1 CA-C-N 106.815 -4.72 . . . . 0.0 104.782 178.123 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.38 -3.19 3.82 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 N-CA-C 105.875 -2.394 . . . . 0.0 105.875 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.73 -12.05 60.32 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 125.927 1.691 . . . . 0.0 109.057 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.708 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -75.63 -28.0 58.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.9 p -87.78 -21.74 24.93 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.483 1.115 . . . . 0.0 110.701 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.6 mt -69.92 -28.87 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.19 58.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.123 -2.308 . . . . 0.0 109.16 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 126' ' ' THR . 7.7 t0 -63.53 -56.43 16.06 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -87.47 1.0 54.72 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 110.854 -2.885 . . . . 0.0 110.311 -177.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -84.37 -47.55 10.59 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 117.302 -1.759 . . . . 0.0 110.079 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.31 -40.49 17.9 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.149 0.906 . . . . 0.0 111.467 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.78 -31.08 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.717 1.261 . . . . 0.0 112.973 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.0 mt -90.11 -33.12 16.39 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.03 -178.678 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.65 -159.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.195 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.59 63.16 0.74 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.267 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.3 p -149.89 110.29 4.21 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.75 109.44 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 111.268 -2.696 . . . . 0.0 104.492 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.96 111.96 23.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.21 148.34 48.67 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.41 -165.27 34.88 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 111.629 -2.532 . . . . 0.0 110.408 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.636 12.4 p 110.68 -113.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 C-N-CA 127.705 2.402 . . . . 0.0 113.091 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.279 3.0 tp 56.06 154.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 129.131 2.972 . . . . 0.0 110.753 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.684 0 CA-C-N 110.485 -3.052 . . . . 0.0 107.269 179.576 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 127.542 3.544 . . . . 0.0 105.376 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER 47.77 44.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.119 2 CA-C-N 103.287 -6.324 . . . . 0.0 109.448 179.104 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.4 -20.39 63.8 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.09 -18.91 65.65 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -71.86 -27.46 62.88 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 p -55.96 -39.52 71.89 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 125.264 1.602 . . . . 0.0 110.55 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -41.27 89.79 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.316 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -21.55 54.77 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 111.606 -2.543 . . . . 0.0 112.431 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -83.67 -3.57 57.87 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.938 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HB3' ' SD ' ' A' ' 130' ' ' MET . . . -126.14 -7.39 6.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.19 71.64 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.359 1.022 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -141.74 143.52 33.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.64 173.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 111.977 -2.374 . . . . 0.0 107.039 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.08 93.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 111.188 -2.733 . . . . 0.0 105.088 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -68.45 117.29 10.02 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.477 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.3 mt -90.1 -41.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.247 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.64 -129.21 5.75 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.41 44.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 113.249 -1.476 . . . . 0.0 109.626 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.4 tp -163.06 109.52 1.17 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.2 t -85.23 95.27 9.12 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -90.3 138.49 31.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.803 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.41 -90.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.856 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.26 -11.17 13.47 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 124.973 1.42 . . . . 0.0 112.786 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -89.18 -46.14 9.03 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 118.348 -1.341 . . . . 0.0 107.475 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -86.88 6.78 30.21 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 117.964 -1.494 . . . . 0.0 108.568 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.28 -29.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.95 -24.5 58.48 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 -4.2 55.42 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 -12.51 38.43 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -38.33 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.41 -65.27 0.7 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 111.823 -2.444 . . . . 0.0 110.356 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -79.94 -47.5 14.92 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.118 -176.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' THR . 3.7 ttmp? 109.8 42.79 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 126.543 2.402 . . . . 0.0 108.357 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.84 120.6 5.46 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 124.485 1.116 . . . . 0.0 108.981 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.73 -66.1 0.96 Allowed 'General case' 0 C--N 1.352 0.708 0 CA-C-N 111.86 -2.427 . . . . 0.0 105.6 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -107.18 148.39 28.93 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.456 1.598 . . . . 0.0 109.35 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.62 148.92 5.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 CA-C-N 109.818 -3.355 . . . . 0.0 104.82 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.42 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 60.9 m -141.73 105.0 4.63 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.69 131.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -110.38 45.35 1.13 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 p -154.06 168.4 26.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.3 tp -74.39 -127.04 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 111.251 -2.704 . . . . 0.0 103.823 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 50.67 1.5 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.95 21.13 47.68 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.549 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -124.09 -31.12 3.39 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.55 166.6 41.49 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.088 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.21 -1.35 32.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 113.581 -1.309 . . . . 0.0 108.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -46.19 18.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.25 -27.12 60.61 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.928 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m -68.99 -50.69 46.71 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -89.53 21.79 3.26 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.569 1.168 . . . . 0.0 109.481 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -27.04 7.75 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.99 -32.28 16.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.27 -1.965 . . . . 0.0 106.473 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -75.55 -22.1 57.34 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.89 -31.67 56.91 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.98 -11.69 60.17 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.497 1.123 . . . . 0.0 109.162 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 73.4 m -90.27 -48.05 7.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 123.239 1.495 . . . . 0.0 107.624 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.296 2.9 p30 -78.27 4.23 13.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 109.672 -3.422 . . . . 0.0 109.233 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.96 -53.38 6.19 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.29 39.79 25.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.084 -2.78 . . . . 0.0 108.042 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.29 -48.58 0.05 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.33 119.94 28.11 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 128.96 34.9 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.49 -1.686 . . . . 0.0 106.506 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.02 59.27 0.01 OUTLIER Glycine 0 C--N 1.347 1.164 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.327 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -8.79 11.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 112.509 -1.846 . . . . 0.0 108.593 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -97.54 129.09 44.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.97 140.68 36.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.27 92.37 2.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.46 93.97 4.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-O 125.118 2.389 . . . . 0.0 110.358 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.48 119.92 8.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 109.895 -3.32 . . . . 0.0 112.453 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.08 -84.04 1.01 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 112.104 -2.048 . . . . 0.0 108.095 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.95 -111.54 0.63 Allowed 'General case' 0 C--N 1.353 0.758 0 CA-C-N 111.79 -2.205 . . . . 0.0 107.63 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.29 126.82 44.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.79 157.44 6.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.74 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 45.28 99.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.918 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.58 152.92 6.11 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 112.091 -2.322 . . . . 0.0 108.895 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -175.83 124.16 0.2 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 86.06 -67.37 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 126.004 2.065 . . . . 0.0 106.369 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.29 134.55 37.93 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -139.03 167.37 19.42 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.75 -145.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.831 1.687 . . . . 0.0 108.549 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.18 -25.06 61.53 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.519 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.13 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 124.768 1.293 . . . . 0.0 111.219 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.35 26.74 1.85 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 117.505 -1.678 . . . . 0.0 109.416 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.03 -42.42 63.2 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -89.98 -24.68 21.18 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 111.676 -2.511 . . . . 0.0 108.411 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -85.77 -13.4 48.34 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -90.57 -20.28 22.79 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.75 74.58 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.2 mtt -87.38 -52.01 5.61 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.97 26.24 1.98 Allowed Glycine 0 C--N 1.356 1.671 0 CA-C-N 112.769 -2.014 . . . . 0.0 117.644 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -4.91 58.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.08 119.54 39.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 179.23 4.16 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.01 151.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 4.8 m-85 -99.63 153.03 37.98 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -65.16 136.57 48.36 Favored 'Trans proline' 0 C--N 1.371 1.722 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.71 110.62 2.97 Favored 'Trans proline' 0 C--N 1.371 1.721 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.94 -103.61 0.4 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 111.647 -2.524 . . . . 0.0 107.561 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -90.27 167.59 12.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.6 p -168.67 70.75 0.77 Allowed Pre-proline 0 C--N 1.349 0.559 0 CA-C-N 113.136 -1.847 . . . . 0.0 106.04 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.27 -84.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 123.264 2.643 . . . . 0.0 109.473 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.25 -19.47 21.76 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.126 2.17 . . . . 0.0 110.683 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -25.43 62.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 124.051 0.844 . . . . 0.0 109.694 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -86.11 -23.4 26.66 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 117.419 -1.712 . . . . 0.0 109.579 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.83 -26.12 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.15 -6.46 56.95 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.011 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 126' ' ' THR . 63.3 t0 -54.22 -66.6 0.37 Allowed 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 30' ' ' ALA . 6.4 mtm -90.36 -6.17 55.34 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 111.343 -2.662 . . . . 0.0 111.755 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.97 -45.33 9.27 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 117.209 -1.796 . . . . 0.0 107.659 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -58.39 -45.8 87.62 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 121.817 0.818 . . . . 0.0 109.168 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.24 -71.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.234 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.5 mt -90.12 55.88 3.24 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.579 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.314 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.651 177.67 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -72.92 172.2 11.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 112.153 -2.294 . . . . 0.0 107.503 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 57.3 pttt -108.1 68.99 0.72 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.654 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.9 p -150.44 109.22 3.85 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.57 136.24 60.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.08 133.42 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 124.502 1.127 . . . . 0.0 108.736 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -116.25 146.77 42.1 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.252 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.2 146.43 17.84 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 112.381 -2.19 . . . . 0.0 109.325 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.25 126.49 75.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 124.96 1.035 . . . . 0.0 110.664 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 tp -152.92 139.91 13.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.99 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 -178.429 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 123.63 1.681 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.307 0.0 OUTLIER 38.82 47.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.777 1 C-N-CA 132.593 4.357 . . . . 0.0 105.786 -175.081 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD23 ' SG ' ' A' ' 59' ' ' CYS . 0.4 OUTLIER -77.63 -26.27 50.41 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 176.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.31 -18.03 65.01 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.39 -1.732 . . . . 0.0 106.584 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.35 -30.77 68.87 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -45.31 -44.33 11.46 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 124.856 1.348 . . . . 0.0 107.962 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -47.97 74.41 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 111.649 -2.523 . . . . 0.0 109.402 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -14.61 58.42 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 112.296 -2.229 . . . . 0.0 113.748 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -75.49 -14.87 60.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.369 1.867 . . . . 0.0 109.781 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.94 19.42 0.59 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 117.445 -1.702 . . . . 0.0 108.216 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.2 28.4 54.35 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 124.182 0.926 . . . . 0.0 112.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -99.73 160.3 14.4 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.43 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 32.3 t30 -89.21 135.62 33.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.248 -2.251 . . . . 0.0 106.373 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.94 170.05 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-N 111.309 -2.678 . . . . 0.0 106.973 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -140.14 106.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 111.557 -2.565 . . . . 0.0 105.446 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.55 123.71 32.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.84 -30.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 -129.24 9.83 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.18 -12.69 8.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 113.353 -1.423 . . . . 0.0 110.002 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.75 86.91 6.8 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -91.44 58.08 3.5 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 112.869 -1.968 . . . . 0.0 105.909 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.5 p -90.03 116.37 28.01 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.385 -3.561 . . . . 0.0 101.385 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -89.96 -54.09 4.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.866 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -62.36 -32.68 73.5 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.143 1.527 . . . . 0.0 110.449 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -79.36 -26.46 42.07 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.94 4.15 42.79 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.541 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.69 -37.35 20.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.064 0 N-CA-C 102.475 -3.158 . . . . 0.0 102.475 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -73.93 -28.68 61.64 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 112.482 -2.145 . . . . 0.0 106.997 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.82 0.54 56.96 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.031 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 -7.67 53.35 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.09 -39.83 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.95 -75.54 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.746 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 p -74.07 -19.28 60.66 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 123.961 0.788 . . . . 0.0 110.471 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 72.47 50.83 0.18 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.99 130.93 35.2 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 125.251 1.594 . . . . 0.0 107.537 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -104.22 -77.12 0.58 Allowed 'General case' 0 C--N 1.364 1.228 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.4 147.66 25.35 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.016 1.448 . . . . 0.0 108.072 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.15 165.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 111.458 -2.61 . . . . 0.0 105.78 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.41 ' SG ' HD23 ' A' ' 23' ' ' LEU . 1.9 p -161.94 158.78 25.73 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.62 168.95 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 69.21 1.05 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 p -174.32 168.48 3.94 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.243 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.73 -105.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 110.732 -2.94 . . . . 0.0 103.203 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -102.68 27.08 7.26 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 112.808 -1.996 . . . . 0.0 106.498 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.74 -9.68 84.92 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.305 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -80.01 -34.66 38.26 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.3 -178.32 49.18 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 113.002 -1.908 . . . . 0.0 112.226 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -77.92 -12.19 59.96 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.152 -2.024 . . . . 0.0 108.644 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -49.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -72.37 -29.44 63.78 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.853 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.43 ' C ' ' H ' ' A' ' 73' ' ' GLY . 82.2 m -65.87 -57.04 8.83 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -88.27 27.46 1.23 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 125.316 1.635 . . . . 0.0 109.944 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -98.21 -30.41 7.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.03 -33.84 16.19 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 111.644 -2.278 . . . . 0.0 107.788 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -24.37 61.06 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.77 -31.42 35.82 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -76.51 -15.09 59.97 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 124.139 0.899 . . . . 0.0 109.479 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.32 -47.04 8.01 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 123.94 1.829 . . . . 0.0 107.293 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.43 -3.58 25.07 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 108.531 -3.94 . . . . 0.0 109.041 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -81.24 -56.65 3.93 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.35 48.93 7.41 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 110.931 -2.85 . . . . 0.0 106.82 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.96 -42.15 0.02 OUTLIER Glycine 0 C--N 1.35 1.335 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.017 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.78 124.95 28.73 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 117.08 15.33 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.73 107.04 0.4 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 112.777 -2.011 . . . . 0.0 109.557 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -157.01 46.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -151.24 119.65 6.42 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.3 149.09 43.83 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 94.59 2.76 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.87 100.07 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 111.209 -2.723 . . . . 0.0 109.732 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.44 81.61 0.38 Allowed Glycine 0 CA--C 1.533 1.178 0 CA-C-N 108.434 -3.985 . . . . 0.0 112.745 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.4 -85.68 0.26 Allowed Glycine 0 C--N 1.351 1.412 0 CA-C-N 112.714 -1.743 . . . . 0.0 109.376 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.6 t30 65.29 -116.15 0.34 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.901 -1.649 . . . . 0.0 106.932 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -104.4 129.34 56.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.42 169.06 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.893 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p 45.63 48.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.812 0 CA-C-N 112.713 -2.039 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 139.03 3.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 112.282 -2.236 . . . . 0.0 108.767 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -161.17 111.52 1.71 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 96.96 -45.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 112.548 -2.115 . . . . 0.0 105.83 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.17 126.54 35.84 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -138.03 160.11 65.72 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.59 -148.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 N-CA-C 107.759 -1.669 . . . . 0.0 107.759 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.48 -20.43 58.79 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.665 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -60.12 -64.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 124.433 1.083 . . . . 0.0 111.429 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.4 18.67 5.04 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 117.009 -1.876 . . . . 0.0 107.965 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.79 -39.08 66.99 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -80.78 -32.16 35.54 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.691 -2.049 . . . . 0.0 106.826 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -91.74 15.03 13.63 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.737 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.7 -41.36 11.33 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.04 74.29 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 112.21 -2.268 . . . . 0.0 107.418 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.3 mtp -82.35 -57.99 3.13 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 27.61 43.32 0.03 OUTLIER Glycine 0 C--N 1.357 1.741 0 C-N-CA 127.401 2.429 . . . . 0.0 117.355 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.8 -2.76 58.82 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -105.01 131.22 52.81 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.475 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.07 169.74 8.53 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 178.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.92 159.41 36.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -99.46 161.39 24.74 Favored Pre-proline 0 N--CA 1.447 -0.615 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.53 158.1 58.67 Favored 'Trans proline' 0 C--N 1.368 1.559 0 N-CA-C 106.873 -2.01 . . . . 0.0 106.873 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.37 122.35 9.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 104.81 -2.804 . . . . 0.0 104.81 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.76 140.88 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 105.905 -2.878 . . . . 0.0 105.905 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 t -75.34 162.05 28.74 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 125.422 2.535 . . . . 0.0 108.164 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.3 p -167.78 113.4 0.62 Allowed Pre-proline 0 N--CA 1.427 -1.595 1 CA-C-N 106.12 -5.036 . . . . 0.0 101.019 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.01 -1.22 11.42 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.234 1.289 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.2 -30.28 67.35 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -16.66 54.41 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.541 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 129' ' ' ASP . 24.1 p -79.04 -25.34 43.2 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 116.67 -2.012 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.52 -26.56 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -3.18 56.31 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.04 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 126' ' ' THR . 38.4 t0 -62.07 -52.76 62.64 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.2 mmt -87.77 -22.85 24.31 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.36 -2.2 . . . . 0.0 110.725 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.92 -12.96 46.12 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.098 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -90.11 -52.9 4.72 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.475 ' HA ' HH21 ' A' ' 115' ' ' ARG . 23.1 t -69.74 -58.88 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.364 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 -14.32 34.12 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 124.431 1.082 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.721 0 C-N-CA 118.542 -1.789 . . . . 0.0 111.461 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.61 177.33 6.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.777 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -105.5 103.58 13.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 110.018 -3.265 . . . . 0.0 109.435 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 172.3 113.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.03 110.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.88 131.23 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.031 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 23' ' ' LEU . 1.5 tm? -125.84 130.25 51.0 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.174 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 171.39 23.72 Favored Glycine 0 C--N 1.36 1.876 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.932 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.28 136.94 13.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.009 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 ' H ' ' HG ' ' A' ' 62' ' ' SER . 4.3 tp -155.01 88.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 115.448 -2.501 . . . . 0.0 110.06 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.439 0 N-CA-C 106.636 -2.585 . . . . 0.0 106.636 179.493 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 126.276 2.941 . . . . 0.0 108.515 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 25' ' ' HIS 0.286 0.0 OUTLIER 31.54 52.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.342 2 CA-C-N 105.157 -5.474 . . . . 0.0 108.155 -178.367 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' CG ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -72.27 -25.91 61.78 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.93 -15.83 63.79 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 14.6 t-80 -72.88 -27.29 61.81 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -50.88 -44.16 59.72 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 125.492 1.745 . . . . 0.0 109.422 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.7 -47.23 80.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.694 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -17.15 61.34 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 111.828 -2.442 . . . . 0.0 113.039 -176.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -18.95 60.64 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 128.372 2.669 . . . . 0.0 109.773 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.43 11.93 2.76 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 124.598 1.186 . . . . 0.0 107.936 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.74 25.79 52.41 Favored Glycine 0 C--N 1.356 1.671 0 O-C-N 124.271 0.982 . . . . 0.0 112.922 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -99.78 145.49 27.64 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.509 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 29.9 m-20 -69.33 137.62 53.09 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 111.846 -2.434 . . . . 0.0 108.099 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.82 172.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 112.117 -2.311 . . . . 0.0 108.886 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.97 73.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 108.786 -3.825 . . . . 0.0 103.71 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -70.11 118.45 12.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.434 HG21 ' H ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -89.66 -90.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.713 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 -177.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' H ' HG21 ' A' ' 37' ' ' ILE . . . 176.8 -112.26 0.38 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -54.59 7.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.055 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.73 153.43 24.16 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.526 -1.67 . . . . 0.0 106.576 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -153.35 59.24 0.76 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.84 158.53 0.48 Allowed 'General case' 0 C--N 1.359 0.99 0 CA-C-N 110.284 -3.144 . . . . 0.0 108.921 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -82.81 -89.24 0.09 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 112.107 -2.315 . . . . 0.0 108.645 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -15.6 31.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 124.736 1.272 . . . . 0.0 112.247 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -90.09 -39.15 13.07 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 118.178 -1.409 . . . . 0.0 107.342 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -81.69 -9.99 59.5 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 117.641 -1.624 . . . . 0.0 109.166 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -28.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -75.66 -28.06 58.58 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.18 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.05 -15.94 30.76 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.22 -38.5 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 104.324 -2.472 . . . . 0.0 104.324 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -62.58 -71.81 0.15 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.24 -2.255 . . . . 0.0 111.087 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -74.59 -38.63 62.57 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.845 0.716 . . . . 0.0 110.629 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 98.28 41.65 0.0 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.49 126.06 20.19 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.266 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -106.08 -79.5 0.56 Allowed 'General case' 0 C--N 1.359 0.989 0 O-C-N 125.337 1.648 . . . . 0.0 106.558 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.45 114.21 20.04 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.91 123.75 54.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.6 m -145.47 145.66 31.18 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-O 123.836 1.779 . . . . 0.0 107.932 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.31 3.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 110.343 -3.117 . . . . 0.0 105.042 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.32 103.75 4.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 117.218 -1.793 . . . . 0.0 107.298 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.455 ' HG ' ' H ' ' A' ' 11' ' ' ILE . 15.4 m 177.78 173.95 0.54 Allowed 'General case' 0 C--N 1.359 1.017 0 O-C-N 126.412 2.32 . . . . 0.0 106.057 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.09 -147.07 0.06 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 111.637 -2.529 . . . . 0.0 104.782 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.42 92.91 7.67 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.95 -29.43 1.82 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-N 111.419 -2.628 . . . . 0.0 108.77 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -86.24 -24.73 25.9 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 112.589 -1.806 . . . . 0.0 107.28 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 178.99 49.36 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.745 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.04 -12.97 59.65 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 111.853 -2.174 . . . . 0.0 108.246 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -76.6 -49.21 24.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -72.82 -16.83 61.6 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.687 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 73' ' ' GLY . 8.8 t -72.14 -42.23 66.23 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -90.09 20.07 4.55 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 124.672 1.232 . . . . 0.0 108.953 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -97.03 -34.24 5.74 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.355 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.28 -23.47 22.3 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 113.04 -1.58 . . . . 0.0 106.845 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -26.92 56.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -81.04 -24.12 38.08 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.512 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -76.55 -17.77 59.04 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 124.113 0.883 . . . . 0.0 108.712 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 86' ' ' ILE . 68.1 m -90.23 -43.9 10.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 123.875 1.798 . . . . 0.0 107.345 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.45 -0.92 21.73 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.701 -3.863 . . . . 0.0 108.624 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.12 -53.6 6.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.65 41.7 11.86 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 110.855 -2.884 . . . . 0.0 107.303 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.44 -47.2 0.03 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.795 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -88.51 118.26 28.03 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 111.89 14.03 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 112.362 -2.199 . . . . 0.0 106.144 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.37 59.26 0.06 OUTLIER Glycine 0 C--N 1.348 1.22 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 78' ' ' CYS . 1.8 mt -91.15 0.75 8.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 CA-C-N 112.29 -1.955 . . . . 0.0 106.973 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -112.83 117.69 32.85 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.16 121.89 15.36 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -104.77 117.23 33.55 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 101.414 -3.55 . . . . 0.0 101.414 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.73 89.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 110.827 -2.897 . . . . 0.0 108.491 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.13 108.39 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 109.52 -3.491 . . . . 0.0 109.417 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.66 -122.74 10.71 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 106.773 -2.531 . . . . 0.0 106.773 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.4 t30 68.97 145.99 0.05 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 125.397 1.293 . . . . 0.0 108.269 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 55.95 81.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 CA-C-N 112.31 -2.223 . . . . 0.0 107.614 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.54 155.64 6.13 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 112.537 -2.12 . . . . 0.0 108.538 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p 46.07 51.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 CA-C-N 112.83 -1.987 . . . . 0.0 111.829 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.83 138.34 5.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.163 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -167.24 140.3 3.5 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.08 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.846 0 O-C-N 125.966 2.041 . . . . 0.0 105.878 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -87.11 114.99 24.2 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -95.15 161.91 26.58 Favored Pre-proline 0 C--N 1.349 0.562 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.738 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.79 -150.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.927 1.751 . . . . 0.0 108.904 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.66 -25.75 62.25 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.19 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.272 0.1 OUTLIER -54.8 -67.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 124.886 1.366 . . . . 0.0 110.457 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.24 20.31 4.48 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 117.951 -1.499 . . . . 0.0 109.149 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.39 -51.78 53.5 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -90.28 -15.59 30.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -89.5 -45.42 9.43 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 117.802 -1.559 . . . . 0.0 108.714 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -77.75 -2.11 34.65 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.723 1.264 . . . . 0.0 107.783 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.53 77.18 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -83.97 -53.95 5.2 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.97 40.51 58.2 Favored Glycine 0 C--N 1.362 1.996 0 O-C-N 124.677 1.236 . . . . 0.0 116.065 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -6.92 59.43 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.09 137.8 42.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.404 ' HB2' ' CE1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -110.35 173.63 6.24 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.12 160.01 26.07 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -99.61 160.54 27.12 Favored Pre-proline 0 C--N 1.355 0.82 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.19 149.01 45.15 Favored 'Trans proline' 0 C--N 1.366 1.46 0 N-CA-C 104.412 -2.957 . . . . 0.0 104.412 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.26 110.05 2.97 Favored 'Trans proline' 0 C--N 1.366 1.489 0 N-CA-C 104.812 -2.803 . . . . 0.0 104.812 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.41 158.65 7.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.716 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.63 143.44 46.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.743 -1.729 . . . . 0.0 106.718 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 p 174.0 100.37 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 110.763 -2.926 . . . . 0.0 106.41 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.29 -2.87 13.13 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.861 1.707 . . . . 0.0 108.155 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.96 -37.9 89.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.352 1.861 . . . . 0.0 107.757 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.82 -21.42 57.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.928 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.494 ' C ' ' H ' ' A' ' 129' ' ' ASP . 2.3 p -80.65 -17.22 51.89 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 117.183 -1.807 . . . . 0.0 110.517 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mt -67.9 -31.53 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.12 2.66 55.05 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.763 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 126' ' ' THR . 61.0 t0 -60.29 -61.69 2.42 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 11.1 mmm -90.1 -15.5 31.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.999 -2.818 . . . . 0.0 111.57 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -87.52 -13.32 43.35 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 118.026 -1.469 . . . . 0.0 108.801 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -90.35 -56.59 3.15 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.56 -51.58 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 112.077 -2.329 . . . . 0.0 114.0 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.4 mp -89.66 -35.93 15.54 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 124.343 1.027 . . . . 0.0 108.604 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.575 0 C-N-CA 119.028 -1.558 . . . . 0.0 112.772 -179.318 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.91 -176.9 3.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 111.862 -2.426 . . . . 0.0 107.969 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -120.43 63.81 0.84 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 110.809 -2.905 . . . . 0.0 108.442 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -149.54 106.42 3.56 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mm -121.87 125.72 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 109.772 -3.377 . . . . 0.0 102.641 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.86 134.05 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 124.766 1.291 . . . . 0.0 109.278 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.18 138.74 54.13 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 113.237 -1.801 . . . . 0.0 107.489 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.5 21.41 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.844 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.5 119.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 118.012 -1.475 . . . . 0.0 110.866 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.434 ' CD1' ' H ' ' A' ' 12' ' ' GLY . 1.9 tp -112.48 179.32 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.434 ' H ' ' CD1' ' A' ' 11' ' ' ILE . . . . . . . . 0 C--N 1.35 1.32 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 123.911 1.815 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.412 42.0 pt 33.91 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.753 1 C-N-CA 132.228 4.211 . . . . 0.0 107.976 -176.034 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mt -74.38 -42.27 59.56 Favored 'General case' 0 C--N 1.373 1.604 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.81 -0.58 16.27 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 112.191 -2.277 . . . . 0.0 108.44 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -79.23 -43.72 23.23 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 117.679 -1.608 . . . . 0.0 107.885 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -19.78 65.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.684 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -43.98 93.05 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.3 -28.18 64.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 110.708 -2.951 . . . . 0.0 111.985 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.57 2.71 50.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 111.836 -2.438 . . . . 0.0 108.823 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.28 4.98 5.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.49 30.38 61.88 Favored Glycine 0 C--N 1.361 1.942 0 O-C-N 124.306 1.004 . . . . 0.0 112.251 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.36 -175.58 2.84 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -106.93 150.73 26.14 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.93 146.21 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 111.047 -2.797 . . . . 0.0 108.115 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.04 82.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 111.317 -2.674 . . . . 0.0 105.333 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -87.83 123.95 33.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -93.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.866 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.55 -120.76 0.58 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.56 10.95 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 113.277 -1.461 . . . . 0.0 110.405 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.22 129.45 34.96 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 t -98.51 41.42 1.14 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-N 113.072 -1.876 . . . . 0.0 107.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.9 p -90.11 80.21 6.35 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -78.32 -36.75 46.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.309 -2.223 . . . . 0.0 108.573 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -35.64 79.79 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.312 1.007 . . . . 0.0 108.619 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.82 -24.8 41.13 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.2 -10.17 59.66 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.73 -33.93 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -74.15 -31.52 62.76 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.368 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.61 -0.5 57.33 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.12 -13.92 34.76 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.88 -41.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.75 -60.49 3.75 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 112.263 -2.244 . . . . 0.0 108.229 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.7 m -60.32 -66.44 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 113.454 -1.703 . . . . 0.0 107.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 102.74 35.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 O-C-N 126.782 2.552 . . . . 0.0 104.294 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.8 107.88 0.1 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 128.457 2.703 . . . . 0.0 109.222 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.88 -42.28 11.95 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.43 144.5 31.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 117.548 -1.661 . . . . 0.0 107.113 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.05 146.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 110.71 -2.95 . . . . 0.0 105.254 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.582 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 9.0 t -150.5 125.88 10.11 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.85 -178.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.852 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.037 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.74 97.12 3.57 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 p 155.93 152.6 0.01 OUTLIER 'General case' 0 C--N 1.356 0.876 0 CA-C-N 112.681 -2.054 . . . . 0.0 106.98 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -65.84 -110.63 0.0 OUTLIER 'General case' 0 C--N 1.36 1.032 0 CA-C-N 111.884 -2.416 . . . . 0.0 105.105 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.94 68.47 2.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.73 55.68 0.76 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 109.63 -3.441 . . . . 0.0 105.016 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -167.14 -28.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 111.044 -2.578 . . . . 0.0 106.977 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.54 -177.21 47.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.029 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -76.61 -3.41 37.55 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.35 -2.425 . . . . 0.0 108.376 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -53.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.0 -22.13 59.72 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 112.561 -2.109 . . . . 0.0 109.111 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.67 -64.24 0.9 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -90.15 27.99 1.51 Allowed 'General case' 0 C--N 1.355 0.807 0 O-C-N 124.717 1.26 . . . . 0.0 109.798 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.63 -40.68 3.81 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.58 -22.77 23.35 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 111.92 -2.14 . . . . 0.0 108.517 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.9 mmt85 -78.71 -26.98 44.9 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.62 -26.74 41.1 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -75.98 -16.75 59.93 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.123 0.889 . . . . 0.0 109.227 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.3 t -90.21 -46.26 8.55 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 123.948 1.832 . . . . 0.0 107.319 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.15 -4.94 28.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 108.536 -3.938 . . . . 0.0 109.002 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.22 -56.29 4.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.0 47.81 4.11 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 110.881 -2.872 . . . . 0.0 106.527 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.54 -42.14 0.02 OUTLIER Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.654 -2.067 . . . . 0.0 109.9 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.34 122.94 27.55 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 128.3 34.8 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.26 113.6 1.55 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.221 -2.263 . . . . 0.0 108.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -146.41 35.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -141.15 112.98 7.72 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 103.527 -2.768 . . . . 0.0 103.527 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.52 106.39 8.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 85.39 3.09 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 100.613 -3.847 . . . . 0.0 100.613 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.26 101.5 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 126.221 2.915 . . . . 0.0 110.085 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.27 116.55 4.77 Favored Glycine 0 C--N 1.343 0.961 1 CA-C-N 108.239 -4.073 . . . . 0.0 108.489 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.64 -84.91 0.44 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 105.738 -2.945 . . . . 0.0 105.738 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t30 72.24 -84.34 0.03 OUTLIER 'General case' 0 C--N 1.357 0.935 0 CA-C-N 112.879 -1.66 . . . . 0.0 107.681 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.37 135.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.34 158.06 4.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.57 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 42.68 75.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.757 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.47 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.2 135.14 1.94 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.196 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -174.16 110.73 0.16 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 91.45 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.355 0.841 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -94.14 135.73 35.19 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -143.06 162.94 40.73 Favored Pre-proline 0 C--N 1.35 0.605 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.27 -150.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.478 -1.778 . . . . 0.0 107.478 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.11 -22.26 63.03 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.216 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 p -58.13 -69.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 O-C-N 124.483 1.114 . . . . 0.0 111.214 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -90.17 24.92 2.33 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.501 -1.68 . . . . 0.0 108.209 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -77.32 -41.03 42.13 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.43 -32.55 42.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 112.472 -2.149 . . . . 0.0 106.41 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -92.78 16.68 11.82 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.678 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -39.82 12.33 Favored 'General case' 0 C--N 1.361 1.096 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.29 75.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.028 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtp -78.96 -60.77 2.25 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.32 37.34 0.02 OUTLIER Glycine 0 C--N 1.356 1.643 0 C-N-CA 128.056 2.741 . . . . 0.0 117.642 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.73 -0.23 57.41 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.18 134.51 48.17 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.23 176.54 5.01 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.01 161.61 25.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.792 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.582 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 5.6 m-85 -99.88 154.9 37.0 Favored Pre-proline 0 C--N 1.355 0.842 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.964 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.49 162.21 38.53 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 106.84 -2.023 . . . . 0.0 106.84 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.53 124.9 10.18 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 105.201 -2.653 . . . . 0.0 105.201 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.13 137.05 9.46 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -73.85 154.34 39.51 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 125.584 2.612 . . . . 0.0 107.492 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 p -166.11 108.67 0.71 Allowed Pre-proline 0 N--CA 1.426 -1.642 1 CA-C-N 105.819 -5.173 . . . . 0.0 100.362 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -78.61 0.31 10.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.3 -38.35 87.53 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.945 1.698 . . . . 0.0 107.631 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -24.29 59.96 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.985 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.7 p -84.64 -19.84 32.28 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.957 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -64.69 -30.17 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.49 -7.65 59.61 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 111.712 -2.495 . . . . 0.0 108.798 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 126' ' ' THR . 25.4 t0 -53.7 -72.34 0.06 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-O 122.116 0.96 . . . . 0.0 108.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 mmt -86.67 -6.07 58.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 112.302 -2.226 . . . . 0.0 110.336 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.14 -66.01 0.96 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.834 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -48.02 -44.69 31.19 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.34 1.056 . . . . 0.0 111.021 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.425 ' HA ' HH21 ' A' ' 115' ' ' ARG . 25.6 t -65.37 -65.57 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.8 mt -90.52 55.76 3.11 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.318 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.59 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -73.05 -162.43 0.11 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 111.689 -2.505 . . . . 0.0 107.505 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -149.69 99.74 2.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.188 -1.824 . . . . 0.0 106.253 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.62 100.33 0.01 OUTLIER 'General case' 0 C--N 1.355 0.845 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.8 116.43 48.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.43 112.25 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 111.621 -2.536 . . . . 0.0 109.113 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.16 134.44 51.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.449 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . 169.86 168.03 31.18 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.734 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.551 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 167.57 -121.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.662 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.513 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -142.92 -168.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.094 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.221 -177.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 2.103 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.156 -179.265 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 125.14 2.4 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER 34.67 54.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.605 1 CA-C-N 106.871 -4.695 . . . . 0.0 106.437 -175.847 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.9 -21.78 65.99 Favored 'General case' 0 C--N 1.377 1.773 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -67.57 -20.47 65.39 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 116.514 -2.075 . . . . 0.0 107.299 176.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -66.02 -29.96 70.41 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.48 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 37.0 t -67.19 -18.38 65.23 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.608 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.496 ' CE2' ' CB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -56.73 -47.1 80.76 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.07 69.11 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 110.482 -3.054 . . . . 0.0 112.763 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -84.72 7.53 20.2 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 111.559 -2.564 . . . . 0.0 108.632 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.78 -0.99 5.39 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.61 28.88 68.5 Favored Glycine 0 C--N 1.36 1.902 0 O-C-N 124.139 0.899 . . . . 0.0 111.377 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -105.38 -168.01 1.4 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 113.342 -1.429 . . . . 0.0 107.605 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.56 149.69 21.02 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.093 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.496 ' CB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.8 124.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 108.871 -3.786 . . . . 0.0 108.79 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.33 132.93 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 110.896 -2.865 . . . . 0.0 105.429 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -139.02 133.19 31.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.55 -20.15 6.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.567 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.68 -123.36 7.9 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.14 113.38 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-O 122.324 1.059 . . . . 0.0 109.28 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tt -175.25 137.79 0.4 Allowed 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 t -94.54 39.55 1.09 Allowed 'General case' 0 C--N 1.354 0.776 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.55 91.52 8.47 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -90.02 -58.54 2.47 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.61 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.93 -20.92 60.08 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 124.771 1.294 . . . . 0.0 112.04 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.95 -38.89 14.14 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.878 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -89.15 12.65 15.2 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.907 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.97 -34.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.73 -27.93 62.34 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.41 -16.65 41.95 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.63 -7.6 58.65 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.2 -43.06 18.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -60.61 -64.0 1.1 Allowed 'General case' 0 C--N 1.354 0.802 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.492 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.84 82.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.4 tttp 84.38 54.47 0.01 OUTLIER 'General case' 0 C--N 1.345 0.386 0 CA-C-N 112.022 -2.354 . . . . 0.0 105.02 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 124.51 23.75 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.112 -2.313 . . . . 0.0 107.489 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.99 -84.09 0.15 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.82 145.62 26.78 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.62 142.37 43.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.1 m -129.56 131.92 46.69 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 112.18 -2.282 . . . . 0.0 105.815 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.32 133.17 63.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.727 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.551 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -110.32 90.77 3.42 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 123.979 1.847 . . . . 0.0 107.016 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.589 ' HG ' ' H ' ' A' ' 65' ' ' GLY . 31.2 t -131.12 176.93 7.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.257 -2.701 . . . . 0.0 106.544 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 52.55 1.02 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 110.405 -3.089 . . . . 0.0 105.906 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.9 49.01 6.22 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.602 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.589 ' H ' ' HG ' ' A' ' 62' ' ' SER . . . -129.2 -0.07 5.96 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.868 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.13 -2.86 49.06 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.67 177.56 8.58 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.35 1.031 . . . . 0.0 111.652 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.17 25.58 2.14 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 112.871 -1.665 . . . . 0.0 108.188 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -52.68 10.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -71.81 -26.86 62.57 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 112.703 -2.044 . . . . 0.0 107.26 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 t -67.78 -58.22 4.98 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -90.07 30.13 1.13 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 124.48 1.112 . . . . 0.0 109.426 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.49 -37.79 3.91 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -90.01 -23.77 21.4 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.625 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -29.6 57.26 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.93 -28.21 55.15 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -16.82 60.62 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 124.155 0.909 . . . . 0.0 109.368 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 39.8 t -90.24 -46.85 8.15 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.847 1.784 . . . . 0.0 107.518 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -75.41 2.34 11.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 108.715 -3.857 . . . . 0.0 109.11 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.72 -55.59 3.9 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 44.78 7.93 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 110.958 -2.837 . . . . 0.0 106.798 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.01 -43.7 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.392 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.06 121.11 25.11 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 140.75 32.65 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 113.302 -1.772 . . . . 0.0 106.412 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.74 71.16 0.28 Allowed Glycine 0 C--N 1.351 1.364 0 CA-C-N 112.633 -2.076 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 tt -103.73 35.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -128.01 118.1 22.91 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -140.29 151.93 45.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.592 -2.094 . . . . 0.0 105.73 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 106.24 5.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 100.654 -3.832 . . . . 0.0 100.654 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.87 93.58 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 125.114 2.388 . . . . 0.0 110.164 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.69 118.47 13.5 Favored Glycine 0 CA--C 1.537 1.453 1 CA-C-N 107.975 -4.193 . . . . 0.0 111.137 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.82 -92.39 1.62 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 72.75 -142.6 0.04 OUTLIER 'General case' 0 C--N 1.356 0.885 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.68 148.71 4.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.31 -164.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 CA-C-N 112.548 -2.115 . . . . 0.0 108.423 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 p 41.77 74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.04 33.79 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 112.068 -2.333 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -159.93 -46.72 0.05 Allowed 'General case' 0 C--N 1.347 0.473 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -129.7 -44.27 1.21 Allowed 'General case' 0 C--N 1.349 0.549 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.97 95.58 9.54 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -103.0 164.24 15.93 Favored Pre-proline 0 C--N 1.35 0.624 0 CA-C-N 112.483 -2.144 . . . . 0.0 105.36 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.08 -152.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.784 1.656 . . . . 0.0 108.792 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.33 -25.54 64.26 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 113.431 -1.713 . . . . 0.0 108.456 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 p -53.53 -74.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 O-C-N 124.912 1.382 . . . . 0.0 110.749 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -90.07 28.71 1.34 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.5 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -76.62 -45.33 30.53 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -80.58 -31.38 36.79 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 111.495 -2.593 . . . . 0.0 107.381 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.3 10.7 21.31 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 118.584 -1.247 . . . . 0.0 109.125 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.31 14.12 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -33.93 74.39 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.652 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 55.7 mtp -81.29 -60.49 2.26 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 34.68 37.55 0.1 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 112.31 -2.223 . . . . 0.0 117.243 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -79.84 -15.47 57.33 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -101.63 138.8 38.14 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.556 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 178.79 4.28 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.19 156.89 24.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.53 114.24 65.46 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 101.785 -3.413 . . . . 0.0 101.785 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -55.34 157.89 13.54 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.418 2.745 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.96 121.03 8.17 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 105.918 -2.378 . . . . 0.0 105.918 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 65.91 0.96 Allowed Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.388 -2.187 . . . . 0.0 107.901 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.4 p -82.12 -151.99 0.1 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.424 -2.388 . . . . 0.0 107.173 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.772 ' HG ' ' HG1' ' A' ' 125' ' ' THR . 2.2 p 176.97 166.33 0.47 Allowed Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 110.805 -2.907 . . . . 0.0 104.243 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.61 -5.15 15.27 Favored 'Trans proline' 0 C--N 1.365 1.424 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.48 -23.87 53.81 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.772 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -77.15 -17.82 58.32 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.753 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.0 p -87.19 -20.79 26.48 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.914 0.758 . . . . 0.0 110.613 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.89 -27.2 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.66 -1.01 57.61 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.606 -2.088 . . . . 0.0 109.264 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 126' ' ' THR . 19.0 t0 -69.75 -68.03 0.44 Allowed 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.48 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 1.9 mpt? -74.45 -13.65 60.73 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.803 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -90.04 -43.45 10.5 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.999 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.39 -31.74 70.65 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 121.053 0.454 . . . . 0.0 109.789 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.09 -77.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.327 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.49 63.06 5.44 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.643 1.215 . . . . 0.0 108.839 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.329 178.111 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -70.82 145.38 50.37 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.53 95.68 5.9 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 111.197 -2.729 . . . . 0.0 108.413 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.41 112.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 132.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.7 141.05 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 110.974 -2.83 . . . . 0.0 110.202 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -125.31 167.23 15.19 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 112.272 -2.24 . . . . 0.0 105.728 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.25 -172.25 44.71 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 126.428 2.33 . . . . 0.0 113.42 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.423 ' CG1' ' H ' ' A' ' 11' ' ' ILE 0.455 13.5 p 69.53 -125.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 110.139 -3.031 . . . . 0.0 114.714 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 4.2 tp 56.71 113.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 128.744 2.817 . . . . 0.0 109.018 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.366 2.197 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.457 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 124.947 2.308 . . . . 0.0 104.995 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.318 38.7 mt 93.61 9.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 1 CA-C-N 107.101 -4.59 . . . . 0.0 112.325 175.518 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.259 0.2 OUTLIER -74.85 -30.46 61.36 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 114.472 -2.891 . . . . 0.0 106.378 176.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.17 -13.13 59.99 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 117.406 -1.717 . . . . 0.0 107.05 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -77.31 -31.89 54.97 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.976 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -74.33 -18.76 60.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.792 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -39.44 81.56 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 118.139 -1.424 . . . . 0.0 107.472 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -31.0 64.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 110.425 -3.08 . . . . 0.0 112.246 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -88.05 0.29 56.14 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 112.077 -2.329 . . . . 0.0 109.989 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.33 -8.26 11.67 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.01 23.64 69.67 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -99.9 170.59 8.42 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -80.86 151.12 28.81 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 111.232 -2.713 . . . . 0.0 105.399 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.88 135.83 33.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 CA-C-N 111.703 -2.499 . . . . 0.0 107.469 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.66 92.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 111.593 -2.549 . . . . 0.0 106.172 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -96.55 126.17 41.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.292 -1.776 . . . . 0.0 107.198 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -98.72 -24.59 4.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 O-C-N 124.778 1.299 . . . . 0.0 107.655 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.78 -151.33 19.51 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.64 14.1 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 114.423 -0.889 . . . . 0.0 111.441 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.89 102.77 6.2 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 p -84.89 83.07 8.17 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 125.05 22.51 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 109.809 -3.36 . . . . 0.0 106.969 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.95 -93.59 0.07 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.987 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.66 -18.45 53.76 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 124.8 1.313 . . . . 0.0 111.462 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.63 -43.24 12.79 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -86.52 4.48 39.74 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 116.862 -1.935 . . . . 0.0 108.982 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -26.89 6.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.16 -30.21 49.04 Favored 'General case' 0 C--N 1.365 1.25 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.26 10.16 33.11 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.77 20.03 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.1 -37.31 76.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.31 -71.75 0.14 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.449 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -61.54 1.86 Allowed 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.512 0.508 . . . . 0.0 110.362 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? 99.87 68.9 0.0 OUTLIER 'General case' 0 C--N 1.348 0.509 0 O-C-N 126.248 2.217 . . . . 0.0 106.654 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.42 116.09 2.66 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.331 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -77.2 -48.55 17.3 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.39 150.49 35.78 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.96 170.63 5.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -153.21 109.02 3.29 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.773 -2.012 . . . . 0.0 105.814 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.86 120.05 48.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.84 113.01 25.82 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 117.851 -1.54 . . . . 0.0 107.685 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 t 150.74 162.83 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.76 74.4 6.59 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 111.517 -2.583 . . . . 0.0 106.682 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.477 ' HH ' ' HG ' ' A' ' 71' ' ' CYS . 0.2 OUTLIER 72.66 49.65 0.18 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 112.558 -2.11 . . . . 0.0 107.805 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.22 2.99 72.16 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.996 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -88.13 -20.49 25.57 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.661 -1.27 . . . . 0.0 109.463 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.04 174.35 40.25 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.58 6.29 9.04 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.85 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -67.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.13 -20.7 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.553 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.477 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 19.4 t -72.94 -56.26 5.41 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -90.07 21.08 3.87 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.617 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -103.44 -27.07 6.6 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.867 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.67 -27.67 25.2 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HG3' HH11 ' A' ' 75' ' ' ARG . 3.0 mmt85 -72.02 -32.38 67.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.28 -23.54 47.19 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 113.624 -1.626 . . . . 0.0 108.391 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -77.11 -16.5 59.16 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 83.7 m -90.24 -42.98 10.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.831 1.777 . . . . 0.0 107.282 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.65 -1.06 22.88 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 108.679 -3.873 . . . . 0.0 108.654 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.27 -54.5 5.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 59.94 40.88 18.47 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 110.882 -2.872 . . . . 0.0 107.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.78 -51.25 0.04 OUTLIER Glycine 0 C--N 1.35 1.308 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 120.19 32.63 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 126.59 31.14 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.153 -1.84 . . . . 0.0 106.29 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.61 56.19 0.04 OUTLIER Glycine 0 C--N 1.345 1.062 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.195 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -99.94 32.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 CA-C-N 112.203 -1.998 . . . . 0.0 106.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -144.36 112.56 6.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 97.35 3.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.67 85.25 3.08 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.45 98.45 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 109.881 -3.327 . . . . 0.0 110.397 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.31 132.92 42.25 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 109.116 -3.675 . . . . 0.0 113.348 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.96 -74.21 0.95 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 111.869 -2.165 . . . . 0.0 109.765 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 18.75 103.67 0.0 OUTLIER 'General case' 0 C--N 1.354 0.769 1 C-N-CA 131.763 4.025 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 58.44 120.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 112.334 -2.212 . . . . 0.0 108.478 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.49 162.5 4.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 112.102 -2.317 . . . . 0.0 108.58 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 p 41.3 69.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 CA-C-N 112.432 -2.167 . . . . 0.0 112.715 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.36 128.96 1.06 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.365 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -157.61 100.0 1.76 Allowed 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 96.49 -51.77 0.01 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -85.68 99.13 11.1 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -113.5 160.47 31.48 Favored Pre-proline 0 C--N 1.351 0.646 0 CA-C-N 112.694 -2.048 . . . . 0.0 106.122 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.58 -155.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 N-CA-C 106.456 -2.171 . . . . 0.0 106.456 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.38 -20.91 62.92 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.688 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -60.01 -69.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.776 0 O-C-N 124.437 1.086 . . . . 0.0 111.621 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.15 27.01 1.72 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 117.688 -1.605 . . . . 0.0 109.3 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -79.92 -42.36 24.25 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.48 -31.79 42.39 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 112.314 -2.221 . . . . 0.0 106.683 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -90.87 14.29 14.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.214 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -90.41 -37.37 14.01 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.78 75.55 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.84 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 29.9 mtp -76.9 -63.51 1.34 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 35.5 31.29 0.02 OUTLIER Glycine 0 C--N 1.355 1.635 0 C-N-CA 127.135 2.302 . . . . 0.0 117.496 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -7.19 59.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -105.25 128.63 53.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 176.91 4.87 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.23 158.47 32.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.17 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 152.62 37.87 Favored Pre-proline 0 C--N 1.358 0.946 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.43 147.89 83.26 Favored 'Trans proline' 0 C--N 1.369 1.654 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.78 114.5 3.2 Favored 'Trans proline' 0 C--N 1.364 1.373 0 N-CA-C 104.011 -3.111 . . . . 0.0 104.011 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.29 42.77 6.1 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.499 -1.682 . . . . 0.0 110.389 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.678 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 7.5 t -90.17 -179.08 5.57 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 125.174 2.416 . . . . 0.0 106.457 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.725 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.357 19.7 p -82.39 170.78 13.63 Favored Pre-proline 0 N--CA 1.426 -1.668 1 CA-C-N 106.806 -4.725 . . . . 0.0 106.031 179.078 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -92.06 -0.06 4.23 Favored 'Trans proline' 0 CA--C 1.554 1.499 0 N-CA-C 104.586 -2.89 . . . . 0.0 104.586 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.97 -16.1 60.65 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.679 1.192 . . . . 0.0 108.284 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.725 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -76.72 -27.75 55.57 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 129' ' ' ASP . 35.6 p -79.83 -23.21 42.17 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.012 -1.475 . . . . 0.0 109.817 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -68.55 -30.34 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.68 -5.14 58.7 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 112.134 -2.303 . . . . 0.0 108.796 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.4 t0 -59.85 -58.56 8.03 Favored 'General case' 0 C--N 1.367 1.347 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -88.29 1.61 54.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.362 -2.199 . . . . 0.0 110.156 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -81.04 -48.35 12.32 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 117.151 -1.82 . . . . 0.0 109.866 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.76 -31.49 19.61 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.235 0.96 . . . . 0.0 111.928 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.25 -26.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.105 0.878 . . . . 0.0 112.379 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -89.21 -36.85 15.41 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.641 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.033 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -70.93 145.94 49.82 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.938 1.351 . . . . 0.0 107.76 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.61 95.85 6.67 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.938 -2.847 . . . . 0.0 108.313 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 172.29 111.51 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.08 122.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.3 147.16 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 110.546 -3.025 . . . . 0.0 110.163 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.13 149.21 48.1 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.1 155.41 26.15 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 125.762 1.914 . . . . 0.0 112.554 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.704 13.6 p 84.94 -127.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 130.406 3.483 . . . . 0.0 117.03 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.316 2.0 tp 72.78 115.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 128.443 2.697 . . . . 0.0 106.382 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 2.286 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.002 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 122.961 1.362 . . . . 0.0 107.68 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 3.35 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 111.502 -2.59 . . . . 0.0 111.357 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -38.58 18.16 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 116.573 -2.051 . . . . 0.0 107.664 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.98 -11.24 60.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 117.489 -1.685 . . . . 0.0 106.478 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -80.78 -38.56 28.3 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.5 m -71.0 -14.84 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 112.242 -2.254 . . . . 0.0 109.903 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -42.03 73.21 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -31.61 66.59 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 110.188 -3.187 . . . . 0.0 112.462 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -87.63 -1.76 58.17 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 111.971 -2.377 . . . . 0.0 110.016 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.72 -10.32 14.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.1 70.76 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -99.88 168.47 9.86 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -78.22 148.74 33.85 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 111.178 -2.737 . . . . 0.0 105.766 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.88 132.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.579 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.85 74.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 111.481 -2.599 . . . . 0.0 105.444 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.09 122.98 31.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.472 -2.149 . . . . 0.0 107.622 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.39 -27.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.71 -141.51 15.58 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.99 -13.67 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.237 -0.982 . . . . 0.0 110.278 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.3 98.89 11.99 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -82.68 80.76 8.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.36 118.15 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 110.883 -2.872 . . . . 0.0 105.387 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.86 -87.37 0.18 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.585 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.11 -18.63 63.63 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 124.63 1.206 . . . . 0.0 110.563 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.52 -41.8 14.99 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -86.47 4.88 37.82 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 116.898 -1.921 . . . . 0.0 108.877 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.37 -26.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -78.65 -31.17 46.68 Favored 'General case' 0 C--N 1.365 1.279 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.88 10.79 29.61 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.419 ' CB ' ' HZ2' ' A' ' 77' ' ' LYS . . . -90.11 -28.0 19.27 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.55 -37.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.87 -71.73 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 112.387 -2.188 . . . . 0.0 110.234 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -63.96 1.13 Allowed 'General case' 0 C--N 1.362 1.148 0 O-C-N 123.491 0.494 . . . . 0.0 110.193 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 101.25 71.14 0.0 OUTLIER 'General case' 0 C--N 1.346 0.444 0 O-C-N 126.4 2.312 . . . . 0.0 106.467 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 122.0 10.87 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.433 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -95.19 -59.41 1.9 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.79 124.83 40.59 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mt -95.79 167.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.2 m -148.98 120.82 8.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 111.918 -2.401 . . . . 0.0 106.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -99.88 133.38 43.0 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -119.66 96.47 5.21 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t 147.57 161.72 0.0 OUTLIER 'General case' 0 C--N 1.354 0.789 0 O-C-N 126.293 2.246 . . . . 0.0 106.031 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.37 77.57 8.88 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 111.279 -2.691 . . . . 0.0 106.527 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.819 -1.992 . . . . 0.0 107.607 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.74 57.69 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.897 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -92.57 4.32 53.81 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 113.444 -1.378 . . . . 0.0 109.357 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.31 -167.53 35.95 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.721 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.11 21.08 3.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 112.498 -1.851 . . . . 0.0 108.072 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -75.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.25 -24.49 62.19 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 112.472 -2.149 . . . . 0.0 108.904 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.48 -49.4 22.36 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -90.02 16.11 8.9 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.554 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.77 -23.61 11.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.149 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.94 -25.41 20.93 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 75' ' ' ARG . 2.3 mmt85 -71.81 -30.49 65.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -79.51 -23.67 42.77 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.187 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HZ2' ' CB ' ' A' ' 50' ' ' ALA . 43.6 tttp -77.64 -12.8 60.0 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.801 0.84 . . . . 0.0 108.904 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.0 m -90.24 -42.91 10.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.923 1.82 . . . . 0.0 106.661 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.43 -3.56 31.31 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 108.527 -3.942 . . . . 0.0 108.741 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.5 -54.58 5.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.71 40.43 23.25 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 111.125 -2.761 . . . . 0.0 107.688 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.75 -52.35 0.05 OUTLIER Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -94.46 122.55 37.14 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 134.89 38.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.13 54.97 0.02 OUTLIER Glycine 0 C--N 1.347 1.14 0 CA-C-N 112.36 -2.2 . . . . 0.0 109.208 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.5 -33.41 11.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.389 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -80.92 117.53 21.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.09 100.22 3.86 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.66 92.76 5.49 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.21 97.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 110.298 -3.137 . . . . 0.0 110.64 -174.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.57 134.74 30.63 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 110.027 -3.261 . . . . 0.0 113.02 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.59 -80.67 1.37 Allowed Glycine 0 C--N 1.354 1.546 0 CA-C-N 111.691 -2.255 . . . . 0.0 108.492 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 21.56 94.06 0.01 OUTLIER 'General case' 0 C--N 1.354 0.767 0 C-N-CA 131.399 3.88 . . . . 0.0 110.171 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt 76.19 131.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.94 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.03 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 CA-C-N 112.313 -2.221 . . . . 0.0 108.103 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p 35.22 63.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 112.241 -2.254 . . . . 0.0 112.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.36 147.55 12.61 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.643 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -175.27 107.99 0.1 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 93.42 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.356 0.888 0 O-C-N 126.137 2.148 . . . . 0.0 105.429 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -87.69 107.51 18.66 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -116.47 163.34 22.45 Favored Pre-proline 0 C--N 1.351 0.651 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.16 -151.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.763 1.642 . . . . 0.0 107.976 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.07 -20.13 57.99 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.523 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -67.69 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.721 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.23 25.86 2.08 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 117.199 -1.8 . . . . 0.0 109.41 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.07 -41.23 26.02 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -78.32 -31.79 48.94 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 112.512 -2.131 . . . . 0.0 106.256 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -92.85 17.02 11.18 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.294 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -90.36 -38.97 12.97 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.19 80.1 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.915 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 12.3 mtp -74.22 -65.29 0.86 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.49 27.57 0.09 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 112.127 -2.306 . . . . 0.0 117.295 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.32 -5.24 58.46 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.12 132.59 51.15 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.75 6.68 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.08 157.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.44 147.68 33.66 Favored Pre-proline 0 C--N 1.359 0.982 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.56 145.06 81.14 Favored 'Trans proline' 0 C--N 1.371 1.723 0 N-CA-C 107.451 -1.788 . . . . 0.0 107.451 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -79.97 111.97 2.78 Favored 'Trans proline' 0 C--N 1.364 1.35 0 N-CA-C 103.552 -3.288 . . . . 0.0 103.552 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.16 42.14 5.04 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 113.47 -1.695 . . . . 0.0 110.478 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.628 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 12.5 t -90.12 -179.15 5.6 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 124.875 2.274 . . . . 0.0 106.644 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.72 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.335 22.3 p -78.73 173.43 7.71 Favored Pre-proline 0 N--CA 1.431 -1.394 1 CA-C-N 107.297 -4.501 . . . . 0.0 105.666 178.797 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -93.75 -4.6 2.82 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 105.198 -2.655 . . . . 0.0 105.198 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.33 -10.68 60.0 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.717 1.607 . . . . 0.0 108.3 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.72 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -75.27 -30.55 60.49 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 129' ' ' ASP . 36.3 p -83.66 -25.66 30.54 Favored 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.46 1.1 . . . . 0.0 110.069 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.8 -28.61 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 103.242 -2.874 . . . . 0.0 103.242 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.35 58.39 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.145 -2.298 . . . . 0.0 108.609 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 126' ' ' THR . 54.7 t0 -61.74 -53.75 51.76 Favored 'General case' 0 C--N 1.366 1.325 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -87.43 -2.61 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 111.956 -2.384 . . . . 0.0 110.168 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -81.32 -49.69 10.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 117.15 -1.82 . . . . 0.0 110.223 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.16 -36.36 21.11 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 124.161 0.913 . . . . 0.0 112.148 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.59 -29.71 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.767 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.09 -39.91 18.95 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.571 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.292 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.4 156.58 16.42 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 124.429 2.061 . . . . 0.0 108.404 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.96 94.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 107.999 -4.182 . . . . 0.0 108.757 -178.483 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.26 106.53 0.02 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.65 111.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 m -89.72 145.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 CA-C-O 123.198 1.475 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.34 111.43 15.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 110.081 -3.236 . . . . 0.0 104.034 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . -160.83 141.61 7.5 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.854 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 11' ' ' ILE . 2.7 p 171.26 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.034 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.622 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 118.97 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.688 0 O-C-N 125.916 2.01 . . . . 0.0 105.879 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.509 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.541 179.746 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 125.696 2.665 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.433 0.1 OUTLIER 45.12 39.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.652 1 CA-C-N 107.405 -4.452 . . . . 0.0 110.181 178.463 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -37.18 63.38 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.74 -9.76 57.98 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 112.019 -2.355 . . . . 0.0 107.268 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -87.11 -7.68 57.79 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 m -59.58 -41.33 90.01 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.95 -42.69 98.73 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 110.013 -3.267 . . . . 0.0 109.137 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -82.38 -9.53 59.42 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.82 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.496 ' HB3' ' SD ' ' A' ' 130' ' ' MET . 0.6 OUTLIER -68.2 -42.03 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.556 1.142 . . . . 0.0 108.664 -177.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.82 39.43 0.06 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.0 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.7 27.78 64.51 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.122 -0.944 . . . . 0.0 114.571 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.87 92.01 5.09 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -35.57 141.33 0.08 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 129.757 3.223 . . . . 0.0 109.213 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.45 136.42 58.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 111.898 -2.41 . . . . 0.0 106.643 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.3 t -102.31 102.7 13.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.004 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -77.71 114.62 16.74 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tt -98.82 -3.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 112.085 -2.325 . . . . 0.0 108.161 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.01 -100.61 2.23 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 123.924 0.765 . . . . 0.0 113.75 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.08 -31.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-N 113.223 -1.489 . . . . 0.0 111.876 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -91.83 111.85 23.54 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -101.5 80.26 2.05 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.6 140.84 58.56 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.928 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.23 -82.6 0.27 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.359 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.05 -21.18 61.07 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.543 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.25 -34.78 14.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.525 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.01 -8.54 58.67 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 116.864 -1.934 . . . . 0.0 109.686 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.75 -26.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -76.67 -29.77 56.5 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.55 2.04 56.16 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.122 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.64 -20.32 26.51 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 mt -74.3 -39.91 49.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.77 -68.03 0.36 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.471 -2.149 . . . . 0.0 110.144 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -63.78 1.01 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 123.779 0.674 . . . . 0.0 109.713 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.2 tttp 111.62 50.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.61 109.76 0.34 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-N 112.177 -2.283 . . . . 0.0 108.782 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.38 -42.95 19.71 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -151.65 160.35 43.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 117.383 -1.727 . . . . 0.0 107.682 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 mm -122.93 139.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 CA-C-N 111.308 -2.678 . . . . 0.0 106.179 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.42 ' SG ' ' CD1' ' A' ' 57' ' ' LEU . 71.5 m -136.85 124.15 21.89 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.51 -2.132 . . . . 0.0 105.386 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.14 135.24 52.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-N 112.592 -2.095 . . . . 0.0 105.532 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.53 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -107.95 106.54 16.84 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 117.37 -1.732 . . . . 0.0 109.662 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 m 131.42 -177.0 0.0 OUTLIER 'General case' 0 C--N 1.352 0.674 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.85 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.648 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -66.0 97.67 0.38 Allowed 'General case' 0 C--N 1.36 1.046 0 CA-C-N 113.749 -1.568 . . . . 0.0 107.187 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.04 -28.27 3.42 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 111.12 -2.764 . . . . 0.0 107.411 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -84.62 -32.02 23.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 111.67 -2.265 . . . . 0.0 106.432 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.46 178.76 46.75 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.081 -1.56 . . . . 0.0 108.529 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mm -80.09 -48.56 20.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -71.97 -20.63 61.71 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.677 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 t -70.61 -45.26 65.6 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.06 18.0 6.31 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 124.464 1.102 . . . . 0.0 109.461 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -31.69 5.68 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.22 -25.35 21.79 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 112.998 -1.601 . . . . 0.0 106.783 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -29.12 60.8 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.13 -24.81 43.09 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.653 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -76.57 -15.62 59.81 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.35 -44.84 9.41 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 123.885 1.802 . . . . 0.0 107.195 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.65 -1.72 22.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 108.589 -3.914 . . . . 0.0 108.857 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -80.81 -54.03 5.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.77 43.59 12.01 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 111.037 -2.801 . . . . 0.0 107.41 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.34 -47.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.212 0 CA-C-N 112.542 -2.117 . . . . 0.0 107.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.04 121.14 31.09 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 119.45 23.11 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.88 75.84 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 CA-C-N 113.087 -1.869 . . . . 0.0 109.711 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.41 30.7 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-N 112.122 -2.039 . . . . 0.0 106.292 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB3' HH22 ' A' ' 115' ' ' ARG . 72.9 mmtt -142.63 119.0 10.88 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.3 112.22 7.57 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.83 83.84 1.86 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.6 99.17 8.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-N 111.453 -2.612 . . . . 0.0 111.044 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.25 122.77 8.11 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 110.184 -3.189 . . . . 0.0 110.299 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.6 -98.39 2.42 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.3 t30 64.89 -97.13 0.05 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 112.48 -1.86 . . . . 0.0 107.616 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.07 111.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.28 168.58 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.628 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.251 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 40.32 57.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.46 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.25 151.34 13.5 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.508 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -173.6 131.83 0.45 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 87.9 -71.6 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 O-C-N 126.113 2.133 . . . . 0.0 105.534 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -92.61 145.43 24.43 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -129.39 160.29 64.98 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.41 -150.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.02 -26.68 63.22 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.352 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 124.881 1.363 . . . . 0.0 110.362 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.39 24.72 2.48 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.635 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.9 -47.72 65.11 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 103.495 -2.779 . . . . 0.0 103.495 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.13 -20.08 23.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 111.575 -2.557 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -84.17 -45.93 12.43 Favored 'General case' 0 C--N 1.364 1.237 0 C-N-CA 117.977 -1.489 . . . . 0.0 108.879 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.33 -0.38 36.52 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.949 1.406 . . . . 0.0 108.252 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.42 79.81 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -87.77 -50.85 6.2 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.67 37.08 50.3 Favored Glycine 0 C--N 1.363 2.04 0 N-CA-C 116.384 1.313 . . . . 0.0 116.384 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.17 -7.44 58.21 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.01 133.09 50.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.416 HH22 ' HB3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -110.04 169.97 8.38 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.13 166.66 19.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 CA-C-N 113.67 -1.604 . . . . 0.0 107.284 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -99.62 150.69 37.02 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.47 160.02 44.93 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.095 1.863 . . . . 0.0 108.708 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.81 122.02 8.45 Favored 'Trans proline' 0 C--N 1.371 1.762 0 N-CA-C 105.219 -2.646 . . . . 0.0 105.219 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.8 -170.27 13.26 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.4 p -69.77 146.03 51.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.16 76.17 8.69 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.57 -20.72 13.63 Favored 'Trans proline' 0 C--N 1.369 1.655 0 O-C-N 123.422 1.222 . . . . 0.0 110.222 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.92 -32.81 51.88 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.374 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -77.73 -11.38 59.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.036 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 129' ' ' ASP . 30.9 p -89.3 -20.93 23.47 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.127 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.69 -26.55 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.29 -2.99 57.27 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.459 -2.155 . . . . 0.0 108.578 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 126' ' ' THR . 48.3 t0 -53.06 -60.58 3.1 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.158 1.456 . . . . 0.0 107.261 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 3.0 ttp -90.02 -22.45 21.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.643 -2.98 . . . . 0.0 111.034 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -86.48 -13.37 46.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.921 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -90.21 -55.6 3.54 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 122.439 1.114 . . . . 0.0 108.366 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.416 ' HA ' HH21 ' A' ' 115' ' ' ARG . 88.1 t -63.65 -53.07 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 112.361 -2.2 . . . . 0.0 114.197 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.16 -12.12 41.91 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.37 1.044 . . . . 0.0 109.646 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.704 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.22 178.695 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -79.72 143.24 34.71 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 95.21 5.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 110.786 -2.916 . . . . 0.0 108.817 -177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.39 115.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 119.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.77 126.52 49.47 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 CA-C-N 112.285 -2.234 . . . . 0.0 108.385 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.9 tp -125.15 140.96 52.41 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.182 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.57 173.96 24.86 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.289 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.2 p 164.98 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.227 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.423 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -175.27 -145.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.514 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.948 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 -179.214 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 126.371 2.986 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 25' ' ' HIS 0.356 0.0 OUTLIER 36.94 48.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.633 2 CA-C-N 106.731 -4.759 . . . . 0.0 108.557 -178.925 . . . . . . . . 5 4 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.514 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -68.35 -33.31 74.06 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 173.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.49 6.49 4.6 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-N 110.971 -2.831 . . . . 0.0 107.817 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 2.0 t60 -76.0 -41.72 50.29 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -44.83 63.62 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 111.318 -2.673 . . . . 0.0 109.601 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.12 -41.35 68.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.363 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -21.67 44.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 112.666 -2.061 . . . . 0.0 113.581 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -78.82 -5.41 53.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.751 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.02 0.75 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 115.984 -2.286 . . . . 0.0 109.215 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.32 97.43 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 118.672 -1.727 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.31 151.45 21.05 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -76.98 136.64 38.75 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 111.479 -2.6 . . . . 0.0 105.932 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.96 148.0 7.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 112.304 -2.225 . . . . 0.0 107.011 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.11 67.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 111.172 -2.74 . . . . 0.0 106.982 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.81 115.3 9.8 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.304 -1.771 . . . . 0.0 106.58 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 tt -94.38 -2.35 10.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.636 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 -115.11 3.99 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.402 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.94 51.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 113.568 -1.316 . . . . 0.0 109.507 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.27 150.51 36.09 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 112.828 -1.987 . . . . 0.0 105.644 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 t -112.13 31.31 6.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 113.059 -1.882 . . . . 0.0 106.043 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 p -82.35 97.58 8.4 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.05 -56.55 3.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.471 -2.15 . . . . 0.0 108.85 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -24.84 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.749 1.281 . . . . 0.0 110.889 -177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.0 -32.83 18.63 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -88.16 2.91 51.06 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.027 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.01 -31.17 7.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.9 -27.4 61.86 Favored 'General case' 0 C--N 1.366 1.284 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.48 -4.43 55.53 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.89 -8.61 57.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.99 -40.32 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.65 -64.08 1.07 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.46 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -62.0 1.57 Allowed 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? 112.32 45.78 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 O-C-N 127.052 2.72 . . . . 0.0 104.85 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.46 112.1 0.76 Allowed 'General case' 0 C--N 1.358 0.953 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -81.69 0.33 Allowed 'General case' 0 C--N 1.358 0.94 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.711 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.52 130.77 37.3 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.737 1.273 . . . . 0.0 108.333 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.6 162.46 2.4 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.297 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 23' ' ' LEU . 21.5 t -156.99 104.65 2.11 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.35 129.9 64.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.505 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.99 111.32 19.42 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 117.426 -1.71 . . . . 0.0 108.767 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t 145.36 173.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.638 0 CA-C-N 111.27 -2.695 . . . . 0.0 104.52 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.04 -129.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.757 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.38 80.81 8.45 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.21 53.95 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -165.52 -20.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 111.689 -2.256 . . . . 0.0 107.654 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.82 177.19 51.66 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.339 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -86.92 9.41 19.43 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.222 -1.489 . . . . 0.0 108.101 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -51.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.51 -27.79 62.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.502 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HG ' HH12 ' A' ' 75' ' ' ARG . 10.7 t -68.49 -57.19 6.2 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -90.18 27.81 1.56 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 124.754 1.284 . . . . 0.0 109.025 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.67 -30.23 6.24 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -90.12 -30.02 17.93 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 112.637 -1.781 . . . . 0.0 107.211 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.4 mmt85 -71.31 -31.89 67.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -75.21 -31.89 61.03 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 113.503 -1.68 . . . . 0.0 108.03 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -71.52 -16.09 62.32 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.298 0.999 . . . . 0.0 109.763 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.415 ' C ' ' H ' ' A' ' 80' ' ' GLU . 50.8 t -90.25 -48.06 7.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 123.169 1.461 . . . . 0.0 108.237 -177.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.307 2.4 p30 -76.63 3.58 11.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 109.727 -3.397 . . . . 0.0 109.389 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 78' ' ' CYS . 9.4 tp10 -81.24 -54.89 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 40.34 12.43 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.841 -2.89 . . . . 0.0 107.409 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -48.08 0.04 OUTLIER Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.5 mt -86.58 121.18 28.75 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 121.98 33.51 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.94 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.32 78.46 0.04 OUTLIER Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.966 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.52 33.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.673 -1.763 . . . . 0.0 106.672 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 113.08 4.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.96 111.19 9.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.61 87.61 3.62 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.43 96.32 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 111.184 -2.735 . . . . 0.0 110.119 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.78 101.24 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-N 108.94 -3.755 . . . . 0.0 110.366 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.78 -108.42 3.09 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 112.37 -1.915 . . . . 0.0 109.766 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.96 -110.79 0.09 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.18 129.59 37.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.89 174.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.487 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.58 80.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.038 -2.346 . . . . 0.0 112.623 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.08 156.13 8.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 111.972 -2.377 . . . . 0.0 109.086 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -168.78 93.35 0.31 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 95.56 -47.98 0.01 OUTLIER 'General case' 0 C--N 1.355 0.828 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -89.37 122.76 32.91 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -135.64 160.84 66.15 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.8 -149.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.773 1.649 . . . . 0.0 108.239 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.86 -21.2 60.98 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.642 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.32 -70.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 O-C-N 124.619 1.199 . . . . 0.0 111.236 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -88.35 21.49 2.84 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 117.33 -1.748 . . . . 0.0 108.393 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.12 -43.07 62.2 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -79.95 -32.05 39.94 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.115 -2.311 . . . . 0.0 107.216 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -91.04 13.45 16.73 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.027 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 -38.8 12.99 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 107.214 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.04 -61.5 1.97 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.22 35.66 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.379 2.419 . . . . 0.0 117.431 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -89.69 -1.39 58.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.18 137.21 43.32 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 173.39 6.35 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.4 24.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 124.499 1.124 . . . . 0.0 109.198 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.72 150.14 36.55 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.24 166.36 5.96 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.123 2.549 . . . . 0.0 109.045 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 -92.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 104.436 -2.948 . . . . 0.0 104.436 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.38 131.64 14.98 Favored Glycine 0 C--N 1.359 1.854 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 t -64.84 162.92 15.27 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 125.494 2.569 . . . . 0.0 109.189 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -170.73 114.35 0.45 Allowed Pre-proline 0 N--CA 1.431 -1.415 1 CA-C-N 106.235 -4.984 . . . . 0.0 100.941 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.68 -4.03 13.82 Favored 'Trans proline' 0 C--N 1.363 1.317 0 O-C-N 122.41 0.689 . . . . 0.0 111.335 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.99 -23.05 65.89 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.958 1.303 . . . . 0.0 108.96 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -28.05 51.5 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.17 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 129' ' ' ASP . 77.9 p -80.65 -18.68 47.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.968 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.56 -25.55 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.01 46.97 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.387 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 126' ' ' THR . 44.7 t0 -52.73 -62.36 1.7 Allowed 'General case' 0 C--N 1.369 1.421 0 CA-C-O 123.781 1.753 . . . . 0.0 106.832 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 45.9 ttm -90.12 -25.8 20.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 109.574 -3.467 . . . . 0.0 111.383 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -78.52 -13.0 60.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.709 -1.596 . . . . 0.0 110.316 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.98 -56.23 3.37 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -34.49 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.611 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.93 -33.02 30.55 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.463 0 O-C-N 124.55 1.156 . . . . 0.0 111.483 -179.864 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -79.07 169.28 18.44 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.601 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -103.84 104.79 14.83 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 109.065 -3.698 . . . . 0.0 108.589 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.32 99.38 0.01 OUTLIER 'General case' 0 C--N 1.355 0.804 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.85 109.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.52 127.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.775 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.28 136.19 53.26 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 112.515 -2.129 . . . . 0.0 105.721 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . -175.29 171.11 44.27 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.405 -2.634 . . . . 0.0 108.343 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.598 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.9 p 164.42 -122.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.464 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.538 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 2.2 tp -168.68 -149.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.379 1.884 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.711 0 C-N-CA 118.76 -1.686 . . . . 0.0 110.234 179.61 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 125.307 2.479 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.336 0.2 OUTLIER 31.05 42.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.39 2 CA-C-N 106.898 -4.683 . . . . 0.0 109.149 -177.897 . . . . . . . . 4 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -35.18 31.91 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.2 -0.85 30.09 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.163 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -78.18 -35.07 49.2 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.7 p -56.58 -44.31 80.91 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.072 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.55 -43.5 75.9 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.889 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -26.82 62.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 111.865 -2.425 . . . . 0.0 112.648 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -79.68 0.49 30.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 112.072 -2.331 . . . . 0.0 109.149 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.6 11.3 2.08 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 118.199 -1.4 . . . . 0.0 108.031 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.6 34.44 55.72 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.289 0.993 . . . . 0.0 112.882 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.67 -177.43 3.57 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.39 145.21 25.5 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.365 -2.198 . . . . 0.0 106.55 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.93 135.41 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 110.777 -2.92 . . . . 0.0 107.262 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.25 76.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.419 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.636 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.91 120.75 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.29 -92.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 111.985 -2.37 . . . . 0.0 104.924 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.12 -140.42 5.63 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.41 4.03 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 113.121 -1.54 . . . . 0.0 110.671 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.06 99.54 11.98 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -97.5 54.6 1.2 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -90.08 85.35 6.28 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.27 -47.65 67.15 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.836 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -36.53 84.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.636 1.21 . . . . 0.0 109.529 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.9 -21.94 50.45 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -85.47 -2.23 57.91 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.46 -35.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -75.6 -33.01 60.53 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.826 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.57 7.09 43.06 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.903 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.21 -21.73 22.01 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -74.47 -38.46 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.7 -69.05 0.23 Allowed 'General case' 0 C--N 1.354 0.787 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.029 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.37 -57.97 3.77 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.158 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' THR . 63.7 tttt 120.47 48.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 126.672 2.483 . . . . 0.0 107.705 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.36 106.62 0.11 Allowed 'General case' 0 C--N 1.355 0.819 0 CA-C-O 122.061 0.934 . . . . 0.0 110.027 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.87 -38.95 31.6 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -151.1 167.52 27.46 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.04 150.75 18.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-N 112.081 -2.327 . . . . 0.0 105.839 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.543 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 44.2 t -145.69 134.78 22.72 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.38 135.28 40.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.806 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.598 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.14 91.12 3.54 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.5 t 150.62 165.92 0.0 OUTLIER 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.8 -127.84 0.0 OUTLIER 'General case' 0 C--N 1.359 1.007 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.308 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 86.4 7.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.84 42.56 1.21 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 110.92 -2.855 . . . . 0.0 106.928 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -147.08 -32.61 0.3 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 111.143 -2.528 . . . . 0.0 106.841 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.84 43.35 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.51 1.55 19.0 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.992 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -47.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -72.27 -27.06 62.24 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 114.303 -1.317 . . . . 0.0 107.66 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 73' ' ' GLY . 93.3 m -68.29 -47.7 66.94 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.12 26.6 1.83 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.909 1.381 . . . . 0.0 108.829 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -95.7 -34.96 5.79 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 mt -88.84 -28.14 20.59 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 112.032 -2.084 . . . . 0.0 107.712 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.06 -24.43 58.23 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -82.04 -29.08 32.13 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -76.6 -15.66 59.78 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.31 1.006 . . . . 0.0 109.189 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 20.7 t -90.29 -47.71 7.59 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 123.982 1.849 . . . . 0.0 107.115 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.91 -3.61 23.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 108.478 -3.965 . . . . 0.0 109.158 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -82.01 -56.08 4.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.01 47.65 5.69 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 110.932 -2.849 . . . . 0.0 106.616 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.95 -44.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.73 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.81 120.9 24.7 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 134.14 34.42 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.47 56.96 0.06 OUTLIER Glycine 0 C--N 1.349 1.284 0 CA-C-N 112.733 -2.03 . . . . 0.0 110.266 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 tt -104.7 47.55 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -142.51 118.17 10.42 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.04 151.84 45.74 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.205 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.34 91.41 2.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 m -89.35 99.11 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 126.039 2.828 . . . . 0.0 110.339 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.08 109.08 2.71 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 108.498 -3.955 . . . . 0.0 109.358 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.8 -101.65 2.23 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 112.244 -1.978 . . . . 0.0 109.353 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t30 64.65 -104.84 0.12 Allowed 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.88 56.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.35 176.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.858 -1.974 . . . . 0.0 108.505 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.51 56.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.838 0 CA-C-N 112.722 -2.036 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.77 141.35 5.15 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.142 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.3 106.22 0.24 Allowed 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.17 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 126.032 2.083 . . . . 0.0 105.608 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.49 130.69 35.79 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -142.99 158.84 58.18 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.77 -148.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.853 0 N-CA-C 107.442 -1.792 . . . . 0.0 107.442 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.97 -22.34 60.71 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.0 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.21 -69.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.804 0 O-C-N 124.519 1.137 . . . . 0.0 111.309 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -89.85 22.95 2.91 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 117.391 -1.723 . . . . 0.0 108.338 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.35 -42.13 59.88 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -79.65 -32.07 41.57 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 112.104 -2.316 . . . . 0.0 106.877 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.72 15.97 13.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.841 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 -40.56 11.94 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 176.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.15 74.86 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 112.355 -2.202 . . . . 0.0 107.473 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.4 mtp -80.78 -58.69 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.11 40.67 0.08 OUTLIER Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.347 2.403 . . . . 0.0 117.32 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -84.62 -6.29 59.36 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.62 132.08 50.19 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -178.26 3.47 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.9 m -140.07 161.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.227 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.543 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 5.6 m-85 -99.36 154.35 37.33 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-N 110.532 -3.031 . . . . 0.0 103.679 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.26 159.73 43.32 Favored 'Trans proline' 0 C--N 1.368 1.554 0 N-CA-C 107.173 -1.895 . . . . 0.0 107.173 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.02 116.46 4.66 Favored 'Trans proline' 0 C--N 1.369 1.649 0 N-CA-C 103.763 -3.206 . . . . 0.0 103.763 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.81 132.79 5.57 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 t -73.62 159.61 32.82 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-O 125.25 2.452 . . . . 0.0 107.67 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.5 p -173.4 119.57 0.39 Allowed Pre-proline 0 N--CA 1.427 -1.607 1 CA-C-N 106.484 -4.871 . . . . 0.0 101.537 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.93 -4.53 14.02 Favored 'Trans proline' 0 C--N 1.358 1.041 0 N-CA-C 108.698 -1.309 . . . . 0.0 108.698 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.29 -37.38 87.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.462 1.905 . . . . 0.0 107.619 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.87 -23.71 59.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.615 -1.629 . . . . 0.0 108.148 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.4 p -81.79 -25.57 35.15 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 116.948 -1.901 . . . . 0.0 109.909 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.72 -24.87 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.44 -6.48 58.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 112.969 -1.923 . . . . 0.0 108.714 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 126' ' ' THR . 36.3 t0 -61.89 -58.03 9.48 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.0 mmt -88.15 -10.78 48.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.069 -1.878 . . . . 0.0 110.874 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -90.21 -49.81 6.35 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 117.864 -1.534 . . . . 0.0 109.013 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.92 -50.27 66.78 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.214 0.946 . . . . 0.0 109.868 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.45 -61.36 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 113.035 -1.893 . . . . 0.0 111.86 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mp -90.38 52.61 2.27 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.768 1.293 . . . . 0.0 109.876 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.367 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.315 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.12 161.16 26.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.802 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 21.2 pttp -119.6 108.91 15.06 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 110.927 -2.851 . . . . 0.0 108.123 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.41 85.48 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.86 107.25 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 110.721 -2.945 . . . . 0.0 103.751 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.68 126.35 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.483 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.27 153.13 43.69 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.4 -2.182 . . . . 0.0 106.679 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . 176.23 174.07 42.42 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 111.137 -2.756 . . . . 0.0 108.171 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.599 ' HB ' ' H ' ' A' ' 61' ' ' SER . 3.0 p 164.48 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.541 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 2.3 tp -168.29 -150.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.38 1.904 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.671 0 C-N-CA 118.681 -1.723 . . . . 0.0 110.327 179.645 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 CA--C 1.51 -0.595 0 CA-C-O 125.421 2.534 . . . . 0.0 107.906 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.348 0.2 OUTLIER 29.65 42.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.332 2 CA-C-N 106.614 -4.812 . . . . 0.0 109.522 -178.213 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -35.53 25.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 2.1 p30 -76.95 -2.95 36.35 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 113.694 -1.594 . . . . 0.0 106.868 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -77.36 -34.97 55.0 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -56.79 -43.53 80.99 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.28 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -55.28 -44.07 75.35 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.928 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -27.33 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 111.545 -2.57 . . . . 0.0 112.782 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -78.74 -0.53 30.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.201 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.28 9.21 2.49 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 118.511 -1.275 . . . . 0.0 107.908 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 33.58 58.57 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 124.243 0.964 . . . . 0.0 112.627 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -99.61 -179.47 4.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 28.2 t-20 -76.85 144.5 38.99 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 112.219 -2.264 . . . . 0.0 106.873 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.92 127.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 110.669 -2.969 . . . . 0.0 107.469 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.8 t -140.19 128.75 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 111.561 -2.563 . . . . 0.0 105.6 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -144.2 132.49 21.91 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -97.08 -87.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 111.85 -2.432 . . . . 0.0 104.886 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.05 -137.99 4.77 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.6 2.28 8.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 CA-C-N 113.201 -1.499 . . . . 0.0 110.716 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.27 98.31 11.26 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -97.9 55.34 1.18 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 p -90.14 86.51 6.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.81 -46.31 75.6 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.144 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -37.71 88.54 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.482 1.113 . . . . 0.0 109.61 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -77.72 -21.01 52.57 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.88 -2.24 58.06 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.7 -35.88 32.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -75.04 -32.21 61.5 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.958 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.98 5.69 49.15 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.988 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.25 -19.04 24.6 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.15 -38.48 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -59.51 -69.13 0.22 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.988 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.85 -54.74 10.42 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.722 -176.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' THR . 64.0 tttt 117.65 47.23 0.0 OUTLIER 'General case' 0 C--N 1.356 0.852 0 O-C-N 126.705 2.503 . . . . 0.0 107.55 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.85 106.46 0.1 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.499 1.142 . . . . 0.0 110.279 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.63 -38.15 34.46 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 111.584 -2.553 . . . . 0.0 104.163 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.39 165.05 37.61 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 111.722 -2.49 . . . . 0.0 106.169 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 44.8 t -137.79 133.67 34.31 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 135.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.138 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.599 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.42 91.85 3.82 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 t 150.09 166.26 0.0 OUTLIER 'General case' 0 C--N 1.36 1.056 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.75 -127.24 0.0 OUTLIER 'General case' 0 C--N 1.358 0.959 0 CA-C-N 113.595 -1.638 . . . . 0.0 107.277 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.61 85.16 7.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.48 42.87 1.26 Allowed Glycine 0 C--N 1.345 1.058 0 CA-C-N 110.881 -2.872 . . . . 0.0 107.089 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -148.38 -32.42 0.25 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 111.181 -2.509 . . . . 0.0 106.857 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.08 167.73 42.79 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.39 1.38 19.17 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.582 -1.309 . . . . 0.0 109.044 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.32 -46.51 17.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -72.6 -27.38 62.13 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.781 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.47 -47.28 67.52 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -90.07 25.43 2.15 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 124.815 1.322 . . . . 0.0 108.988 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.35 -33.31 6.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.27 -29.67 20.23 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 111.939 -2.131 . . . . 0.0 107.678 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -24.23 58.67 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.1 -29.25 31.84 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -76.49 -15.1 59.97 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.235 0.959 . . . . 0.0 109.238 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.35 -48.12 7.33 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 124.014 1.864 . . . . 0.0 107.059 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.61 -3.67 22.83 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 108.43 -3.986 . . . . 0.0 109.207 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.45 -56.36 3.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.75 48.02 5.81 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 110.964 -2.835 . . . . 0.0 106.641 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.75 -43.62 0.02 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.905 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.35 120.57 23.98 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 136.12 33.95 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.72 53.96 0.09 OUTLIER Glycine 0 C--N 1.35 1.307 0 CA-C-N 112.734 -2.03 . . . . 0.0 110.117 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.86 55.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -148.35 118.67 7.33 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -139.98 151.84 45.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.862 -1.972 . . . . 0.0 106.121 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 90.99 2.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 m -89.33 98.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 CA-C-O 126.106 2.86 . . . . 0.0 110.307 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 109.54 2.82 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 108.456 -3.975 . . . . 0.0 109.367 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -101.14 2.14 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.195 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.3 t30 64.38 -104.94 0.12 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.34 125.28 56.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.44 177.32 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.824 -1.989 . . . . 0.0 108.449 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.57 55.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-N 112.654 -2.067 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.92 141.34 5.1 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.227 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.27 105.51 0.23 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.36 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.356 0.856 0 O-C-N 126.056 2.097 . . . . 0.0 105.526 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -89.22 130.09 35.69 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -142.91 158.82 58.45 Favored Pre-proline 0 C--N 1.352 0.675 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.73 -148.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.374 1.872 0 N-CA-C 107.433 -1.795 . . . . 0.0 107.433 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.96 -22.32 60.72 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.969 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.21 -69.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 124.495 1.122 . . . . 0.0 111.282 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -89.99 23.11 2.9 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.403 -1.719 . . . . 0.0 108.41 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -74.43 -42.41 59.18 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 112.065 -2.334 . . . . 0.0 106.869 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.19 16.43 13.06 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.914 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -40.71 11.83 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.25 75.28 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 112.212 -2.267 . . . . 0.0 107.408 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.1 mtp -80.78 -58.51 3.06 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 31.52 41.04 0.07 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.399 2.428 . . . . 0.0 117.373 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.69 -6.09 59.34 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.4 132.14 49.91 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -178.97 3.66 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.02 161.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 117.793 -1.563 . . . . 0.0 110.255 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.538 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 5.9 m-85 -99.39 154.41 37.3 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.815 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.08 160.66 42.42 Favored 'Trans proline' 0 C--N 1.368 1.579 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.9 116.43 4.66 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 103.823 -3.183 . . . . 0.0 103.823 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.11 133.86 5.94 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -73.84 159.61 32.62 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 125.144 2.402 . . . . 0.0 107.52 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.7 p -173.17 120.57 0.41 Allowed Pre-proline 0 N--CA 1.427 -1.606 1 CA-C-N 106.583 -4.826 . . . . 0.0 101.648 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.8 -5.45 14.68 Favored 'Trans proline' 0 C--N 1.357 0.999 0 N-CA-C 108.685 -1.313 . . . . 0.0 108.685 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.84 -37.92 89.17 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.547 1.939 . . . . 0.0 107.744 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.256 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.3 p -82.09 -25.44 34.51 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 116.94 -1.904 . . . . 0.0 109.983 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.3 mt -67.65 -24.78 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.77 -6.3 58.23 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.77 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 126' ' ' THR . 36.1 t0 -61.91 -58.37 8.19 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 35.1 mmt -87.09 -11.93 48.7 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.82 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -90.13 -48.55 7.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.201 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -47.99 71.27 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 124.131 0.894 . . . . 0.0 109.921 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.3 t -71.42 -61.19 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.638 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mp -90.37 53.97 2.62 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.842 1.339 . . . . 0.0 109.635 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.29 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.309 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -63.04 144.06 57.23 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.404 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.24 102.44 14.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 111.786 -2.461 . . . . 0.0 107.505 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.03 105.75 0.03 OUTLIER 'General case' 0 C--N 1.357 0.919 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 112.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 117.92 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 111.779 -2.464 . . . . 0.0 108.293 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 tp -90.14 159.89 16.54 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.912 -1.949 . . . . 0.0 108.262 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.48 29.84 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 111.422 -2.626 . . . . 0.0 107.844 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.36 131.75 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 122.312 1.053 . . . . 0.0 112.087 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.54 133.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.719 0 C-N-CA 117.818 -2.134 . . . . 0.0 113.192 -177.434 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 CA--C 1.498 -1.039 0 CA-C-O 125.48 2.562 . . . . 0.0 107.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.355 0.2 OUTLIER 30.09 54.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.434 1 CA-C-N 106.242 -4.981 . . . . 0.0 107.922 -177.371 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -70.91 -25.54 62.81 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 102.11 -3.292 . . . . 0.0 102.11 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -66.32 -17.44 64.76 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 116.744 -1.982 . . . . 0.0 107.221 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -69.4 -24.5 63.86 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.461 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 7.4 p -56.78 -37.82 71.63 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 125.024 1.453 . . . . 0.0 108.739 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CD2' ' CB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -54.64 -49.42 70.58 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.029 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -22.78 61.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.114 -2.312 . . . . 0.0 112.904 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -81.33 0.07 38.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.688 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.93 12.9 1.45 Allowed 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.001 -1.48 . . . . 0.0 107.906 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 37.74 46.2 Favored Glycine 0 C--N 1.36 1.869 0 O-C-N 124.229 0.955 . . . . 0.0 113.056 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.71 -168.11 1.56 Allowed 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.303 -1.449 . . . . 0.0 107.519 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -93.8 140.04 30.14 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.705 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.419 ' CB ' ' CD2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.74 127.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 109.995 -3.275 . . . . 0.0 108.927 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.31 144.48 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 109.909 -3.314 . . . . 0.0 104.432 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.13 135.79 8.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.96 -67.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.36 -145.63 16.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 112.144 -2.298 . . . . 0.0 108.374 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.52 88.7 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.68 119.72 1.41 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 t -98.31 37.11 1.49 Allowed 'General case' 0 C--N 1.358 0.974 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.478 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.9 p -90.17 98.15 11.6 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.16 -55.45 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.985 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.78 -20.44 66.37 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.65 1.219 . . . . 0.0 111.597 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.34 -37.26 17.27 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.239 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -90.04 10.16 25.24 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 118.027 -1.469 . . . . 0.0 108.629 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.04 -32.46 6.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.022 0 N-CA-C 102.27 -3.234 . . . . 0.0 102.27 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.68 -26.1 60.57 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.27 -6.79 56.5 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.64 51.34 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mt -83.87 -41.64 16.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.22 -57.52 12.08 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 112.146 -2.297 . . . . 0.0 108.835 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -55.06 20.68 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 90.21 53.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.114 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.57 126.52 27.79 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 111.2 -2.727 . . . . 0.0 107.335 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -88.21 -31.92 18.83 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 112.825 -1.988 . . . . 0.0 107.214 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -157.76 154.34 28.02 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.73 165.91 9.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 111.908 -2.405 . . . . 0.0 105.489 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 89.0 m -153.14 100.56 2.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 111.333 -2.667 . . . . 0.0 103.989 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.92 137.39 36.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 m -99.71 125.8 45.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 65' ' ' GLY . 18.1 t -157.99 175.4 13.87 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 114.639 -2.824 . . . . 0.0 107.519 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.67 48.38 0.8 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.814 -2.903 . . . . 0.0 106.454 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 72.78 32.76 1.39 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 113.734 -1.576 . . . . 0.0 107.305 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.672 ' H ' ' HG ' ' A' ' 62' ' ' SER . . . -114.53 -3.01 22.62 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.367 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -87.63 -17.75 31.19 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.72 177.44 49.12 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.341 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.07 18.9 5.36 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.6 -1.3 . . . . 0.0 108.048 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -53.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.19 -26.17 62.84 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.413 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' GLY . 26.9 t -66.67 -56.18 11.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -90.1 30.1 1.14 Allowed 'General case' 0 C--N 1.359 1.0 0 O-C-N 124.684 1.24 . . . . 0.0 109.36 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -98.14 -38.83 3.94 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.03 -23.13 21.55 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 112.705 -1.747 . . . . 0.0 107.771 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -29.94 59.9 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.36 -26.56 52.09 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.69 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -74.71 -17.62 60.63 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.005 0.816 . . . . 0.0 109.261 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.404 ' C ' ' H ' ' A' ' 80' ' ' GLU . 36.5 t -90.22 -46.47 8.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.919 1.819 . . . . 0.0 107.524 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -74.17 0.76 12.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 108.67 -3.877 . . . . 0.0 109.095 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 78' ' ' CYS . 10.1 tp10 -84.03 -55.97 3.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.27 45.56 6.7 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-N 110.84 -2.891 . . . . 0.0 106.68 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.07 -43.62 0.02 OUTLIER Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.492 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -79.62 120.87 24.56 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.57 35.91 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.21 122.42 2.68 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 112.17 -2.286 . . . . 0.0 107.459 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 tt -149.56 34.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -138.4 118.18 13.19 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 112.87 8.6 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.49 89.77 4.06 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.84 91.19 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 111.076 -2.784 . . . . 0.0 110.351 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -69.71 142.17 36.22 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 110.218 -3.174 . . . . 0.0 110.393 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.84 -83.67 1.61 Allowed Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.406 -2.397 . . . . 0.0 107.229 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 61.5 -108.05 0.3 Allowed 'General case' 0 C--N 1.355 0.835 0 CA-C-N 112.56 -1.82 . . . . 0.0 107.053 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.3 mt -118.09 149.71 20.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.43 -172.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.667 0 CA-C-N 112.728 -2.033 . . . . 0.0 108.73 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 39.24 68.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.834 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.881 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.9 171.13 35.13 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 112.316 -2.22 . . . . 0.0 109.878 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -157.03 -49.25 0.07 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.21 -38.14 2.0 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.76 111.44 22.45 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -119.09 166.09 15.28 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.48 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 N-CA-C 108.1 -1.539 . . . . 0.0 108.1 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.91 -24.45 61.64 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 113.844 -1.526 . . . . 0.0 108.41 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.78 -72.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 O-C-N 124.739 1.275 . . . . 0.0 111.323 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.78 25.94 1.64 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.65 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.78 -45.37 36.6 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -80.57 -30.04 36.98 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 111.541 -2.572 . . . . 0.0 107.531 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -91.51 12.65 20.1 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.878 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -38.46 13.36 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.9 73.08 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.729 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.9 mtp -81.79 -61.53 1.9 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.0 39.87 0.01 OUTLIER Glycine 0 C--N 1.356 1.641 0 C-N-CA 127.698 2.571 . . . . 0.0 117.432 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -87.79 -6.19 58.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.07 137.66 42.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 170.45 8.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 102.496 -3.15 . . . . 0.0 102.496 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.88 156.47 25.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.212 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.434 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 1.6 m-85 -99.59 128.66 30.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.92 160.27 26.19 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.324 2.016 . . . . 0.0 109.322 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.24 121.27 7.64 Favored 'Trans proline' 0 C--N 1.369 1.646 0 N-CA-C 104.684 -2.852 . . . . 0.0 104.684 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 67.18 0.94 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -165.77 1.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 110.466 -2.867 . . . . 0.0 106.775 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.76 ' HG ' ' HG1' ' A' ' 125' ' ' THR . 3.5 p -168.26 168.35 5.83 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 111.566 -2.561 . . . . 0.0 104.447 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.19 -8.15 17.41 Favored 'Trans proline' 0 C--N 1.367 1.543 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.33 -29.21 65.86 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.76 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -79.02 -20.41 49.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.822 -1.536 . . . . 0.0 108.006 -179.09 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.483 ' C ' ' H ' ' A' ' 129' ' ' ASP . 4.5 p -82.7 -16.81 46.7 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 118.048 -1.461 . . . . 0.0 110.264 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.0 -29.38 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 -1.33 57.75 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 126' ' ' THR . 53.4 t0 -64.5 -63.59 1.09 Allowed 'General case' 0 C--N 1.359 1.01 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' MET . . . . . 0.461 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -83.23 -10.49 58.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.431 -2.168 . . . . 0.0 110.299 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.18 -46.06 8.69 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.91 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.45 -37.28 77.72 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.591 0.557 . . . . 0.0 109.957 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.51 -73.98 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.41 57.11 3.56 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 124.644 1.215 . . . . 0.0 109.423 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.129 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.26 178.252 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.24 141.3 54.66 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 123.197 1.475 . . . . 0.0 108.617 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.29 95.64 8.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 110.548 -3.023 . . . . 0.0 107.894 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.65 111.55 0.09 Allowed 'General case' 0 C--N 1.355 0.807 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.27 111.94 9.93 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.82 18.56 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 O-C-N 125.866 1.979 . . . . 0.0 105.689 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.45 149.36 34.34 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 123.114 1.435 . . . . 0.0 108.81 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 149.87 21.4 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 110.866 -2.879 . . . . 0.0 106.577 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.32 98.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.714 0 CA-C-O 122.328 1.061 . . . . 0.0 110.587 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.3 156.69 4.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.817 0 C-N-CA 115.574 -3.203 . . . . 0.0 113.597 -178.042 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 CA--C 1.499 -1.016 0 CA-C-O 125.918 2.771 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.383 0.3 OUTLIER 26.61 54.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.408 -2.571 2 CA-C-N 105.222 -5.445 . . . . 0.0 108.263 -177.142 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.17 -24.84 59.45 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 102.386 -3.19 . . . . 0.0 102.386 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 35.4 m-20 -71.9 -8.99 57.63 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -74.51 -30.09 61.66 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -53.29 -44.36 68.23 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 125.647 1.842 . . . . 0.0 110.349 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -60.07 -41.71 93.01 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.87 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.7 -24.57 59.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.668 -2.06 . . . . 0.0 112.689 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -81.87 -1.19 46.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 112.224 -2.262 . . . . 0.0 108.926 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.59 3.7 2.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.75 32.06 68.97 Favored Glycine 0 C--N 1.358 1.795 0 O-C-N 123.952 0.783 . . . . 0.0 111.674 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -99.7 -175.3 2.94 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 113.206 -1.497 . . . . 0.0 107.542 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -86.26 138.63 31.71 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 112.291 -2.231 . . . . 0.0 108.271 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.62 127.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 109.824 -3.353 . . . . 0.0 107.807 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.1 125.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 110.036 -3.256 . . . . 0.0 104.662 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -142.77 128.6 19.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.03 -75.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.34 -151.18 23.42 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.638 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -87.79 84.05 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tp -162.49 117.5 1.84 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.1 t -93.53 48.34 1.29 Allowed 'General case' 0 C--N 1.356 0.889 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.281 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.257 8.8 p -90.5 95.45 10.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 103.767 -2.679 . . . . 0.0 103.767 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -90.13 -57.83 2.71 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 118.03 -1.468 . . . . 0.0 108.322 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.1 -18.46 63.44 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.828 1.33 . . . . 0.0 111.382 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -91.35 -37.11 13.44 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 118.495 -1.282 . . . . 0.0 107.65 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -90.06 10.05 25.74 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.924 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 -33.69 6.35 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -73.37 -25.02 60.41 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 -9.45 48.61 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.2 -41.6 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.62 -58.69 7.51 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 112.129 -2.305 . . . . 0.0 108.404 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -56.21 12.96 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.68 1.237 . . . . 0.0 107.821 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 tttp 95.64 47.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 110.362 -3.108 . . . . 0.0 102.722 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.62 5.43 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 111.851 -2.431 . . . . 0.0 106.819 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -80.48 -36.44 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 111.706 -2.497 . . . . 0.0 106.555 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.41 158.39 44.1 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.21 141.32 46.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 CA-C-N 111.797 -2.456 . . . . 0.0 104.957 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.97 109.16 9.85 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.32 133.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -100.94 117.55 35.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.684 ' HG ' ' H ' ' A' ' 65' ' ' GLY . 15.9 t -157.76 177.83 10.93 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 115.623 -2.431 . . . . 0.0 108.133 -176.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' A' ' 62' ' ' SER . 0.6 OUTLIER -152.6 46.19 0.72 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 111.405 -2.634 . . . . 0.0 106.947 -178.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.32 30.1 0.53 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.197 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.684 ' H ' ' HG ' ' A' ' 62' ' ' SER . . . -111.68 -2.02 27.33 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.092 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.97 -8.95 44.72 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.44 177.38 13.19 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.524 1.14 . . . . 0.0 110.558 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 25.5 2.18 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.807 -1.196 . . . . 0.0 108.028 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -54.16 8.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.21 -26.37 62.02 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.954 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -68.71 -58.51 4.12 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -90.1 27.88 1.52 Allowed 'General case' 0 C--N 1.359 0.99 0 O-C-N 124.751 1.282 . . . . 0.0 110.145 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.03 -30.15 5.53 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.0 mt -90.07 -28.28 19.12 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.332 -1.934 . . . . 0.0 107.484 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -29.79 58.88 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.09 -27.87 57.33 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.484 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -73.58 -19.54 60.85 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 123.92 0.762 . . . . 0.0 109.651 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 80' ' ' GLU . 44.8 t -90.25 -46.3 8.5 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.806 1.765 . . . . 0.0 107.902 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -73.98 0.95 11.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 108.788 -3.824 . . . . 0.0 109.167 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 78' ' ' CYS . 10.3 tp10 -84.24 -56.29 3.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.83 45.66 5.54 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.73 -2.941 . . . . 0.0 106.494 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.48 -42.1 0.02 OUTLIER Glycine 0 C--N 1.352 1.423 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.841 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 mt -78.8 122.78 26.48 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.49 117.58 2.35 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 112.229 -2.259 . . . . 0.0 108.554 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 tt -143.36 40.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -140.66 117.26 10.88 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 108.3 5.79 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.19 86.84 3.3 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.027 -3.323 . . . . 0.0 102.027 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.35 95.98 5.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 CA-C-N 111.338 -2.664 . . . . 0.0 109.65 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -60.31 128.44 45.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 109.259 -3.61 . . . . 0.0 111.82 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.88 -83.12 1.55 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 111.539 -2.331 . . . . 0.0 107.372 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 71.22 -88.35 0.03 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 112.505 -1.847 . . . . 0.0 106.827 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 mt -135.33 149.72 28.86 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -175.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.835 -1.984 . . . . 0.0 108.864 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.7 84.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-N 112.007 -2.361 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.47 -178.42 28.81 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.239 -2.255 . . . . 0.0 110.608 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -159.33 -44.73 0.05 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 111.523 -2.338 . . . . 0.0 104.839 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.18 -37.16 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -87.13 89.84 8.14 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -101.99 169.26 7.86 Favored Pre-proline 0 C--N 1.35 0.615 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -152.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.752 0 N-CA-C 108.092 -1.541 . . . . 0.0 108.092 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.45 -24.15 61.97 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.459 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.69 -72.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 O-C-N 124.764 1.29 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -89.03 26.25 1.62 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 117.773 -1.571 . . . . 0.0 109.846 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -76.66 -45.77 28.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -80.24 -29.0 38.38 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 111.46 -2.609 . . . . 0.0 107.509 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.72 12.77 22.24 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.897 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -37.12 14.22 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.25 75.14 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-N 112.845 -1.979 . . . . 0.0 107.494 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.7 mtp -80.2 -61.21 2.05 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.95 38.57 0.01 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.91 2.671 . . . . 0.0 117.708 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -84.84 -6.84 59.35 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.14 135.97 45.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 170.42 8.09 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.15 163.01 24.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.413 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 1.0 OUTLIER -99.58 153.45 37.77 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.42 164.92 25.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.826 1.684 . . . . 0.0 108.056 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.23 118.01 3.91 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 102.377 -3.74 . . . . 0.0 102.377 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.71 68.98 1.09 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.273 0.2 OUTLIER -90.25 -158.08 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 109.496 -3.352 . . . . 0.0 107.336 -177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.726 ' HG ' ' HG1' ' A' ' 125' ' ' THR . 10.4 p -174.22 164.14 2.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 110.47 -3.059 . . . . 0.0 103.936 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.25 -5.4 15.67 Favored 'Trans proline' 0 C--N 1.365 1.401 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.56 -29.5 64.8 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.726 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -76.29 -20.8 56.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.647 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -85.34 -14.78 45.39 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.764 -1.175 . . . . 0.0 110.06 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mt -69.61 -28.62 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 -2.49 58.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.41 -2.177 . . . . 0.0 108.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 126' ' ' THR . 44.1 t0 -61.33 -62.4 1.86 Allowed 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -7.72 59.63 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.282 -2.235 . . . . 0.0 110.444 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.1 -54.25 4.12 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.443 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.92 -39.5 71.75 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.752 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.99 -68.99 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 125.193 1.558 . . . . 0.0 111.778 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -90.31 54.25 2.71 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.746 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.088 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.736 178.196 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -107.66 19.82 19.65 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' HZ1' ' HG1' ' A' ' 5' ' ' THR . 0.1 OUTLIER -76.27 133.76 39.98 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -81.25 89.57 6.05 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 111.023 -2.808 . . . . 0.0 107.335 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.613 ' HG1' ' HZ1' ' A' ' 3' ' ' LYS . 0.1 OUTLIER -174.36 120.2 0.25 Allowed 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.12 112.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.3 p -98.98 113.6 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.678 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -125.2 154.04 42.17 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.911 1.382 . . . . 0.0 109.762 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.25 -154.32 25.12 Favored Glycine 0 C--N 1.361 1.963 0 CA-C-N 111.931 -2.395 . . . . 0.0 112.689 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.704 14.9 p 88.28 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 131.095 3.758 . . . . 0.0 115.398 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.271 1.2 tt 67.03 148.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.173 2.189 . . . . 0.0 109.22 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.61 -121.84 4.98 Favored Glycine 0 C--N 1.361 1.956 0 CA-C-N 112.267 -2.242 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 p -93.95 103.16 15.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 111.969 -2.116 . . . . 0.0 106.314 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -172.52 72.97 0.04 OUTLIER 'General case' 0 C--N 1.352 0.698 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t 71.26 -84.25 0.03 OUTLIER 'General case' 0 C--N 1.368 1.399 0 O-C-N 124.787 1.304 . . . . 0.0 107.908 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -154.64 -65.7 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.34 92.02 0.54 Allowed 'General case' 0 C--N 1.352 0.705 0 O-C-N 125.404 1.69 . . . . 0.0 107.02 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.3 18.99 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 112.024 -2.353 . . . . 0.0 108.987 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -32.55 1.8 Allowed Glycine 0 C--N 1.36 1.869 0 C-N-CA 125.607 1.575 . . . . 0.0 109.463 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -46.22 -40.41 11.33 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 111.879 -2.161 . . . . 0.0 105.714 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -12.51 55.38 0.0 OUTLIER 'General case' 0 C--N 1.38 1.925 2 C-N-CA 141.405 7.882 . . . . 0.0 108.154 176.2 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.325 0.9 OUTLIER 43.13 44.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 1 CA-C-N 106.659 -4.791 . . . . 0.0 109.539 -178.473 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 tt -68.68 -24.07 64.47 Favored 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 114.679 -2.809 . . . . 0.0 103.602 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.23 -15.99 64.02 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.901 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . 0.265 0.7 OUTLIER -69.72 -26.3 64.26 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 117.969 -1.492 . . . . 0.0 108.241 178.808 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -20.17 65.34 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 113.161 -1.836 . . . . 0.0 108.814 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' CD2' HG21 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -58.62 -46.27 87.43 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -29.66 69.45 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 112.121 -2.309 . . . . 0.0 112.133 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.69 10.88 19.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.068 -2.333 . . . . 0.0 108.55 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -8.81 2.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.91 31.49 76.33 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.75 -175.21 2.91 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 113.006 -1.597 . . . . 0.0 108.328 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -108.71 154.64 21.74 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 112.287 -2.233 . . . . 0.0 106.777 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG21 ' CD2' ' A' ' 27' ' ' PHE . 78.5 t -99.94 135.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 CA-C-N 111.781 -2.463 . . . . 0.0 108.83 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.8 t -140.36 54.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 111.418 -2.628 . . . . 0.0 107.005 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.8 126.43 30.37 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.8 mt -89.84 -65.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.86 -116.82 0.73 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.394 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.12 23.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.323 -1.438 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.85 167.91 10.46 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.9 t -123.61 66.53 1.02 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 111.37 -2.65 . . . . 0.0 104.166 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.9 m -77.75 102.77 7.32 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -88.16 -85.9 0.18 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 113.06 -1.882 . . . . 0.0 107.38 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.19 -11.25 56.85 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 124.94 1.4 . . . . 0.0 110.926 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -89.21 -45.62 9.41 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -87.68 3.18 48.84 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.683 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 -29.03 7.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -73.05 -27.9 62.01 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.71 2.86 54.19 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.39 -9.13 48.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.24 -36.91 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -62.0 -69.07 0.27 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.192 -2.276 . . . . 0.0 110.195 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . 0.279 6.4 p -78.34 -32.43 49.15 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 123.783 0.677 . . . . 0.0 109.685 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 81.15 61.09 0.02 OUTLIER 'General case' 0 C--N 1.349 0.552 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.8 118.27 3.03 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.851 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -83.31 -49.35 9.47 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -142.83 161.2 38.71 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 125.426 1.704 . . . . 0.0 106.78 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.28 137.2 54.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 111.139 -2.755 . . . . 0.0 105.295 -179.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.95 112.28 14.5 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.62 142.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.207 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -114.39 63.61 0.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 p -168.67 148.62 4.44 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 70.59 0.74 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 111.61 -2.541 . . . . 0.0 104.341 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 72.22 87.3 0.11 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-N 110.413 -3.085 . . . . 0.0 106.818 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.28 33.52 0.51 Allowed Glycine 0 CA--C 1.535 1.32 0 CA-C-N 109.833 -3.349 . . . . 0.0 106.61 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.78 -14.65 0.54 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 111.259 -2.471 . . . . 0.0 108.476 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.76 -162.78 54.55 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 122.53 1.072 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.2 3.27 27.99 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 111.79 -2.205 . . . . 0.0 108.055 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mm -73.15 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.85 -24.6 65.28 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.843 1.339 . . . . 0.0 108.813 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 21.9 t -62.91 -72.13 0.14 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -90.17 33.09 0.89 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.313 1.008 . . . . 0.0 109.33 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.74 -47.61 2.47 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.82 -20.82 23.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 112.047 -2.076 . . . . 0.0 107.89 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.449 ' HG3' HH11 ' A' ' 75' ' ' ARG . 5.5 mmt85 -74.84 -31.85 61.76 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.05 -23.79 47.97 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.057 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.95 -16.11 59.45 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.96 0.787 . . . . 0.0 109.183 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.4 m -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 123.868 1.794 . . . . 0.0 107.229 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.38 -1.51 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 108.692 -3.867 . . . . 0.0 108.667 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.83 -53.46 6.47 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.73 48.76 5.32 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 111.024 -2.807 . . . . 0.0 107.101 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.06 -47.14 0.01 OUTLIER Glycine 0 C--N 1.347 1.166 0 CA-C-N 112.268 -2.242 . . . . 0.0 108.357 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.46 124.51 35.03 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 124.61 33.9 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.918 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.29 65.59 0.03 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 112.825 -1.988 . . . . 0.0 109.32 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.4 tt -105.54 11.32 8.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 112.097 -2.052 . . . . 0.0 108.139 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.4 mmtm -122.51 114.26 20.43 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.11 101.88 4.25 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -178.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -99.87 90.96 4.61 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.81 96.52 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 108.89 -3.777 . . . . 0.0 111.323 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.0 124.12 34.56 Favored Glycine 0 CA--C 1.537 1.417 1 CA-C-N 107.433 -4.439 . . . . 0.0 112.69 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.37 -80.84 0.94 Allowed Glycine 0 C--N 1.352 1.441 0 CA-C-N 112.549 -1.825 . . . . 0.0 109.143 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 25.44 94.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.431 3.492 . . . . 0.0 110.823 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 69.91 123.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.511 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.63 169.9 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 112.343 -2.208 . . . . 0.0 107.318 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.42 61.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.648 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.03 148.03 9.74 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.275 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.47 105.12 0.36 Allowed 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 87.14 -58.94 0.04 OUTLIER 'General case' 0 C--N 1.357 0.899 0 O-C-N 125.915 2.01 . . . . 0.0 106.753 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -86.17 101.21 12.8 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -106.86 160.91 24.61 Favored Pre-proline 0 C--N 1.351 0.64 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.23 -158.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.61 1.54 . . . . 0.0 108.631 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.78 -23.45 67.25 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.592 -2.094 . . . . 0.0 108.771 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.9 p -57.81 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.735 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.746 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -90.3 29.42 1.26 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.911 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -82.54 -41.18 19.96 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -80.46 -32.67 37.16 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.117 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -90.32 14.81 11.82 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.081 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -90.35 -38.77 13.12 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.23 75.05 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 112.63 -2.077 . . . . 0.0 106.99 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtp -77.63 -62.58 1.62 Allowed 'General case' 0 C--N 1.355 0.81 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.79 34.41 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.547 2.498 . . . . 0.0 117.261 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -4.76 58.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.27 132.67 51.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.403 HH21 HG23 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.31 171.87 7.2 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.13 152.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.188 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -99.74 117.74 63.07 Favored Pre-proline 0 C--N 1.36 1.05 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.82 147.95 90.31 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.417 2.078 . . . . 0.0 107.99 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.47 115.97 3.65 Favored 'Trans proline' 0 C--N 1.365 1.42 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.1 32.09 1.75 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.547 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.07 -166.37 1.57 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.771 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.263 3.2 p -143.2 170.68 8.19 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.489 -176.315 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.57 -4.61 13.68 Favored 'Trans proline' 0 C--N 1.37 1.666 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.83 -25.75 61.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.771 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -79.4 -17.53 54.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.668 -179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 129' ' ' ASP . 5.6 p -83.96 -16.77 42.91 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 118.498 -1.281 . . . . 0.0 109.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.18 -32.92 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.06 -1.23 52.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.236 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.491 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.7 t0 -61.32 -65.32 0.71 Allowed 'General case' 0 C--N 1.365 1.264 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.444 ' SD ' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -90.1 9.26 28.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 111.995 -2.366 . . . . 0.0 110.657 -176.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -88.66 -34.19 17.33 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 116.884 -1.927 . . . . 0.0 108.281 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.97 -43.45 10.54 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 124.256 0.973 . . . . 0.0 110.503 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.403 HG23 HH21 ' A' ' 115' ' ' ARG . 44.5 t -66.48 -31.15 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.682 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.09 -33.83 16.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.53 -91.73 0.03 OUTLIER Glycine 0 C--N 1.354 1.563 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.066 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -164.41 153.09 2.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 113.024 -1.588 . . . . 0.0 107.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--N 1.346 0.441 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -179.19 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.28 16.51 22.72 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.437 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 130.82 36.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 123.38 1.562 . . . . 0.0 107.049 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -81.69 95.69 7.3 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 109.952 -3.295 . . . . 0.0 107.886 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.36 109.28 0.01 OUTLIER 'General case' 0 C--N 1.35 0.608 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.21 117.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -179.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.2 p -98.95 133.42 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 111.55 -2.568 . . . . 0.0 108.301 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 52.5 tp -125.2 143.71 50.81 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.976 1.422 . . . . 0.0 107.63 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.29 170.4 42.95 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.443 176.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.711 11.7 p 99.63 -130.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 130.893 3.677 . . . . 0.0 116.526 178.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.09 102.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 127.401 2.281 . . . . 0.0 107.618 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.41 50.23 0.29 Allowed Glycine 0 C--N 1.36 1.871 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.211 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -108.59 -86.68 0.51 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.75 97.9 9.94 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 103.933 -2.618 . . . . 0.0 103.933 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.4 m 63.35 -133.05 0.41 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -147.97 -178.79 6.47 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 72.55 -168.21 0.13 Allowed 'General case' 0 C--N 1.354 0.786 0 CA-C-N 112.752 -2.022 . . . . 0.0 106.727 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . 0.31 57.5 t 82.23 15.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.579 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.64 -36.61 3.22 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -50.0 -35.94 26.6 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 111.447 -2.377 . . . . 0.0 107.844 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -32.57 72.69 0.0 OUTLIER 'General case' 0 C--N 1.364 1.233 1 C-N-CA 137.815 6.446 . . . . 0.0 108.077 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 mp 56.4 15.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 1 CA-C-N 105.725 -5.216 . . . . 0.0 112.049 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.9 mp -76.89 -40.07 48.72 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 116.512 -2.075 . . . . 0.0 106.059 178.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.62 -1.25 37.22 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.787 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -82.32 -34.2 28.67 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 1.2 t -66.57 -29.26 69.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.124 -1.853 . . . . 0.0 110.438 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.26 -42.68 93.01 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.901 -179.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -29.18 64.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.648 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -98.01 15.41 24.17 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.606 -2.543 . . . . 0.0 109.72 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.03 2.91 1.77 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.37 67.87 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.793 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 1.7 m-30 -99.76 156.18 17.24 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 112.603 -1.798 . . . . 0.0 106.169 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.26 140.8 34.65 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 111.327 -2.669 . . . . 0.0 105.85 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.4 p -99.88 137.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 112.145 -2.298 . . . . 0.0 107.457 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.74 63.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.652 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -81.71 120.92 25.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.436 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -89.95 -79.47 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.8 -158.38 22.65 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.062 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.37 59.76 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.661 1.219 . . . . 0.0 110.117 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 tp -165.63 124.59 1.66 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 t -96.25 84.72 3.81 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.68 122.98 27.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.404 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.81 -94.63 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.23 -2.259 . . . . 0.0 108.745 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.46 -17.25 19.37 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.813 1.645 . . . . 0.0 111.735 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.92 -48.88 8.3 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -84.85 0.51 50.65 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 116.58 -2.048 . . . . 0.0 109.001 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 -27.88 7.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.23 -29.03 57.39 Favored 'General case' 0 C--N 1.365 1.27 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.95 6.96 46.79 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -20.93 22.54 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.19 -38.26 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.22 -68.65 0.27 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 112.337 -2.21 . . . . 0.0 110.332 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -64.97 0.95 Allowed 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? 129.69 47.36 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 O-C-N 126.912 2.632 . . . . 0.0 106.933 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.73 108.36 0.73 Allowed 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.67 -82.64 0.2 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.267 -2.242 . . . . 0.0 104.972 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -89.57 142.08 28.0 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.45 144.66 36.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.5 m -134.68 129.31 34.6 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 112.433 -2.167 . . . . 0.0 106.686 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.5 t -99.96 137.04 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 110.042 -3.254 . . . . 0.0 103.451 178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -123.14 89.56 3.13 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.555 ' HG ' ' H ' ' A' ' 63' ' ' LEU . 10.0 t -165.77 -172.62 2.43 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.555 ' H ' ' HG ' ' A' ' 62' ' ' SER . 0.9 OUTLIER -133.05 42.68 3.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 179.06 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.587 ' HH ' ' HG ' ' A' ' 71' ' ' CYS . 0.1 OUTLIER 81.29 96.02 0.05 OUTLIER 'General case' 0 C--N 1.356 0.873 0 CA-C-N 112.779 -2.01 . . . . 0.0 106.205 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.33 19.85 0.11 Allowed Glycine 0 CA--C 1.538 1.515 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.689 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -109.4 -0.81 18.81 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 160.18 13.18 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -81.56 6.87 13.61 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.455 -1.373 . . . . 0.0 108.263 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -48.2 16.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.31 -25.14 62.29 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.587 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 52.7 t -67.46 -57.88 5.75 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.15 25.55 2.14 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 124.879 1.362 . . . . 0.0 109.295 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.414 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -104.63 -32.72 4.08 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.264 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.41 -26.71 24.6 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.488 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.5 mmt85 -73.03 -33.38 65.7 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.69 -19.93 47.79 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.659 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -76.42 -20.33 57.19 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 66.5 m -90.15 -43.22 10.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 123.698 1.713 . . . . 0.0 107.434 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.45 1.09 17.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 108.932 -3.758 . . . . 0.0 108.478 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.89 -54.69 5.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.08 39.37 7.81 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 110.686 -2.961 . . . . 0.0 107.114 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -49.22 0.04 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.43 120.28 27.6 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 122.0 28.59 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.13 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.6 81.73 0.04 OUTLIER Glycine 0 C--N 1.348 1.211 0 CA-C-N 112.339 -2.21 . . . . 0.0 109.995 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -111.78 38.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -145.48 114.17 6.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 98.76 3.5 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 90.84 4.62 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 15.5 m -89.42 93.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 110.294 -3.139 . . . . 0.0 109.696 -175.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.43 118.43 7.84 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 110.181 -3.19 . . . . 0.0 113.912 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.9 -45.1 2.89 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 111.915 -2.143 . . . . 0.0 113.778 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -46.12 129.77 10.04 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 127.743 2.417 . . . . 0.0 107.184 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 60.33 72.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.16 -161.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.312 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.279 17.2 m 61.46 118.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 127.831 2.453 . . . . 0.0 109.482 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 160.07 7.1 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.181 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -152.07 109.57 3.6 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 98.29 -53.01 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -92.73 75.86 4.95 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -83.85 159.92 59.39 Favored Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 112.652 -2.067 . . . . 0.0 105.808 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.34 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.684 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.29 -21.2 64.79 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.724 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.87 -68.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.82 0 O-C-N 124.477 1.111 . . . . 0.0 111.282 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -90.18 27.41 1.64 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 117.986 -1.486 . . . . 0.0 108.967 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -80.51 -41.25 24.59 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -80.52 -31.87 37.01 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.468 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.3 15.11 12.67 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.42 -40.41 12.07 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.2 78.66 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.316 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 37.6 mtp -77.56 -61.45 1.99 Allowed 'General case' 0 C--N 1.354 0.791 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.52 27.13 0.09 OUTLIER Glycine 0 C--N 1.353 1.493 0 CA-C-N 112.177 -2.283 . . . . 0.0 118.085 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.05 -2.7 58.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.22 128.75 53.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 102.937 -2.986 . . . . 0.0 102.937 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.5 t -140.01 151.66 21.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.63 148.06 34.22 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 102.95 -2.982 . . . . 0.0 102.95 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -70.39 155.75 63.18 Favored 'Trans proline' 0 C--N 1.364 1.356 0 N-CA-C 106.017 -2.339 . . . . 0.0 106.017 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -75.93 118.11 4.92 Favored 'Trans proline' 0 C--N 1.365 1.441 0 N-CA-C 105.08 -2.7 . . . . 0.0 105.08 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.46 56.56 5.03 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.186 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.67 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 13.8 t -88.35 179.1 6.4 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 125.151 2.405 . . . . 0.0 107.501 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.708 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.331 21.4 p -75.87 170.68 14.73 Favored Pre-proline 0 N--CA 1.431 -1.4 1 CA-C-N 106.815 -4.72 . . . . 0.0 104.782 178.123 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.38 -3.19 3.82 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 N-CA-C 105.875 -2.394 . . . . 0.0 105.875 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.73 -12.05 60.32 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 125.927 1.691 . . . . 0.0 109.057 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.708 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.1 OUTLIER -75.63 -28.0 58.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.476 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.9 p -87.78 -21.74 24.93 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.483 1.115 . . . . 0.0 110.701 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.6 mt -69.92 -28.87 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.19 58.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.123 -2.308 . . . . 0.0 109.16 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 126' ' ' THR . 7.7 t0 -63.53 -56.43 16.06 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -87.47 1.0 54.72 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 110.854 -2.885 . . . . 0.0 110.311 -177.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -84.37 -47.55 10.59 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 117.302 -1.759 . . . . 0.0 110.079 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.31 -40.49 17.9 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.149 0.906 . . . . 0.0 111.467 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.5 t -68.78 -31.08 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.717 1.261 . . . . 0.0 112.973 -177.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 45.0 mt -90.11 -33.12 16.39 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.6 -93.03 0.02 OUTLIER Glycine 0 C--N 1.355 1.584 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.03 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -169.37 160.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 113.319 -1.44 . . . . 0.0 108.36 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--N 1.349 0.566 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 179.628 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -152.45 81.92 1.24 Allowed 'General case' 0 C--N 1.352 0.696 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.65 -159.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.195 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.59 63.16 0.74 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.267 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.3 p -149.89 110.29 4.21 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.75 109.44 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 111.268 -2.696 . . . . 0.0 104.492 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.96 111.96 23.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -125.21 148.34 48.67 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.127 -177.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.41 -165.27 34.88 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 111.629 -2.532 . . . . 0.0 110.408 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.636 12.4 p 110.68 -113.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 C-N-CA 127.705 2.402 . . . . 0.0 113.091 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.279 3.0 tp 56.06 154.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 129.131 2.972 . . . . 0.0 110.753 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.81 76.84 0.09 OUTLIER Glycine 0 C--N 1.356 1.684 0 CA-C-N 110.485 -3.052 . . . . 0.0 107.269 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -151.25 -111.5 0.05 Allowed 'General case' 0 C--N 1.351 0.637 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -173.24 -142.67 0.03 OUTLIER 'General case' 0 C--N 1.357 0.915 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.5 m 72.16 -108.18 0.04 OUTLIER 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.182 0.926 . . . . 0.0 108.54 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -133.81 41.69 3.0 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.44 45.01 14.23 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.6 t -23.25 120.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 O-C-N 126.279 2.237 . . . . 0.0 113.469 -179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 105.36 -62.45 0.34 Allowed Glycine 0 C--N 1.353 1.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.019 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -27.37 40.14 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 113.413 -1.393 . . . . 0.0 107.333 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -39.48 71.08 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 140.923 7.689 . . . . 0.0 105.376 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 0.2 OUTLIER 47.77 44.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.119 2 CA-C-N 103.287 -6.324 . . . . 0.0 109.448 179.104 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.1 mt -69.4 -20.39 63.8 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 172.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.09 -18.91 65.65 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -71.86 -27.46 62.88 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 p -55.96 -39.52 71.89 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 125.264 1.602 . . . . 0.0 110.55 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -41.27 89.79 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.316 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -21.55 54.77 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 111.606 -2.543 . . . . 0.0 112.431 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -83.67 -3.57 57.87 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.938 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' HB3' ' SD ' ' A' ' 130' ' ' MET . . . -126.14 -7.39 6.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.19 71.64 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.359 1.022 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -141.74 143.52 33.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.5 p -99.64 173.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 111.977 -2.374 . . . . 0.0 107.039 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.08 93.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 111.188 -2.733 . . . . 0.0 105.088 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -68.45 117.29 10.02 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.477 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.3 mt -90.1 -41.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.247 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.64 -129.21 5.75 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.41 44.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 113.249 -1.476 . . . . 0.0 109.626 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.4 tp -163.06 109.52 1.17 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.2 t -85.23 95.27 9.12 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -90.3 138.49 31.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.803 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.41 -90.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.856 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.26 -11.17 13.47 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 124.973 1.42 . . . . 0.0 112.786 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -89.18 -46.14 9.03 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 118.348 -1.341 . . . . 0.0 107.475 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -86.88 6.78 30.21 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 117.964 -1.494 . . . . 0.0 108.568 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.28 -29.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.95 -24.5 58.48 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 -4.2 55.42 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 -12.51 38.43 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -38.33 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.41 -65.27 0.7 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 111.823 -2.444 . . . . 0.0 110.356 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -79.94 -47.5 14.92 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.118 -176.011 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' THR . 3.7 ttmp? 109.8 42.79 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 126.543 2.402 . . . . 0.0 108.357 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.84 120.6 5.46 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 124.485 1.116 . . . . 0.0 108.981 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.73 -66.1 0.96 Allowed 'General case' 0 C--N 1.352 0.708 0 CA-C-N 111.86 -2.427 . . . . 0.0 105.6 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -107.18 148.39 28.93 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.456 1.598 . . . . 0.0 109.35 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -97.62 148.92 5.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 CA-C-N 109.818 -3.355 . . . . 0.0 104.82 178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.42 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 60.9 m -141.73 105.0 4.63 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.69 131.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -110.38 45.35 1.13 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 p -154.06 168.4 26.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 15.3 tp -74.39 -127.04 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 111.251 -2.704 . . . . 0.0 103.823 177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.53 50.67 1.5 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.95 21.13 47.68 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.549 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -124.09 -31.12 3.39 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.55 166.6 41.49 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.088 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.21 -1.35 32.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 113.581 -1.309 . . . . 0.0 108.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -46.19 18.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -74.25 -27.12 60.61 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.928 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m -68.99 -50.69 46.71 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -89.53 21.79 3.26 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.569 1.168 . . . . 0.0 109.481 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -27.04 7.75 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.8 mt -89.99 -32.28 16.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.27 -1.965 . . . . 0.0 106.473 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -75.55 -22.1 57.34 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.89 -31.67 56.91 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.98 -11.69 60.17 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.497 1.123 . . . . 0.0 109.162 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 73.4 m -90.27 -48.05 7.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 123.239 1.495 . . . . 0.0 107.624 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.296 2.9 p30 -78.27 4.23 13.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 109.672 -3.422 . . . . 0.0 109.233 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.96 -53.38 6.19 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.29 39.79 25.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.084 -2.78 . . . . 0.0 108.042 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.29 -48.58 0.05 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.33 119.94 28.11 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 128.96 34.9 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.49 -1.686 . . . . 0.0 106.506 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.02 59.27 0.01 OUTLIER Glycine 0 C--N 1.347 1.164 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.327 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -8.79 11.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 112.509 -1.846 . . . . 0.0 108.593 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -97.54 129.09 44.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -139.97 140.68 36.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.27 92.37 2.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.46 93.97 4.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-O 125.118 2.389 . . . . 0.0 110.358 -176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.48 119.92 8.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 109.895 -3.32 . . . . 0.0 112.453 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.08 -84.04 1.01 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 112.104 -2.048 . . . . 0.0 108.095 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 53.95 -111.54 0.63 Allowed 'General case' 0 C--N 1.353 0.758 0 CA-C-N 111.79 -2.205 . . . . 0.0 107.63 178.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -92.29 126.82 44.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.79 157.44 6.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.74 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 45.28 99.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.918 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.58 152.92 6.11 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 112.091 -2.322 . . . . 0.0 108.895 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -175.83 124.16 0.2 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 86.06 -67.37 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 126.004 2.065 . . . . 0.0 106.369 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.29 134.55 37.93 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -139.03 167.37 19.42 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.75 -145.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.831 1.687 . . . . 0.0 108.549 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.18 -25.06 61.53 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.519 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.7 p -54.13 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 124.768 1.293 . . . . 0.0 111.219 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -90.35 26.74 1.85 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 117.505 -1.678 . . . . 0.0 109.416 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.03 -42.42 63.2 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -89.98 -24.68 21.18 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 111.676 -2.511 . . . . 0.0 108.411 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -85.77 -13.4 48.34 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -90.57 -20.28 22.79 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.75 74.58 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.2 mtt -87.38 -52.01 5.61 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.97 26.24 1.98 Allowed Glycine 0 C--N 1.356 1.671 0 CA-C-N 112.769 -2.014 . . . . 0.0 117.644 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -4.91 58.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.08 119.54 39.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 179.23 4.16 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 48.9 t -140.01 151.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 4.8 m-85 -99.63 153.03 37.98 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -65.16 136.57 48.36 Favored 'Trans proline' 0 C--N 1.371 1.722 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.71 110.62 2.97 Favored 'Trans proline' 0 C--N 1.371 1.721 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.94 -103.61 0.4 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 111.647 -2.524 . . . . 0.0 107.561 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -90.27 167.59 12.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.6 p -168.67 70.75 0.77 Allowed Pre-proline 0 C--N 1.349 0.559 0 CA-C-N 113.136 -1.847 . . . . 0.0 106.04 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.27 -84.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 123.264 2.643 . . . . 0.0 109.473 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.25 -19.47 21.76 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.126 2.17 . . . . 0.0 110.683 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -25.43 62.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 124.051 0.844 . . . . 0.0 109.694 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.498 ' C ' ' H ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -86.11 -23.4 26.66 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 117.419 -1.712 . . . . 0.0 109.579 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.83 -26.12 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.15 -6.46 56.95 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.011 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.498 ' H ' ' C ' ' A' ' 126' ' ' THR . 63.3 t0 -54.22 -66.6 0.37 Allowed 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.425 ' SD ' ' HB3' ' A' ' 30' ' ' ALA . 6.4 mtm -90.36 -6.17 55.34 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 111.343 -2.662 . . . . 0.0 111.755 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.97 -45.33 9.27 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 117.209 -1.796 . . . . 0.0 107.659 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -58.39 -45.8 87.62 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 121.817 0.818 . . . . 0.0 109.168 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 84.6 t -82.24 -71.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.234 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.5 mt -90.12 55.88 3.24 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.579 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.39 -70.78 0.02 OUTLIER Glycine 0 C--N 1.35 1.314 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.651 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -171.38 153.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.446 -1.377 . . . . 0.0 107.598 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 112.566 -2.106 . . . . 0.0 107.355 179.39 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.4 ttp . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.1 74.67 1.61 Allowed 'General case' 0 C--N 1.352 0.694 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -72.92 172.2 11.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 112.153 -2.294 . . . . 0.0 107.503 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 57.3 pttt -108.1 68.99 0.72 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.654 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.9 p -150.44 109.22 3.85 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.57 136.24 60.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.08 133.42 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 124.502 1.127 . . . . 0.0 108.736 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.1 pp -116.25 146.77 42.1 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.252 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -131.2 146.43 17.84 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 112.381 -2.19 . . . . 0.0 109.325 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -120.25 126.49 75.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 124.96 1.035 . . . . 0.0 110.664 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 tp -152.92 139.91 13.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.07 84.69 0.2 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -98.21 47.67 1.0 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 110.826 -2.687 . . . . 0.0 106.711 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -73.0 -40.43 65.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 112.928 -1.942 . . . . 0.0 106.687 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.95 -43.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.596 -2.093 . . . . 0.0 105.578 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -149.98 134.44 17.4 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.78 10.36 40.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.543 -2.571 . . . . 0.0 106.076 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -55.72 116.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.418 0 CA-C-O 121.957 0.884 . . . . 0.0 111.729 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.13 32.68 7.27 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.154 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.442 ' O ' ' N ' ' A' ' 22' ' ' ILE . 6.5 t30 -41.32 -63.88 0.63 Allowed 'General case' 0 C--N 1.368 1.38 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp 12.25 32.68 0.0 OUTLIER 'General case' 0 C--N 1.38 1.913 2 C-N-CA 139.689 7.196 . . . . 0.0 109.855 176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.442 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.307 0.0 OUTLIER 38.82 47.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.777 1 C-N-CA 132.593 4.357 . . . . 0.0 105.786 -175.081 . . . . . . . . 5 4 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD23 ' SG ' ' A' ' 59' ' ' CYS . 0.4 OUTLIER -77.63 -26.27 50.41 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 176.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.31 -18.03 65.01 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.39 -1.732 . . . . 0.0 106.584 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.35 -30.77 68.87 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -45.31 -44.33 11.46 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 124.856 1.348 . . . . 0.0 107.962 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -47.97 74.41 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 111.649 -2.523 . . . . 0.0 109.402 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -14.61 58.42 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 112.296 -2.229 . . . . 0.0 113.748 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -75.49 -14.87 60.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.369 1.867 . . . . 0.0 109.781 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.94 19.42 0.59 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 117.445 -1.702 . . . . 0.0 108.216 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.2 28.4 54.35 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 124.182 0.926 . . . . 0.0 112.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -99.73 160.3 14.4 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.43 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 32.3 t30 -89.21 135.62 33.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.248 -2.251 . . . . 0.0 106.373 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.94 170.05 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-N 111.309 -2.678 . . . . 0.0 106.973 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -140.14 106.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 111.557 -2.565 . . . . 0.0 105.446 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.55 123.71 32.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -89.84 -30.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 -129.24 9.83 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.8 m -98.18 -12.69 8.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 113.353 -1.423 . . . . 0.0 110.002 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.75 86.91 6.8 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -91.44 58.08 3.5 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 112.869 -1.968 . . . . 0.0 105.909 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.5 p -90.03 116.37 28.01 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.385 -3.561 . . . . 0.0 101.385 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -89.96 -54.09 4.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.866 -176.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -62.36 -32.68 73.5 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.143 1.527 . . . . 0.0 110.449 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -79.36 -26.46 42.07 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -86.94 4.15 42.79 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.541 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.69 -37.35 20.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.064 0 N-CA-C 102.475 -3.158 . . . . 0.0 102.475 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -73.93 -28.68 61.64 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 112.482 -2.145 . . . . 0.0 106.997 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.82 0.54 56.96 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.031 179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 -7.67 53.35 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.09 -39.83 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.95 -75.54 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.746 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 p -74.07 -19.28 60.66 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 123.961 0.788 . . . . 0.0 110.471 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 72.47 50.83 0.18 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.99 130.93 35.2 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 125.251 1.594 . . . . 0.0 107.537 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -104.22 -77.12 0.58 Allowed 'General case' 0 C--N 1.364 1.228 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -87.4 147.66 25.35 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.016 1.448 . . . . 0.0 108.072 -176.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.15 165.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 111.458 -2.61 . . . . 0.0 105.78 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.41 ' SG ' HD23 ' A' ' 23' ' ' LEU . 1.9 p -161.94 158.78 25.73 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.62 168.95 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 69.21 1.05 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 p -174.32 168.48 3.94 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.243 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' H51' ' A' ' 138' ' ' FOP . 65.3 mt -79.73 -105.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 110.732 -2.94 . . . . 0.0 103.203 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -102.68 27.08 7.26 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 112.808 -1.996 . . . . 0.0 106.498 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.74 -9.68 84.92 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.305 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -80.01 -34.66 38.26 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.3 -178.32 49.18 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 113.002 -1.908 . . . . 0.0 112.226 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -77.92 -12.19 59.96 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.152 -2.024 . . . . 0.0 108.644 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -49.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -72.37 -29.44 63.78 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.853 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.43 ' C ' ' H ' ' A' ' 73' ' ' GLY . 82.2 m -65.87 -57.04 8.83 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -88.27 27.46 1.23 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 125.316 1.635 . . . . 0.0 109.944 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -98.21 -30.41 7.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 176.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 8.0 mt -90.03 -33.84 16.19 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 111.644 -2.278 . . . . 0.0 107.788 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -24.37 61.06 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.77 -31.42 35.82 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -76.51 -15.09 59.97 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 124.139 0.899 . . . . 0.0 109.479 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.32 -47.04 8.01 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 123.94 1.829 . . . . 0.0 107.293 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.43 -3.58 25.07 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 108.531 -3.94 . . . . 0.0 109.041 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -81.24 -56.65 3.93 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.35 48.93 7.41 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 110.931 -2.85 . . . . 0.0 106.82 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.96 -42.15 0.02 OUTLIER Glycine 0 C--N 1.35 1.335 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.017 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.78 124.95 28.73 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 117.08 15.33 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.73 107.04 0.4 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 112.777 -2.011 . . . . 0.0 109.557 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -157.01 46.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -151.24 119.65 6.42 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -139.3 149.09 43.83 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 94.59 2.76 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.87 100.07 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 111.209 -2.723 . . . . 0.0 109.732 -175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.44 81.61 0.38 Allowed Glycine 0 CA--C 1.533 1.178 0 CA-C-N 108.434 -3.985 . . . . 0.0 112.745 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.4 -85.68 0.26 Allowed Glycine 0 C--N 1.351 1.412 0 CA-C-N 112.714 -1.743 . . . . 0.0 109.376 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 65.6 t30 65.29 -116.15 0.34 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.901 -1.649 . . . . 0.0 106.932 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -104.4 129.34 56.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.42 169.06 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.893 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p 45.63 48.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.812 0 CA-C-N 112.713 -2.039 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 139.03 3.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 112.282 -2.236 . . . . 0.0 108.767 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -161.17 111.52 1.71 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 96.96 -45.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 112.548 -2.115 . . . . 0.0 105.83 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.17 126.54 35.84 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -138.03 160.11 65.72 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.59 -148.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 N-CA-C 107.759 -1.669 . . . . 0.0 107.759 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.48 -20.43 58.79 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.665 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -60.12 -64.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 124.433 1.083 . . . . 0.0 111.429 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -89.4 18.67 5.04 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 117.009 -1.876 . . . . 0.0 107.965 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.79 -39.08 66.99 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -80.78 -32.16 35.54 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.691 -2.049 . . . . 0.0 106.826 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -91.74 15.03 13.63 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.737 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.7 -41.36 11.33 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.04 74.29 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 112.21 -2.268 . . . . 0.0 107.418 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.3 mtp -82.35 -57.99 3.13 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 27.61 43.32 0.03 OUTLIER Glycine 0 C--N 1.357 1.741 0 C-N-CA 127.401 2.429 . . . . 0.0 117.355 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.8 -2.76 58.82 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -105.01 131.22 52.81 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.475 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.07 169.74 8.53 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 178.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.92 159.41 36.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -99.46 161.39 24.74 Favored Pre-proline 0 N--CA 1.447 -0.615 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.53 158.1 58.67 Favored 'Trans proline' 0 C--N 1.368 1.559 0 N-CA-C 106.873 -2.01 . . . . 0.0 106.873 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.37 122.35 9.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 104.81 -2.804 . . . . 0.0 104.81 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.76 140.88 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 105.905 -2.878 . . . . 0.0 105.905 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 t -75.34 162.05 28.74 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 125.422 2.535 . . . . 0.0 108.164 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.3 p -167.78 113.4 0.62 Allowed Pre-proline 0 N--CA 1.427 -1.595 1 CA-C-N 106.12 -5.036 . . . . 0.0 101.019 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.01 -1.22 11.42 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.234 1.289 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.2 -30.28 67.35 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -16.66 54.41 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.541 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 129' ' ' ASP . 24.1 p -79.04 -25.34 43.2 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 116.67 -2.012 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.52 -26.56 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -3.18 56.31 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.04 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 126' ' ' THR . 38.4 t0 -62.07 -52.76 62.64 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.2 mmt -87.77 -22.85 24.31 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.36 -2.2 . . . . 0.0 110.725 -177.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.92 -12.96 46.12 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.098 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -90.11 -52.9 4.72 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.475 ' HA ' HH21 ' A' ' 115' ' ' ARG . 23.1 t -69.74 -58.88 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.364 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 -14.32 34.12 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 124.431 1.082 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.71 -72.59 1.28 Allowed Glycine 0 C--N 1.357 1.721 0 C-N-CA 118.542 -1.789 . . . . 0.0 111.461 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -174.12 152.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 113.624 -1.288 . . . . 0.0 107.885 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.693 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . 0.4 ' H51' ' H ' ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.77 79.78 4.73 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.61 177.33 6.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.777 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.509 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -105.5 103.58 13.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 110.018 -3.265 . . . . 0.0 109.435 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 172.3 113.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.03 110.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.88 131.23 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.031 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.412 HD22 ' CG ' ' A' ' 23' ' ' LEU . 1.5 tm? -125.84 130.25 51.0 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.174 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 171.39 23.72 Favored Glycine 0 C--N 1.36 1.876 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.932 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.28 136.94 13.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.009 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 ' H ' ' HG ' ' A' ' 62' ' ' SER . 4.3 tp -155.01 88.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 115.448 -2.501 . . . . 0.0 110.06 -178.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.51 108.75 0.38 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 106.636 -2.585 . . . . 0.0 106.636 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 t -85.97 159.63 19.57 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 123.798 1.761 . . . . 0.0 109.52 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -174.38 56.28 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 109.04 -3.709 . . . . 0.0 103.199 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 m 86.79 -56.25 0.05 Allowed 'General case' 0 C--N 1.363 1.17 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.057 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -135.44 -36.27 0.79 Allowed 'General case' 0 C--N 1.357 0.929 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 101.05 -11.67 0.03 OUTLIER 'General case' 0 C--N 1.358 0.936 0 O-C-N 125.9 2.0 . . . . 0.0 107.045 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.425 ' CB ' ' HB ' ' A' ' 121' ' ' THR 0.312 3.3 m 68.18 16.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 O-C-N 124.311 1.007 . . . . 0.0 110.757 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.53 -40.67 5.31 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 123.076 1.375 . . . . 0.0 110.255 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -46.35 -54.52 8.85 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 111.479 -2.361 . . . . 0.0 106.03 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -14.83 57.78 0.0 OUTLIER 'General case' 0 C--N 1.38 1.914 2 C-N-CA 140.008 7.323 . . . . 0.0 108.515 177.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.408 ' CG2' ' HB2' ' A' ' 25' ' ' HIS 0.286 0.0 OUTLIER 31.54 52.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.342 2 CA-C-N 105.157 -5.474 . . . . 0.0 108.155 -178.367 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' CG ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -72.27 -25.91 61.78 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.93 -15.83 63.79 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.408 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 14.6 t-80 -72.88 -27.29 61.81 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -50.88 -44.16 59.72 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 125.492 1.745 . . . . 0.0 109.422 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.7 -47.23 80.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.694 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -17.15 61.34 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 111.828 -2.442 . . . . 0.0 113.039 -176.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -18.95 60.64 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 128.372 2.669 . . . . 0.0 109.773 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.43 11.93 2.76 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 124.598 1.186 . . . . 0.0 107.936 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.74 25.79 52.41 Favored Glycine 0 C--N 1.356 1.671 0 O-C-N 124.271 0.982 . . . . 0.0 112.922 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -99.78 145.49 27.64 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.509 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 29.9 m-20 -69.33 137.62 53.09 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 111.846 -2.434 . . . . 0.0 108.099 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.82 172.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 112.117 -2.311 . . . . 0.0 108.886 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.97 73.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 108.786 -3.825 . . . . 0.0 103.71 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -70.11 118.45 12.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.434 HG21 ' H ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -89.66 -90.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.713 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 -177.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' H ' HG21 ' A' ' 37' ' ' ILE . . . 176.8 -112.26 0.38 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -54.59 7.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.055 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.73 153.43 24.16 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.526 -1.67 . . . . 0.0 106.576 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -153.35 59.24 0.76 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.84 158.53 0.48 Allowed 'General case' 0 C--N 1.359 0.99 0 CA-C-N 110.284 -3.144 . . . . 0.0 108.921 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -82.81 -89.24 0.09 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 112.107 -2.315 . . . . 0.0 108.645 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -15.6 31.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 124.736 1.272 . . . . 0.0 112.247 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -90.09 -39.15 13.07 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 118.178 -1.409 . . . . 0.0 107.342 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -81.69 -9.99 59.5 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 117.641 -1.624 . . . . 0.0 109.166 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -28.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -75.66 -28.06 58.58 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.18 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.05 -15.94 30.76 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.22 -38.5 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 104.324 -2.472 . . . . 0.0 104.324 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -62.58 -71.81 0.15 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.24 -2.255 . . . . 0.0 111.087 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -74.59 -38.63 62.57 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.845 0.716 . . . . 0.0 110.629 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 98.28 41.65 0.0 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.49 126.06 20.19 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.266 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -106.08 -79.5 0.56 Allowed 'General case' 0 C--N 1.359 0.989 0 O-C-N 125.337 1.648 . . . . 0.0 106.558 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.45 114.21 20.04 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.91 123.75 54.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.6 m -145.47 145.66 31.18 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-O 123.836 1.779 . . . . 0.0 107.932 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.31 3.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 110.343 -3.117 . . . . 0.0 105.042 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.32 103.75 4.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 117.218 -1.793 . . . . 0.0 107.298 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.455 ' HG ' ' H ' ' A' ' 11' ' ' ILE . 15.4 m 177.78 173.95 0.54 Allowed 'General case' 0 C--N 1.359 1.017 0 O-C-N 126.412 2.32 . . . . 0.0 106.057 178.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.09 -147.07 0.06 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 111.637 -2.529 . . . . 0.0 104.782 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.42 92.91 7.67 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.95 -29.43 1.82 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-N 111.419 -2.628 . . . . 0.0 108.77 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -86.24 -24.73 25.9 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 112.589 -1.806 . . . . 0.0 107.28 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 178.99 49.36 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.745 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.04 -12.97 59.65 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 111.853 -2.174 . . . . 0.0 108.246 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -76.6 -49.21 24.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -72.82 -16.83 61.6 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.687 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.402 ' C ' ' H ' ' A' ' 73' ' ' GLY . 8.8 t -72.14 -42.23 66.23 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -90.09 20.07 4.55 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 124.672 1.232 . . . . 0.0 108.953 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -97.03 -34.24 5.74 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.355 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.28 -23.47 22.3 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 113.04 -1.58 . . . . 0.0 106.845 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -26.92 56.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -81.04 -24.12 38.08 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.512 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -76.55 -17.77 59.04 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 124.113 0.883 . . . . 0.0 108.712 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 86' ' ' ILE . 68.1 m -90.23 -43.9 10.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 123.875 1.798 . . . . 0.0 107.345 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.45 -0.92 21.73 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.701 -3.863 . . . . 0.0 108.624 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.12 -53.6 6.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.65 41.7 11.86 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 110.855 -2.884 . . . . 0.0 107.303 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.44 -47.2 0.03 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.795 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -88.51 118.26 28.03 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 111.89 14.03 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 112.362 -2.199 . . . . 0.0 106.144 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.37 59.26 0.06 OUTLIER Glycine 0 C--N 1.348 1.22 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 78' ' ' CYS . 1.8 mt -91.15 0.75 8.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 CA-C-N 112.29 -1.955 . . . . 0.0 106.973 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -112.83 117.69 32.85 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.16 121.89 15.36 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.404 ' CE1' ' HB2' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -104.77 117.23 33.55 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 101.414 -3.55 . . . . 0.0 101.414 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.1 t -89.73 89.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 110.827 -2.897 . . . . 0.0 108.491 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.13 108.39 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 109.52 -3.491 . . . . 0.0 109.417 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.66 -122.74 10.71 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 106.773 -2.531 . . . . 0.0 106.773 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.4 t30 68.97 145.99 0.05 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 125.397 1.293 . . . . 0.0 108.269 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 55.95 81.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 CA-C-N 112.31 -2.223 . . . . 0.0 107.614 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.54 155.64 6.13 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 112.537 -2.12 . . . . 0.0 108.538 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p 46.07 51.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 CA-C-N 112.83 -1.987 . . . . 0.0 111.829 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.83 138.34 5.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.163 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -167.24 140.3 3.5 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.08 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.846 0 O-C-N 125.966 2.041 . . . . 0.0 105.878 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -87.11 114.99 24.2 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -95.15 161.91 26.58 Favored Pre-proline 0 C--N 1.349 0.562 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.738 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.79 -150.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.927 1.751 . . . . 0.0 108.904 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.66 -25.75 62.25 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.19 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . 0.272 0.1 OUTLIER -54.8 -67.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 124.886 1.366 . . . . 0.0 110.457 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -90.24 20.31 4.48 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 117.951 -1.499 . . . . 0.0 109.149 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.39 -51.78 53.5 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -90.28 -15.59 30.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -89.5 -45.42 9.43 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 117.802 -1.559 . . . . 0.0 108.714 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -77.75 -2.11 34.65 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.723 1.264 . . . . 0.0 107.783 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.53 77.18 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -83.97 -53.95 5.2 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.97 40.51 58.2 Favored Glycine 0 C--N 1.362 1.996 0 O-C-N 124.677 1.236 . . . . 0.0 116.065 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -6.92 59.43 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.09 137.8 42.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.404 ' HB2' ' CE1' ' A' ' 89' ' ' PHE . 0.0 OUTLIER -110.35 173.63 6.24 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.12 160.01 26.07 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -99.61 160.54 27.12 Favored Pre-proline 0 C--N 1.355 0.82 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.19 149.01 45.15 Favored 'Trans proline' 0 C--N 1.366 1.46 0 N-CA-C 104.412 -2.957 . . . . 0.0 104.412 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.26 110.05 2.97 Favored 'Trans proline' 0 C--N 1.366 1.489 0 N-CA-C 104.812 -2.803 . . . . 0.0 104.812 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.41 158.65 7.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.716 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.425 ' HB ' ' CB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.63 143.44 46.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.743 -1.729 . . . . 0.0 106.718 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 p 174.0 100.37 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 110.763 -2.926 . . . . 0.0 106.41 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.29 -2.87 13.13 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.861 1.707 . . . . 0.0 108.155 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.96 -37.9 89.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.352 1.861 . . . . 0.0 107.757 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.82 -21.42 57.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.928 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.494 ' C ' ' H ' ' A' ' 129' ' ' ASP . 2.3 p -80.65 -17.22 51.89 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 117.183 -1.807 . . . . 0.0 110.517 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mt -67.9 -31.53 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.12 2.66 55.05 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.763 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 126' ' ' THR . 61.0 t0 -60.29 -61.69 2.42 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 11.1 mmm -90.1 -15.5 31.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.999 -2.818 . . . . 0.0 111.57 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -87.52 -13.32 43.35 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 118.026 -1.469 . . . . 0.0 108.801 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -90.35 -56.59 3.15 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.5 t -57.56 -51.58 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 112.077 -2.329 . . . . 0.0 114.0 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.4 mp -89.66 -35.93 15.54 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 124.343 1.027 . . . . 0.0 108.604 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.67 -74.8 0.51 Allowed Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.028 -1.558 . . . . 0.0 112.772 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.39 148.06 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 122.425 1.107 . . . . 0.0 109.033 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 CA--C 1.545 0.759 0 CA-C-N 111.468 -2.606 . . . . 0.0 107.946 179.688 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.6 ttp . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -127.26 79.95 1.92 Allowed 'General case' 0 C--N 1.352 0.678 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.91 -176.9 3.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 111.862 -2.426 . . . . 0.0 107.969 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -120.43 63.81 0.84 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 110.809 -2.905 . . . . 0.0 108.442 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -149.54 106.42 3.56 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.0 mm -121.87 125.72 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 109.772 -3.377 . . . . 0.0 102.641 -177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.86 134.05 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 124.766 1.291 . . . . 0.0 109.278 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.18 138.74 54.13 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 113.237 -1.801 . . . . 0.0 107.489 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.5 21.41 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.844 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.5 119.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 118.012 -1.475 . . . . 0.0 110.866 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.434 ' CD1' ' H ' ' A' ' 12' ' ' GLY . 1.9 tp -112.48 179.32 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.434 ' H ' ' CD1' ' A' ' 11' ' ' ILE . . . 92.14 98.73 1.35 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -80.95 0.05 37.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.213 -1.993 . . . . 0.0 109.301 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.0 118.77 17.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 m 85.77 -70.81 0.03 OUTLIER 'General case' 0 C--N 1.359 0.99 0 O-C-N 125.585 1.803 . . . . 0.0 106.777 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -157.39 -69.75 0.1 Allowed 'General case' 0 C--N 1.365 1.276 0 C-N-CA 115.791 -2.363 . . . . 0.0 106.827 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 127.19 36.24 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -73.21 111.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.383 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.61 11.61 62.97 Favored Glycine 0 C--N 1.359 1.826 0 CA-C-O 123.425 1.57 . . . . 0.0 112.491 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.6 m-20 -44.95 -63.07 1.0 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp 10.26 38.41 0.0 OUTLIER 'General case' 0 C--N 1.378 1.826 2 C-N-CA 138.349 6.66 . . . . 0.0 109.472 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.412 42.0 pt 33.91 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.753 1 C-N-CA 132.228 4.211 . . . . 0.0 107.976 -176.034 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mt -74.38 -42.27 59.56 Favored 'General case' 0 C--N 1.373 1.604 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.81 -0.58 16.27 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 112.191 -2.277 . . . . 0.0 108.44 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -79.23 -43.72 23.23 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 117.679 -1.608 . . . . 0.0 107.885 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -19.78 65.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.684 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.3 -43.98 93.05 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.3 -28.18 64.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 110.708 -2.951 . . . . 0.0 111.985 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.57 2.71 50.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 111.836 -2.438 . . . . 0.0 108.823 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.28 4.98 5.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.49 30.38 61.88 Favored Glycine 0 C--N 1.361 1.942 0 O-C-N 124.306 1.004 . . . . 0.0 112.251 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.36 -175.58 2.84 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -106.93 150.73 26.14 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.2 p -99.93 146.21 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 111.047 -2.797 . . . . 0.0 108.115 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.9 t -140.04 82.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 111.317 -2.674 . . . . 0.0 105.333 179.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -87.83 123.95 33.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -93.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.866 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.55 -120.76 0.58 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.56 10.95 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 113.277 -1.461 . . . . 0.0 110.405 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.22 129.45 34.96 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 t -98.51 41.42 1.14 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-N 113.072 -1.876 . . . . 0.0 107.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.9 p -90.11 80.21 6.35 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -78.32 -36.75 46.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.309 -2.223 . . . . 0.0 108.573 -177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -35.64 79.79 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.312 1.007 . . . . 0.0 108.619 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.82 -24.8 41.13 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.2 -10.17 59.66 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.73 -33.93 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -74.15 -31.52 62.76 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.368 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.61 -0.5 57.33 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.12 -13.92 34.76 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.88 -41.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.75 -60.49 3.75 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 112.263 -2.244 . . . . 0.0 108.229 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 16.7 m -60.32 -66.44 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 113.454 -1.703 . . . . 0.0 107.819 -178.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 102.74 35.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 O-C-N 126.782 2.552 . . . . 0.0 104.294 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.8 107.88 0.1 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 128.457 2.703 . . . . 0.0 109.222 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.88 -42.28 11.95 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.43 144.5 31.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 117.548 -1.661 . . . . 0.0 107.113 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.05 146.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 110.71 -2.95 . . . . 0.0 105.254 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.582 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 9.0 t -150.5 125.88 10.11 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.85 -178.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.852 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.037 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.74 97.12 3.57 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 p 155.93 152.6 0.01 OUTLIER 'General case' 0 C--N 1.356 0.876 0 CA-C-N 112.681 -2.054 . . . . 0.0 106.98 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -65.84 -110.63 0.0 OUTLIER 'General case' 0 C--N 1.36 1.032 0 CA-C-N 111.884 -2.416 . . . . 0.0 105.105 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.94 68.47 2.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -131.73 55.68 0.76 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 109.63 -3.441 . . . . 0.0 105.016 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.0 pt20 -167.14 -28.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 111.044 -2.578 . . . . 0.0 106.977 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 74.54 -177.21 47.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.029 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -76.61 -3.41 37.55 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.35 -2.425 . . . . 0.0 108.376 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -71.55 -53.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.0 -22.13 59.72 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 112.561 -2.109 . . . . 0.0 109.111 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.67 -64.24 0.9 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -90.15 27.99 1.51 Allowed 'General case' 0 C--N 1.355 0.807 0 O-C-N 124.717 1.26 . . . . 0.0 109.798 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.63 -40.68 3.81 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.7 mt -88.58 -22.77 23.35 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 111.92 -2.14 . . . . 0.0 108.517 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.431 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.9 mmt85 -78.71 -26.98 44.9 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.62 -26.74 41.1 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -75.98 -16.75 59.93 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.123 0.889 . . . . 0.0 109.227 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.3 t -90.21 -46.26 8.55 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 123.948 1.832 . . . . 0.0 107.319 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.15 -4.94 28.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 108.536 -3.938 . . . . 0.0 109.002 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.22 -56.29 4.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.0 47.81 4.11 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 110.881 -2.872 . . . . 0.0 106.527 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.54 -42.14 0.02 OUTLIER Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.654 -2.067 . . . . 0.0 109.9 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.34 122.94 27.55 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 128.3 34.8 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.26 113.6 1.55 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.221 -2.263 . . . . 0.0 108.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -146.41 35.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -141.15 112.98 7.72 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 103.527 -2.768 . . . . 0.0 103.527 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.52 106.39 8.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 85.39 3.09 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 100.613 -3.847 . . . . 0.0 100.613 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.26 101.5 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 126.221 2.915 . . . . 0.0 110.085 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.27 116.55 4.77 Favored Glycine 0 C--N 1.343 0.961 1 CA-C-N 108.239 -4.073 . . . . 0.0 108.489 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.64 -84.91 0.44 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 105.738 -2.945 . . . . 0.0 105.738 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t30 72.24 -84.34 0.03 OUTLIER 'General case' 0 C--N 1.357 0.935 0 CA-C-N 112.879 -1.66 . . . . 0.0 107.681 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.37 135.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.34 158.06 4.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.57 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 42.68 75.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.757 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.47 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.2 135.14 1.94 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.196 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -174.16 110.73 0.16 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 91.45 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.355 0.841 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -94.14 135.73 35.19 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -143.06 162.94 40.73 Favored Pre-proline 0 C--N 1.35 0.605 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.27 -150.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.478 -1.778 . . . . 0.0 107.478 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.11 -22.26 63.03 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.216 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.3 p -58.13 -69.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 O-C-N 124.483 1.114 . . . . 0.0 111.214 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -90.17 24.92 2.33 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.501 -1.68 . . . . 0.0 108.209 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -77.32 -41.03 42.13 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.43 -32.55 42.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 112.472 -2.149 . . . . 0.0 106.41 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -92.78 16.68 11.82 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.678 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -39.82 12.33 Favored 'General case' 0 C--N 1.361 1.096 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.29 75.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.028 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtp -78.96 -60.77 2.25 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.32 37.34 0.02 OUTLIER Glycine 0 C--N 1.356 1.643 0 C-N-CA 128.056 2.741 . . . . 0.0 117.642 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.73 -0.23 57.41 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.18 134.51 48.17 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.23 176.54 5.01 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.01 161.61 25.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.792 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.582 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 5.6 m-85 -99.88 154.9 37.0 Favored Pre-proline 0 C--N 1.355 0.842 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.964 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.49 162.21 38.53 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 106.84 -2.023 . . . . 0.0 106.84 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.53 124.9 10.18 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 105.201 -2.653 . . . . 0.0 105.201 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.13 137.05 9.46 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -73.85 154.34 39.51 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 125.584 2.612 . . . . 0.0 107.492 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 p -166.11 108.67 0.71 Allowed Pre-proline 0 N--CA 1.426 -1.642 1 CA-C-N 105.819 -5.173 . . . . 0.0 100.362 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -78.61 0.31 10.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.3 -38.35 87.53 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.945 1.698 . . . . 0.0 107.631 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -24.29 59.96 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.985 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.493 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.7 p -84.64 -19.84 32.28 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.957 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -64.69 -30.17 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.49 -7.65 59.61 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 111.712 -2.495 . . . . 0.0 108.798 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 126' ' ' THR . 25.4 t0 -53.7 -72.34 0.06 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-O 122.116 0.96 . . . . 0.0 108.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 4.9 mmt -86.67 -6.07 58.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 112.302 -2.226 . . . . 0.0 110.336 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.14 -66.01 0.96 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.834 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -48.02 -44.69 31.19 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.34 1.056 . . . . 0.0 111.021 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.425 ' HA ' HH21 ' A' ' 115' ' ' ARG . 25.6 t -65.37 -65.57 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 49.8 mt -90.52 55.76 3.11 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.65 -83.59 0.05 OUTLIER Glycine 0 C--N 1.35 1.318 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -164.24 152.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 113.272 -1.464 . . . . 0.0 107.862 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--N 1.346 0.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.554 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -90.49 77.01 6.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -73.05 -162.43 0.11 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 111.689 -2.505 . . . . 0.0 107.505 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -149.69 99.74 2.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.188 -1.824 . . . . 0.0 106.253 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.62 100.33 0.01 OUTLIER 'General case' 0 C--N 1.355 0.845 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.8 116.43 48.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.8 p -107.43 112.25 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 111.621 -2.536 . . . . 0.0 109.113 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.16 134.44 51.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.449 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . 169.86 168.03 31.18 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.734 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.551 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 167.57 -121.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.662 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.513 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 0.7 OUTLIER -142.92 -168.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.094 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.221 -177.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.82 162.34 27.2 Favored Glycine 0 C--N 1.364 2.103 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.156 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -105.97 -24.51 12.4 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 110.755 -2.722 . . . . 0.0 107.618 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -134.56 156.4 48.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.66 58.06 1.04 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -173.36 131.92 0.47 Allowed 'General case' 0 C--N 1.365 1.243 0 C-N-CA 116.988 -1.885 . . . . 0.0 107.509 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 22.11 63.36 0.03 OUTLIER 'General case' 0 C--N 1.354 0.796 0 C-N-CA 131.344 3.858 . . . . 0.0 111.278 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.4 66.5 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.628 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.08 -34.57 3.21 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.832 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -39.21 -48.33 1.75 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 112.285 -1.958 . . . . 0.0 106.559 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -5.81 50.11 0.0 OUTLIER 'General case' 0 C--N 1.392 2.423 2 C-N-CA 140.728 7.611 . . . . 0.0 108.365 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.328 0.0 OUTLIER 34.67 54.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.605 1 CA-C-N 106.871 -4.695 . . . . 0.0 106.437 -175.847 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.9 -21.78 65.99 Favored 'General case' 0 C--N 1.377 1.773 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -67.57 -20.47 65.39 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 116.514 -2.075 . . . . 0.0 107.299 176.284 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -66.02 -29.96 70.41 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.48 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 37.0 t -67.19 -18.38 65.23 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.608 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.496 ' CE2' ' CB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -56.73 -47.1 80.76 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.07 69.11 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 110.482 -3.054 . . . . 0.0 112.763 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -84.72 7.53 20.2 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 111.559 -2.564 . . . . 0.0 108.632 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.78 -0.99 5.39 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.61 28.88 68.5 Favored Glycine 0 C--N 1.36 1.902 0 O-C-N 124.139 0.899 . . . . 0.0 111.377 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -105.38 -168.01 1.4 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 113.342 -1.429 . . . . 0.0 107.605 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.56 149.69 21.02 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.093 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.496 ' CB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.8 124.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 108.871 -3.786 . . . . 0.0 108.79 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.33 132.93 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 110.896 -2.865 . . . . 0.0 105.429 176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -139.02 133.19 31.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.55 -20.15 6.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.567 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.68 -123.36 7.9 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.14 113.38 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-O 122.324 1.059 . . . . 0.0 109.28 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.7 tt -175.25 137.79 0.4 Allowed 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 t -94.54 39.55 1.09 Allowed 'General case' 0 C--N 1.354 0.776 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.55 91.52 8.47 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -90.02 -58.54 2.47 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.61 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -59.93 -20.92 60.08 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 124.771 1.294 . . . . 0.0 112.04 -176.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.95 -38.89 14.14 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.878 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -89.15 12.65 15.2 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.907 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.97 -34.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 175.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.73 -27.93 62.34 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -84.41 -16.65 41.95 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.63 -7.6 58.65 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.2 -43.06 18.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -60.61 -64.0 1.1 Allowed 'General case' 0 C--N 1.354 0.802 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.492 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.84 82.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.4 tttp 84.38 54.47 0.01 OUTLIER 'General case' 0 C--N 1.345 0.386 0 CA-C-N 112.022 -2.354 . . . . 0.0 105.02 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 124.51 23.75 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.112 -2.313 . . . . 0.0 107.489 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.99 -84.09 0.15 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.82 145.62 26.78 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.62 142.37 43.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.1 m -129.56 131.92 46.69 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 112.18 -2.282 . . . . 0.0 105.815 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.32 133.17 63.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.727 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.551 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -110.32 90.77 3.42 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 123.979 1.847 . . . . 0.0 107.016 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.589 ' HG ' ' H ' ' A' ' 65' ' ' GLY . 31.2 t -131.12 176.93 7.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.257 -2.701 . . . . 0.0 106.544 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 52.55 1.02 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 110.405 -3.089 . . . . 0.0 105.906 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 60.9 49.01 6.22 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.602 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.589 ' H ' ' HG ' ' A' ' 62' ' ' SER . . . -129.2 -0.07 5.96 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.868 178.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.13 -2.86 49.06 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.67 177.56 8.58 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.35 1.031 . . . . 0.0 111.652 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.17 25.58 2.14 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 112.871 -1.665 . . . . 0.0 108.188 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -52.68 10.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -71.81 -26.86 62.57 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 112.703 -2.044 . . . . 0.0 107.26 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 t -67.78 -58.22 4.98 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -90.07 30.13 1.13 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 124.48 1.112 . . . . 0.0 109.426 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.49 -37.79 3.91 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -90.01 -23.77 21.4 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.625 179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -29.6 57.26 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.93 -28.21 55.15 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -16.82 60.62 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 124.155 0.909 . . . . 0.0 109.368 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 39.8 t -90.24 -46.85 8.15 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.847 1.784 . . . . 0.0 107.518 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -75.41 2.34 11.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 108.715 -3.857 . . . . 0.0 109.11 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.72 -55.59 3.9 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 44.78 7.93 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 110.958 -2.837 . . . . 0.0 106.798 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.01 -43.7 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.392 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.06 121.11 25.11 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 140.75 32.65 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 113.302 -1.772 . . . . 0.0 106.412 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.74 71.16 0.28 Allowed Glycine 0 C--N 1.351 1.364 0 CA-C-N 112.633 -2.076 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 tt -103.73 35.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -128.01 118.1 22.91 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -140.29 151.93 45.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.592 -2.094 . . . . 0.0 105.73 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 106.24 5.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 100.654 -3.832 . . . . 0.0 100.654 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.87 93.58 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 125.114 2.388 . . . . 0.0 110.164 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.69 118.47 13.5 Favored Glycine 0 CA--C 1.537 1.453 1 CA-C-N 107.975 -4.193 . . . . 0.0 111.137 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.82 -92.39 1.62 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 72.75 -142.6 0.04 OUTLIER 'General case' 0 C--N 1.356 0.885 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -91.68 148.71 4.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.31 -164.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 CA-C-N 112.548 -2.115 . . . . 0.0 108.423 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 p 41.77 74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.04 33.79 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 112.068 -2.333 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -159.93 -46.72 0.05 Allowed 'General case' 0 C--N 1.347 0.473 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -129.7 -44.27 1.21 Allowed 'General case' 0 C--N 1.349 0.549 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.97 95.58 9.54 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -103.0 164.24 15.93 Favored Pre-proline 0 C--N 1.35 0.624 0 CA-C-N 112.483 -2.144 . . . . 0.0 105.36 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.08 -152.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.784 1.656 . . . . 0.0 108.792 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.33 -25.54 64.26 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 113.431 -1.713 . . . . 0.0 108.456 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.0 p -53.53 -74.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 O-C-N 124.912 1.382 . . . . 0.0 110.749 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -90.07 28.71 1.34 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.5 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -76.62 -45.33 30.53 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -80.58 -31.38 36.79 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 111.495 -2.593 . . . . 0.0 107.381 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.3 10.7 21.31 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 118.584 -1.247 . . . . 0.0 109.125 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.31 14.12 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -33.93 74.39 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.652 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 55.7 mtp -81.29 -60.49 2.26 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 34.68 37.55 0.1 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 112.31 -2.223 . . . . 0.0 117.243 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -79.84 -15.47 57.33 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -101.63 138.8 38.14 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.556 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 178.79 4.28 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 177.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.19 156.89 24.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.53 114.24 65.46 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 101.785 -3.413 . . . . 0.0 101.785 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -55.34 157.89 13.54 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.418 2.745 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.96 121.03 8.17 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 105.918 -2.378 . . . . 0.0 105.918 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 65.91 0.96 Allowed Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.388 -2.187 . . . . 0.0 107.901 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.4 p -82.12 -151.99 0.1 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.424 -2.388 . . . . 0.0 107.173 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.772 ' HG ' ' HG1' ' A' ' 125' ' ' THR . 2.2 p 176.97 166.33 0.47 Allowed Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 110.805 -2.907 . . . . 0.0 104.243 -179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.61 -5.15 15.27 Favored 'Trans proline' 0 C--N 1.365 1.424 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.48 -23.87 53.81 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.772 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -77.15 -17.82 58.32 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.753 -179.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.471 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.0 p -87.19 -20.79 26.48 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.914 0.758 . . . . 0.0 110.613 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.89 -27.2 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.66 -1.01 57.61 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.606 -2.088 . . . . 0.0 109.264 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' A' ' 126' ' ' THR . 19.0 t0 -69.75 -68.03 0.44 Allowed 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.48 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 1.9 mpt? -74.45 -13.65 60.73 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.803 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -90.04 -43.45 10.5 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.999 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.39 -31.74 70.65 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 121.053 0.454 . . . . 0.0 109.789 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 53.8 t -90.09 -77.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.327 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 27.2 mt -90.49 63.06 5.44 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.643 1.215 . . . . 0.0 108.839 -179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.97 -36.67 0.02 OUTLIER Glycine 0 CA--C 1.531 1.071 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.329 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.75 162.22 4.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 CA--C 1.543 0.703 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.016 179.508 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -121.63 16.6 11.17 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 124.924 1.39 . . . . 0.0 107.745 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -70.82 145.38 50.37 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.53 95.68 5.9 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 111.197 -2.729 . . . . 0.0 108.413 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.41 112.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 132.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -125.7 141.05 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 110.974 -2.83 . . . . 0.0 110.202 -176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 pp -125.31 167.23 15.19 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 112.272 -2.24 . . . . 0.0 105.728 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.25 -172.25 44.71 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 126.428 2.33 . . . . 0.0 113.42 177.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.423 ' CG1' ' H ' ' A' ' 11' ' ' ILE 0.455 13.5 p 69.53 -125.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 110.139 -3.031 . . . . 0.0 114.714 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 4.2 tp 56.71 113.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 128.744 2.817 . . . . 0.0 109.018 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.52 78.23 0.16 Allowed Glycine 0 C--N 1.366 2.197 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.06 -36.81 1.74 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 110.773 -2.714 . . . . 0.0 106.836 -177.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.32 -156.0 0.56 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.33 98.57 4.54 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 80.67 -89.1 0.02 OUTLIER 'General case' 0 C--N 1.354 0.771 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 93.34 33.52 0.01 OUTLIER 'General case' 0 C--N 1.354 0.776 0 C-N-CA 126.535 1.934 . . . . 0.0 106.819 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t 59.07 113.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.73 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.471 ' C ' ' H ' ' A' ' 21' ' ' LYS . . . -169.94 -78.17 0.04 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.88 -0.13 17.49 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 112.252 -1.974 . . . . 0.0 108.684 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 19' ' ' GLY . 7.1 tmtm? -82.54 73.45 9.57 Favored 'General case' 0 N--CA 1.437 -1.118 1 C-N-CA 133.556 4.742 . . . . 0.0 104.995 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.318 38.7 mt 93.61 9.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 1 CA-C-N 107.101 -4.59 . . . . 0.0 112.325 175.518 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . 0.259 0.2 OUTLIER -74.85 -30.46 61.36 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 114.472 -2.891 . . . . 0.0 106.378 176.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.17 -13.13 59.99 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 117.406 -1.717 . . . . 0.0 107.05 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -77.31 -31.89 54.97 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.976 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -74.33 -18.76 60.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.792 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.43 -39.44 81.56 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 118.139 -1.424 . . . . 0.0 107.472 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -31.0 64.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 110.425 -3.08 . . . . 0.0 112.246 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -88.05 0.29 56.14 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 112.077 -2.329 . . . . 0.0 109.989 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.33 -8.26 11.67 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.01 23.64 69.67 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -99.9 170.59 8.42 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -80.86 151.12 28.81 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 111.232 -2.713 . . . . 0.0 105.399 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.88 135.83 33.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 CA-C-N 111.703 -2.499 . . . . 0.0 107.469 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 60.0 t -136.66 92.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 111.593 -2.549 . . . . 0.0 106.172 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -96.55 126.17 41.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.292 -1.776 . . . . 0.0 107.198 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 15.8 mt -98.72 -24.59 4.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 O-C-N 124.778 1.299 . . . . 0.0 107.655 178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.78 -151.33 19.51 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.64 14.1 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 114.423 -0.889 . . . . 0.0 111.441 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.89 102.77 6.2 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 53.8 p -84.89 83.07 8.17 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 125.05 22.51 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 109.809 -3.36 . . . . 0.0 106.969 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.95 -93.59 0.07 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.987 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.66 -18.45 53.76 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 124.8 1.313 . . . . 0.0 111.462 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.63 -43.24 12.79 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -86.52 4.48 39.74 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 116.862 -1.935 . . . . 0.0 108.982 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -26.89 6.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.16 -30.21 49.04 Favored 'General case' 0 C--N 1.365 1.25 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.26 10.16 33.11 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.77 20.03 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.1 -37.31 76.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.31 -71.75 0.14 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.449 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -61.54 1.86 Allowed 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.512 0.508 . . . . 0.0 110.362 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? 99.87 68.9 0.0 OUTLIER 'General case' 0 C--N 1.348 0.509 0 O-C-N 126.248 2.217 . . . . 0.0 106.654 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.42 116.09 2.66 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.331 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -77.2 -48.55 17.3 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.39 150.49 35.78 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.96 170.63 5.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -153.21 109.02 3.29 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.773 -2.012 . . . . 0.0 105.814 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -99.86 120.05 48.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.84 113.01 25.82 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 117.851 -1.54 . . . . 0.0 107.685 -176.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 t 150.74 162.83 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.76 74.4 6.59 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 111.517 -2.583 . . . . 0.0 106.682 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.477 ' HH ' ' HG ' ' A' ' 71' ' ' CYS . 0.2 OUTLIER 72.66 49.65 0.18 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 112.558 -2.11 . . . . 0.0 107.805 178.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.22 2.99 72.16 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.996 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -88.13 -20.49 25.57 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.661 -1.27 . . . . 0.0 109.463 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.04 174.35 40.25 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.58 6.29 9.04 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.85 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -67.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.13 -20.7 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.553 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.477 ' HG ' ' HH ' ' A' ' 64' ' ' TYR . 19.4 t -72.94 -56.26 5.41 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -90.07 21.08 3.87 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.617 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -103.44 -27.07 6.6 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.867 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 20.6 mt -85.67 -27.67 25.2 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.514 ' HG3' HH11 ' A' ' 75' ' ' ARG . 3.0 mmt85 -72.02 -32.38 67.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.28 -23.54 47.19 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 113.624 -1.626 . . . . 0.0 108.391 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -77.11 -16.5 59.16 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 83.7 m -90.24 -42.98 10.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.831 1.777 . . . . 0.0 107.282 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.65 -1.06 22.88 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 108.679 -3.873 . . . . 0.0 108.654 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.27 -54.5 5.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 59.94 40.88 18.47 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 110.882 -2.872 . . . . 0.0 107.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.78 -51.25 0.04 OUTLIER Glycine 0 C--N 1.35 1.308 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 120.19 32.63 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 126.59 31.14 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.153 -1.84 . . . . 0.0 106.29 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.61 56.19 0.04 OUTLIER Glycine 0 C--N 1.345 1.062 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.195 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -99.94 32.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 CA-C-N 112.203 -1.998 . . . . 0.0 106.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -144.36 112.56 6.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 97.35 3.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.67 85.25 3.08 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.4 m -89.45 98.45 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 109.881 -3.327 . . . . 0.0 110.397 -175.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.31 132.92 42.25 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 109.116 -3.675 . . . . 0.0 113.348 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.96 -74.21 0.95 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 111.869 -2.165 . . . . 0.0 109.765 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 18.75 103.67 0.0 OUTLIER 'General case' 0 C--N 1.354 0.769 1 C-N-CA 131.763 4.025 . . . . 0.0 111.06 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 58.44 120.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 112.334 -2.212 . . . . 0.0 108.478 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.49 162.5 4.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 112.102 -2.317 . . . . 0.0 108.58 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 p 41.3 69.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 CA-C-N 112.432 -2.167 . . . . 0.0 112.715 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.36 128.96 1.06 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.365 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -157.61 100.0 1.76 Allowed 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 96.49 -51.77 0.01 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -85.68 99.13 11.1 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -113.5 160.47 31.48 Favored Pre-proline 0 C--N 1.351 0.646 0 CA-C-N 112.694 -2.048 . . . . 0.0 106.122 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.58 -155.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 N-CA-C 106.456 -2.171 . . . . 0.0 106.456 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.38 -20.91 62.92 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.688 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 2.6 p -60.01 -69.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.776 0 O-C-N 124.437 1.086 . . . . 0.0 111.621 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -90.15 27.01 1.72 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 117.688 -1.605 . . . . 0.0 109.3 -179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -79.92 -42.36 24.25 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.48 -31.79 42.39 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 112.314 -2.221 . . . . 0.0 106.683 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -90.87 14.29 14.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.214 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -90.41 -37.37 14.01 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.78 75.55 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.84 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 29.9 mtp -76.9 -63.51 1.34 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 35.5 31.29 0.02 OUTLIER Glycine 0 C--N 1.355 1.635 0 C-N-CA 127.135 2.302 . . . . 0.0 117.496 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -7.19 59.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -105.25 128.63 53.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 176.91 4.87 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.23 158.47 32.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.17 -179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -99.9 152.62 37.87 Favored Pre-proline 0 C--N 1.358 0.946 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.43 147.89 83.26 Favored 'Trans proline' 0 C--N 1.369 1.654 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.78 114.5 3.2 Favored 'Trans proline' 0 C--N 1.364 1.373 0 N-CA-C 104.011 -3.111 . . . . 0.0 104.011 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.29 42.77 6.1 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.499 -1.682 . . . . 0.0 110.389 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.678 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 7.5 t -90.17 -179.08 5.57 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 125.174 2.416 . . . . 0.0 106.457 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.725 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.357 19.7 p -82.39 170.78 13.63 Favored Pre-proline 0 N--CA 1.426 -1.668 1 CA-C-N 106.806 -4.725 . . . . 0.0 106.031 179.078 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -92.06 -0.06 4.23 Favored 'Trans proline' 0 CA--C 1.554 1.499 0 N-CA-C 104.586 -2.89 . . . . 0.0 104.586 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -74.97 -16.1 60.65 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.679 1.192 . . . . 0.0 108.284 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.725 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.0 OUTLIER -76.72 -27.75 55.57 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -178.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 129' ' ' ASP . 35.6 p -79.83 -23.21 42.17 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.012 -1.475 . . . . 0.0 109.817 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 5.8 mt -68.55 -30.34 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 176.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.68 -5.14 58.7 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 112.134 -2.303 . . . . 0.0 108.796 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.4 t0 -59.85 -58.56 8.03 Favored 'General case' 0 C--N 1.367 1.347 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -88.29 1.61 54.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.362 -2.199 . . . . 0.0 110.156 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -81.04 -48.35 12.32 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 117.151 -1.82 . . . . 0.0 109.866 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.76 -31.49 19.61 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.235 0.96 . . . . 0.0 111.928 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.9 t -73.25 -26.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.105 0.878 . . . . 0.0 112.379 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -89.21 -36.85 15.41 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.83 -95.42 0.06 OUTLIER Glycine 0 C--N 1.356 1.641 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.033 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -169.31 154.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.548 -1.326 . . . . 0.0 108.635 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 C--N 1.347 0.486 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.558 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.71 13.45 19.85 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 125.296 1.622 . . . . 0.0 107.543 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -70.93 145.94 49.82 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.938 1.351 . . . . 0.0 107.76 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.61 95.85 6.67 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.938 -2.847 . . . . 0.0 108.313 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 172.29 111.51 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.08 122.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.3 147.16 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 110.546 -3.025 . . . . 0.0 110.163 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.13 149.21 48.1 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.1 155.41 26.15 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 125.762 1.914 . . . . 0.0 112.554 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.704 13.6 p 84.94 -127.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 130.406 3.483 . . . . 0.0 117.03 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.316 2.0 tp 72.78 115.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 128.443 2.697 . . . . 0.0 106.382 -175.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.5 73.6 0.17 Allowed Glycine 0 C--N 1.367 2.286 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 -44.59 2.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 110.058 -3.071 . . . . 0.0 104.816 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -159.01 -131.15 0.03 OUTLIER 'General case' 0 C--N 1.354 0.773 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -89.08 77.25 7.63 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 75.9 -142.66 0.02 OUTLIER 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 164.93 46.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.641 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m 61.19 179.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.965 0 CA-C-N 113.58 -1.646 . . . . 0.0 110.708 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -70.74 1.13 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.674 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -56.59 -25.97 54.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.525 -1.838 . . . . 0.0 110.945 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -60.96 -66.79 0.48 Allowed 'General case' 0 C--N 1.345 0.381 0 CA-C-O 122.961 1.362 . . . . 0.0 107.68 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 3.35 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 111.502 -2.59 . . . . 0.0 111.357 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.69 -38.58 18.16 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 116.573 -2.051 . . . . 0.0 107.664 -179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.98 -11.24 60.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 117.489 -1.685 . . . . 0.0 106.478 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -80.78 -38.56 28.3 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.5 m -71.0 -14.84 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 112.242 -2.254 . . . . 0.0 109.903 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.11 -42.03 73.21 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -31.61 66.59 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 110.188 -3.187 . . . . 0.0 112.462 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -87.63 -1.76 58.17 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 111.971 -2.377 . . . . 0.0 110.016 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.72 -10.32 14.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.1 70.76 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -99.88 168.47 9.86 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -78.22 148.74 33.85 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 111.178 -2.737 . . . . 0.0 105.766 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.88 132.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.579 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.85 74.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 111.481 -2.599 . . . . 0.0 105.444 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.09 122.98 31.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.472 -2.149 . . . . 0.0 107.622 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 53.3 mt -98.39 -27.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.71 -141.51 15.58 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.99 -13.67 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.237 -0.982 . . . . 0.0 110.278 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.3 98.89 11.99 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -82.68 80.76 8.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.36 118.15 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 110.883 -2.872 . . . . 0.0 105.387 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -89.86 -87.37 0.18 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.585 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.11 -18.63 63.63 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 124.63 1.206 . . . . 0.0 110.563 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.52 -41.8 14.99 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -86.47 4.88 37.82 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 116.898 -1.921 . . . . 0.0 108.877 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.37 -26.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -78.65 -31.17 46.68 Favored 'General case' 0 C--N 1.365 1.279 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.88 10.79 29.61 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.419 ' CB ' ' HZ2' ' A' ' 77' ' ' LYS . . . -90.11 -28.0 19.27 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.55 -37.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.87 -71.73 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 112.387 -2.188 . . . . 0.0 110.234 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -63.96 1.13 Allowed 'General case' 0 C--N 1.362 1.148 0 O-C-N 123.491 0.494 . . . . 0.0 110.193 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 101.25 71.14 0.0 OUTLIER 'General case' 0 C--N 1.346 0.444 0 O-C-N 126.4 2.312 . . . . 0.0 106.467 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 122.0 10.87 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.433 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -95.19 -59.41 1.9 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.79 124.83 40.59 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 mt -95.79 167.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.2 m -148.98 120.82 8.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 111.918 -2.401 . . . . 0.0 106.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 23.5 t -99.88 133.38 43.0 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -119.66 96.47 5.21 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t 147.57 161.72 0.0 OUTLIER 'General case' 0 C--N 1.354 0.789 0 O-C-N 126.293 2.246 . . . . 0.0 106.031 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.37 77.57 8.88 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 111.279 -2.691 . . . . 0.0 106.527 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.819 -1.992 . . . . 0.0 107.607 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.74 57.69 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.897 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -92.57 4.32 53.81 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 113.444 -1.378 . . . . 0.0 109.357 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.31 -167.53 35.95 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.721 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.11 21.08 3.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 112.498 -1.851 . . . . 0.0 108.072 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -75.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -71.25 -24.49 62.19 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 112.472 -2.149 . . . . 0.0 108.904 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.48 -49.4 22.36 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -90.02 16.11 8.9 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.554 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.77 -23.61 11.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.149 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 29.5 mt -89.94 -25.41 20.93 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 75' ' ' ARG . 2.3 mmt85 -71.81 -30.49 65.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -79.51 -23.67 42.77 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.187 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.419 ' HZ2' ' CB ' ' A' ' 50' ' ' ALA . 43.6 tttp -77.64 -12.8 60.0 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.801 0.84 . . . . 0.0 108.904 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.0 m -90.24 -42.91 10.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.923 1.82 . . . . 0.0 106.661 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.43 -3.56 31.31 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 108.527 -3.942 . . . . 0.0 108.741 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.5 -54.58 5.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.71 40.43 23.25 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 111.125 -2.761 . . . . 0.0 107.688 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.75 -52.35 0.05 OUTLIER Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -94.46 122.55 37.14 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 134.89 38.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.13 54.97 0.02 OUTLIER Glycine 0 C--N 1.347 1.14 0 CA-C-N 112.36 -2.2 . . . . 0.0 109.208 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.5 -33.41 11.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.389 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -80.92 117.53 21.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.09 100.22 3.86 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.66 92.76 5.49 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 27.3 m -89.21 97.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 110.298 -3.137 . . . . 0.0 110.64 -174.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.57 134.74 30.63 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 110.027 -3.261 . . . . 0.0 113.02 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.59 -80.67 1.37 Allowed Glycine 0 C--N 1.354 1.546 0 CA-C-N 111.691 -2.255 . . . . 0.0 108.492 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 21.56 94.06 0.01 OUTLIER 'General case' 0 C--N 1.354 0.767 0 C-N-CA 131.399 3.88 . . . . 0.0 110.171 179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt 76.19 131.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.94 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.03 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 CA-C-N 112.313 -2.221 . . . . 0.0 108.103 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p 35.22 63.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 112.241 -2.254 . . . . 0.0 112.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.36 147.55 12.61 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.643 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -175.27 107.99 0.1 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 93.42 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.356 0.888 0 O-C-N 126.137 2.148 . . . . 0.0 105.429 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -87.69 107.51 18.66 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -116.47 163.34 22.45 Favored Pre-proline 0 C--N 1.351 0.651 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.16 -151.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.763 1.642 . . . . 0.0 107.976 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.07 -20.13 57.99 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.523 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -67.69 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.721 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.23 25.86 2.08 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 117.199 -1.8 . . . . 0.0 109.41 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.07 -41.23 26.02 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -78.32 -31.79 48.94 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 112.512 -2.131 . . . . 0.0 106.256 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -92.85 17.02 11.18 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.294 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -90.36 -38.97 12.97 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.19 80.1 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.915 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 12.3 mtp -74.22 -65.29 0.86 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.49 27.57 0.09 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 112.127 -2.306 . . . . 0.0 117.295 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.32 -5.24 58.46 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.12 132.59 51.15 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.75 6.68 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.08 157.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -99.44 147.68 33.66 Favored Pre-proline 0 C--N 1.359 0.982 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 -178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.56 145.06 81.14 Favored 'Trans proline' 0 C--N 1.371 1.723 0 N-CA-C 107.451 -1.788 . . . . 0.0 107.451 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -79.97 111.97 2.78 Favored 'Trans proline' 0 C--N 1.364 1.35 0 N-CA-C 103.552 -3.288 . . . . 0.0 103.552 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.16 42.14 5.04 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 113.47 -1.695 . . . . 0.0 110.478 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.628 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 12.5 t -90.12 -179.15 5.6 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 124.875 2.274 . . . . 0.0 106.644 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.72 ' HG ' ' HG1' ' A' ' 125' ' ' THR 0.335 22.3 p -78.73 173.43 7.71 Favored Pre-proline 0 N--CA 1.431 -1.394 1 CA-C-N 107.297 -4.501 . . . . 0.0 105.666 178.797 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -93.75 -4.6 2.82 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 105.198 -2.655 . . . . 0.0 105.198 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.33 -10.68 60.0 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.717 1.607 . . . . 0.0 108.3 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.72 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -75.27 -30.55 60.49 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.492 ' C ' ' H ' ' A' ' 129' ' ' ASP . 36.3 p -83.66 -25.66 30.54 Favored 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.46 1.1 . . . . 0.0 110.069 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.8 -28.61 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 103.242 -2.874 . . . . 0.0 103.242 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.35 58.39 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.145 -2.298 . . . . 0.0 108.609 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' A' ' 126' ' ' THR . 54.7 t0 -61.74 -53.75 51.76 Favored 'General case' 0 C--N 1.366 1.325 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -87.43 -2.61 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 111.956 -2.384 . . . . 0.0 110.168 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -81.32 -49.69 10.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 117.15 -1.82 . . . . 0.0 110.223 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.16 -36.36 21.11 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 124.161 0.913 . . . . 0.0 112.148 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.8 t -70.59 -29.71 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.767 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.09 -39.91 18.95 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.09 -91.39 0.05 OUTLIER Glycine 0 C--N 1.354 1.571 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.292 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -164.71 150.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 113.564 -1.318 . . . . 0.0 108.608 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 . . . . . 0 C--N 1.347 0.471 0 CA-C-N 111.29 -2.687 . . . . 0.0 104.162 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ttt . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.3 77.88 3.95 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.4 156.58 16.42 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 124.429 2.061 . . . . 0.0 108.404 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.409 ' H ' ' HD3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.96 94.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 107.999 -4.182 . . . . 0.0 108.757 -178.483 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.26 106.53 0.02 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -145.65 111.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.6 m -89.72 145.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 CA-C-O 123.198 1.475 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.34 111.43 15.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 110.081 -3.236 . . . . 0.0 104.034 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . -160.83 141.61 7.5 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.854 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.622 ' CG1' ' H ' ' A' ' 11' ' ' ILE . 2.7 p 171.26 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.034 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.622 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 0.3 OUTLIER 118.97 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.688 0 O-C-N 125.916 2.01 . . . . 0.0 105.879 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.7 -104.11 0.19 Allowed Glycine 0 C--N 1.353 1.509 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.541 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.35 87.44 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 t0 174.9 134.79 0.04 OUTLIER 'General case' 0 C--N 1.346 0.44 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.64 83.69 7.93 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 113.608 -1.633 . . . . 0.0 106.652 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.0 t60 152.31 -49.2 0.01 OUTLIER 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.79 24.64 11.39 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.789 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m 53.78 -151.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 118.153 -1.419 . . . . 0.0 109.719 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.25 3.09 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.649 0.593 . . . . 0.0 113.237 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.7 t30 -46.27 -52.13 13.17 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -14.87 55.94 0.0 OUTLIER 'General case' 0 C--N 1.369 1.442 2 C-N-CA 140.133 7.373 . . . . 0.0 109.348 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.433 0.1 OUTLIER 45.12 39.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.652 1 CA-C-N 107.405 -4.452 . . . . 0.0 110.181 178.463 . . . . . . . . 5 4 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -37.18 63.38 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.74 -9.76 57.98 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 112.019 -2.355 . . . . 0.0 107.268 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -87.11 -7.68 57.79 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 m -59.58 -41.33 90.01 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.95 -42.69 98.73 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 110.013 -3.267 . . . . 0.0 109.137 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -82.38 -9.53 59.42 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.82 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.496 ' HB3' ' SD ' ' A' ' 130' ' ' MET . 0.6 OUTLIER -68.2 -42.03 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.556 1.142 . . . . 0.0 108.664 -177.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.82 39.43 0.06 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.0 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.7 27.78 64.51 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.122 -0.944 . . . . 0.0 114.571 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.87 92.01 5.09 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -35.57 141.33 0.08 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 129.757 3.223 . . . . 0.0 109.213 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.6 m -121.45 136.42 58.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 111.898 -2.41 . . . . 0.0 106.643 179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.3 t -102.31 102.7 13.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.004 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -77.71 114.62 16.74 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.1 tt -98.82 -3.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 112.085 -2.325 . . . . 0.0 108.161 -178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.01 -100.61 2.23 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 123.924 0.765 . . . . 0.0 113.75 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.08 -31.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-N 113.223 -1.489 . . . . 0.0 111.876 -177.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -91.83 111.85 23.54 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -101.5 80.26 2.05 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.6 140.84 58.56 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.928 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.23 -82.6 0.27 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.359 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.05 -21.18 61.07 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.543 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.25 -34.78 14.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.525 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.01 -8.54 58.67 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 116.864 -1.934 . . . . 0.0 109.686 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -82.75 -26.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -76.67 -29.77 56.5 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.55 2.04 56.16 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.122 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.64 -20.32 26.51 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 mt -74.3 -39.91 49.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.77 -68.03 0.36 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.471 -2.149 . . . . 0.0 110.144 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -63.78 1.01 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 123.779 0.674 . . . . 0.0 109.713 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.2 tttp 111.62 50.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.61 109.76 0.34 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-N 112.177 -2.283 . . . . 0.0 108.782 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.38 -42.95 19.71 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' CD1' ' SG ' ' A' ' 59' ' ' CYS . 0.9 OUTLIER -151.65 160.35 43.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 117.383 -1.727 . . . . 0.0 107.682 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 mm -122.93 139.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 CA-C-N 111.308 -2.678 . . . . 0.0 106.179 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.42 ' SG ' ' CD1' ' A' ' 57' ' ' LEU . 71.5 m -136.85 124.15 21.89 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.51 -2.132 . . . . 0.0 105.386 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 34.6 m -112.14 135.24 52.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-N 112.592 -2.095 . . . . 0.0 105.532 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.53 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -107.95 106.54 16.84 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 117.37 -1.732 . . . . 0.0 109.662 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 m 131.42 -177.0 0.0 OUTLIER 'General case' 0 C--N 1.352 0.674 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.85 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.648 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -66.0 97.67 0.38 Allowed 'General case' 0 C--N 1.36 1.046 0 CA-C-N 113.749 -1.568 . . . . 0.0 107.187 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.04 -28.27 3.42 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 111.12 -2.764 . . . . 0.0 107.411 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -84.62 -32.02 23.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 111.67 -2.265 . . . . 0.0 106.432 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.46 178.76 46.75 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.081 -1.56 . . . . 0.0 108.529 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mm -80.09 -48.56 20.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -71.97 -20.63 61.71 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.677 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 t -70.61 -45.26 65.6 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.06 18.0 6.31 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 124.464 1.102 . . . . 0.0 109.461 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -31.69 5.68 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.6 mt -89.22 -25.35 21.79 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 112.998 -1.601 . . . . 0.0 106.783 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -29.12 60.8 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.13 -24.81 43.09 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.653 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -76.57 -15.62 59.81 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 62.2 m -90.35 -44.84 9.41 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 123.885 1.802 . . . . 0.0 107.195 -178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.65 -1.72 22.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 108.589 -3.914 . . . . 0.0 108.857 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -80.81 -54.03 5.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.77 43.59 12.01 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 111.037 -2.801 . . . . 0.0 107.41 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.34 -47.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.212 0 CA-C-N 112.542 -2.117 . . . . 0.0 107.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 88.1 mt -89.04 121.14 31.09 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 178.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 119.45 23.11 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.88 75.84 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 CA-C-N 113.087 -1.869 . . . . 0.0 109.711 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -115.41 30.7 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-N 112.122 -2.039 . . . . 0.0 106.292 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.416 ' HB3' HH22 ' A' ' 115' ' ' ARG . 72.9 mmtt -142.63 119.0 10.88 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.3 112.22 7.57 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.83 83.84 1.86 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.6 99.17 8.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-N 111.453 -2.612 . . . . 0.0 111.044 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.25 122.77 8.11 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 110.184 -3.189 . . . . 0.0 110.299 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.6 -98.39 2.42 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.3 t30 64.89 -97.13 0.05 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 112.48 -1.86 . . . . 0.0 107.616 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.07 111.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.28 168.58 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.628 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.251 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 40.32 57.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.46 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.25 151.34 13.5 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.508 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -173.6 131.83 0.45 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 87.9 -71.6 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 O-C-N 126.113 2.133 . . . . 0.0 105.534 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -92.61 145.43 24.43 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.3 m95 -129.39 160.29 64.98 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.41 -150.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.02 -26.68 63.22 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.352 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -52.85 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 124.881 1.363 . . . . 0.0 110.362 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -90.39 24.72 2.48 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.635 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.9 -47.72 65.11 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 103.495 -2.779 . . . . 0.0 103.495 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.13 -20.08 23.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 111.575 -2.557 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -84.17 -45.93 12.43 Favored 'General case' 0 C--N 1.364 1.237 0 C-N-CA 117.977 -1.489 . . . . 0.0 108.879 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.33 -0.38 36.52 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.949 1.406 . . . . 0.0 108.252 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.42 79.81 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -87.77 -50.85 6.2 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.67 37.08 50.3 Favored Glycine 0 C--N 1.363 2.04 0 N-CA-C 116.384 1.313 . . . . 0.0 116.384 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.17 -7.44 58.21 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.01 133.09 50.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.416 HH22 ' HB3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -110.04 169.97 8.38 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.13 166.66 19.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 CA-C-N 113.67 -1.604 . . . . 0.0 107.284 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -99.62 150.69 37.02 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.47 160.02 44.93 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.095 1.863 . . . . 0.0 108.708 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.81 122.02 8.45 Favored 'Trans proline' 0 C--N 1.371 1.762 0 N-CA-C 105.219 -2.646 . . . . 0.0 105.219 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.8 -170.27 13.26 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.4 p -69.77 146.03 51.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.16 76.17 8.69 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.57 -20.72 13.63 Favored 'Trans proline' 0 C--N 1.369 1.655 0 O-C-N 123.422 1.222 . . . . 0.0 110.222 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.92 -32.81 51.88 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.374 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -77.73 -11.38 59.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.036 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.533 ' C ' ' H ' ' A' ' 129' ' ' ASP . 30.9 p -89.3 -20.93 23.47 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.127 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.69 -26.55 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.29 -2.99 57.27 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.459 -2.155 . . . . 0.0 108.578 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.533 ' H ' ' C ' ' A' ' 126' ' ' THR . 48.3 t0 -53.06 -60.58 3.1 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.158 1.456 . . . . 0.0 107.261 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.496 ' SD ' ' HB3' ' A' ' 29' ' ' ASN . 3.0 ttp -90.02 -22.45 21.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.643 -2.98 . . . . 0.0 111.034 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -86.48 -13.37 46.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.921 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -90.21 -55.6 3.54 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 122.439 1.114 . . . . 0.0 108.366 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.416 ' HA ' HH21 ' A' ' 115' ' ' ARG . 88.1 t -63.65 -53.07 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 112.361 -2.2 . . . . 0.0 114.197 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.8 mp -89.16 -12.12 41.91 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.37 1.044 . . . . 0.0 109.646 -177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.54 -78.34 1.35 Allowed Glycine 0 C--N 1.357 1.704 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.22 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 t -163.21 149.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 CA-C-N 113.64 -1.28 . . . . 0.0 108.69 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 . . . . . 0 CA--C 1.546 0.82 0 CA-C-N 111.876 -2.42 . . . . 0.0 107.959 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.74 37.97 3.6 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -79.72 143.24 34.71 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.24 95.21 5.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 110.786 -2.916 . . . . 0.0 108.817 -177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.39 115.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 119.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.77 126.52 49.47 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 CA-C-N 112.285 -2.234 . . . . 0.0 108.385 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 56.9 tp -125.15 140.96 52.41 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.182 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.57 173.96 24.86 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.289 179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.505 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.2 p 164.98 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.227 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.423 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 0.1 OUTLIER -175.27 -145.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.514 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.4 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.49 83.49 1.67 Allowed Glycine 0 C--N 1.361 1.948 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 t -90.41 74.61 6.89 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.594 -1.303 . . . . 0.0 107.968 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -83.14 -30.95 27.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.37 -40.89 0.07 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.449 2.699 . . . . 0.0 104.595 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -166.98 -65.63 0.03 OUTLIER 'General case' 0 C--N 1.369 1.432 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 133.54 100.87 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 127.018 2.699 . . . . 0.0 105.34 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 p -85.64 65.94 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.636 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.37 -19.16 42.79 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.202 179.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' ILE . 52.6 m-80 -45.04 -54.07 7.1 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 111.57 -2.315 . . . . 0.0 105.13 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -6.68 50.17 0.0 OUTLIER 'General case' 0 C--N 1.38 1.907 2 C-N-CA 140.32 7.448 . . . . 0.0 109.445 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 ' CG2' ' HB2' ' A' ' 25' ' ' HIS 0.356 0.0 OUTLIER 36.94 48.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.633 2 CA-C-N 106.731 -4.759 . . . . 0.0 108.557 -178.925 . . . . . . . . 5 4 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.514 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -68.35 -33.31 74.06 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 173.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.49 6.49 4.6 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-N 110.971 -2.831 . . . . 0.0 107.817 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.421 ' HB2' ' CG2' ' A' ' 22' ' ' ILE . 2.0 t60 -76.0 -41.72 50.29 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -44.83 63.62 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 111.318 -2.673 . . . . 0.0 109.601 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.12 -41.35 68.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.363 -178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -21.67 44.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 112.666 -2.061 . . . . 0.0 113.581 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -78.82 -5.41 53.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.751 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.02 0.75 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 115.984 -2.286 . . . . 0.0 109.215 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.32 97.43 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 118.672 -1.727 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.31 151.45 21.05 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -76.98 136.64 38.75 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 111.479 -2.6 . . . . 0.0 105.932 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.96 148.0 7.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 112.304 -2.225 . . . . 0.0 107.011 178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.11 67.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 111.172 -2.74 . . . . 0.0 106.982 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.81 115.3 9.8 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.304 -1.771 . . . . 0.0 106.58 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 tt -94.38 -2.35 10.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.636 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 -115.11 3.99 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.402 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -143.94 51.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 113.568 -1.316 . . . . 0.0 109.507 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.27 150.51 36.09 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 112.828 -1.987 . . . . 0.0 105.644 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 t -112.13 31.31 6.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 113.059 -1.882 . . . . 0.0 106.043 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 p -82.35 97.58 8.4 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.05 -56.55 3.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.471 -2.15 . . . . 0.0 108.85 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -24.84 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.749 1.281 . . . . 0.0 110.889 -177.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.0 -32.83 18.63 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -88.16 2.91 51.06 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.027 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.01 -31.17 7.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.9 -27.4 61.86 Favored 'General case' 0 C--N 1.366 1.284 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.48 -4.43 55.53 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.89 -8.61 57.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.99 -40.32 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.65 -64.08 1.07 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.46 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -62.0 1.57 Allowed 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? 112.32 45.78 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 O-C-N 127.052 2.72 . . . . 0.0 104.85 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.46 112.1 0.76 Allowed 'General case' 0 C--N 1.358 0.953 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -81.69 0.33 Allowed 'General case' 0 C--N 1.358 0.94 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.711 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.52 130.77 37.3 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.737 1.273 . . . . 0.0 108.333 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.6 162.46 2.4 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.297 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.514 ' SG ' HD12 ' A' ' 23' ' ' LEU . 21.5 t -156.99 104.65 2.11 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 p -110.35 129.9 64.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.505 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.99 111.32 19.42 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 117.426 -1.71 . . . . 0.0 108.767 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t 145.36 173.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.638 0 CA-C-N 111.27 -2.695 . . . . 0.0 104.52 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.04 -129.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.757 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.38 80.81 8.45 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.21 53.95 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -165.52 -20.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 111.689 -2.256 . . . . 0.0 107.654 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 81.82 177.19 51.66 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.339 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -86.92 9.41 19.43 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.222 -1.489 . . . . 0.0 108.101 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -51.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.51 -27.79 62.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.502 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HG ' HH12 ' A' ' 75' ' ' ARG . 10.7 t -68.49 -57.19 6.2 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -90.18 27.81 1.56 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 124.754 1.284 . . . . 0.0 109.025 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.67 -30.23 6.24 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -90.12 -30.02 17.93 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 112.637 -1.781 . . . . 0.0 107.211 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.4 mmt85 -71.31 -31.89 67.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -75.21 -31.89 61.03 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 113.503 -1.68 . . . . 0.0 108.03 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -71.52 -16.09 62.32 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.298 0.999 . . . . 0.0 109.763 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.415 ' C ' ' H ' ' A' ' 80' ' ' GLU . 50.8 t -90.25 -48.06 7.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 123.169 1.461 . . . . 0.0 108.237 -177.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.307 2.4 p30 -76.63 3.58 11.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 109.727 -3.397 . . . . 0.0 109.389 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 78' ' ' CYS . 9.4 tp10 -81.24 -54.89 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 40.34 12.43 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.841 -2.89 . . . . 0.0 107.409 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -48.08 0.04 OUTLIER Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.5 mt -86.58 121.18 28.75 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 121.98 33.51 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.94 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.32 78.46 0.04 OUTLIER Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.966 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.52 33.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.673 -1.763 . . . . 0.0 106.672 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 113.08 4.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.96 111.19 9.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.61 87.61 3.62 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 33.9 m -89.43 96.32 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 111.184 -2.735 . . . . 0.0 110.119 -176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.78 101.24 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-N 108.94 -3.755 . . . . 0.0 110.366 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.78 -108.42 3.09 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 112.37 -1.915 . . . . 0.0 109.766 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.96 -110.79 0.09 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.18 129.59 37.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.89 174.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.487 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.58 80.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.038 -2.346 . . . . 0.0 112.623 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.08 156.13 8.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 111.972 -2.377 . . . . 0.0 109.086 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -168.78 93.35 0.31 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 95.56 -47.98 0.01 OUTLIER 'General case' 0 C--N 1.355 0.828 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -89.37 122.76 32.91 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -135.64 160.84 66.15 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.8 -149.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.773 1.649 . . . . 0.0 108.239 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.86 -21.2 60.98 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.642 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.32 -70.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 O-C-N 124.619 1.199 . . . . 0.0 111.236 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -88.35 21.49 2.84 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 117.33 -1.748 . . . . 0.0 108.393 -179.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.12 -43.07 62.2 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -79.95 -32.05 39.94 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.115 -2.311 . . . . 0.0 107.216 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -91.04 13.45 16.73 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.027 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 -38.8 12.99 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 107.214 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.04 -61.5 1.97 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.22 35.66 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.379 2.419 . . . . 0.0 117.431 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -89.69 -1.39 58.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.18 137.21 43.32 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 173.39 6.35 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.9 m -140.09 156.4 24.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 124.499 1.124 . . . . 0.0 109.198 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -99.72 150.14 36.55 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 177.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.24 166.36 5.96 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.123 2.549 . . . . 0.0 109.045 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 -92.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 104.436 -2.948 . . . . 0.0 104.436 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.38 131.64 14.98 Favored Glycine 0 C--N 1.359 1.854 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 t -64.84 162.92 15.27 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 125.494 2.569 . . . . 0.0 109.189 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -170.73 114.35 0.45 Allowed Pre-proline 0 N--CA 1.431 -1.415 1 CA-C-N 106.235 -4.984 . . . . 0.0 100.941 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.68 -4.03 13.82 Favored 'Trans proline' 0 C--N 1.363 1.317 0 O-C-N 122.41 0.689 . . . . 0.0 111.335 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.99 -23.05 65.89 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.958 1.303 . . . . 0.0 108.96 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -28.05 51.5 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.17 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.467 ' C ' ' H ' ' A' ' 129' ' ' ASP . 77.9 p -80.65 -18.68 47.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.968 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.56 -25.55 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.01 46.97 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.387 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' A' ' 126' ' ' THR . 44.7 t0 -52.73 -62.36 1.7 Allowed 'General case' 0 C--N 1.369 1.421 0 CA-C-O 123.781 1.753 . . . . 0.0 106.832 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 45.9 ttm -90.12 -25.8 20.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 109.574 -3.467 . . . . 0.0 111.383 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -78.52 -13.0 60.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.709 -1.596 . . . . 0.0 110.316 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.98 -56.23 3.37 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 45.3 t -63.18 -34.49 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.611 -177.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.93 -33.02 30.55 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.63 -86.04 0.15 Allowed Glycine 0 C--N 1.352 1.463 0 O-C-N 124.55 1.156 . . . . 0.0 111.483 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 t -92.23 164.42 2.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 112.527 -1.836 . . . . 0.0 108.698 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.352 0.702 0 CA-C-N 112.709 -2.041 . . . . 0.0 107.715 178.687 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.82 68.75 0.83 Allowed 'General case' 0 C--N 1.352 0.696 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -79.07 169.28 18.44 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.601 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -103.84 104.79 14.83 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 109.065 -3.698 . . . . 0.0 108.589 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.32 99.38 0.01 OUTLIER 'General case' 0 C--N 1.355 0.804 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.85 109.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.52 127.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.775 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.28 136.19 53.26 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 112.515 -2.129 . . . . 0.0 105.721 178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . -175.29 171.11 44.27 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.405 -2.634 . . . . 0.0 108.343 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.598 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.9 p 164.42 -122.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.464 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 2.2 tp -168.68 -149.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.379 1.884 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.82 -142.11 6.15 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 118.76 -1.686 . . . . 0.0 110.234 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.5 -60.83 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -79.82 151.5 30.24 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 113.053 -1.885 . . . . 0.0 106.987 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t 68.49 -108.83 0.09 Allowed 'General case' 0 C--N 1.362 1.114 0 O-C-N 125.272 1.608 . . . . 0.0 107.232 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -164.16 44.14 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.23 43.68 13.57 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.871 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.55 106.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 O-C-N 124.642 1.214 . . . . 0.0 110.922 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.76 -21.97 14.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.256 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ILE . 85.8 m-20 -41.83 -53.15 3.82 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.671 -2.265 . . . . 0.0 104.969 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -9.12 54.05 0.0 OUTLIER 'General case' 0 C--N 1.373 1.62 2 C-N-CA 140.354 7.462 . . . . 0.0 108.265 175.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.336 0.2 OUTLIER 31.05 42.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.39 2 CA-C-N 106.898 -4.683 . . . . 0.0 109.149 -177.897 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.12 -35.18 31.91 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.2 -0.85 30.09 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.163 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -78.18 -35.07 49.2 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.7 p -56.58 -44.31 80.91 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.072 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -55.55 -43.5 75.9 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.889 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -26.82 62.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 111.865 -2.425 . . . . 0.0 112.648 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -79.68 0.49 30.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 112.072 -2.331 . . . . 0.0 109.149 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.6 11.3 2.08 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 118.199 -1.4 . . . . 0.0 108.031 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.6 34.44 55.72 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.289 0.993 . . . . 0.0 112.882 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.67 -177.43 3.57 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.39 145.21 25.5 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.365 -2.198 . . . . 0.0 106.55 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -99.93 135.41 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 110.777 -2.92 . . . . 0.0 107.262 179.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.25 76.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.419 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.636 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.91 120.75 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.29 -92.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 111.985 -2.37 . . . . 0.0 104.924 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.12 -140.42 5.63 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.41 4.03 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 113.121 -1.54 . . . . 0.0 110.671 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.06 99.54 11.98 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -97.5 54.6 1.2 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -90.08 85.35 6.28 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.27 -47.65 67.15 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.836 -176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -36.53 84.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.636 1.21 . . . . 0.0 109.529 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.9 -21.94 50.45 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -85.47 -2.23 57.91 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.46 -35.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -75.6 -33.01 60.53 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.826 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.57 7.09 43.06 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.903 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.21 -21.73 22.01 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -74.47 -38.46 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.7 -69.05 0.23 Allowed 'General case' 0 C--N 1.354 0.787 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.029 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.37 -57.97 3.77 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.158 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' THR . 63.7 tttt 120.47 48.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 126.672 2.483 . . . . 0.0 107.705 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -49.36 106.62 0.11 Allowed 'General case' 0 C--N 1.355 0.819 0 CA-C-O 122.061 0.934 . . . . 0.0 110.027 -178.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.87 -38.95 31.6 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 pp -151.1 167.52 27.46 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -142.04 150.75 18.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-N 112.081 -2.327 . . . . 0.0 105.839 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.543 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 44.2 t -145.69 134.78 22.72 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.38 135.28 40.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.806 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.598 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.14 91.12 3.54 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.5 t 150.62 165.92 0.0 OUTLIER 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.8 -127.84 0.0 OUTLIER 'General case' 0 C--N 1.359 1.007 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.308 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 86.4 7.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.84 42.56 1.21 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 110.92 -2.855 . . . . 0.0 106.928 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -147.08 -32.61 0.3 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 111.143 -2.528 . . . . 0.0 106.841 -178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.84 43.35 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.51 1.55 19.0 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.992 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -47.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -72.27 -27.06 62.24 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 114.303 -1.317 . . . . 0.0 107.66 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.4 ' C ' ' H ' ' A' ' 73' ' ' GLY . 93.3 m -68.29 -47.7 66.94 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.12 26.6 1.83 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.909 1.381 . . . . 0.0 108.829 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -95.7 -34.96 5.79 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 mt -88.84 -28.14 20.59 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 112.032 -2.084 . . . . 0.0 107.712 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.06 -24.43 58.23 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -82.04 -29.08 32.13 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -76.6 -15.66 59.78 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.31 1.006 . . . . 0.0 109.189 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 20.7 t -90.29 -47.71 7.59 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 123.982 1.849 . . . . 0.0 107.115 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.91 -3.61 23.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 108.478 -3.965 . . . . 0.0 109.158 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -82.01 -56.08 4.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.01 47.65 5.69 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 110.932 -2.849 . . . . 0.0 106.616 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.95 -44.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.73 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.81 120.9 24.7 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 134.14 34.42 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.47 56.96 0.06 OUTLIER Glycine 0 C--N 1.349 1.284 0 CA-C-N 112.733 -2.03 . . . . 0.0 110.266 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 tt -104.7 47.55 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -142.51 118.17 10.42 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -140.04 151.84 45.74 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.205 -177.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.34 91.41 2.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 m -89.35 99.11 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 126.039 2.828 . . . . 0.0 110.339 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.08 109.08 2.71 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 108.498 -3.955 . . . . 0.0 109.358 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.8 -101.65 2.23 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 112.244 -1.978 . . . . 0.0 109.353 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t30 64.65 -104.84 0.12 Allowed 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.88 56.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.35 176.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.858 -1.974 . . . . 0.0 108.505 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.51 56.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.838 0 CA-C-N 112.722 -2.036 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.77 141.35 5.15 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.142 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.3 106.22 0.24 Allowed 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.17 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 126.032 2.083 . . . . 0.0 105.608 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.49 130.69 35.79 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -142.99 158.84 58.18 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.77 -148.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.853 0 N-CA-C 107.442 -1.792 . . . . 0.0 107.442 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.97 -22.34 60.71 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.0 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.21 -69.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.804 0 O-C-N 124.519 1.137 . . . . 0.0 111.309 -179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -89.85 22.95 2.91 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 117.391 -1.723 . . . . 0.0 108.338 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.35 -42.13 59.88 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -79.65 -32.07 41.57 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 112.104 -2.316 . . . . 0.0 106.877 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.72 15.97 13.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.841 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 -40.56 11.94 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 176.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.15 74.86 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 112.355 -2.202 . . . . 0.0 107.473 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.4 mtp -80.78 -58.69 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.11 40.67 0.08 OUTLIER Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.347 2.403 . . . . 0.0 117.32 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -84.62 -6.29 59.36 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.62 132.08 50.19 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -178.26 3.47 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.9 m -140.07 161.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.227 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.543 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 5.6 m-85 -99.36 154.35 37.33 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-N 110.532 -3.031 . . . . 0.0 103.679 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.26 159.73 43.32 Favored 'Trans proline' 0 C--N 1.368 1.554 0 N-CA-C 107.173 -1.895 . . . . 0.0 107.173 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.02 116.46 4.66 Favored 'Trans proline' 0 C--N 1.369 1.649 0 N-CA-C 103.763 -3.206 . . . . 0.0 103.763 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.81 132.79 5.57 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 t -73.62 159.61 32.82 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-O 125.25 2.452 . . . . 0.0 107.67 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.5 p -173.4 119.57 0.39 Allowed Pre-proline 0 N--CA 1.427 -1.607 1 CA-C-N 106.484 -4.871 . . . . 0.0 101.537 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -78.93 -4.53 14.02 Favored 'Trans proline' 0 C--N 1.358 1.041 0 N-CA-C 108.698 -1.309 . . . . 0.0 108.698 -179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.29 -37.38 87.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.462 1.905 . . . . 0.0 107.619 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.87 -23.71 59.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.615 -1.629 . . . . 0.0 108.148 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.44 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.4 p -81.79 -25.57 35.15 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 116.948 -1.901 . . . . 0.0 109.909 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.72 -24.87 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.44 -6.48 58.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 112.969 -1.923 . . . . 0.0 108.714 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 126' ' ' THR . 36.3 t0 -61.89 -58.03 9.48 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.0 mmt -88.15 -10.78 48.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.069 -1.878 . . . . 0.0 110.874 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -90.21 -49.81 6.35 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 117.864 -1.534 . . . . 0.0 109.013 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.92 -50.27 66.78 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.214 0.946 . . . . 0.0 109.868 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 51.1 t -69.45 -61.36 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 113.035 -1.893 . . . . 0.0 111.86 -179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.1 mp -90.38 52.61 2.27 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.768 1.293 . . . . 0.0 109.876 -177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.75 -77.7 0.03 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -165.22 149.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.148 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 112.508 -2.133 . . . . 0.0 105.392 -178.883 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttp . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -95.39 80.26 3.5 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.12 161.16 26.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.802 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 21.2 pttp -119.6 108.91 15.06 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 110.927 -2.851 . . . . 0.0 108.123 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.41 85.48 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -109.86 107.25 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 110.721 -2.945 . . . . 0.0 103.751 -176.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -113.68 126.35 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.483 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.27 153.13 43.69 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.4 -2.182 . . . . 0.0 106.679 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.41 ' O ' ' HB ' ' A' ' 10' ' ' VAL . . . 176.23 174.07 42.42 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 111.137 -2.756 . . . . 0.0 108.171 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.599 ' HB ' ' H ' ' A' ' 61' ' ' SER . 3.0 p 164.48 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.541 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' H ' ' CG1' ' A' ' 10' ' ' VAL . 2.3 tp -168.29 -150.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.38 1.904 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.17 -142.17 6.11 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 118.681 -1.723 . . . . 0.0 110.327 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.87 -61.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.05 151.8 29.73 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.965 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t 68.91 -109.09 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.116 1.51 . . . . 0.0 107.252 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -163.93 43.14 0.1 Allowed 'General case' 0 C--N 1.361 1.104 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.308 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.17 42.44 15.41 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.034 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.15 107.68 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 O-C-N 124.647 1.217 . . . . 0.0 110.997 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.96 -22.13 16.44 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.133 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 22' ' ' ILE . 86.1 m-20 -42.33 -52.36 4.56 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 111.639 -2.28 . . . . 0.0 105.034 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -11.39 56.86 0.0 OUTLIER 'General case' 0 C--N 1.373 1.592 2 C-N-CA 140.014 7.325 . . . . 0.0 107.906 175.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.414 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.348 0.2 OUTLIER 29.65 42.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.332 2 CA-C-N 106.614 -4.812 . . . . 0.0 109.522 -178.213 . . . . . . . . 5 4 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -35.53 25.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 2.1 p30 -76.95 -2.95 36.35 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 113.694 -1.594 . . . . 0.0 106.868 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -77.36 -34.97 55.0 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -56.79 -43.53 80.99 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.28 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 24' ' ' ASP . 0.2 OUTLIER -55.28 -44.07 75.35 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.928 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -27.33 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 111.545 -2.57 . . . . 0.0 112.782 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -78.74 -0.53 30.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.201 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.28 9.21 2.49 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 118.511 -1.275 . . . . 0.0 107.908 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 33.58 58.57 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 124.243 0.964 . . . . 0.0 112.627 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -99.61 -179.47 4.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 28.2 t-20 -76.85 144.5 38.99 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 112.219 -2.264 . . . . 0.0 106.873 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -99.92 127.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 110.669 -2.969 . . . . 0.0 107.469 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.8 t -140.19 128.75 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 111.561 -2.563 . . . . 0.0 105.6 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -144.2 132.49 21.91 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -97.08 -87.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 111.85 -2.432 . . . . 0.0 104.886 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.05 -137.99 4.77 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.6 2.28 8.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 CA-C-N 113.201 -1.499 . . . . 0.0 110.716 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.27 98.31 11.26 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.6 t -97.9 55.34 1.18 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 -178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 p -90.14 86.51 6.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -66.81 -46.31 75.6 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.144 -176.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -37.71 88.54 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.482 1.113 . . . . 0.0 109.61 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -77.72 -21.01 52.57 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.88 -2.24 58.06 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.7 -35.88 32.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -75.04 -32.21 61.5 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.958 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.98 5.69 49.15 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.988 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.25 -19.04 24.6 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.15 -38.48 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -59.51 -69.13 0.22 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.988 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.85 -54.74 10.42 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.722 -176.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' THR . 64.0 tttt 117.65 47.23 0.0 OUTLIER 'General case' 0 C--N 1.356 0.852 0 O-C-N 126.705 2.503 . . . . 0.0 107.55 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -48.85 106.46 0.1 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.499 1.142 . . . . 0.0 110.279 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.63 -38.15 34.46 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 111.584 -2.553 . . . . 0.0 104.163 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.9 pp -154.39 165.05 37.61 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.61 142.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 111.722 -2.49 . . . . 0.0 106.169 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . 0.538 ' HG ' ' HH ' ' A' ' 117' ' ' TYR . 44.8 t -137.79 133.67 34.31 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 135.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.138 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.599 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.42 91.85 3.82 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 t 150.09 166.26 0.0 OUTLIER 'General case' 0 C--N 1.36 1.056 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.75 -127.24 0.0 OUTLIER 'General case' 0 C--N 1.358 0.959 0 CA-C-N 113.595 -1.638 . . . . 0.0 107.277 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.61 85.16 7.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.48 42.87 1.26 Allowed Glycine 0 C--N 1.345 1.058 0 CA-C-N 110.881 -2.872 . . . . 0.0 107.089 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -148.38 -32.42 0.25 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 111.181 -2.509 . . . . 0.0 106.857 -178.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.08 167.73 42.79 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.39 1.38 19.17 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.582 -1.309 . . . . 0.0 109.044 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.32 -46.51 17.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -72.6 -27.38 62.13 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.781 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.47 -47.28 67.52 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -90.07 25.43 2.15 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 124.815 1.322 . . . . 0.0 108.988 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.35 -33.31 6.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.27 -29.67 20.23 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 111.939 -2.131 . . . . 0.0 107.678 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -24.23 58.67 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.1 -29.25 31.84 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -76.49 -15.1 59.97 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.235 0.959 . . . . 0.0 109.238 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.35 -48.12 7.33 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 124.014 1.864 . . . . 0.0 107.059 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.61 -3.67 22.83 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 108.43 -3.986 . . . . 0.0 109.207 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.45 -56.36 3.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.75 48.02 5.81 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 110.964 -2.835 . . . . 0.0 106.641 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.75 -43.62 0.02 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.905 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.35 120.57 23.98 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 136.12 33.95 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.72 53.96 0.09 OUTLIER Glycine 0 C--N 1.35 1.307 0 CA-C-N 112.734 -2.03 . . . . 0.0 110.117 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.86 55.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -148.35 118.67 7.33 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -139.98 151.84 45.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.862 -1.972 . . . . 0.0 106.121 -177.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 90.99 2.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 m -89.33 98.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 CA-C-O 126.106 2.86 . . . . 0.0 110.307 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 109.54 2.82 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 108.456 -3.975 . . . . 0.0 109.367 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -101.14 2.14 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.195 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.3 t30 64.38 -104.94 0.12 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.34 125.28 56.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.44 177.32 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.824 -1.989 . . . . 0.0 108.449 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.57 55.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-N 112.654 -2.067 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.92 141.34 5.1 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.227 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.27 105.51 0.23 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.36 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.356 0.856 0 O-C-N 126.056 2.097 . . . . 0.0 105.526 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -89.22 130.09 35.69 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -142.91 158.82 58.45 Favored Pre-proline 0 C--N 1.352 0.675 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.73 -148.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.374 1.872 0 N-CA-C 107.433 -1.795 . . . . 0.0 107.433 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.96 -22.32 60.72 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.969 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -57.21 -69.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 124.495 1.122 . . . . 0.0 111.282 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -89.99 23.11 2.9 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.403 -1.719 . . . . 0.0 108.41 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -74.43 -42.41 59.18 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 112.065 -2.334 . . . . 0.0 106.869 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.19 16.43 13.06 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.914 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -40.71 11.83 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.25 75.28 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 112.212 -2.267 . . . . 0.0 107.408 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.1 mtp -80.78 -58.51 3.06 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 31.52 41.04 0.07 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.399 2.428 . . . . 0.0 117.373 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.69 -6.09 59.34 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.4 132.14 49.91 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -178.97 3.66 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.02 161.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 117.793 -1.563 . . . . 0.0 110.255 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.538 ' HH ' ' HG ' ' A' ' 59' ' ' CYS . 5.9 m-85 -99.39 154.41 37.3 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.815 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.08 160.66 42.42 Favored 'Trans proline' 0 C--N 1.368 1.579 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.9 116.43 4.66 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 103.823 -3.183 . . . . 0.0 103.823 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.11 133.86 5.94 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -73.84 159.61 32.62 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 125.144 2.402 . . . . 0.0 107.52 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.7 p -173.17 120.57 0.41 Allowed Pre-proline 0 N--CA 1.427 -1.606 1 CA-C-N 106.583 -4.826 . . . . 0.0 101.648 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -78.8 -5.45 14.68 Favored 'Trans proline' 0 C--N 1.357 0.999 0 N-CA-C 108.685 -1.313 . . . . 0.0 108.685 -179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.84 -37.92 89.17 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.547 1.939 . . . . 0.0 107.744 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.256 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.443 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.3 p -82.09 -25.44 34.51 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 116.94 -1.904 . . . . 0.0 109.983 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.3 mt -67.65 -24.78 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.77 -6.3 58.23 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.77 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.443 ' H ' ' C ' ' A' ' 126' ' ' THR . 36.1 t0 -61.91 -58.37 8.19 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 35.1 mmt -87.09 -11.93 48.7 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.82 -177.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -90.13 -48.55 7.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.201 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -47.99 71.27 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 124.131 0.894 . . . . 0.0 109.921 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 52.3 t -71.42 -61.19 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.638 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 mp -90.37 53.97 2.62 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.842 1.339 . . . . 0.0 109.635 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.26 -78.08 0.04 OUTLIER Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.07 151.28 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.638 0 CA-C-N 113.74 -1.23 . . . . 0.0 108.241 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 112.387 -2.188 . . . . 0.0 105.211 -179.141 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.39 43.74 1.05 Allowed 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.212 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -63.04 144.06 57.23 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.404 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.24 102.44 14.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 111.786 -2.461 . . . . 0.0 107.505 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.03 105.75 0.03 OUTLIER 'General case' 0 C--N 1.357 0.919 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 112.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.8 117.92 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 111.779 -2.464 . . . . 0.0 108.293 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.2 tp -90.14 159.89 16.54 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.912 -1.949 . . . . 0.0 108.262 -177.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.48 29.84 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 111.422 -2.626 . . . . 0.0 107.844 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.36 131.75 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 122.312 1.053 . . . . 0.0 112.087 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.54 133.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.31 175.71 36.19 Favored Glycine 0 C--N 1.357 1.719 0 C-N-CA 117.818 -2.134 . . . . 0.0 113.192 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.307 13.7 p -114.45 20.56 15.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 108.25 -3.975 . . . . 0.0 107.258 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.09 132.84 3.12 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.5 p -81.56 115.91 21.07 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 61.0 t60 79.04 142.02 0.08 Allowed 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.17 73.33 0.34 Allowed 'General case' 0 C--N 1.356 0.88 0 CA-C-N 112.938 -1.937 . . . . 0.0 106.26 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -161.84 41.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 112.709 -2.042 . . . . 0.0 111.06 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.21 -28.32 15.26 Favored Glycine 0 C--N 1.359 1.81 0 CA-C-O 122.157 0.865 . . . . 0.0 113.857 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -41.85 -47.31 4.18 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -11.49 57.2 0.0 OUTLIER 'General case' 0 C--N 1.382 2.001 3 C-N-CA 140.77 7.628 . . . . 0.0 107.833 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.355 0.2 OUTLIER 30.09 54.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.434 1 CA-C-N 106.242 -4.981 . . . . 0.0 107.922 -177.371 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 6.8 tt -70.91 -25.54 62.81 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 102.11 -3.292 . . . . 0.0 102.11 173.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -66.32 -17.44 64.76 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 116.744 -1.982 . . . . 0.0 107.221 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -69.4 -24.5 63.86 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.461 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 7.4 p -56.78 -37.82 71.63 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 125.024 1.453 . . . . 0.0 108.739 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CD2' ' CB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -54.64 -49.42 70.58 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.029 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -22.78 61.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.114 -2.312 . . . . 0.0 112.904 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -81.33 0.07 38.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.688 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.93 12.9 1.45 Allowed 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.001 -1.48 . . . . 0.0 107.906 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 37.74 46.2 Favored Glycine 0 C--N 1.36 1.869 0 O-C-N 124.229 0.955 . . . . 0.0 113.056 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.71 -168.11 1.56 Allowed 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.303 -1.449 . . . . 0.0 107.519 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -93.8 140.04 30.14 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.705 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.419 ' CB ' ' CD2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.74 127.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 109.995 -3.275 . . . . 0.0 108.927 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.7 t -140.31 144.48 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 109.909 -3.314 . . . . 0.0 104.432 176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.13 135.79 8.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.96 -67.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.36 -145.63 16.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 112.144 -2.298 . . . . 0.0 108.374 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.52 88.7 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 tp -164.68 119.72 1.41 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 t -98.31 37.11 1.49 Allowed 'General case' 0 C--N 1.358 0.974 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.478 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 72.9 p -90.17 98.15 11.6 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.16 -55.45 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.985 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.78 -20.44 66.37 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.65 1.219 . . . . 0.0 111.597 -177.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.34 -37.26 17.27 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.239 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -90.04 10.16 25.24 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 118.027 -1.469 . . . . 0.0 108.629 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.04 -32.46 6.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.022 0 N-CA-C 102.27 -3.234 . . . . 0.0 102.27 174.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.68 -26.1 60.57 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.27 -6.79 56.5 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.64 51.34 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mt -83.87 -41.64 16.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.22 -57.52 12.08 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 112.146 -2.297 . . . . 0.0 108.835 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.21 -55.06 20.68 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 90.21 53.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.114 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.57 126.52 27.79 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 111.2 -2.727 . . . . 0.0 107.335 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -88.21 -31.92 18.83 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 112.825 -1.988 . . . . 0.0 107.214 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -157.76 154.34 28.02 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 mt -114.73 165.91 9.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 111.908 -2.405 . . . . 0.0 105.489 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 89.0 m -153.14 100.56 2.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 111.333 -2.667 . . . . 0.0 103.989 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.92 137.39 36.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 m -99.71 125.8 45.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.672 ' HG ' ' H ' ' A' ' 65' ' ' GLY . 18.1 t -157.99 175.4 13.87 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 114.639 -2.824 . . . . 0.0 107.519 -178.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.67 48.38 0.8 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.814 -2.903 . . . . 0.0 106.454 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 72.78 32.76 1.39 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 113.734 -1.576 . . . . 0.0 107.305 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.672 ' H ' ' HG ' ' A' ' 62' ' ' SER . . . -114.53 -3.01 22.62 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.367 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -87.63 -17.75 31.19 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.72 177.44 49.12 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.341 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.07 18.9 5.36 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.6 -1.3 . . . . 0.0 108.048 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -53.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -71.19 -26.17 62.84 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.413 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . 0.401 ' C ' ' H ' ' A' ' 73' ' ' GLY . 26.9 t -66.67 -56.18 11.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -90.1 30.1 1.14 Allowed 'General case' 0 C--N 1.359 1.0 0 O-C-N 124.684 1.24 . . . . 0.0 109.36 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 71' ' ' CYS . . . -98.14 -38.83 3.94 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -90.03 -23.13 21.55 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 112.705 -1.747 . . . . 0.0 107.771 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -29.94 59.9 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.36 -26.56 52.09 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.69 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -74.71 -17.62 60.63 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.005 0.816 . . . . 0.0 109.261 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.404 ' C ' ' H ' ' A' ' 80' ' ' GLU . 36.5 t -90.22 -46.47 8.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.919 1.819 . . . . 0.0 107.524 -178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -74.17 0.76 12.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 108.67 -3.877 . . . . 0.0 109.095 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 78' ' ' CYS . 10.1 tp10 -84.03 -55.97 3.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.27 45.56 6.7 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-N 110.84 -2.891 . . . . 0.0 106.68 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.07 -43.62 0.02 OUTLIER Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.492 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -79.62 120.87 24.56 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.57 35.91 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.21 122.42 2.68 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 112.17 -2.286 . . . . 0.0 107.459 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 tt -149.56 34.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -138.4 118.18 13.19 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.79 112.87 8.6 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.49 89.77 4.06 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.84 91.19 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 111.076 -2.784 . . . . 0.0 110.351 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -69.71 142.17 36.22 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 110.218 -3.174 . . . . 0.0 110.393 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.84 -83.67 1.61 Allowed Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.406 -2.397 . . . . 0.0 107.229 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 61.5 -108.05 0.3 Allowed 'General case' 0 C--N 1.355 0.835 0 CA-C-N 112.56 -1.82 . . . . 0.0 107.053 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.3 mt -118.09 149.71 20.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.43 -172.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.667 0 CA-C-N 112.728 -2.033 . . . . 0.0 108.73 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 39.24 68.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.834 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.881 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.9 171.13 35.13 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 112.316 -2.22 . . . . 0.0 109.878 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -157.03 -49.25 0.07 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.21 -38.14 2.0 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.76 111.44 22.45 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -119.09 166.09 15.28 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.48 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 N-CA-C 108.1 -1.539 . . . . 0.0 108.1 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.91 -24.45 61.64 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 113.844 -1.526 . . . . 0.0 108.41 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.4 p -55.78 -72.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 O-C-N 124.739 1.275 . . . . 0.0 111.323 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -88.78 25.94 1.64 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.65 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.78 -45.37 36.6 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -80.57 -30.04 36.98 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 111.541 -2.572 . . . . 0.0 107.531 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -91.51 12.65 20.1 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.878 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -38.46 13.36 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.9 73.08 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.729 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.9 mtp -81.79 -61.53 1.9 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.0 39.87 0.01 OUTLIER Glycine 0 C--N 1.356 1.641 0 C-N-CA 127.698 2.571 . . . . 0.0 117.432 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -87.79 -6.19 58.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.07 137.66 42.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 170.45 8.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 102.496 -3.15 . . . . 0.0 102.496 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.88 156.47 25.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.212 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.434 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 1.6 m-85 -99.59 128.66 30.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.92 160.27 26.19 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.324 2.016 . . . . 0.0 109.322 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.24 121.27 7.64 Favored 'Trans proline' 0 C--N 1.369 1.646 0 N-CA-C 104.684 -2.852 . . . . 0.0 104.684 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 67.18 0.94 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 -165.77 1.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 110.466 -2.867 . . . . 0.0 106.775 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.76 ' HG ' ' HG1' ' A' ' 125' ' ' THR . 3.5 p -168.26 168.35 5.83 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 111.566 -2.561 . . . . 0.0 104.447 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.19 -8.15 17.41 Favored 'Trans proline' 0 C--N 1.367 1.543 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.33 -29.21 65.86 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.76 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -79.02 -20.41 49.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.822 -1.536 . . . . 0.0 108.006 -179.09 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.483 ' C ' ' H ' ' A' ' 129' ' ' ASP . 4.5 p -82.7 -16.81 46.7 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 118.048 -1.461 . . . . 0.0 110.264 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.0 -29.38 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 -1.33 57.75 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 126' ' ' THR . 53.4 t0 -64.5 -63.59 1.09 Allowed 'General case' 0 C--N 1.359 1.01 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' MET . . . . . 0.461 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -83.23 -10.49 58.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.431 -2.168 . . . . 0.0 110.299 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.18 -46.06 8.69 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.91 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.45 -37.28 77.72 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.591 0.557 . . . . 0.0 109.957 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.51 -73.98 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.41 57.11 3.56 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 124.644 1.215 . . . . 0.0 109.423 -178.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.49 -36.64 0.02 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.26 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.25 159.21 11.2 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 CA--C 1.543 0.674 0 CA-C-N 113.175 -1.829 . . . . 0.0 107.042 179.531 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ttt . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -105.92 36.15 2.66 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 112.962 -1.927 . . . . 0.0 106.188 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.24 141.3 54.66 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 123.197 1.475 . . . . 0.0 108.617 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.29 95.64 8.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 110.548 -3.023 . . . . 0.0 107.894 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -176.65 111.55 0.09 Allowed 'General case' 0 C--N 1.355 0.807 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.27 111.94 9.93 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.82 18.56 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 O-C-N 125.866 1.979 . . . . 0.0 105.689 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -113.45 149.36 34.34 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 123.114 1.435 . . . . 0.0 108.81 -177.741 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 149.87 21.4 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 110.866 -2.879 . . . . 0.0 106.577 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.32 98.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.714 0 CA-C-O 122.328 1.061 . . . . 0.0 110.587 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.3 156.69 4.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.73 175.41 46.92 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 115.574 -3.203 . . . . 0.0 113.597 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.288 25.2 p -115.26 22.68 13.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 108.2 -4.0 . . . . 0.0 106.344 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -161.92 132.76 5.07 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -79.0 103.65 9.09 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.7 t60 77.27 149.84 0.11 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 71.49 73.1 0.18 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -159.47 -12.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.198 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.51 -23.58 0.1 Allowed Glycine 0 C--N 1.354 1.569 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.004 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -40.92 -49.61 3.24 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -12.96 58.84 0.0 OUTLIER 'General case' 0 C--N 1.381 1.941 2 C-N-CA 139.927 7.291 . . . . 0.0 107.757 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.383 0.3 OUTLIER 26.61 54.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.408 -2.571 2 CA-C-N 105.222 -5.445 . . . . 0.0 108.263 -177.142 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.17 -24.84 59.45 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 102.386 -3.19 . . . . 0.0 102.386 173.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 35.4 m-20 -71.9 -8.99 57.63 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -74.51 -30.09 61.66 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -53.29 -44.36 68.23 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 125.647 1.842 . . . . 0.0 110.349 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 24' ' ' ASP . 0.3 OUTLIER -60.07 -41.71 93.01 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.87 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.7 -24.57 59.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.668 -2.06 . . . . 0.0 112.689 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -81.87 -1.19 46.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 112.224 -2.262 . . . . 0.0 108.926 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.59 3.7 2.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.75 32.06 68.97 Favored Glycine 0 C--N 1.358 1.795 0 O-C-N 123.952 0.783 . . . . 0.0 111.674 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -99.7 -175.3 2.94 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 113.206 -1.497 . . . . 0.0 107.542 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -86.26 138.63 31.71 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 112.291 -2.231 . . . . 0.0 108.271 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -99.62 127.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 109.824 -3.353 . . . . 0.0 107.807 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.9 t -140.1 125.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 110.036 -3.256 . . . . 0.0 104.662 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -142.77 128.6 19.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.03 -75.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.34 -151.18 23.42 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.638 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -87.79 84.05 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 tp -162.49 117.5 1.84 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.1 t -93.53 48.34 1.29 Allowed 'General case' 0 C--N 1.356 0.889 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.281 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . 0.257 8.8 p -90.5 95.45 10.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 103.767 -2.679 . . . . 0.0 103.767 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -90.13 -57.83 2.71 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 118.03 -1.468 . . . . 0.0 108.322 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.1 -18.46 63.44 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.828 1.33 . . . . 0.0 111.382 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -91.35 -37.11 13.44 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 118.495 -1.282 . . . . 0.0 107.65 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -90.06 10.05 25.74 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.924 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 -33.69 6.35 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -73.37 -25.02 60.41 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.05 -2.33 56.73 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 -9.45 48.61 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.2 -41.6 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.62 -58.69 7.51 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 112.129 -2.305 . . . . 0.0 108.404 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.89 -56.21 12.96 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.68 1.237 . . . . 0.0 107.821 -178.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 tttp 95.64 47.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 110.362 -3.108 . . . . 0.0 102.722 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.62 5.43 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 111.851 -2.431 . . . . 0.0 106.819 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -80.48 -36.44 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 111.706 -2.497 . . . . 0.0 106.555 -178.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.41 158.39 44.1 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.21 141.32 46.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 CA-C-N 111.797 -2.456 . . . . 0.0 104.957 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.97 109.16 9.85 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.32 133.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -100.94 117.55 35.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.684 ' HG ' ' H ' ' A' ' 65' ' ' GLY . 15.9 t -157.76 177.83 10.93 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 115.623 -2.431 . . . . 0.0 108.133 -176.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.4 ' H ' ' HG ' ' A' ' 62' ' ' SER . 0.6 OUTLIER -152.6 46.19 0.72 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 111.405 -2.634 . . . . 0.0 106.947 -178.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.32 30.1 0.53 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.197 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.684 ' H ' ' HG ' ' A' ' 62' ' ' SER . . . -111.68 -2.02 27.33 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.092 178.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.97 -8.95 44.72 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.44 177.38 13.19 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.524 1.14 . . . . 0.0 110.558 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 25.5 2.18 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.807 -1.196 . . . . 0.0 108.028 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -54.16 8.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.21 -26.37 62.02 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.954 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -68.71 -58.51 4.12 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -90.1 27.88 1.52 Allowed 'General case' 0 C--N 1.359 0.99 0 O-C-N 124.751 1.282 . . . . 0.0 110.145 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.03 -30.15 5.53 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 31.0 mt -90.07 -28.28 19.12 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.332 -1.934 . . . . 0.0 107.484 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -29.79 58.88 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.09 -27.87 57.33 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.484 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -73.58 -19.54 60.85 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 123.92 0.762 . . . . 0.0 109.651 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' CYS . . . . . 0.416 ' C ' ' H ' ' A' ' 80' ' ' GLU . 44.8 t -90.25 -46.3 8.5 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.806 1.765 . . . . 0.0 107.902 -177.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -73.98 0.95 11.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 108.788 -3.824 . . . . 0.0 109.167 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 78' ' ' CYS . 10.3 tp10 -84.24 -56.29 3.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 176.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.83 45.66 5.54 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.73 -2.941 . . . . 0.0 106.494 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.48 -42.1 0.02 OUTLIER Glycine 0 C--N 1.352 1.423 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.841 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 mt -78.8 122.78 26.48 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.49 117.58 2.35 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 112.229 -2.259 . . . . 0.0 108.554 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 tt -143.36 40.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -140.66 117.26 10.88 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.09 108.3 5.79 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.19 86.84 3.3 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.027 -3.323 . . . . 0.0 102.027 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.35 95.98 5.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 CA-C-N 111.338 -2.664 . . . . 0.0 109.65 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.413 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -60.31 128.44 45.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 109.259 -3.61 . . . . 0.0 111.82 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.88 -83.12 1.55 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 111.539 -2.331 . . . . 0.0 107.372 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 71.22 -88.35 0.03 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 112.505 -1.847 . . . . 0.0 106.827 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 mt -135.33 149.72 28.86 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -175.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.835 -1.984 . . . . 0.0 108.864 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.7 84.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-N 112.007 -2.361 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.47 -178.42 28.81 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.239 -2.255 . . . . 0.0 110.608 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -159.33 -44.73 0.05 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 111.523 -2.338 . . . . 0.0 104.839 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.18 -37.16 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -87.13 89.84 8.14 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -101.99 169.26 7.86 Favored Pre-proline 0 C--N 1.35 0.615 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -152.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.752 0 N-CA-C 108.092 -1.541 . . . . 0.0 108.092 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.45 -24.15 61.97 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.459 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 1.5 p -56.69 -72.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 O-C-N 124.764 1.29 . . . . 0.0 111.544 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -89.03 26.25 1.62 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 117.773 -1.571 . . . . 0.0 109.846 -178.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -76.66 -45.77 28.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -80.24 -29.0 38.38 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 111.46 -2.609 . . . . 0.0 107.509 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.72 12.77 22.24 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.897 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -37.12 14.22 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.25 75.14 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-N 112.845 -1.979 . . . . 0.0 107.494 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.7 mtp -80.2 -61.21 2.05 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.95 38.57 0.01 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.91 2.671 . . . . 0.0 117.708 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -84.84 -6.84 59.35 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.14 135.97 45.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.19 170.42 8.09 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.15 163.01 24.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.413 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 1.0 OUTLIER -99.58 153.45 37.77 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.42 164.92 25.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.826 1.684 . . . . 0.0 108.056 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.23 118.01 3.91 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 102.377 -3.74 . . . . 0.0 102.377 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.71 68.98 1.09 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . 0.273 0.2 OUTLIER -90.25 -158.08 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 109.496 -3.352 . . . . 0.0 107.336 -177.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.726 ' HG ' ' HG1' ' A' ' 125' ' ' THR . 10.4 p -174.22 164.14 2.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 110.47 -3.059 . . . . 0.0 103.936 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.25 -5.4 15.67 Favored 'Trans proline' 0 C--N 1.365 1.401 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.56 -29.5 64.8 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.726 ' HG1' ' HG ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -76.29 -20.8 56.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.647 -179.713 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.485 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -85.34 -14.78 45.39 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.764 -1.175 . . . . 0.0 110.06 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mt -69.61 -28.62 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 -2.49 58.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.41 -2.177 . . . . 0.0 108.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 126' ' ' THR . 44.1 t0 -61.33 -62.4 1.86 Allowed 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -82.31 -7.72 59.63 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.282 -2.235 . . . . 0.0 110.444 -176.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.1 -54.25 4.12 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.443 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.92 -39.5 71.75 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.752 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 80.6 t -89.99 -68.99 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 125.193 1.558 . . . . 0.0 111.778 -178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 89.1 mt -90.31 54.25 2.71 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.746 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -162.67 -37.22 0.02 OUTLIER Glycine 0 C--N 1.346 1.088 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.736 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.23 161.98 17.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 CA--C 1.543 0.711 0 CA-C-N 113.394 -1.73 . . . . 0.0 107.268 179.219 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' DBI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.27 133.76 39.98 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -81.25 89.57 6.05 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 111.023 -2.808 . . . . 0.0 107.335 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -174.36 120.2 0.25 Allowed 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.12 112.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.528 HG23 HG12 ' A' ' 35' ' ' VAL . 2.3 p -98.98 113.6 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.678 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -125.2 154.04 42.17 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.911 1.382 . . . . 0.0 109.762 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.25 -154.32 25.12 Favored Glycine 0 C--N 1.361 1.963 0 CA-C-N 111.931 -2.395 . . . . 0.0 112.689 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 14.9 p 88.28 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 131.095 3.758 . . . . 0.0 115.398 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 10' ' ' VAL 0.271 1.2 tt 67.03 148.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.173 2.189 . . . . 0.0 109.22 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.956 0 CA-C-N 112.267 -2.242 . . . . 0.0 110.763 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 125.883 2.754 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.503 ' HB ' ' ND1' ' A' ' 25' ' ' HIS 0.325 0.9 OUTLIER 43.13 44.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 1 CA-C-N 106.659 -4.791 . . . . 0.0 109.539 -178.473 . . . . . . . . 5 4 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 2.3 tt -68.68 -24.07 64.47 Favored 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 114.679 -2.809 . . . . 0.0 103.602 171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.23 -15.99 64.02 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.901 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.503 ' ND1' ' HB ' ' A' ' 22' ' ' ILE 0.265 0.7 OUTLIER -69.72 -26.3 64.26 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 117.969 -1.492 . . . . 0.0 108.241 178.808 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -20.17 65.34 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 113.161 -1.836 . . . . 0.0 108.814 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' CD2' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -58.62 -46.27 87.43 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -29.66 69.45 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 112.121 -2.309 . . . . 0.0 112.133 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.69 10.88 19.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.068 -2.333 . . . . 0.0 108.55 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -8.81 2.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.91 31.49 76.33 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.75 -175.21 2.91 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 113.006 -1.597 . . . . 0.0 108.328 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -108.71 154.64 21.74 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 112.287 -2.233 . . . . 0.0 106.777 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 27' ' ' PHE . 78.5 t -99.94 135.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 CA-C-N 111.781 -2.463 . . . . 0.0 108.83 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 7' ' ' VAL . 21.8 t -140.36 54.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 111.418 -2.628 . . . . 0.0 107.005 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.8 126.43 30.37 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 46' ' ' PHE . 4.8 mt -89.84 -65.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.86 -116.82 0.73 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.394 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.12 23.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.323 -1.438 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.85 167.91 10.46 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.9 t -123.61 66.53 1.02 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 111.37 -2.65 . . . . 0.0 104.166 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.9 m -77.75 102.77 7.32 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -88.16 -85.9 0.18 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 113.06 -1.882 . . . . 0.0 107.38 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.19 -11.25 56.85 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 124.94 1.4 . . . . 0.0 110.926 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -89.21 -45.62 9.41 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.68 3.18 48.84 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.683 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 -29.03 7.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -73.05 -27.9 62.01 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.71 2.86 54.19 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.39 -9.13 48.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.24 -36.91 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -62.0 -69.07 0.27 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.192 -2.276 . . . . 0.0 110.195 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . 0.279 6.4 p -78.34 -32.43 49.15 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 123.783 0.677 . . . . 0.0 109.685 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 81.15 61.09 0.02 OUTLIER 'General case' 0 C--N 1.349 0.552 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.8 118.27 3.03 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.851 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 5' ' ' THR . 40.5 t0 -83.31 -49.35 9.47 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 130' ' ' MET . 3.2 pp -142.83 161.2 38.71 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 125.426 1.704 . . . . 0.0 106.78 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -120.28 137.2 54.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 111.139 -2.755 . . . . 0.0 105.295 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.95 112.28 14.5 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -100.62 142.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.207 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -114.39 63.61 0.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 p -168.67 148.62 4.44 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 70.59 0.74 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 111.61 -2.541 . . . . 0.0 104.341 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 72.22 87.3 0.11 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-N 110.413 -3.085 . . . . 0.0 106.818 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.28 33.52 0.51 Allowed Glycine 0 CA--C 1.535 1.32 0 CA-C-N 109.833 -3.349 . . . . 0.0 106.61 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.78 -14.65 0.54 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 111.259 -2.471 . . . . 0.0 108.476 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.76 -162.78 54.55 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 122.53 1.072 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.2 3.27 27.99 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 111.79 -2.205 . . . . 0.0 108.055 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mm -73.15 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.85 -24.6 65.28 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.843 1.339 . . . . 0.0 108.813 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 21.9 t -62.91 -72.13 0.14 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -90.17 33.09 0.89 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.313 1.008 . . . . 0.0 109.33 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.74 -47.61 2.47 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.82 -20.82 23.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 112.047 -2.076 . . . . 0.0 107.89 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 75' ' ' ARG . 5.5 mmt85 -74.84 -31.85 61.76 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.05 -23.79 47.97 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.057 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.95 -16.11 59.45 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.96 0.787 . . . . 0.0 109.183 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.4 m -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 123.868 1.794 . . . . 0.0 107.229 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.38 -1.51 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 108.692 -3.867 . . . . 0.0 108.667 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.83 -53.46 6.47 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.73 48.76 5.32 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 111.024 -2.807 . . . . 0.0 107.101 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.06 -47.14 0.01 OUTLIER Glycine 0 C--N 1.347 1.166 0 CA-C-N 112.268 -2.242 . . . . 0.0 108.357 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.46 124.51 35.03 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 124.61 33.9 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.918 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.29 65.59 0.03 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 112.825 -1.988 . . . . 0.0 109.32 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.4 tt -105.54 11.32 8.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 112.097 -2.052 . . . . 0.0 108.139 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 88' ' ' LEU . 48.4 mmtm -122.51 114.26 20.43 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -140.11 101.88 4.25 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -99.87 90.96 4.61 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.81 96.52 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 108.89 -3.777 . . . . 0.0 111.323 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.0 124.12 34.56 Favored Glycine 0 CA--C 1.537 1.417 1 CA-C-N 107.433 -4.439 . . . . 0.0 112.69 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.37 -80.84 0.94 Allowed Glycine 0 C--N 1.352 1.441 0 CA-C-N 112.549 -1.825 . . . . 0.0 109.143 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 25.44 94.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.431 3.492 . . . . 0.0 110.823 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 69.91 123.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.511 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.63 169.9 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 112.343 -2.208 . . . . 0.0 107.318 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.42 61.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.648 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.03 148.03 9.74 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.275 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.47 105.12 0.36 Allowed 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 87.14 -58.94 0.04 OUTLIER 'General case' 0 C--N 1.357 0.899 0 O-C-N 125.915 2.01 . . . . 0.0 106.753 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -86.17 101.21 12.8 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -106.86 160.91 24.61 Favored Pre-proline 0 C--N 1.351 0.64 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.23 -158.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.61 1.54 . . . . 0.0 108.631 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.78 -23.45 67.25 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.592 -2.094 . . . . 0.0 108.771 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.67 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.9 p -57.81 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.735 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.746 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.67 ' H ' HG13 ' A' ' 104' ' ' VAL . 31.5 mt-10 -90.3 29.42 1.26 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.911 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -82.54 -41.18 19.96 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -80.46 -32.67 37.16 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.117 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -90.32 14.81 11.82 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.081 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -90.35 -38.77 13.12 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.23 75.05 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 112.63 -2.077 . . . . 0.0 106.99 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtp -77.63 -62.58 1.62 Allowed 'General case' 0 C--N 1.355 0.81 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.79 34.41 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.547 2.498 . . . . 0.0 117.261 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -4.76 58.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.27 132.67 51.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 171.87 7.2 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.13 152.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.188 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -99.74 117.74 63.07 Favored Pre-proline 0 C--N 1.36 1.05 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.82 147.95 90.31 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.417 2.078 . . . . 0.0 107.99 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.47 115.97 3.65 Favored 'Trans proline' 0 C--N 1.365 1.42 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.1 32.09 1.75 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.547 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.07 -166.37 1.57 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.263 3.2 p -143.2 170.68 8.19 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.489 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.57 -4.61 13.68 Favored 'Trans proline' 0 C--N 1.37 1.666 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.83 -25.75 61.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -17.53 54.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.668 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.581 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 5.6 p -83.96 -16.77 42.91 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 118.498 -1.281 . . . . 0.0 109.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.18 -32.92 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.06 -1.23 52.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.236 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 133' ' ' VAL . 50.7 t0 -61.32 -65.32 0.71 Allowed 'General case' 0 C--N 1.365 1.264 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.485 ' HE2' HD21 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -90.1 9.26 28.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 111.995 -2.366 . . . . 0.0 110.657 -176.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -88.66 -34.19 17.33 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 116.884 -1.927 . . . . 0.0 108.281 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.97 -43.45 10.54 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 124.256 0.973 . . . . 0.0 110.503 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 129' ' ' ASP . 44.5 t -66.48 -31.15 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.682 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.09 -33.83 16.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.563 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.066 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 130.82 36.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 123.38 1.562 . . . . 0.0 107.049 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -81.69 95.69 7.3 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 109.952 -3.295 . . . . 0.0 107.886 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.36 109.28 0.01 OUTLIER 'General case' 0 C--N 1.35 0.608 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -134.21 117.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.678 HG23 HG12 ' A' ' 35' ' ' VAL . 4.2 p -98.95 133.42 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 111.55 -2.568 . . . . 0.0 108.301 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD1' HD22 ' A' ' 23' ' ' LEU . 52.5 tp -125.2 143.71 50.81 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.976 1.422 . . . . 0.0 107.63 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -177.29 170.4 42.95 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.443 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' GLY 0.711 11.7 p 99.63 -130.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 130.893 3.677 . . . . 0.0 116.526 178.126 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.09 102.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 127.401 2.281 . . . . 0.0 107.618 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.871 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.211 -179.185 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 31.7 ttmt . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 125.583 2.611 . . . . 0.0 108.077 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 21' ' ' LYS . 1.3 mp 56.4 15.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 1 CA-C-N 105.725 -5.216 . . . . 0.0 112.049 177.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 8' ' ' LEU . 10.9 mp -76.89 -40.07 48.72 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 116.512 -2.075 . . . . 0.0 106.059 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.62 -1.25 37.22 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.787 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -82.32 -34.2 28.67 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 1.2 t -66.57 -29.26 69.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.124 -1.853 . . . . 0.0 110.438 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -65.26 -42.68 93.01 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.901 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -29.18 64.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.648 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.01 15.41 24.17 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.606 -2.543 . . . . 0.0 109.72 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.03 2.91 1.77 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.37 67.87 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.793 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' A' ' 134' ' ' LEU . 1.7 m-30 -99.76 156.18 17.24 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 112.603 -1.798 . . . . 0.0 106.169 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.26 140.8 34.65 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 111.327 -2.669 . . . . 0.0 105.85 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.628 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 1.4 p -99.88 137.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 112.145 -2.298 . . . . 0.0 107.457 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 7' ' ' VAL . 40.0 t -132.74 63.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.652 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -81.71 120.92 25.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.436 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -89.95 -79.47 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.8 -158.38 22.65 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.062 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.37 59.76 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.661 1.219 . . . . 0.0 110.117 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 tp -165.63 124.59 1.66 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 t -96.25 84.72 3.81 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.68 122.98 27.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.404 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -80.81 -94.63 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.23 -2.259 . . . . 0.0 108.745 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.46 -17.25 19.37 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.813 1.645 . . . . 0.0 111.735 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.92 -48.88 8.3 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -84.85 0.51 50.65 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 116.58 -2.048 . . . . 0.0 109.001 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 -27.88 7.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.23 -29.03 57.39 Favored 'General case' 0 C--N 1.365 1.27 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.95 6.96 46.79 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -20.93 22.54 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.19 -38.26 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.22 -68.65 0.27 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 112.337 -2.21 . . . . 0.0 110.332 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -64.97 0.95 Allowed 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? 129.69 47.36 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 O-C-N 126.912 2.632 . . . . 0.0 106.933 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.73 108.36 0.73 Allowed 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.67 -82.64 0.2 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.267 -2.242 . . . . 0.0 104.972 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -89.57 142.08 28.0 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.45 144.66 36.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.5 m -134.68 129.31 34.6 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 112.433 -2.167 . . . . 0.0 106.686 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 90' ' ' VAL . 92.5 t -99.96 137.04 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 110.042 -3.254 . . . . 0.0 103.451 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -123.14 89.56 3.13 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -165.77 -172.62 2.43 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.05 42.68 3.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 81.29 96.02 0.05 OUTLIER 'General case' 0 C--N 1.356 0.873 0 CA-C-N 112.779 -2.01 . . . . 0.0 106.205 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.33 19.85 0.11 Allowed Glycine 0 CA--C 1.538 1.515 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.689 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -109.4 -0.81 18.81 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 160.18 13.18 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -81.56 6.87 13.61 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.455 -1.373 . . . . 0.0 108.263 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -48.2 16.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.31 -25.14 62.29 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.46 -57.88 5.75 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.15 25.55 2.14 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 124.879 1.362 . . . . 0.0 109.295 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.63 -32.72 4.08 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.264 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.41 -26.71 24.6 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.525 HH11 ' HG3' ' A' ' 75' ' ' ARG . 1.5 mmt85 -73.03 -33.38 65.7 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.69 -19.93 47.79 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.659 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -76.42 -20.33 57.19 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 66.5 m -90.15 -43.22 10.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 123.698 1.713 . . . . 0.0 107.434 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.45 1.09 17.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 108.932 -3.758 . . . . 0.0 108.478 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.89 -54.69 5.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.08 39.37 7.81 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 110.686 -2.961 . . . . 0.0 107.114 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -49.22 0.04 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.43 120.28 27.6 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 122.0 28.59 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.13 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.6 81.73 0.04 OUTLIER Glycine 0 C--N 1.348 1.211 0 CA-C-N 112.339 -2.21 . . . . 0.0 109.995 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -111.78 38.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -145.48 114.17 6.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 98.76 3.5 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 90.84 4.62 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 60' ' ' VAL . 15.5 m -89.42 93.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 110.294 -3.139 . . . . 0.0 109.696 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -70.43 118.43 7.84 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 110.181 -3.19 . . . . 0.0 113.912 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.9 -45.1 2.89 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 111.915 -2.143 . . . . 0.0 113.778 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -46.12 129.77 10.04 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 127.743 2.417 . . . . 0.0 107.184 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 60.33 72.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -78.16 -161.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.312 -178.274 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 95' ' ' VAL 0.279 17.2 m 61.46 118.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 127.831 2.453 . . . . 0.0 109.482 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 160.07 7.1 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.181 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -152.07 109.57 3.6 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 98.29 -53.01 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -92.73 75.86 4.95 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CH2' ' HB ' ' A' ' 116' ' ' VAL . 95.3 m95 -83.85 159.92 59.39 Favored Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 112.652 -2.067 . . . . 0.0 105.808 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.34 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.684 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.29 -21.2 64.79 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.724 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.7 p -59.87 -68.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.82 0 O-C-N 124.477 1.111 . . . . 0.0 111.282 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.557 ' H ' HG13 ' A' ' 104' ' ' VAL . 35.7 mt-10 -90.18 27.41 1.64 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 117.986 -1.486 . . . . 0.0 108.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -80.51 -41.25 24.59 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -80.52 -31.87 37.01 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.468 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.3 15.11 12.67 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.42 -40.41 12.07 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.2 78.66 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.316 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 37.6 mtp -77.56 -61.45 1.99 Allowed 'General case' 0 C--N 1.354 0.791 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.52 27.13 0.09 OUTLIER Glycine 0 C--N 1.353 1.493 0 CA-C-N 112.177 -2.283 . . . . 0.0 118.085 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.05 -2.7 58.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.22 128.75 53.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 102.937 -2.986 . . . . 0.0 102.937 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' HB ' ' CH2' ' A' ' 101' ' ' TRP . 42.5 t -140.01 151.66 21.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -99.63 148.06 34.22 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 102.95 -2.982 . . . . 0.0 102.95 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -70.39 155.75 63.18 Favored 'Trans proline' 0 C--N 1.364 1.356 0 N-CA-C 106.017 -2.339 . . . . 0.0 106.017 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -75.93 118.11 4.92 Favored 'Trans proline' 0 C--N 1.365 1.441 0 N-CA-C 105.08 -2.7 . . . . 0.0 105.08 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.46 56.56 5.03 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.186 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -88.35 179.1 6.4 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 125.151 2.405 . . . . 0.0 107.501 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.331 21.4 p -75.87 170.68 14.73 Favored Pre-proline 0 N--CA 1.431 -1.4 1 CA-C-N 106.815 -4.72 . . . . 0.0 104.782 178.123 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.38 -3.19 3.82 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 N-CA-C 105.875 -2.394 . . . . 0.0 105.875 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.73 -12.05 60.32 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 125.927 1.691 . . . . 0.0 109.057 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -28.0 58.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.9 p -87.78 -21.74 24.93 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.483 1.115 . . . . 0.0 110.701 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.6 mt -69.92 -28.87 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.19 58.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.123 -2.308 . . . . 0.0 109.16 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 7.7 t0 -63.53 -56.43 16.06 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -87.47 1.0 54.72 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 110.854 -2.885 . . . . 0.0 110.311 -177.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -84.37 -47.55 10.59 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 117.302 -1.759 . . . . 0.0 110.079 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.31 -40.49 17.9 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.149 0.906 . . . . 0.0 111.467 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.5 t -68.78 -31.08 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.717 1.261 . . . . 0.0 112.973 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' A' ' 32' ' ' PHE . 45.0 mt -90.11 -33.12 16.39 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.03 -178.678 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.65 -159.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.195 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.59 63.16 0.74 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.267 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.3 p -149.89 110.29 4.21 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.75 109.44 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 111.268 -2.696 . . . . 0.0 104.492 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.96 111.96 23.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.21 148.34 48.67 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.127 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.41 -165.27 34.88 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 111.629 -2.532 . . . . 0.0 110.408 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.636 12.4 p 110.68 -113.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 C-N-CA 127.705 2.402 . . . . 0.0 113.091 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.279 3.0 tp 56.06 154.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 129.131 2.972 . . . . 0.0 110.753 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.684 0 CA-C-N 110.485 -3.052 . . . . 0.0 107.269 179.576 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 127.542 3.544 . . . . 0.0 105.376 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.82 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.266 0.2 OUTLIER 47.77 44.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.119 2 CA-C-N 103.287 -6.324 . . . . 0.0 109.448 179.104 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' CB ' HD23 ' A' ' 8' ' ' LEU . 1.1 mt -69.4 -20.39 63.8 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 172.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.09 -18.91 65.65 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.82 ' HB2' HG22 ' A' ' 22' ' ' ILE . 4.8 t60 -71.86 -27.46 62.88 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 p -55.96 -39.52 71.89 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 125.264 1.602 . . . . 0.0 110.55 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.665 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -59.56 -41.27 89.79 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.316 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -21.55 54.77 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 111.606 -2.543 . . . . 0.0 112.431 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -83.67 -3.57 57.87 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.938 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' SD ' ' A' ' 130' ' ' MET . . . -126.14 -7.39 6.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.19 71.64 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.359 1.022 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -141.74 143.52 33.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.5 p -99.64 173.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 111.977 -2.374 . . . . 0.0 107.039 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.08 93.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 111.188 -2.733 . . . . 0.0 105.088 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -68.45 117.29 10.02 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.477 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 32.3 mt -90.1 -41.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.247 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.64 -129.21 5.75 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.41 44.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 113.249 -1.476 . . . . 0.0 109.626 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.4 tp -163.06 109.52 1.17 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.2 t -85.23 95.27 9.12 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -90.3 138.49 31.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.803 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.41 -90.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.856 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.26 -11.17 13.47 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 124.973 1.42 . . . . 0.0 112.786 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -89.18 -46.14 9.03 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 118.348 -1.341 . . . . 0.0 107.475 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 37' ' ' ILE . 11.5 m-85 -86.88 6.78 30.21 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 117.964 -1.494 . . . . 0.0 108.568 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.28 -29.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.95 -24.5 58.48 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 -4.2 55.42 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 -12.51 38.43 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -38.33 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.41 -65.27 0.7 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 111.823 -2.444 . . . . 0.0 110.356 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -79.94 -47.5 14.92 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.118 -176.011 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' THR . 3.7 ttmp? 109.8 42.79 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 126.543 2.402 . . . . 0.0 108.357 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.84 120.6 5.46 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 124.485 1.116 . . . . 0.0 108.981 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.73 -66.1 0.96 Allowed 'General case' 0 C--N 1.352 0.708 0 CA-C-N 111.86 -2.427 . . . . 0.0 105.6 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -107.18 148.39 28.93 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.456 1.598 . . . . 0.0 109.35 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -97.62 148.92 5.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 CA-C-N 109.818 -3.355 . . . . 0.0 104.82 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.552 ' N ' HD12 ' A' ' 58' ' ' ILE . 60.9 m -141.73 105.0 4.63 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.69 131.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -110.38 45.35 1.13 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 p -154.06 168.4 26.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 15.3 tp -74.39 -127.04 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 111.251 -2.704 . . . . 0.0 103.823 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.476 ' HE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -93.53 50.67 1.5 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.95 21.13 47.68 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.549 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -124.09 -31.12 3.39 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.55 166.6 41.49 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.088 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.21 -1.35 32.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 113.581 -1.309 . . . . 0.0 108.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -46.19 18.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 3.9 m-20 -74.25 -27.12 60.61 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.928 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m -68.99 -50.69 46.71 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -89.53 21.79 3.26 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.569 1.168 . . . . 0.0 109.481 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -27.04 7.75 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 17.8 mt -89.99 -32.28 16.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.27 -1.965 . . . . 0.0 106.473 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -75.55 -22.1 57.34 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.89 -31.67 56.91 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.98 -11.69 60.17 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.497 1.123 . . . . 0.0 109.162 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 73.4 m -90.27 -48.05 7.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 123.239 1.495 . . . . 0.0 107.624 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.296 2.9 p30 -78.27 4.23 13.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 109.672 -3.422 . . . . 0.0 109.233 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.96 -53.38 6.19 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.29 39.79 25.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.084 -2.78 . . . . 0.0 108.042 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.29 -48.58 0.05 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.33 119.94 28.11 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 128.96 34.9 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.49 -1.686 . . . . 0.0 106.506 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.02 59.27 0.01 OUTLIER Glycine 0 C--N 1.347 1.164 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.327 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -8.79 11.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 112.509 -1.846 . . . . 0.0 108.593 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -97.54 129.09 44.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.571 HD13 ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -139.97 140.68 36.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.27 92.37 2.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -89.46 93.97 4.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-O 125.118 2.389 . . . . 0.0 110.358 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.48 119.92 8.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 109.895 -3.32 . . . . 0.0 112.453 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.08 -84.04 1.01 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 112.104 -2.048 . . . . 0.0 108.095 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 93' ' ' ASN . 5.6 t-20 53.95 -111.54 0.63 Allowed 'General case' 0 C--N 1.353 0.758 0 CA-C-N 111.79 -2.205 . . . . 0.0 107.63 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HB ' ' HE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.29 126.82 44.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 10.8 p -73.79 157.44 6.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.74 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 45.28 99.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.918 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.58 152.92 6.11 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 112.091 -2.322 . . . . 0.0 108.895 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -175.83 124.16 0.2 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 86.06 -67.37 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 126.004 2.065 . . . . 0.0 106.369 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.29 134.55 37.93 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -139.03 167.37 19.42 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.75 -145.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.831 1.687 . . . . 0.0 108.549 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.18 -25.06 61.53 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.519 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.7 p -54.13 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 124.768 1.293 . . . . 0.0 111.219 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' HG13 ' A' ' 104' ' ' VAL . 11.2 mt-10 -90.35 26.74 1.85 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 117.505 -1.678 . . . . 0.0 109.416 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.03 -42.42 63.2 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -89.98 -24.68 21.18 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 111.676 -2.511 . . . . 0.0 108.411 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -85.77 -13.4 48.34 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -90.57 -20.28 22.79 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.75 74.58 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.2 mtt -87.38 -52.01 5.61 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.97 26.24 1.98 Allowed Glycine 0 C--N 1.356 1.671 0 CA-C-N 112.769 -2.014 . . . . 0.0 117.644 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -4.91 58.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.08 119.54 39.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 179.23 4.16 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 48.9 t -140.01 151.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.43 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 4.8 m-85 -99.63 153.03 37.98 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -65.16 136.57 48.36 Favored 'Trans proline' 0 C--N 1.371 1.722 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.71 110.62 2.97 Favored 'Trans proline' 0 C--N 1.371 1.721 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.94 -103.61 0.4 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 111.647 -2.524 . . . . 0.0 107.561 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -90.27 167.59 12.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.6 p -168.67 70.75 0.77 Allowed Pre-proline 0 C--N 1.349 0.559 0 CA-C-N 113.136 -1.847 . . . . 0.0 106.04 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.27 -84.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 123.264 2.643 . . . . 0.0 109.473 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.25 -19.47 21.76 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.126 2.17 . . . . 0.0 110.683 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -25.43 62.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 124.051 0.844 . . . . 0.0 109.694 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -86.11 -23.4 26.66 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 117.419 -1.712 . . . . 0.0 109.579 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.83 -26.12 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.15 -6.46 56.95 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.011 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 133' ' ' VAL . 63.3 t0 -54.22 -66.6 0.37 Allowed 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 30' ' ' ALA . 6.4 mtm -90.36 -6.17 55.34 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 111.343 -2.662 . . . . 0.0 111.755 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.97 -45.33 9.27 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 117.209 -1.796 . . . . 0.0 107.659 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -58.39 -45.8 87.62 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 121.817 0.818 . . . . 0.0 109.168 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 129' ' ' ASP . 84.6 t -82.24 -71.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.234 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.5 mt -90.12 55.88 3.24 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.579 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.314 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.651 177.67 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -72.92 172.2 11.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 112.153 -2.294 . . . . 0.0 107.503 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 57.3 pttt -108.1 68.99 0.72 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.654 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.9 p -150.44 109.22 3.85 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 ' SD ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -123.57 136.24 60.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.08 133.42 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 124.502 1.127 . . . . 0.0 108.736 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.1 pp -116.25 146.77 42.1 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.252 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . -131.2 146.43 17.84 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 112.381 -2.19 . . . . 0.0 109.325 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -120.25 126.49 75.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 124.96 1.035 . . . . 0.0 110.664 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 tp -152.92 139.91 13.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.99 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 -178.429 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 123.63 1.681 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.307 0.0 OUTLIER 38.82 47.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.777 1 C-N-CA 132.593 4.357 . . . . 0.0 105.786 -175.081 . . . . . . . . 5 4 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -26.27 50.41 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.31 -18.03 65.01 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.39 -1.732 . . . . 0.0 106.584 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -69.35 -30.77 68.87 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -45.31 -44.33 11.46 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 124.856 1.348 . . . . 0.0 107.962 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -47.97 74.41 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 111.649 -2.523 . . . . 0.0 109.402 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -14.61 58.42 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 112.296 -2.229 . . . . 0.0 113.748 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -75.49 -14.87 60.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.369 1.867 . . . . 0.0 109.781 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.94 19.42 0.59 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 117.445 -1.702 . . . . 0.0 108.216 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.2 28.4 54.35 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 124.182 0.926 . . . . 0.0 112.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -99.73 160.3 14.4 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 32.3 t30 -89.21 135.62 33.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.248 -2.251 . . . . 0.0 106.373 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.94 170.05 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-N 111.309 -2.678 . . . . 0.0 106.973 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -140.14 106.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 111.557 -2.565 . . . . 0.0 105.446 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.55 123.71 32.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.423 HD11 ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -89.84 -30.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 -129.24 9.83 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' HG12 ' A' ' 10' ' ' VAL . 2.8 m -98.18 -12.69 8.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 113.353 -1.423 . . . . 0.0 110.002 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.75 86.91 6.8 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -91.44 58.08 3.5 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 112.869 -1.968 . . . . 0.0 105.909 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.5 p -90.03 116.37 28.01 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.385 -3.561 . . . . 0.0 101.385 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.538 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.5 tp-100 -89.96 -54.09 4.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.866 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -62.36 -32.68 73.5 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.143 1.527 . . . . 0.0 110.449 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -79.36 -26.46 42.07 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 2.7 t80 -86.94 4.15 42.79 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.541 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.69 -37.35 20.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.064 0 N-CA-C 102.475 -3.158 . . . . 0.0 102.475 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -73.93 -28.68 61.64 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 112.482 -2.145 . . . . 0.0 106.997 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -89.82 0.54 56.96 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.031 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 -7.67 53.35 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.09 -39.83 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.95 -75.54 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.746 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 p -74.07 -19.28 60.66 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 123.961 0.788 . . . . 0.0 110.471 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 72.47 50.83 0.18 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.99 130.93 35.2 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 125.251 1.594 . . . . 0.0 107.537 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -104.22 -77.12 0.58 Allowed 'General case' 0 C--N 1.364 1.228 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -87.4 147.66 25.35 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.016 1.448 . . . . 0.0 108.072 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -134.15 165.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 111.458 -2.61 . . . . 0.0 105.78 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.9 p -161.94 158.78 25.73 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.62 168.95 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 69.21 1.05 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 p -174.32 168.48 3.94 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.243 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.73 -105.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 110.732 -2.94 . . . . 0.0 103.203 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -102.68 27.08 7.26 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 112.808 -1.996 . . . . 0.0 106.498 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.74 -9.68 84.92 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.305 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -80.01 -34.66 38.26 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.3 -178.32 49.18 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 113.002 -1.908 . . . . 0.0 112.226 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -77.92 -12.19 59.96 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.152 -2.024 . . . . 0.0 108.644 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -49.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -72.37 -29.44 63.78 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.853 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -57.04 8.83 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -88.27 27.46 1.23 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 125.316 1.635 . . . . 0.0 109.944 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.21 -30.41 7.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD21 ' CD ' ' A' ' 43' ' ' GLN . 8.0 mt -90.03 -33.84 16.19 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 111.644 -2.278 . . . . 0.0 107.788 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -24.37 61.06 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.77 -31.42 35.82 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -76.51 -15.09 59.97 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 124.139 0.899 . . . . 0.0 109.479 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.32 -47.04 8.01 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 123.94 1.829 . . . . 0.0 107.293 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.43 -3.58 25.07 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 108.531 -3.94 . . . . 0.0 109.041 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -81.24 -56.65 3.93 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.35 48.93 7.41 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 110.931 -2.85 . . . . 0.0 106.82 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.96 -42.15 0.02 OUTLIER Glycine 0 C--N 1.35 1.335 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.017 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.78 124.95 28.73 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 117.08 15.33 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.73 107.04 0.4 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 112.777 -2.011 . . . . 0.0 109.557 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -157.01 46.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -151.24 119.65 6.42 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 58' ' ' ILE . 3.2 mm? -139.3 149.09 43.83 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 94.59 2.76 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -89.87 100.07 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 111.209 -2.723 . . . . 0.0 109.732 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.44 81.61 0.38 Allowed Glycine 0 CA--C 1.533 1.178 0 CA-C-N 108.434 -3.985 . . . . 0.0 112.745 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.4 -85.68 0.26 Allowed Glycine 0 C--N 1.351 1.412 0 CA-C-N 112.714 -1.743 . . . . 0.0 109.376 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG23 ' A' ' 90' ' ' VAL . 65.6 t30 65.29 -116.15 0.34 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.901 -1.649 . . . . 0.0 106.932 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -104.4 129.34 56.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.42 169.06 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.893 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p 45.63 48.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.812 0 CA-C-N 112.713 -2.039 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 139.03 3.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 112.282 -2.236 . . . . 0.0 108.767 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -161.17 111.52 1.71 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 96.96 -45.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 112.548 -2.115 . . . . 0.0 105.83 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.17 126.54 35.84 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -138.03 160.11 65.72 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.59 -148.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 N-CA-C 107.759 -1.669 . . . . 0.0 107.759 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.48 -20.43 58.79 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.665 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -60.12 -64.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 124.433 1.083 . . . . 0.0 111.429 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' H ' HG13 ' A' ' 104' ' ' VAL . 9.6 mm-40 -89.4 18.67 5.04 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 117.009 -1.876 . . . . 0.0 107.965 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.79 -39.08 66.99 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -80.78 -32.16 35.54 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.691 -2.049 . . . . 0.0 106.826 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -91.74 15.03 13.63 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.737 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.7 -41.36 11.33 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.04 74.29 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 112.21 -2.268 . . . . 0.0 107.418 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.3 mtp -82.35 -57.99 3.13 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 27.61 43.32 0.03 OUTLIER Glycine 0 C--N 1.357 1.741 0 C-N-CA 127.401 2.429 . . . . 0.0 117.355 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.8 -2.76 58.82 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -105.01 131.22 52.81 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.485 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.07 169.74 8.53 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 178.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.92 159.41 36.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -99.46 161.39 24.74 Favored Pre-proline 0 N--CA 1.447 -0.615 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.53 158.1 58.67 Favored 'Trans proline' 0 C--N 1.368 1.559 0 N-CA-C 106.873 -2.01 . . . . 0.0 106.873 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.37 122.35 9.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 104.81 -2.804 . . . . 0.0 104.81 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.76 140.88 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 105.905 -2.878 . . . . 0.0 105.905 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 t -75.34 162.05 28.74 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 125.422 2.535 . . . . 0.0 108.164 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.3 p -167.78 113.4 0.62 Allowed Pre-proline 0 N--CA 1.427 -1.595 1 CA-C-N 106.12 -5.036 . . . . 0.0 101.019 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.01 -1.22 11.42 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.234 1.289 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.2 -30.28 67.35 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -16.66 54.41 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.541 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 129' ' ' ASP . 24.1 p -79.04 -25.34 43.2 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 116.67 -2.012 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.52 -26.56 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -3.18 56.31 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.04 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 126' ' ' THR . 38.4 t0 -62.07 -52.76 62.64 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 6' ' ' ILE . 36.2 mmt -87.77 -22.85 24.31 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.36 -2.2 . . . . 0.0 110.725 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.92 -12.96 46.12 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.098 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -90.11 -52.9 4.72 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.485 ' HA ' HH21 ' A' ' 115' ' ' ARG . 23.1 t -69.74 -58.88 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.364 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 -14.32 34.12 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 124.431 1.082 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.721 0 C-N-CA 118.542 -1.789 . . . . 0.0 111.461 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.61 177.33 6.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.777 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -105.5 103.58 13.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 110.018 -3.265 . . . . 0.0 109.435 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 172.3 113.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HB ' ' CE ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -148.03 110.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.88 131.23 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.031 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.833 ' CD2' ' HG ' ' A' ' 23' ' ' LEU . 1.5 tm? -125.84 130.25 51.0 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.174 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 171.39 23.72 Favored Glycine 0 C--N 1.36 1.876 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.932 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.28 136.94 13.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.009 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.01 88.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 115.448 -2.501 . . . . 0.0 110.06 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.439 0 N-CA-C 106.636 -2.585 . . . . 0.0 106.636 179.493 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 126.276 2.941 . . . . 0.0 108.515 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.286 0.0 OUTLIER 31.54 52.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.342 2 CA-C-N 105.157 -5.474 . . . . 0.0 108.155 -178.367 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.833 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -72.27 -25.91 61.78 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.93 -15.83 63.79 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 22' ' ' ILE . 14.6 t-80 -72.88 -27.29 61.81 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -50.88 -44.16 59.72 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 125.492 1.745 . . . . 0.0 109.422 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.7 -47.23 80.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.694 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -17.15 61.34 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 111.828 -2.442 . . . . 0.0 113.039 -176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -18.95 60.64 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 128.372 2.669 . . . . 0.0 109.773 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.43 11.93 2.76 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 124.598 1.186 . . . . 0.0 107.936 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.74 25.79 52.41 Favored Glycine 0 C--N 1.356 1.671 0 O-C-N 124.271 0.982 . . . . 0.0 112.922 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -99.78 145.49 27.64 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 29.9 m-20 -69.33 137.62 53.09 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 111.846 -2.434 . . . . 0.0 108.099 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.82 172.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 112.117 -2.311 . . . . 0.0 108.886 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.97 73.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 108.786 -3.825 . . . . 0.0 103.71 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -70.11 118.45 12.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -89.66 -90.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.713 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 -177.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 37' ' ' ILE . . . 176.8 -112.26 0.38 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -54.59 7.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.055 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.73 153.43 24.16 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.526 -1.67 . . . . 0.0 106.576 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -153.35 59.24 0.76 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.84 158.53 0.48 Allowed 'General case' 0 C--N 1.359 0.99 0 CA-C-N 110.284 -3.144 . . . . 0.0 108.921 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -82.81 -89.24 0.09 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 112.107 -2.315 . . . . 0.0 108.645 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -15.6 31.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 124.736 1.272 . . . . 0.0 112.247 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -90.09 -39.15 13.07 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 118.178 -1.409 . . . . 0.0 107.342 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -81.69 -9.99 59.5 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 117.641 -1.624 . . . . 0.0 109.166 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -28.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -75.66 -28.06 58.58 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.18 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.05 -15.94 30.76 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.22 -38.5 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 104.324 -2.472 . . . . 0.0 104.324 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -62.58 -71.81 0.15 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.24 -2.255 . . . . 0.0 111.087 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -74.59 -38.63 62.57 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.845 0.716 . . . . 0.0 110.629 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 98.28 41.65 0.0 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.49 126.06 20.19 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.266 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -106.08 -79.5 0.56 Allowed 'General case' 0 C--N 1.359 0.989 0 O-C-N 125.337 1.648 . . . . 0.0 106.558 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.45 114.21 20.04 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.91 123.75 54.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.6 m -145.47 145.66 31.18 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-O 123.836 1.779 . . . . 0.0 107.932 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.31 3.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 110.343 -3.117 . . . . 0.0 105.042 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.32 103.75 4.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 117.218 -1.793 . . . . 0.0 107.298 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m 177.78 173.95 0.54 Allowed 'General case' 0 C--N 1.359 1.017 0 O-C-N 126.412 2.32 . . . . 0.0 106.057 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.09 -147.07 0.06 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 111.637 -2.529 . . . . 0.0 104.782 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.42 92.91 7.67 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.95 -29.43 1.82 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-N 111.419 -2.628 . . . . 0.0 108.77 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -86.24 -24.73 25.9 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 112.589 -1.806 . . . . 0.0 107.28 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 178.99 49.36 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.745 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.04 -12.97 59.65 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 111.853 -2.174 . . . . 0.0 108.246 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -76.6 -49.21 24.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -72.82 -16.83 61.6 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.687 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HG ' ' HD2' ' A' ' 108' ' ' PHE . 8.8 t -72.14 -42.23 66.23 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -90.09 20.07 4.55 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 124.672 1.232 . . . . 0.0 108.953 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 -34.24 5.74 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.355 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.28 -23.47 22.3 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 113.04 -1.58 . . . . 0.0 106.845 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -26.92 56.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -81.04 -24.12 38.08 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.512 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -76.55 -17.77 59.04 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 124.113 0.883 . . . . 0.0 108.712 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 86' ' ' ILE . 68.1 m -90.23 -43.9 10.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 123.875 1.798 . . . . 0.0 107.345 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.45 -0.92 21.73 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.701 -3.863 . . . . 0.0 108.624 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.12 -53.6 6.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.65 41.7 11.86 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 110.855 -2.884 . . . . 0.0 107.303 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.44 -47.2 0.03 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.795 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -88.51 118.26 28.03 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 111.89 14.03 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 112.362 -2.199 . . . . 0.0 106.144 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.37 59.26 0.06 OUTLIER Glycine 0 C--N 1.348 1.22 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 78' ' ' CYS . 1.8 mt -91.15 0.75 8.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 CA-C-N 112.29 -1.955 . . . . 0.0 106.973 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -112.83 117.69 32.85 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.16 121.89 15.36 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -104.77 117.23 33.55 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 101.414 -3.55 . . . . 0.0 101.414 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 115' ' ' ARG . 88.1 t -89.73 89.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 110.827 -2.897 . . . . 0.0 108.491 -175.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.13 108.39 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 109.52 -3.491 . . . . 0.0 109.417 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.66 -122.74 10.71 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 106.773 -2.531 . . . . 0.0 106.773 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.4 t30 68.97 145.99 0.05 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 125.397 1.293 . . . . 0.0 108.269 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 55.95 81.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 CA-C-N 112.31 -2.223 . . . . 0.0 107.614 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.54 155.64 6.13 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 112.537 -2.12 . . . . 0.0 108.538 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p 46.07 51.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 CA-C-N 112.83 -1.987 . . . . 0.0 111.829 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.83 138.34 5.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.163 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -167.24 140.3 3.5 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.08 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.846 0 O-C-N 125.966 2.041 . . . . 0.0 105.878 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -87.11 114.99 24.2 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -95.15 161.91 26.58 Favored Pre-proline 0 C--N 1.349 0.562 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.738 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.79 -150.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.927 1.751 . . . . 0.0 108.904 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.66 -25.75 62.25 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.19 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 105' ' ' GLU 0.272 0.1 OUTLIER -54.8 -67.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 124.886 1.366 . . . . 0.0 110.457 -179.429 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.5 mm-40 -90.24 20.31 4.48 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 117.951 -1.499 . . . . 0.0 109.149 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.39 -51.78 53.5 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -90.28 -15.59 30.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.466 ' HD2' ' HG ' ' A' ' 71' ' ' CYS . 4.1 m-30 -89.5 -45.42 9.43 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 117.802 -1.559 . . . . 0.0 108.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -77.75 -2.11 34.65 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.723 1.264 . . . . 0.0 107.783 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.53 77.18 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -83.97 -53.95 5.2 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.97 40.51 58.2 Favored Glycine 0 C--N 1.362 1.996 0 O-C-N 124.677 1.236 . . . . 0.0 116.065 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -6.92 59.43 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.09 137.8 42.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.35 173.63 6.24 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.12 160.01 26.07 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -99.61 160.54 27.12 Favored Pre-proline 0 C--N 1.355 0.82 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.19 149.01 45.15 Favored 'Trans proline' 0 C--N 1.366 1.46 0 N-CA-C 104.412 -2.957 . . . . 0.0 104.412 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.26 110.05 2.97 Favored 'Trans proline' 0 C--N 1.366 1.489 0 N-CA-C 104.812 -2.803 . . . . 0.0 104.812 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.41 158.65 7.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.716 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.63 143.44 46.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.743 -1.729 . . . . 0.0 106.718 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 p 174.0 100.37 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 110.763 -2.926 . . . . 0.0 106.41 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.29 -2.87 13.13 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.861 1.707 . . . . 0.0 108.155 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.96 -37.9 89.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.352 1.861 . . . . 0.0 107.757 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.82 -21.42 57.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.928 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 129' ' ' ASP . 2.3 p -80.65 -17.22 51.89 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 117.183 -1.807 . . . . 0.0 110.517 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mt -67.9 -31.53 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.12 2.66 55.05 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.763 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 133' ' ' VAL . 61.0 t0 -60.29 -61.69 2.42 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' ' HB ' ' A' ' 6' ' ' ILE . 11.1 mmm -90.1 -15.5 31.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.999 -2.818 . . . . 0.0 111.57 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -87.52 -13.32 43.35 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 118.026 -1.469 . . . . 0.0 108.801 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -90.35 -56.59 3.15 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 129' ' ' ASP . 2.5 t -57.56 -51.58 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 112.077 -2.329 . . . . 0.0 114.0 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.4 mp -89.66 -35.93 15.54 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 124.343 1.027 . . . . 0.0 108.604 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.575 0 C-N-CA 119.028 -1.558 . . . . 0.0 112.772 -179.318 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.91 -176.9 3.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 111.862 -2.426 . . . . 0.0 107.969 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -120.43 63.81 0.84 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 110.809 -2.905 . . . . 0.0 108.442 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -149.54 106.42 3.56 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.487 ' CD1' HD21 ' A' ' 57' ' ' LEU . 4.0 mm -121.87 125.72 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 109.772 -3.377 . . . . 0.0 102.641 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -127.86 134.05 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 124.766 1.291 . . . . 0.0 109.278 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.18 138.74 54.13 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 113.237 -1.801 . . . . 0.0 107.489 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.5 21.41 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.844 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.5 119.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 118.012 -1.475 . . . . 0.0 110.866 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 1.9 tp -112.48 179.32 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.572 ' H ' HD12 ' A' ' 11' ' ' ILE . . . . . . . . 0 C--N 1.35 1.32 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 123.911 1.815 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.412 42.0 pt 33.91 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.753 1 C-N-CA 132.228 4.211 . . . . 0.0 107.976 -176.034 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mt -74.38 -42.27 59.56 Favored 'General case' 0 C--N 1.373 1.604 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.81 -0.58 16.27 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 112.191 -2.277 . . . . 0.0 108.44 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -79.23 -43.72 23.23 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 117.679 -1.608 . . . . 0.0 107.885 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -19.78 65.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.684 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.851 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -64.3 -43.98 93.05 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.3 -28.18 64.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 110.708 -2.951 . . . . 0.0 111.985 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -87.57 2.71 50.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 111.836 -2.438 . . . . 0.0 108.823 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.28 4.98 5.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.49 30.38 61.88 Favored Glycine 0 C--N 1.361 1.942 0 O-C-N 124.306 1.004 . . . . 0.0 112.251 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.36 -175.58 2.84 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -106.93 150.73 26.14 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.851 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.2 p -99.93 146.21 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 111.047 -2.797 . . . . 0.0 108.115 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' ILE . 86.9 t -140.04 82.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 111.317 -2.674 . . . . 0.0 105.333 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -87.83 123.95 33.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -93.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.866 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.55 -120.76 0.58 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.56 10.95 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 113.277 -1.461 . . . . 0.0 110.405 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.22 129.45 34.96 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 t -98.51 41.42 1.14 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-N 113.072 -1.876 . . . . 0.0 107.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.9 p -90.11 80.21 6.35 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.423 ' CD ' HD21 ' A' ' 74' ' ' LEU . 25.9 tp60 -78.32 -36.75 46.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.309 -2.223 . . . . 0.0 108.573 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -35.64 79.79 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.312 1.007 . . . . 0.0 108.619 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.82 -24.8 41.13 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.2 -10.17 59.66 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.73 -33.93 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -74.15 -31.52 62.76 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.368 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.61 -0.5 57.33 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.12 -13.92 34.76 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.88 -41.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.75 -60.49 3.75 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 112.263 -2.244 . . . . 0.0 108.229 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.418 ' CG2' HG21 ' A' ' 35' ' ' VAL . 16.7 m -60.32 -66.44 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 113.454 -1.703 . . . . 0.0 107.819 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 102.74 35.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 O-C-N 126.782 2.552 . . . . 0.0 104.294 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.8 107.88 0.1 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 128.457 2.703 . . . . 0.0 109.222 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.88 -42.28 11.95 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -144.43 144.5 31.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 117.548 -1.661 . . . . 0.0 107.113 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.05 146.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 110.71 -2.95 . . . . 0.0 105.254 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.0 t -150.5 125.88 10.11 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.85 -178.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.852 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.037 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.74 97.12 3.57 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 p 155.93 152.6 0.01 OUTLIER 'General case' 0 C--N 1.356 0.876 0 CA-C-N 112.681 -2.054 . . . . 0.0 106.98 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -65.84 -110.63 0.0 OUTLIER 'General case' 0 C--N 1.36 1.032 0 CA-C-N 111.884 -2.416 . . . . 0.0 105.105 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -95.94 68.47 2.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . -131.73 55.68 0.76 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 109.63 -3.441 . . . . 0.0 105.016 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.431 ' H ' ' H ' ' A' ' 67' ' ' GLY . 20.0 pt20 -167.14 -28.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 111.044 -2.578 . . . . 0.0 106.977 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 74.54 -177.21 47.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.029 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -76.61 -3.41 37.55 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.35 -2.425 . . . . 0.0 108.376 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -71.55 -53.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.0 -22.13 59.72 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 112.561 -2.109 . . . . 0.0 109.111 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.67 -64.24 0.9 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -90.15 27.99 1.51 Allowed 'General case' 0 C--N 1.355 0.807 0 O-C-N 124.717 1.26 . . . . 0.0 109.798 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.63 -40.68 3.81 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.423 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.7 mt -88.58 -22.77 23.35 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 111.92 -2.14 . . . . 0.0 108.517 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.9 mmt85 -78.71 -26.98 44.9 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.62 -26.74 41.1 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -75.98 -16.75 59.93 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.123 0.889 . . . . 0.0 109.227 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.3 t -90.21 -46.26 8.55 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 123.948 1.832 . . . . 0.0 107.319 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.15 -4.94 28.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 108.536 -3.938 . . . . 0.0 109.002 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.22 -56.29 4.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.0 47.81 4.11 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 110.881 -2.872 . . . . 0.0 106.527 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.54 -42.14 0.02 OUTLIER Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.654 -2.067 . . . . 0.0 109.9 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.34 122.94 27.55 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 128.3 34.8 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.26 113.6 1.55 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.221 -2.263 . . . . 0.0 108.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -146.41 35.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -141.15 112.98 7.72 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 103.527 -2.768 . . . . 0.0 103.527 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.52 106.39 8.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 85.39 3.09 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 100.613 -3.847 . . . . 0.0 100.613 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.26 101.5 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 126.221 2.915 . . . . 0.0 110.085 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.27 116.55 4.77 Favored Glycine 0 C--N 1.343 0.961 1 CA-C-N 108.239 -4.073 . . . . 0.0 108.489 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.64 -84.91 0.44 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 105.738 -2.945 . . . . 0.0 105.738 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t30 72.24 -84.34 0.03 OUTLIER 'General case' 0 C--N 1.357 0.935 0 CA-C-N 112.879 -1.66 . . . . 0.0 107.681 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -140.37 135.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.34 158.06 4.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.57 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 42.68 75.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.757 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.47 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.2 135.14 1.94 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.196 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -174.16 110.73 0.16 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 91.45 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.355 0.841 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -94.14 135.73 35.19 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -143.06 162.94 40.73 Favored Pre-proline 0 C--N 1.35 0.605 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.27 -150.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.478 -1.778 . . . . 0.0 107.478 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.11 -22.26 63.03 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.216 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.3 p -58.13 -69.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 O-C-N 124.483 1.114 . . . . 0.0 111.214 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' H ' HG13 ' A' ' 104' ' ' VAL . 15.3 mm-40 -90.17 24.92 2.33 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.501 -1.68 . . . . 0.0 108.209 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -77.32 -41.03 42.13 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.43 -32.55 42.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 112.472 -2.149 . . . . 0.0 106.41 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -92.78 16.68 11.82 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.678 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -39.82 12.33 Favored 'General case' 0 C--N 1.361 1.096 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.29 75.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.028 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtp -78.96 -60.77 2.25 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.32 37.34 0.02 OUTLIER Glycine 0 C--N 1.356 1.643 0 C-N-CA 128.056 2.741 . . . . 0.0 117.642 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.73 -0.23 57.41 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.18 134.51 48.17 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.471 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.23 176.54 5.01 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.01 161.61 25.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.792 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -99.88 154.9 37.0 Favored Pre-proline 0 C--N 1.355 0.842 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.964 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.49 162.21 38.53 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 106.84 -2.023 . . . . 0.0 106.84 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.53 124.9 10.18 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 105.201 -2.653 . . . . 0.0 105.201 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.13 137.05 9.46 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -73.85 154.34 39.51 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 125.584 2.612 . . . . 0.0 107.492 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 p -166.11 108.67 0.71 Allowed Pre-proline 0 N--CA 1.426 -1.642 1 CA-C-N 105.819 -5.173 . . . . 0.0 100.362 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -78.61 0.31 10.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.3 -38.35 87.53 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.945 1.698 . . . . 0.0 107.631 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -24.29 59.96 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.985 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.7 p -84.64 -19.84 32.28 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.957 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -64.69 -30.17 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.49 -7.65 59.61 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 111.712 -2.495 . . . . 0.0 108.798 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 126' ' ' THR . 25.4 t0 -53.7 -72.34 0.06 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-O 122.116 0.96 . . . . 0.0 108.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.403 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 4.9 mmt -86.67 -6.07 58.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 112.302 -2.226 . . . . 0.0 110.336 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.14 -66.01 0.96 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.834 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -48.02 -44.69 31.19 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.34 1.056 . . . . 0.0 111.021 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.502 HG12 HD23 ' A' ' 134' ' ' LEU . 25.6 t -65.37 -65.57 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 133' ' ' VAL . 49.8 mt -90.52 55.76 3.11 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.318 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.59 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -73.05 -162.43 0.11 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 111.689 -2.505 . . . . 0.0 107.505 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -149.69 99.74 2.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.188 -1.824 . . . . 0.0 106.253 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.62 100.33 0.01 OUTLIER 'General case' 0 C--N 1.355 0.845 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.8 116.43 48.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 35' ' ' VAL . 5.8 p -107.43 112.25 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 111.621 -2.536 . . . . 0.0 109.113 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.16 134.44 51.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.449 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.86 168.03 31.18 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.734 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.81 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 167.57 -121.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.662 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.704 HG22 HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -142.92 -168.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.094 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.221 -177.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 2.103 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.156 -179.265 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 125.14 2.4 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.328 0.0 OUTLIER 34.67 54.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.605 1 CA-C-N 106.871 -4.695 . . . . 0.0 106.437 -175.847 . . . . . . . . 5 4 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -66.9 -21.78 65.99 Favored 'General case' 0 C--N 1.377 1.773 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 173.558 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -67.57 -20.47 65.39 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 116.514 -2.075 . . . . 0.0 107.299 176.284 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.521 ' HB2' HG22 ' A' ' 22' ' ' ILE . 7.9 t60 -66.02 -29.96 70.41 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.436 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 37.0 t -67.19 -18.38 65.23 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.608 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.99 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -56.73 -47.1 80.76 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.07 69.11 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 110.482 -3.054 . . . . 0.0 112.763 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -84.72 7.53 20.2 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 111.559 -2.564 . . . . 0.0 108.632 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.78 -0.99 5.39 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.61 28.88 68.5 Favored Glycine 0 C--N 1.36 1.902 0 O-C-N 124.139 0.899 . . . . 0.0 111.377 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -105.38 -168.01 1.4 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 113.342 -1.429 . . . . 0.0 107.605 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.56 149.69 21.02 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.093 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.99 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.8 124.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 108.871 -3.786 . . . . 0.0 108.79 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG12 HG23 ' A' ' 7' ' ' VAL . 2.8 t -140.33 132.93 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 110.896 -2.865 . . . . 0.0 105.429 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -139.02 133.19 31.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.55 -20.15 6.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.567 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.68 -123.36 7.9 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.14 113.38 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-O 122.324 1.059 . . . . 0.0 109.28 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 42' ' ' SER . 3.7 tt -175.25 137.79 0.4 Allowed 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 t -94.54 39.55 1.09 Allowed 'General case' 0 C--N 1.354 0.776 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.435 ' HB2' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -90.55 91.52 8.47 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -90.02 -58.54 2.47 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.61 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.7 pt-20 -59.93 -20.92 60.08 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 124.771 1.294 . . . . 0.0 112.04 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.95 -38.89 14.14 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.878 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 54.7 m-85 -89.15 12.65 15.2 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.907 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -91.97 -34.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 175.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.73 -27.93 62.34 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -84.41 -16.65 41.95 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.63 -7.6 58.65 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.2 -43.06 18.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -60.61 -64.0 1.1 Allowed 'General case' 0 C--N 1.354 0.802 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.492 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.84 82.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.4 tttp 84.38 54.47 0.01 OUTLIER 'General case' 0 C--N 1.345 0.386 0 CA-C-N 112.022 -2.354 . . . . 0.0 105.02 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 124.51 23.75 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.112 -2.313 . . . . 0.0 107.489 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.99 -84.09 0.15 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.82 145.62 26.78 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.62 142.37 43.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.1 m -129.56 131.92 46.69 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 112.18 -2.282 . . . . 0.0 105.815 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.757 HG22 HG23 ' A' ' 10' ' ' VAL . 13.1 p -116.32 133.17 63.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.727 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.81 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -110.32 90.77 3.42 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 123.979 1.847 . . . . 0.0 107.016 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.2 t -131.12 176.93 7.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.257 -2.701 . . . . 0.0 106.544 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 52.55 1.02 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 110.405 -3.089 . . . . 0.0 105.906 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER 60.9 49.01 6.22 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.602 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.2 -0.07 5.96 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.868 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.13 -2.86 49.06 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.67 177.56 8.58 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.35 1.031 . . . . 0.0 111.652 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.17 25.58 2.14 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 112.871 -1.665 . . . . 0.0 108.188 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -52.68 10.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.529 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.6 m-20 -71.81 -26.86 62.57 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 112.703 -2.044 . . . . 0.0 107.26 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 t -67.78 -58.22 4.98 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -90.07 30.13 1.13 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 124.48 1.112 . . . . 0.0 109.426 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.49 -37.79 3.91 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 70' ' ' ASP . 2.0 mm? -90.01 -23.77 21.4 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.625 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -29.6 57.26 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.93 -28.21 55.15 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -16.82 60.62 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 124.155 0.909 . . . . 0.0 109.368 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 39.8 t -90.24 -46.85 8.15 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.847 1.784 . . . . 0.0 107.518 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -75.41 2.34 11.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 108.715 -3.857 . . . . 0.0 109.11 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.72 -55.59 3.9 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 44.78 7.93 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 110.958 -2.837 . . . . 0.0 106.798 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.01 -43.7 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.392 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.06 121.11 25.11 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 140.75 32.65 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 113.302 -1.772 . . . . 0.0 106.412 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.74 71.16 0.28 Allowed Glycine 0 C--N 1.351 1.364 0 CA-C-N 112.633 -2.076 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 tt -103.73 35.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -128.01 118.1 22.91 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -140.29 151.93 45.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.592 -2.094 . . . . 0.0 105.73 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 106.24 5.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 100.654 -3.832 . . . . 0.0 100.654 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.87 93.58 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 125.114 2.388 . . . . 0.0 110.164 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.69 118.47 13.5 Favored Glycine 0 CA--C 1.537 1.453 1 CA-C-N 107.975 -4.193 . . . . 0.0 111.137 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.82 -92.39 1.62 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 72.75 -142.6 0.04 OUTLIER 'General case' 0 C--N 1.356 0.885 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.502 HG12 HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -91.68 148.71 4.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.31 -164.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 CA-C-N 112.548 -2.115 . . . . 0.0 108.423 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 p 41.77 74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.04 33.79 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 112.068 -2.333 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -159.93 -46.72 0.05 Allowed 'General case' 0 C--N 1.347 0.473 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -129.7 -44.27 1.21 Allowed 'General case' 0 C--N 1.349 0.549 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.97 95.58 9.54 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -103.0 164.24 15.93 Favored Pre-proline 0 C--N 1.35 0.624 0 CA-C-N 112.483 -2.144 . . . . 0.0 105.36 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.08 -152.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.784 1.656 . . . . 0.0 108.792 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.33 -25.54 64.26 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 113.431 -1.713 . . . . 0.0 108.456 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.0 p -53.53 -74.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 O-C-N 124.912 1.382 . . . . 0.0 110.749 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.675 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.8 mt-10 -90.07 28.71 1.34 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.5 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -76.62 -45.33 30.53 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -80.58 -31.38 36.79 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 111.495 -2.593 . . . . 0.0 107.381 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.3 10.7 21.31 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 118.584 -1.247 . . . . 0.0 109.125 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.31 14.12 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -33.93 74.39 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.652 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 55.7 mtp -81.29 -60.49 2.26 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 34.68 37.55 0.1 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 112.31 -2.223 . . . . 0.0 117.243 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -79.84 -15.47 57.33 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -101.63 138.8 38.14 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.556 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.422 ' HE ' HG22 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.31 178.79 4.28 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.19 156.89 24.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.53 114.24 65.46 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 101.785 -3.413 . . . . 0.0 101.785 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -55.34 157.89 13.54 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.418 2.745 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.96 121.03 8.17 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 105.918 -2.378 . . . . 0.0 105.918 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 65.91 0.96 Allowed Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.388 -2.187 . . . . 0.0 107.901 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.4 p -82.12 -151.99 0.1 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.424 -2.388 . . . . 0.0 107.173 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 p 176.97 166.33 0.47 Allowed Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 110.805 -2.907 . . . . 0.0 104.243 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.61 -5.15 15.27 Favored 'Trans proline' 0 C--N 1.365 1.424 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.48 -23.87 53.81 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -17.82 58.32 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.753 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.0 p -87.19 -20.79 26.48 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.914 0.758 . . . . 0.0 110.613 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.89 -27.2 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.66 -1.01 57.61 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.606 -2.088 . . . . 0.0 109.264 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 133' ' ' VAL . 19.0 t0 -69.75 -68.03 0.44 Allowed 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.436 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 1.9 mpt? -74.45 -13.65 60.73 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.803 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -90.04 -43.45 10.5 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.999 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.39 -31.74 70.65 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 121.053 0.454 . . . . 0.0 109.789 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 129' ' ' ASP . 53.8 t -90.09 -77.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.327 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.421 HD23 HG12 ' A' ' 133' ' ' VAL . 27.2 mt -90.49 63.06 5.44 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.643 1.215 . . . . 0.0 108.839 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.329 178.111 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -70.82 145.38 50.37 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -79.53 95.68 5.9 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 111.197 -2.729 . . . . 0.0 108.413 -177.336 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.41 112.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 132.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -125.7 141.05 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 110.974 -2.83 . . . . 0.0 110.202 -176.478 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.9 pp -125.31 167.23 15.19 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 112.272 -2.24 . . . . 0.0 105.728 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 178.25 -172.25 44.71 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 126.428 2.33 . . . . 0.0 113.42 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 60' ' ' VAL 0.455 13.5 p 69.53 -125.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 110.139 -3.031 . . . . 0.0 114.714 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.54 ' H ' HG13 ' A' ' 10' ' ' VAL . 4.2 tp 56.71 113.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 128.744 2.817 . . . . 0.0 109.018 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.366 2.197 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.457 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.1 tmtm? . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 124.947 2.308 . . . . 0.0 104.995 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' LYS 0.318 38.7 mt 93.61 9.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 1 CA-C-N 107.101 -4.59 . . . . 0.0 112.325 175.518 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.474 ' HG ' ' CG2' ' A' ' 126' ' ' THR 0.259 0.2 OUTLIER -74.85 -30.46 61.36 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 114.472 -2.891 . . . . 0.0 106.378 176.32 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.17 -13.13 59.99 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 117.406 -1.717 . . . . 0.0 107.05 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.31 -31.89 54.97 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.976 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -74.33 -18.76 60.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.792 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -68.43 -39.44 81.56 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 118.139 -1.424 . . . . 0.0 107.472 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -31.0 64.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 110.425 -3.08 . . . . 0.0 112.246 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -88.05 0.29 56.14 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 112.077 -2.329 . . . . 0.0 109.989 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.33 -8.26 11.67 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.01 23.64 69.67 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -99.9 170.59 8.42 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -80.86 151.12 28.81 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 111.232 -2.713 . . . . 0.0 105.399 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 135.83 33.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 CA-C-N 111.703 -2.499 . . . . 0.0 107.469 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 60.0 t -136.66 92.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 111.593 -2.549 . . . . 0.0 106.172 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -96.55 126.17 41.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.292 -1.776 . . . . 0.0 107.198 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 8' ' ' LEU . 15.8 mt -98.72 -24.59 4.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 O-C-N 124.778 1.299 . . . . 0.0 107.655 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.78 -151.33 19.51 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.64 14.1 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 114.423 -0.889 . . . . 0.0 111.441 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.89 102.77 6.2 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.8 p -84.89 83.07 8.17 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 125.05 22.51 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 109.809 -3.36 . . . . 0.0 106.969 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -83.95 -93.59 0.07 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.987 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.66 -18.45 53.76 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 124.8 1.313 . . . . 0.0 111.462 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.63 -43.24 12.79 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD2' HG12 ' A' ' 37' ' ' ILE . 1.3 t80 -86.52 4.48 39.74 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 116.862 -1.935 . . . . 0.0 108.982 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -26.89 6.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.16 -30.21 49.04 Favored 'General case' 0 C--N 1.365 1.25 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.26 10.16 33.11 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.77 20.03 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.1 -37.31 76.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.31 -71.75 0.14 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.449 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -61.54 1.86 Allowed 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.512 0.508 . . . . 0.0 110.362 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? 99.87 68.9 0.0 OUTLIER 'General case' 0 C--N 1.348 0.509 0 O-C-N 126.248 2.217 . . . . 0.0 106.654 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.42 116.09 2.66 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.331 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -77.2 -48.55 17.3 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.39 150.49 35.78 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.96 170.63 5.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -153.21 109.02 3.29 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.773 -2.012 . . . . 0.0 105.814 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 10' ' ' VAL . 3.0 t -99.86 120.05 48.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -101.84 113.01 25.82 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 117.851 -1.54 . . . . 0.0 107.685 -176.783 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 t 150.74 162.83 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.76 74.4 6.59 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 111.517 -2.583 . . . . 0.0 106.682 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 72.66 49.65 0.18 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 112.558 -2.11 . . . . 0.0 107.805 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.22 2.99 72.16 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.996 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.627 ' HB3' HG11 ' A' ' 60' ' ' VAL . 12.2 pt20 -88.13 -20.49 25.57 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.661 -1.27 . . . . 0.0 109.463 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.04 174.35 40.25 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.58 6.29 9.04 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.85 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -67.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.576 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 29.4 t70 -71.13 -20.7 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.553 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.4 t -72.94 -56.26 5.41 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -90.07 21.08 3.87 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.617 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.44 -27.07 6.6 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.867 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 20.6 mt -85.67 -27.67 25.2 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.567 HH11 ' HG3' ' A' ' 75' ' ' ARG . 3.0 mmt85 -72.02 -32.38 67.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.28 -23.54 47.19 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 113.624 -1.626 . . . . 0.0 108.391 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -77.11 -16.5 59.16 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 83.7 m -90.24 -42.98 10.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.831 1.777 . . . . 0.0 107.282 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.65 -1.06 22.88 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 108.679 -3.873 . . . . 0.0 108.654 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.27 -54.5 5.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 59.94 40.88 18.47 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 110.882 -2.872 . . . . 0.0 107.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.78 -51.25 0.04 OUTLIER Glycine 0 C--N 1.35 1.308 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 120.19 32.63 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 126.59 31.14 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.153 -1.84 . . . . 0.0 106.29 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.61 56.19 0.04 OUTLIER Glycine 0 C--N 1.345 1.062 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.195 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -99.94 32.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 CA-C-N 112.203 -1.998 . . . . 0.0 106.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -144.36 112.56 6.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 97.35 3.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.67 85.25 3.08 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.492 HG23 ' CB ' ' A' ' 93' ' ' ASN . 4.4 m -89.45 98.45 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 109.881 -3.327 . . . . 0.0 110.397 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -63.31 132.92 42.25 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 109.116 -3.675 . . . . 0.0 113.348 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.96 -74.21 0.95 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 111.869 -2.165 . . . . 0.0 109.765 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.492 ' CB ' HG23 ' A' ' 90' ' ' VAL . 15.7 t-20 18.75 103.67 0.0 OUTLIER 'General case' 0 C--N 1.354 0.769 1 C-N-CA 131.763 4.025 . . . . 0.0 111.06 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 58.44 120.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 112.334 -2.212 . . . . 0.0 108.478 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.49 162.5 4.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 112.102 -2.317 . . . . 0.0 108.58 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 p 41.3 69.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 CA-C-N 112.432 -2.167 . . . . 0.0 112.715 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.36 128.96 1.06 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.365 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -157.61 100.0 1.76 Allowed 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 96.49 -51.77 0.01 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -85.68 99.13 11.1 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.508 ' HH2' HG21 ' A' ' 116' ' ' VAL . 88.6 m95 -113.5 160.47 31.48 Favored Pre-proline 0 C--N 1.351 0.646 0 CA-C-N 112.694 -2.048 . . . . 0.0 106.122 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.58 -155.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 N-CA-C 106.456 -2.171 . . . . 0.0 106.456 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.38 -20.91 62.92 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.688 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.6 p -60.01 -69.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.776 0 O-C-N 124.437 1.086 . . . . 0.0 111.621 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.522 ' H ' HG13 ' A' ' 104' ' ' VAL . 29.5 mt-10 -90.15 27.01 1.72 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 117.688 -1.605 . . . . 0.0 109.3 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -79.92 -42.36 24.25 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.48 -31.79 42.39 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 112.314 -2.221 . . . . 0.0 106.683 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -90.87 14.29 14.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.214 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -90.41 -37.37 14.01 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.78 75.55 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.84 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 29.9 mtp -76.9 -63.51 1.34 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 35.5 31.29 0.02 OUTLIER Glycine 0 C--N 1.355 1.635 0 C-N-CA 127.135 2.302 . . . . 0.0 117.496 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -7.19 59.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -105.25 128.63 53.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 176.91 4.87 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.508 HG21 ' HH2' ' A' ' 101' ' ' TRP . 4.8 m -138.23 158.47 32.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.17 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.5 OUTLIER -99.9 152.62 37.87 Favored Pre-proline 0 C--N 1.358 0.946 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.43 147.89 83.26 Favored 'Trans proline' 0 C--N 1.369 1.654 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.78 114.5 3.2 Favored 'Trans proline' 0 C--N 1.364 1.373 0 N-CA-C 104.011 -3.111 . . . . 0.0 104.011 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.29 42.77 6.1 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.499 -1.682 . . . . 0.0 110.389 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.5 t -90.17 -179.08 5.57 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 125.174 2.416 . . . . 0.0 106.457 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.357 19.7 p -82.39 170.78 13.63 Favored Pre-proline 0 N--CA 1.426 -1.668 1 CA-C-N 106.806 -4.725 . . . . 0.0 106.031 179.078 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -92.06 -0.06 4.23 Favored 'Trans proline' 0 CA--C 1.554 1.499 0 N-CA-C 104.586 -2.89 . . . . 0.0 104.586 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 127' ' ' ILE . 38.6 tt0 -74.97 -16.1 60.65 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.679 1.192 . . . . 0.0 108.284 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.75 55.57 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 129' ' ' ASP . 35.6 p -79.83 -23.21 42.17 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.012 -1.475 . . . . 0.0 109.817 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 124' ' ' GLU . 5.8 mt -68.55 -30.34 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.68 -5.14 58.7 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 112.134 -2.303 . . . . 0.0 108.796 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.4 t0 -59.85 -58.56 8.03 Favored 'General case' 0 C--N 1.367 1.347 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -88.29 1.61 54.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.362 -2.199 . . . . 0.0 110.156 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -81.04 -48.35 12.32 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 117.151 -1.82 . . . . 0.0 109.866 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.76 -31.49 19.61 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.235 0.96 . . . . 0.0 111.928 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 129' ' ' ASP . 16.9 t -73.25 -26.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.105 0.878 . . . . 0.0 112.379 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -89.21 -36.85 15.41 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.641 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.033 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -70.93 145.94 49.82 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.938 1.351 . . . . 0.0 107.76 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -80.61 95.85 6.67 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.938 -2.847 . . . . 0.0 108.313 -177.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 172.29 111.51 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.08 122.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.3 147.16 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 110.546 -3.025 . . . . 0.0 110.163 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 tm? -125.13 149.21 48.1 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.1 155.41 26.15 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 125.762 1.914 . . . . 0.0 112.554 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 13.6 p 84.94 -127.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 130.406 3.483 . . . . 0.0 117.03 177.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 10' ' ' VAL 0.316 2.0 tp 72.78 115.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 128.443 2.697 . . . . 0.0 106.382 -175.964 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 2.286 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.002 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 122.961 1.362 . . . . 0.0 107.68 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 3.35 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 111.502 -2.59 . . . . 0.0 111.357 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 0.2 OUTLIER -85.69 -38.58 18.16 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 116.573 -2.051 . . . . 0.0 107.664 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.98 -11.24 60.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 117.489 -1.685 . . . . 0.0 106.478 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -80.78 -38.56 28.3 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.5 m -71.0 -14.84 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 112.242 -2.254 . . . . 0.0 109.903 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.481 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.11 -42.03 73.21 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -31.61 66.59 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 110.188 -3.187 . . . . 0.0 112.462 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -87.63 -1.76 58.17 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 111.971 -2.377 . . . . 0.0 110.016 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.72 -10.32 14.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.1 70.76 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -99.88 168.47 9.86 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -78.22 148.74 33.85 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 111.178 -2.737 . . . . 0.0 105.766 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 132.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.579 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.85 74.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 111.481 -2.599 . . . . 0.0 105.444 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.09 122.98 31.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.472 -2.149 . . . . 0.0 107.622 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 8' ' ' LEU . 53.3 mt -98.39 -27.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.71 -141.51 15.58 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.99 -13.67 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.237 -0.982 . . . . 0.0 110.278 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.3 98.89 11.99 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -82.68 80.76 8.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.36 118.15 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 110.883 -2.872 . . . . 0.0 105.387 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -89.86 -87.37 0.18 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.585 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.11 -18.63 63.63 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 124.63 1.206 . . . . 0.0 110.563 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.52 -41.8 14.99 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -86.47 4.88 37.82 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 116.898 -1.921 . . . . 0.0 108.877 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.37 -26.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -78.65 -31.17 46.68 Favored 'General case' 0 C--N 1.365 1.279 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.88 10.79 29.61 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.11 -28.0 19.27 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.55 -37.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.87 -71.73 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 112.387 -2.188 . . . . 0.0 110.234 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -63.96 1.13 Allowed 'General case' 0 C--N 1.362 1.148 0 O-C-N 123.491 0.494 . . . . 0.0 110.193 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 101.25 71.14 0.0 OUTLIER 'General case' 0 C--N 1.346 0.444 0 O-C-N 126.4 2.312 . . . . 0.0 106.467 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 122.0 10.87 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.433 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -95.19 -59.41 1.9 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.79 124.83 40.59 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.459 HG21 HD13 ' A' ' 74' ' ' LEU . 39.6 mt -95.79 167.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.2 m -148.98 120.82 8.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 111.918 -2.401 . . . . 0.0 106.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.593 HG23 HG12 ' A' ' 90' ' ' VAL . 23.5 t -99.88 133.38 43.0 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -119.66 96.47 5.21 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t 147.57 161.72 0.0 OUTLIER 'General case' 0 C--N 1.354 0.789 0 O-C-N 126.293 2.246 . . . . 0.0 106.031 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.37 77.57 8.88 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 111.279 -2.691 . . . . 0.0 106.527 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.819 -1.992 . . . . 0.0 107.607 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.74 57.69 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.897 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -92.57 4.32 53.81 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 113.444 -1.378 . . . . 0.0 109.357 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.31 -167.53 35.95 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.721 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.11 21.08 3.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 112.498 -1.851 . . . . 0.0 108.072 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -75.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 20.8 t70 -71.25 -24.49 62.19 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 112.472 -2.149 . . . . 0.0 108.904 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.48 -49.4 22.36 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -90.02 16.11 8.9 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.554 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.77 -23.61 11.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.149 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 29.5 mt -89.94 -25.41 20.93 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.513 ' HG3' HH11 ' A' ' 75' ' ' ARG . 2.3 mmt85 -71.81 -30.49 65.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -79.51 -23.67 42.77 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.187 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -77.64 -12.8 60.0 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.801 0.84 . . . . 0.0 108.904 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.0 m -90.24 -42.91 10.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.923 1.82 . . . . 0.0 106.661 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.43 -3.56 31.31 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 108.527 -3.942 . . . . 0.0 108.741 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.5 -54.58 5.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.71 40.43 23.25 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 111.125 -2.761 . . . . 0.0 107.688 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.75 -52.35 0.05 OUTLIER Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -94.46 122.55 37.14 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 134.89 38.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.13 54.97 0.02 OUTLIER Glycine 0 C--N 1.347 1.14 0 CA-C-N 112.36 -2.2 . . . . 0.0 109.208 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.5 -33.41 11.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.389 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -80.92 117.53 21.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.09 100.22 3.86 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.66 92.76 5.49 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 60' ' ' VAL . 27.3 m -89.21 97.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 110.298 -3.137 . . . . 0.0 110.64 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -67.57 134.74 30.63 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 110.027 -3.261 . . . . 0.0 113.02 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.59 -80.67 1.37 Allowed Glycine 0 C--N 1.354 1.546 0 CA-C-N 111.691 -2.255 . . . . 0.0 108.492 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.49 ' CB ' HG23 ' A' ' 90' ' ' VAL . 11.1 t-20 21.56 94.06 0.01 OUTLIER 'General case' 0 C--N 1.354 0.767 0 C-N-CA 131.399 3.88 . . . . 0.0 110.171 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt 76.19 131.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.94 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.03 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 CA-C-N 112.313 -2.221 . . . . 0.0 108.103 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p 35.22 63.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 112.241 -2.254 . . . . 0.0 112.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.36 147.55 12.61 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.643 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -175.27 107.99 0.1 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 93.42 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.356 0.888 0 O-C-N 126.137 2.148 . . . . 0.0 105.429 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -87.69 107.51 18.66 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -116.47 163.34 22.45 Favored Pre-proline 0 C--N 1.351 0.651 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.16 -151.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.763 1.642 . . . . 0.0 107.976 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.07 -20.13 57.99 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.523 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -67.69 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.721 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.23 25.86 2.08 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 117.199 -1.8 . . . . 0.0 109.41 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.07 -41.23 26.02 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -78.32 -31.79 48.94 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 112.512 -2.131 . . . . 0.0 106.256 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -92.85 17.02 11.18 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.294 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -90.36 -38.97 12.97 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.19 80.1 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.915 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 12.3 mtp -74.22 -65.29 0.86 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.49 27.57 0.09 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 112.127 -2.306 . . . . 0.0 117.295 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.32 -5.24 58.46 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.12 132.59 51.15 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.75 6.68 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.08 157.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.429 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 0.7 OUTLIER -99.44 147.68 33.66 Favored Pre-proline 0 C--N 1.359 0.982 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 -178.745 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.56 145.06 81.14 Favored 'Trans proline' 0 C--N 1.371 1.723 0 N-CA-C 107.451 -1.788 . . . . 0.0 107.451 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -79.97 111.97 2.78 Favored 'Trans proline' 0 C--N 1.364 1.35 0 N-CA-C 103.552 -3.288 . . . . 0.0 103.552 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.16 42.14 5.04 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 113.47 -1.695 . . . . 0.0 110.478 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.5 t -90.12 -179.15 5.6 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 124.875 2.274 . . . . 0.0 106.644 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.335 22.3 p -78.73 173.43 7.71 Favored Pre-proline 0 N--CA 1.431 -1.394 1 CA-C-N 107.297 -4.501 . . . . 0.0 105.666 178.797 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -93.75 -4.6 2.82 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 105.198 -2.655 . . . . 0.0 105.198 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.33 -10.68 60.0 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.717 1.607 . . . . 0.0 108.3 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -30.55 60.49 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.796 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 36.3 p -83.66 -25.66 30.54 Favored 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.46 1.1 . . . . 0.0 110.069 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.8 -28.61 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 103.242 -2.874 . . . . 0.0 103.242 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.35 58.39 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.145 -2.298 . . . . 0.0 108.609 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.7 t0 -61.74 -53.75 51.76 Favored 'General case' 0 C--N 1.366 1.325 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -87.43 -2.61 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 111.956 -2.384 . . . . 0.0 110.168 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -81.32 -49.69 10.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 117.15 -1.82 . . . . 0.0 110.223 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.16 -36.36 21.11 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 124.161 0.913 . . . . 0.0 112.148 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.8 t -70.59 -29.71 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.767 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.09 -39.91 18.95 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.571 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.292 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.4 156.58 16.42 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 124.429 2.061 . . . . 0.0 108.404 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.96 94.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 107.999 -4.182 . . . . 0.0 108.757 -178.483 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.26 106.53 0.02 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.623 ' HB ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -145.65 111.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.597 ' HB ' HG22 ' A' ' 37' ' ' ILE . 7.6 m -89.72 145.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 CA-C-O 123.198 1.475 . . . . 0.0 109.385 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.34 111.43 15.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 110.081 -3.236 . . . . 0.0 104.034 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . . . -160.83 141.61 7.5 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.854 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.734 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 171.26 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.034 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER 118.97 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.688 0 O-C-N 125.916 2.01 . . . . 0.0 105.879 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.509 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.541 179.746 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 125.696 2.665 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 25' ' ' HIS 0.433 0.1 OUTLIER 45.12 39.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.652 1 CA-C-N 107.405 -4.452 . . . . 0.0 110.181 178.463 . . . . . . . . 5 4 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -37.18 63.38 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.74 -9.76 57.98 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 112.019 -2.355 . . . . 0.0 107.268 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HB3' HG13 ' A' ' 22' ' ' ILE . 16.9 t-80 -87.11 -7.68 57.79 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 m -59.58 -41.33 90.01 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.95 -42.69 98.73 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 110.013 -3.267 . . . . 0.0 109.137 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -82.38 -9.53 59.42 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.82 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 130' ' ' MET . 0.6 OUTLIER -68.2 -42.03 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.556 1.142 . . . . 0.0 108.664 -177.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.82 39.43 0.06 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.0 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.7 27.78 64.51 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.122 -0.944 . . . . 0.0 114.571 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.87 92.01 5.09 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -35.57 141.33 0.08 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 129.757 3.223 . . . . 0.0 109.213 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 2.6 m -121.45 136.42 58.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 111.898 -2.41 . . . . 0.0 106.643 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.3 t -102.31 102.7 13.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.004 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -77.71 114.62 16.74 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.597 HG22 ' HB ' ' A' ' 7' ' ' VAL . 1.1 tt -98.82 -3.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 112.085 -2.325 . . . . 0.0 108.161 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.01 -100.61 2.23 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 123.924 0.765 . . . . 0.0 113.75 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 16.3 m -127.08 -31.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-N 113.223 -1.489 . . . . 0.0 111.876 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -91.83 111.85 23.54 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -101.5 80.26 2.05 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.6 140.84 58.56 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.928 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -90.23 -82.6 0.27 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.359 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.05 -21.18 61.07 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.543 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.25 -34.78 14.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.525 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.01 -8.54 58.67 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 116.864 -1.934 . . . . 0.0 109.686 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.614 ' HB ' HD13 ' A' ' 83' ' ' LEU . 1.1 mp -82.75 -26.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -76.67 -29.77 56.5 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.55 2.04 56.16 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.122 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.64 -20.32 26.51 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 mt -74.3 -39.91 49.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.77 -68.03 0.36 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.471 -2.149 . . . . 0.0 110.144 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -63.78 1.01 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 123.779 0.674 . . . . 0.0 109.713 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.2 tttp 111.62 50.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.61 109.76 0.34 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-N 112.177 -2.283 . . . . 0.0 108.782 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.38 -42.95 19.71 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -151.65 160.35 43.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 117.383 -1.727 . . . . 0.0 107.682 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 mm -122.93 139.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 CA-C-N 111.308 -2.678 . . . . 0.0 106.179 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.42 ' SG ' ' CD1' ' A' ' 57' ' ' LEU . 71.5 m -136.85 124.15 21.89 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.51 -2.132 . . . . 0.0 105.386 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 34.6 m -112.14 135.24 52.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-N 112.592 -2.095 . . . . 0.0 105.532 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.734 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -107.95 106.54 16.84 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 117.37 -1.732 . . . . 0.0 109.662 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 m 131.42 -177.0 0.0 OUTLIER 'General case' 0 C--N 1.352 0.674 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.85 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.648 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -66.0 97.67 0.38 Allowed 'General case' 0 C--N 1.36 1.046 0 CA-C-N 113.749 -1.568 . . . . 0.0 107.187 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.04 -28.27 3.42 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 111.12 -2.764 . . . . 0.0 107.411 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -84.62 -32.02 23.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 111.67 -2.265 . . . . 0.0 106.432 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.46 178.76 46.75 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.081 -1.56 . . . . 0.0 108.529 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mm -80.09 -48.56 20.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -71.97 -20.63 61.71 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.677 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 t -70.61 -45.26 65.6 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.06 18.0 6.31 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 124.464 1.102 . . . . 0.0 109.461 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -31.69 5.68 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 88' ' ' LEU . 12.6 mt -89.22 -25.35 21.79 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 112.998 -1.601 . . . . 0.0 106.783 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -29.12 60.8 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.13 -24.81 43.09 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.653 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -76.57 -15.62 59.81 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' CYS . . . . . 0.426 ' SG ' HG12 ' A' ' 86' ' ' ILE . 62.2 m -90.35 -44.84 9.41 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 123.885 1.802 . . . . 0.0 107.195 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.65 -1.72 22.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 108.589 -3.914 . . . . 0.0 108.857 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -80.81 -54.03 5.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.77 43.59 12.01 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 111.037 -2.801 . . . . 0.0 107.41 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.34 -47.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.212 0 CA-C-N 112.542 -2.117 . . . . 0.0 107.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.614 HD13 ' HB ' ' A' ' 47' ' ' ILE . 88.1 mt -89.04 121.14 31.09 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 119.45 23.11 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.88 75.84 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 CA-C-N 113.087 -1.869 . . . . 0.0 109.711 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.426 HG12 ' SG ' ' A' ' 78' ' ' CYS . 0.6 OUTLIER -115.41 30.7 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-N 112.122 -2.039 . . . . 0.0 106.292 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB3' HH22 ' A' ' 115' ' ' ARG . 72.9 mmtt -142.63 119.0 10.88 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.3 112.22 7.57 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.83 83.84 1.86 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.6 99.17 8.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-N 111.453 -2.612 . . . . 0.0 111.044 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.25 122.77 8.11 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 110.184 -3.189 . . . . 0.0 110.299 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.6 -98.39 2.42 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.3 t30 64.89 -97.13 0.05 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 112.48 -1.86 . . . . 0.0 107.616 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -85.07 111.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.28 168.58 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.628 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.251 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 40.32 57.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.46 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.25 151.34 13.5 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.508 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -173.6 131.83 0.45 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 87.9 -71.6 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 O-C-N 126.113 2.133 . . . . 0.0 105.534 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -92.61 145.43 24.43 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CZ3' HD13 ' A' ' 94' ' ' ILE . 87.3 m95 -129.39 160.29 64.98 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.41 -150.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.02 -26.68 63.22 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.352 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.85 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 124.881 1.363 . . . . 0.0 110.362 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.527 ' H ' HG23 ' A' ' 104' ' ' VAL . 19.7 mt-10 -90.39 24.72 2.48 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.635 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.9 -47.72 65.11 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 103.495 -2.779 . . . . 0.0 103.495 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.13 -20.08 23.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 111.575 -2.557 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -84.17 -45.93 12.43 Favored 'General case' 0 C--N 1.364 1.237 0 C-N-CA 117.977 -1.489 . . . . 0.0 108.879 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.33 -0.38 36.52 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.949 1.406 . . . . 0.0 108.252 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.42 79.81 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -87.77 -50.85 6.2 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.67 37.08 50.3 Favored Glycine 0 C--N 1.363 2.04 0 N-CA-C 116.384 1.313 . . . . 0.0 116.384 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.17 -7.44 58.21 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.01 133.09 50.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.473 HH22 ' HB3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -110.04 169.97 8.38 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.13 166.66 19.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 CA-C-N 113.67 -1.604 . . . . 0.0 107.284 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -99.62 150.69 37.02 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.47 160.02 44.93 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.095 1.863 . . . . 0.0 108.708 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.81 122.02 8.45 Favored 'Trans proline' 0 C--N 1.371 1.762 0 N-CA-C 105.219 -2.646 . . . . 0.0 105.219 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.8 -170.27 13.26 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.4 p -69.77 146.03 51.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.16 76.17 8.69 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.57 -20.72 13.63 Favored 'Trans proline' 0 C--N 1.369 1.655 0 O-C-N 123.422 1.222 . . . . 0.0 110.222 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.92 -32.81 51.88 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.374 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -77.73 -11.38 59.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.036 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 129' ' ' ASP . 30.9 p -89.3 -20.93 23.47 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.127 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.69 -26.55 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.29 -2.99 57.27 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.459 -2.155 . . . . 0.0 108.578 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t0 -53.06 -60.58 3.1 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.158 1.456 . . . . 0.0 107.261 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.639 ' HG2' HD13 ' A' ' 134' ' ' LEU . 3.0 ttp -90.02 -22.45 21.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.643 -2.98 . . . . 0.0 111.034 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -86.48 -13.37 46.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.921 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -90.21 -55.6 3.54 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 122.439 1.114 . . . . 0.0 108.366 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 129' ' ' ASP . 88.1 t -63.65 -53.07 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 112.361 -2.2 . . . . 0.0 114.197 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' A' ' 130' ' ' MET . 3.8 mp -89.16 -12.12 41.91 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.37 1.044 . . . . 0.0 109.646 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.704 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.22 178.695 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -79.72 143.24 34.71 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -79.24 95.21 5.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 110.786 -2.916 . . . . 0.0 108.817 -177.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.39 115.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 119.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.77 126.52 49.47 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 CA-C-N 112.285 -2.234 . . . . 0.0 108.385 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 23' ' ' LEU . 56.9 tp -125.15 140.96 52.41 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.182 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 155.57 173.96 24.86 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.997 HG23 HG22 ' A' ' 60' ' ' VAL . 2.2 p 164.98 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.227 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -175.27 -145.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.514 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.948 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 -179.214 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 126.371 2.986 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.356 0.0 OUTLIER 36.94 48.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.633 2 CA-C-N 106.731 -4.759 . . . . 0.0 108.557 -178.925 . . . . . . . . 5 4 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.574 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -68.35 -33.31 74.06 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 173.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.49 6.49 4.6 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-N 110.971 -2.831 . . . . 0.0 107.817 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 22' ' ' ILE . 15.7 t-160 -76.0 -41.72 50.29 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -44.83 63.62 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 111.318 -2.673 . . . . 0.0 109.601 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -54.12 -41.35 68.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.363 -178.597 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -21.67 44.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 112.666 -2.061 . . . . 0.0 113.581 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -78.82 -5.41 53.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.751 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.02 0.75 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 115.984 -2.286 . . . . 0.0 109.215 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.32 97.43 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 118.672 -1.727 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.31 151.45 21.05 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -76.98 136.64 38.75 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 111.479 -2.6 . . . . 0.0 105.932 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.96 148.0 7.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 112.304 -2.225 . . . . 0.0 107.011 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.11 67.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 111.172 -2.74 . . . . 0.0 106.982 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.81 115.3 9.8 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.304 -1.771 . . . . 0.0 106.58 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 tt -94.38 -2.35 10.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.636 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 -115.11 3.99 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.402 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -143.94 51.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 113.568 -1.316 . . . . 0.0 109.507 -179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.27 150.51 36.09 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 112.828 -1.987 . . . . 0.0 105.644 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 t -112.13 31.31 6.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 113.059 -1.882 . . . . 0.0 106.043 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 p -82.35 97.58 8.4 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.05 -56.55 3.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.471 -2.15 . . . . 0.0 108.85 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -24.84 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.749 1.281 . . . . 0.0 110.889 -177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.0 -32.83 18.63 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -88.16 2.91 51.06 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.027 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.01 -31.17 7.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.9 -27.4 61.86 Favored 'General case' 0 C--N 1.366 1.284 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.48 -4.43 55.53 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.89 -8.61 57.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.99 -40.32 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.65 -64.08 1.07 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.46 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -62.0 1.57 Allowed 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? 112.32 45.78 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 O-C-N 127.052 2.72 . . . . 0.0 104.85 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.46 112.1 0.76 Allowed 'General case' 0 C--N 1.358 0.953 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -81.69 0.33 Allowed 'General case' 0 C--N 1.358 0.94 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.711 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.52 130.77 37.3 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.737 1.273 . . . . 0.0 108.333 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.6 162.46 2.4 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.297 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' CYS . . . . . 0.574 ' SG ' HD12 ' A' ' 23' ' ' LEU . 21.5 t -156.99 104.65 2.11 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 HG23 ' A' ' 10' ' ' VAL . 2.1 p -110.35 129.9 64.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.731 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.99 111.32 19.42 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 117.426 -1.71 . . . . 0.0 108.767 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t 145.36 173.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.638 0 CA-C-N 111.27 -2.695 . . . . 0.0 104.52 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.04 -129.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.757 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.38 80.81 8.45 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.21 53.95 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' H ' ' H ' ' A' ' 67' ' ' GLY . 12.9 pt20 -165.52 -20.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 111.689 -2.256 . . . . 0.0 107.654 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.434 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 81.82 177.19 51.66 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.339 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -86.92 9.41 19.43 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.222 -1.489 . . . . 0.0 108.101 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -51.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.51 -27.79 62.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.502 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.49 -57.19 6.2 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -90.18 27.81 1.56 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 124.754 1.284 . . . . 0.0 109.025 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.67 -30.23 6.24 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -90.12 -30.02 17.93 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 112.637 -1.781 . . . . 0.0 107.211 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.509 HH11 ' HG3' ' A' ' 75' ' ' ARG . 1.4 mmt85 -71.31 -31.89 67.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -75.21 -31.89 61.03 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 113.503 -1.68 . . . . 0.0 108.03 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -71.52 -16.09 62.32 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.298 0.999 . . . . 0.0 109.763 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.25 -48.06 7.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 123.169 1.461 . . . . 0.0 108.237 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.307 2.4 p30 -76.63 3.58 11.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 109.727 -3.397 . . . . 0.0 109.389 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.24 -54.89 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 40.34 12.43 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.841 -2.89 . . . . 0.0 107.409 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -48.08 0.04 OUTLIER Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.5 mt -86.58 121.18 28.75 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 121.98 33.51 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.94 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.32 78.46 0.04 OUTLIER Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.966 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.52 33.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.673 -1.763 . . . . 0.0 106.672 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 113.08 4.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.96 111.19 9.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.61 87.61 3.62 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 HG12 ' A' ' 116' ' ' VAL . 33.9 m -89.43 96.32 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 111.184 -2.735 . . . . 0.0 110.119 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.78 101.24 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-N 108.94 -3.755 . . . . 0.0 110.366 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.78 -108.42 3.09 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 112.37 -1.915 . . . . 0.0 109.766 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.96 -110.79 0.09 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -79.18 129.59 37.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.89 174.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.487 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.58 80.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.038 -2.346 . . . . 0.0 112.623 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.08 156.13 8.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 111.972 -2.377 . . . . 0.0 109.086 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -168.78 93.35 0.31 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 95.56 -47.98 0.01 OUTLIER 'General case' 0 C--N 1.355 0.828 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -89.37 122.76 32.91 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -135.64 160.84 66.15 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.8 -149.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.773 1.649 . . . . 0.0 108.239 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.86 -21.2 60.98 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.642 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.8 p -57.32 -70.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 O-C-N 124.619 1.199 . . . . 0.0 111.236 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 104' ' ' VAL . 12.2 mm-40 -88.35 21.49 2.84 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 117.33 -1.748 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.12 -43.07 62.2 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -79.95 -32.05 39.94 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.115 -2.311 . . . . 0.0 107.216 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -91.04 13.45 16.73 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.027 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 -38.8 12.99 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 107.214 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.04 -61.5 1.97 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.22 35.66 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.379 2.419 . . . . 0.0 117.431 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -89.69 -1.39 58.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.18 137.21 43.32 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 173.39 6.35 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 90' ' ' VAL . 18.9 m -140.09 156.4 24.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 124.499 1.124 . . . . 0.0 109.198 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.469 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 2.0 m-85 -99.72 150.14 36.55 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.24 166.36 5.96 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.123 2.549 . . . . 0.0 109.045 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 -92.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 104.436 -2.948 . . . . 0.0 104.436 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.38 131.64 14.98 Favored Glycine 0 C--N 1.359 1.854 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 t -64.84 162.92 15.27 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 125.494 2.569 . . . . 0.0 109.189 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -170.73 114.35 0.45 Allowed Pre-proline 0 N--CA 1.431 -1.415 1 CA-C-N 106.235 -4.984 . . . . 0.0 100.941 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.68 -4.03 13.82 Favored 'Trans proline' 0 C--N 1.363 1.317 0 O-C-N 122.41 0.689 . . . . 0.0 111.335 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.99 -23.05 65.89 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.958 1.303 . . . . 0.0 108.96 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -28.05 51.5 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.17 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 77.9 p -80.65 -18.68 47.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.968 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.56 -25.55 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.01 46.97 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.387 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.7 t0 -52.73 -62.36 1.7 Allowed 'General case' 0 C--N 1.369 1.421 0 CA-C-O 123.781 1.753 . . . . 0.0 106.832 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 45.9 ttm -90.12 -25.8 20.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 109.574 -3.467 . . . . 0.0 111.383 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -78.52 -13.0 60.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.709 -1.596 . . . . 0.0 110.316 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.98 -56.23 3.37 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.3 t -63.18 -34.49 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.611 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.93 -33.02 30.55 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.463 0 O-C-N 124.55 1.156 . . . . 0.0 111.483 -179.864 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -79.07 169.28 18.44 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.601 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -103.84 104.79 14.83 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 109.065 -3.698 . . . . 0.0 108.589 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.32 99.38 0.01 OUTLIER 'General case' 0 C--N 1.355 0.804 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.85 109.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.52 127.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.775 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 23' ' ' LEU . 2.0 pp -125.28 136.19 53.26 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 112.515 -2.129 . . . . 0.0 105.721 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 171.11 44.27 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.405 -2.634 . . . . 0.0 108.343 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.931 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.9 p 164.42 -122.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.464 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.2 tp -168.68 -149.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.379 1.884 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.711 0 C-N-CA 118.76 -1.686 . . . . 0.0 110.234 179.61 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 125.307 2.479 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.336 0.2 OUTLIER 31.05 42.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.39 2 CA-C-N 106.898 -4.683 . . . . 0.0 109.149 -177.897 . . . . . . . . 5 4 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.12 -35.18 31.91 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 176.739 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.2 -0.85 30.09 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.163 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -78.18 -35.07 49.2 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.7 p -56.58 -44.31 80.91 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.072 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.824 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.55 -43.5 75.9 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.889 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -26.82 62.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 111.865 -2.425 . . . . 0.0 112.648 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -79.68 0.49 30.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 112.072 -2.331 . . . . 0.0 109.149 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.6 11.3 2.08 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 118.199 -1.4 . . . . 0.0 108.031 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.6 34.44 55.72 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.289 0.993 . . . . 0.0 112.882 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.67 -177.43 3.57 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.39 145.21 25.5 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.365 -2.198 . . . . 0.0 106.55 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.824 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -99.93 135.41 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 110.777 -2.92 . . . . 0.0 107.262 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.25 76.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.419 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.636 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.91 120.75 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.29 -92.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 111.985 -2.37 . . . . 0.0 104.924 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.12 -140.42 5.63 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.41 4.03 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 113.121 -1.54 . . . . 0.0 110.671 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.06 99.54 11.98 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -97.5 54.6 1.2 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -90.08 85.35 6.28 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' CD ' HD21 ' A' ' 74' ' ' LEU . 21.9 tp60 -68.27 -47.65 67.15 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.836 -176.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -36.53 84.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.636 1.21 . . . . 0.0 109.529 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.9 -21.94 50.45 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -85.47 -2.23 57.91 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.46 -35.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -75.6 -33.01 60.53 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.826 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.57 7.09 43.06 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.903 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.21 -21.73 22.01 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -74.47 -38.46 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.7 -69.05 0.23 Allowed 'General case' 0 C--N 1.354 0.787 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.029 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.37 -57.97 3.77 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.158 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' THR . 63.7 tttt 120.47 48.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 126.672 2.483 . . . . 0.0 107.705 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -49.36 106.62 0.11 Allowed 'General case' 0 C--N 1.355 0.819 0 CA-C-O 122.061 0.934 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.87 -38.95 31.6 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' HD11 ' A' ' 134' ' ' LEU . 2.6 pp -151.1 167.52 27.46 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -142.04 150.75 18.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-N 112.081 -2.327 . . . . 0.0 105.839 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.69 134.78 22.72 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.38 135.28 40.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.806 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.931 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.14 91.12 3.54 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.5 t 150.62 165.92 0.0 OUTLIER 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.8 -127.84 0.0 OUTLIER 'General case' 0 C--N 1.359 1.007 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.308 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 86.4 7.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.84 42.56 1.21 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 110.92 -2.855 . . . . 0.0 106.928 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -147.08 -32.61 0.3 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 111.143 -2.528 . . . . 0.0 106.841 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.49 167.84 43.35 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.51 1.55 19.0 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.992 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -47.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -72.27 -27.06 62.24 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 114.303 -1.317 . . . . 0.0 107.66 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.29 -47.7 66.94 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.12 26.6 1.83 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.909 1.381 . . . . 0.0 108.829 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.7 -34.96 5.79 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.464 HD21 ' CD ' ' A' ' 43' ' ' GLN . 1.6 mt -88.84 -28.14 20.59 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 112.032 -2.084 . . . . 0.0 107.712 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.06 -24.43 58.23 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -82.04 -29.08 32.13 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -76.6 -15.66 59.78 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.31 1.006 . . . . 0.0 109.189 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 20.7 t -90.29 -47.71 7.59 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 123.982 1.849 . . . . 0.0 107.115 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.91 -3.61 23.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 108.478 -3.965 . . . . 0.0 109.158 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -82.01 -56.08 4.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.01 47.65 5.69 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 110.932 -2.849 . . . . 0.0 106.616 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.95 -44.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.73 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.81 120.9 24.7 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 134.14 34.42 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.47 56.96 0.06 OUTLIER Glycine 0 C--N 1.349 1.284 0 CA-C-N 112.733 -2.03 . . . . 0.0 110.266 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 tt -104.7 47.55 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -142.51 118.17 10.42 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -140.04 151.84 45.74 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.205 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.34 91.41 2.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 m -89.35 99.11 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 126.039 2.828 . . . . 0.0 110.339 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.08 109.08 2.71 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 108.498 -3.955 . . . . 0.0 109.358 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.8 -101.65 2.23 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 112.244 -1.978 . . . . 0.0 109.353 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t30 64.65 -104.84 0.12 Allowed 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.88 56.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.35 176.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.858 -1.974 . . . . 0.0 108.505 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.51 56.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.838 0 CA-C-N 112.722 -2.036 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.77 141.35 5.15 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.142 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.3 106.22 0.24 Allowed 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.17 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 126.032 2.083 . . . . 0.0 105.608 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.49 130.69 35.79 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -142.99 158.84 58.18 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.77 -148.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.853 0 N-CA-C 107.442 -1.792 . . . . 0.0 107.442 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.97 -22.34 60.71 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.0 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.804 0 O-C-N 124.519 1.137 . . . . 0.0 111.309 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.3 mm-40 -89.85 22.95 2.91 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 117.391 -1.723 . . . . 0.0 108.338 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.35 -42.13 59.88 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -79.65 -32.07 41.57 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 112.104 -2.316 . . . . 0.0 106.877 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.72 15.97 13.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.841 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 -40.56 11.94 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 176.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.15 74.86 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 112.355 -2.202 . . . . 0.0 107.473 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.4 mtp -80.78 -58.69 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.11 40.67 0.08 OUTLIER Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.347 2.403 . . . . 0.0 117.32 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -84.62 -6.29 59.36 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.62 132.08 50.19 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -178.26 3.47 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.9 m -140.07 161.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.227 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -99.36 154.35 37.33 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-N 110.532 -3.031 . . . . 0.0 103.679 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.26 159.73 43.32 Favored 'Trans proline' 0 C--N 1.368 1.554 0 N-CA-C 107.173 -1.895 . . . . 0.0 107.173 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.02 116.46 4.66 Favored 'Trans proline' 0 C--N 1.369 1.649 0 N-CA-C 103.763 -3.206 . . . . 0.0 103.763 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.81 132.79 5.57 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 t -73.62 159.61 32.82 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-O 125.25 2.452 . . . . 0.0 107.67 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.5 p -173.4 119.57 0.39 Allowed Pre-proline 0 N--CA 1.427 -1.607 1 CA-C-N 106.484 -4.871 . . . . 0.0 101.537 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 71.5 Cg_endo -78.93 -4.53 14.02 Favored 'Trans proline' 0 C--N 1.358 1.041 0 N-CA-C 108.698 -1.309 . . . . 0.0 108.698 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.29 -37.38 87.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.462 1.905 . . . . 0.0 107.619 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.87 -23.71 59.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.615 -1.629 . . . . 0.0 108.148 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.4 p -81.79 -25.57 35.15 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 116.948 -1.901 . . . . 0.0 109.909 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.72 -24.87 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.44 -6.48 58.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 112.969 -1.923 . . . . 0.0 108.714 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.3 t0 -61.89 -58.03 9.48 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.0 mmt -88.15 -10.78 48.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.069 -1.878 . . . . 0.0 110.874 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -90.21 -49.81 6.35 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 117.864 -1.534 . . . . 0.0 109.013 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.92 -50.27 66.78 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.214 0.946 . . . . 0.0 109.868 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 129' ' ' ASP . 51.1 t -69.45 -61.36 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 113.035 -1.893 . . . . 0.0 111.86 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.1 mp -90.38 52.61 2.27 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.768 1.293 . . . . 0.0 109.876 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.367 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.315 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.12 161.16 26.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.802 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 21.2 pttp -119.6 108.91 15.06 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 110.927 -2.851 . . . . 0.0 108.123 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.41 85.48 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' SD ' ' A' ' 130' ' ' MET . 0.8 OUTLIER -109.86 107.25 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 110.721 -2.945 . . . . 0.0 103.751 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.68 126.35 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.483 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.27 153.13 43.69 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.4 -2.182 . . . . 0.0 106.679 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.23 174.07 42.42 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 111.137 -2.756 . . . . 0.0 108.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.933 ' HB ' ' H ' ' A' ' 61' ' ' SER . 3.0 p 164.48 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.541 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.3 tp -168.29 -150.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.38 1.904 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.671 0 C-N-CA 118.681 -1.723 . . . . 0.0 110.327 179.645 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' C ' HD13 ' A' ' 22' ' ' ILE . 88.7 tttt . . . . . 0 CA--C 1.51 -0.595 0 CA-C-O 125.421 2.534 . . . . 0.0 107.906 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.466 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.348 0.2 OUTLIER 29.65 42.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.332 2 CA-C-N 106.614 -4.812 . . . . 0.0 109.522 -178.213 . . . . . . . . 5 4 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -35.53 25.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 2.1 p30 -76.95 -2.95 36.35 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 113.694 -1.594 . . . . 0.0 106.868 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -77.36 -34.97 55.0 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -56.79 -43.53 80.99 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.28 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.748 ' CZ ' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.28 -44.07 75.35 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.928 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -27.33 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 111.545 -2.57 . . . . 0.0 112.782 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -78.74 -0.53 30.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.201 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.28 9.21 2.49 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 118.511 -1.275 . . . . 0.0 107.908 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 33.58 58.57 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 124.243 0.964 . . . . 0.0 112.627 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -99.61 -179.47 4.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 28.2 t-20 -76.85 144.5 38.99 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 112.219 -2.264 . . . . 0.0 106.873 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.748 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.92 127.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 110.669 -2.969 . . . . 0.0 107.469 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 7' ' ' VAL . 5.8 t -140.19 128.75 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 111.561 -2.563 . . . . 0.0 105.6 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -144.2 132.49 21.91 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -97.08 -87.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 111.85 -2.432 . . . . 0.0 104.886 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.05 -137.99 4.77 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.6 2.28 8.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 CA-C-N 113.201 -1.499 . . . . 0.0 110.716 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.27 98.31 11.26 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 47.6 t -97.9 55.34 1.18 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 p -90.14 86.51 6.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.413 ' CD ' HD21 ' A' ' 74' ' ' LEU . 19.9 tp60 -66.81 -46.31 75.6 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.144 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -37.71 88.54 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.482 1.113 . . . . 0.0 109.61 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -77.72 -21.01 52.57 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.88 -2.24 58.06 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.7 -35.88 32.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -75.04 -32.21 61.5 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.958 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.98 5.69 49.15 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.988 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.25 -19.04 24.6 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.15 -38.48 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -59.51 -69.13 0.22 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.988 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.85 -54.74 10.42 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.722 -176.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' THR . 64.0 tttt 117.65 47.23 0.0 OUTLIER 'General case' 0 C--N 1.356 0.852 0 O-C-N 126.705 2.503 . . . . 0.0 107.55 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -48.85 106.46 0.1 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.499 1.142 . . . . 0.0 110.279 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.63 -38.15 34.46 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 111.584 -2.553 . . . . 0.0 104.163 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 134' ' ' LEU . 1.9 pp -154.39 165.05 37.61 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -138.61 142.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 111.722 -2.49 . . . . 0.0 106.169 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.79 133.67 34.31 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 135.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.138 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.933 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.42 91.85 3.82 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 t 150.09 166.26 0.0 OUTLIER 'General case' 0 C--N 1.36 1.056 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.75 -127.24 0.0 OUTLIER 'General case' 0 C--N 1.358 0.959 0 CA-C-N 113.595 -1.638 . . . . 0.0 107.277 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.61 85.16 7.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.48 42.87 1.26 Allowed Glycine 0 C--N 1.345 1.058 0 CA-C-N 110.881 -2.872 . . . . 0.0 107.089 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -148.38 -32.42 0.25 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 111.181 -2.509 . . . . 0.0 106.857 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.08 167.73 42.79 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.39 1.38 19.17 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.582 -1.309 . . . . 0.0 109.044 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.32 -46.51 17.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -72.6 -27.38 62.13 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.781 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.47 -47.28 67.52 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -90.07 25.43 2.15 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 124.815 1.322 . . . . 0.0 108.988 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.35 -33.31 6.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.3 mt -88.27 -29.67 20.23 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 111.939 -2.131 . . . . 0.0 107.678 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -24.23 58.67 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.1 -29.25 31.84 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -76.49 -15.1 59.97 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.235 0.959 . . . . 0.0 109.238 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.35 -48.12 7.33 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 124.014 1.864 . . . . 0.0 107.059 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.61 -3.67 22.83 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 108.43 -3.986 . . . . 0.0 109.207 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.45 -56.36 3.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.75 48.02 5.81 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 110.964 -2.835 . . . . 0.0 106.641 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.75 -43.62 0.02 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.905 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.35 120.57 23.98 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 136.12 33.95 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.72 53.96 0.09 OUTLIER Glycine 0 C--N 1.35 1.307 0 CA-C-N 112.734 -2.03 . . . . 0.0 110.117 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.86 55.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -148.35 118.67 7.33 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.55 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -139.98 151.84 45.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.862 -1.972 . . . . 0.0 106.121 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 90.99 2.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 m -89.33 98.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 CA-C-O 126.106 2.86 . . . . 0.0 110.307 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 109.54 2.82 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 108.456 -3.975 . . . . 0.0 109.367 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -101.14 2.14 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.195 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.3 t30 64.38 -104.94 0.12 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.34 125.28 56.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.44 177.32 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.824 -1.989 . . . . 0.0 108.449 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.57 55.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-N 112.654 -2.067 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.92 141.34 5.1 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.227 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.27 105.51 0.23 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.36 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.356 0.856 0 O-C-N 126.056 2.097 . . . . 0.0 105.526 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -89.22 130.09 35.69 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -142.91 158.82 58.45 Favored Pre-proline 0 C--N 1.352 0.675 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.73 -148.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.374 1.872 0 N-CA-C 107.433 -1.795 . . . . 0.0 107.433 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.96 -22.32 60.72 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.969 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 124.495 1.122 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.49 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.0 mm-40 -89.99 23.11 2.9 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.403 -1.719 . . . . 0.0 108.41 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -74.43 -42.41 59.18 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 112.065 -2.334 . . . . 0.0 106.869 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.19 16.43 13.06 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.914 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -40.71 11.83 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.25 75.28 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 112.212 -2.267 . . . . 0.0 107.408 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.1 mtp -80.78 -58.51 3.06 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 31.52 41.04 0.07 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.399 2.428 . . . . 0.0 117.373 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.69 -6.09 59.34 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.4 132.14 49.91 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -178.97 3.66 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.02 161.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 117.793 -1.563 . . . . 0.0 110.255 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -99.39 154.41 37.3 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.815 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.08 160.66 42.42 Favored 'Trans proline' 0 C--N 1.368 1.579 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.9 116.43 4.66 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 103.823 -3.183 . . . . 0.0 103.823 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.11 133.86 5.94 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -73.84 159.61 32.62 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 125.144 2.402 . . . . 0.0 107.52 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.7 p -173.17 120.57 0.41 Allowed Pre-proline 0 N--CA 1.427 -1.606 1 CA-C-N 106.583 -4.826 . . . . 0.0 101.648 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 80.1 Cg_endo -78.8 -5.45 14.68 Favored 'Trans proline' 0 C--N 1.357 0.999 0 N-CA-C 108.685 -1.313 . . . . 0.0 108.685 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.84 -37.92 89.17 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.547 1.939 . . . . 0.0 107.744 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.256 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.3 p -82.09 -25.44 34.51 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 116.94 -1.904 . . . . 0.0 109.983 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.3 mt -67.65 -24.78 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.77 -6.3 58.23 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.77 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.1 t0 -61.91 -58.37 8.19 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.579 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 35.1 mmt -87.09 -11.93 48.7 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.82 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -90.13 -48.55 7.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.201 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -47.99 71.27 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 124.131 0.894 . . . . 0.0 109.921 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.3 t -71.42 -61.19 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.638 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.9 mp -90.37 53.97 2.62 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.842 1.339 . . . . 0.0 109.635 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.29 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.309 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -63.04 144.06 57.23 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.404 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.24 102.44 14.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 111.786 -2.461 . . . . 0.0 107.505 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.03 105.75 0.03 OUTLIER 'General case' 0 C--N 1.357 0.919 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 112.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -101.8 117.92 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 111.779 -2.464 . . . . 0.0 108.293 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 23' ' ' LEU . 16.2 tp -90.14 159.89 16.54 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.912 -1.949 . . . . 0.0 108.262 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.48 29.84 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 111.422 -2.626 . . . . 0.0 107.844 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.36 131.75 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 122.312 1.053 . . . . 0.0 112.087 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.54 133.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.719 0 C-N-CA 117.818 -2.134 . . . . 0.0 113.192 -177.434 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 CA--C 1.498 -1.039 0 CA-C-O 125.48 2.562 . . . . 0.0 107.833 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.355 0.2 OUTLIER 30.09 54.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.434 1 CA-C-N 106.242 -4.981 . . . . 0.0 107.922 -177.371 . . . . . . . . 5 4 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 tt -70.91 -25.54 62.81 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 102.11 -3.292 . . . . 0.0 102.11 173.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -66.32 -17.44 64.76 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 116.744 -1.982 . . . . 0.0 107.221 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.515 ' HB2' HG22 ' A' ' 22' ' ' ILE . 13.0 t-80 -69.4 -24.5 63.86 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.461 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 7.4 p -56.78 -37.82 71.63 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 125.024 1.453 . . . . 0.0 108.739 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.953 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -54.64 -49.42 70.58 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.029 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -22.78 61.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.114 -2.312 . . . . 0.0 112.904 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -81.33 0.07 38.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.688 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.93 12.9 1.45 Allowed 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.001 -1.48 . . . . 0.0 107.906 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 37.74 46.2 Favored Glycine 0 C--N 1.36 1.869 0 O-C-N 124.229 0.955 . . . . 0.0 113.056 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.71 -168.11 1.56 Allowed 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.303 -1.449 . . . . 0.0 107.519 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -93.8 140.04 30.14 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.705 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.953 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.74 127.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 109.995 -3.275 . . . . 0.0 108.927 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 7' ' ' VAL . 3.7 t -140.31 144.48 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 109.909 -3.314 . . . . 0.0 104.432 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.13 135.79 8.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.96 -67.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.36 -145.63 16.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 112.144 -2.298 . . . . 0.0 108.374 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.52 88.7 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.744 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 1.2 tp -164.68 119.72 1.41 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 t -98.31 37.11 1.49 Allowed 'General case' 0 C--N 1.358 0.974 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.478 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.744 ' OG ' ' HG ' ' A' ' 40' ' ' LEU . 72.9 p -90.17 98.15 11.6 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.16 -55.45 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.985 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.9 pt-20 -64.78 -20.44 66.37 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.65 1.219 . . . . 0.0 111.597 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.34 -37.26 17.27 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.239 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -90.04 10.16 25.24 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 118.027 -1.469 . . . . 0.0 108.629 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -86.04 -32.46 6.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.022 0 N-CA-C 102.27 -3.234 . . . . 0.0 102.27 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.68 -26.1 60.57 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.27 -6.79 56.5 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.64 51.34 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mt -83.87 -41.64 16.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.22 -57.52 12.08 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 112.146 -2.297 . . . . 0.0 108.835 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.21 -55.06 20.68 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 90.21 53.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.114 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.57 126.52 27.79 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 111.2 -2.727 . . . . 0.0 107.335 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -88.21 -31.92 18.83 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 112.825 -1.988 . . . . 0.0 107.214 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -157.76 154.34 28.02 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 88' ' ' LEU . 2.7 mt -114.73 165.91 9.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 111.908 -2.405 . . . . 0.0 105.489 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 89.0 m -153.14 100.56 2.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 111.333 -2.667 . . . . 0.0 103.989 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.92 137.39 36.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 m -99.71 125.8 45.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 t -157.99 175.4 13.87 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 114.639 -2.824 . . . . 0.0 107.519 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.67 48.38 0.8 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.814 -2.903 . . . . 0.0 106.454 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 72.78 32.76 1.39 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 113.734 -1.576 . . . . 0.0 107.305 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.53 -3.01 22.62 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.367 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -87.63 -17.75 31.19 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.72 177.44 49.12 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.341 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.07 18.9 5.36 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.6 -1.3 . . . . 0.0 108.048 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -53.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 m-20 -71.19 -26.17 62.84 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.413 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.9 t -66.67 -56.18 11.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -90.1 30.1 1.14 Allowed 'General case' 0 C--N 1.359 1.0 0 O-C-N 124.684 1.24 . . . . 0.0 109.36 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.14 -38.83 3.94 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 70' ' ' ASP . 1.7 mm? -90.03 -23.13 21.55 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 112.705 -1.747 . . . . 0.0 107.771 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -29.94 59.9 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.36 -26.56 52.09 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.69 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -74.71 -17.62 60.63 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.005 0.816 . . . . 0.0 109.261 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.5 t -90.22 -46.47 8.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.919 1.819 . . . . 0.0 107.524 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -74.17 0.76 12.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 108.67 -3.877 . . . . 0.0 109.095 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.03 -55.97 3.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.27 45.56 6.7 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-N 110.84 -2.891 . . . . 0.0 106.68 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.07 -43.62 0.02 OUTLIER Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.492 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -79.62 120.87 24.56 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.57 35.91 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.21 122.42 2.68 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 112.17 -2.286 . . . . 0.0 107.459 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 tt -149.56 34.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -138.4 118.18 13.19 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -138.79 112.87 8.6 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.49 89.77 4.06 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.84 91.19 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 111.076 -2.784 . . . . 0.0 110.351 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.49 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -69.71 142.17 36.22 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 110.218 -3.174 . . . . 0.0 110.393 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.84 -83.67 1.61 Allowed Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.406 -2.397 . . . . 0.0 107.229 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 61.5 -108.05 0.3 Allowed 'General case' 0 C--N 1.355 0.835 0 CA-C-N 112.56 -1.82 . . . . 0.0 107.053 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.3 mt -118.09 149.71 20.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.43 -172.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.667 0 CA-C-N 112.728 -2.033 . . . . 0.0 108.73 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 39.24 68.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.834 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.881 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.9 171.13 35.13 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 112.316 -2.22 . . . . 0.0 109.878 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -157.03 -49.25 0.07 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.21 -38.14 2.0 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.76 111.44 22.45 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -119.09 166.09 15.28 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.48 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 N-CA-C 108.1 -1.539 . . . . 0.0 108.1 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.91 -24.45 61.64 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 113.844 -1.526 . . . . 0.0 108.41 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.4 p -55.78 -72.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 O-C-N 124.739 1.275 . . . . 0.0 111.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.57 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.1 mt-10 -88.78 25.94 1.64 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.65 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.78 -45.37 36.6 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -80.57 -30.04 36.98 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 111.541 -2.572 . . . . 0.0 107.531 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -91.51 12.65 20.1 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.878 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -38.46 13.36 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.9 73.08 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.729 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.9 mtp -81.79 -61.53 1.9 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.0 39.87 0.01 OUTLIER Glycine 0 C--N 1.356 1.641 0 C-N-CA 127.698 2.571 . . . . 0.0 117.432 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -87.79 -6.19 58.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.07 137.66 42.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 170.45 8.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 102.496 -3.15 . . . . 0.0 102.496 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.88 156.47 25.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.212 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.49 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 1.6 m-85 -99.59 128.66 30.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.92 160.27 26.19 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.324 2.016 . . . . 0.0 109.322 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.24 121.27 7.64 Favored 'Trans proline' 0 C--N 1.369 1.646 0 N-CA-C 104.684 -2.852 . . . . 0.0 104.684 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 67.18 0.94 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -89.85 -165.77 1.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 110.466 -2.867 . . . . 0.0 106.775 -178.004 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 121' ' ' THR . 3.5 p -168.26 168.35 5.83 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 111.566 -2.561 . . . . 0.0 104.447 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.19 -8.15 17.41 Favored 'Trans proline' 0 C--N 1.367 1.543 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.33 -29.21 65.86 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -20.41 49.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.822 -1.536 . . . . 0.0 108.006 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 129' ' ' ASP . 4.5 p -82.7 -16.81 46.7 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 118.048 -1.461 . . . . 0.0 110.264 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.0 -29.38 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 -1.33 57.75 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 133' ' ' VAL . 53.4 t0 -64.5 -63.59 1.09 Allowed 'General case' 0 C--N 1.359 1.01 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.461 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -83.23 -10.49 58.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.431 -2.168 . . . . 0.0 110.299 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.18 -46.06 8.69 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.91 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.45 -37.28 77.72 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.591 0.557 . . . . 0.0 109.957 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 129' ' ' ASP . 74.1 t -88.51 -73.98 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.016 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 133' ' ' VAL . 95.9 mt -90.41 57.11 3.56 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 124.644 1.215 . . . . 0.0 109.423 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.129 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.26 178.252 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.24 141.3 54.66 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 123.197 1.475 . . . . 0.0 108.617 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.29 95.64 8.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 110.548 -3.023 . . . . 0.0 107.894 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -176.65 111.55 0.09 Allowed 'General case' 0 C--N 1.355 0.807 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.27 111.94 9.93 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.82 18.56 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 O-C-N 125.866 1.979 . . . . 0.0 105.689 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.654 HD13 HD22 ' A' ' 23' ' ' LEU . 16.6 tp -113.45 149.36 34.34 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 123.114 1.435 . . . . 0.0 108.81 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 149.87 21.4 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 110.866 -2.879 . . . . 0.0 106.577 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.32 98.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.714 0 CA-C-O 122.328 1.061 . . . . 0.0 110.587 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.3 156.69 4.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.817 0 C-N-CA 115.574 -3.203 . . . . 0.0 113.597 -178.042 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 CA--C 1.499 -1.016 0 CA-C-O 125.918 2.771 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.383 0.3 OUTLIER 26.61 54.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.408 -2.571 2 CA-C-N 105.222 -5.445 . . . . 0.0 108.263 -177.142 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 8' ' ' LEU . 7.1 tt -74.17 -24.84 59.45 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 102.386 -3.19 . . . . 0.0 102.386 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 35.4 m-20 -71.9 -8.99 57.63 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 22' ' ' ILE . 10.2 t-160 -74.51 -30.09 61.66 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -53.29 -44.36 68.23 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 125.647 1.842 . . . . 0.0 110.349 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -60.07 -41.71 93.01 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.87 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.7 -24.57 59.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.668 -2.06 . . . . 0.0 112.689 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -81.87 -1.19 46.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 112.224 -2.262 . . . . 0.0 108.926 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.59 3.7 2.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.75 32.06 68.97 Favored Glycine 0 C--N 1.358 1.795 0 O-C-N 123.952 0.783 . . . . 0.0 111.674 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -99.7 -175.3 2.94 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 113.206 -1.497 . . . . 0.0 107.542 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -86.26 138.63 31.71 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 112.291 -2.231 . . . . 0.0 108.271 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.838 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.62 127.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 109.824 -3.353 . . . . 0.0 107.807 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 53' ' ' THR . 10.9 t -140.1 125.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 110.036 -3.256 . . . . 0.0 104.662 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -142.77 128.6 19.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.03 -75.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.34 -151.18 23.42 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.638 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -87.79 84.05 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 9.8 tp -162.49 117.5 1.84 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.1 t -93.53 48.34 1.29 Allowed 'General case' 0 C--N 1.356 0.889 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.281 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.732 ' OG ' ' HG ' ' A' ' 40' ' ' LEU 0.257 8.8 p -90.5 95.45 10.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 103.767 -2.679 . . . . 0.0 103.767 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -90.13 -57.83 2.71 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 118.03 -1.468 . . . . 0.0 108.322 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.1 -18.46 63.44 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.828 1.33 . . . . 0.0 111.382 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -91.35 -37.11 13.44 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 118.495 -1.282 . . . . 0.0 107.65 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.496 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 23.3 m-85 -90.06 10.05 25.74 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.924 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 -33.69 6.35 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -73.37 -25.02 60.41 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -92.05 -2.33 56.73 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 -9.45 48.61 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.2 -41.6 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.62 -58.69 7.51 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 112.129 -2.305 . . . . 0.0 108.404 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.89 -56.21 12.96 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.68 1.237 . . . . 0.0 107.821 -178.445 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 tttp 95.64 47.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 110.362 -3.108 . . . . 0.0 102.722 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.62 5.43 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 111.851 -2.431 . . . . 0.0 106.819 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 5' ' ' THR . 24.6 t0 -80.48 -36.44 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 111.706 -2.497 . . . . 0.0 106.555 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.41 158.39 44.1 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.21 141.32 46.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 CA-C-N 111.797 -2.456 . . . . 0.0 104.957 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.97 109.16 9.85 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.32 133.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -100.94 117.55 35.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 t -157.76 177.83 10.93 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 115.623 -2.431 . . . . 0.0 108.133 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.6 46.19 0.72 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 111.405 -2.634 . . . . 0.0 106.947 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.32 30.1 0.53 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.197 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -2.02 27.33 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.092 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.97 -8.95 44.72 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.44 177.38 13.19 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.524 1.14 . . . . 0.0 110.558 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 25.5 2.18 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.807 -1.196 . . . . 0.0 108.028 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -54.16 8.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.21 -26.37 62.02 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.954 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -68.71 -58.51 4.12 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -90.1 27.88 1.52 Allowed 'General case' 0 C--N 1.359 0.99 0 O-C-N 124.751 1.282 . . . . 0.0 110.145 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.03 -30.15 5.53 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 88' ' ' LEU . 31.0 mt -90.07 -28.28 19.12 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.332 -1.934 . . . . 0.0 107.484 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -29.79 58.88 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.09 -27.87 57.33 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.484 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -73.58 -19.54 60.85 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 123.92 0.762 . . . . 0.0 109.651 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.25 -46.3 8.5 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.806 1.765 . . . . 0.0 107.902 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -73.98 0.95 11.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 108.788 -3.824 . . . . 0.0 109.167 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.24 -56.29 3.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.83 45.66 5.54 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.73 -2.941 . . . . 0.0 106.494 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.48 -42.1 0.02 OUTLIER Glycine 0 C--N 1.352 1.423 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.841 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 mt -78.8 122.78 26.48 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.49 117.58 2.35 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 112.229 -2.259 . . . . 0.0 108.554 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 tt -143.36 40.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -140.66 117.26 10.88 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -140.09 108.3 5.79 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.19 86.84 3.3 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.027 -3.323 . . . . 0.0 102.027 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.35 95.98 5.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 CA-C-N 111.338 -2.664 . . . . 0.0 109.65 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -60.31 128.44 45.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 109.259 -3.61 . . . . 0.0 111.82 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.88 -83.12 1.55 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 111.539 -2.331 . . . . 0.0 107.372 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 71.22 -88.35 0.03 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 112.505 -1.847 . . . . 0.0 106.827 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 mt -135.33 149.72 28.86 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -175.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.835 -1.984 . . . . 0.0 108.864 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.7 84.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-N 112.007 -2.361 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.47 -178.42 28.81 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.239 -2.255 . . . . 0.0 110.608 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -159.33 -44.73 0.05 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 111.523 -2.338 . . . . 0.0 104.839 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.18 -37.16 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -87.13 89.84 8.14 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -101.99 169.26 7.86 Favored Pre-proline 0 C--N 1.35 0.615 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -152.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.752 0 N-CA-C 108.092 -1.541 . . . . 0.0 108.092 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.45 -24.15 61.97 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.459 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -56.69 -72.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 O-C-N 124.764 1.29 . . . . 0.0 111.544 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' H ' HG13 ' A' ' 104' ' ' VAL . 25.7 mt-10 -89.03 26.25 1.62 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 117.773 -1.571 . . . . 0.0 109.846 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -76.66 -45.77 28.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -80.24 -29.0 38.38 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 111.46 -2.609 . . . . 0.0 107.509 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.72 12.77 22.24 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.897 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -37.12 14.22 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.25 75.14 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-N 112.845 -1.979 . . . . 0.0 107.494 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.7 mtp -80.2 -61.21 2.05 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.95 38.57 0.01 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.91 2.671 . . . . 0.0 117.708 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -84.84 -6.84 59.35 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.14 135.97 45.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.437 HH21 HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.19 170.42 8.09 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.15 163.01 24.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.476 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 1.0 OUTLIER -99.58 153.45 37.77 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.42 164.92 25.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.826 1.684 . . . . 0.0 108.056 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.23 118.01 3.91 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 102.377 -3.74 . . . . 0.0 102.377 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.71 68.98 1.09 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 122' ' ' SER 0.273 0.2 OUTLIER -90.25 -158.08 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 109.496 -3.352 . . . . 0.0 107.336 -177.848 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.512 ' H ' HG22 ' A' ' 121' ' ' THR . 10.4 p -174.22 164.14 2.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 110.47 -3.059 . . . . 0.0 103.936 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.25 -5.4 15.67 Favored 'Trans proline' 0 C--N 1.365 1.401 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.56 -29.5 64.8 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -20.8 56.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.647 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -85.34 -14.78 45.39 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.764 -1.175 . . . . 0.0 110.06 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mt -69.61 -28.62 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 -2.49 58.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.41 -2.177 . . . . 0.0 108.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.1 t0 -61.33 -62.4 1.86 Allowed 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -82.31 -7.72 59.63 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.282 -2.235 . . . . 0.0 110.444 -176.362 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.1 -54.25 4.12 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.443 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.92 -39.5 71.75 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.752 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.661 HG12 HD23 ' A' ' 134' ' ' LEU . 80.6 t -89.99 -68.99 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 125.193 1.558 . . . . 0.0 111.778 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 133' ' ' VAL . 89.1 mt -90.31 54.25 2.71 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.746 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.088 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.736 178.196 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -107.66 19.82 19.65 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.27 133.76 39.98 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -81.25 89.57 6.05 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 111.023 -2.808 . . . . 0.0 107.335 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -174.36 120.2 0.25 Allowed 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.12 112.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.528 HG23 HG12 ' A' ' 35' ' ' VAL . 2.3 p -98.98 113.6 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.678 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -125.2 154.04 42.17 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.911 1.382 . . . . 0.0 109.762 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.25 -154.32 25.12 Favored Glycine 0 C--N 1.361 1.963 0 CA-C-N 111.931 -2.395 . . . . 0.0 112.689 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 14.9 p 88.28 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 131.095 3.758 . . . . 0.0 115.398 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 10' ' ' VAL 0.271 1.2 tt 67.03 148.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.173 2.189 . . . . 0.0 109.22 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.61 -121.84 4.98 Favored Glycine 0 C--N 1.361 1.956 0 CA-C-N 112.267 -2.242 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 p -93.95 103.16 15.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 111.969 -2.116 . . . . 0.0 106.314 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -172.52 72.97 0.04 OUTLIER 'General case' 0 C--N 1.352 0.698 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t 71.26 -84.25 0.03 OUTLIER 'General case' 0 C--N 1.368 1.399 0 O-C-N 124.787 1.304 . . . . 0.0 107.908 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -154.64 -65.7 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.34 92.02 0.54 Allowed 'General case' 0 C--N 1.352 0.705 0 O-C-N 125.404 1.69 . . . . 0.0 107.02 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.3 18.99 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 112.024 -2.353 . . . . 0.0 108.987 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -32.55 1.8 Allowed Glycine 0 C--N 1.36 1.869 0 C-N-CA 125.607 1.575 . . . . 0.0 109.463 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -46.22 -40.41 11.33 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 111.879 -2.161 . . . . 0.0 105.714 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -12.51 55.38 0.0 OUTLIER 'General case' 0 C--N 1.38 1.925 2 C-N-CA 141.405 7.882 . . . . 0.0 108.154 176.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.503 ' HB ' ' ND1' ' A' ' 25' ' ' HIS 0.325 0.9 OUTLIER 43.13 44.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 1 CA-C-N 106.659 -4.791 . . . . 0.0 109.539 -178.473 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 2.3 tt -68.68 -24.07 64.47 Favored 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 114.679 -2.809 . . . . 0.0 103.602 171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.23 -15.99 64.02 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.901 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.503 ' ND1' ' HB ' ' A' ' 22' ' ' ILE 0.265 0.7 OUTLIER -69.72 -26.3 64.26 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 117.969 -1.492 . . . . 0.0 108.241 178.808 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -20.17 65.34 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 113.161 -1.836 . . . . 0.0 108.814 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' CD2' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -58.62 -46.27 87.43 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -29.66 69.45 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 112.121 -2.309 . . . . 0.0 112.133 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.69 10.88 19.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.068 -2.333 . . . . 0.0 108.55 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -8.81 2.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.91 31.49 76.33 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.75 -175.21 2.91 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 113.006 -1.597 . . . . 0.0 108.328 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -108.71 154.64 21.74 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 112.287 -2.233 . . . . 0.0 106.777 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 27' ' ' PHE . 78.5 t -99.94 135.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 CA-C-N 111.781 -2.463 . . . . 0.0 108.83 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 7' ' ' VAL . 21.8 t -140.36 54.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 111.418 -2.628 . . . . 0.0 107.005 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.8 126.43 30.37 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 46' ' ' PHE . 4.8 mt -89.84 -65.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.86 -116.82 0.73 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.394 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.12 23.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.323 -1.438 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.85 167.91 10.46 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.9 t -123.61 66.53 1.02 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 111.37 -2.65 . . . . 0.0 104.166 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.9 m -77.75 102.77 7.32 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -88.16 -85.9 0.18 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 113.06 -1.882 . . . . 0.0 107.38 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.19 -11.25 56.85 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 124.94 1.4 . . . . 0.0 110.926 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -89.21 -45.62 9.41 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.68 3.18 48.84 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.683 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 -29.03 7.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -73.05 -27.9 62.01 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.71 2.86 54.19 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.39 -9.13 48.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.24 -36.91 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -62.0 -69.07 0.27 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.192 -2.276 . . . . 0.0 110.195 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . 0.279 6.4 p -78.34 -32.43 49.15 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 123.783 0.677 . . . . 0.0 109.685 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 81.15 61.09 0.02 OUTLIER 'General case' 0 C--N 1.349 0.552 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.8 118.27 3.03 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.851 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 5' ' ' THR . 40.5 t0 -83.31 -49.35 9.47 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 130' ' ' MET . 3.2 pp -142.83 161.2 38.71 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 125.426 1.704 . . . . 0.0 106.78 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -120.28 137.2 54.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 111.139 -2.755 . . . . 0.0 105.295 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.95 112.28 14.5 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -100.62 142.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.207 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -114.39 63.61 0.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 p -168.67 148.62 4.44 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 70.59 0.74 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 111.61 -2.541 . . . . 0.0 104.341 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 72.22 87.3 0.11 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-N 110.413 -3.085 . . . . 0.0 106.818 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.28 33.52 0.51 Allowed Glycine 0 CA--C 1.535 1.32 0 CA-C-N 109.833 -3.349 . . . . 0.0 106.61 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.78 -14.65 0.54 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 111.259 -2.471 . . . . 0.0 108.476 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.76 -162.78 54.55 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 122.53 1.072 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.2 3.27 27.99 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 111.79 -2.205 . . . . 0.0 108.055 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mm -73.15 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.85 -24.6 65.28 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.843 1.339 . . . . 0.0 108.813 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 21.9 t -62.91 -72.13 0.14 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -90.17 33.09 0.89 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.313 1.008 . . . . 0.0 109.33 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.74 -47.61 2.47 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.82 -20.82 23.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 112.047 -2.076 . . . . 0.0 107.89 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.489 HH11 ' HG3' ' A' ' 75' ' ' ARG . 5.5 mmt85 -74.84 -31.85 61.76 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.05 -23.79 47.97 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.057 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.95 -16.11 59.45 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.96 0.787 . . . . 0.0 109.183 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.4 m -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 123.868 1.794 . . . . 0.0 107.229 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.38 -1.51 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 108.692 -3.867 . . . . 0.0 108.667 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.83 -53.46 6.47 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.73 48.76 5.32 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 111.024 -2.807 . . . . 0.0 107.101 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.06 -47.14 0.01 OUTLIER Glycine 0 C--N 1.347 1.166 0 CA-C-N 112.268 -2.242 . . . . 0.0 108.357 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.46 124.51 35.03 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 124.61 33.9 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.918 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.29 65.59 0.03 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 112.825 -1.988 . . . . 0.0 109.32 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.4 tt -105.54 11.32 8.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 112.097 -2.052 . . . . 0.0 108.139 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 88' ' ' LEU . 48.4 mmtm -122.51 114.26 20.43 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -140.11 101.88 4.25 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -99.87 90.96 4.61 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.81 96.52 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 108.89 -3.777 . . . . 0.0 111.323 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.493 ' HA3' ' C10' ' A' ' 139' ' ' DBI . . . -61.0 124.12 34.56 Favored Glycine 0 CA--C 1.537 1.417 1 CA-C-N 107.433 -4.439 . . . . 0.0 112.69 176.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.37 -80.84 0.94 Allowed Glycine 0 C--N 1.352 1.441 0 CA-C-N 112.549 -1.825 . . . . 0.0 109.143 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 25.44 94.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.431 3.492 . . . . 0.0 110.823 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 69.91 123.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.511 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.63 169.9 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 112.343 -2.208 . . . . 0.0 107.318 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.42 61.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.648 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.03 148.03 9.74 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.275 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.47 105.12 0.36 Allowed 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 87.14 -58.94 0.04 OUTLIER 'General case' 0 C--N 1.357 0.899 0 O-C-N 125.915 2.01 . . . . 0.0 106.753 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -86.17 101.21 12.8 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -106.86 160.91 24.61 Favored Pre-proline 0 C--N 1.351 0.64 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.23 -158.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.61 1.54 . . . . 0.0 108.631 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.78 -23.45 67.25 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.592 -2.094 . . . . 0.0 108.771 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.67 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.9 p -57.81 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.735 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.746 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.67 ' H ' HG13 ' A' ' 104' ' ' VAL . 31.5 mt-10 -90.3 29.42 1.26 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.911 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -82.54 -41.18 19.96 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -80.46 -32.67 37.16 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.117 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -90.32 14.81 11.82 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.081 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -90.35 -38.77 13.12 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.23 75.05 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 112.63 -2.077 . . . . 0.0 106.99 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtp -77.63 -62.58 1.62 Allowed 'General case' 0 C--N 1.355 0.81 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.79 34.41 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.547 2.498 . . . . 0.0 117.261 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -4.76 58.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.27 132.67 51.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 171.87 7.2 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.13 152.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.188 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -99.74 117.74 63.07 Favored Pre-proline 0 C--N 1.36 1.05 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.82 147.95 90.31 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.417 2.078 . . . . 0.0 107.99 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.47 115.97 3.65 Favored 'Trans proline' 0 C--N 1.365 1.42 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.1 32.09 1.75 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.547 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.462 ' OG1' H112 ' A' ' 139' ' ' DBI . 0.3 OUTLIER -90.07 -166.37 1.57 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.263 3.2 p -143.2 170.68 8.19 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.489 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.57 -4.61 13.68 Favored 'Trans proline' 0 C--N 1.37 1.666 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.83 -25.75 61.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -17.53 54.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.668 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.581 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 5.6 p -83.96 -16.77 42.91 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 118.498 -1.281 . . . . 0.0 109.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.18 -32.92 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.06 -1.23 52.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.236 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 133' ' ' VAL . 50.7 t0 -61.32 -65.32 0.71 Allowed 'General case' 0 C--N 1.365 1.264 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.485 ' HE2' HD21 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -90.1 9.26 28.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 111.995 -2.366 . . . . 0.0 110.657 -176.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -88.66 -34.19 17.33 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 116.884 -1.927 . . . . 0.0 108.281 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.97 -43.45 10.54 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 124.256 0.973 . . . . 0.0 110.503 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 129' ' ' ASP . 44.5 t -66.48 -31.15 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.682 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.09 -33.83 16.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.53 -91.73 0.03 OUTLIER Glycine 0 C--N 1.354 1.563 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.066 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -164.41 153.09 2.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 113.024 -1.588 . . . . 0.0 107.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--N 1.346 0.441 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -179.19 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.493 ' C10' ' HA3' ' A' ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' HD22 ' A' ' 134' ' ' LEU . 23.7 ttt . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.28 16.51 22.72 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.437 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 130.82 36.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 123.38 1.562 . . . . 0.0 107.049 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -81.69 95.69 7.3 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 109.952 -3.295 . . . . 0.0 107.886 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.36 109.28 0.01 OUTLIER 'General case' 0 C--N 1.35 0.608 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -134.21 117.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.678 HG23 HG12 ' A' ' 35' ' ' VAL . 4.2 p -98.95 133.42 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 111.55 -2.568 . . . . 0.0 108.301 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD1' HD22 ' A' ' 23' ' ' LEU . 52.5 tp -125.2 143.71 50.81 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.976 1.422 . . . . 0.0 107.63 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -177.29 170.4 42.95 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.443 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' GLY 0.711 11.7 p 99.63 -130.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 130.893 3.677 . . . . 0.0 116.526 178.126 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER 56.09 102.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 127.401 2.281 . . . . 0.0 107.618 -175.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.41 50.23 0.29 Allowed Glycine 0 C--N 1.36 1.871 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.211 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -108.59 -86.68 0.51 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.75 97.9 9.94 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 103.933 -2.618 . . . . 0.0 103.933 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.4 m 63.35 -133.05 0.41 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -147.97 -178.79 6.47 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 72.55 -168.21 0.13 Allowed 'General case' 0 C--N 1.354 0.786 0 CA-C-N 112.752 -2.022 . . . . 0.0 106.727 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 18' ' ' VAL 0.31 57.5 t 82.23 15.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.579 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.64 -36.61 3.22 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -50.0 -35.94 26.6 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 111.447 -2.377 . . . . 0.0 107.844 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 31.7 ttmt -32.57 72.69 0.0 OUTLIER 'General case' 0 C--N 1.364 1.233 1 C-N-CA 137.815 6.446 . . . . 0.0 108.077 177.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 21' ' ' LYS . 1.3 mp 56.4 15.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 1 CA-C-N 105.725 -5.216 . . . . 0.0 112.049 177.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 8' ' ' LEU . 10.9 mp -76.89 -40.07 48.72 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 116.512 -2.075 . . . . 0.0 106.059 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.62 -1.25 37.22 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.787 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -82.32 -34.2 28.67 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 1.2 t -66.57 -29.26 69.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.124 -1.853 . . . . 0.0 110.438 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -65.26 -42.68 93.01 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.901 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -29.18 64.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.648 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -98.01 15.41 24.17 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.606 -2.543 . . . . 0.0 109.72 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.03 2.91 1.77 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.37 67.87 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.793 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' A' ' 134' ' ' LEU . 1.7 m-30 -99.76 156.18 17.24 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 112.603 -1.798 . . . . 0.0 106.169 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.26 140.8 34.65 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 111.327 -2.669 . . . . 0.0 105.85 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.628 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 1.4 p -99.88 137.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 112.145 -2.298 . . . . 0.0 107.457 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 7' ' ' VAL . 40.0 t -132.74 63.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.652 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -81.71 120.92 25.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.436 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -89.95 -79.47 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.8 -158.38 22.65 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.062 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.37 59.76 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.661 1.219 . . . . 0.0 110.117 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 tp -165.63 124.59 1.66 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 t -96.25 84.72 3.81 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.68 122.98 27.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.404 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 36.6 tp60 -80.81 -94.63 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.23 -2.259 . . . . 0.0 108.745 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.46 -17.25 19.37 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.813 1.645 . . . . 0.0 111.735 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.92 -48.88 8.3 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -84.85 0.51 50.65 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 116.58 -2.048 . . . . 0.0 109.001 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 -27.88 7.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.23 -29.03 57.39 Favored 'General case' 0 C--N 1.365 1.27 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.95 6.96 46.79 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -20.93 22.54 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.19 -38.26 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.22 -68.65 0.27 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 112.337 -2.21 . . . . 0.0 110.332 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -64.97 0.95 Allowed 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? 129.69 47.36 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 O-C-N 126.912 2.632 . . . . 0.0 106.933 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.73 108.36 0.73 Allowed 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.67 -82.64 0.2 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.267 -2.242 . . . . 0.0 104.972 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -89.57 142.08 28.0 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.45 144.66 36.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.5 m -134.68 129.31 34.6 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 112.433 -2.167 . . . . 0.0 106.686 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 90' ' ' VAL . 92.5 t -99.96 137.04 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 110.042 -3.254 . . . . 0.0 103.451 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -123.14 89.56 3.13 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -165.77 -172.62 2.43 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.05 42.68 3.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 81.29 96.02 0.05 OUTLIER 'General case' 0 C--N 1.356 0.873 0 CA-C-N 112.779 -2.01 . . . . 0.0 106.205 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.33 19.85 0.11 Allowed Glycine 0 CA--C 1.538 1.515 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.689 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -109.4 -0.81 18.81 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 160.18 13.18 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -81.56 6.87 13.61 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.455 -1.373 . . . . 0.0 108.263 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -48.2 16.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -71.31 -25.14 62.29 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.46 -57.88 5.75 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.15 25.55 2.14 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 124.879 1.362 . . . . 0.0 109.295 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.63 -32.72 4.08 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.264 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 52.1 mt -86.41 -26.71 24.6 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.525 HH11 ' HG3' ' A' ' 75' ' ' ARG . 1.5 mmt85 -73.03 -33.38 65.7 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.69 -19.93 47.79 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.659 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -76.42 -20.33 57.19 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 66.5 m -90.15 -43.22 10.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 123.698 1.713 . . . . 0.0 107.434 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.45 1.09 17.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 108.932 -3.758 . . . . 0.0 108.478 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.89 -54.69 5.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.08 39.37 7.81 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 110.686 -2.961 . . . . 0.0 107.114 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -49.22 0.04 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.43 120.28 27.6 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 122.0 28.59 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.13 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.6 81.73 0.04 OUTLIER Glycine 0 C--N 1.348 1.211 0 CA-C-N 112.339 -2.21 . . . . 0.0 109.995 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -111.78 38.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -145.48 114.17 6.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 98.76 3.5 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 90.84 4.62 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 60' ' ' VAL . 15.5 m -89.42 93.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 110.294 -3.139 . . . . 0.0 109.696 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -70.43 118.43 7.84 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 110.181 -3.19 . . . . 0.0 113.912 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.9 -45.1 2.89 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 111.915 -2.143 . . . . 0.0 113.778 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -46.12 129.77 10.04 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 127.743 2.417 . . . . 0.0 107.184 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 60.33 72.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -78.16 -161.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.312 -178.274 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 95' ' ' VAL 0.279 17.2 m 61.46 118.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 127.831 2.453 . . . . 0.0 109.482 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 160.07 7.1 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.181 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -152.07 109.57 3.6 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 98.29 -53.01 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -92.73 75.86 4.95 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CH2' ' HB ' ' A' ' 116' ' ' VAL . 95.3 m95 -83.85 159.92 59.39 Favored Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 112.652 -2.067 . . . . 0.0 105.808 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.34 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.684 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.29 -21.2 64.79 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.724 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.7 p -59.87 -68.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.82 0 O-C-N 124.477 1.111 . . . . 0.0 111.282 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.557 ' H ' HG13 ' A' ' 104' ' ' VAL . 35.7 mt-10 -90.18 27.41 1.64 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 117.986 -1.486 . . . . 0.0 108.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -80.51 -41.25 24.59 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -80.52 -31.87 37.01 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.468 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.3 15.11 12.67 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.42 -40.41 12.07 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.2 78.66 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.316 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 37.6 mtp -77.56 -61.45 1.99 Allowed 'General case' 0 C--N 1.354 0.791 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.52 27.13 0.09 OUTLIER Glycine 0 C--N 1.353 1.493 0 CA-C-N 112.177 -2.283 . . . . 0.0 118.085 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.05 -2.7 58.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.22 128.75 53.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 102.937 -2.986 . . . . 0.0 102.937 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' HB ' ' CH2' ' A' ' 101' ' ' TRP . 42.5 t -140.01 151.66 21.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -99.63 148.06 34.22 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 102.95 -2.982 . . . . 0.0 102.95 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -70.39 155.75 63.18 Favored 'Trans proline' 0 C--N 1.364 1.356 0 N-CA-C 106.017 -2.339 . . . . 0.0 106.017 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -75.93 118.11 4.92 Favored 'Trans proline' 0 C--N 1.365 1.441 0 N-CA-C 105.08 -2.7 . . . . 0.0 105.08 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.46 56.56 5.03 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.186 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.591 ' CG2' H112 ' A' ' 139' ' ' DBI . 13.8 t -88.35 179.1 6.4 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 125.151 2.405 . . . . 0.0 107.501 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.331 21.4 p -75.87 170.68 14.73 Favored Pre-proline 0 N--CA 1.431 -1.4 1 CA-C-N 106.815 -4.72 . . . . 0.0 104.782 178.123 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.38 -3.19 3.82 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 N-CA-C 105.875 -2.394 . . . . 0.0 105.875 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.73 -12.05 60.32 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 125.927 1.691 . . . . 0.0 109.057 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -28.0 58.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.9 p -87.78 -21.74 24.93 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.483 1.115 . . . . 0.0 110.701 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.6 mt -69.92 -28.87 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.19 58.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.123 -2.308 . . . . 0.0 109.16 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 7.7 t0 -63.53 -56.43 16.06 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -87.47 1.0 54.72 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 110.854 -2.885 . . . . 0.0 110.311 -177.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -84.37 -47.55 10.59 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 117.302 -1.759 . . . . 0.0 110.079 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.31 -40.49 17.9 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.149 0.906 . . . . 0.0 111.467 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.5 t -68.78 -31.08 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.717 1.261 . . . . 0.0 112.973 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 1' ' ' MET . 45.0 mt -90.11 -33.12 16.39 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.6 -93.03 0.02 OUTLIER Glycine 0 C--N 1.355 1.584 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.03 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -169.37 160.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 113.319 -1.44 . . . . 0.0 108.36 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--N 1.349 0.566 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 179.628 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.591 H112 ' CG2' ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -152.45 81.92 1.24 Allowed 'General case' 0 C--N 1.352 0.696 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.65 -159.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.195 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.59 63.16 0.74 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.267 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.3 p -149.89 110.29 4.21 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.75 109.44 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 111.268 -2.696 . . . . 0.0 104.492 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.96 111.96 23.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.21 148.34 48.67 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.127 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.41 -165.27 34.88 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 111.629 -2.532 . . . . 0.0 110.408 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.636 12.4 p 110.68 -113.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 C-N-CA 127.705 2.402 . . . . 0.0 113.091 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 18' ' ' VAL 0.279 3.0 tp 56.06 154.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 129.131 2.972 . . . . 0.0 110.753 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.81 76.84 0.09 OUTLIER Glycine 0 C--N 1.356 1.684 0 CA-C-N 110.485 -3.052 . . . . 0.0 107.269 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -151.25 -111.5 0.05 Allowed 'General case' 0 C--N 1.351 0.637 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -173.24 -142.67 0.03 OUTLIER 'General case' 0 C--N 1.357 0.915 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.5 m 72.16 -108.18 0.04 OUTLIER 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.182 0.926 . . . . 0.0 108.54 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -133.81 41.69 3.0 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.44 45.01 14.23 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.449 HG21 H5'2 ' A' ' 139' ' ' DBI . 1.6 t -23.25 120.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 O-C-N 126.279 2.237 . . . . 0.0 113.469 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . 105.36 -62.45 0.34 Allowed Glycine 0 C--N 1.353 1.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.019 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -27.37 40.14 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 113.413 -1.393 . . . . 0.0 107.333 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -39.48 71.08 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 140.923 7.689 . . . . 0.0 105.376 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.82 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.266 0.2 OUTLIER 47.77 44.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.119 2 CA-C-N 103.287 -6.324 . . . . 0.0 109.448 179.104 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' CB ' HD23 ' A' ' 8' ' ' LEU . 1.1 mt -69.4 -20.39 63.8 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 172.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.09 -18.91 65.65 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.82 ' HB2' HG22 ' A' ' 22' ' ' ILE . 4.8 t60 -71.86 -27.46 62.88 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 p -55.96 -39.52 71.89 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 125.264 1.602 . . . . 0.0 110.55 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.665 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -59.56 -41.27 89.79 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.316 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -21.55 54.77 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 111.606 -2.543 . . . . 0.0 112.431 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -83.67 -3.57 57.87 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.938 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' SD ' ' A' ' 130' ' ' MET . . . -126.14 -7.39 6.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.19 71.64 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.359 1.022 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -141.74 143.52 33.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.5 p -99.64 173.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 111.977 -2.374 . . . . 0.0 107.039 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.08 93.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 111.188 -2.733 . . . . 0.0 105.088 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -68.45 117.29 10.02 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.477 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 32.3 mt -90.1 -41.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.247 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.64 -129.21 5.75 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.41 44.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 113.249 -1.476 . . . . 0.0 109.626 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.4 tp -163.06 109.52 1.17 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.2 t -85.23 95.27 9.12 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -90.3 138.49 31.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.803 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.41 -90.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.856 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.26 -11.17 13.47 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 124.973 1.42 . . . . 0.0 112.786 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -89.18 -46.14 9.03 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 118.348 -1.341 . . . . 0.0 107.475 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 37' ' ' ILE . 11.5 m-85 -86.88 6.78 30.21 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 117.964 -1.494 . . . . 0.0 108.568 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.28 -29.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.95 -24.5 58.48 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 -4.2 55.42 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 -12.51 38.43 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -38.33 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.41 -65.27 0.7 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 111.823 -2.444 . . . . 0.0 110.356 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -79.94 -47.5 14.92 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.118 -176.011 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' THR . 3.7 ttmp? 109.8 42.79 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 126.543 2.402 . . . . 0.0 108.357 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.84 120.6 5.46 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 124.485 1.116 . . . . 0.0 108.981 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.73 -66.1 0.96 Allowed 'General case' 0 C--N 1.352 0.708 0 CA-C-N 111.86 -2.427 . . . . 0.0 105.6 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -107.18 148.39 28.93 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.456 1.598 . . . . 0.0 109.35 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -97.62 148.92 5.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 CA-C-N 109.818 -3.355 . . . . 0.0 104.82 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.552 ' N ' HD12 ' A' ' 58' ' ' ILE . 60.9 m -141.73 105.0 4.63 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.69 131.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -110.38 45.35 1.13 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 p -154.06 168.4 26.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 15.3 tp -74.39 -127.04 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 111.251 -2.704 . . . . 0.0 103.823 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' HE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -93.53 50.67 1.5 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.95 21.13 47.68 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.549 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -124.09 -31.12 3.39 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.55 166.6 41.49 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.088 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.21 -1.35 32.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 113.581 -1.309 . . . . 0.0 108.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -46.19 18.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 3.9 m-20 -74.25 -27.12 60.61 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.928 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m -68.99 -50.69 46.71 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -89.53 21.79 3.26 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.569 1.168 . . . . 0.0 109.481 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -27.04 7.75 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 17.8 mt -89.99 -32.28 16.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.27 -1.965 . . . . 0.0 106.473 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -75.55 -22.1 57.34 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.89 -31.67 56.91 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.98 -11.69 60.17 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.497 1.123 . . . . 0.0 109.162 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 73.4 m -90.27 -48.05 7.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 123.239 1.495 . . . . 0.0 107.624 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.296 2.9 p30 -78.27 4.23 13.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 109.672 -3.422 . . . . 0.0 109.233 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.96 -53.38 6.19 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.29 39.79 25.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.084 -2.78 . . . . 0.0 108.042 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.29 -48.58 0.05 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.33 119.94 28.11 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 128.96 34.9 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.49 -1.686 . . . . 0.0 106.506 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.02 59.27 0.01 OUTLIER Glycine 0 C--N 1.347 1.164 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.327 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -8.79 11.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 112.509 -1.846 . . . . 0.0 108.593 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -97.54 129.09 44.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.571 HD13 ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -139.97 140.68 36.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 179.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.27 92.37 2.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -89.46 93.97 4.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-O 125.118 2.389 . . . . 0.0 110.358 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.48 119.92 8.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 109.895 -3.32 . . . . 0.0 112.453 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.08 -84.04 1.01 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 112.104 -2.048 . . . . 0.0 108.095 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 93' ' ' ASN . 5.6 t-20 53.95 -111.54 0.63 Allowed 'General case' 0 C--N 1.353 0.758 0 CA-C-N 111.79 -2.205 . . . . 0.0 107.63 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HB ' ' HE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.29 126.82 44.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 10.8 p -73.79 157.44 6.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.74 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 45.28 99.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.918 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.58 152.92 6.11 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 112.091 -2.322 . . . . 0.0 108.895 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -175.83 124.16 0.2 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 86.06 -67.37 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 126.004 2.065 . . . . 0.0 106.369 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.29 134.55 37.93 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -139.03 167.37 19.42 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.75 -145.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.831 1.687 . . . . 0.0 108.549 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.18 -25.06 61.53 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.519 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.7 p -54.13 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 124.768 1.293 . . . . 0.0 111.219 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' HG13 ' A' ' 104' ' ' VAL . 11.2 mt-10 -90.35 26.74 1.85 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 117.505 -1.678 . . . . 0.0 109.416 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.03 -42.42 63.2 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -89.98 -24.68 21.18 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 111.676 -2.511 . . . . 0.0 108.411 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -85.77 -13.4 48.34 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -90.57 -20.28 22.79 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.75 74.58 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.2 mtt -87.38 -52.01 5.61 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.97 26.24 1.98 Allowed Glycine 0 C--N 1.356 1.671 0 CA-C-N 112.769 -2.014 . . . . 0.0 117.644 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -4.91 58.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.08 119.54 39.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 179.23 4.16 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 48.9 t -140.01 151.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.43 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 4.8 m-85 -99.63 153.03 37.98 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -65.16 136.57 48.36 Favored 'Trans proline' 0 C--N 1.371 1.722 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.71 110.62 2.97 Favored 'Trans proline' 0 C--N 1.371 1.721 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' H ' ' H7 ' ' A' ' 139' ' ' DBI . . . 138.94 -103.61 0.4 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 111.647 -2.524 . . . . 0.0 107.561 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -90.27 167.59 12.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.6 p -168.67 70.75 0.77 Allowed Pre-proline 0 C--N 1.349 0.559 0 CA-C-N 113.136 -1.847 . . . . 0.0 106.04 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.27 -84.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 123.264 2.643 . . . . 0.0 109.473 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.25 -19.47 21.76 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.126 2.17 . . . . 0.0 110.683 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -25.43 62.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 124.051 0.844 . . . . 0.0 109.694 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -86.11 -23.4 26.66 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 117.419 -1.712 . . . . 0.0 109.579 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.83 -26.12 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.15 -6.46 56.95 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.011 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 133' ' ' VAL . 63.3 t0 -54.22 -66.6 0.37 Allowed 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 30' ' ' ALA . 6.4 mtm -90.36 -6.17 55.34 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 111.343 -2.662 . . . . 0.0 111.755 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.97 -45.33 9.27 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 117.209 -1.796 . . . . 0.0 107.659 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -58.39 -45.8 87.62 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 121.817 0.818 . . . . 0.0 109.168 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 129' ' ' ASP . 84.6 t -82.24 -71.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.234 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.5 mt -90.12 55.88 3.24 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.579 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.39 -70.78 0.02 OUTLIER Glycine 0 C--N 1.35 1.314 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.651 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -171.38 153.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.446 -1.377 . . . . 0.0 107.598 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 112.566 -2.106 . . . . 0.0 107.355 179.39 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.489 ' H7 ' ' H ' ' A' ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.4 ttp . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.1 74.67 1.61 Allowed 'General case' 0 C--N 1.352 0.694 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -72.92 172.2 11.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 112.153 -2.294 . . . . 0.0 107.503 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 57.3 pttt -108.1 68.99 0.72 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.654 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.9 p -150.44 109.22 3.85 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 ' SD ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -123.57 136.24 60.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.08 133.42 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 124.502 1.127 . . . . 0.0 108.736 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.1 pp -116.25 146.77 42.1 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.252 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . -131.2 146.43 17.84 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 112.381 -2.19 . . . . 0.0 109.325 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -120.25 126.49 75.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 124.96 1.035 . . . . 0.0 110.664 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 tp -152.92 139.91 13.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.07 84.69 0.2 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -98.21 47.67 1.0 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 110.826 -2.687 . . . . 0.0 106.711 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -73.0 -40.43 65.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 112.928 -1.942 . . . . 0.0 106.687 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.95 -43.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.596 -2.093 . . . . 0.0 105.578 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -149.98 134.44 17.4 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.78 10.36 40.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.543 -2.571 . . . . 0.0 106.076 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -55.72 116.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.418 0 CA-C-O 121.957 0.884 . . . . 0.0 111.729 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.13 32.68 7.27 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.154 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' ILE . 6.5 t30 -41.32 -63.88 0.63 Allowed 'General case' 0 C--N 1.368 1.38 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp 12.25 32.68 0.0 OUTLIER 'General case' 0 C--N 1.38 1.913 2 C-N-CA 139.689 7.196 . . . . 0.0 109.855 176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.307 0.0 OUTLIER 38.82 47.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.777 1 C-N-CA 132.593 4.357 . . . . 0.0 105.786 -175.081 . . . . . . . . 5 4 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD11 H103 ' A' ' 139' ' ' DBI . 0.4 OUTLIER -77.63 -26.27 50.41 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 176.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.31 -18.03 65.01 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.39 -1.732 . . . . 0.0 106.584 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -69.35 -30.77 68.87 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -45.31 -44.33 11.46 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 124.856 1.348 . . . . 0.0 107.962 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -47.97 74.41 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 111.649 -2.523 . . . . 0.0 109.402 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -14.61 58.42 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 112.296 -2.229 . . . . 0.0 113.748 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -75.49 -14.87 60.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.369 1.867 . . . . 0.0 109.781 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.94 19.42 0.59 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 117.445 -1.702 . . . . 0.0 108.216 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.2 28.4 54.35 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 124.182 0.926 . . . . 0.0 112.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -99.73 160.3 14.4 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 32.3 t30 -89.21 135.62 33.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.248 -2.251 . . . . 0.0 106.373 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.94 170.05 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-N 111.309 -2.678 . . . . 0.0 106.973 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -140.14 106.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 111.557 -2.565 . . . . 0.0 105.446 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.55 123.71 32.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.423 HD11 ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -89.84 -30.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 -129.24 9.83 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' HG12 ' A' ' 10' ' ' VAL . 2.8 m -98.18 -12.69 8.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 113.353 -1.423 . . . . 0.0 110.002 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.75 86.91 6.8 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -91.44 58.08 3.5 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 112.869 -1.968 . . . . 0.0 105.909 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.5 p -90.03 116.37 28.01 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.385 -3.561 . . . . 0.0 101.385 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.538 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.5 tp-100 -89.96 -54.09 4.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.866 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -62.36 -32.68 73.5 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.143 1.527 . . . . 0.0 110.449 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -79.36 -26.46 42.07 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 2.7 t80 -86.94 4.15 42.79 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.541 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.69 -37.35 20.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.064 0 N-CA-C 102.475 -3.158 . . . . 0.0 102.475 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -73.93 -28.68 61.64 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 112.482 -2.145 . . . . 0.0 106.997 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -89.82 0.54 56.96 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.031 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 -7.67 53.35 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.09 -39.83 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.95 -75.54 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.746 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 p -74.07 -19.28 60.66 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 123.961 0.788 . . . . 0.0 110.471 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 72.47 50.83 0.18 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.99 130.93 35.2 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 125.251 1.594 . . . . 0.0 107.537 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -104.22 -77.12 0.58 Allowed 'General case' 0 C--N 1.364 1.228 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -87.4 147.66 25.35 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.016 1.448 . . . . 0.0 108.072 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -134.15 165.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 111.458 -2.61 . . . . 0.0 105.78 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.9 p -161.94 158.78 25.73 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.62 168.95 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 69.21 1.05 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 p -174.32 168.48 3.94 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.243 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.413 ' H ' ' H51' ' A' ' 138' ' ' FOP . 65.3 mt -79.73 -105.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 110.732 -2.94 . . . . 0.0 103.203 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -102.68 27.08 7.26 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 112.808 -1.996 . . . . 0.0 106.498 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.74 -9.68 84.92 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.305 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -80.01 -34.66 38.26 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.3 -178.32 49.18 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 113.002 -1.908 . . . . 0.0 112.226 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -77.92 -12.19 59.96 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.152 -2.024 . . . . 0.0 108.644 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -49.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -72.37 -29.44 63.78 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.853 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -57.04 8.83 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -88.27 27.46 1.23 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 125.316 1.635 . . . . 0.0 109.944 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.21 -30.41 7.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD21 ' CD ' ' A' ' 43' ' ' GLN . 8.0 mt -90.03 -33.84 16.19 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 111.644 -2.278 . . . . 0.0 107.788 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -24.37 61.06 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.77 -31.42 35.82 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -76.51 -15.09 59.97 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 124.139 0.899 . . . . 0.0 109.479 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.32 -47.04 8.01 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 123.94 1.829 . . . . 0.0 107.293 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.43 -3.58 25.07 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 108.531 -3.94 . . . . 0.0 109.041 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -81.24 -56.65 3.93 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.35 48.93 7.41 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 110.931 -2.85 . . . . 0.0 106.82 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.96 -42.15 0.02 OUTLIER Glycine 0 C--N 1.35 1.335 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.017 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.78 124.95 28.73 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 117.08 15.33 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.73 107.04 0.4 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 112.777 -2.011 . . . . 0.0 109.557 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -157.01 46.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -151.24 119.65 6.42 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 58' ' ' ILE . 3.2 mm? -139.3 149.09 43.83 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 94.59 2.76 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -89.87 100.07 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 111.209 -2.723 . . . . 0.0 109.732 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.44 81.61 0.38 Allowed Glycine 0 CA--C 1.533 1.178 0 CA-C-N 108.434 -3.985 . . . . 0.0 112.745 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.4 -85.68 0.26 Allowed Glycine 0 C--N 1.351 1.412 0 CA-C-N 112.714 -1.743 . . . . 0.0 109.376 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG23 ' A' ' 90' ' ' VAL . 65.6 t30 65.29 -116.15 0.34 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.901 -1.649 . . . . 0.0 106.932 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -104.4 129.34 56.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.42 169.06 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.893 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p 45.63 48.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.812 0 CA-C-N 112.713 -2.039 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 139.03 3.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 112.282 -2.236 . . . . 0.0 108.767 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -161.17 111.52 1.71 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 96.96 -45.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 112.548 -2.115 . . . . 0.0 105.83 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.17 126.54 35.84 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -138.03 160.11 65.72 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.59 -148.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 N-CA-C 107.759 -1.669 . . . . 0.0 107.759 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.48 -20.43 58.79 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.665 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -60.12 -64.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 124.433 1.083 . . . . 0.0 111.429 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' H ' HG13 ' A' ' 104' ' ' VAL . 9.6 mm-40 -89.4 18.67 5.04 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 117.009 -1.876 . . . . 0.0 107.965 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.79 -39.08 66.99 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -80.78 -32.16 35.54 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.691 -2.049 . . . . 0.0 106.826 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -91.74 15.03 13.63 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.737 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.7 -41.36 11.33 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.04 74.29 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 112.21 -2.268 . . . . 0.0 107.418 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.3 mtp -82.35 -57.99 3.13 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 27.61 43.32 0.03 OUTLIER Glycine 0 C--N 1.357 1.741 0 C-N-CA 127.401 2.429 . . . . 0.0 117.355 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.8 -2.76 58.82 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -105.01 131.22 52.81 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.485 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.07 169.74 8.53 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 178.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.92 159.41 36.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.601 ' CD2' H111 ' A' ' 139' ' ' DBI . 11.5 m-85 -99.46 161.39 24.74 Favored Pre-proline 0 N--CA 1.447 -0.615 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.53 158.1 58.67 Favored 'Trans proline' 0 C--N 1.368 1.559 0 N-CA-C 106.873 -2.01 . . . . 0.0 106.873 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.37 122.35 9.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 104.81 -2.804 . . . . 0.0 104.81 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.76 140.88 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 105.905 -2.878 . . . . 0.0 105.905 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 t -75.34 162.05 28.74 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 125.422 2.535 . . . . 0.0 108.164 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.3 p -167.78 113.4 0.62 Allowed Pre-proline 0 N--CA 1.427 -1.595 1 CA-C-N 106.12 -5.036 . . . . 0.0 101.019 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.01 -1.22 11.42 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.234 1.289 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.2 -30.28 67.35 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -16.66 54.41 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.541 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 129' ' ' ASP . 24.1 p -79.04 -25.34 43.2 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 116.67 -2.012 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.52 -26.56 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -3.18 56.31 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.04 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 126' ' ' THR . 38.4 t0 -62.07 -52.76 62.64 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 6' ' ' ILE . 36.2 mmt -87.77 -22.85 24.31 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.36 -2.2 . . . . 0.0 110.725 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.92 -12.96 46.12 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.098 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -90.11 -52.9 4.72 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.485 ' HA ' HH21 ' A' ' 115' ' ' ARG . 23.1 t -69.74 -58.88 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.364 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 -14.32 34.12 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 124.431 1.082 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.71 -72.59 1.28 Allowed Glycine 0 C--N 1.357 1.721 0 C-N-CA 118.542 -1.789 . . . . 0.0 111.461 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -174.12 152.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 113.624 -1.288 . . . . 0.0 107.885 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.693 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 138' ' ' FOP . . . . . 0.413 ' H51' ' H ' ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.601 H111 ' CD2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.77 79.78 4.73 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.61 177.33 6.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.777 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -105.5 103.58 13.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 110.018 -3.265 . . . . 0.0 109.435 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 172.3 113.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HB ' ' CE ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -148.03 110.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.88 131.23 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.031 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.833 ' CD2' ' HG ' ' A' ' 23' ' ' LEU . 1.5 tm? -125.84 130.25 51.0 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.174 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 171.39 23.72 Favored Glycine 0 C--N 1.36 1.876 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.932 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.28 136.94 13.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.009 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.01 88.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 115.448 -2.501 . . . . 0.0 110.06 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.51 108.75 0.38 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 106.636 -2.585 . . . . 0.0 106.636 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 t -85.97 159.63 19.57 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 123.798 1.761 . . . . 0.0 109.52 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -174.38 56.28 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 109.04 -3.709 . . . . 0.0 103.199 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 m 86.79 -56.25 0.05 Allowed 'General case' 0 C--N 1.363 1.17 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.057 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -135.44 -36.27 0.79 Allowed 'General case' 0 C--N 1.357 0.929 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 101.05 -11.67 0.03 OUTLIER 'General case' 0 C--N 1.358 0.936 0 O-C-N 125.9 2.0 . . . . 0.0 107.045 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.921 ' HB ' ' HB ' ' A' ' 121' ' ' THR 0.312 3.3 m 68.18 16.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 O-C-N 124.311 1.007 . . . . 0.0 110.757 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.53 -40.67 5.31 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 123.076 1.375 . . . . 0.0 110.255 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -46.35 -54.52 8.85 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 111.479 -2.361 . . . . 0.0 106.03 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -14.83 57.78 0.0 OUTLIER 'General case' 0 C--N 1.38 1.914 2 C-N-CA 140.008 7.323 . . . . 0.0 108.515 177.987 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.286 0.0 OUTLIER 31.54 52.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.342 2 CA-C-N 105.157 -5.474 . . . . 0.0 108.155 -178.367 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.833 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -72.27 -25.91 61.78 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.93 -15.83 63.79 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 22' ' ' ILE . 14.6 t-80 -72.88 -27.29 61.81 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -50.88 -44.16 59.72 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 125.492 1.745 . . . . 0.0 109.422 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.7 -47.23 80.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.694 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -17.15 61.34 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 111.828 -2.442 . . . . 0.0 113.039 -176.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -18.95 60.64 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 128.372 2.669 . . . . 0.0 109.773 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.43 11.93 2.76 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 124.598 1.186 . . . . 0.0 107.936 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.74 25.79 52.41 Favored Glycine 0 C--N 1.356 1.671 0 O-C-N 124.271 0.982 . . . . 0.0 112.922 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -99.78 145.49 27.64 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 29.9 m-20 -69.33 137.62 53.09 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 111.846 -2.434 . . . . 0.0 108.099 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.82 172.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 112.117 -2.311 . . . . 0.0 108.886 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.97 73.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 108.786 -3.825 . . . . 0.0 103.71 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -70.11 118.45 12.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -89.66 -90.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.713 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 -177.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 37' ' ' ILE . . . 176.8 -112.26 0.38 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -54.59 7.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.055 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.73 153.43 24.16 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.526 -1.67 . . . . 0.0 106.576 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -153.35 59.24 0.76 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.84 158.53 0.48 Allowed 'General case' 0 C--N 1.359 0.99 0 CA-C-N 110.284 -3.144 . . . . 0.0 108.921 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -82.81 -89.24 0.09 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 112.107 -2.315 . . . . 0.0 108.645 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -15.6 31.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 124.736 1.272 . . . . 0.0 112.247 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -90.09 -39.15 13.07 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 118.178 -1.409 . . . . 0.0 107.342 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -81.69 -9.99 59.5 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 117.641 -1.624 . . . . 0.0 109.166 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -28.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -75.66 -28.06 58.58 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.18 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.05 -15.94 30.76 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.22 -38.5 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 104.324 -2.472 . . . . 0.0 104.324 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -62.58 -71.81 0.15 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.24 -2.255 . . . . 0.0 111.087 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -74.59 -38.63 62.57 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.845 0.716 . . . . 0.0 110.629 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 98.28 41.65 0.0 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.49 126.06 20.19 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.266 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -106.08 -79.5 0.56 Allowed 'General case' 0 C--N 1.359 0.989 0 O-C-N 125.337 1.648 . . . . 0.0 106.558 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.45 114.21 20.04 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.91 123.75 54.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.6 m -145.47 145.66 31.18 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-O 123.836 1.779 . . . . 0.0 107.932 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.31 3.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 110.343 -3.117 . . . . 0.0 105.042 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.465 ' HA ' ' H4 ' ' A' ' 139' ' ' DBI . 0.0 OUTLIER -140.32 103.75 4.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 117.218 -1.793 . . . . 0.0 107.298 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m 177.78 173.95 0.54 Allowed 'General case' 0 C--N 1.359 1.017 0 O-C-N 126.412 2.32 . . . . 0.0 106.057 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.09 -147.07 0.06 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 111.637 -2.529 . . . . 0.0 104.782 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.42 92.91 7.67 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.95 -29.43 1.82 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-N 111.419 -2.628 . . . . 0.0 108.77 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -86.24 -24.73 25.9 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 112.589 -1.806 . . . . 0.0 107.28 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 178.99 49.36 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.745 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.04 -12.97 59.65 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 111.853 -2.174 . . . . 0.0 108.246 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -76.6 -49.21 24.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -72.82 -16.83 61.6 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.687 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HG ' ' HD2' ' A' ' 108' ' ' PHE . 8.8 t -72.14 -42.23 66.23 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -90.09 20.07 4.55 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 124.672 1.232 . . . . 0.0 108.953 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 -34.24 5.74 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.355 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.28 -23.47 22.3 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 113.04 -1.58 . . . . 0.0 106.845 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -26.92 56.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -81.04 -24.12 38.08 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.512 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -76.55 -17.77 59.04 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 124.113 0.883 . . . . 0.0 108.712 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 86' ' ' ILE . 68.1 m -90.23 -43.9 10.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 123.875 1.798 . . . . 0.0 107.345 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.45 -0.92 21.73 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.701 -3.863 . . . . 0.0 108.624 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.12 -53.6 6.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.65 41.7 11.86 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 110.855 -2.884 . . . . 0.0 107.303 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.44 -47.2 0.03 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.795 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -88.51 118.26 28.03 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 111.89 14.03 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 112.362 -2.199 . . . . 0.0 106.144 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.37 59.26 0.06 OUTLIER Glycine 0 C--N 1.348 1.22 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 78' ' ' CYS . 1.8 mt -91.15 0.75 8.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 CA-C-N 112.29 -1.955 . . . . 0.0 106.973 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -112.83 117.69 32.85 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.16 121.89 15.36 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -104.77 117.23 33.55 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 101.414 -3.55 . . . . 0.0 101.414 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 115' ' ' ARG . 88.1 t -89.73 89.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 110.827 -2.897 . . . . 0.0 108.491 -175.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.509 ' HA3' H101 ' A' ' 139' ' ' DBI . . . -69.13 108.39 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 109.52 -3.491 . . . . 0.0 109.417 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.66 -122.74 10.71 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 106.773 -2.531 . . . . 0.0 106.773 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.4 t30 68.97 145.99 0.05 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 125.397 1.293 . . . . 0.0 108.269 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 55.95 81.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 CA-C-N 112.31 -2.223 . . . . 0.0 107.614 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.54 155.64 6.13 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 112.537 -2.12 . . . . 0.0 108.538 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p 46.07 51.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 CA-C-N 112.83 -1.987 . . . . 0.0 111.829 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.83 138.34 5.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.163 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -167.24 140.3 3.5 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.08 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.846 0 O-C-N 125.966 2.041 . . . . 0.0 105.878 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -87.11 114.99 24.2 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -95.15 161.91 26.58 Favored Pre-proline 0 C--N 1.349 0.562 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.738 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.79 -150.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.927 1.751 . . . . 0.0 108.904 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.66 -25.75 62.25 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.19 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 105' ' ' GLU 0.272 0.1 OUTLIER -54.8 -67.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 124.886 1.366 . . . . 0.0 110.457 -179.429 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.5 mm-40 -90.24 20.31 4.48 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 117.951 -1.499 . . . . 0.0 109.149 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.39 -51.78 53.5 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -90.28 -15.59 30.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.466 ' HD2' ' HG ' ' A' ' 71' ' ' CYS . 4.1 m-30 -89.5 -45.42 9.43 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 117.802 -1.559 . . . . 0.0 108.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -77.75 -2.11 34.65 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.723 1.264 . . . . 0.0 107.783 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.53 77.18 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -83.97 -53.95 5.2 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.97 40.51 58.2 Favored Glycine 0 C--N 1.362 1.996 0 O-C-N 124.677 1.236 . . . . 0.0 116.065 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -6.92 59.43 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.09 137.8 42.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.35 173.63 6.24 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.12 160.01 26.07 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -99.61 160.54 27.12 Favored Pre-proline 0 C--N 1.355 0.82 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.19 149.01 45.15 Favored 'Trans proline' 0 C--N 1.366 1.46 0 N-CA-C 104.412 -2.957 . . . . 0.0 104.412 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.26 110.05 2.97 Favored 'Trans proline' 0 C--N 1.366 1.489 0 N-CA-C 104.812 -2.803 . . . . 0.0 104.812 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.41 158.65 7.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.716 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.921 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.63 143.44 46.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.743 -1.729 . . . . 0.0 106.718 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 p 174.0 100.37 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 110.763 -2.926 . . . . 0.0 106.41 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.29 -2.87 13.13 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.861 1.707 . . . . 0.0 108.155 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.96 -37.9 89.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.352 1.861 . . . . 0.0 107.757 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.82 -21.42 57.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.928 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 129' ' ' ASP . 2.3 p -80.65 -17.22 51.89 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 117.183 -1.807 . . . . 0.0 110.517 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mt -67.9 -31.53 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.12 2.66 55.05 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.763 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 133' ' ' VAL . 61.0 t0 -60.29 -61.69 2.42 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' ' HB ' ' A' ' 6' ' ' ILE . 11.1 mmm -90.1 -15.5 31.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.999 -2.818 . . . . 0.0 111.57 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -87.52 -13.32 43.35 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 118.026 -1.469 . . . . 0.0 108.801 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -90.35 -56.59 3.15 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 129' ' ' ASP . 2.5 t -57.56 -51.58 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 112.077 -2.329 . . . . 0.0 114.0 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.4 mp -89.66 -35.93 15.54 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 124.343 1.027 . . . . 0.0 108.604 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.67 -74.8 0.51 Allowed Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.028 -1.558 . . . . 0.0 112.772 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.39 148.06 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 122.425 1.107 . . . . 0.0 109.033 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 CA--C 1.545 0.759 0 CA-C-N 111.468 -2.606 . . . . 0.0 107.946 179.688 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.509 H101 ' HA3' ' A' ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.6 ttp . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -127.26 79.95 1.92 Allowed 'General case' 0 C--N 1.352 0.678 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.91 -176.9 3.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 111.862 -2.426 . . . . 0.0 107.969 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -120.43 63.81 0.84 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 110.809 -2.905 . . . . 0.0 108.442 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -149.54 106.42 3.56 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.487 ' CD1' HD21 ' A' ' 57' ' ' LEU . 4.0 mm -121.87 125.72 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 109.772 -3.377 . . . . 0.0 102.641 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -127.86 134.05 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 124.766 1.291 . . . . 0.0 109.278 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.18 138.74 54.13 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 113.237 -1.801 . . . . 0.0 107.489 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.5 21.41 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.844 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.5 119.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 118.012 -1.475 . . . . 0.0 110.866 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 1.9 tp -112.48 179.32 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.572 ' H ' HD12 ' A' ' 11' ' ' ILE . . . 92.14 98.73 1.35 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -80.95 0.05 37.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.213 -1.993 . . . . 0.0 109.301 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.0 118.77 17.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 m 85.77 -70.81 0.03 OUTLIER 'General case' 0 C--N 1.359 0.99 0 O-C-N 125.585 1.803 . . . . 0.0 106.777 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -157.39 -69.75 0.1 Allowed 'General case' 0 C--N 1.365 1.276 0 C-N-CA 115.791 -2.363 . . . . 0.0 106.827 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 127.19 36.24 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -73.21 111.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.383 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.61 11.61 62.97 Favored Glycine 0 C--N 1.359 1.826 0 CA-C-O 123.425 1.57 . . . . 0.0 112.491 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.6 m-20 -44.95 -63.07 1.0 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp 10.26 38.41 0.0 OUTLIER 'General case' 0 C--N 1.378 1.826 2 C-N-CA 138.349 6.66 . . . . 0.0 109.472 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.412 42.0 pt 33.91 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.753 1 C-N-CA 132.228 4.211 . . . . 0.0 107.976 -176.034 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.548 HD21 H103 ' A' ' 139' ' ' DBI . 4.7 mt -74.38 -42.27 59.56 Favored 'General case' 0 C--N 1.373 1.604 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.81 -0.58 16.27 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 112.191 -2.277 . . . . 0.0 108.44 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -79.23 -43.72 23.23 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 117.679 -1.608 . . . . 0.0 107.885 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -19.78 65.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.684 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.851 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -64.3 -43.98 93.05 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.3 -28.18 64.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 110.708 -2.951 . . . . 0.0 111.985 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 17.8 m-20 -87.57 2.71 50.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 111.836 -2.438 . . . . 0.0 108.823 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.28 4.98 5.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.49 30.38 61.88 Favored Glycine 0 C--N 1.361 1.942 0 O-C-N 124.306 1.004 . . . . 0.0 112.251 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.36 -175.58 2.84 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -106.93 150.73 26.14 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.851 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.2 p -99.93 146.21 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 111.047 -2.797 . . . . 0.0 108.115 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' ILE . 86.9 t -140.04 82.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 111.317 -2.674 . . . . 0.0 105.333 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -87.83 123.95 33.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -93.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.866 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.55 -120.76 0.58 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.56 10.95 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 113.277 -1.461 . . . . 0.0 110.405 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.22 129.45 34.96 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 t -98.51 41.42 1.14 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-N 113.072 -1.876 . . . . 0.0 107.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.9 p -90.11 80.21 6.35 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' CD ' HD21 ' A' ' 74' ' ' LEU . 25.9 tp60 -78.32 -36.75 46.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.309 -2.223 . . . . 0.0 108.573 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -35.64 79.79 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.312 1.007 . . . . 0.0 108.619 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.82 -24.8 41.13 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.2 -10.17 59.66 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.73 -33.93 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -74.15 -31.52 62.76 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.368 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.61 -0.5 57.33 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.12 -13.92 34.76 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.88 -41.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.75 -60.49 3.75 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 112.263 -2.244 . . . . 0.0 108.229 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.418 ' CG2' HG21 ' A' ' 35' ' ' VAL . 16.7 m -60.32 -66.44 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 113.454 -1.703 . . . . 0.0 107.819 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 102.74 35.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 O-C-N 126.782 2.552 . . . . 0.0 104.294 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.8 107.88 0.1 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 128.457 2.703 . . . . 0.0 109.222 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.88 -42.28 11.95 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -144.43 144.5 31.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 117.548 -1.661 . . . . 0.0 107.113 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.05 146.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 110.71 -2.95 . . . . 0.0 105.254 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.0 t -150.5 125.88 10.11 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.85 -178.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.852 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.037 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.74 97.12 3.57 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 p 155.93 152.6 0.01 OUTLIER 'General case' 0 C--N 1.356 0.876 0 CA-C-N 112.681 -2.054 . . . . 0.0 106.98 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' H ' ' H51' ' A' ' 138' ' ' FOP . 43.9 mt -65.84 -110.63 0.0 OUTLIER 'General case' 0 C--N 1.36 1.032 0 CA-C-N 111.884 -2.416 . . . . 0.0 105.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -95.94 68.47 2.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . -131.73 55.68 0.76 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 109.63 -3.441 . . . . 0.0 105.016 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.431 ' H ' ' H ' ' A' ' 67' ' ' GLY . 20.0 pt20 -167.14 -28.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 111.044 -2.578 . . . . 0.0 106.977 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 74.54 -177.21 47.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.029 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -76.61 -3.41 37.55 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.35 -2.425 . . . . 0.0 108.376 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -71.55 -53.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.0 -22.13 59.72 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 112.561 -2.109 . . . . 0.0 109.111 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.67 -64.24 0.9 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -90.15 27.99 1.51 Allowed 'General case' 0 C--N 1.355 0.807 0 O-C-N 124.717 1.26 . . . . 0.0 109.798 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.63 -40.68 3.81 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.423 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.7 mt -88.58 -22.77 23.35 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 111.92 -2.14 . . . . 0.0 108.517 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.458 HH11 ' HG3' ' A' ' 75' ' ' ARG . 1.9 mmt85 -78.71 -26.98 44.9 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.62 -26.74 41.1 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -75.98 -16.75 59.93 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.123 0.889 . . . . 0.0 109.227 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.3 t -90.21 -46.26 8.55 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 123.948 1.832 . . . . 0.0 107.319 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.15 -4.94 28.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 108.536 -3.938 . . . . 0.0 109.002 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.22 -56.29 4.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.0 47.81 4.11 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 110.881 -2.872 . . . . 0.0 106.527 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.54 -42.14 0.02 OUTLIER Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.654 -2.067 . . . . 0.0 109.9 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.34 122.94 27.55 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 128.3 34.8 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.26 113.6 1.55 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.221 -2.263 . . . . 0.0 108.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -146.41 35.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -141.15 112.98 7.72 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 103.527 -2.768 . . . . 0.0 103.527 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.52 106.39 8.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 85.39 3.09 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 100.613 -3.847 . . . . 0.0 100.613 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.26 101.5 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 126.221 2.915 . . . . 0.0 110.085 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.27 116.55 4.77 Favored Glycine 0 C--N 1.343 0.961 1 CA-C-N 108.239 -4.073 . . . . 0.0 108.489 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.64 -84.91 0.44 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 105.738 -2.945 . . . . 0.0 105.738 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t30 72.24 -84.34 0.03 OUTLIER 'General case' 0 C--N 1.357 0.935 0 CA-C-N 112.879 -1.66 . . . . 0.0 107.681 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -140.37 135.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.34 158.06 4.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.57 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 42.68 75.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.757 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.47 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.2 135.14 1.94 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.196 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -174.16 110.73 0.16 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 91.45 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.355 0.841 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -94.14 135.73 35.19 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -143.06 162.94 40.73 Favored Pre-proline 0 C--N 1.35 0.605 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.27 -150.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.478 -1.778 . . . . 0.0 107.478 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.11 -22.26 63.03 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.216 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.3 p -58.13 -69.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 O-C-N 124.483 1.114 . . . . 0.0 111.214 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' H ' HG13 ' A' ' 104' ' ' VAL . 15.3 mm-40 -90.17 24.92 2.33 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.501 -1.68 . . . . 0.0 108.209 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -77.32 -41.03 42.13 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.43 -32.55 42.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 112.472 -2.149 . . . . 0.0 106.41 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -92.78 16.68 11.82 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.678 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -39.82 12.33 Favored 'General case' 0 C--N 1.361 1.096 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.29 75.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.028 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtp -78.96 -60.77 2.25 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.32 37.34 0.02 OUTLIER Glycine 0 C--N 1.356 1.643 0 C-N-CA 128.056 2.741 . . . . 0.0 117.642 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.73 -0.23 57.41 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.18 134.51 48.17 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.471 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.23 176.54 5.01 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.01 161.61 25.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.792 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.609 ' CD2' H102 ' A' ' 139' ' ' DBI . 5.6 m-85 -99.88 154.9 37.0 Favored Pre-proline 0 C--N 1.355 0.842 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.964 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.49 162.21 38.53 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 106.84 -2.023 . . . . 0.0 106.84 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.53 124.9 10.18 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 105.201 -2.653 . . . . 0.0 105.201 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.13 137.05 9.46 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -73.85 154.34 39.51 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 125.584 2.612 . . . . 0.0 107.492 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 p -166.11 108.67 0.71 Allowed Pre-proline 0 N--CA 1.426 -1.642 1 CA-C-N 105.819 -5.173 . . . . 0.0 100.362 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -78.61 0.31 10.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.3 -38.35 87.53 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.945 1.698 . . . . 0.0 107.631 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -24.29 59.96 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.985 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.7 p -84.64 -19.84 32.28 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.957 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -64.69 -30.17 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.49 -7.65 59.61 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 111.712 -2.495 . . . . 0.0 108.798 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 126' ' ' THR . 25.4 t0 -53.7 -72.34 0.06 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-O 122.116 0.96 . . . . 0.0 108.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.403 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 4.9 mmt -86.67 -6.07 58.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 112.302 -2.226 . . . . 0.0 110.336 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.14 -66.01 0.96 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.834 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -48.02 -44.69 31.19 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.34 1.056 . . . . 0.0 111.021 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.502 HG12 HD23 ' A' ' 134' ' ' LEU . 25.6 t -65.37 -65.57 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 133' ' ' VAL . 49.8 mt -90.52 55.76 3.11 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.65 -83.59 0.05 OUTLIER Glycine 0 C--N 1.35 1.318 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -164.24 152.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 113.272 -1.464 . . . . 0.0 107.862 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--N 1.346 0.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.554 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 138' ' ' FOP . . . . . 0.443 ' H51' ' H ' ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.609 H102 ' CD2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -90.49 77.01 6.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -73.05 -162.43 0.11 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 111.689 -2.505 . . . . 0.0 107.505 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -149.69 99.74 2.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.188 -1.824 . . . . 0.0 106.253 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.62 100.33 0.01 OUTLIER 'General case' 0 C--N 1.355 0.845 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.8 116.43 48.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 35' ' ' VAL . 5.8 p -107.43 112.25 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 111.621 -2.536 . . . . 0.0 109.113 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.16 134.44 51.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.449 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.86 168.03 31.18 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.734 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.81 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 167.57 -121.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.662 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.704 HG22 HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -142.92 -168.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.094 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.221 -177.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.82 162.34 27.2 Favored Glycine 0 C--N 1.364 2.103 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.156 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -105.97 -24.51 12.4 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 110.755 -2.722 . . . . 0.0 107.618 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -134.56 156.4 48.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.66 58.06 1.04 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -173.36 131.92 0.47 Allowed 'General case' 0 C--N 1.365 1.243 0 C-N-CA 116.988 -1.885 . . . . 0.0 107.509 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 22.11 63.36 0.03 OUTLIER 'General case' 0 C--N 1.354 0.796 0 C-N-CA 131.344 3.858 . . . . 0.0 111.278 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.4 66.5 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.628 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.08 -34.57 3.21 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.832 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -39.21 -48.33 1.75 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 112.285 -1.958 . . . . 0.0 106.559 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -5.81 50.11 0.0 OUTLIER 'General case' 0 C--N 1.392 2.423 2 C-N-CA 140.728 7.611 . . . . 0.0 108.365 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.328 0.0 OUTLIER 34.67 54.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.605 1 CA-C-N 106.871 -4.695 . . . . 0.0 106.437 -175.847 . . . . . . . . 5 4 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.55 HD23 H103 ' A' ' 139' ' ' DBI . 0.2 OUTLIER -66.9 -21.78 65.99 Favored 'General case' 0 C--N 1.377 1.773 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 173.558 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -67.57 -20.47 65.39 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 116.514 -2.075 . . . . 0.0 107.299 176.284 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.521 ' HB2' HG22 ' A' ' 22' ' ' ILE . 7.9 t60 -66.02 -29.96 70.41 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.436 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 37.0 t -67.19 -18.38 65.23 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.608 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.99 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -56.73 -47.1 80.76 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.07 69.11 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 110.482 -3.054 . . . . 0.0 112.763 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -84.72 7.53 20.2 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 111.559 -2.564 . . . . 0.0 108.632 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.78 -0.99 5.39 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.61 28.88 68.5 Favored Glycine 0 C--N 1.36 1.902 0 O-C-N 124.139 0.899 . . . . 0.0 111.377 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -105.38 -168.01 1.4 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 113.342 -1.429 . . . . 0.0 107.605 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.56 149.69 21.02 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.093 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.99 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.8 124.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 108.871 -3.786 . . . . 0.0 108.79 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG12 HG23 ' A' ' 7' ' ' VAL . 2.8 t -140.33 132.93 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 110.896 -2.865 . . . . 0.0 105.429 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -139.02 133.19 31.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.55 -20.15 6.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.567 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.68 -123.36 7.9 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.14 113.38 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-O 122.324 1.059 . . . . 0.0 109.28 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 42' ' ' SER . 3.7 tt -175.25 137.79 0.4 Allowed 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 t -94.54 39.55 1.09 Allowed 'General case' 0 C--N 1.354 0.776 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.435 ' HB2' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -90.55 91.52 8.47 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -90.02 -58.54 2.47 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.61 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.7 pt-20 -59.93 -20.92 60.08 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 124.771 1.294 . . . . 0.0 112.04 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.95 -38.89 14.14 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.878 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 54.7 m-85 -89.15 12.65 15.2 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.907 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -91.97 -34.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 175.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.73 -27.93 62.34 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -84.41 -16.65 41.95 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.63 -7.6 58.65 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.2 -43.06 18.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -60.61 -64.0 1.1 Allowed 'General case' 0 C--N 1.354 0.802 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.492 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.84 82.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.4 tttp 84.38 54.47 0.01 OUTLIER 'General case' 0 C--N 1.345 0.386 0 CA-C-N 112.022 -2.354 . . . . 0.0 105.02 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 124.51 23.75 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.112 -2.313 . . . . 0.0 107.489 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.99 -84.09 0.15 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.82 145.62 26.78 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.62 142.37 43.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.1 m -129.56 131.92 46.69 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 112.18 -2.282 . . . . 0.0 105.815 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.757 HG22 HG23 ' A' ' 10' ' ' VAL . 13.1 p -116.32 133.17 63.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.727 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.81 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -110.32 90.77 3.42 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 123.979 1.847 . . . . 0.0 107.016 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.2 t -131.12 176.93 7.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.257 -2.701 . . . . 0.0 106.544 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 52.55 1.02 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 110.405 -3.089 . . . . 0.0 105.906 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER 60.9 49.01 6.22 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.602 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.2 -0.07 5.96 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.868 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.13 -2.86 49.06 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.67 177.56 8.58 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.35 1.031 . . . . 0.0 111.652 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.17 25.58 2.14 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 112.871 -1.665 . . . . 0.0 108.188 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -52.68 10.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.529 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.6 m-20 -71.81 -26.86 62.57 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 112.703 -2.044 . . . . 0.0 107.26 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 t -67.78 -58.22 4.98 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -90.07 30.13 1.13 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 124.48 1.112 . . . . 0.0 109.426 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.49 -37.79 3.91 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 70' ' ' ASP . 2.0 mm? -90.01 -23.77 21.4 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.625 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -29.6 57.26 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.93 -28.21 55.15 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -16.82 60.62 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 124.155 0.909 . . . . 0.0 109.368 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 39.8 t -90.24 -46.85 8.15 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.847 1.784 . . . . 0.0 107.518 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -75.41 2.34 11.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 108.715 -3.857 . . . . 0.0 109.11 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.72 -55.59 3.9 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 44.78 7.93 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 110.958 -2.837 . . . . 0.0 106.798 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.01 -43.7 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.392 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.06 121.11 25.11 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 140.75 32.65 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 113.302 -1.772 . . . . 0.0 106.412 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.74 71.16 0.28 Allowed Glycine 0 C--N 1.351 1.364 0 CA-C-N 112.633 -2.076 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 tt -103.73 35.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -128.01 118.1 22.91 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -140.29 151.93 45.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.592 -2.094 . . . . 0.0 105.73 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 106.24 5.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 100.654 -3.832 . . . . 0.0 100.654 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.87 93.58 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 125.114 2.388 . . . . 0.0 110.164 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.42 ' HA3' ' C10' ' A' ' 139' ' ' DBI . . . -63.69 118.47 13.5 Favored Glycine 0 CA--C 1.537 1.453 1 CA-C-N 107.975 -4.193 . . . . 0.0 111.137 176.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.82 -92.39 1.62 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 72.75 -142.6 0.04 OUTLIER 'General case' 0 C--N 1.356 0.885 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.502 HG12 HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -91.68 148.71 4.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.195 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.31 -164.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 CA-C-N 112.548 -2.115 . . . . 0.0 108.423 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 p 41.77 74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.04 33.79 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 112.068 -2.333 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -159.93 -46.72 0.05 Allowed 'General case' 0 C--N 1.347 0.473 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -129.7 -44.27 1.21 Allowed 'General case' 0 C--N 1.349 0.549 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.97 95.58 9.54 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -103.0 164.24 15.93 Favored Pre-proline 0 C--N 1.35 0.624 0 CA-C-N 112.483 -2.144 . . . . 0.0 105.36 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.08 -152.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.784 1.656 . . . . 0.0 108.792 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.33 -25.54 64.26 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 113.431 -1.713 . . . . 0.0 108.456 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.0 p -53.53 -74.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 O-C-N 124.912 1.382 . . . . 0.0 110.749 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.675 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.8 mt-10 -90.07 28.71 1.34 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.5 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -76.62 -45.33 30.53 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -80.58 -31.38 36.79 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 111.495 -2.593 . . . . 0.0 107.381 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.3 10.7 21.31 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 118.584 -1.247 . . . . 0.0 109.125 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.31 14.12 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -33.93 74.39 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.652 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 55.7 mtp -81.29 -60.49 2.26 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 34.68 37.55 0.1 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 112.31 -2.223 . . . . 0.0 117.243 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -79.84 -15.47 57.33 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -101.63 138.8 38.14 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.556 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.422 ' HE ' HG22 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.31 178.79 4.28 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.19 156.89 24.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.53 114.24 65.46 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 101.785 -3.413 . . . . 0.0 101.785 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -55.34 157.89 13.54 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.418 2.745 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.96 121.03 8.17 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 105.918 -2.378 . . . . 0.0 105.918 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 65.91 0.96 Allowed Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.388 -2.187 . . . . 0.0 107.901 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.559 HG21 H112 ' A' ' 139' ' ' DBI . 15.4 p -82.12 -151.99 0.1 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.424 -2.388 . . . . 0.0 107.173 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 p 176.97 166.33 0.47 Allowed Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 110.805 -2.907 . . . . 0.0 104.243 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.61 -5.15 15.27 Favored 'Trans proline' 0 C--N 1.365 1.424 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.48 -23.87 53.81 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -17.82 58.32 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.753 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.0 p -87.19 -20.79 26.48 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.914 0.758 . . . . 0.0 110.613 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.89 -27.2 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.66 -1.01 57.61 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.606 -2.088 . . . . 0.0 109.264 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 133' ' ' VAL . 19.0 t0 -69.75 -68.03 0.44 Allowed 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.436 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 1.9 mpt? -74.45 -13.65 60.73 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.803 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -90.04 -43.45 10.5 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.999 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.39 -31.74 70.65 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 121.053 0.454 . . . . 0.0 109.789 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 129' ' ' ASP . 53.8 t -90.09 -77.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.327 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.421 HD23 HG12 ' A' ' 133' ' ' VAL . 27.2 mt -90.49 63.06 5.44 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.643 1.215 . . . . 0.0 108.839 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.97 -36.67 0.02 OUTLIER Glycine 0 CA--C 1.531 1.071 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.329 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.75 162.22 4.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 CA--C 1.543 0.703 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.016 179.508 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.559 H112 HG21 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -121.63 16.6 11.17 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 124.924 1.39 . . . . 0.0 107.745 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -70.82 145.38 50.37 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -79.53 95.68 5.9 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 111.197 -2.729 . . . . 0.0 108.413 -177.336 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.41 112.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 132.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -125.7 141.05 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 110.974 -2.83 . . . . 0.0 110.202 -176.478 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.9 pp -125.31 167.23 15.19 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 112.272 -2.24 . . . . 0.0 105.728 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 178.25 -172.25 44.71 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 126.428 2.33 . . . . 0.0 113.42 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 60' ' ' VAL 0.455 13.5 p 69.53 -125.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 110.139 -3.031 . . . . 0.0 114.714 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.54 ' H ' HG13 ' A' ' 10' ' ' VAL . 4.2 tp 56.71 113.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 128.744 2.817 . . . . 0.0 109.018 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.52 78.23 0.16 Allowed Glycine 0 C--N 1.366 2.197 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.404 ' OG ' ' H72' ' A' ' 138' ' ' FOP . 0.9 OUTLIER -129.06 -36.81 1.74 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 110.773 -2.714 . . . . 0.0 106.836 -177.349 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.32 -156.0 0.56 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.33 98.57 4.54 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 80.67 -89.1 0.02 OUTLIER 'General case' 0 C--N 1.354 0.771 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 93.34 33.52 0.01 OUTLIER 'General case' 0 C--N 1.354 0.776 0 C-N-CA 126.535 1.934 . . . . 0.0 106.819 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t 59.07 113.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.73 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 21' ' ' LYS . . . -169.94 -78.17 0.04 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.88 -0.13 17.49 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 112.252 -1.974 . . . . 0.0 108.684 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.1 tmtm? -82.54 73.45 9.57 Favored 'General case' 0 N--CA 1.437 -1.118 1 C-N-CA 133.556 4.742 . . . . 0.0 104.995 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' LYS 0.318 38.7 mt 93.61 9.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 1 CA-C-N 107.101 -4.59 . . . . 0.0 112.325 175.518 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' HG ' ' CG2' ' A' ' 126' ' ' THR 0.259 0.2 OUTLIER -74.85 -30.46 61.36 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 114.472 -2.891 . . . . 0.0 106.378 176.32 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.17 -13.13 59.99 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 117.406 -1.717 . . . . 0.0 107.05 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -77.31 -31.89 54.97 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.976 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -74.33 -18.76 60.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.792 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -68.43 -39.44 81.56 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 118.139 -1.424 . . . . 0.0 107.472 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -31.0 64.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 110.425 -3.08 . . . . 0.0 112.246 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -88.05 0.29 56.14 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 112.077 -2.329 . . . . 0.0 109.989 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.33 -8.26 11.67 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.01 23.64 69.67 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -99.9 170.59 8.42 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -80.86 151.12 28.81 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 111.232 -2.713 . . . . 0.0 105.399 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 135.83 33.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 CA-C-N 111.703 -2.499 . . . . 0.0 107.469 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 60.0 t -136.66 92.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 111.593 -2.549 . . . . 0.0 106.172 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -96.55 126.17 41.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.292 -1.776 . . . . 0.0 107.198 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 8' ' ' LEU . 15.8 mt -98.72 -24.59 4.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 O-C-N 124.778 1.299 . . . . 0.0 107.655 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.78 -151.33 19.51 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.64 14.1 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 114.423 -0.889 . . . . 0.0 111.441 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.89 102.77 6.2 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.8 p -84.89 83.07 8.17 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 125.05 22.51 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 109.809 -3.36 . . . . 0.0 106.969 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 28.4 tp60 -83.95 -93.59 0.07 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.987 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.66 -18.45 53.76 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 124.8 1.313 . . . . 0.0 111.462 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.63 -43.24 12.79 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD2' HG12 ' A' ' 37' ' ' ILE . 1.3 t80 -86.52 4.48 39.74 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 116.862 -1.935 . . . . 0.0 108.982 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -26.89 6.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.16 -30.21 49.04 Favored 'General case' 0 C--N 1.365 1.25 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.26 10.16 33.11 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.77 20.03 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.1 -37.31 76.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.31 -71.75 0.14 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.449 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -61.54 1.86 Allowed 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.512 0.508 . . . . 0.0 110.362 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? 99.87 68.9 0.0 OUTLIER 'General case' 0 C--N 1.348 0.509 0 O-C-N 126.248 2.217 . . . . 0.0 106.654 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.42 116.09 2.66 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.331 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -77.2 -48.55 17.3 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.39 150.49 35.78 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.96 170.63 5.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -153.21 109.02 3.29 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.773 -2.012 . . . . 0.0 105.814 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 10' ' ' VAL . 3.0 t -99.86 120.05 48.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -101.84 113.01 25.82 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 117.851 -1.54 . . . . 0.0 107.685 -176.783 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 t 150.74 162.83 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.76 74.4 6.59 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 111.517 -2.583 . . . . 0.0 106.682 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 72.66 49.65 0.18 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 112.558 -2.11 . . . . 0.0 107.805 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.22 2.99 72.16 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.996 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.627 ' HB3' HG11 ' A' ' 60' ' ' VAL . 12.2 pt20 -88.13 -20.49 25.57 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.661 -1.27 . . . . 0.0 109.463 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.04 174.35 40.25 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.58 6.29 9.04 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.85 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -67.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.576 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 29.4 t70 -71.13 -20.7 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.553 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.4 t -72.94 -56.26 5.41 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -90.07 21.08 3.87 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.617 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.44 -27.07 6.6 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.867 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 20.6 mt -85.67 -27.67 25.2 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.567 HH11 ' HG3' ' A' ' 75' ' ' ARG . 3.0 mmt85 -72.02 -32.38 67.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.28 -23.54 47.19 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 113.624 -1.626 . . . . 0.0 108.391 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -77.11 -16.5 59.16 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 83.7 m -90.24 -42.98 10.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.831 1.777 . . . . 0.0 107.282 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.65 -1.06 22.88 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 108.679 -3.873 . . . . 0.0 108.654 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.27 -54.5 5.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 59.94 40.88 18.47 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 110.882 -2.872 . . . . 0.0 107.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.78 -51.25 0.04 OUTLIER Glycine 0 C--N 1.35 1.308 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 120.19 32.63 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 126.59 31.14 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.153 -1.84 . . . . 0.0 106.29 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.61 56.19 0.04 OUTLIER Glycine 0 C--N 1.345 1.062 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.195 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -99.94 32.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 CA-C-N 112.203 -1.998 . . . . 0.0 106.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -144.36 112.56 6.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 97.35 3.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.67 85.25 3.08 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.492 HG23 ' CB ' ' A' ' 93' ' ' ASN . 4.4 m -89.45 98.45 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 109.881 -3.327 . . . . 0.0 110.397 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -63.31 132.92 42.25 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 109.116 -3.675 . . . . 0.0 113.348 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.96 -74.21 0.95 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 111.869 -2.165 . . . . 0.0 109.765 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' CB ' HG23 ' A' ' 90' ' ' VAL . 15.7 t-20 18.75 103.67 0.0 OUTLIER 'General case' 0 C--N 1.354 0.769 1 C-N-CA 131.763 4.025 . . . . 0.0 111.06 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 58.44 120.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 112.334 -2.212 . . . . 0.0 108.478 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.49 162.5 4.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 112.102 -2.317 . . . . 0.0 108.58 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 p 41.3 69.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 CA-C-N 112.432 -2.167 . . . . 0.0 112.715 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.36 128.96 1.06 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.365 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -157.61 100.0 1.76 Allowed 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 96.49 -51.77 0.01 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -85.68 99.13 11.1 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.508 ' HH2' HG21 ' A' ' 116' ' ' VAL . 88.6 m95 -113.5 160.47 31.48 Favored Pre-proline 0 C--N 1.351 0.646 0 CA-C-N 112.694 -2.048 . . . . 0.0 106.122 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.58 -155.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 N-CA-C 106.456 -2.171 . . . . 0.0 106.456 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.38 -20.91 62.92 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.688 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.6 p -60.01 -69.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.776 0 O-C-N 124.437 1.086 . . . . 0.0 111.621 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.522 ' H ' HG13 ' A' ' 104' ' ' VAL . 29.5 mt-10 -90.15 27.01 1.72 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 117.688 -1.605 . . . . 0.0 109.3 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -79.92 -42.36 24.25 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.48 -31.79 42.39 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 112.314 -2.221 . . . . 0.0 106.683 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -90.87 14.29 14.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.214 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -90.41 -37.37 14.01 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.78 75.55 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.84 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 29.9 mtp -76.9 -63.51 1.34 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 35.5 31.29 0.02 OUTLIER Glycine 0 C--N 1.355 1.635 0 C-N-CA 127.135 2.302 . . . . 0.0 117.496 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -7.19 59.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -105.25 128.63 53.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 176.91 4.87 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.508 HG21 ' HH2' ' A' ' 101' ' ' TRP . 4.8 m -138.23 158.47 32.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.17 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.5 OUTLIER -99.9 152.62 37.87 Favored Pre-proline 0 C--N 1.358 0.946 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.43 147.89 83.26 Favored 'Trans proline' 0 C--N 1.369 1.654 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.78 114.5 3.2 Favored 'Trans proline' 0 C--N 1.364 1.373 0 N-CA-C 104.011 -3.111 . . . . 0.0 104.011 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.29 42.77 6.1 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.499 -1.682 . . . . 0.0 110.389 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.564 HG23 H112 ' A' ' 139' ' ' DBI . 7.5 t -90.17 -179.08 5.57 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 125.174 2.416 . . . . 0.0 106.457 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.357 19.7 p -82.39 170.78 13.63 Favored Pre-proline 0 N--CA 1.426 -1.668 1 CA-C-N 106.806 -4.725 . . . . 0.0 106.031 179.078 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -92.06 -0.06 4.23 Favored 'Trans proline' 0 CA--C 1.554 1.499 0 N-CA-C 104.586 -2.89 . . . . 0.0 104.586 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 127' ' ' ILE . 38.6 tt0 -74.97 -16.1 60.65 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.679 1.192 . . . . 0.0 108.284 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.75 55.57 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 129' ' ' ASP . 35.6 p -79.83 -23.21 42.17 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.012 -1.475 . . . . 0.0 109.817 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 124' ' ' GLU . 5.8 mt -68.55 -30.34 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.68 -5.14 58.7 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 112.134 -2.303 . . . . 0.0 108.796 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.4 t0 -59.85 -58.56 8.03 Favored 'General case' 0 C--N 1.367 1.347 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -88.29 1.61 54.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.362 -2.199 . . . . 0.0 110.156 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -81.04 -48.35 12.32 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 117.151 -1.82 . . . . 0.0 109.866 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.76 -31.49 19.61 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.235 0.96 . . . . 0.0 111.928 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 129' ' ' ASP . 16.9 t -73.25 -26.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.105 0.878 . . . . 0.0 112.379 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -89.21 -36.85 15.41 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.83 -95.42 0.06 OUTLIER Glycine 0 C--N 1.356 1.641 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.033 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -169.31 154.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.548 -1.326 . . . . 0.0 108.635 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 C--N 1.347 0.486 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.558 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 138' ' ' FOP . . . . . 0.404 ' H72' ' OG ' ' A' ' 13' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.564 H112 HG23 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.71 13.45 19.85 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 125.296 1.622 . . . . 0.0 107.543 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -70.93 145.94 49.82 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.938 1.351 . . . . 0.0 107.76 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -80.61 95.85 6.67 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.938 -2.847 . . . . 0.0 108.313 -177.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 172.29 111.51 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.08 122.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.3 147.16 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 110.546 -3.025 . . . . 0.0 110.163 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 tm? -125.13 149.21 48.1 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.1 155.41 26.15 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 125.762 1.914 . . . . 0.0 112.554 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 13.6 p 84.94 -127.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 130.406 3.483 . . . . 0.0 117.03 177.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 10' ' ' VAL 0.316 2.0 tp 72.78 115.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 128.443 2.697 . . . . 0.0 106.382 -175.964 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.5 73.6 0.17 Allowed Glycine 0 C--N 1.367 2.286 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 -44.59 2.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 110.058 -3.071 . . . . 0.0 104.816 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -159.01 -131.15 0.03 OUTLIER 'General case' 0 C--N 1.354 0.773 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -89.08 77.25 7.63 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 75.9 -142.66 0.02 OUTLIER 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 164.93 46.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.641 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m 61.19 179.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.965 0 CA-C-N 113.58 -1.646 . . . . 0.0 110.708 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -70.74 1.13 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.674 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 4.1 p-10 -56.59 -25.97 54.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.525 -1.838 . . . . 0.0 110.945 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -60.96 -66.79 0.48 Allowed 'General case' 0 C--N 1.345 0.381 0 CA-C-O 122.961 1.362 . . . . 0.0 107.68 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 3.35 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 111.502 -2.59 . . . . 0.0 111.357 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 0.2 OUTLIER -85.69 -38.58 18.16 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 116.573 -2.051 . . . . 0.0 107.664 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.98 -11.24 60.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 117.489 -1.685 . . . . 0.0 106.478 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -80.78 -38.56 28.3 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.5 m -71.0 -14.84 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 112.242 -2.254 . . . . 0.0 109.903 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.481 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.11 -42.03 73.21 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -31.61 66.59 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 110.188 -3.187 . . . . 0.0 112.462 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -87.63 -1.76 58.17 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 111.971 -2.377 . . . . 0.0 110.016 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.72 -10.32 14.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.1 70.76 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -99.88 168.47 9.86 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -78.22 148.74 33.85 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 111.178 -2.737 . . . . 0.0 105.766 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 132.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.579 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.85 74.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 111.481 -2.599 . . . . 0.0 105.444 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.09 122.98 31.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.472 -2.149 . . . . 0.0 107.622 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 8' ' ' LEU . 53.3 mt -98.39 -27.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.71 -141.51 15.58 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.99 -13.67 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.237 -0.982 . . . . 0.0 110.278 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.3 98.89 11.99 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -82.68 80.76 8.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.36 118.15 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 110.883 -2.872 . . . . 0.0 105.387 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -89.86 -87.37 0.18 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.585 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.11 -18.63 63.63 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 124.63 1.206 . . . . 0.0 110.563 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.52 -41.8 14.99 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -86.47 4.88 37.82 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 116.898 -1.921 . . . . 0.0 108.877 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.37 -26.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -78.65 -31.17 46.68 Favored 'General case' 0 C--N 1.365 1.279 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.88 10.79 29.61 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.11 -28.0 19.27 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.55 -37.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.87 -71.73 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 112.387 -2.188 . . . . 0.0 110.234 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -63.96 1.13 Allowed 'General case' 0 C--N 1.362 1.148 0 O-C-N 123.491 0.494 . . . . 0.0 110.193 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 101.25 71.14 0.0 OUTLIER 'General case' 0 C--N 1.346 0.444 0 O-C-N 126.4 2.312 . . . . 0.0 106.467 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 122.0 10.87 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.433 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -95.19 -59.41 1.9 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.79 124.83 40.59 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.459 HG21 HD13 ' A' ' 74' ' ' LEU . 39.6 mt -95.79 167.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.2 m -148.98 120.82 8.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 111.918 -2.401 . . . . 0.0 106.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.593 HG23 HG12 ' A' ' 90' ' ' VAL . 23.5 t -99.88 133.38 43.0 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -119.66 96.47 5.21 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t 147.57 161.72 0.0 OUTLIER 'General case' 0 C--N 1.354 0.789 0 O-C-N 126.293 2.246 . . . . 0.0 106.031 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.37 77.57 8.88 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 111.279 -2.691 . . . . 0.0 106.527 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.819 -1.992 . . . . 0.0 107.607 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.74 57.69 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.897 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -92.57 4.32 53.81 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 113.444 -1.378 . . . . 0.0 109.357 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.31 -167.53 35.95 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.721 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.11 21.08 3.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 112.498 -1.851 . . . . 0.0 108.072 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -75.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 20.8 t70 -71.25 -24.49 62.19 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 112.472 -2.149 . . . . 0.0 108.904 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.48 -49.4 22.36 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -90.02 16.11 8.9 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.554 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.77 -23.61 11.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.149 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 29.5 mt -89.94 -25.41 20.93 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.513 HH11 ' HG3' ' A' ' 75' ' ' ARG . 2.3 mmt85 -71.81 -30.49 65.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -79.51 -23.67 42.77 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.187 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -77.64 -12.8 60.0 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.801 0.84 . . . . 0.0 108.904 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.0 m -90.24 -42.91 10.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.923 1.82 . . . . 0.0 106.661 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.43 -3.56 31.31 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 108.527 -3.942 . . . . 0.0 108.741 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.5 -54.58 5.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.71 40.43 23.25 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 111.125 -2.761 . . . . 0.0 107.688 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.75 -52.35 0.05 OUTLIER Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -94.46 122.55 37.14 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 134.89 38.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.13 54.97 0.02 OUTLIER Glycine 0 C--N 1.347 1.14 0 CA-C-N 112.36 -2.2 . . . . 0.0 109.208 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.5 -33.41 11.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.389 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -80.92 117.53 21.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.09 100.22 3.86 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.66 92.76 5.49 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 60' ' ' VAL . 27.3 m -89.21 97.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 110.298 -3.137 . . . . 0.0 110.64 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -67.57 134.74 30.63 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 110.027 -3.261 . . . . 0.0 113.02 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.59 -80.67 1.37 Allowed Glycine 0 C--N 1.354 1.546 0 CA-C-N 111.691 -2.255 . . . . 0.0 108.492 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.49 ' CB ' HG23 ' A' ' 90' ' ' VAL . 11.1 t-20 21.56 94.06 0.01 OUTLIER 'General case' 0 C--N 1.354 0.767 0 C-N-CA 131.399 3.88 . . . . 0.0 110.171 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt 76.19 131.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.94 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.03 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 CA-C-N 112.313 -2.221 . . . . 0.0 108.103 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p 35.22 63.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 112.241 -2.254 . . . . 0.0 112.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.36 147.55 12.61 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.643 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -175.27 107.99 0.1 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 93.42 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.356 0.888 0 O-C-N 126.137 2.148 . . . . 0.0 105.429 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -87.69 107.51 18.66 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -116.47 163.34 22.45 Favored Pre-proline 0 C--N 1.351 0.651 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.16 -151.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.763 1.642 . . . . 0.0 107.976 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.07 -20.13 57.99 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.523 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -67.69 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.721 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.23 25.86 2.08 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 117.199 -1.8 . . . . 0.0 109.41 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.07 -41.23 26.02 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -78.32 -31.79 48.94 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 112.512 -2.131 . . . . 0.0 106.256 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -92.85 17.02 11.18 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.294 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -90.36 -38.97 12.97 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.19 80.1 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.915 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 12.3 mtp -74.22 -65.29 0.86 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.49 27.57 0.09 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 112.127 -2.306 . . . . 0.0 117.295 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.32 -5.24 58.46 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.12 132.59 51.15 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.75 6.68 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.08 157.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.429 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 0.7 OUTLIER -99.44 147.68 33.66 Favored Pre-proline 0 C--N 1.359 0.982 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 -178.745 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.56 145.06 81.14 Favored 'Trans proline' 0 C--N 1.371 1.723 0 N-CA-C 107.451 -1.788 . . . . 0.0 107.451 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -79.97 111.97 2.78 Favored 'Trans proline' 0 C--N 1.364 1.35 0 N-CA-C 103.552 -3.288 . . . . 0.0 103.552 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.16 42.14 5.04 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 113.47 -1.695 . . . . 0.0 110.478 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.591 HG23 H112 ' A' ' 139' ' ' DBI . 12.5 t -90.12 -179.15 5.6 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 124.875 2.274 . . . . 0.0 106.644 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.335 22.3 p -78.73 173.43 7.71 Favored Pre-proline 0 N--CA 1.431 -1.394 1 CA-C-N 107.297 -4.501 . . . . 0.0 105.666 178.797 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -93.75 -4.6 2.82 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 105.198 -2.655 . . . . 0.0 105.198 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.33 -10.68 60.0 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.717 1.607 . . . . 0.0 108.3 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -30.55 60.49 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.796 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 36.3 p -83.66 -25.66 30.54 Favored 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.46 1.1 . . . . 0.0 110.069 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.8 -28.61 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 103.242 -2.874 . . . . 0.0 103.242 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.35 58.39 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.145 -2.298 . . . . 0.0 108.609 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.7 t0 -61.74 -53.75 51.76 Favored 'General case' 0 C--N 1.366 1.325 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -87.43 -2.61 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 111.956 -2.384 . . . . 0.0 110.168 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -81.32 -49.69 10.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 117.15 -1.82 . . . . 0.0 110.223 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.16 -36.36 21.11 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 124.161 0.913 . . . . 0.0 112.148 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.8 t -70.59 -29.71 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.767 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.09 -39.91 18.95 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.09 -91.39 0.05 OUTLIER Glycine 0 C--N 1.354 1.571 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.292 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -164.71 150.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 113.564 -1.318 . . . . 0.0 108.608 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 . . . . . 0 C--N 1.347 0.471 0 CA-C-N 111.29 -2.687 . . . . 0.0 104.162 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.591 H112 HG23 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ttt . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.3 77.88 3.95 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.4 156.58 16.42 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 124.429 2.061 . . . . 0.0 108.404 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.96 94.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 107.999 -4.182 . . . . 0.0 108.757 -178.483 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.26 106.53 0.02 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.623 ' HB ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -145.65 111.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.597 ' HB ' HG22 ' A' ' 37' ' ' ILE . 7.6 m -89.72 145.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 CA-C-O 123.198 1.475 . . . . 0.0 109.385 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.34 111.43 15.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 110.081 -3.236 . . . . 0.0 104.034 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . . . -160.83 141.61 7.5 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.854 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.734 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 171.26 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.034 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER 118.97 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.688 0 O-C-N 125.916 2.01 . . . . 0.0 105.879 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.7 -104.11 0.19 Allowed Glycine 0 C--N 1.353 1.509 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.541 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.35 87.44 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 t0 174.9 134.79 0.04 OUTLIER 'General case' 0 C--N 1.346 0.44 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.64 83.69 7.93 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 113.608 -1.633 . . . . 0.0 106.652 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.0 t60 152.31 -49.2 0.01 OUTLIER 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.79 24.64 11.39 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.789 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m 53.78 -151.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 118.153 -1.419 . . . . 0.0 109.719 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.25 3.09 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.649 0.593 . . . . 0.0 113.237 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.7 t30 -46.27 -52.13 13.17 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -14.87 55.94 0.0 OUTLIER 'General case' 0 C--N 1.369 1.442 2 C-N-CA 140.133 7.373 . . . . 0.0 109.348 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 25' ' ' HIS 0.433 0.1 OUTLIER 45.12 39.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.652 1 CA-C-N 107.405 -4.452 . . . . 0.0 110.181 178.463 . . . . . . . . 5 4 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD21 H103 ' A' ' 139' ' ' DBI . 0.1 OUTLIER -74.43 -37.18 63.38 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 174.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.74 -9.76 57.98 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 112.019 -2.355 . . . . 0.0 107.268 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HB3' HG13 ' A' ' 22' ' ' ILE . 16.9 t-80 -87.11 -7.68 57.79 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 m -59.58 -41.33 90.01 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.95 -42.69 98.73 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 110.013 -3.267 . . . . 0.0 109.137 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -82.38 -9.53 59.42 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.82 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 130' ' ' MET . 0.6 OUTLIER -68.2 -42.03 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.556 1.142 . . . . 0.0 108.664 -177.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.82 39.43 0.06 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.0 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.7 27.78 64.51 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.122 -0.944 . . . . 0.0 114.571 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.87 92.01 5.09 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -35.57 141.33 0.08 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 129.757 3.223 . . . . 0.0 109.213 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 2.6 m -121.45 136.42 58.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 111.898 -2.41 . . . . 0.0 106.643 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.3 t -102.31 102.7 13.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.004 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -77.71 114.62 16.74 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.597 HG22 ' HB ' ' A' ' 7' ' ' VAL . 1.1 tt -98.82 -3.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 112.085 -2.325 . . . . 0.0 108.161 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.01 -100.61 2.23 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 123.924 0.765 . . . . 0.0 113.75 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 16.3 m -127.08 -31.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-N 113.223 -1.489 . . . . 0.0 111.876 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -91.83 111.85 23.54 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -101.5 80.26 2.05 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.6 140.84 58.56 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.928 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -90.23 -82.6 0.27 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.359 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.05 -21.18 61.07 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.543 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.25 -34.78 14.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.525 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.01 -8.54 58.67 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 116.864 -1.934 . . . . 0.0 109.686 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.614 ' HB ' HD13 ' A' ' 83' ' ' LEU . 1.1 mp -82.75 -26.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -76.67 -29.77 56.5 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.55 2.04 56.16 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.122 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.64 -20.32 26.51 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 mt -74.3 -39.91 49.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.77 -68.03 0.36 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.471 -2.149 . . . . 0.0 110.144 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -63.78 1.01 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 123.779 0.674 . . . . 0.0 109.713 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.2 tttp 111.62 50.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.61 109.76 0.34 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-N 112.177 -2.283 . . . . 0.0 108.782 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.38 -42.95 19.71 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -151.65 160.35 43.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 117.383 -1.727 . . . . 0.0 107.682 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 mm -122.93 139.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 CA-C-N 111.308 -2.678 . . . . 0.0 106.179 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.42 ' SG ' ' CD1' ' A' ' 57' ' ' LEU . 71.5 m -136.85 124.15 21.89 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.51 -2.132 . . . . 0.0 105.386 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 34.6 m -112.14 135.24 52.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-N 112.592 -2.095 . . . . 0.0 105.532 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.734 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -107.95 106.54 16.84 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 117.37 -1.732 . . . . 0.0 109.662 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 m 131.42 -177.0 0.0 OUTLIER 'General case' 0 C--N 1.352 0.674 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.85 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.648 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -66.0 97.67 0.38 Allowed 'General case' 0 C--N 1.36 1.046 0 CA-C-N 113.749 -1.568 . . . . 0.0 107.187 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.04 -28.27 3.42 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 111.12 -2.764 . . . . 0.0 107.411 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -84.62 -32.02 23.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 111.67 -2.265 . . . . 0.0 106.432 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.46 178.76 46.75 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.081 -1.56 . . . . 0.0 108.529 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mm -80.09 -48.56 20.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -71.97 -20.63 61.71 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.677 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 t -70.61 -45.26 65.6 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.06 18.0 6.31 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 124.464 1.102 . . . . 0.0 109.461 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -31.69 5.68 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 88' ' ' LEU . 12.6 mt -89.22 -25.35 21.79 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 112.998 -1.601 . . . . 0.0 106.783 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -29.12 60.8 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.13 -24.81 43.09 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.653 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -76.57 -15.62 59.81 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' CYS . . . . . 0.426 ' SG ' HG12 ' A' ' 86' ' ' ILE . 62.2 m -90.35 -44.84 9.41 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 123.885 1.802 . . . . 0.0 107.195 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.65 -1.72 22.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 108.589 -3.914 . . . . 0.0 108.857 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -80.81 -54.03 5.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.77 43.59 12.01 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 111.037 -2.801 . . . . 0.0 107.41 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.34 -47.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.212 0 CA-C-N 112.542 -2.117 . . . . 0.0 107.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.614 HD13 ' HB ' ' A' ' 47' ' ' ILE . 88.1 mt -89.04 121.14 31.09 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 119.45 23.11 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.88 75.84 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 CA-C-N 113.087 -1.869 . . . . 0.0 109.711 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.426 HG12 ' SG ' ' A' ' 78' ' ' CYS . 0.6 OUTLIER -115.41 30.7 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-N 112.122 -2.039 . . . . 0.0 106.292 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB3' HH22 ' A' ' 115' ' ' ARG . 72.9 mmtt -142.63 119.0 10.88 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.3 112.22 7.57 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.83 83.84 1.86 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.6 99.17 8.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-N 111.453 -2.612 . . . . 0.0 111.044 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.25 122.77 8.11 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 110.184 -3.189 . . . . 0.0 110.299 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.6 -98.39 2.42 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.3 t30 64.89 -97.13 0.05 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 112.48 -1.86 . . . . 0.0 107.616 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -85.07 111.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.28 168.58 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.628 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.251 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 40.32 57.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.46 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.25 151.34 13.5 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.508 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -173.6 131.83 0.45 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 87.9 -71.6 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 O-C-N 126.113 2.133 . . . . 0.0 105.534 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -92.61 145.43 24.43 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CZ3' HD13 ' A' ' 94' ' ' ILE . 87.3 m95 -129.39 160.29 64.98 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.41 -150.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.02 -26.68 63.22 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.352 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.85 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 124.881 1.363 . . . . 0.0 110.362 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.527 ' H ' HG23 ' A' ' 104' ' ' VAL . 19.7 mt-10 -90.39 24.72 2.48 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.635 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.9 -47.72 65.11 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 103.495 -2.779 . . . . 0.0 103.495 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.13 -20.08 23.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 111.575 -2.557 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -84.17 -45.93 12.43 Favored 'General case' 0 C--N 1.364 1.237 0 C-N-CA 117.977 -1.489 . . . . 0.0 108.879 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.33 -0.38 36.52 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.949 1.406 . . . . 0.0 108.252 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.42 79.81 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -87.77 -50.85 6.2 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.67 37.08 50.3 Favored Glycine 0 C--N 1.363 2.04 0 N-CA-C 116.384 1.313 . . . . 0.0 116.384 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.17 -7.44 58.21 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.01 133.09 50.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.473 HH22 ' HB3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -110.04 169.97 8.38 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.13 166.66 19.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 CA-C-N 113.67 -1.604 . . . . 0.0 107.284 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.596 ' CE2' H102 ' A' ' 139' ' ' DBI . 1.2 m-85 -99.62 150.69 37.02 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.47 160.02 44.93 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.095 1.863 . . . . 0.0 108.708 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.81 122.02 8.45 Favored 'Trans proline' 0 C--N 1.371 1.762 0 N-CA-C 105.219 -2.646 . . . . 0.0 105.219 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.8 -170.27 13.26 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.4 p -69.77 146.03 51.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.16 76.17 8.69 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.57 -20.72 13.63 Favored 'Trans proline' 0 C--N 1.369 1.655 0 O-C-N 123.422 1.222 . . . . 0.0 110.222 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.92 -32.81 51.88 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.374 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -77.73 -11.38 59.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.036 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 129' ' ' ASP . 30.9 p -89.3 -20.93 23.47 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.127 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.69 -26.55 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.29 -2.99 57.27 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.459 -2.155 . . . . 0.0 108.578 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t0 -53.06 -60.58 3.1 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.158 1.456 . . . . 0.0 107.261 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.639 ' HG2' HD13 ' A' ' 134' ' ' LEU . 3.0 ttp -90.02 -22.45 21.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.643 -2.98 . . . . 0.0 111.034 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -86.48 -13.37 46.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.921 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -90.21 -55.6 3.54 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 122.439 1.114 . . . . 0.0 108.366 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 129' ' ' ASP . 88.1 t -63.65 -53.07 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 112.361 -2.2 . . . . 0.0 114.197 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' A' ' 130' ' ' MET . 3.8 mp -89.16 -12.12 41.91 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.37 1.044 . . . . 0.0 109.646 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.54 -78.34 1.35 Allowed Glycine 0 C--N 1.357 1.704 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.22 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 t -163.21 149.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 CA-C-N 113.64 -1.28 . . . . 0.0 108.69 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 . . . . . 0 CA--C 1.546 0.82 0 CA-C-N 111.876 -2.42 . . . . 0.0 107.959 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.596 H102 ' CE2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.74 37.97 3.6 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -79.72 143.24 34.71 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -79.24 95.21 5.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 110.786 -2.916 . . . . 0.0 108.817 -177.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.39 115.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 119.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.77 126.52 49.47 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 CA-C-N 112.285 -2.234 . . . . 0.0 108.385 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 23' ' ' LEU . 56.9 tp -125.15 140.96 52.41 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.182 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 155.57 173.96 24.86 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.997 HG23 HG22 ' A' ' 60' ' ' VAL . 2.2 p 164.98 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.227 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -175.27 -145.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.514 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.49 83.49 1.67 Allowed Glycine 0 C--N 1.361 1.948 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 t -90.41 74.61 6.89 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.594 -1.303 . . . . 0.0 107.968 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -83.14 -30.95 27.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.37 -40.89 0.07 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.449 2.699 . . . . 0.0 104.595 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -166.98 -65.63 0.03 OUTLIER 'General case' 0 C--N 1.369 1.432 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 133.54 100.87 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 127.018 2.699 . . . . 0.0 105.34 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 p -85.64 65.94 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.636 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.548 ' O ' HD23 ' A' ' 23' ' ' LEU . . . -91.37 -19.16 42.79 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.202 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' ILE . 52.6 m-80 -45.04 -54.07 7.1 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 111.57 -2.315 . . . . 0.0 105.13 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -6.68 50.17 0.0 OUTLIER 'General case' 0 C--N 1.38 1.907 2 C-N-CA 140.32 7.448 . . . . 0.0 109.445 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.356 0.0 OUTLIER 36.94 48.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.633 2 CA-C-N 106.731 -4.759 . . . . 0.0 108.557 -178.925 . . . . . . . . 5 4 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.574 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -68.35 -33.31 74.06 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 173.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.49 6.49 4.6 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-N 110.971 -2.831 . . . . 0.0 107.817 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 22' ' ' ILE . 15.7 t-160 -76.0 -41.72 50.29 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -44.83 63.62 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 111.318 -2.673 . . . . 0.0 109.601 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -54.12 -41.35 68.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.363 -178.597 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -21.67 44.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 112.666 -2.061 . . . . 0.0 113.581 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -78.82 -5.41 53.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.751 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.02 0.75 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 115.984 -2.286 . . . . 0.0 109.215 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.32 97.43 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 118.672 -1.727 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.31 151.45 21.05 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -76.98 136.64 38.75 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 111.479 -2.6 . . . . 0.0 105.932 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.96 148.0 7.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 112.304 -2.225 . . . . 0.0 107.011 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.11 67.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 111.172 -2.74 . . . . 0.0 106.982 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.81 115.3 9.8 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.304 -1.771 . . . . 0.0 106.58 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 tt -94.38 -2.35 10.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.636 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 -115.11 3.99 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.402 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -143.94 51.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 113.568 -1.316 . . . . 0.0 109.507 -179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.27 150.51 36.09 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 112.828 -1.987 . . . . 0.0 105.644 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 t -112.13 31.31 6.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 113.059 -1.882 . . . . 0.0 106.043 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 p -82.35 97.58 8.4 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.05 -56.55 3.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.471 -2.15 . . . . 0.0 108.85 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -24.84 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.749 1.281 . . . . 0.0 110.889 -177.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.0 -32.83 18.63 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -88.16 2.91 51.06 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.027 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.01 -31.17 7.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.9 -27.4 61.86 Favored 'General case' 0 C--N 1.366 1.284 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.48 -4.43 55.53 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.89 -8.61 57.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.99 -40.32 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.65 -64.08 1.07 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.46 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -62.0 1.57 Allowed 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? 112.32 45.78 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 O-C-N 127.052 2.72 . . . . 0.0 104.85 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.46 112.1 0.76 Allowed 'General case' 0 C--N 1.358 0.953 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -81.69 0.33 Allowed 'General case' 0 C--N 1.358 0.94 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.711 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.52 130.77 37.3 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.737 1.273 . . . . 0.0 108.333 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.6 162.46 2.4 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.297 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' CYS . . . . . 0.574 ' SG ' HD12 ' A' ' 23' ' ' LEU . 21.5 t -156.99 104.65 2.11 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 HG23 ' A' ' 10' ' ' VAL . 2.1 p -110.35 129.9 64.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.731 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.99 111.32 19.42 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 117.426 -1.71 . . . . 0.0 108.767 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t 145.36 173.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.638 0 CA-C-N 111.27 -2.695 . . . . 0.0 104.52 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.04 -129.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.757 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.38 80.81 8.45 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.21 53.95 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' H ' ' H ' ' A' ' 67' ' ' GLY . 12.9 pt20 -165.52 -20.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 111.689 -2.256 . . . . 0.0 107.654 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.434 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 81.82 177.19 51.66 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.339 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -86.92 9.41 19.43 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.222 -1.489 . . . . 0.0 108.101 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -51.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.51 -27.79 62.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.502 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.49 -57.19 6.2 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -90.18 27.81 1.56 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 124.754 1.284 . . . . 0.0 109.025 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.67 -30.23 6.24 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -90.12 -30.02 17.93 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 112.637 -1.781 . . . . 0.0 107.211 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.509 HH11 ' HG3' ' A' ' 75' ' ' ARG . 1.4 mmt85 -71.31 -31.89 67.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -75.21 -31.89 61.03 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 113.503 -1.68 . . . . 0.0 108.03 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -71.52 -16.09 62.32 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.298 0.999 . . . . 0.0 109.763 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.25 -48.06 7.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 123.169 1.461 . . . . 0.0 108.237 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.307 2.4 p30 -76.63 3.58 11.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 109.727 -3.397 . . . . 0.0 109.389 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.24 -54.89 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 40.34 12.43 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.841 -2.89 . . . . 0.0 107.409 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -48.08 0.04 OUTLIER Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.5 mt -86.58 121.18 28.75 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 121.98 33.51 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.94 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.32 78.46 0.04 OUTLIER Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.966 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.52 33.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.673 -1.763 . . . . 0.0 106.672 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 113.08 4.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.96 111.19 9.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.61 87.61 3.62 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 HG12 ' A' ' 116' ' ' VAL . 33.9 m -89.43 96.32 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 111.184 -2.735 . . . . 0.0 110.119 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.78 101.24 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-N 108.94 -3.755 . . . . 0.0 110.366 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.78 -108.42 3.09 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 112.37 -1.915 . . . . 0.0 109.766 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.96 -110.79 0.09 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -79.18 129.59 37.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.89 174.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.487 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.58 80.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.038 -2.346 . . . . 0.0 112.623 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.08 156.13 8.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 111.972 -2.377 . . . . 0.0 109.086 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -168.78 93.35 0.31 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 95.56 -47.98 0.01 OUTLIER 'General case' 0 C--N 1.355 0.828 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -89.37 122.76 32.91 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -135.64 160.84 66.15 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.8 -149.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.773 1.649 . . . . 0.0 108.239 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.86 -21.2 60.98 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.642 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.8 p -57.32 -70.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 O-C-N 124.619 1.199 . . . . 0.0 111.236 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 104' ' ' VAL . 12.2 mm-40 -88.35 21.49 2.84 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 117.33 -1.748 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.12 -43.07 62.2 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -79.95 -32.05 39.94 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.115 -2.311 . . . . 0.0 107.216 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -91.04 13.45 16.73 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.027 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 -38.8 12.99 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 107.214 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.04 -61.5 1.97 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.22 35.66 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.379 2.419 . . . . 0.0 117.431 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -89.69 -1.39 58.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.18 137.21 43.32 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 173.39 6.35 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 90' ' ' VAL . 18.9 m -140.09 156.4 24.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 124.499 1.124 . . . . 0.0 109.198 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.639 ' CD2' H102 ' A' ' 139' ' ' DBI . 2.0 m-85 -99.72 150.14 36.55 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.24 166.36 5.96 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.123 2.549 . . . . 0.0 109.045 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 -92.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 104.436 -2.948 . . . . 0.0 104.436 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.38 131.64 14.98 Favored Glycine 0 C--N 1.359 1.854 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 t -64.84 162.92 15.27 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 125.494 2.569 . . . . 0.0 109.189 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -170.73 114.35 0.45 Allowed Pre-proline 0 N--CA 1.431 -1.415 1 CA-C-N 106.235 -4.984 . . . . 0.0 100.941 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.68 -4.03 13.82 Favored 'Trans proline' 0 C--N 1.363 1.317 0 O-C-N 122.41 0.689 . . . . 0.0 111.335 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.99 -23.05 65.89 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.958 1.303 . . . . 0.0 108.96 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -28.05 51.5 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.17 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 77.9 p -80.65 -18.68 47.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.968 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.56 -25.55 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.01 46.97 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.387 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.7 t0 -52.73 -62.36 1.7 Allowed 'General case' 0 C--N 1.369 1.421 0 CA-C-O 123.781 1.753 . . . . 0.0 106.832 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 45.9 ttm -90.12 -25.8 20.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 109.574 -3.467 . . . . 0.0 111.383 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -78.52 -13.0 60.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.709 -1.596 . . . . 0.0 110.316 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.98 -56.23 3.37 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.3 t -63.18 -34.49 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.611 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.93 -33.02 30.55 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.63 -86.04 0.15 Allowed Glycine 0 C--N 1.352 1.463 0 O-C-N 124.55 1.156 . . . . 0.0 111.483 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 t -92.23 164.42 2.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 112.527 -1.836 . . . . 0.0 108.698 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.352 0.702 0 CA-C-N 112.709 -2.041 . . . . 0.0 107.715 178.687 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.639 H102 ' CD2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.82 68.75 0.83 Allowed 'General case' 0 C--N 1.352 0.696 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -79.07 169.28 18.44 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.601 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -103.84 104.79 14.83 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 109.065 -3.698 . . . . 0.0 108.589 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.32 99.38 0.01 OUTLIER 'General case' 0 C--N 1.355 0.804 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.85 109.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.52 127.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.775 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 23' ' ' LEU . 2.0 pp -125.28 136.19 53.26 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 112.515 -2.129 . . . . 0.0 105.721 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 171.11 44.27 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.405 -2.634 . . . . 0.0 108.343 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.931 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.9 p 164.42 -122.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.464 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.2 tp -168.68 -149.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.379 1.884 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.82 -142.11 6.15 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 118.76 -1.686 . . . . 0.0 110.234 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.5 -60.83 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -79.82 151.5 30.24 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 113.053 -1.885 . . . . 0.0 106.987 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t 68.49 -108.83 0.09 Allowed 'General case' 0 C--N 1.362 1.114 0 O-C-N 125.272 1.608 . . . . 0.0 107.232 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -164.16 44.14 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.23 43.68 13.57 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.871 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.55 106.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 O-C-N 124.642 1.214 . . . . 0.0 110.922 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.76 -21.97 14.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.256 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ILE . 85.8 m-20 -41.83 -53.15 3.82 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.671 -2.265 . . . . 0.0 104.969 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -9.12 54.05 0.0 OUTLIER 'General case' 0 C--N 1.373 1.62 2 C-N-CA 140.354 7.462 . . . . 0.0 108.265 175.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.336 0.2 OUTLIER 31.05 42.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.39 2 CA-C-N 106.898 -4.683 . . . . 0.0 109.149 -177.897 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.12 -35.18 31.91 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 176.739 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.2 -0.85 30.09 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.163 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -78.18 -35.07 49.2 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.7 p -56.58 -44.31 80.91 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.072 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.824 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.55 -43.5 75.9 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.889 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -26.82 62.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 111.865 -2.425 . . . . 0.0 112.648 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -79.68 0.49 30.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 112.072 -2.331 . . . . 0.0 109.149 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.6 11.3 2.08 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 118.199 -1.4 . . . . 0.0 108.031 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.6 34.44 55.72 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.289 0.993 . . . . 0.0 112.882 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.67 -177.43 3.57 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.39 145.21 25.5 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.365 -2.198 . . . . 0.0 106.55 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.824 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -99.93 135.41 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 110.777 -2.92 . . . . 0.0 107.262 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.25 76.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.419 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.636 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.91 120.75 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.29 -92.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 111.985 -2.37 . . . . 0.0 104.924 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.12 -140.42 5.63 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.41 4.03 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 113.121 -1.54 . . . . 0.0 110.671 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.06 99.54 11.98 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -97.5 54.6 1.2 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -90.08 85.35 6.28 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' CD ' HD21 ' A' ' 74' ' ' LEU . 21.9 tp60 -68.27 -47.65 67.15 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.836 -176.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -36.53 84.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.636 1.21 . . . . 0.0 109.529 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.9 -21.94 50.45 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -85.47 -2.23 57.91 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.46 -35.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -75.6 -33.01 60.53 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.826 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.57 7.09 43.06 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.903 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.21 -21.73 22.01 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -74.47 -38.46 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.7 -69.05 0.23 Allowed 'General case' 0 C--N 1.354 0.787 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.029 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.37 -57.97 3.77 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.158 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' THR . 63.7 tttt 120.47 48.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 126.672 2.483 . . . . 0.0 107.705 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -49.36 106.62 0.11 Allowed 'General case' 0 C--N 1.355 0.819 0 CA-C-O 122.061 0.934 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.87 -38.95 31.6 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' HD11 ' A' ' 134' ' ' LEU . 2.6 pp -151.1 167.52 27.46 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -142.04 150.75 18.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-N 112.081 -2.327 . . . . 0.0 105.839 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.69 134.78 22.72 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.38 135.28 40.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.806 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.931 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.14 91.12 3.54 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.5 t 150.62 165.92 0.0 OUTLIER 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.8 -127.84 0.0 OUTLIER 'General case' 0 C--N 1.359 1.007 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.308 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 86.4 7.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.84 42.56 1.21 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 110.92 -2.855 . . . . 0.0 106.928 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -147.08 -32.61 0.3 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 111.143 -2.528 . . . . 0.0 106.841 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.49 167.84 43.35 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.51 1.55 19.0 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.992 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -47.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -72.27 -27.06 62.24 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 114.303 -1.317 . . . . 0.0 107.66 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.29 -47.7 66.94 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.12 26.6 1.83 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.909 1.381 . . . . 0.0 108.829 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.7 -34.96 5.79 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.464 HD21 ' CD ' ' A' ' 43' ' ' GLN . 1.6 mt -88.84 -28.14 20.59 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 112.032 -2.084 . . . . 0.0 107.712 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.06 -24.43 58.23 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -82.04 -29.08 32.13 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -76.6 -15.66 59.78 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.31 1.006 . . . . 0.0 109.189 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 20.7 t -90.29 -47.71 7.59 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 123.982 1.849 . . . . 0.0 107.115 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.91 -3.61 23.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 108.478 -3.965 . . . . 0.0 109.158 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -82.01 -56.08 4.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.01 47.65 5.69 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 110.932 -2.849 . . . . 0.0 106.616 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.95 -44.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.73 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.81 120.9 24.7 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 134.14 34.42 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.47 56.96 0.06 OUTLIER Glycine 0 C--N 1.349 1.284 0 CA-C-N 112.733 -2.03 . . . . 0.0 110.266 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 tt -104.7 47.55 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -142.51 118.17 10.42 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -140.04 151.84 45.74 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.205 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.34 91.41 2.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 m -89.35 99.11 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 126.039 2.828 . . . . 0.0 110.339 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.08 109.08 2.71 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 108.498 -3.955 . . . . 0.0 109.358 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.8 -101.65 2.23 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 112.244 -1.978 . . . . 0.0 109.353 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t30 64.65 -104.84 0.12 Allowed 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.88 56.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.35 176.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.858 -1.974 . . . . 0.0 108.505 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.51 56.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.838 0 CA-C-N 112.722 -2.036 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.77 141.35 5.15 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.142 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.3 106.22 0.24 Allowed 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.17 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 126.032 2.083 . . . . 0.0 105.608 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.49 130.69 35.79 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -142.99 158.84 58.18 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.77 -148.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.853 0 N-CA-C 107.442 -1.792 . . . . 0.0 107.442 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.97 -22.34 60.71 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.0 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.804 0 O-C-N 124.519 1.137 . . . . 0.0 111.309 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.3 mm-40 -89.85 22.95 2.91 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 117.391 -1.723 . . . . 0.0 108.338 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.35 -42.13 59.88 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -79.65 -32.07 41.57 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 112.104 -2.316 . . . . 0.0 106.877 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.72 15.97 13.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.841 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 -40.56 11.94 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 176.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.15 74.86 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 112.355 -2.202 . . . . 0.0 107.473 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.4 mtp -80.78 -58.69 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.11 40.67 0.08 OUTLIER Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.347 2.403 . . . . 0.0 117.32 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -84.62 -6.29 59.36 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.62 132.08 50.19 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -178.26 3.47 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.9 m -140.07 161.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.227 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.489 ' CE2' H102 ' A' ' 139' ' ' DBI . 5.6 m-85 -99.36 154.35 37.33 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-N 110.532 -3.031 . . . . 0.0 103.679 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.26 159.73 43.32 Favored 'Trans proline' 0 C--N 1.368 1.554 0 N-CA-C 107.173 -1.895 . . . . 0.0 107.173 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.02 116.46 4.66 Favored 'Trans proline' 0 C--N 1.369 1.649 0 N-CA-C 103.763 -3.206 . . . . 0.0 103.763 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.81 132.79 5.57 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 t -73.62 159.61 32.82 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-O 125.25 2.452 . . . . 0.0 107.67 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.5 p -173.4 119.57 0.39 Allowed Pre-proline 0 N--CA 1.427 -1.607 1 CA-C-N 106.484 -4.871 . . . . 0.0 101.537 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 71.5 Cg_endo -78.93 -4.53 14.02 Favored 'Trans proline' 0 C--N 1.358 1.041 0 N-CA-C 108.698 -1.309 . . . . 0.0 108.698 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.29 -37.38 87.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.462 1.905 . . . . 0.0 107.619 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.87 -23.71 59.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.615 -1.629 . . . . 0.0 108.148 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.4 p -81.79 -25.57 35.15 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 116.948 -1.901 . . . . 0.0 109.909 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.72 -24.87 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.44 -6.48 58.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 112.969 -1.923 . . . . 0.0 108.714 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.3 t0 -61.89 -58.03 9.48 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.0 mmt -88.15 -10.78 48.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.069 -1.878 . . . . 0.0 110.874 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -90.21 -49.81 6.35 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 117.864 -1.534 . . . . 0.0 109.013 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.92 -50.27 66.78 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.214 0.946 . . . . 0.0 109.868 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 129' ' ' ASP . 51.1 t -69.45 -61.36 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 113.035 -1.893 . . . . 0.0 111.86 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.1 mp -90.38 52.61 2.27 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.768 1.293 . . . . 0.0 109.876 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.75 -77.7 0.03 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -165.22 149.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.148 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 112.508 -2.133 . . . . 0.0 105.392 -178.883 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.489 H102 ' CE2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttp . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -95.39 80.26 3.5 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.12 161.16 26.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.802 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 21.2 pttp -119.6 108.91 15.06 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 110.927 -2.851 . . . . 0.0 108.123 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.41 85.48 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' SD ' ' A' ' 130' ' ' MET . 0.8 OUTLIER -109.86 107.25 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 110.721 -2.945 . . . . 0.0 103.751 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.68 126.35 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.483 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.27 153.13 43.69 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.4 -2.182 . . . . 0.0 106.679 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.23 174.07 42.42 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 111.137 -2.756 . . . . 0.0 108.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.933 ' HB ' ' H ' ' A' ' 61' ' ' SER . 3.0 p 164.48 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.541 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.3 tp -168.29 -150.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.38 1.904 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.17 -142.17 6.11 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 118.681 -1.723 . . . . 0.0 110.327 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.87 -61.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.05 151.8 29.73 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.965 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t 68.91 -109.09 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.116 1.51 . . . . 0.0 107.252 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -163.93 43.14 0.1 Allowed 'General case' 0 C--N 1.361 1.104 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.308 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.17 42.44 15.41 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.034 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.15 107.68 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 O-C-N 124.647 1.217 . . . . 0.0 110.997 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.96 -22.13 16.44 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.133 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 22' ' ' ILE . 86.1 m-20 -42.33 -52.36 4.56 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 111.639 -2.28 . . . . 0.0 105.034 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' C ' HD13 ' A' ' 22' ' ' ILE . 88.7 tttt -11.39 56.86 0.0 OUTLIER 'General case' 0 C--N 1.373 1.592 2 C-N-CA 140.014 7.325 . . . . 0.0 107.906 175.548 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.466 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.348 0.2 OUTLIER 29.65 42.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.332 2 CA-C-N 106.614 -4.812 . . . . 0.0 109.522 -178.213 . . . . . . . . 5 4 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -35.53 25.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 2.1 p30 -76.95 -2.95 36.35 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 113.694 -1.594 . . . . 0.0 106.868 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -77.36 -34.97 55.0 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -56.79 -43.53 80.99 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.28 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.748 ' CZ ' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.28 -44.07 75.35 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.928 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -27.33 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 111.545 -2.57 . . . . 0.0 112.782 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -78.74 -0.53 30.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.201 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.28 9.21 2.49 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 118.511 -1.275 . . . . 0.0 107.908 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 33.58 58.57 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 124.243 0.964 . . . . 0.0 112.627 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -99.61 -179.47 4.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 28.2 t-20 -76.85 144.5 38.99 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 112.219 -2.264 . . . . 0.0 106.873 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.748 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.92 127.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 110.669 -2.969 . . . . 0.0 107.469 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 7' ' ' VAL . 5.8 t -140.19 128.75 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 111.561 -2.563 . . . . 0.0 105.6 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -144.2 132.49 21.91 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -97.08 -87.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 111.85 -2.432 . . . . 0.0 104.886 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.05 -137.99 4.77 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.6 2.28 8.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 CA-C-N 113.201 -1.499 . . . . 0.0 110.716 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.27 98.31 11.26 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 47.6 t -97.9 55.34 1.18 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 p -90.14 86.51 6.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.413 ' CD ' HD21 ' A' ' 74' ' ' LEU . 19.9 tp60 -66.81 -46.31 75.6 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.144 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -37.71 88.54 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.482 1.113 . . . . 0.0 109.61 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -77.72 -21.01 52.57 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.88 -2.24 58.06 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.7 -35.88 32.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -75.04 -32.21 61.5 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.958 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.98 5.69 49.15 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.988 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.25 -19.04 24.6 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.15 -38.48 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -59.51 -69.13 0.22 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.988 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.85 -54.74 10.42 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.722 -176.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' THR . 64.0 tttt 117.65 47.23 0.0 OUTLIER 'General case' 0 C--N 1.356 0.852 0 O-C-N 126.705 2.503 . . . . 0.0 107.55 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -48.85 106.46 0.1 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.499 1.142 . . . . 0.0 110.279 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.63 -38.15 34.46 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 111.584 -2.553 . . . . 0.0 104.163 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 134' ' ' LEU . 1.9 pp -154.39 165.05 37.61 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -138.61 142.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 111.722 -2.49 . . . . 0.0 106.169 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.79 133.67 34.31 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 135.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.138 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.933 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.42 91.85 3.82 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 t 150.09 166.26 0.0 OUTLIER 'General case' 0 C--N 1.36 1.056 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.75 -127.24 0.0 OUTLIER 'General case' 0 C--N 1.358 0.959 0 CA-C-N 113.595 -1.638 . . . . 0.0 107.277 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.61 85.16 7.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.48 42.87 1.26 Allowed Glycine 0 C--N 1.345 1.058 0 CA-C-N 110.881 -2.872 . . . . 0.0 107.089 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -148.38 -32.42 0.25 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 111.181 -2.509 . . . . 0.0 106.857 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.08 167.73 42.79 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.39 1.38 19.17 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.582 -1.309 . . . . 0.0 109.044 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.32 -46.51 17.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -72.6 -27.38 62.13 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.781 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.47 -47.28 67.52 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -90.07 25.43 2.15 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 124.815 1.322 . . . . 0.0 108.988 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.35 -33.31 6.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.3 mt -88.27 -29.67 20.23 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 111.939 -2.131 . . . . 0.0 107.678 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -24.23 58.67 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.1 -29.25 31.84 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -76.49 -15.1 59.97 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.235 0.959 . . . . 0.0 109.238 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.35 -48.12 7.33 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 124.014 1.864 . . . . 0.0 107.059 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.61 -3.67 22.83 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 108.43 -3.986 . . . . 0.0 109.207 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.45 -56.36 3.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.75 48.02 5.81 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 110.964 -2.835 . . . . 0.0 106.641 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.75 -43.62 0.02 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.905 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.35 120.57 23.98 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 136.12 33.95 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.72 53.96 0.09 OUTLIER Glycine 0 C--N 1.35 1.307 0 CA-C-N 112.734 -2.03 . . . . 0.0 110.117 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.86 55.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -148.35 118.67 7.33 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.55 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -139.98 151.84 45.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.862 -1.972 . . . . 0.0 106.121 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 90.99 2.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 m -89.33 98.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 CA-C-O 126.106 2.86 . . . . 0.0 110.307 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 109.54 2.82 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 108.456 -3.975 . . . . 0.0 109.367 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -101.14 2.14 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.195 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.3 t30 64.38 -104.94 0.12 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.34 125.28 56.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.44 177.32 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.824 -1.989 . . . . 0.0 108.449 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.57 55.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-N 112.654 -2.067 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.92 141.34 5.1 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.227 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.27 105.51 0.23 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.36 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.356 0.856 0 O-C-N 126.056 2.097 . . . . 0.0 105.526 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -89.22 130.09 35.69 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -142.91 158.82 58.45 Favored Pre-proline 0 C--N 1.352 0.675 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.73 -148.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.374 1.872 0 N-CA-C 107.433 -1.795 . . . . 0.0 107.433 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.96 -22.32 60.72 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.969 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 124.495 1.122 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.49 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.0 mm-40 -89.99 23.11 2.9 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.403 -1.719 . . . . 0.0 108.41 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -74.43 -42.41 59.18 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 112.065 -2.334 . . . . 0.0 106.869 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.19 16.43 13.06 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.914 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -40.71 11.83 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.25 75.28 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 112.212 -2.267 . . . . 0.0 107.408 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.1 mtp -80.78 -58.51 3.06 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 31.52 41.04 0.07 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.399 2.428 . . . . 0.0 117.373 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.69 -6.09 59.34 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.4 132.14 49.91 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -178.97 3.66 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.02 161.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 117.793 -1.563 . . . . 0.0 110.255 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.506 ' CE2' H102 ' A' ' 139' ' ' DBI . 5.9 m-85 -99.39 154.41 37.3 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.815 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.08 160.66 42.42 Favored 'Trans proline' 0 C--N 1.368 1.579 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.9 116.43 4.66 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 103.823 -3.183 . . . . 0.0 103.823 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.11 133.86 5.94 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -73.84 159.61 32.62 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 125.144 2.402 . . . . 0.0 107.52 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.7 p -173.17 120.57 0.41 Allowed Pre-proline 0 N--CA 1.427 -1.606 1 CA-C-N 106.583 -4.826 . . . . 0.0 101.648 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 80.1 Cg_endo -78.8 -5.45 14.68 Favored 'Trans proline' 0 C--N 1.357 0.999 0 N-CA-C 108.685 -1.313 . . . . 0.0 108.685 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.84 -37.92 89.17 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.547 1.939 . . . . 0.0 107.744 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.256 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.3 p -82.09 -25.44 34.51 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 116.94 -1.904 . . . . 0.0 109.983 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.3 mt -67.65 -24.78 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.77 -6.3 58.23 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.77 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.1 t0 -61.91 -58.37 8.19 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.579 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 35.1 mmt -87.09 -11.93 48.7 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.82 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -90.13 -48.55 7.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.201 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -47.99 71.27 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 124.131 0.894 . . . . 0.0 109.921 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.3 t -71.42 -61.19 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.638 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.9 mp -90.37 53.97 2.62 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.842 1.339 . . . . 0.0 109.635 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.26 -78.08 0.04 OUTLIER Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.07 151.28 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.638 0 CA-C-N 113.74 -1.23 . . . . 0.0 108.241 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 112.387 -2.188 . . . . 0.0 105.211 -179.141 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.506 H102 ' CE2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.39 43.74 1.05 Allowed 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.212 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -63.04 144.06 57.23 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.404 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.24 102.44 14.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 111.786 -2.461 . . . . 0.0 107.505 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.03 105.75 0.03 OUTLIER 'General case' 0 C--N 1.357 0.919 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 112.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -101.8 117.92 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 111.779 -2.464 . . . . 0.0 108.293 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 23' ' ' LEU . 16.2 tp -90.14 159.89 16.54 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.912 -1.949 . . . . 0.0 108.262 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.48 29.84 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 111.422 -2.626 . . . . 0.0 107.844 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.36 131.75 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 122.312 1.053 . . . . 0.0 112.087 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.54 133.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.31 175.71 36.19 Favored Glycine 0 C--N 1.357 1.719 0 C-N-CA 117.818 -2.134 . . . . 0.0 113.192 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.307 13.7 p -114.45 20.56 15.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 108.25 -3.975 . . . . 0.0 107.258 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.09 132.84 3.12 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.5 p -81.56 115.91 21.07 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 61.0 t60 79.04 142.02 0.08 Allowed 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.17 73.33 0.34 Allowed 'General case' 0 C--N 1.356 0.88 0 CA-C-N 112.938 -1.937 . . . . 0.0 106.26 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -161.84 41.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 112.709 -2.042 . . . . 0.0 111.06 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.21 -28.32 15.26 Favored Glycine 0 C--N 1.359 1.81 0 CA-C-O 122.157 0.865 . . . . 0.0 113.857 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -41.85 -47.31 4.18 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -11.49 57.2 0.0 OUTLIER 'General case' 0 C--N 1.382 2.001 3 C-N-CA 140.77 7.628 . . . . 0.0 107.833 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.355 0.2 OUTLIER 30.09 54.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.434 1 CA-C-N 106.242 -4.981 . . . . 0.0 107.922 -177.371 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 tt -70.91 -25.54 62.81 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 102.11 -3.292 . . . . 0.0 102.11 173.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -66.32 -17.44 64.76 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 116.744 -1.982 . . . . 0.0 107.221 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.515 ' HB2' HG22 ' A' ' 22' ' ' ILE . 13.0 t-80 -69.4 -24.5 63.86 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.461 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 7.4 p -56.78 -37.82 71.63 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 125.024 1.453 . . . . 0.0 108.739 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.953 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -54.64 -49.42 70.58 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.029 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -22.78 61.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.114 -2.312 . . . . 0.0 112.904 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -81.33 0.07 38.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.688 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.93 12.9 1.45 Allowed 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.001 -1.48 . . . . 0.0 107.906 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 37.74 46.2 Favored Glycine 0 C--N 1.36 1.869 0 O-C-N 124.229 0.955 . . . . 0.0 113.056 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.71 -168.11 1.56 Allowed 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.303 -1.449 . . . . 0.0 107.519 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -93.8 140.04 30.14 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.705 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.953 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.74 127.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 109.995 -3.275 . . . . 0.0 108.927 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 7' ' ' VAL . 3.7 t -140.31 144.48 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 109.909 -3.314 . . . . 0.0 104.432 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.13 135.79 8.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.96 -67.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.36 -145.63 16.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 112.144 -2.298 . . . . 0.0 108.374 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.52 88.7 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.744 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 1.2 tp -164.68 119.72 1.41 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 t -98.31 37.11 1.49 Allowed 'General case' 0 C--N 1.358 0.974 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.478 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.744 ' OG ' ' HG ' ' A' ' 40' ' ' LEU . 72.9 p -90.17 98.15 11.6 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.16 -55.45 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.985 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.9 pt-20 -64.78 -20.44 66.37 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.65 1.219 . . . . 0.0 111.597 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.34 -37.26 17.27 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.239 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -90.04 10.16 25.24 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 118.027 -1.469 . . . . 0.0 108.629 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -86.04 -32.46 6.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.022 0 N-CA-C 102.27 -3.234 . . . . 0.0 102.27 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.68 -26.1 60.57 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.27 -6.79 56.5 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.64 51.34 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mt -83.87 -41.64 16.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.22 -57.52 12.08 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 112.146 -2.297 . . . . 0.0 108.835 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.21 -55.06 20.68 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 90.21 53.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.114 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.57 126.52 27.79 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 111.2 -2.727 . . . . 0.0 107.335 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -88.21 -31.92 18.83 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 112.825 -1.988 . . . . 0.0 107.214 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -157.76 154.34 28.02 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 88' ' ' LEU . 2.7 mt -114.73 165.91 9.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 111.908 -2.405 . . . . 0.0 105.489 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 89.0 m -153.14 100.56 2.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 111.333 -2.667 . . . . 0.0 103.989 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.92 137.39 36.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.493 ' HA ' ' H4 ' ' A' ' 139' ' ' DBI . 3.6 m -99.71 125.8 45.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 t -157.99 175.4 13.87 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 114.639 -2.824 . . . . 0.0 107.519 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.67 48.38 0.8 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.814 -2.903 . . . . 0.0 106.454 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 72.78 32.76 1.39 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 113.734 -1.576 . . . . 0.0 107.305 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.53 -3.01 22.62 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.367 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -87.63 -17.75 31.19 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.72 177.44 49.12 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.341 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.07 18.9 5.36 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.6 -1.3 . . . . 0.0 108.048 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -53.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 m-20 -71.19 -26.17 62.84 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.413 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.9 t -66.67 -56.18 11.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -90.1 30.1 1.14 Allowed 'General case' 0 C--N 1.359 1.0 0 O-C-N 124.684 1.24 . . . . 0.0 109.36 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.14 -38.83 3.94 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 70' ' ' ASP . 1.7 mm? -90.03 -23.13 21.55 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 112.705 -1.747 . . . . 0.0 107.771 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -29.94 59.9 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.36 -26.56 52.09 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.69 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -74.71 -17.62 60.63 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.005 0.816 . . . . 0.0 109.261 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.5 t -90.22 -46.47 8.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.919 1.819 . . . . 0.0 107.524 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -74.17 0.76 12.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 108.67 -3.877 . . . . 0.0 109.095 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.03 -55.97 3.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.27 45.56 6.7 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-N 110.84 -2.891 . . . . 0.0 106.68 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.07 -43.62 0.02 OUTLIER Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.492 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -79.62 120.87 24.56 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.57 35.91 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.21 122.42 2.68 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 112.17 -2.286 . . . . 0.0 107.459 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 tt -149.56 34.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -138.4 118.18 13.19 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -138.79 112.87 8.6 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.49 89.77 4.06 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.84 91.19 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 111.076 -2.784 . . . . 0.0 110.351 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.645 ' HA3' H102 ' A' ' 139' ' ' DBI . . . -69.71 142.17 36.22 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 110.218 -3.174 . . . . 0.0 110.393 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.84 -83.67 1.61 Allowed Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.406 -2.397 . . . . 0.0 107.229 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 61.5 -108.05 0.3 Allowed 'General case' 0 C--N 1.355 0.835 0 CA-C-N 112.56 -1.82 . . . . 0.0 107.053 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.3 mt -118.09 149.71 20.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.43 -172.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.667 0 CA-C-N 112.728 -2.033 . . . . 0.0 108.73 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 39.24 68.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.834 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.881 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.9 171.13 35.13 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 112.316 -2.22 . . . . 0.0 109.878 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -157.03 -49.25 0.07 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.21 -38.14 2.0 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.76 111.44 22.45 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -119.09 166.09 15.28 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.48 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 N-CA-C 108.1 -1.539 . . . . 0.0 108.1 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.91 -24.45 61.64 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 113.844 -1.526 . . . . 0.0 108.41 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.4 p -55.78 -72.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 O-C-N 124.739 1.275 . . . . 0.0 111.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.57 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.1 mt-10 -88.78 25.94 1.64 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.65 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.78 -45.37 36.6 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -80.57 -30.04 36.98 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 111.541 -2.572 . . . . 0.0 107.531 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -91.51 12.65 20.1 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.878 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -38.46 13.36 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.9 73.08 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.729 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.9 mtp -81.79 -61.53 1.9 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.0 39.87 0.01 OUTLIER Glycine 0 C--N 1.356 1.641 0 C-N-CA 127.698 2.571 . . . . 0.0 117.432 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -87.79 -6.19 58.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.07 137.66 42.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 170.45 8.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 102.496 -3.15 . . . . 0.0 102.496 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.88 156.47 25.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.212 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.49 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 1.6 m-85 -99.59 128.66 30.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.92 160.27 26.19 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.324 2.016 . . . . 0.0 109.322 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.24 121.27 7.64 Favored 'Trans proline' 0 C--N 1.369 1.646 0 N-CA-C 104.684 -2.852 . . . . 0.0 104.684 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 67.18 0.94 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -89.85 -165.77 1.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 110.466 -2.867 . . . . 0.0 106.775 -178.004 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 121' ' ' THR . 3.5 p -168.26 168.35 5.83 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 111.566 -2.561 . . . . 0.0 104.447 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.19 -8.15 17.41 Favored 'Trans proline' 0 C--N 1.367 1.543 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.33 -29.21 65.86 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -20.41 49.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.822 -1.536 . . . . 0.0 108.006 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 129' ' ' ASP . 4.5 p -82.7 -16.81 46.7 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 118.048 -1.461 . . . . 0.0 110.264 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.0 -29.38 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 -1.33 57.75 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 133' ' ' VAL . 53.4 t0 -64.5 -63.59 1.09 Allowed 'General case' 0 C--N 1.359 1.01 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.461 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -83.23 -10.49 58.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.431 -2.168 . . . . 0.0 110.299 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.18 -46.06 8.69 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.91 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.45 -37.28 77.72 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.591 0.557 . . . . 0.0 109.957 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 129' ' ' ASP . 74.1 t -88.51 -73.98 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.016 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 133' ' ' VAL . 95.9 mt -90.41 57.11 3.56 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 124.644 1.215 . . . . 0.0 109.423 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.49 -36.64 0.02 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.26 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.25 159.21 11.2 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 CA--C 1.543 0.674 0 CA-C-N 113.175 -1.829 . . . . 0.0 107.042 179.531 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.645 H102 ' HA3' ' A' ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ttt . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -105.92 36.15 2.66 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 112.962 -1.927 . . . . 0.0 106.188 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.24 141.3 54.66 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 123.197 1.475 . . . . 0.0 108.617 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.29 95.64 8.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 110.548 -3.023 . . . . 0.0 107.894 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -176.65 111.55 0.09 Allowed 'General case' 0 C--N 1.355 0.807 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.27 111.94 9.93 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.82 18.56 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 O-C-N 125.866 1.979 . . . . 0.0 105.689 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.654 HD13 HD22 ' A' ' 23' ' ' LEU . 16.6 tp -113.45 149.36 34.34 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 123.114 1.435 . . . . 0.0 108.81 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 149.87 21.4 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 110.866 -2.879 . . . . 0.0 106.577 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.32 98.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.714 0 CA-C-O 122.328 1.061 . . . . 0.0 110.587 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.3 156.69 4.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.73 175.41 46.92 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 115.574 -3.203 . . . . 0.0 113.597 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.288 25.2 p -115.26 22.68 13.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 108.2 -4.0 . . . . 0.0 106.344 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -161.92 132.76 5.07 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -79.0 103.65 9.09 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.7 t60 77.27 149.84 0.11 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 71.49 73.1 0.18 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -159.47 -12.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.198 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.51 -23.58 0.1 Allowed Glycine 0 C--N 1.354 1.569 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.004 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -40.92 -49.61 3.24 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -12.96 58.84 0.0 OUTLIER 'General case' 0 C--N 1.381 1.941 2 C-N-CA 139.927 7.291 . . . . 0.0 107.757 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.383 0.3 OUTLIER 26.61 54.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.408 -2.571 2 CA-C-N 105.222 -5.445 . . . . 0.0 108.263 -177.142 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 8' ' ' LEU . 7.1 tt -74.17 -24.84 59.45 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 102.386 -3.19 . . . . 0.0 102.386 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 35.4 m-20 -71.9 -8.99 57.63 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 22' ' ' ILE . 10.2 t-160 -74.51 -30.09 61.66 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -53.29 -44.36 68.23 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 125.647 1.842 . . . . 0.0 110.349 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -60.07 -41.71 93.01 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.87 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.7 -24.57 59.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.668 -2.06 . . . . 0.0 112.689 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -81.87 -1.19 46.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 112.224 -2.262 . . . . 0.0 108.926 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.59 3.7 2.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.75 32.06 68.97 Favored Glycine 0 C--N 1.358 1.795 0 O-C-N 123.952 0.783 . . . . 0.0 111.674 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -99.7 -175.3 2.94 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 113.206 -1.497 . . . . 0.0 107.542 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -86.26 138.63 31.71 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 112.291 -2.231 . . . . 0.0 108.271 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.838 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.62 127.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 109.824 -3.353 . . . . 0.0 107.807 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 53' ' ' THR . 10.9 t -140.1 125.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 110.036 -3.256 . . . . 0.0 104.662 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -142.77 128.6 19.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.03 -75.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.34 -151.18 23.42 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.638 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -87.79 84.05 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 9.8 tp -162.49 117.5 1.84 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.1 t -93.53 48.34 1.29 Allowed 'General case' 0 C--N 1.356 0.889 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.281 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.732 ' OG ' ' HG ' ' A' ' 40' ' ' LEU 0.257 8.8 p -90.5 95.45 10.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 103.767 -2.679 . . . . 0.0 103.767 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -90.13 -57.83 2.71 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 118.03 -1.468 . . . . 0.0 108.322 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.1 -18.46 63.44 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.828 1.33 . . . . 0.0 111.382 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -91.35 -37.11 13.44 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 118.495 -1.282 . . . . 0.0 107.65 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.496 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 23.3 m-85 -90.06 10.05 25.74 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.924 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 -33.69 6.35 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -73.37 -25.02 60.41 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -92.05 -2.33 56.73 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 -9.45 48.61 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.2 -41.6 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.62 -58.69 7.51 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 112.129 -2.305 . . . . 0.0 108.404 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.89 -56.21 12.96 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.68 1.237 . . . . 0.0 107.821 -178.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 tttp 95.64 47.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 110.362 -3.108 . . . . 0.0 102.722 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.62 5.43 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 111.851 -2.431 . . . . 0.0 106.819 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 5' ' ' THR . 24.6 t0 -80.48 -36.44 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 111.706 -2.497 . . . . 0.0 106.555 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.41 158.39 44.1 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.21 141.32 46.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 CA-C-N 111.797 -2.456 . . . . 0.0 104.957 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.97 109.16 9.85 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.32 133.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' H4 ' ' A' ' 139' ' ' DBI . 1.2 m -100.94 117.55 35.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 t -157.76 177.83 10.93 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 115.623 -2.431 . . . . 0.0 108.133 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.6 46.19 0.72 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 111.405 -2.634 . . . . 0.0 106.947 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.32 30.1 0.53 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.197 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -2.02 27.33 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.092 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.97 -8.95 44.72 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.44 177.38 13.19 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.524 1.14 . . . . 0.0 110.558 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 25.5 2.18 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.807 -1.196 . . . . 0.0 108.028 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -54.16 8.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.21 -26.37 62.02 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.954 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -68.71 -58.51 4.12 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -90.1 27.88 1.52 Allowed 'General case' 0 C--N 1.359 0.99 0 O-C-N 124.751 1.282 . . . . 0.0 110.145 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.03 -30.15 5.53 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 88' ' ' LEU . 31.0 mt -90.07 -28.28 19.12 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.332 -1.934 . . . . 0.0 107.484 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -29.79 58.88 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.09 -27.87 57.33 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.484 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -73.58 -19.54 60.85 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 123.92 0.762 . . . . 0.0 109.651 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.25 -46.3 8.5 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.806 1.765 . . . . 0.0 107.902 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -73.98 0.95 11.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 108.788 -3.824 . . . . 0.0 109.167 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.24 -56.29 3.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.83 45.66 5.54 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.73 -2.941 . . . . 0.0 106.494 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.48 -42.1 0.02 OUTLIER Glycine 0 C--N 1.352 1.423 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.841 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 mt -78.8 122.78 26.48 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.49 117.58 2.35 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 112.229 -2.259 . . . . 0.0 108.554 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 tt -143.36 40.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -140.66 117.26 10.88 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -140.09 108.3 5.79 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.19 86.84 3.3 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.027 -3.323 . . . . 0.0 102.027 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.35 95.98 5.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 CA-C-N 111.338 -2.664 . . . . 0.0 109.65 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -60.31 128.44 45.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 109.259 -3.61 . . . . 0.0 111.82 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.88 -83.12 1.55 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 111.539 -2.331 . . . . 0.0 107.372 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 71.22 -88.35 0.03 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 112.505 -1.847 . . . . 0.0 106.827 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 mt -135.33 149.72 28.86 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -175.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.835 -1.984 . . . . 0.0 108.864 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.7 84.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-N 112.007 -2.361 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.47 -178.42 28.81 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.239 -2.255 . . . . 0.0 110.608 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -159.33 -44.73 0.05 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 111.523 -2.338 . . . . 0.0 104.839 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.18 -37.16 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -87.13 89.84 8.14 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -101.99 169.26 7.86 Favored Pre-proline 0 C--N 1.35 0.615 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -152.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.752 0 N-CA-C 108.092 -1.541 . . . . 0.0 108.092 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.45 -24.15 61.97 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.459 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -56.69 -72.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 O-C-N 124.764 1.29 . . . . 0.0 111.544 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' H ' HG13 ' A' ' 104' ' ' VAL . 25.7 mt-10 -89.03 26.25 1.62 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 117.773 -1.571 . . . . 0.0 109.846 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -76.66 -45.77 28.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -80.24 -29.0 38.38 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 111.46 -2.609 . . . . 0.0 107.509 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.72 12.77 22.24 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.897 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -37.12 14.22 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.25 75.14 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-N 112.845 -1.979 . . . . 0.0 107.494 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.7 mtp -80.2 -61.21 2.05 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.95 38.57 0.01 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.91 2.671 . . . . 0.0 117.708 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -84.84 -6.84 59.35 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.14 135.97 45.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.437 HH21 HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.19 170.42 8.09 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.15 163.01 24.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.476 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 1.0 OUTLIER -99.58 153.45 37.77 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.42 164.92 25.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.826 1.684 . . . . 0.0 108.056 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.23 118.01 3.91 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 102.377 -3.74 . . . . 0.0 102.377 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.71 68.98 1.09 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 122' ' ' SER 0.273 0.2 OUTLIER -90.25 -158.08 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 109.496 -3.352 . . . . 0.0 107.336 -177.848 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.512 ' H ' HG22 ' A' ' 121' ' ' THR . 10.4 p -174.22 164.14 2.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 110.47 -3.059 . . . . 0.0 103.936 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.25 -5.4 15.67 Favored 'Trans proline' 0 C--N 1.365 1.401 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.56 -29.5 64.8 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -20.8 56.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.647 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -85.34 -14.78 45.39 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.764 -1.175 . . . . 0.0 110.06 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mt -69.61 -28.62 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 -2.49 58.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.41 -2.177 . . . . 0.0 108.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.1 t0 -61.33 -62.4 1.86 Allowed 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -82.31 -7.72 59.63 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.282 -2.235 . . . . 0.0 110.444 -176.362 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.1 -54.25 4.12 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.443 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.92 -39.5 71.75 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.752 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.661 HG12 HD23 ' A' ' 134' ' ' LEU . 80.6 t -89.99 -68.99 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 125.193 1.558 . . . . 0.0 111.778 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 133' ' ' VAL . 89.1 mt -90.31 54.25 2.71 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.746 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -162.67 -37.22 0.02 OUTLIER Glycine 0 C--N 1.346 1.088 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.736 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.23 161.98 17.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 CA--C 1.543 0.711 0 CA-C-N 113.394 -1.73 . . . . 0.0 107.268 179.219 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 139' ' ' DBI . . . . . 0.448 H112 HG21 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 . . . . . 0 CA--C 1.545 0.764 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.27 133.76 39.98 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -81.25 89.57 6.05 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 111.023 -2.808 . . . . 0.0 107.335 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -174.36 120.2 0.25 Allowed 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.12 112.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.528 HG23 HG12 ' A' ' 35' ' ' VAL . 2.3 p -98.98 113.6 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.678 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -125.2 154.04 42.17 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.911 1.382 . . . . 0.0 109.762 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.25 -154.32 25.12 Favored Glycine 0 C--N 1.361 1.963 0 CA-C-N 111.931 -2.395 . . . . 0.0 112.689 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 14.9 p 88.28 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 131.095 3.758 . . . . 0.0 115.398 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 10' ' ' VAL 0.271 1.2 tt 67.03 148.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.173 2.189 . . . . 0.0 109.22 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.956 0 CA-C-N 112.267 -2.242 . . . . 0.0 110.763 179.812 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.472 0.663 0 CA-C-O 125.883 2.754 . . . . 0.0 108.154 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.503 ' HB ' ' ND1' ' A' ' 25' ' ' HIS 0.325 0.9 OUTLIER 43.13 44.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 1 CA-C-N 106.659 -4.791 . . . . 0.0 109.539 -178.473 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 2.3 tt -68.68 -24.07 64.47 Favored 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 114.679 -2.809 . . . . 0.0 103.602 171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.23 -15.99 64.02 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.901 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.503 ' ND1' ' HB ' ' A' ' 22' ' ' ILE 0.265 0.7 OUTLIER -69.72 -26.3 64.26 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 117.969 -1.492 . . . . 0.0 108.241 178.808 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -20.17 65.34 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 113.161 -1.836 . . . . 0.0 108.814 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.599 ' CD2' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -58.62 -46.27 87.43 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -29.66 69.45 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 112.121 -2.309 . . . . 0.0 112.133 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.69 10.88 19.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.068 -2.333 . . . . 0.0 108.55 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -8.81 2.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.91 31.49 76.33 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.75 -175.21 2.91 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 113.006 -1.597 . . . . 0.0 108.328 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -108.71 154.64 21.74 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 112.287 -2.233 . . . . 0.0 106.777 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 27' ' ' PHE . 78.5 t -99.94 135.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 CA-C-N 111.781 -2.463 . . . . 0.0 108.83 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 7' ' ' VAL . 21.8 t -140.36 54.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 111.418 -2.628 . . . . 0.0 107.005 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.8 126.43 30.37 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 46' ' ' PHE . 4.8 mt -89.84 -65.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.86 -116.82 0.73 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.394 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.12 23.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.323 -1.438 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.85 167.91 10.46 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.9 t -123.61 66.53 1.02 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 111.37 -2.65 . . . . 0.0 104.166 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.9 m -77.75 102.77 7.32 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -88.16 -85.9 0.18 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 113.06 -1.882 . . . . 0.0 107.38 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.19 -11.25 56.85 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 124.94 1.4 . . . . 0.0 110.926 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -89.21 -45.62 9.41 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.68 3.18 48.84 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.683 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 -29.03 7.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -73.05 -27.9 62.01 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.71 2.86 54.19 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.39 -9.13 48.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.24 -36.91 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -62.0 -69.07 0.27 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.192 -2.276 . . . . 0.0 110.195 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . 0.279 6.4 p -78.34 -32.43 49.15 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 123.783 0.677 . . . . 0.0 109.685 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 81.15 61.09 0.02 OUTLIER 'General case' 0 C--N 1.349 0.552 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.8 118.27 3.03 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.851 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 5' ' ' THR . 40.5 t0 -83.31 -49.35 9.47 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 130' ' ' MET . 3.2 pp -142.83 161.2 38.71 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 125.426 1.704 . . . . 0.0 106.78 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -120.28 137.2 54.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 111.139 -2.755 . . . . 0.0 105.295 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.95 112.28 14.5 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -100.62 142.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.207 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -114.39 63.61 0.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 p -168.67 148.62 4.44 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 70.59 0.74 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 111.61 -2.541 . . . . 0.0 104.341 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 72.22 87.3 0.11 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-N 110.413 -3.085 . . . . 0.0 106.818 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.28 33.52 0.51 Allowed Glycine 0 CA--C 1.535 1.32 0 CA-C-N 109.833 -3.349 . . . . 0.0 106.61 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.78 -14.65 0.54 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 111.259 -2.471 . . . . 0.0 108.476 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.76 -162.78 54.55 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 122.53 1.072 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.2 3.27 27.99 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 111.79 -2.205 . . . . 0.0 108.055 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mm -73.15 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.85 -24.6 65.28 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.843 1.339 . . . . 0.0 108.813 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 21.9 t -62.91 -72.13 0.14 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -90.17 33.09 0.89 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.313 1.008 . . . . 0.0 109.33 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.74 -47.61 2.47 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.82 -20.82 23.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 112.047 -2.076 . . . . 0.0 107.89 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 75' ' ' ARG . 5.5 mmt85 -74.84 -31.85 61.76 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.05 -23.79 47.97 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.057 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.95 -16.11 59.45 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.96 0.787 . . . . 0.0 109.183 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.4 m -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 123.868 1.794 . . . . 0.0 107.229 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.38 -1.51 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 108.692 -3.867 . . . . 0.0 108.667 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.83 -53.46 6.47 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.73 48.76 5.32 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 111.024 -2.807 . . . . 0.0 107.101 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.06 -47.14 0.01 OUTLIER Glycine 0 C--N 1.347 1.166 0 CA-C-N 112.268 -2.242 . . . . 0.0 108.357 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.46 124.51 35.03 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 124.61 33.9 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.918 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.29 65.59 0.03 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 112.825 -1.988 . . . . 0.0 109.32 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.4 tt -105.54 11.32 8.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 112.097 -2.052 . . . . 0.0 108.139 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 88' ' ' LEU . 48.4 mmtm -122.51 114.26 20.43 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -140.11 101.88 4.25 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -99.87 90.96 4.61 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.81 96.52 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 108.89 -3.777 . . . . 0.0 111.323 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.0 124.12 34.56 Favored Glycine 0 CA--C 1.537 1.417 1 CA-C-N 107.433 -4.439 . . . . 0.0 112.69 176.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.37 -80.84 0.94 Allowed Glycine 0 C--N 1.352 1.441 0 CA-C-N 112.549 -1.825 . . . . 0.0 109.143 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 25.44 94.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.431 3.492 . . . . 0.0 110.823 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 69.91 123.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.511 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.63 169.9 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 112.343 -2.208 . . . . 0.0 107.318 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.42 61.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.648 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.03 148.03 9.74 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.275 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.47 105.12 0.36 Allowed 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 87.14 -58.94 0.04 OUTLIER 'General case' 0 C--N 1.357 0.899 0 O-C-N 125.915 2.01 . . . . 0.0 106.753 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -86.17 101.21 12.8 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -106.86 160.91 24.61 Favored Pre-proline 0 C--N 1.351 0.64 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.23 -158.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.61 1.54 . . . . 0.0 108.631 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.78 -23.45 67.25 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.592 -2.094 . . . . 0.0 108.771 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.67 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.9 p -57.81 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.735 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.746 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.67 ' H ' HG13 ' A' ' 104' ' ' VAL . 31.5 mt-10 -90.3 29.42 1.26 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.911 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -82.54 -41.18 19.96 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -80.46 -32.67 37.16 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.117 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -90.32 14.81 11.82 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.081 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -90.35 -38.77 13.12 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.23 75.05 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 112.63 -2.077 . . . . 0.0 106.99 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtp -77.63 -62.58 1.62 Allowed 'General case' 0 C--N 1.355 0.81 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.79 34.41 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.547 2.498 . . . . 0.0 117.261 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -4.76 58.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.27 132.67 51.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 171.87 7.2 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.13 152.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.188 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -99.74 117.74 63.07 Favored Pre-proline 0 C--N 1.36 1.05 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.82 147.95 90.31 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.417 2.078 . . . . 0.0 107.99 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.47 115.97 3.65 Favored 'Trans proline' 0 C--N 1.365 1.42 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.1 32.09 1.75 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.547 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -90.07 -166.37 1.57 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.263 3.2 p -143.2 170.68 8.19 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.489 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.57 -4.61 13.68 Favored 'Trans proline' 0 C--N 1.37 1.666 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.83 -25.75 61.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -17.53 54.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.668 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.581 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 5.6 p -83.96 -16.77 42.91 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 118.498 -1.281 . . . . 0.0 109.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.18 -32.92 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.06 -1.23 52.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.236 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 133' ' ' VAL . 50.7 t0 -61.32 -65.32 0.71 Allowed 'General case' 0 C--N 1.365 1.264 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.485 ' HE2' HD21 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -90.1 9.26 28.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 111.995 -2.366 . . . . 0.0 110.657 -176.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -88.66 -34.19 17.33 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 116.884 -1.927 . . . . 0.0 108.281 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.97 -43.45 10.54 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 124.256 0.973 . . . . 0.0 110.503 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 129' ' ' ASP . 44.5 t -66.48 -31.15 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.682 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.09 -33.83 16.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.563 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.066 -179.38 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 . . . . . 0 CA--C 1.542 0.667 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 130.82 36.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 123.38 1.562 . . . . 0.0 107.049 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -81.69 95.69 7.3 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 109.952 -3.295 . . . . 0.0 107.886 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.36 109.28 0.01 OUTLIER 'General case' 0 C--N 1.35 0.608 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -134.21 117.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.678 HG23 HG12 ' A' ' 35' ' ' VAL . 4.2 p -98.95 133.42 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 111.55 -2.568 . . . . 0.0 108.301 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD1' HD22 ' A' ' 23' ' ' LEU . 52.5 tp -125.2 143.71 50.81 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.976 1.422 . . . . 0.0 107.63 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -177.29 170.4 42.95 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.443 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' GLY 0.711 11.7 p 99.63 -130.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 130.893 3.677 . . . . 0.0 116.526 178.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER 56.09 102.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 127.401 2.281 . . . . 0.0 107.618 -175.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.36 1.871 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.211 -179.185 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 31.7 ttmt . . . . . 0 CA--C 1.51 -0.578 0 CA-C-O 125.583 2.611 . . . . 0.0 108.077 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 21' ' ' LYS . 1.3 mp 56.4 15.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 1 CA-C-N 105.725 -5.216 . . . . 0.0 112.049 177.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 8' ' ' LEU . 10.9 mp -76.89 -40.07 48.72 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 116.512 -2.075 . . . . 0.0 106.059 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.62 -1.25 37.22 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.787 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -82.32 -34.2 28.67 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 1.2 t -66.57 -29.26 69.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.124 -1.853 . . . . 0.0 110.438 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -65.26 -42.68 93.01 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.901 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -29.18 64.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.648 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -98.01 15.41 24.17 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.606 -2.543 . . . . 0.0 109.72 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.03 2.91 1.77 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.37 67.87 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.793 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' A' ' 134' ' ' LEU . 1.7 m-30 -99.76 156.18 17.24 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 112.603 -1.798 . . . . 0.0 106.169 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.26 140.8 34.65 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 111.327 -2.669 . . . . 0.0 105.85 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.628 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 1.4 p -99.88 137.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 112.145 -2.298 . . . . 0.0 107.457 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 7' ' ' VAL . 40.0 t -132.74 63.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.652 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -81.71 120.92 25.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.436 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -89.95 -79.47 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.8 -158.38 22.65 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.062 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.37 59.76 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.661 1.219 . . . . 0.0 110.117 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 tp -165.63 124.59 1.66 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 t -96.25 84.72 3.81 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.68 122.98 27.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.404 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.421 HE22 ' CD2' ' A' ' 74' ' ' LEU . 8.1 tp-100 -80.81 -94.63 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.23 -2.259 . . . . 0.0 108.745 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.46 -17.25 19.37 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.813 1.645 . . . . 0.0 111.735 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.92 -48.88 8.3 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -84.85 0.51 50.65 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 116.58 -2.048 . . . . 0.0 109.001 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 -27.88 7.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.23 -29.03 57.39 Favored 'General case' 0 C--N 1.365 1.27 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.95 6.96 46.79 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -20.93 22.54 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.19 -38.26 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.22 -68.65 0.27 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 112.337 -2.21 . . . . 0.0 110.332 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -64.97 0.95 Allowed 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? 129.69 47.36 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 O-C-N 126.912 2.632 . . . . 0.0 106.933 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.73 108.36 0.73 Allowed 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.67 -82.64 0.2 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.267 -2.242 . . . . 0.0 104.972 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -89.57 142.08 28.0 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.45 144.66 36.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.5 m -134.68 129.31 34.6 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 112.433 -2.167 . . . . 0.0 106.686 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 90' ' ' VAL . 92.5 t -99.96 137.04 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 110.042 -3.254 . . . . 0.0 103.451 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -123.14 89.56 3.13 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -165.77 -172.62 2.43 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.05 42.68 3.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 81.29 96.02 0.05 OUTLIER 'General case' 0 C--N 1.356 0.873 0 CA-C-N 112.779 -2.01 . . . . 0.0 106.205 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.33 19.85 0.11 Allowed Glycine 0 CA--C 1.538 1.515 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.689 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -109.4 -0.81 18.81 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 160.18 13.18 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -81.56 6.87 13.61 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.455 -1.373 . . . . 0.0 108.263 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -48.2 16.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.401 ' HA ' HE21 ' A' ' 43' ' ' GLN . 13.6 t70 -71.31 -25.14 62.29 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.46 -57.88 5.75 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.15 25.55 2.14 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 124.879 1.362 . . . . 0.0 109.295 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.63 -32.72 4.08 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.264 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.421 ' CD2' HE22 ' A' ' 43' ' ' GLN . 52.1 mt -86.41 -26.71 24.6 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.5 mmt85 -73.03 -33.38 65.7 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.69 -19.93 47.79 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.659 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -76.42 -20.33 57.19 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 66.5 m -90.15 -43.22 10.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 123.698 1.713 . . . . 0.0 107.434 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.45 1.09 17.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 108.932 -3.758 . . . . 0.0 108.478 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.89 -54.69 5.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.08 39.37 7.81 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 110.686 -2.961 . . . . 0.0 107.114 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -49.22 0.04 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.43 120.28 27.6 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 122.0 28.59 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.13 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.6 81.73 0.04 OUTLIER Glycine 0 C--N 1.348 1.211 0 CA-C-N 112.339 -2.21 . . . . 0.0 109.995 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -111.78 38.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -145.48 114.17 6.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 98.76 3.5 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 90.84 4.62 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 60' ' ' VAL . 15.5 m -89.42 93.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 110.294 -3.139 . . . . 0.0 109.696 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -70.43 118.43 7.84 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 110.181 -3.19 . . . . 0.0 113.912 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.9 -45.1 2.89 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 111.915 -2.143 . . . . 0.0 113.778 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -46.12 129.77 10.04 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 127.743 2.417 . . . . 0.0 107.184 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 60.33 72.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -78.16 -161.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.312 -178.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 95' ' ' VAL 0.279 17.2 m 61.46 118.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 127.831 2.453 . . . . 0.0 109.482 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 160.07 7.1 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.181 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -152.07 109.57 3.6 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 98.29 -53.01 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -92.73 75.86 4.95 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CH2' ' HB ' ' A' ' 116' ' ' VAL . 95.3 m95 -83.85 159.92 59.39 Favored Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 112.652 -2.067 . . . . 0.0 105.808 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.34 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.684 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.29 -21.2 64.79 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.724 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.7 p -59.87 -68.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.82 0 O-C-N 124.477 1.111 . . . . 0.0 111.282 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.557 ' H ' HG13 ' A' ' 104' ' ' VAL . 35.7 mt-10 -90.18 27.41 1.64 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 117.986 -1.486 . . . . 0.0 108.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -80.51 -41.25 24.59 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -80.52 -31.87 37.01 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.468 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.3 15.11 12.67 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.42 -40.41 12.07 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.2 78.66 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.316 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 37.6 mtp -77.56 -61.45 1.99 Allowed 'General case' 0 C--N 1.354 0.791 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.52 27.13 0.09 OUTLIER Glycine 0 C--N 1.353 1.493 0 CA-C-N 112.177 -2.283 . . . . 0.0 118.085 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.05 -2.7 58.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.22 128.75 53.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 102.937 -2.986 . . . . 0.0 102.937 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' HB ' ' CH2' ' A' ' 101' ' ' TRP . 42.5 t -140.01 151.66 21.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -99.63 148.06 34.22 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 102.95 -2.982 . . . . 0.0 102.95 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -70.39 155.75 63.18 Favored 'Trans proline' 0 C--N 1.364 1.356 0 N-CA-C 106.017 -2.339 . . . . 0.0 106.017 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -75.93 118.11 4.92 Favored 'Trans proline' 0 C--N 1.365 1.441 0 N-CA-C 105.08 -2.7 . . . . 0.0 105.08 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.46 56.56 5.03 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.186 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.8 t -88.35 179.1 6.4 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 125.151 2.405 . . . . 0.0 107.501 -178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.331 21.4 p -75.87 170.68 14.73 Favored Pre-proline 0 N--CA 1.431 -1.4 1 CA-C-N 106.815 -4.72 . . . . 0.0 104.782 178.123 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.38 -3.19 3.82 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 N-CA-C 105.875 -2.394 . . . . 0.0 105.875 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.73 -12.05 60.32 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 125.927 1.691 . . . . 0.0 109.057 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -28.0 58.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.9 p -87.78 -21.74 24.93 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.483 1.115 . . . . 0.0 110.701 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.6 mt -69.92 -28.87 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.19 58.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.123 -2.308 . . . . 0.0 109.16 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 7.7 t0 -63.53 -56.43 16.06 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -87.47 1.0 54.72 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 110.854 -2.885 . . . . 0.0 110.311 -177.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -84.37 -47.55 10.59 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 117.302 -1.759 . . . . 0.0 110.079 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.31 -40.49 17.9 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.149 0.906 . . . . 0.0 111.467 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.5 t -68.78 -31.08 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.717 1.261 . . . . 0.0 112.973 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.401 HD21 ' CE2' ' A' ' 32' ' ' PHE . 45.0 mt -90.11 -33.12 16.39 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.355 1.584 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.03 -178.678 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.65 -159.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.195 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.59 63.16 0.74 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.267 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.3 p -149.89 110.29 4.21 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.75 109.44 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 111.268 -2.696 . . . . 0.0 104.492 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.96 111.96 23.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.21 148.34 48.67 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.127 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.41 -165.27 34.88 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 111.629 -2.532 . . . . 0.0 110.408 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.636 12.4 p 110.68 -113.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 C-N-CA 127.705 2.402 . . . . 0.0 113.091 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . 0.279 3.0 tp 56.06 154.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 129.131 2.972 . . . . 0.0 110.753 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.684 0 CA-C-N 110.485 -3.052 . . . . 0.0 107.269 179.576 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 127.542 3.544 . . . . 0.0 105.376 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.82 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.266 0.2 OUTLIER 47.77 44.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.119 2 CA-C-N 103.287 -6.324 . . . . 0.0 109.448 179.104 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.446 ' CB ' HD23 ' A' ' 8' ' ' LEU . 1.1 mt -69.4 -20.39 63.8 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 172.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.09 -18.91 65.65 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.82 ' HB2' HG22 ' A' ' 22' ' ' ILE . 4.8 t60 -71.86 -27.46 62.88 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 p -55.96 -39.52 71.89 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 125.264 1.602 . . . . 0.0 110.55 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.665 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -59.56 -41.27 89.79 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.316 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -21.55 54.77 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 111.606 -2.543 . . . . 0.0 112.431 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -83.67 -3.57 57.87 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.938 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' SD ' ' A' ' 130' ' ' MET . . . -126.14 -7.39 6.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.19 71.64 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.359 1.022 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -141.74 143.52 33.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.5 p -99.64 173.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 111.977 -2.374 . . . . 0.0 107.039 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.08 93.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 111.188 -2.733 . . . . 0.0 105.088 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -68.45 117.29 10.02 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.477 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 32.3 mt -90.1 -41.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.247 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.64 -129.21 5.75 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.41 44.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 113.249 -1.476 . . . . 0.0 109.626 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.4 tp -163.06 109.52 1.17 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.2 t -85.23 95.27 9.12 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -90.3 138.49 31.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.803 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.41 -90.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.856 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.26 -11.17 13.47 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 124.973 1.42 . . . . 0.0 112.786 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -89.18 -46.14 9.03 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 118.348 -1.341 . . . . 0.0 107.475 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 37' ' ' ILE . 11.5 m-85 -86.88 6.78 30.21 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 117.964 -1.494 . . . . 0.0 108.568 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.28 -29.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.95 -24.5 58.48 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 -4.2 55.42 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 -12.51 38.43 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -38.33 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.41 -65.27 0.7 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 111.823 -2.444 . . . . 0.0 110.356 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -79.94 -47.5 14.92 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.118 -176.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' THR . 3.7 ttmp? 109.8 42.79 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 126.543 2.402 . . . . 0.0 108.357 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.84 120.6 5.46 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 124.485 1.116 . . . . 0.0 108.981 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.73 -66.1 0.96 Allowed 'General case' 0 C--N 1.352 0.708 0 CA-C-N 111.86 -2.427 . . . . 0.0 105.6 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -107.18 148.39 28.93 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.456 1.598 . . . . 0.0 109.35 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -97.62 148.92 5.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 CA-C-N 109.818 -3.355 . . . . 0.0 104.82 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.552 ' N ' HD12 ' A' ' 58' ' ' ILE . 60.9 m -141.73 105.0 4.63 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.69 131.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -110.38 45.35 1.13 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 p -154.06 168.4 26.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 15.3 tp -74.39 -127.04 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 111.251 -2.704 . . . . 0.0 103.823 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.476 ' HE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -93.53 50.67 1.5 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.95 21.13 47.68 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.549 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -124.09 -31.12 3.39 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.55 166.6 41.49 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.088 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.21 -1.35 32.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 113.581 -1.309 . . . . 0.0 108.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -46.19 18.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 3.9 m-20 -74.25 -27.12 60.61 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.928 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m -68.99 -50.69 46.71 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -89.53 21.79 3.26 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.569 1.168 . . . . 0.0 109.481 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -27.04 7.75 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 17.8 mt -89.99 -32.28 16.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.27 -1.965 . . . . 0.0 106.473 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -75.55 -22.1 57.34 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.89 -31.67 56.91 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.98 -11.69 60.17 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.497 1.123 . . . . 0.0 109.162 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 73.4 m -90.27 -48.05 7.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 123.239 1.495 . . . . 0.0 107.624 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.296 2.9 p30 -78.27 4.23 13.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 109.672 -3.422 . . . . 0.0 109.233 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.96 -53.38 6.19 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.29 39.79 25.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.084 -2.78 . . . . 0.0 108.042 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.29 -48.58 0.05 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.33 119.94 28.11 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 128.96 34.9 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.49 -1.686 . . . . 0.0 106.506 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.02 59.27 0.01 OUTLIER Glycine 0 C--N 1.347 1.164 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.327 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -8.79 11.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 112.509 -1.846 . . . . 0.0 108.593 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -97.54 129.09 44.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.571 HD13 ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -139.97 140.68 36.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.27 92.37 2.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -89.46 93.97 4.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-O 125.118 2.389 . . . . 0.0 110.358 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.48 119.92 8.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 109.895 -3.32 . . . . 0.0 112.453 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.08 -84.04 1.01 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 112.104 -2.048 . . . . 0.0 108.095 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 93' ' ' ASN . 5.6 t-20 53.95 -111.54 0.63 Allowed 'General case' 0 C--N 1.353 0.758 0 CA-C-N 111.79 -2.205 . . . . 0.0 107.63 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HB ' ' HE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.29 126.82 44.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 10.8 p -73.79 157.44 6.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.74 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 45.28 99.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.918 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.58 152.92 6.11 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 112.091 -2.322 . . . . 0.0 108.895 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -175.83 124.16 0.2 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 86.06 -67.37 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 126.004 2.065 . . . . 0.0 106.369 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.29 134.55 37.93 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -139.03 167.37 19.42 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.75 -145.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.831 1.687 . . . . 0.0 108.549 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.18 -25.06 61.53 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.519 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.7 p -54.13 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 124.768 1.293 . . . . 0.0 111.219 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' HG13 ' A' ' 104' ' ' VAL . 11.2 mt-10 -90.35 26.74 1.85 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 117.505 -1.678 . . . . 0.0 109.416 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.03 -42.42 63.2 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -89.98 -24.68 21.18 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 111.676 -2.511 . . . . 0.0 108.411 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -85.77 -13.4 48.34 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -90.57 -20.28 22.79 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.75 74.58 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.2 mtt -87.38 -52.01 5.61 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.97 26.24 1.98 Allowed Glycine 0 C--N 1.356 1.671 0 CA-C-N 112.769 -2.014 . . . . 0.0 117.644 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -4.91 58.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.08 119.54 39.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 179.23 4.16 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 48.9 t -140.01 151.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.43 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 4.8 m-85 -99.63 153.03 37.98 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -65.16 136.57 48.36 Favored 'Trans proline' 0 C--N 1.371 1.722 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.71 110.62 2.97 Favored 'Trans proline' 0 C--N 1.371 1.721 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 138.94 -103.61 0.4 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 111.647 -2.524 . . . . 0.0 107.561 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -90.27 167.59 12.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.6 p -168.67 70.75 0.77 Allowed Pre-proline 0 C--N 1.349 0.559 0 CA-C-N 113.136 -1.847 . . . . 0.0 106.04 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.27 -84.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 123.264 2.643 . . . . 0.0 109.473 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.25 -19.47 21.76 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.126 2.17 . . . . 0.0 110.683 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -25.43 62.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 124.051 0.844 . . . . 0.0 109.694 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -86.11 -23.4 26.66 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 117.419 -1.712 . . . . 0.0 109.579 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.83 -26.12 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.15 -6.46 56.95 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.011 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 133' ' ' VAL . 63.3 t0 -54.22 -66.6 0.37 Allowed 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 30' ' ' ALA . 6.4 mtm -90.36 -6.17 55.34 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 111.343 -2.662 . . . . 0.0 111.755 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.97 -45.33 9.27 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 117.209 -1.796 . . . . 0.0 107.659 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -58.39 -45.8 87.62 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 121.817 0.818 . . . . 0.0 109.168 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 129' ' ' ASP . 84.6 t -82.24 -71.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.234 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.5 mt -90.12 55.88 3.24 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.579 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.314 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.651 177.67 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -72.92 172.2 11.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 112.153 -2.294 . . . . 0.0 107.503 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 57.3 pttt -108.1 68.99 0.72 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.654 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.9 p -150.44 109.22 3.85 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 ' SD ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -123.57 136.24 60.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.08 133.42 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 124.502 1.127 . . . . 0.0 108.736 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.1 pp -116.25 146.77 42.1 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.252 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . -131.2 146.43 17.84 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 112.381 -2.19 . . . . 0.0 109.325 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -120.25 126.49 75.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 124.96 1.035 . . . . 0.0 110.664 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 tp -152.92 139.91 13.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.344 0.99 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 -178.429 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 123.63 1.681 . . . . 0.0 109.855 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.307 0.0 OUTLIER 38.82 47.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.777 1 C-N-CA 132.593 4.357 . . . . 0.0 105.786 -175.081 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.63 -26.27 50.41 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.31 -18.03 65.01 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.39 -1.732 . . . . 0.0 106.584 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -69.35 -30.77 68.87 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -45.31 -44.33 11.46 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 124.856 1.348 . . . . 0.0 107.962 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -47.97 74.41 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 111.649 -2.523 . . . . 0.0 109.402 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -14.61 58.42 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 112.296 -2.229 . . . . 0.0 113.748 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.408 HD21 ' CG ' ' A' ' 25' ' ' HIS . 7.5 m120 -75.49 -14.87 60.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.369 1.867 . . . . 0.0 109.781 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.94 19.42 0.59 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 117.445 -1.702 . . . . 0.0 108.216 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.2 28.4 54.35 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 124.182 0.926 . . . . 0.0 112.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -99.73 160.3 14.4 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 32.3 t30 -89.21 135.62 33.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.248 -2.251 . . . . 0.0 106.373 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.94 170.05 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-N 111.309 -2.678 . . . . 0.0 106.973 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -140.14 106.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 111.557 -2.565 . . . . 0.0 105.446 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.55 123.71 32.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.423 HD11 ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -89.84 -30.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 -129.24 9.83 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' HG12 ' A' ' 10' ' ' VAL . 2.8 m -98.18 -12.69 8.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 113.353 -1.423 . . . . 0.0 110.002 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.75 86.91 6.8 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -91.44 58.08 3.5 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 112.869 -1.968 . . . . 0.0 105.909 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.5 p -90.03 116.37 28.01 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.385 -3.561 . . . . 0.0 101.385 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.538 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.5 tp-100 -89.96 -54.09 4.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.866 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -62.36 -32.68 73.5 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.143 1.527 . . . . 0.0 110.449 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -79.36 -26.46 42.07 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 2.7 t80 -86.94 4.15 42.79 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.541 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.69 -37.35 20.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.064 0 N-CA-C 102.475 -3.158 . . . . 0.0 102.475 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -73.93 -28.68 61.64 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 112.482 -2.145 . . . . 0.0 106.997 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -89.82 0.54 56.96 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.031 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 -7.67 53.35 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.09 -39.83 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.95 -75.54 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.746 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 p -74.07 -19.28 60.66 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 123.961 0.788 . . . . 0.0 110.471 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 72.47 50.83 0.18 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.99 130.93 35.2 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 125.251 1.594 . . . . 0.0 107.537 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -104.22 -77.12 0.58 Allowed 'General case' 0 C--N 1.364 1.228 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -87.4 147.66 25.35 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.016 1.448 . . . . 0.0 108.072 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -134.15 165.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 111.458 -2.61 . . . . 0.0 105.78 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.9 p -161.94 158.78 25.73 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.62 168.95 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 69.21 1.05 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 p -174.32 168.48 3.94 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.243 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.3 mt -79.73 -105.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 110.732 -2.94 . . . . 0.0 103.203 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -102.68 27.08 7.26 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 112.808 -1.996 . . . . 0.0 106.498 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.74 -9.68 84.92 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.305 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -80.01 -34.66 38.26 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.3 -178.32 49.18 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 113.002 -1.908 . . . . 0.0 112.226 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -77.92 -12.19 59.96 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.152 -2.024 . . . . 0.0 108.644 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -49.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -72.37 -29.44 63.78 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.853 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -57.04 8.83 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -88.27 27.46 1.23 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 125.316 1.635 . . . . 0.0 109.944 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.21 -30.41 7.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.538 HD21 ' CD ' ' A' ' 43' ' ' GLN . 8.0 mt -90.03 -33.84 16.19 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 111.644 -2.278 . . . . 0.0 107.788 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -24.37 61.06 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.77 -31.42 35.82 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -76.51 -15.09 59.97 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 124.139 0.899 . . . . 0.0 109.479 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.32 -47.04 8.01 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 123.94 1.829 . . . . 0.0 107.293 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.43 -3.58 25.07 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 108.531 -3.94 . . . . 0.0 109.041 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -81.24 -56.65 3.93 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.35 48.93 7.41 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 110.931 -2.85 . . . . 0.0 106.82 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.96 -42.15 0.02 OUTLIER Glycine 0 C--N 1.35 1.335 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.017 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.78 124.95 28.73 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 117.08 15.33 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.73 107.04 0.4 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 112.777 -2.011 . . . . 0.0 109.557 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -157.01 46.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -151.24 119.65 6.42 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 58' ' ' ILE . 3.2 mm? -139.3 149.09 43.83 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 94.59 2.76 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -89.87 100.07 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 111.209 -2.723 . . . . 0.0 109.732 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.44 81.61 0.38 Allowed Glycine 0 CA--C 1.533 1.178 0 CA-C-N 108.434 -3.985 . . . . 0.0 112.745 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.4 -85.68 0.26 Allowed Glycine 0 C--N 1.351 1.412 0 CA-C-N 112.714 -1.743 . . . . 0.0 109.376 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG23 ' A' ' 90' ' ' VAL . 65.6 t30 65.29 -116.15 0.34 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.901 -1.649 . . . . 0.0 106.932 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -104.4 129.34 56.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.42 169.06 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.893 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p 45.63 48.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.812 0 CA-C-N 112.713 -2.039 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 139.03 3.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 112.282 -2.236 . . . . 0.0 108.767 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -161.17 111.52 1.71 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 96.96 -45.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 112.548 -2.115 . . . . 0.0 105.83 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.17 126.54 35.84 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -138.03 160.11 65.72 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.59 -148.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 N-CA-C 107.759 -1.669 . . . . 0.0 107.759 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.48 -20.43 58.79 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.665 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -60.12 -64.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 124.433 1.083 . . . . 0.0 111.429 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.406 ' H ' HG13 ' A' ' 104' ' ' VAL . 9.6 mm-40 -89.4 18.67 5.04 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 117.009 -1.876 . . . . 0.0 107.965 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.79 -39.08 66.99 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -80.78 -32.16 35.54 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.691 -2.049 . . . . 0.0 106.826 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -91.74 15.03 13.63 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.737 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.7 -41.36 11.33 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.04 74.29 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 112.21 -2.268 . . . . 0.0 107.418 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.3 mtp -82.35 -57.99 3.13 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 27.61 43.32 0.03 OUTLIER Glycine 0 C--N 1.357 1.741 0 C-N-CA 127.401 2.429 . . . . 0.0 117.355 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.8 -2.76 58.82 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -105.01 131.22 52.81 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.485 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.07 169.74 8.53 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 178.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.92 159.41 36.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -99.46 161.39 24.74 Favored Pre-proline 0 N--CA 1.447 -0.615 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.53 158.1 58.67 Favored 'Trans proline' 0 C--N 1.368 1.559 0 N-CA-C 106.873 -2.01 . . . . 0.0 106.873 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.37 122.35 9.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 104.81 -2.804 . . . . 0.0 104.81 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.76 140.88 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 105.905 -2.878 . . . . 0.0 105.905 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 t -75.34 162.05 28.74 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 125.422 2.535 . . . . 0.0 108.164 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.3 p -167.78 113.4 0.62 Allowed Pre-proline 0 N--CA 1.427 -1.595 1 CA-C-N 106.12 -5.036 . . . . 0.0 101.019 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.01 -1.22 11.42 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.234 1.289 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.2 -30.28 67.35 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -16.66 54.41 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.541 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 129' ' ' ASP . 24.1 p -79.04 -25.34 43.2 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 116.67 -2.012 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.52 -26.56 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -3.18 56.31 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.04 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 126' ' ' THR . 38.4 t0 -62.07 -52.76 62.64 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 6' ' ' ILE . 36.2 mmt -87.77 -22.85 24.31 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.36 -2.2 . . . . 0.0 110.725 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.92 -12.96 46.12 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.098 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -90.11 -52.9 4.72 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.485 ' HA ' HH21 ' A' ' 115' ' ' ARG . 23.1 t -69.74 -58.88 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.364 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 -14.32 34.12 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 124.431 1.082 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.721 0 C-N-CA 118.542 -1.789 . . . . 0.0 111.461 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.61 177.33 6.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.777 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -105.5 103.58 13.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 110.018 -3.265 . . . . 0.0 109.435 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 172.3 113.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HB ' ' CE ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -148.03 110.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.88 131.23 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.031 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.833 ' CD2' ' HG ' ' A' ' 23' ' ' LEU . 1.5 tm? -125.84 130.25 51.0 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.174 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 171.39 23.72 Favored Glycine 0 C--N 1.36 1.876 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.932 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.28 136.94 13.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.009 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.01 88.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 115.448 -2.501 . . . . 0.0 110.06 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.439 0 N-CA-C 106.636 -2.585 . . . . 0.0 106.636 179.493 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 126.276 2.941 . . . . 0.0 108.515 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.286 0.0 OUTLIER 31.54 52.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.342 2 CA-C-N 105.157 -5.474 . . . . 0.0 108.155 -178.367 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.833 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -72.27 -25.91 61.78 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.93 -15.83 63.79 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 22' ' ' ILE . 14.6 t-80 -72.88 -27.29 61.81 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -50.88 -44.16 59.72 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 125.492 1.745 . . . . 0.0 109.422 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.7 -47.23 80.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.694 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -17.15 61.34 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 111.828 -2.442 . . . . 0.0 113.039 -176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -18.95 60.64 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 128.372 2.669 . . . . 0.0 109.773 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.43 11.93 2.76 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 124.598 1.186 . . . . 0.0 107.936 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.74 25.79 52.41 Favored Glycine 0 C--N 1.356 1.671 0 O-C-N 124.271 0.982 . . . . 0.0 112.922 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -99.78 145.49 27.64 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 29.9 m-20 -69.33 137.62 53.09 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 111.846 -2.434 . . . . 0.0 108.099 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.82 172.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 112.117 -2.311 . . . . 0.0 108.886 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.97 73.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 108.786 -3.825 . . . . 0.0 103.71 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -70.11 118.45 12.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -89.66 -90.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.713 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 -177.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 37' ' ' ILE . . . 176.8 -112.26 0.38 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -54.59 7.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.055 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.73 153.43 24.16 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.526 -1.67 . . . . 0.0 106.576 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -153.35 59.24 0.76 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.84 158.53 0.48 Allowed 'General case' 0 C--N 1.359 0.99 0 CA-C-N 110.284 -3.144 . . . . 0.0 108.921 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -82.81 -89.24 0.09 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 112.107 -2.315 . . . . 0.0 108.645 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -15.6 31.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 124.736 1.272 . . . . 0.0 112.247 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -90.09 -39.15 13.07 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 118.178 -1.409 . . . . 0.0 107.342 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -81.69 -9.99 59.5 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 117.641 -1.624 . . . . 0.0 109.166 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -28.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -75.66 -28.06 58.58 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.18 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.05 -15.94 30.76 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.22 -38.5 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 104.324 -2.472 . . . . 0.0 104.324 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -62.58 -71.81 0.15 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.24 -2.255 . . . . 0.0 111.087 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -74.59 -38.63 62.57 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.845 0.716 . . . . 0.0 110.629 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 98.28 41.65 0.0 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.49 126.06 20.19 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.266 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -106.08 -79.5 0.56 Allowed 'General case' 0 C--N 1.359 0.989 0 O-C-N 125.337 1.648 . . . . 0.0 106.558 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.45 114.21 20.04 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.91 123.75 54.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.6 m -145.47 145.66 31.18 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-O 123.836 1.779 . . . . 0.0 107.932 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.31 3.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 110.343 -3.117 . . . . 0.0 105.042 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.32 103.75 4.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 117.218 -1.793 . . . . 0.0 107.298 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m 177.78 173.95 0.54 Allowed 'General case' 0 C--N 1.359 1.017 0 O-C-N 126.412 2.32 . . . . 0.0 106.057 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.09 -147.07 0.06 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 111.637 -2.529 . . . . 0.0 104.782 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.42 92.91 7.67 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.95 -29.43 1.82 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-N 111.419 -2.628 . . . . 0.0 108.77 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -86.24 -24.73 25.9 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 112.589 -1.806 . . . . 0.0 107.28 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 178.99 49.36 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.745 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.04 -12.97 59.65 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 111.853 -2.174 . . . . 0.0 108.246 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -76.6 -49.21 24.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -72.82 -16.83 61.6 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.687 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HG ' ' HD2' ' A' ' 108' ' ' PHE . 8.8 t -72.14 -42.23 66.23 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -90.09 20.07 4.55 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 124.672 1.232 . . . . 0.0 108.953 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 -34.24 5.74 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.355 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.28 -23.47 22.3 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 113.04 -1.58 . . . . 0.0 106.845 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -26.92 56.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -81.04 -24.12 38.08 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.512 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -76.55 -17.77 59.04 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 124.113 0.883 . . . . 0.0 108.712 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 86' ' ' ILE . 68.1 m -90.23 -43.9 10.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 123.875 1.798 . . . . 0.0 107.345 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.45 -0.92 21.73 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.701 -3.863 . . . . 0.0 108.624 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.12 -53.6 6.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.65 41.7 11.86 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 110.855 -2.884 . . . . 0.0 107.303 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.44 -47.2 0.03 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.795 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -88.51 118.26 28.03 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 111.89 14.03 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 112.362 -2.199 . . . . 0.0 106.144 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.37 59.26 0.06 OUTLIER Glycine 0 C--N 1.348 1.22 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 78' ' ' CYS . 1.8 mt -91.15 0.75 8.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 CA-C-N 112.29 -1.955 . . . . 0.0 106.973 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -112.83 117.69 32.85 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.16 121.89 15.36 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -104.77 117.23 33.55 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 101.414 -3.55 . . . . 0.0 101.414 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 115' ' ' ARG . 88.1 t -89.73 89.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 110.827 -2.897 . . . . 0.0 108.491 -175.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -69.13 108.39 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 109.52 -3.491 . . . . 0.0 109.417 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.66 -122.74 10.71 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 106.773 -2.531 . . . . 0.0 106.773 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.4 t30 68.97 145.99 0.05 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 125.397 1.293 . . . . 0.0 108.269 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 55.95 81.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 CA-C-N 112.31 -2.223 . . . . 0.0 107.614 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.54 155.64 6.13 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 112.537 -2.12 . . . . 0.0 108.538 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p 46.07 51.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 CA-C-N 112.83 -1.987 . . . . 0.0 111.829 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.83 138.34 5.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.163 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -167.24 140.3 3.5 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.08 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.846 0 O-C-N 125.966 2.041 . . . . 0.0 105.878 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -87.11 114.99 24.2 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -95.15 161.91 26.58 Favored Pre-proline 0 C--N 1.349 0.562 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.738 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.79 -150.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.927 1.751 . . . . 0.0 108.904 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.66 -25.75 62.25 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.19 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 105' ' ' GLU 0.272 0.1 OUTLIER -54.8 -67.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 124.886 1.366 . . . . 0.0 110.457 -179.429 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.5 mm-40 -90.24 20.31 4.48 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 117.951 -1.499 . . . . 0.0 109.149 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.39 -51.78 53.5 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -90.28 -15.59 30.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.466 ' HD2' ' HG ' ' A' ' 71' ' ' CYS . 4.1 m-30 -89.5 -45.42 9.43 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 117.802 -1.559 . . . . 0.0 108.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -77.75 -2.11 34.65 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.723 1.264 . . . . 0.0 107.783 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.53 77.18 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -83.97 -53.95 5.2 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.97 40.51 58.2 Favored Glycine 0 C--N 1.362 1.996 0 O-C-N 124.677 1.236 . . . . 0.0 116.065 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -6.92 59.43 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.09 137.8 42.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.35 173.63 6.24 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.12 160.01 26.07 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -99.61 160.54 27.12 Favored Pre-proline 0 C--N 1.355 0.82 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.19 149.01 45.15 Favored 'Trans proline' 0 C--N 1.366 1.46 0 N-CA-C 104.412 -2.957 . . . . 0.0 104.412 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.26 110.05 2.97 Favored 'Trans proline' 0 C--N 1.366 1.489 0 N-CA-C 104.812 -2.803 . . . . 0.0 104.812 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.41 158.65 7.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.716 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.63 143.44 46.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.743 -1.729 . . . . 0.0 106.718 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 p 174.0 100.37 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 110.763 -2.926 . . . . 0.0 106.41 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.29 -2.87 13.13 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.861 1.707 . . . . 0.0 108.155 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.96 -37.9 89.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.352 1.861 . . . . 0.0 107.757 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.82 -21.42 57.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.928 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 129' ' ' ASP . 2.3 p -80.65 -17.22 51.89 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 117.183 -1.807 . . . . 0.0 110.517 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mt -67.9 -31.53 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.12 2.66 55.05 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.763 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 133' ' ' VAL . 61.0 t0 -60.29 -61.69 2.42 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' ' HB ' ' A' ' 6' ' ' ILE . 11.1 mmm -90.1 -15.5 31.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.999 -2.818 . . . . 0.0 111.57 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -87.52 -13.32 43.35 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 118.026 -1.469 . . . . 0.0 108.801 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -90.35 -56.59 3.15 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 129' ' ' ASP . 2.5 t -57.56 -51.58 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 112.077 -2.329 . . . . 0.0 114.0 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.4 mp -89.66 -35.93 15.54 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 124.343 1.027 . . . . 0.0 108.604 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.575 0 C-N-CA 119.028 -1.558 . . . . 0.0 112.772 -179.318 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.91 -176.9 3.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 111.862 -2.426 . . . . 0.0 107.969 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -120.43 63.81 0.84 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 110.809 -2.905 . . . . 0.0 108.442 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -149.54 106.42 3.56 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.487 ' CD1' HD21 ' A' ' 57' ' ' LEU . 4.0 mm -121.87 125.72 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 109.772 -3.377 . . . . 0.0 102.641 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -127.86 134.05 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 124.766 1.291 . . . . 0.0 109.278 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.18 138.74 54.13 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 113.237 -1.801 . . . . 0.0 107.489 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.5 21.41 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.844 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.5 119.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 118.012 -1.475 . . . . 0.0 110.866 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 1.9 tp -112.48 179.32 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.572 ' H ' HD12 ' A' ' 11' ' ' ILE . . . . . . . . 0 C--N 1.35 1.32 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -179.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 123.911 1.815 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.412 42.0 pt 33.91 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.753 1 C-N-CA 132.228 4.211 . . . . 0.0 107.976 -176.034 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.7 mt -74.38 -42.27 59.56 Favored 'General case' 0 C--N 1.373 1.604 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.81 -0.58 16.27 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 112.191 -2.277 . . . . 0.0 108.44 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -79.23 -43.72 23.23 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 117.679 -1.608 . . . . 0.0 107.885 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -19.78 65.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.684 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.851 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -64.3 -43.98 93.05 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.3 -28.18 64.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 110.708 -2.951 . . . . 0.0 111.985 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.57 2.71 50.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 111.836 -2.438 . . . . 0.0 108.823 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.28 4.98 5.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.49 30.38 61.88 Favored Glycine 0 C--N 1.361 1.942 0 O-C-N 124.306 1.004 . . . . 0.0 112.251 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.36 -175.58 2.84 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -106.93 150.73 26.14 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.851 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.2 p -99.93 146.21 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 111.047 -2.797 . . . . 0.0 108.115 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' ILE . 86.9 t -140.04 82.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 111.317 -2.674 . . . . 0.0 105.333 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -87.83 123.95 33.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -93.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.866 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.55 -120.76 0.58 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.56 10.95 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 113.277 -1.461 . . . . 0.0 110.405 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.22 129.45 34.96 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 t -98.51 41.42 1.14 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-N 113.072 -1.876 . . . . 0.0 107.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.9 p -90.11 80.21 6.35 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.423 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.5 tp-100 -78.32 -36.75 46.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.309 -2.223 . . . . 0.0 108.573 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -35.64 79.79 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.312 1.007 . . . . 0.0 108.619 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.82 -24.8 41.13 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.2 -10.17 59.66 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.73 -33.93 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -74.15 -31.52 62.76 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.368 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.61 -0.5 57.33 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.12 -13.92 34.76 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.88 -41.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.75 -60.49 3.75 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 112.263 -2.244 . . . . 0.0 108.229 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.418 ' CG2' HG21 ' A' ' 35' ' ' VAL . 16.7 m -60.32 -66.44 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 113.454 -1.703 . . . . 0.0 107.819 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 102.74 35.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 O-C-N 126.782 2.552 . . . . 0.0 104.294 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.8 107.88 0.1 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 128.457 2.703 . . . . 0.0 109.222 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.88 -42.28 11.95 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -144.43 144.5 31.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 117.548 -1.661 . . . . 0.0 107.113 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.05 146.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 110.71 -2.95 . . . . 0.0 105.254 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.0 t -150.5 125.88 10.11 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.85 -178.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.852 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.037 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.74 97.12 3.57 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 p 155.93 152.6 0.01 OUTLIER 'General case' 0 C--N 1.356 0.876 0 CA-C-N 112.681 -2.054 . . . . 0.0 106.98 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 43.9 mt -65.84 -110.63 0.0 OUTLIER 'General case' 0 C--N 1.36 1.032 0 CA-C-N 111.884 -2.416 . . . . 0.0 105.105 178.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -95.94 68.47 2.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . -131.73 55.68 0.76 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 109.63 -3.441 . . . . 0.0 105.016 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.431 ' H ' ' H ' ' A' ' 67' ' ' GLY . 20.0 pt20 -167.14 -28.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 111.044 -2.578 . . . . 0.0 106.977 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 74.54 -177.21 47.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.029 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -76.61 -3.41 37.55 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.35 -2.425 . . . . 0.0 108.376 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -71.55 -53.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.0 -22.13 59.72 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 112.561 -2.109 . . . . 0.0 109.111 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.67 -64.24 0.9 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -90.15 27.99 1.51 Allowed 'General case' 0 C--N 1.355 0.807 0 O-C-N 124.717 1.26 . . . . 0.0 109.798 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.63 -40.68 3.81 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.423 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.7 mt -88.58 -22.77 23.35 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 111.92 -2.14 . . . . 0.0 108.517 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.9 mmt85 -78.71 -26.98 44.9 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.62 -26.74 41.1 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -75.98 -16.75 59.93 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.123 0.889 . . . . 0.0 109.227 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.3 t -90.21 -46.26 8.55 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 123.948 1.832 . . . . 0.0 107.319 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.15 -4.94 28.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 108.536 -3.938 . . . . 0.0 109.002 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.22 -56.29 4.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.0 47.81 4.11 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 110.881 -2.872 . . . . 0.0 106.527 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.54 -42.14 0.02 OUTLIER Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.654 -2.067 . . . . 0.0 109.9 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.34 122.94 27.55 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 128.3 34.8 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.26 113.6 1.55 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.221 -2.263 . . . . 0.0 108.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -146.41 35.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -141.15 112.98 7.72 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 103.527 -2.768 . . . . 0.0 103.527 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.52 106.39 8.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 85.39 3.09 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 100.613 -3.847 . . . . 0.0 100.613 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.26 101.5 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 126.221 2.915 . . . . 0.0 110.085 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.27 116.55 4.77 Favored Glycine 0 C--N 1.343 0.961 1 CA-C-N 108.239 -4.073 . . . . 0.0 108.489 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.64 -84.91 0.44 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 105.738 -2.945 . . . . 0.0 105.738 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t30 72.24 -84.34 0.03 OUTLIER 'General case' 0 C--N 1.357 0.935 0 CA-C-N 112.879 -1.66 . . . . 0.0 107.681 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -140.37 135.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.34 158.06 4.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.57 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 42.68 75.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.757 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.47 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.2 135.14 1.94 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.196 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -174.16 110.73 0.16 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 91.45 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.355 0.841 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -94.14 135.73 35.19 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -143.06 162.94 40.73 Favored Pre-proline 0 C--N 1.35 0.605 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.27 -150.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.478 -1.778 . . . . 0.0 107.478 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.11 -22.26 63.03 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.216 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.3 p -58.13 -69.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 O-C-N 124.483 1.114 . . . . 0.0 111.214 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.533 ' H ' HG13 ' A' ' 104' ' ' VAL . 15.3 mm-40 -90.17 24.92 2.33 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.501 -1.68 . . . . 0.0 108.209 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -77.32 -41.03 42.13 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.43 -32.55 42.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 112.472 -2.149 . . . . 0.0 106.41 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -92.78 16.68 11.82 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.678 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -39.82 12.33 Favored 'General case' 0 C--N 1.361 1.096 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.29 75.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.028 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtp -78.96 -60.77 2.25 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.32 37.34 0.02 OUTLIER Glycine 0 C--N 1.356 1.643 0 C-N-CA 128.056 2.741 . . . . 0.0 117.642 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.73 -0.23 57.41 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.18 134.51 48.17 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.471 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.23 176.54 5.01 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.01 161.61 25.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.792 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -99.88 154.9 37.0 Favored Pre-proline 0 C--N 1.355 0.842 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.964 178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.49 162.21 38.53 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 106.84 -2.023 . . . . 0.0 106.84 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.53 124.9 10.18 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 105.201 -2.653 . . . . 0.0 105.201 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.13 137.05 9.46 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -73.85 154.34 39.51 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 125.584 2.612 . . . . 0.0 107.492 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 p -166.11 108.67 0.71 Allowed Pre-proline 0 N--CA 1.426 -1.642 1 CA-C-N 105.819 -5.173 . . . . 0.0 100.362 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -78.61 0.31 10.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.3 -38.35 87.53 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.945 1.698 . . . . 0.0 107.631 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -24.29 59.96 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.985 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.7 p -84.64 -19.84 32.28 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.957 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -64.69 -30.17 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.49 -7.65 59.61 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 111.712 -2.495 . . . . 0.0 108.798 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 126' ' ' THR . 25.4 t0 -53.7 -72.34 0.06 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-O 122.116 0.96 . . . . 0.0 108.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.403 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 4.9 mmt -86.67 -6.07 58.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 112.302 -2.226 . . . . 0.0 110.336 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.14 -66.01 0.96 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.834 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -48.02 -44.69 31.19 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.34 1.056 . . . . 0.0 111.021 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.502 HG12 HD23 ' A' ' 134' ' ' LEU . 25.6 t -65.37 -65.57 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 133' ' ' VAL . 49.8 mt -90.52 55.76 3.11 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.35 1.318 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.59 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -73.05 -162.43 0.11 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 111.689 -2.505 . . . . 0.0 107.505 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -149.69 99.74 2.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.188 -1.824 . . . . 0.0 106.253 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.62 100.33 0.01 OUTLIER 'General case' 0 C--N 1.355 0.845 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.8 116.43 48.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 35' ' ' VAL . 5.8 p -107.43 112.25 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 111.621 -2.536 . . . . 0.0 109.113 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.16 134.44 51.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.449 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.86 168.03 31.18 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.734 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.81 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 167.57 -121.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.662 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.704 HG22 HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -142.92 -168.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.094 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.221 -177.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.364 2.103 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.156 -179.265 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm . . . . . 0 N--CA 1.485 1.283 0 CA-C-O 125.14 2.4 . . . . 0.0 108.365 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.328 0.0 OUTLIER 34.67 54.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.605 1 CA-C-N 106.871 -4.695 . . . . 0.0 106.437 -175.847 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.461 HD21 HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -66.9 -21.78 65.99 Favored 'General case' 0 C--N 1.377 1.773 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 173.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -67.57 -20.47 65.39 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 116.514 -2.075 . . . . 0.0 107.299 176.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.521 ' HB2' HG22 ' A' ' 22' ' ' ILE . 7.9 t60 -66.02 -29.96 70.41 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.436 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 37.0 t -67.19 -18.38 65.23 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.608 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.99 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -56.73 -47.1 80.76 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.07 69.11 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 110.482 -3.054 . . . . 0.0 112.763 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -84.72 7.53 20.2 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 111.559 -2.564 . . . . 0.0 108.632 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.78 -0.99 5.39 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.61 28.88 68.5 Favored Glycine 0 C--N 1.36 1.902 0 O-C-N 124.139 0.899 . . . . 0.0 111.377 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -105.38 -168.01 1.4 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 113.342 -1.429 . . . . 0.0 107.605 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.56 149.69 21.02 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.093 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.99 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.8 124.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 108.871 -3.786 . . . . 0.0 108.79 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.677 HG12 HG23 ' A' ' 7' ' ' VAL . 2.8 t -140.33 132.93 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 110.896 -2.865 . . . . 0.0 105.429 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -139.02 133.19 31.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.55 -20.15 6.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.567 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.68 -123.36 7.9 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.14 113.38 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-O 122.324 1.059 . . . . 0.0 109.28 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 42' ' ' SER . 3.7 tt -175.25 137.79 0.4 Allowed 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 t -94.54 39.55 1.09 Allowed 'General case' 0 C--N 1.354 0.776 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.435 ' HB2' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -90.55 91.52 8.47 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -90.02 -58.54 2.47 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.61 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.7 pt-20 -59.93 -20.92 60.08 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 124.771 1.294 . . . . 0.0 112.04 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.95 -38.89 14.14 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.878 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 54.7 m-85 -89.15 12.65 15.2 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.907 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -91.97 -34.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 175.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.73 -27.93 62.34 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -84.41 -16.65 41.95 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.63 -7.6 58.65 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.2 -43.06 18.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -60.61 -64.0 1.1 Allowed 'General case' 0 C--N 1.354 0.802 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.492 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.84 82.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.4 tttp 84.38 54.47 0.01 OUTLIER 'General case' 0 C--N 1.345 0.386 0 CA-C-N 112.022 -2.354 . . . . 0.0 105.02 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 124.51 23.75 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.112 -2.313 . . . . 0.0 107.489 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.99 -84.09 0.15 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.82 145.62 26.78 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.62 142.37 43.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.1 m -129.56 131.92 46.69 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 112.18 -2.282 . . . . 0.0 105.815 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.757 HG22 HG23 ' A' ' 10' ' ' VAL . 13.1 p -116.32 133.17 63.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.727 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.81 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -110.32 90.77 3.42 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 123.979 1.847 . . . . 0.0 107.016 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.2 t -131.12 176.93 7.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.257 -2.701 . . . . 0.0 106.544 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 52.55 1.02 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 110.405 -3.089 . . . . 0.0 105.906 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER 60.9 49.01 6.22 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.602 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.2 -0.07 5.96 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.868 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.13 -2.86 49.06 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.67 177.56 8.58 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.35 1.031 . . . . 0.0 111.652 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.17 25.58 2.14 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 112.871 -1.665 . . . . 0.0 108.188 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -52.68 10.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.529 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.6 m-20 -71.81 -26.86 62.57 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 112.703 -2.044 . . . . 0.0 107.26 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 t -67.78 -58.22 4.98 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -90.07 30.13 1.13 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 124.48 1.112 . . . . 0.0 109.426 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.49 -37.79 3.91 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 70' ' ' ASP . 2.0 mm? -90.01 -23.77 21.4 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.625 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -29.6 57.26 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.93 -28.21 55.15 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -16.82 60.62 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 124.155 0.909 . . . . 0.0 109.368 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 39.8 t -90.24 -46.85 8.15 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.847 1.784 . . . . 0.0 107.518 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -75.41 2.34 11.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 108.715 -3.857 . . . . 0.0 109.11 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.72 -55.59 3.9 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 44.78 7.93 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 110.958 -2.837 . . . . 0.0 106.798 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.01 -43.7 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.392 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.06 121.11 25.11 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 140.75 32.65 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 113.302 -1.772 . . . . 0.0 106.412 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.74 71.16 0.28 Allowed Glycine 0 C--N 1.351 1.364 0 CA-C-N 112.633 -2.076 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 tt -103.73 35.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -128.01 118.1 22.91 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -140.29 151.93 45.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.592 -2.094 . . . . 0.0 105.73 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 106.24 5.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 100.654 -3.832 . . . . 0.0 100.654 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.87 93.58 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 125.114 2.388 . . . . 0.0 110.164 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.69 118.47 13.5 Favored Glycine 0 CA--C 1.537 1.453 1 CA-C-N 107.975 -4.193 . . . . 0.0 111.137 176.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.82 -92.39 1.62 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 72.75 -142.6 0.04 OUTLIER 'General case' 0 C--N 1.356 0.885 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.502 HG12 HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -91.68 148.71 4.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.31 -164.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 CA-C-N 112.548 -2.115 . . . . 0.0 108.423 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 p 41.77 74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.04 33.79 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 112.068 -2.333 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -159.93 -46.72 0.05 Allowed 'General case' 0 C--N 1.347 0.473 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -129.7 -44.27 1.21 Allowed 'General case' 0 C--N 1.349 0.549 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.97 95.58 9.54 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -103.0 164.24 15.93 Favored Pre-proline 0 C--N 1.35 0.624 0 CA-C-N 112.483 -2.144 . . . . 0.0 105.36 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.08 -152.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.784 1.656 . . . . 0.0 108.792 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.33 -25.54 64.26 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 113.431 -1.713 . . . . 0.0 108.456 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.0 p -53.53 -74.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 O-C-N 124.912 1.382 . . . . 0.0 110.749 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.675 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.8 mt-10 -90.07 28.71 1.34 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.5 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -76.62 -45.33 30.53 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -80.58 -31.38 36.79 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 111.495 -2.593 . . . . 0.0 107.381 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.3 10.7 21.31 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 118.584 -1.247 . . . . 0.0 109.125 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.31 14.12 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -33.93 74.39 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.652 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 55.7 mtp -81.29 -60.49 2.26 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 34.68 37.55 0.1 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 112.31 -2.223 . . . . 0.0 117.243 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -79.84 -15.47 57.33 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -101.63 138.8 38.14 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.556 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.422 ' HE ' HG22 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.31 178.79 4.28 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.19 156.89 24.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.53 114.24 65.46 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 101.785 -3.413 . . . . 0.0 101.785 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -55.34 157.89 13.54 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.418 2.745 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.96 121.03 8.17 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 105.918 -2.378 . . . . 0.0 105.918 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 65.91 0.96 Allowed Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.388 -2.187 . . . . 0.0 107.901 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.4 p -82.12 -151.99 0.1 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.424 -2.388 . . . . 0.0 107.173 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 p 176.97 166.33 0.47 Allowed Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 110.805 -2.907 . . . . 0.0 104.243 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.61 -5.15 15.27 Favored 'Trans proline' 0 C--N 1.365 1.424 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.48 -23.87 53.81 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -17.82 58.32 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.753 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.0 p -87.19 -20.79 26.48 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.914 0.758 . . . . 0.0 110.613 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.89 -27.2 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.66 -1.01 57.61 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.606 -2.088 . . . . 0.0 109.264 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 133' ' ' VAL . 19.0 t0 -69.75 -68.03 0.44 Allowed 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.436 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 1.9 mpt? -74.45 -13.65 60.73 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.803 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -90.04 -43.45 10.5 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.999 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.39 -31.74 70.65 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 121.053 0.454 . . . . 0.0 109.789 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 129' ' ' ASP . 53.8 t -90.09 -77.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.327 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.421 HD23 HG12 ' A' ' 133' ' ' VAL . 27.2 mt -90.49 63.06 5.44 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.643 1.215 . . . . 0.0 108.839 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.071 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.329 178.111 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 . . . . . 0 CA--C 1.537 0.457 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -70.82 145.38 50.37 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -79.53 95.68 5.9 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 111.197 -2.729 . . . . 0.0 108.413 -177.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.41 112.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 132.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -125.7 141.05 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 110.974 -2.83 . . . . 0.0 110.202 -176.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.9 pp -125.31 167.23 15.19 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 112.272 -2.24 . . . . 0.0 105.728 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 178.25 -172.25 44.71 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 126.428 2.33 . . . . 0.0 113.42 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 60' ' ' VAL 0.455 13.5 p 69.53 -125.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 110.139 -3.031 . . . . 0.0 114.714 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.54 ' H ' HG13 ' A' ' 10' ' ' VAL . 4.2 tp 56.71 113.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 128.744 2.817 . . . . 0.0 109.018 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.366 2.197 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.457 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.1 tmtm? . . . . . 0 N--CA 1.437 -1.118 0 CA-C-O 124.947 2.308 . . . . 0.0 104.995 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' LYS 0.318 38.7 mt 93.61 9.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 1 CA-C-N 107.101 -4.59 . . . . 0.0 112.325 175.518 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.474 ' HG ' ' CG2' ' A' ' 126' ' ' THR 0.259 0.2 OUTLIER -74.85 -30.46 61.36 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 114.472 -2.891 . . . . 0.0 106.378 176.32 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.17 -13.13 59.99 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 117.406 -1.717 . . . . 0.0 107.05 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -77.31 -31.89 54.97 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.976 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -74.33 -18.76 60.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.792 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -68.43 -39.44 81.56 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 118.139 -1.424 . . . . 0.0 107.472 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -31.0 64.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 110.425 -3.08 . . . . 0.0 112.246 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -88.05 0.29 56.14 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 112.077 -2.329 . . . . 0.0 109.989 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.33 -8.26 11.67 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.01 23.64 69.67 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -99.9 170.59 8.42 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -80.86 151.12 28.81 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 111.232 -2.713 . . . . 0.0 105.399 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 135.83 33.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 CA-C-N 111.703 -2.499 . . . . 0.0 107.469 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 60.0 t -136.66 92.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 111.593 -2.549 . . . . 0.0 106.172 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -96.55 126.17 41.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.292 -1.776 . . . . 0.0 107.198 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 8' ' ' LEU . 15.8 mt -98.72 -24.59 4.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 O-C-N 124.778 1.299 . . . . 0.0 107.655 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.78 -151.33 19.51 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.64 14.1 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 114.423 -0.889 . . . . 0.0 111.441 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.89 102.77 6.2 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.8 p -84.89 83.07 8.17 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 125.05 22.51 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 109.809 -3.36 . . . . 0.0 106.969 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.95 -93.59 0.07 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.987 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.66 -18.45 53.76 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 124.8 1.313 . . . . 0.0 111.462 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.63 -43.24 12.79 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD2' HG12 ' A' ' 37' ' ' ILE . 1.3 t80 -86.52 4.48 39.74 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 116.862 -1.935 . . . . 0.0 108.982 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -26.89 6.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.16 -30.21 49.04 Favored 'General case' 0 C--N 1.365 1.25 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.26 10.16 33.11 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.77 20.03 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.1 -37.31 76.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.31 -71.75 0.14 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.449 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -61.54 1.86 Allowed 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.512 0.508 . . . . 0.0 110.362 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? 99.87 68.9 0.0 OUTLIER 'General case' 0 C--N 1.348 0.509 0 O-C-N 126.248 2.217 . . . . 0.0 106.654 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.42 116.09 2.66 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.331 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -77.2 -48.55 17.3 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.39 150.49 35.78 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.96 170.63 5.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -153.21 109.02 3.29 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.773 -2.012 . . . . 0.0 105.814 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 10' ' ' VAL . 3.0 t -99.86 120.05 48.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -101.84 113.01 25.82 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 117.851 -1.54 . . . . 0.0 107.685 -176.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 t 150.74 162.83 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.76 74.4 6.59 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 111.517 -2.583 . . . . 0.0 106.682 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 72.66 49.65 0.18 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 112.558 -2.11 . . . . 0.0 107.805 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.22 2.99 72.16 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.996 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.627 ' HB3' HG11 ' A' ' 60' ' ' VAL . 12.2 pt20 -88.13 -20.49 25.57 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.661 -1.27 . . . . 0.0 109.463 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.04 174.35 40.25 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.58 6.29 9.04 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.85 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -67.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.576 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 29.4 t70 -71.13 -20.7 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.553 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.4 t -72.94 -56.26 5.41 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -90.07 21.08 3.87 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.617 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.44 -27.07 6.6 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.867 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 20.6 mt -85.67 -27.67 25.2 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.567 ' HG3' HH11 ' A' ' 75' ' ' ARG . 3.0 mmt85 -72.02 -32.38 67.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.28 -23.54 47.19 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 113.624 -1.626 . . . . 0.0 108.391 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -77.11 -16.5 59.16 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 83.7 m -90.24 -42.98 10.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.831 1.777 . . . . 0.0 107.282 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.65 -1.06 22.88 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 108.679 -3.873 . . . . 0.0 108.654 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.27 -54.5 5.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 59.94 40.88 18.47 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 110.882 -2.872 . . . . 0.0 107.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.78 -51.25 0.04 OUTLIER Glycine 0 C--N 1.35 1.308 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 120.19 32.63 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 126.59 31.14 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.153 -1.84 . . . . 0.0 106.29 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.61 56.19 0.04 OUTLIER Glycine 0 C--N 1.345 1.062 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.195 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -99.94 32.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 CA-C-N 112.203 -1.998 . . . . 0.0 106.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -144.36 112.56 6.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 97.35 3.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.67 85.25 3.08 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.492 HG23 ' CB ' ' A' ' 93' ' ' ASN . 4.4 m -89.45 98.45 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 109.881 -3.327 . . . . 0.0 110.397 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -63.31 132.92 42.25 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 109.116 -3.675 . . . . 0.0 113.348 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.96 -74.21 0.95 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 111.869 -2.165 . . . . 0.0 109.765 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.492 ' CB ' HG23 ' A' ' 90' ' ' VAL . 15.7 t-20 18.75 103.67 0.0 OUTLIER 'General case' 0 C--N 1.354 0.769 1 C-N-CA 131.763 4.025 . . . . 0.0 111.06 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 58.44 120.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 112.334 -2.212 . . . . 0.0 108.478 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.49 162.5 4.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 112.102 -2.317 . . . . 0.0 108.58 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 p 41.3 69.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 CA-C-N 112.432 -2.167 . . . . 0.0 112.715 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.36 128.96 1.06 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.365 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -157.61 100.0 1.76 Allowed 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 96.49 -51.77 0.01 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -85.68 99.13 11.1 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.508 ' HH2' HG21 ' A' ' 116' ' ' VAL . 88.6 m95 -113.5 160.47 31.48 Favored Pre-proline 0 C--N 1.351 0.646 0 CA-C-N 112.694 -2.048 . . . . 0.0 106.122 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.58 -155.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 N-CA-C 106.456 -2.171 . . . . 0.0 106.456 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.38 -20.91 62.92 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.688 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.6 p -60.01 -69.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.776 0 O-C-N 124.437 1.086 . . . . 0.0 111.621 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.522 ' H ' HG13 ' A' ' 104' ' ' VAL . 29.5 mt-10 -90.15 27.01 1.72 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 117.688 -1.605 . . . . 0.0 109.3 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -79.92 -42.36 24.25 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.48 -31.79 42.39 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 112.314 -2.221 . . . . 0.0 106.683 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -90.87 14.29 14.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.214 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -90.41 -37.37 14.01 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.78 75.55 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.84 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 29.9 mtp -76.9 -63.51 1.34 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 35.5 31.29 0.02 OUTLIER Glycine 0 C--N 1.355 1.635 0 C-N-CA 127.135 2.302 . . . . 0.0 117.496 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -7.19 59.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -105.25 128.63 53.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 176.91 4.87 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.508 HG21 ' HH2' ' A' ' 101' ' ' TRP . 4.8 m -138.23 158.47 32.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.17 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.412 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.5 OUTLIER -99.9 152.62 37.87 Favored Pre-proline 0 C--N 1.358 0.946 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.43 147.89 83.26 Favored 'Trans proline' 0 C--N 1.369 1.654 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.78 114.5 3.2 Favored 'Trans proline' 0 C--N 1.364 1.373 0 N-CA-C 104.011 -3.111 . . . . 0.0 104.011 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.29 42.77 6.1 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.499 -1.682 . . . . 0.0 110.389 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.5 t -90.17 -179.08 5.57 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 125.174 2.416 . . . . 0.0 106.457 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.357 19.7 p -82.39 170.78 13.63 Favored Pre-proline 0 N--CA 1.426 -1.668 1 CA-C-N 106.806 -4.725 . . . . 0.0 106.031 179.078 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -92.06 -0.06 4.23 Favored 'Trans proline' 0 CA--C 1.554 1.499 0 N-CA-C 104.586 -2.89 . . . . 0.0 104.586 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 127' ' ' ILE . 38.6 tt0 -74.97 -16.1 60.65 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.679 1.192 . . . . 0.0 108.284 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.75 55.57 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 129' ' ' ASP . 35.6 p -79.83 -23.21 42.17 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.012 -1.475 . . . . 0.0 109.817 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 124' ' ' GLU . 5.8 mt -68.55 -30.34 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.68 -5.14 58.7 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 112.134 -2.303 . . . . 0.0 108.796 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.4 t0 -59.85 -58.56 8.03 Favored 'General case' 0 C--N 1.367 1.347 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -88.29 1.61 54.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.362 -2.199 . . . . 0.0 110.156 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -81.04 -48.35 12.32 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 117.151 -1.82 . . . . 0.0 109.866 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.76 -31.49 19.61 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.235 0.96 . . . . 0.0 111.928 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 129' ' ' ASP . 16.9 t -73.25 -26.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.105 0.878 . . . . 0.0 112.379 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -89.21 -36.85 15.41 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.641 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.033 179.95 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -70.93 145.94 49.82 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.938 1.351 . . . . 0.0 107.76 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.443 ' H ' ' HD3' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -80.61 95.85 6.67 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.938 -2.847 . . . . 0.0 108.313 -177.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 172.29 111.51 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.08 122.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.3 147.16 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 110.546 -3.025 . . . . 0.0 110.163 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 tm? -125.13 149.21 48.1 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.1 155.41 26.15 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 125.762 1.914 . . . . 0.0 112.554 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 13.6 p 84.94 -127.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 130.406 3.483 . . . . 0.0 117.03 177.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 10' ' ' VAL 0.316 2.0 tp 72.78 115.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 128.443 2.697 . . . . 0.0 106.382 -175.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.367 2.286 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.002 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.453 -0.306 0 CA-C-O 122.961 1.362 . . . . 0.0 107.68 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 3.35 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 111.502 -2.59 . . . . 0.0 111.357 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 0.2 OUTLIER -85.69 -38.58 18.16 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 116.573 -2.051 . . . . 0.0 107.664 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.98 -11.24 60.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 117.489 -1.685 . . . . 0.0 106.478 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -80.78 -38.56 28.3 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.5 m -71.0 -14.84 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 112.242 -2.254 . . . . 0.0 109.903 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.481 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.11 -42.03 73.21 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -31.61 66.59 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 110.188 -3.187 . . . . 0.0 112.462 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -87.63 -1.76 58.17 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 111.971 -2.377 . . . . 0.0 110.016 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.72 -10.32 14.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.1 70.76 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -99.88 168.47 9.86 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -78.22 148.74 33.85 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 111.178 -2.737 . . . . 0.0 105.766 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.481 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 132.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.579 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.85 74.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 111.481 -2.599 . . . . 0.0 105.444 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.09 122.98 31.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.472 -2.149 . . . . 0.0 107.622 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 8' ' ' LEU . 53.3 mt -98.39 -27.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.71 -141.51 15.58 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.99 -13.67 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.237 -0.982 . . . . 0.0 110.278 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.3 98.89 11.99 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -82.68 80.76 8.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.36 118.15 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 110.883 -2.872 . . . . 0.0 105.387 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 70' ' ' ASP . 6.7 tp-100 -89.86 -87.37 0.18 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.585 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.11 -18.63 63.63 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 124.63 1.206 . . . . 0.0 110.563 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.52 -41.8 14.99 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -86.47 4.88 37.82 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 116.898 -1.921 . . . . 0.0 108.877 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.37 -26.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -78.65 -31.17 46.68 Favored 'General case' 0 C--N 1.365 1.279 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.88 10.79 29.61 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.11 -28.0 19.27 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.55 -37.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.87 -71.73 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 112.387 -2.188 . . . . 0.0 110.234 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -63.96 1.13 Allowed 'General case' 0 C--N 1.362 1.148 0 O-C-N 123.491 0.494 . . . . 0.0 110.193 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 101.25 71.14 0.0 OUTLIER 'General case' 0 C--N 1.346 0.444 0 O-C-N 126.4 2.312 . . . . 0.0 106.467 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 122.0 10.87 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.433 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -95.19 -59.41 1.9 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.79 124.83 40.59 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.459 HG21 HD13 ' A' ' 74' ' ' LEU . 39.6 mt -95.79 167.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.2 m -148.98 120.82 8.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 111.918 -2.401 . . . . 0.0 106.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.593 HG23 HG12 ' A' ' 90' ' ' VAL . 23.5 t -99.88 133.38 43.0 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -119.66 96.47 5.21 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t 147.57 161.72 0.0 OUTLIER 'General case' 0 C--N 1.354 0.789 0 O-C-N 126.293 2.246 . . . . 0.0 106.031 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.37 77.57 8.88 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 111.279 -2.691 . . . . 0.0 106.527 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.819 -1.992 . . . . 0.0 107.607 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.74 57.69 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.897 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -92.57 4.32 53.81 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 113.444 -1.378 . . . . 0.0 109.357 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.31 -167.53 35.95 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.721 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.11 21.08 3.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 112.498 -1.851 . . . . 0.0 108.072 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -75.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 20.8 t70 -71.25 -24.49 62.19 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 112.472 -2.149 . . . . 0.0 108.904 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.48 -49.4 22.36 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -90.02 16.11 8.9 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.554 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.77 -23.61 11.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.149 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 29.5 mt -89.94 -25.41 20.93 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.513 ' HG3' HH11 ' A' ' 75' ' ' ARG . 2.3 mmt85 -71.81 -30.49 65.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -79.51 -23.67 42.77 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.187 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -77.64 -12.8 60.0 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.801 0.84 . . . . 0.0 108.904 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.0 m -90.24 -42.91 10.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.923 1.82 . . . . 0.0 106.661 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.43 -3.56 31.31 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 108.527 -3.942 . . . . 0.0 108.741 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.5 -54.58 5.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.71 40.43 23.25 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 111.125 -2.761 . . . . 0.0 107.688 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.75 -52.35 0.05 OUTLIER Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -94.46 122.55 37.14 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 134.89 38.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.13 54.97 0.02 OUTLIER Glycine 0 C--N 1.347 1.14 0 CA-C-N 112.36 -2.2 . . . . 0.0 109.208 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.5 -33.41 11.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.389 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -80.92 117.53 21.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.09 100.22 3.86 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.66 92.76 5.49 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 60' ' ' VAL . 27.3 m -89.21 97.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 110.298 -3.137 . . . . 0.0 110.64 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -67.57 134.74 30.63 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 110.027 -3.261 . . . . 0.0 113.02 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.59 -80.67 1.37 Allowed Glycine 0 C--N 1.354 1.546 0 CA-C-N 111.691 -2.255 . . . . 0.0 108.492 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.49 ' CB ' HG23 ' A' ' 90' ' ' VAL . 11.1 t-20 21.56 94.06 0.01 OUTLIER 'General case' 0 C--N 1.354 0.767 0 C-N-CA 131.399 3.88 . . . . 0.0 110.171 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt 76.19 131.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.94 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.03 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 CA-C-N 112.313 -2.221 . . . . 0.0 108.103 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p 35.22 63.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 112.241 -2.254 . . . . 0.0 112.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.36 147.55 12.61 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.643 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -175.27 107.99 0.1 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 93.42 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.356 0.888 0 O-C-N 126.137 2.148 . . . . 0.0 105.429 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -87.69 107.51 18.66 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -116.47 163.34 22.45 Favored Pre-proline 0 C--N 1.351 0.651 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.16 -151.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.763 1.642 . . . . 0.0 107.976 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.07 -20.13 57.99 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.523 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -67.69 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.721 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.23 25.86 2.08 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 117.199 -1.8 . . . . 0.0 109.41 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.07 -41.23 26.02 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -78.32 -31.79 48.94 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 112.512 -2.131 . . . . 0.0 106.256 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -92.85 17.02 11.18 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.294 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -90.36 -38.97 12.97 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.19 80.1 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.915 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 12.3 mtp -74.22 -65.29 0.86 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.49 27.57 0.09 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 112.127 -2.306 . . . . 0.0 117.295 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.32 -5.24 58.46 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.12 132.59 51.15 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.75 6.68 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.08 157.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.429 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 0.7 OUTLIER -99.44 147.68 33.66 Favored Pre-proline 0 C--N 1.359 0.982 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 -178.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.56 145.06 81.14 Favored 'Trans proline' 0 C--N 1.371 1.723 0 N-CA-C 107.451 -1.788 . . . . 0.0 107.451 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -79.97 111.97 2.78 Favored 'Trans proline' 0 C--N 1.364 1.35 0 N-CA-C 103.552 -3.288 . . . . 0.0 103.552 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.16 42.14 5.04 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 113.47 -1.695 . . . . 0.0 110.478 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.5 t -90.12 -179.15 5.6 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 124.875 2.274 . . . . 0.0 106.644 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.335 22.3 p -78.73 173.43 7.71 Favored Pre-proline 0 N--CA 1.431 -1.394 1 CA-C-N 107.297 -4.501 . . . . 0.0 105.666 178.797 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -93.75 -4.6 2.82 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 105.198 -2.655 . . . . 0.0 105.198 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.33 -10.68 60.0 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.717 1.607 . . . . 0.0 108.3 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -30.55 60.49 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.796 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 36.3 p -83.66 -25.66 30.54 Favored 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.46 1.1 . . . . 0.0 110.069 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.8 -28.61 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 103.242 -2.874 . . . . 0.0 103.242 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.35 58.39 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.145 -2.298 . . . . 0.0 108.609 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.7 t0 -61.74 -53.75 51.76 Favored 'General case' 0 C--N 1.366 1.325 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -87.43 -2.61 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 111.956 -2.384 . . . . 0.0 110.168 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -81.32 -49.69 10.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 117.15 -1.82 . . . . 0.0 110.223 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.16 -36.36 21.11 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 124.161 0.913 . . . . 0.0 112.148 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.8 t -70.59 -29.71 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.767 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.09 -39.91 18.95 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.354 1.571 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.292 179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.4 156.58 16.42 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 124.429 2.061 . . . . 0.0 108.404 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.96 94.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 107.999 -4.182 . . . . 0.0 108.757 -178.483 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.26 106.53 0.02 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.623 ' HB ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -145.65 111.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.597 ' HB ' HG22 ' A' ' 37' ' ' ILE . 7.6 m -89.72 145.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 CA-C-O 123.198 1.475 . . . . 0.0 109.385 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.34 111.43 15.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 110.081 -3.236 . . . . 0.0 104.034 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . . . -160.83 141.61 7.5 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.854 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.734 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 171.26 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.034 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER 118.97 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.688 0 O-C-N 125.916 2.01 . . . . 0.0 105.879 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.353 1.509 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.541 179.746 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.51 -0.593 0 CA-C-O 125.696 2.665 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 25' ' ' HIS 0.433 0.1 OUTLIER 45.12 39.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.652 1 CA-C-N 107.405 -4.452 . . . . 0.0 110.181 178.463 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.43 -37.18 63.38 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 174.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.74 -9.76 57.98 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 112.019 -2.355 . . . . 0.0 107.268 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HB3' HG13 ' A' ' 22' ' ' ILE . 16.9 t-80 -87.11 -7.68 57.79 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 m -59.58 -41.33 90.01 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.95 -42.69 98.73 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 110.013 -3.267 . . . . 0.0 109.137 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -82.38 -9.53 59.42 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.82 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 130' ' ' MET . 0.6 OUTLIER -68.2 -42.03 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.556 1.142 . . . . 0.0 108.664 -177.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.82 39.43 0.06 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.0 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.7 27.78 64.51 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.122 -0.944 . . . . 0.0 114.571 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.87 92.01 5.09 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -35.57 141.33 0.08 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 129.757 3.223 . . . . 0.0 109.213 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 2.6 m -121.45 136.42 58.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 111.898 -2.41 . . . . 0.0 106.643 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.3 t -102.31 102.7 13.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.004 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -77.71 114.62 16.74 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.597 HG22 ' HB ' ' A' ' 7' ' ' VAL . 1.1 tt -98.82 -3.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 112.085 -2.325 . . . . 0.0 108.161 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.01 -100.61 2.23 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 123.924 0.765 . . . . 0.0 113.75 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 16.3 m -127.08 -31.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-N 113.223 -1.489 . . . . 0.0 111.876 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -91.83 111.85 23.54 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -101.5 80.26 2.05 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.6 140.84 58.56 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.928 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.23 -82.6 0.27 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.359 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.05 -21.18 61.07 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.543 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.25 -34.78 14.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.525 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.01 -8.54 58.67 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 116.864 -1.934 . . . . 0.0 109.686 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.614 ' HB ' HD13 ' A' ' 83' ' ' LEU . 1.1 mp -82.75 -26.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -76.67 -29.77 56.5 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.55 2.04 56.16 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.122 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.64 -20.32 26.51 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 mt -74.3 -39.91 49.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.77 -68.03 0.36 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.471 -2.149 . . . . 0.0 110.144 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -63.78 1.01 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 123.779 0.674 . . . . 0.0 109.713 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.2 tttp 111.62 50.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.61 109.76 0.34 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-N 112.177 -2.283 . . . . 0.0 108.782 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.38 -42.95 19.71 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -151.65 160.35 43.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 117.383 -1.727 . . . . 0.0 107.682 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 mm -122.93 139.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 CA-C-N 111.308 -2.678 . . . . 0.0 106.179 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.42 ' SG ' ' CD1' ' A' ' 57' ' ' LEU . 71.5 m -136.85 124.15 21.89 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.51 -2.132 . . . . 0.0 105.386 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 34.6 m -112.14 135.24 52.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-N 112.592 -2.095 . . . . 0.0 105.532 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.734 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -107.95 106.54 16.84 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 117.37 -1.732 . . . . 0.0 109.662 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 m 131.42 -177.0 0.0 OUTLIER 'General case' 0 C--N 1.352 0.674 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.85 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.648 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -66.0 97.67 0.38 Allowed 'General case' 0 C--N 1.36 1.046 0 CA-C-N 113.749 -1.568 . . . . 0.0 107.187 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.04 -28.27 3.42 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 111.12 -2.764 . . . . 0.0 107.411 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -84.62 -32.02 23.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 111.67 -2.265 . . . . 0.0 106.432 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.46 178.76 46.75 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.081 -1.56 . . . . 0.0 108.529 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mm -80.09 -48.56 20.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -71.97 -20.63 61.71 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.677 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 t -70.61 -45.26 65.6 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.06 18.0 6.31 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 124.464 1.102 . . . . 0.0 109.461 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -31.69 5.68 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 88' ' ' LEU . 12.6 mt -89.22 -25.35 21.79 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 112.998 -1.601 . . . . 0.0 106.783 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -29.12 60.8 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.13 -24.81 43.09 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.653 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -76.57 -15.62 59.81 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . 0.426 ' SG ' HG12 ' A' ' 86' ' ' ILE . 62.2 m -90.35 -44.84 9.41 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 123.885 1.802 . . . . 0.0 107.195 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.65 -1.72 22.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 108.589 -3.914 . . . . 0.0 108.857 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -80.81 -54.03 5.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.77 43.59 12.01 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 111.037 -2.801 . . . . 0.0 107.41 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.34 -47.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.212 0 CA-C-N 112.542 -2.117 . . . . 0.0 107.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.614 HD13 ' HB ' ' A' ' 47' ' ' ILE . 88.1 mt -89.04 121.14 31.09 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 119.45 23.11 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.88 75.84 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 CA-C-N 113.087 -1.869 . . . . 0.0 109.711 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.426 HG12 ' SG ' ' A' ' 78' ' ' CYS . 0.6 OUTLIER -115.41 30.7 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-N 112.122 -2.039 . . . . 0.0 106.292 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB3' HH22 ' A' ' 115' ' ' ARG . 72.9 mmtt -142.63 119.0 10.88 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.3 112.22 7.57 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.83 83.84 1.86 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.6 99.17 8.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-N 111.453 -2.612 . . . . 0.0 111.044 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.25 122.77 8.11 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 110.184 -3.189 . . . . 0.0 110.299 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.6 -98.39 2.42 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.3 t30 64.89 -97.13 0.05 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 112.48 -1.86 . . . . 0.0 107.616 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -85.07 111.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.28 168.58 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.628 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.251 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 40.32 57.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.46 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.25 151.34 13.5 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.508 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -173.6 131.83 0.45 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 87.9 -71.6 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 O-C-N 126.113 2.133 . . . . 0.0 105.534 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -92.61 145.43 24.43 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CZ3' HD13 ' A' ' 94' ' ' ILE . 87.3 m95 -129.39 160.29 64.98 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.41 -150.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.02 -26.68 63.22 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.352 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.85 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 124.881 1.363 . . . . 0.0 110.362 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.527 ' H ' HG23 ' A' ' 104' ' ' VAL . 19.7 mt-10 -90.39 24.72 2.48 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.635 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.9 -47.72 65.11 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 103.495 -2.779 . . . . 0.0 103.495 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.13 -20.08 23.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 111.575 -2.557 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -84.17 -45.93 12.43 Favored 'General case' 0 C--N 1.364 1.237 0 C-N-CA 117.977 -1.489 . . . . 0.0 108.879 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.33 -0.38 36.52 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.949 1.406 . . . . 0.0 108.252 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.42 79.81 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -87.77 -50.85 6.2 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.67 37.08 50.3 Favored Glycine 0 C--N 1.363 2.04 0 N-CA-C 116.384 1.313 . . . . 0.0 116.384 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.17 -7.44 58.21 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.01 133.09 50.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.473 HH22 ' HB3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -110.04 169.97 8.38 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.13 166.66 19.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 CA-C-N 113.67 -1.604 . . . . 0.0 107.284 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -99.62 150.69 37.02 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.47 160.02 44.93 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.095 1.863 . . . . 0.0 108.708 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.81 122.02 8.45 Favored 'Trans proline' 0 C--N 1.371 1.762 0 N-CA-C 105.219 -2.646 . . . . 0.0 105.219 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.8 -170.27 13.26 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.4 p -69.77 146.03 51.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.16 76.17 8.69 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.57 -20.72 13.63 Favored 'Trans proline' 0 C--N 1.369 1.655 0 O-C-N 123.422 1.222 . . . . 0.0 110.222 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.92 -32.81 51.88 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.374 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -77.73 -11.38 59.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.036 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 129' ' ' ASP . 30.9 p -89.3 -20.93 23.47 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.127 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.69 -26.55 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.29 -2.99 57.27 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.459 -2.155 . . . . 0.0 108.578 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t0 -53.06 -60.58 3.1 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.158 1.456 . . . . 0.0 107.261 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.639 ' HG2' HD13 ' A' ' 134' ' ' LEU . 3.0 ttp -90.02 -22.45 21.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.643 -2.98 . . . . 0.0 111.034 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -86.48 -13.37 46.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.921 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -90.21 -55.6 3.54 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 122.439 1.114 . . . . 0.0 108.366 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 129' ' ' ASP . 88.1 t -63.65 -53.07 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 112.361 -2.2 . . . . 0.0 114.197 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' A' ' 130' ' ' MET . 3.8 mp -89.16 -12.12 41.91 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.37 1.044 . . . . 0.0 109.646 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.704 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.22 178.695 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.532 0.276 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -79.72 143.24 34.71 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -79.24 95.21 5.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 110.786 -2.916 . . . . 0.0 108.817 -177.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.39 115.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 119.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.77 126.52 49.47 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 CA-C-N 112.285 -2.234 . . . . 0.0 108.385 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 23' ' ' LEU . 56.9 tp -125.15 140.96 52.41 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.182 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 155.57 173.96 24.86 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.997 HG23 HG22 ' A' ' 60' ' ' VAL . 2.2 p 164.98 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.227 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -175.27 -145.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.514 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.361 1.948 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 -179.214 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? . . . . . 0 N--CA 1.477 0.925 0 CA-C-O 126.371 2.986 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.356 0.0 OUTLIER 36.94 48.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.633 2 CA-C-N 106.731 -4.759 . . . . 0.0 108.557 -178.925 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.574 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -68.35 -33.31 74.06 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 173.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.49 6.49 4.6 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-N 110.971 -2.831 . . . . 0.0 107.817 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 22' ' ' ILE . 2.0 t60 -76.0 -41.72 50.29 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -44.83 63.62 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 111.318 -2.673 . . . . 0.0 109.601 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -54.12 -41.35 68.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.363 -178.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -21.67 44.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 112.666 -2.061 . . . . 0.0 113.581 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -78.82 -5.41 53.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.751 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.02 0.75 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 115.984 -2.286 . . . . 0.0 109.215 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.32 97.43 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 118.672 -1.727 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.31 151.45 21.05 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -76.98 136.64 38.75 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 111.479 -2.6 . . . . 0.0 105.932 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.96 148.0 7.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 112.304 -2.225 . . . . 0.0 107.011 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.11 67.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 111.172 -2.74 . . . . 0.0 106.982 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.81 115.3 9.8 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.304 -1.771 . . . . 0.0 106.58 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 tt -94.38 -2.35 10.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.636 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 -115.11 3.99 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.402 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -143.94 51.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 113.568 -1.316 . . . . 0.0 109.507 -179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.27 150.51 36.09 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 112.828 -1.987 . . . . 0.0 105.644 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 t -112.13 31.31 6.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 113.059 -1.882 . . . . 0.0 106.043 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 p -82.35 97.58 8.4 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.05 -56.55 3.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.471 -2.15 . . . . 0.0 108.85 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -24.84 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.749 1.281 . . . . 0.0 110.889 -177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.0 -32.83 18.63 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -88.16 2.91 51.06 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.027 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.01 -31.17 7.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.9 -27.4 61.86 Favored 'General case' 0 C--N 1.366 1.284 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.48 -4.43 55.53 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.89 -8.61 57.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.99 -40.32 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.65 -64.08 1.07 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.46 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -62.0 1.57 Allowed 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? 112.32 45.78 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 O-C-N 127.052 2.72 . . . . 0.0 104.85 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.46 112.1 0.76 Allowed 'General case' 0 C--N 1.358 0.953 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -81.69 0.33 Allowed 'General case' 0 C--N 1.358 0.94 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.711 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.52 130.77 37.3 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.737 1.273 . . . . 0.0 108.333 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.6 162.46 2.4 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.297 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . 0.574 ' SG ' HD12 ' A' ' 23' ' ' LEU . 21.5 t -156.99 104.65 2.11 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 HG23 ' A' ' 10' ' ' VAL . 2.1 p -110.35 129.9 64.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.731 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.99 111.32 19.42 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 117.426 -1.71 . . . . 0.0 108.767 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t 145.36 173.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.638 0 CA-C-N 111.27 -2.695 . . . . 0.0 104.52 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.04 -129.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.757 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.38 80.81 8.45 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.21 53.95 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' H ' ' H ' ' A' ' 67' ' ' GLY . 12.9 pt20 -165.52 -20.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 111.689 -2.256 . . . . 0.0 107.654 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.434 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 81.82 177.19 51.66 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.339 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -86.92 9.41 19.43 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.222 -1.489 . . . . 0.0 108.101 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -51.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.51 -27.79 62.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.502 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.49 -57.19 6.2 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -90.18 27.81 1.56 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 124.754 1.284 . . . . 0.0 109.025 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.67 -30.23 6.24 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -90.12 -30.02 17.93 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 112.637 -1.781 . . . . 0.0 107.211 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.4 mmt85 -71.31 -31.89 67.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -75.21 -31.89 61.03 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 113.503 -1.68 . . . . 0.0 108.03 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -71.52 -16.09 62.32 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.298 0.999 . . . . 0.0 109.763 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.25 -48.06 7.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 123.169 1.461 . . . . 0.0 108.237 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.307 2.4 p30 -76.63 3.58 11.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 109.727 -3.397 . . . . 0.0 109.389 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.24 -54.89 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 40.34 12.43 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.841 -2.89 . . . . 0.0 107.409 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -48.08 0.04 OUTLIER Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.5 mt -86.58 121.18 28.75 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 121.98 33.51 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.94 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.32 78.46 0.04 OUTLIER Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.966 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.52 33.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.673 -1.763 . . . . 0.0 106.672 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 113.08 4.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.96 111.19 9.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.61 87.61 3.62 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 HG12 ' A' ' 116' ' ' VAL . 33.9 m -89.43 96.32 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 111.184 -2.735 . . . . 0.0 110.119 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.78 101.24 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-N 108.94 -3.755 . . . . 0.0 110.366 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.78 -108.42 3.09 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 112.37 -1.915 . . . . 0.0 109.766 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.96 -110.79 0.09 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -79.18 129.59 37.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.89 174.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.487 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.58 80.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.038 -2.346 . . . . 0.0 112.623 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.08 156.13 8.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 111.972 -2.377 . . . . 0.0 109.086 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -168.78 93.35 0.31 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 95.56 -47.98 0.01 OUTLIER 'General case' 0 C--N 1.355 0.828 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -89.37 122.76 32.91 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -135.64 160.84 66.15 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.8 -149.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.773 1.649 . . . . 0.0 108.239 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.86 -21.2 60.98 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.642 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.8 p -57.32 -70.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 O-C-N 124.619 1.199 . . . . 0.0 111.236 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 104' ' ' VAL . 12.2 mm-40 -88.35 21.49 2.84 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 117.33 -1.748 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.12 -43.07 62.2 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -79.95 -32.05 39.94 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.115 -2.311 . . . . 0.0 107.216 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -91.04 13.45 16.73 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.027 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 -38.8 12.99 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 107.214 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.04 -61.5 1.97 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.22 35.66 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.379 2.419 . . . . 0.0 117.431 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -89.69 -1.39 58.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.18 137.21 43.32 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 173.39 6.35 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 90' ' ' VAL . 18.9 m -140.09 156.4 24.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 124.499 1.124 . . . . 0.0 109.198 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.469 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 2.0 m-85 -99.72 150.14 36.55 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.24 166.36 5.96 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.123 2.549 . . . . 0.0 109.045 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 -92.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 104.436 -2.948 . . . . 0.0 104.436 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.38 131.64 14.98 Favored Glycine 0 C--N 1.359 1.854 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 t -64.84 162.92 15.27 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 125.494 2.569 . . . . 0.0 109.189 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -170.73 114.35 0.45 Allowed Pre-proline 0 N--CA 1.431 -1.415 1 CA-C-N 106.235 -4.984 . . . . 0.0 100.941 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.68 -4.03 13.82 Favored 'Trans proline' 0 C--N 1.363 1.317 0 O-C-N 122.41 0.689 . . . . 0.0 111.335 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.99 -23.05 65.89 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.958 1.303 . . . . 0.0 108.96 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -28.05 51.5 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.17 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 77.9 p -80.65 -18.68 47.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.968 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.56 -25.55 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.01 46.97 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.387 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.7 t0 -52.73 -62.36 1.7 Allowed 'General case' 0 C--N 1.369 1.421 0 CA-C-O 123.781 1.753 . . . . 0.0 106.832 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 45.9 ttm -90.12 -25.8 20.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 109.574 -3.467 . . . . 0.0 111.383 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -78.52 -13.0 60.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.709 -1.596 . . . . 0.0 110.316 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.98 -56.23 3.37 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.3 t -63.18 -34.49 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.611 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.93 -33.02 30.55 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.352 1.463 0 O-C-N 124.55 1.156 . . . . 0.0 111.483 -179.864 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.225 -0.223 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -79.07 169.28 18.44 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.601 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -103.84 104.79 14.83 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 109.065 -3.698 . . . . 0.0 108.589 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.32 99.38 0.01 OUTLIER 'General case' 0 C--N 1.355 0.804 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.85 109.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.52 127.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.775 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 23' ' ' LEU . 2.0 pp -125.28 136.19 53.26 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 112.515 -2.129 . . . . 0.0 105.721 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 171.11 44.27 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.405 -2.634 . . . . 0.0 108.343 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.931 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.9 p 164.42 -122.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.464 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.2 tp -168.68 -149.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.379 1.884 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.711 0 C-N-CA 118.76 -1.686 . . . . 0.0 110.234 179.61 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 125.307 2.479 . . . . 0.0 108.265 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.336 0.2 OUTLIER 31.05 42.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.39 2 CA-C-N 106.898 -4.683 . . . . 0.0 109.149 -177.897 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.12 -35.18 31.91 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 176.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.2 -0.85 30.09 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.163 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -78.18 -35.07 49.2 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.7 p -56.58 -44.31 80.91 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.072 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.824 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.55 -43.5 75.9 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.889 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -26.82 62.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 111.865 -2.425 . . . . 0.0 112.648 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -79.68 0.49 30.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 112.072 -2.331 . . . . 0.0 109.149 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.6 11.3 2.08 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 118.199 -1.4 . . . . 0.0 108.031 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.6 34.44 55.72 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.289 0.993 . . . . 0.0 112.882 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.67 -177.43 3.57 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.39 145.21 25.5 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.365 -2.198 . . . . 0.0 106.55 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.824 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -99.93 135.41 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 110.777 -2.92 . . . . 0.0 107.262 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.25 76.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.419 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.636 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.91 120.75 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.29 -92.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 111.985 -2.37 . . . . 0.0 104.924 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.12 -140.42 5.63 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.41 4.03 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 113.121 -1.54 . . . . 0.0 110.671 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.06 99.54 11.98 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -97.5 54.6 1.2 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -90.08 85.35 6.28 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.464 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.1 tp-100 -68.27 -47.65 67.15 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.836 -176.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -36.53 84.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.636 1.21 . . . . 0.0 109.529 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.9 -21.94 50.45 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -85.47 -2.23 57.91 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.46 -35.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -75.6 -33.01 60.53 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.826 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.57 7.09 43.06 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.903 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.21 -21.73 22.01 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -74.47 -38.46 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.7 -69.05 0.23 Allowed 'General case' 0 C--N 1.354 0.787 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.029 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.37 -57.97 3.77 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.158 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' THR . 63.7 tttt 120.47 48.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 126.672 2.483 . . . . 0.0 107.705 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -49.36 106.62 0.11 Allowed 'General case' 0 C--N 1.355 0.819 0 CA-C-O 122.061 0.934 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.87 -38.95 31.6 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' HD11 ' A' ' 134' ' ' LEU . 2.6 pp -151.1 167.52 27.46 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -142.04 150.75 18.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-N 112.081 -2.327 . . . . 0.0 105.839 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.69 134.78 22.72 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.38 135.28 40.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.806 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.931 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.14 91.12 3.54 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.5 t 150.62 165.92 0.0 OUTLIER 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.8 -127.84 0.0 OUTLIER 'General case' 0 C--N 1.359 1.007 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.308 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 86.4 7.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.84 42.56 1.21 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 110.92 -2.855 . . . . 0.0 106.928 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -147.08 -32.61 0.3 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 111.143 -2.528 . . . . 0.0 106.841 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.49 167.84 43.35 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.51 1.55 19.0 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.992 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -47.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -72.27 -27.06 62.24 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 114.303 -1.317 . . . . 0.0 107.66 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.29 -47.7 66.94 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.12 26.6 1.83 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.909 1.381 . . . . 0.0 108.829 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.7 -34.96 5.79 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.464 HD21 ' CD ' ' A' ' 43' ' ' GLN . 1.6 mt -88.84 -28.14 20.59 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 112.032 -2.084 . . . . 0.0 107.712 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.06 -24.43 58.23 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -82.04 -29.08 32.13 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -76.6 -15.66 59.78 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.31 1.006 . . . . 0.0 109.189 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 20.7 t -90.29 -47.71 7.59 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 123.982 1.849 . . . . 0.0 107.115 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.91 -3.61 23.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 108.478 -3.965 . . . . 0.0 109.158 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -82.01 -56.08 4.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.01 47.65 5.69 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 110.932 -2.849 . . . . 0.0 106.616 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.95 -44.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.73 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.81 120.9 24.7 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 134.14 34.42 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.47 56.96 0.06 OUTLIER Glycine 0 C--N 1.349 1.284 0 CA-C-N 112.733 -2.03 . . . . 0.0 110.266 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 tt -104.7 47.55 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -142.51 118.17 10.42 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -140.04 151.84 45.74 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.205 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.34 91.41 2.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 m -89.35 99.11 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 126.039 2.828 . . . . 0.0 110.339 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.08 109.08 2.71 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 108.498 -3.955 . . . . 0.0 109.358 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.8 -101.65 2.23 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 112.244 -1.978 . . . . 0.0 109.353 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t30 64.65 -104.84 0.12 Allowed 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.88 56.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.35 176.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.858 -1.974 . . . . 0.0 108.505 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.51 56.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.838 0 CA-C-N 112.722 -2.036 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.77 141.35 5.15 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.142 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.3 106.22 0.24 Allowed 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.17 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 126.032 2.083 . . . . 0.0 105.608 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.49 130.69 35.79 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -142.99 158.84 58.18 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.77 -148.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.853 0 N-CA-C 107.442 -1.792 . . . . 0.0 107.442 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.97 -22.34 60.71 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.0 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.804 0 O-C-N 124.519 1.137 . . . . 0.0 111.309 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.3 mm-40 -89.85 22.95 2.91 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 117.391 -1.723 . . . . 0.0 108.338 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.35 -42.13 59.88 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -79.65 -32.07 41.57 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 112.104 -2.316 . . . . 0.0 106.877 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.72 15.97 13.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.841 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 -40.56 11.94 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 176.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.15 74.86 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 112.355 -2.202 . . . . 0.0 107.473 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.4 mtp -80.78 -58.69 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.11 40.67 0.08 OUTLIER Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.347 2.403 . . . . 0.0 117.32 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -84.62 -6.29 59.36 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.62 132.08 50.19 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -178.26 3.47 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.9 m -140.07 161.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.227 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -99.36 154.35 37.33 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-N 110.532 -3.031 . . . . 0.0 103.679 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.26 159.73 43.32 Favored 'Trans proline' 0 C--N 1.368 1.554 0 N-CA-C 107.173 -1.895 . . . . 0.0 107.173 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.02 116.46 4.66 Favored 'Trans proline' 0 C--N 1.369 1.649 0 N-CA-C 103.763 -3.206 . . . . 0.0 103.763 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.81 132.79 5.57 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 t -73.62 159.61 32.82 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-O 125.25 2.452 . . . . 0.0 107.67 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.5 p -173.4 119.57 0.39 Allowed Pre-proline 0 N--CA 1.427 -1.607 1 CA-C-N 106.484 -4.871 . . . . 0.0 101.537 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 71.5 Cg_endo -78.93 -4.53 14.02 Favored 'Trans proline' 0 C--N 1.358 1.041 0 N-CA-C 108.698 -1.309 . . . . 0.0 108.698 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.29 -37.38 87.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.462 1.905 . . . . 0.0 107.619 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.87 -23.71 59.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.615 -1.629 . . . . 0.0 108.148 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.4 p -81.79 -25.57 35.15 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 116.948 -1.901 . . . . 0.0 109.909 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.72 -24.87 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.44 -6.48 58.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 112.969 -1.923 . . . . 0.0 108.714 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.3 t0 -61.89 -58.03 9.48 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.0 mmt -88.15 -10.78 48.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.069 -1.878 . . . . 0.0 110.874 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -90.21 -49.81 6.35 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 117.864 -1.534 . . . . 0.0 109.013 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.92 -50.27 66.78 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.214 0.946 . . . . 0.0 109.868 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 129' ' ' ASP . 51.1 t -69.45 -61.36 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 113.035 -1.893 . . . . 0.0 111.86 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.1 mp -90.38 52.61 2.27 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.768 1.293 . . . . 0.0 109.876 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.351 1.367 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.315 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.12 161.16 26.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.802 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 21.2 pttp -119.6 108.91 15.06 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 110.927 -2.851 . . . . 0.0 108.123 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.41 85.48 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' SD ' ' A' ' 130' ' ' MET . 0.8 OUTLIER -109.86 107.25 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 110.721 -2.945 . . . . 0.0 103.751 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.68 126.35 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.483 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.27 153.13 43.69 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.4 -2.182 . . . . 0.0 106.679 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.23 174.07 42.42 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 111.137 -2.756 . . . . 0.0 108.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.933 ' HB ' ' H ' ' A' ' 61' ' ' SER . 3.0 p 164.48 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.541 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.3 tp -168.29 -150.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.38 1.904 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.356 1.671 0 C-N-CA 118.681 -1.723 . . . . 0.0 110.327 179.645 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' C ' HD13 ' A' ' 22' ' ' ILE . 88.7 tttt . . . . . 0 CA--C 1.51 -0.595 0 CA-C-O 125.421 2.534 . . . . 0.0 107.906 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.466 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.348 0.2 OUTLIER 29.65 42.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.332 2 CA-C-N 106.614 -4.812 . . . . 0.0 109.522 -178.213 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -35.53 25.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 2.1 p30 -76.95 -2.95 36.35 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 113.694 -1.594 . . . . 0.0 106.868 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -77.36 -34.97 55.0 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -56.79 -43.53 80.99 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.28 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.748 ' CZ ' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.28 -44.07 75.35 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.928 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -27.33 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 111.545 -2.57 . . . . 0.0 112.782 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -78.74 -0.53 30.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.201 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.28 9.21 2.49 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 118.511 -1.275 . . . . 0.0 107.908 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 33.58 58.57 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 124.243 0.964 . . . . 0.0 112.627 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -99.61 -179.47 4.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 28.2 t-20 -76.85 144.5 38.99 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 112.219 -2.264 . . . . 0.0 106.873 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.748 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.92 127.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 110.669 -2.969 . . . . 0.0 107.469 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 7' ' ' VAL . 5.8 t -140.19 128.75 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 111.561 -2.563 . . . . 0.0 105.6 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -144.2 132.49 21.91 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -97.08 -87.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 111.85 -2.432 . . . . 0.0 104.886 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.05 -137.99 4.77 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.6 2.28 8.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 CA-C-N 113.201 -1.499 . . . . 0.0 110.716 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.27 98.31 11.26 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 47.6 t -97.9 55.34 1.18 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 p -90.14 86.51 6.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.413 ' CD ' HD21 ' A' ' 74' ' ' LEU . 5.7 tp-100 -66.81 -46.31 75.6 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.144 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -37.71 88.54 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.482 1.113 . . . . 0.0 109.61 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -77.72 -21.01 52.57 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.88 -2.24 58.06 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.7 -35.88 32.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -75.04 -32.21 61.5 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.958 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.98 5.69 49.15 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.988 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.25 -19.04 24.6 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.15 -38.48 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -59.51 -69.13 0.22 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.988 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.85 -54.74 10.42 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.722 -176.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' THR . 64.0 tttt 117.65 47.23 0.0 OUTLIER 'General case' 0 C--N 1.356 0.852 0 O-C-N 126.705 2.503 . . . . 0.0 107.55 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -48.85 106.46 0.1 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.499 1.142 . . . . 0.0 110.279 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.63 -38.15 34.46 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 111.584 -2.553 . . . . 0.0 104.163 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 134' ' ' LEU . 1.9 pp -154.39 165.05 37.61 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -138.61 142.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 111.722 -2.49 . . . . 0.0 106.169 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.79 133.67 34.31 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 135.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.138 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.933 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.42 91.85 3.82 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 t 150.09 166.26 0.0 OUTLIER 'General case' 0 C--N 1.36 1.056 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.75 -127.24 0.0 OUTLIER 'General case' 0 C--N 1.358 0.959 0 CA-C-N 113.595 -1.638 . . . . 0.0 107.277 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.61 85.16 7.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.48 42.87 1.26 Allowed Glycine 0 C--N 1.345 1.058 0 CA-C-N 110.881 -2.872 . . . . 0.0 107.089 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -148.38 -32.42 0.25 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 111.181 -2.509 . . . . 0.0 106.857 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.08 167.73 42.79 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.39 1.38 19.17 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.582 -1.309 . . . . 0.0 109.044 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.32 -46.51 17.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -72.6 -27.38 62.13 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.781 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.47 -47.28 67.52 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -90.07 25.43 2.15 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 124.815 1.322 . . . . 0.0 108.988 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.35 -33.31 6.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.3 mt -88.27 -29.67 20.23 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 111.939 -2.131 . . . . 0.0 107.678 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -24.23 58.67 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.1 -29.25 31.84 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -76.49 -15.1 59.97 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.235 0.959 . . . . 0.0 109.238 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.35 -48.12 7.33 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 124.014 1.864 . . . . 0.0 107.059 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.61 -3.67 22.83 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 108.43 -3.986 . . . . 0.0 109.207 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.45 -56.36 3.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.75 48.02 5.81 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 110.964 -2.835 . . . . 0.0 106.641 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.75 -43.62 0.02 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.905 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.35 120.57 23.98 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 136.12 33.95 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.72 53.96 0.09 OUTLIER Glycine 0 C--N 1.35 1.307 0 CA-C-N 112.734 -2.03 . . . . 0.0 110.117 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.86 55.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -148.35 118.67 7.33 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.55 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -139.98 151.84 45.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.862 -1.972 . . . . 0.0 106.121 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 90.99 2.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 m -89.33 98.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 CA-C-O 126.106 2.86 . . . . 0.0 110.307 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 109.54 2.82 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 108.456 -3.975 . . . . 0.0 109.367 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -101.14 2.14 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.195 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.3 t30 64.38 -104.94 0.12 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.34 125.28 56.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.44 177.32 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.824 -1.989 . . . . 0.0 108.449 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.57 55.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-N 112.654 -2.067 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.92 141.34 5.1 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.227 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.27 105.51 0.23 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.36 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.356 0.856 0 O-C-N 126.056 2.097 . . . . 0.0 105.526 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -89.22 130.09 35.69 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -142.91 158.82 58.45 Favored Pre-proline 0 C--N 1.352 0.675 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.73 -148.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.374 1.872 0 N-CA-C 107.433 -1.795 . . . . 0.0 107.433 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.96 -22.32 60.72 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.969 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 124.495 1.122 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.49 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.0 mm-40 -89.99 23.11 2.9 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.403 -1.719 . . . . 0.0 108.41 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -74.43 -42.41 59.18 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 112.065 -2.334 . . . . 0.0 106.869 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.19 16.43 13.06 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.914 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -40.71 11.83 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.25 75.28 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 112.212 -2.267 . . . . 0.0 107.408 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.1 mtp -80.78 -58.51 3.06 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 31.52 41.04 0.07 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.399 2.428 . . . . 0.0 117.373 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.69 -6.09 59.34 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.4 132.14 49.91 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -178.97 3.66 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.02 161.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 117.793 -1.563 . . . . 0.0 110.255 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -99.39 154.41 37.3 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.815 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.08 160.66 42.42 Favored 'Trans proline' 0 C--N 1.368 1.579 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.9 116.43 4.66 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 103.823 -3.183 . . . . 0.0 103.823 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.11 133.86 5.94 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -73.84 159.61 32.62 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 125.144 2.402 . . . . 0.0 107.52 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.7 p -173.17 120.57 0.41 Allowed Pre-proline 0 N--CA 1.427 -1.606 1 CA-C-N 106.583 -4.826 . . . . 0.0 101.648 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 80.1 Cg_endo -78.8 -5.45 14.68 Favored 'Trans proline' 0 C--N 1.357 0.999 0 N-CA-C 108.685 -1.313 . . . . 0.0 108.685 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.84 -37.92 89.17 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.547 1.939 . . . . 0.0 107.744 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.256 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.3 p -82.09 -25.44 34.51 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 116.94 -1.904 . . . . 0.0 109.983 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.3 mt -67.65 -24.78 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.77 -6.3 58.23 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.77 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.1 t0 -61.91 -58.37 8.19 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.579 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 35.1 mmt -87.09 -11.93 48.7 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.82 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -90.13 -48.55 7.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.201 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -47.99 71.27 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 124.131 0.894 . . . . 0.0 109.921 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.3 t -71.42 -61.19 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.638 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.9 mp -90.37 53.97 2.62 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.842 1.339 . . . . 0.0 109.635 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.349 1.29 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.309 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 CA--C 1.536 0.41 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -63.04 144.06 57.23 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.404 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.24 102.44 14.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 111.786 -2.461 . . . . 0.0 107.505 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.03 105.75 0.03 OUTLIER 'General case' 0 C--N 1.357 0.919 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 112.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -101.8 117.92 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 111.779 -2.464 . . . . 0.0 108.293 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 23' ' ' LEU . 16.2 tp -90.14 159.89 16.54 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.912 -1.949 . . . . 0.0 108.262 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.48 29.84 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 111.422 -2.626 . . . . 0.0 107.844 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.36 131.75 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 122.312 1.053 . . . . 0.0 112.087 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.54 133.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.357 1.719 0 C-N-CA 117.818 -2.134 . . . . 0.0 113.192 -177.434 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttm . . . . . 0 CA--C 1.498 -1.039 0 CA-C-O 125.48 2.562 . . . . 0.0 107.833 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.355 0.2 OUTLIER 30.09 54.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.434 1 CA-C-N 106.242 -4.981 . . . . 0.0 107.922 -177.371 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 tt -70.91 -25.54 62.81 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 102.11 -3.292 . . . . 0.0 102.11 173.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -66.32 -17.44 64.76 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 116.744 -1.982 . . . . 0.0 107.221 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.515 ' HB2' HG22 ' A' ' 22' ' ' ILE . 13.0 t-80 -69.4 -24.5 63.86 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.461 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 7.4 p -56.78 -37.82 71.63 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 125.024 1.453 . . . . 0.0 108.739 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.953 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -54.64 -49.42 70.58 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.029 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -22.78 61.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.114 -2.312 . . . . 0.0 112.904 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -81.33 0.07 38.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.688 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.93 12.9 1.45 Allowed 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.001 -1.48 . . . . 0.0 107.906 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 37.74 46.2 Favored Glycine 0 C--N 1.36 1.869 0 O-C-N 124.229 0.955 . . . . 0.0 113.056 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.71 -168.11 1.56 Allowed 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.303 -1.449 . . . . 0.0 107.519 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -93.8 140.04 30.14 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.705 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.953 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.74 127.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 109.995 -3.275 . . . . 0.0 108.927 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 7' ' ' VAL . 3.7 t -140.31 144.48 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 109.909 -3.314 . . . . 0.0 104.432 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.13 135.79 8.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.96 -67.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.36 -145.63 16.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 112.144 -2.298 . . . . 0.0 108.374 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.52 88.7 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.744 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 1.2 tp -164.68 119.72 1.41 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 t -98.31 37.11 1.49 Allowed 'General case' 0 C--N 1.358 0.974 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.478 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.744 ' OG ' ' HG ' ' A' ' 40' ' ' LEU . 72.9 p -90.17 98.15 11.6 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.16 -55.45 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.985 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.9 pt-20 -64.78 -20.44 66.37 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.65 1.219 . . . . 0.0 111.597 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.34 -37.26 17.27 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.239 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -90.04 10.16 25.24 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 118.027 -1.469 . . . . 0.0 108.629 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -86.04 -32.46 6.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.022 0 N-CA-C 102.27 -3.234 . . . . 0.0 102.27 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.68 -26.1 60.57 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.27 -6.79 56.5 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.64 51.34 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mt -83.87 -41.64 16.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.22 -57.52 12.08 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 112.146 -2.297 . . . . 0.0 108.835 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.21 -55.06 20.68 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 90.21 53.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.114 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.57 126.52 27.79 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 111.2 -2.727 . . . . 0.0 107.335 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -88.21 -31.92 18.83 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 112.825 -1.988 . . . . 0.0 107.214 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -157.76 154.34 28.02 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 88' ' ' LEU . 2.7 mt -114.73 165.91 9.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 111.908 -2.405 . . . . 0.0 105.489 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 89.0 m -153.14 100.56 2.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 111.333 -2.667 . . . . 0.0 103.989 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.92 137.39 36.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.6 m -99.71 125.8 45.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 -177.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 t -157.99 175.4 13.87 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 114.639 -2.824 . . . . 0.0 107.519 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.67 48.38 0.8 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.814 -2.903 . . . . 0.0 106.454 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 72.78 32.76 1.39 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 113.734 -1.576 . . . . 0.0 107.305 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.53 -3.01 22.62 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.367 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -87.63 -17.75 31.19 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.72 177.44 49.12 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.341 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.07 18.9 5.36 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.6 -1.3 . . . . 0.0 108.048 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -53.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.488 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 m-20 -71.19 -26.17 62.84 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.413 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.9 t -66.67 -56.18 11.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -90.1 30.1 1.14 Allowed 'General case' 0 C--N 1.359 1.0 0 O-C-N 124.684 1.24 . . . . 0.0 109.36 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.14 -38.83 3.94 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 70' ' ' ASP . 1.7 mm? -90.03 -23.13 21.55 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 112.705 -1.747 . . . . 0.0 107.771 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -29.94 59.9 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.36 -26.56 52.09 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.69 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -74.71 -17.62 60.63 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.005 0.816 . . . . 0.0 109.261 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.5 t -90.22 -46.47 8.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.919 1.819 . . . . 0.0 107.524 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -74.17 0.76 12.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 108.67 -3.877 . . . . 0.0 109.095 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.03 -55.97 3.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.27 45.56 6.7 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-N 110.84 -2.891 . . . . 0.0 106.68 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.07 -43.62 0.02 OUTLIER Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.492 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -79.62 120.87 24.56 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.57 35.91 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.21 122.42 2.68 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 112.17 -2.286 . . . . 0.0 107.459 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 tt -149.56 34.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -138.4 118.18 13.19 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -138.79 112.87 8.6 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.49 89.77 4.06 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.84 91.19 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 111.076 -2.784 . . . . 0.0 110.351 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.49 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -69.71 142.17 36.22 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 110.218 -3.174 . . . . 0.0 110.393 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.84 -83.67 1.61 Allowed Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.406 -2.397 . . . . 0.0 107.229 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 61.5 -108.05 0.3 Allowed 'General case' 0 C--N 1.355 0.835 0 CA-C-N 112.56 -1.82 . . . . 0.0 107.053 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.3 mt -118.09 149.71 20.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.43 -172.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.667 0 CA-C-N 112.728 -2.033 . . . . 0.0 108.73 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 39.24 68.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.834 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.881 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.9 171.13 35.13 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 112.316 -2.22 . . . . 0.0 109.878 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -157.03 -49.25 0.07 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.21 -38.14 2.0 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.76 111.44 22.45 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -119.09 166.09 15.28 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.48 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 N-CA-C 108.1 -1.539 . . . . 0.0 108.1 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.91 -24.45 61.64 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 113.844 -1.526 . . . . 0.0 108.41 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.4 p -55.78 -72.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 O-C-N 124.739 1.275 . . . . 0.0 111.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.57 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.1 mt-10 -88.78 25.94 1.64 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.65 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.78 -45.37 36.6 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -80.57 -30.04 36.98 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 111.541 -2.572 . . . . 0.0 107.531 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -91.51 12.65 20.1 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.878 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -38.46 13.36 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.9 73.08 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.729 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.9 mtp -81.79 -61.53 1.9 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.0 39.87 0.01 OUTLIER Glycine 0 C--N 1.356 1.641 0 C-N-CA 127.698 2.571 . . . . 0.0 117.432 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -87.79 -6.19 58.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.07 137.66 42.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 170.45 8.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 102.496 -3.15 . . . . 0.0 102.496 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.88 156.47 25.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.212 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.49 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 1.6 m-85 -99.59 128.66 30.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.92 160.27 26.19 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.324 2.016 . . . . 0.0 109.322 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.24 121.27 7.64 Favored 'Trans proline' 0 C--N 1.369 1.646 0 N-CA-C 104.684 -2.852 . . . . 0.0 104.684 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 67.18 0.94 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -89.85 -165.77 1.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 110.466 -2.867 . . . . 0.0 106.775 -178.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 121' ' ' THR . 3.5 p -168.26 168.35 5.83 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 111.566 -2.561 . . . . 0.0 104.447 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.19 -8.15 17.41 Favored 'Trans proline' 0 C--N 1.367 1.543 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.33 -29.21 65.86 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -20.41 49.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.822 -1.536 . . . . 0.0 108.006 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 129' ' ' ASP . 4.5 p -82.7 -16.81 46.7 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 118.048 -1.461 . . . . 0.0 110.264 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.0 -29.38 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 -1.33 57.75 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 133' ' ' VAL . 53.4 t0 -64.5 -63.59 1.09 Allowed 'General case' 0 C--N 1.359 1.01 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.461 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -83.23 -10.49 58.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.431 -2.168 . . . . 0.0 110.299 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.18 -46.06 8.69 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.91 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.45 -37.28 77.72 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.591 0.557 . . . . 0.0 109.957 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 129' ' ' ASP . 74.1 t -88.51 -73.98 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.016 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 133' ' ' VAL . 95.9 mt -90.41 57.11 3.56 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 124.644 1.215 . . . . 0.0 109.423 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.129 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.26 178.252 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.24 141.3 54.66 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 123.197 1.475 . . . . 0.0 108.617 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.29 95.64 8.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 110.548 -3.023 . . . . 0.0 107.894 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -176.65 111.55 0.09 Allowed 'General case' 0 C--N 1.355 0.807 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.27 111.94 9.93 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.82 18.56 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 O-C-N 125.866 1.979 . . . . 0.0 105.689 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.654 HD13 HD22 ' A' ' 23' ' ' LEU . 16.6 tp -113.45 149.36 34.34 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 123.114 1.435 . . . . 0.0 108.81 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 149.87 21.4 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 110.866 -2.879 . . . . 0.0 106.577 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.32 98.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.714 0 CA-C-O 122.328 1.061 . . . . 0.0 110.587 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.3 156.69 4.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.359 1.817 0 C-N-CA 115.574 -3.203 . . . . 0.0 113.597 -178.042 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 CA--C 1.499 -1.016 0 CA-C-O 125.918 2.771 . . . . 0.0 107.757 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.383 0.3 OUTLIER 26.61 54.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.408 -2.571 2 CA-C-N 105.222 -5.445 . . . . 0.0 108.263 -177.142 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 8' ' ' LEU . 7.1 tt -74.17 -24.84 59.45 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 102.386 -3.19 . . . . 0.0 102.386 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 35.4 m-20 -71.9 -8.99 57.63 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 22' ' ' ILE . 10.2 t-160 -74.51 -30.09 61.66 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -53.29 -44.36 68.23 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 125.647 1.842 . . . . 0.0 110.349 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -60.07 -41.71 93.01 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.87 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.7 -24.57 59.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.668 -2.06 . . . . 0.0 112.689 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -81.87 -1.19 46.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 112.224 -2.262 . . . . 0.0 108.926 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.59 3.7 2.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.75 32.06 68.97 Favored Glycine 0 C--N 1.358 1.795 0 O-C-N 123.952 0.783 . . . . 0.0 111.674 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -99.7 -175.3 2.94 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 113.206 -1.497 . . . . 0.0 107.542 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -86.26 138.63 31.71 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 112.291 -2.231 . . . . 0.0 108.271 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.838 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.62 127.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 109.824 -3.353 . . . . 0.0 107.807 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 53' ' ' THR . 10.9 t -140.1 125.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 110.036 -3.256 . . . . 0.0 104.662 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -142.77 128.6 19.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.03 -75.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.34 -151.18 23.42 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.638 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -87.79 84.05 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 9.8 tp -162.49 117.5 1.84 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.1 t -93.53 48.34 1.29 Allowed 'General case' 0 C--N 1.356 0.889 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.281 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.732 ' OG ' ' HG ' ' A' ' 40' ' ' LEU 0.257 8.8 p -90.5 95.45 10.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 103.767 -2.679 . . . . 0.0 103.767 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -90.13 -57.83 2.71 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 118.03 -1.468 . . . . 0.0 108.322 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.1 -18.46 63.44 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.828 1.33 . . . . 0.0 111.382 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -91.35 -37.11 13.44 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 118.495 -1.282 . . . . 0.0 107.65 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.496 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 23.3 m-85 -90.06 10.05 25.74 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.924 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 -33.69 6.35 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -73.37 -25.02 60.41 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -92.05 -2.33 56.73 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 -9.45 48.61 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.2 -41.6 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.62 -58.69 7.51 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 112.129 -2.305 . . . . 0.0 108.404 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.89 -56.21 12.96 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.68 1.237 . . . . 0.0 107.821 -178.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 tttp 95.64 47.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 110.362 -3.108 . . . . 0.0 102.722 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.62 5.43 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 111.851 -2.431 . . . . 0.0 106.819 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 5' ' ' THR . 24.6 t0 -80.48 -36.44 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 111.706 -2.497 . . . . 0.0 106.555 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.41 158.39 44.1 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.21 141.32 46.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 CA-C-N 111.797 -2.456 . . . . 0.0 104.957 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.97 109.16 9.85 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.32 133.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -100.94 117.55 35.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 t -157.76 177.83 10.93 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 115.623 -2.431 . . . . 0.0 108.133 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.6 46.19 0.72 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 111.405 -2.634 . . . . 0.0 106.947 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.32 30.1 0.53 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.197 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -2.02 27.33 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.092 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.97 -8.95 44.72 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.44 177.38 13.19 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.524 1.14 . . . . 0.0 110.558 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 25.5 2.18 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.807 -1.196 . . . . 0.0 108.028 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -54.16 8.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.21 -26.37 62.02 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.954 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -68.71 -58.51 4.12 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -90.1 27.88 1.52 Allowed 'General case' 0 C--N 1.359 0.99 0 O-C-N 124.751 1.282 . . . . 0.0 110.145 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.03 -30.15 5.53 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 88' ' ' LEU . 31.0 mt -90.07 -28.28 19.12 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.332 -1.934 . . . . 0.0 107.484 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -29.79 58.88 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.09 -27.87 57.33 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.484 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -73.58 -19.54 60.85 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 123.92 0.762 . . . . 0.0 109.651 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.25 -46.3 8.5 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.806 1.765 . . . . 0.0 107.902 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -73.98 0.95 11.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 108.788 -3.824 . . . . 0.0 109.167 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.24 -56.29 3.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.83 45.66 5.54 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.73 -2.941 . . . . 0.0 106.494 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.48 -42.1 0.02 OUTLIER Glycine 0 C--N 1.352 1.423 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.841 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 mt -78.8 122.78 26.48 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.49 117.58 2.35 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 112.229 -2.259 . . . . 0.0 108.554 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 tt -143.36 40.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -140.66 117.26 10.88 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -140.09 108.3 5.79 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.19 86.84 3.3 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.027 -3.323 . . . . 0.0 102.027 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.35 95.98 5.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 CA-C-N 111.338 -2.664 . . . . 0.0 109.65 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -60.31 128.44 45.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 109.259 -3.61 . . . . 0.0 111.82 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.88 -83.12 1.55 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 111.539 -2.331 . . . . 0.0 107.372 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 71.22 -88.35 0.03 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 112.505 -1.847 . . . . 0.0 106.827 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 mt -135.33 149.72 28.86 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -175.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.835 -1.984 . . . . 0.0 108.864 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.7 84.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-N 112.007 -2.361 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.47 -178.42 28.81 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.239 -2.255 . . . . 0.0 110.608 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -159.33 -44.73 0.05 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 111.523 -2.338 . . . . 0.0 104.839 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.18 -37.16 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -87.13 89.84 8.14 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -101.99 169.26 7.86 Favored Pre-proline 0 C--N 1.35 0.615 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -152.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.752 0 N-CA-C 108.092 -1.541 . . . . 0.0 108.092 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.45 -24.15 61.97 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.459 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -56.69 -72.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 O-C-N 124.764 1.29 . . . . 0.0 111.544 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.545 ' H ' HG13 ' A' ' 104' ' ' VAL . 25.7 mt-10 -89.03 26.25 1.62 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 117.773 -1.571 . . . . 0.0 109.846 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -76.66 -45.77 28.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -80.24 -29.0 38.38 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 111.46 -2.609 . . . . 0.0 107.509 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.72 12.77 22.24 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.897 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -37.12 14.22 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.25 75.14 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-N 112.845 -1.979 . . . . 0.0 107.494 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.7 mtp -80.2 -61.21 2.05 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.95 38.57 0.01 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.91 2.671 . . . . 0.0 117.708 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -84.84 -6.84 59.35 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.14 135.97 45.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.437 HH21 HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.19 170.42 8.09 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.15 163.01 24.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.476 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 1.0 OUTLIER -99.58 153.45 37.77 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.42 164.92 25.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.826 1.684 . . . . 0.0 108.056 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.23 118.01 3.91 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 102.377 -3.74 . . . . 0.0 102.377 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.71 68.98 1.09 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 122' ' ' SER 0.273 0.2 OUTLIER -90.25 -158.08 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 109.496 -3.352 . . . . 0.0 107.336 -177.848 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.512 ' H ' HG22 ' A' ' 121' ' ' THR . 10.4 p -174.22 164.14 2.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 110.47 -3.059 . . . . 0.0 103.936 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.25 -5.4 15.67 Favored 'Trans proline' 0 C--N 1.365 1.401 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.56 -29.5 64.8 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -20.8 56.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.647 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -85.34 -14.78 45.39 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.764 -1.175 . . . . 0.0 110.06 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mt -69.61 -28.62 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 -2.49 58.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.41 -2.177 . . . . 0.0 108.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.1 t0 -61.33 -62.4 1.86 Allowed 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -82.31 -7.72 59.63 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.282 -2.235 . . . . 0.0 110.444 -176.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.1 -54.25 4.12 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.443 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.92 -39.5 71.75 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.752 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.661 HG12 HD23 ' A' ' 134' ' ' LEU . 80.6 t -89.99 -68.99 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 125.193 1.558 . . . . 0.0 111.778 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 133' ' ' VAL . 89.1 mt -90.31 54.25 2.71 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.746 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.346 1.088 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.736 178.196 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -107.66 19.82 19.65 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.27 133.76 39.98 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 -179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -81.25 89.57 6.05 Favored 'General case' 0 C--N 1.346 0.454 0 CA-C-N 111.023 -2.808 . . . . 0.0 107.335 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.433 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -174.36 120.2 0.25 Allowed 'General case' 0 C--N 1.357 0.899 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 -179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -143.12 112.67 2.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.788 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.528 HG23 HG12 ' A' ' 35' ' ' VAL . 2.3 p -98.98 113.6 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 112.494 -2.139 . . . . 0.0 106.678 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.3 pp -125.2 154.04 42.17 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 124.911 1.382 . . . . 0.0 109.762 -176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 164.25 -154.32 25.12 Favored Glycine 0 C--N 1.361 1.963 0 CA-C-N 111.931 -2.395 . . . . 0.0 112.689 178.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.545 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 14.9 p 88.28 -123.79 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 131.095 3.758 . . . . 0.0 115.398 179.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.545 HG22 ' O ' ' A' ' 10' ' ' VAL 0.271 1.2 tt 67.03 148.18 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 127.173 2.189 . . . . 0.0 109.22 -177.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -102.61 -121.84 4.98 Favored Glycine 0 C--N 1.361 1.956 0 CA-C-N 112.267 -2.242 . . . . 0.0 110.763 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 p -93.95 103.16 15.27 Favored 'General case' 0 C--N 1.349 0.58 0 CA-C-N 111.969 -2.116 . . . . 0.0 106.314 -179.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -172.52 72.97 0.04 OUTLIER 'General case' 0 C--N 1.352 0.698 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t 71.26 -84.25 0.03 OUTLIER 'General case' 0 C--N 1.368 1.399 0 O-C-N 124.787 1.304 . . . . 0.0 107.908 179.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 25.8 t-80 -154.64 -65.7 0.13 Allowed 'General case' 0 C--N 1.359 1.014 0 N-CA-C 104.686 -2.339 . . . . 0.0 104.686 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -165.34 92.02 0.54 Allowed 'General case' 0 C--N 1.352 0.705 0 O-C-N 125.404 1.69 . . . . 0.0 107.02 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.3 18.99 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 112.024 -2.353 . . . . 0.0 108.987 176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.18 -32.55 1.8 Allowed Glycine 0 C--N 1.36 1.869 0 C-N-CA 125.607 1.575 . . . . 0.0 109.463 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -46.22 -40.41 11.33 Favored 'General case' 0 C--N 1.367 1.359 0 CA-C-N 111.879 -2.161 . . . . 0.0 105.714 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -12.51 55.38 0.0 OUTLIER 'General case' 0 C--N 1.38 1.925 2 C-N-CA 141.405 7.882 . . . . 0.0 108.154 176.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.503 ' HB ' ' ND1' ' A' ' 25' ' ' HIS 0.325 0.9 OUTLIER 43.13 44.56 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.726 1 CA-C-N 106.659 -4.791 . . . . 0.0 109.539 -178.473 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.581 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 2.3 tt -68.68 -24.07 64.47 Favored 'General case' 0 CA--C 1.574 1.867 0 C-N-CA 114.679 -2.809 . . . . 0.0 103.602 171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.23 -15.99 64.02 Favored 'General case' 0 CA--C 1.563 1.468 0 CA-C-N 114.354 -1.294 . . . . 0.0 107.901 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.503 ' ND1' ' HB ' ' A' ' 22' ' ' ILE 0.265 0.7 OUTLIER -69.72 -26.3 64.26 Favored 'General case' 0 C--N 1.361 1.075 0 C-N-CA 117.969 -1.492 . . . . 0.0 108.241 178.808 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 -20.17 65.34 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 113.161 -1.836 . . . . 0.0 108.814 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.599 ' CD2' HG22 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -58.62 -46.27 87.43 Favored 'General case' 0 C--N 1.359 1.019 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 177.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.13 -29.66 69.45 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 112.121 -2.309 . . . . 0.0 112.133 -176.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -88.69 10.88 19.15 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 112.068 -2.333 . . . . 0.0 108.55 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -133.99 -8.81 2.69 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.91 31.49 76.33 Favored Glycine 0 C--N 1.356 1.649 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 7.9 m-30 -99.75 -175.21 2.91 Favored 'General case' 0 C--N 1.36 1.026 0 CA-C-N 113.006 -1.597 . . . . 0.0 108.328 -176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -108.71 154.64 21.74 Favored 'General case' 0 C--N 1.358 0.969 0 CA-C-N 112.287 -2.233 . . . . 0.0 106.777 -178.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.599 HG22 ' CD2' ' A' ' 27' ' ' PHE . 78.5 t -99.94 135.13 36.9 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 CA-C-N 111.781 -2.463 . . . . 0.0 108.83 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.528 HG12 HG23 ' A' ' 7' ' ' VAL . 21.8 t -140.36 54.87 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 111.418 -2.628 . . . . 0.0 107.005 177.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -73.8 126.43 30.37 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 105.905 -1.887 . . . . 0.0 105.905 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.425 HD13 ' CD2' ' A' ' 46' ' ' PHE . 4.8 mt -89.84 -65.72 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.845 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 162.86 -116.82 0.73 Allowed Glycine 0 C--N 1.35 1.311 0 CA-C-N 113.331 -1.759 . . . . 0.0 109.394 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.5 m -126.12 23.12 3.25 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.323 -1.438 . . . . 0.0 110.011 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.9 mt -98.85 167.91 10.46 Favored 'General case' 0 C--N 1.352 0.682 0 N-CA-C 106.114 -1.81 . . . . 0.0 106.114 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 10.9 t -123.61 66.53 1.02 Allowed 'General case' 0 C--N 1.35 0.614 0 CA-C-N 111.37 -2.65 . . . . 0.0 104.166 179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.9 m -77.75 102.77 7.32 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -88.16 -85.9 0.18 Allowed 'General case' 0 C--N 1.349 0.586 0 CA-C-N 113.06 -1.882 . . . . 0.0 107.38 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.19 -11.25 56.85 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 124.94 1.4 . . . . 0.0 110.926 -177.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -89.21 -45.62 9.41 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.425 ' CD2' HD13 ' A' ' 37' ' ' ILE . 0.2 OUTLIER -87.68 3.18 48.84 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 116.963 -1.895 . . . . 0.0 108.683 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -83.59 -29.03 7.6 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 N-CA-C 103.573 -2.751 . . . . 0.0 103.573 176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -73.05 -27.9 62.01 Favored 'General case' 0 C--N 1.368 1.387 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -95.71 2.86 54.19 Favored 'General case' 0 C--N 1.362 1.141 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.39 -9.13 48.75 Favored 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -91.24 -36.91 8.52 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 N-CA-C 103.574 -2.75 . . . . 0.0 103.574 176.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -62.0 -69.07 0.27 Allowed 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.192 -2.276 . . . . 0.0 110.195 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . 0.279 6.4 p -78.34 -32.43 49.15 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 123.783 0.677 . . . . 0.0 109.685 -176.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.6 tppt? 81.15 61.09 0.02 OUTLIER 'General case' 0 C--N 1.349 0.552 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.8 118.27 3.03 Favored 'General case' 0 C--N 1.357 0.912 0 CA-C-N 113.112 -1.858 . . . . 0.0 107.851 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.433 ' H ' ' HB ' ' A' ' 5' ' ' THR . 40.5 t0 -83.31 -49.35 9.47 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.485 HD21 ' HE2' ' A' ' 130' ' ' MET . 3.2 pp -142.83 161.2 38.71 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 125.426 1.704 . . . . 0.0 106.78 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CD1' HG13 ' A' ' 60' ' ' VAL . 0.1 OUTLIER -120.28 137.2 54.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.747 0 CA-C-N 111.139 -2.755 . . . . 0.0 105.295 -179.169 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 98.7 m -127.95 112.28 14.5 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG13 ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -100.62 142.57 15.45 Favored 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.282 -1.781 . . . . 0.0 107.207 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 62.7 p -114.39 63.61 0.67 Allowed 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 104.613 -2.365 . . . . 0.0 104.613 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.2 p -168.67 148.62 4.44 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.13 70.59 0.74 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 111.61 -2.541 . . . . 0.0 104.341 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 72.22 87.3 0.11 Allowed 'General case' 0 C--N 1.35 0.589 0 CA-C-N 110.413 -3.085 . . . . 0.0 106.818 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -158.28 33.52 0.51 Allowed Glycine 0 CA--C 1.535 1.32 0 CA-C-N 109.833 -3.349 . . . . 0.0 106.61 178.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -144.78 -14.65 0.54 Allowed 'General case' 0 C--N 1.35 0.627 0 CA-C-N 111.259 -2.471 . . . . 0.0 108.476 -175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 73.76 -162.78 54.55 Favored Glycine 0 CA--C 1.535 1.316 0 CA-C-O 122.53 1.072 . . . . 0.0 112.314 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -82.2 3.27 27.99 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 111.79 -2.205 . . . . 0.0 108.055 179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.8 mm -73.15 -61.35 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -67.85 -24.6 65.28 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 124.843 1.339 . . . . 0.0 108.813 -178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 21.9 t -62.91 -72.13 0.14 Allowed 'General case' 0 C--N 1.352 0.707 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.6 mtmm -90.17 33.09 0.89 Allowed 'General case' 0 C--N 1.353 0.751 0 O-C-N 124.313 1.008 . . . . 0.0 109.33 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.74 -47.61 2.47 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.206 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.82 -20.82 23.03 Favored 'General case' 0 C--N 1.35 0.616 0 CA-C-N 112.047 -2.076 . . . . 0.0 107.89 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HG3' HH11 ' A' ' 75' ' ' ARG . 5.5 mmt85 -74.84 -31.85 61.76 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -78.05 -23.79 47.97 Favored 'General case' 0 C--N 1.36 1.022 0 CA-C-N 114.068 -1.424 . . . . 0.0 108.057 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 47.7 tttp -76.95 -16.11 59.45 Favored 'General case' 0 CA--C 1.55 0.951 0 O-C-N 123.96 0.787 . . . . 0.0 109.183 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.4 m -90.25 -43.39 10.42 Favored 'General case' 0 CA--C 1.508 -0.645 0 CA-C-O 123.868 1.794 . . . . 0.0 107.229 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.38 -1.51 24.18 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-N 108.692 -3.867 . . . . 0.0 108.667 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.83 -53.46 6.47 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.73 48.76 5.32 Favored 'General case' 0 C--N 1.352 0.715 0 CA-C-N 111.024 -2.807 . . . . 0.0 107.101 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.06 -47.14 0.01 OUTLIER Glycine 0 C--N 1.347 1.166 0 CA-C-N 112.268 -2.242 . . . . 0.0 108.357 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.7 mt -90.46 124.51 35.03 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 103.909 -2.626 . . . . 0.0 103.909 178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.98 124.61 33.9 Favored 'General case' 0 C--N 1.35 0.612 0 CA-C-N 113.499 -1.682 . . . . 0.0 106.918 -178.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.29 65.59 0.03 OUTLIER Glycine 0 C--N 1.349 1.271 0 CA-C-N 112.825 -1.988 . . . . 0.0 109.32 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 6.4 tt -105.54 11.32 8.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.703 0 CA-C-N 112.097 -2.052 . . . . 0.0 108.139 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 88' ' ' LEU . 48.4 mmtm -122.51 114.26 20.43 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 103.465 -2.791 . . . . 0.0 103.465 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 87' ' ' LYS . 0.1 OUTLIER -140.11 101.88 4.25 Favored 'General case' 0 C--N 1.345 0.391 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.454 ' CD1' ' CE1' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -99.87 90.96 4.61 Favored 'General case' 0 C--N 1.352 0.708 0 N-CA-C 100.884 -3.747 . . . . 0.0 100.884 179.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -89.81 96.52 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 108.89 -3.777 . . . . 0.0 111.323 -174.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.493 ' HA3' ' C10' ' A' ' 139' ' ' DBI . . . -61.0 124.12 34.56 Favored Glycine 0 CA--C 1.537 1.417 1 CA-C-N 107.433 -4.439 . . . . 0.0 112.69 176.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.37 -80.84 0.94 Allowed Glycine 0 C--N 1.352 1.441 0 CA-C-N 112.549 -1.825 . . . . 0.0 109.143 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 25.44 94.3 0.01 OUTLIER 'General case' 0 C--N 1.356 0.868 0 C-N-CA 130.431 3.492 . . . . 0.0 110.823 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER 69.91 123.66 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.687 0 CA-C-N 113.203 -1.817 . . . . 0.0 107.511 178.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -86.63 169.9 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.647 0 CA-C-N 112.343 -2.208 . . . . 0.0 107.318 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.42 61.39 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.798 0 CA-C-N 113.52 -1.673 . . . . 0.0 112.648 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -174.03 148.03 9.74 Favored Glycine 0 C--N 1.348 1.244 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.275 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -169.47 105.12 0.36 Allowed 'General case' 0 C--N 1.349 0.566 0 N-CA-C 104.47 -2.419 . . . . 0.0 104.47 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 87.14 -58.94 0.04 OUTLIER 'General case' 0 C--N 1.357 0.899 0 O-C-N 125.915 2.01 . . . . 0.0 106.753 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -86.17 101.21 12.8 Favored 'General case' 0 C--N 1.35 0.627 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -106.86 160.91 24.61 Favored Pre-proline 0 C--N 1.351 0.64 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_exo -68.23 -158.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 121.61 1.54 . . . . 0.0 108.631 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -64.78 -23.45 67.25 Favored 'General case' 0 C--N 1.354 0.799 0 CA-C-N 112.592 -2.094 . . . . 0.0 108.771 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.67 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.9 p -57.81 -70.96 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.735 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.746 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.67 ' H ' HG13 ' A' ' 104' ' ' VAL . 31.5 mt-10 -90.3 29.42 1.26 Allowed 'General case' 0 C--N 1.355 0.825 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.911 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -82.54 -41.18 19.96 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 103.616 -2.735 . . . . 0.0 103.616 175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -80.46 -32.67 37.16 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.117 178.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.8 m-85 -90.32 14.81 11.82 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 118.659 -1.216 . . . . 0.0 108.081 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.4 tmtt? -90.35 -38.77 13.12 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 104.287 -2.486 . . . . 0.0 104.287 176.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.43 -34.23 75.05 Favored 'General case' 0 C--N 1.361 1.089 0 CA-C-N 112.63 -2.077 . . . . 0.0 106.99 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 38.5 mtp -77.63 -62.58 1.62 Allowed 'General case' 0 C--N 1.355 0.81 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.79 34.41 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.547 2.498 . . . . 0.0 117.261 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -87.73 -4.76 58.88 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.27 132.67 51.18 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 105.026 -2.212 . . . . 0.0 105.026 179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.31 171.87 7.2 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 102.854 -3.017 . . . . 0.0 102.854 178.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -140.13 152.31 21.86 Favored 'Isoleucine or valine' 0 C--N 1.35 0.597 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.188 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.454 ' CE1' ' CD1' ' A' ' 89' ' ' PHE . 0.9 OUTLIER -99.74 117.74 63.07 Favored Pre-proline 0 C--N 1.36 1.05 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -59.82 147.95 90.31 Favored 'Trans proline' 0 C--N 1.371 1.717 0 C-N-CA 122.417 2.078 . . . . 0.0 107.99 -178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -65.47 115.97 3.65 Favored 'Trans proline' 0 C--N 1.365 1.42 0 N-CA-C 106.598 -2.116 . . . . 0.0 106.598 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 116.1 32.09 1.75 Allowed Glycine 0 C--N 1.351 1.416 0 CA-C-N 112.36 -2.2 . . . . 0.0 111.547 -179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.462 ' OG1' H112 ' A' ' 139' ' ' DBI . 0.3 OUTLIER -90.07 -166.37 1.57 Allowed 'General case' 0 C--N 1.352 0.7 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.263 3.2 p -143.2 170.68 8.19 Favored Pre-proline 0 N--CA 1.432 -1.332 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.489 -176.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -79.57 -4.61 13.68 Favored 'Trans proline' 0 C--N 1.37 1.666 0 N-CA-C 107.184 -1.891 . . . . 0.0 107.184 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -72.83 -25.75 61.24 Favored 'General case' 0 C--N 1.357 0.909 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -17.53 54.17 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 113.65 -1.614 . . . . 0.0 107.668 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.581 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 5.6 p -83.96 -16.77 42.91 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 118.498 -1.281 . . . . 0.0 109.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.9 mt -68.18 -32.92 57.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.939 0 N-CA-C 102.788 -3.041 . . . . 0.0 102.788 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.06 -1.23 52.2 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-N 112.147 -2.297 . . . . 0.0 109.236 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.688 ' O ' HG23 ' A' ' 133' ' ' VAL . 50.7 t0 -61.32 -65.32 0.71 Allowed 'General case' 0 C--N 1.365 1.264 0 N-CA-C 106.668 -1.605 . . . . 0.0 106.668 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.485 ' HE2' HD21 ' A' ' 57' ' ' LEU . 0.1 OUTLIER -90.1 9.26 28.89 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 111.995 -2.366 . . . . 0.0 110.657 -176.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -88.66 -34.19 17.33 Favored 'General case' 0 C--N 1.353 0.75 0 C-N-CA 116.884 -1.927 . . . . 0.0 108.281 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -89.97 -43.45 10.54 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 124.256 0.973 . . . . 0.0 110.503 -176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 129' ' ' ASP . 44.5 t -66.48 -31.15 52.29 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 CA-C-N 114.055 -1.43 . . . . 0.0 112.682 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 20.1 mt -90.09 -33.83 16.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -64.53 -91.73 0.03 OUTLIER Glycine 0 C--N 1.354 1.563 0 CA-C-N 114.754 -1.112 . . . . 0.0 112.066 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -164.41 153.09 2.4 Favored 'Isoleucine or valine' 0 C--N 1.347 0.474 0 CA-C-N 113.024 -1.588 . . . . 0.0 107.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--N 1.346 0.441 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 -179.19 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.493 ' C10' ' HA3' ' A' ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' O ' HD22 ' A' ' 134' ' ' LEU . 23.7 ttt . . . . . 0 N--CA 1.445 -0.703 0 N-CA-C 105.215 -2.143 . . . . 0.0 105.215 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -99.28 16.51 22.72 Favored 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.449 -1.705 . . . . 0.0 107.437 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.99 130.82 36.97 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 123.38 1.562 . . . . 0.0 107.049 -179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -81.69 95.69 7.3 Favored 'General case' 0 C--N 1.347 0.492 0 CA-C-N 109.952 -3.295 . . . . 0.0 107.886 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.36 109.28 0.01 OUTLIER 'General case' 0 C--N 1.35 0.608 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.41 HD11 ' HA ' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -134.21 117.27 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 -179.001 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.678 HG23 HG12 ' A' ' 35' ' ' VAL . 4.2 p -98.95 133.42 41.64 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 111.55 -2.568 . . . . 0.0 108.301 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.41 ' CD1' HD22 ' A' ' 23' ' ' LEU . 52.5 tp -125.2 143.71 50.81 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 124.976 1.422 . . . . 0.0 107.63 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.573 ' O ' HG12 ' A' ' 10' ' ' VAL . . . -177.29 170.4 42.95 Favored Glycine 0 C--N 1.36 1.875 0 CA-C-N 112.412 -2.176 . . . . 0.0 113.443 176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG12 ' O ' ' A' ' 9' ' ' GLY 0.711 11.7 p 99.63 -130.16 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.861 0 C-N-CA 130.893 3.677 . . . . 0.0 116.526 178.126 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 17' ' ' ALA . 0.1 OUTLIER 56.09 102.34 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.357 0.92 0 C-N-CA 127.401 2.281 . . . . 0.0 107.618 -175.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -164.41 50.23 0.29 Allowed Glycine 0 C--N 1.36 1.871 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.211 -179.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.2 t -108.59 -86.68 0.51 Allowed 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 103.181 -2.896 . . . . 0.0 103.181 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -84.75 97.9 9.94 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 103.933 -2.618 . . . . 0.0 103.933 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 57.4 m 63.35 -133.05 0.41 Allowed 'General case' 0 C--N 1.359 0.996 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -178.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -147.97 -178.79 6.47 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . 72.55 -168.21 0.13 Allowed 'General case' 0 C--N 1.354 0.786 0 CA-C-N 112.752 -2.022 . . . . 0.0 106.727 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 18' ' ' VAL 0.31 57.5 t 82.23 15.93 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.331 0 CA-C-N 113.351 -1.749 . . . . 0.0 110.579 -179.659 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -103.64 -36.61 3.22 Favored Glycine 0 C--N 1.354 1.567 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -50.0 -35.94 26.6 Favored 'General case' 0 C--N 1.358 0.953 0 CA-C-N 111.447 -2.377 . . . . 0.0 107.844 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' HG22 ' A' ' 22' ' ' ILE . 31.7 ttmt -32.57 72.69 0.0 OUTLIER 'General case' 0 C--N 1.364 1.233 1 C-N-CA 137.815 6.446 . . . . 0.0 108.077 177.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.451 HG22 ' O ' ' A' ' 21' ' ' LYS . 1.3 mp 56.4 15.66 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.44 -0.966 1 CA-C-N 105.725 -5.216 . . . . 0.0 112.049 177.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.41 HD22 ' CD1' ' A' ' 8' ' ' LEU . 10.9 mp -76.89 -40.07 48.72 Favored 'General case' 0 C--N 1.364 1.226 0 C-N-CA 116.512 -2.075 . . . . 0.0 106.059 178.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.5 m-20 -79.62 -1.25 37.22 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 114.134 -1.394 . . . . 0.0 107.787 178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -82.32 -34.2 28.67 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.52 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 1.2 t -66.57 -29.26 69.28 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 113.124 -1.853 . . . . 0.0 110.438 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.628 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -65.26 -42.68 93.01 Favored 'General case' 0 C--N 1.35 0.59 0 C-N-CA 118.449 -1.3 . . . . 0.0 108.901 -179.002 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.8 -29.18 64.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 111.716 -2.493 . . . . 0.0 112.648 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -98.01 15.41 24.17 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-N 111.606 -2.543 . . . . 0.0 109.72 -176.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.03 2.91 1.77 Allowed 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 178.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.0 29.37 67.87 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 120.209 -0.996 . . . . 0.0 110.793 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.401 ' CE2' HD21 ' A' ' 134' ' ' LEU . 1.7 m-30 -99.76 156.18 17.24 Favored 'General case' 0 C--N 1.353 0.737 0 CA-C-N 112.603 -1.798 . . . . 0.0 106.169 -178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 61.0 m-20 -81.26 140.8 34.65 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 111.327 -2.669 . . . . 0.0 105.85 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.628 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 1.4 p -99.88 137.23 28.01 Favored 'Isoleucine or valine' 0 C--N 1.348 0.518 0 CA-C-N 112.145 -2.298 . . . . 0.0 107.457 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.678 HG12 HG23 ' A' ' 7' ' ' VAL . 40.0 t -132.74 63.48 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 CA-C-N 111.563 -2.562 . . . . 0.0 105.652 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -81.71 120.92 25.73 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 112.426 -2.17 . . . . 0.0 106.436 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -89.95 -79.47 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.965 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 178.8 -158.38 22.65 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 113.231 -1.804 . . . . 0.0 109.062 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -88.37 59.76 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.661 1.219 . . . . 0.0 110.117 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.5 tp -165.63 124.59 1.66 Allowed 'General case' 0 C--N 1.351 0.639 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 26.7 t -96.25 84.72 3.81 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.872 -3.01 . . . . 0.0 102.872 178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.68 122.98 27.22 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 110.96 -2.836 . . . . 0.0 105.404 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.421 HE22 ' CD2' ' A' ' 74' ' ' LEU . 8.1 tp-100 -80.81 -94.63 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.731 0 CA-C-N 112.23 -2.259 . . . . 0.0 108.745 -177.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -58.46 -17.25 19.37 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 125.813 1.645 . . . . 0.0 111.735 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -85.92 -48.88 8.3 Favored 'General case' 0 C--N 1.35 0.587 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD2' HD13 ' A' ' 37' ' ' ILE . 1.0 OUTLIER -84.85 0.51 50.65 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 116.58 -2.048 . . . . 0.0 109.001 -179.273 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.1 mp -83.92 -27.88 7.33 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 176.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -76.23 -29.03 57.39 Favored 'General case' 0 C--N 1.365 1.27 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.95 6.96 46.79 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -20.93 22.54 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 177.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.4 mt -77.19 -38.26 27.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -60.22 -68.65 0.27 Allowed 'General case' 0 C--N 1.354 0.798 0 CA-C-N 112.337 -2.21 . . . . 0.0 110.332 -179.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.39 -64.97 0.95 Allowed 'General case' 0 C--N 1.362 1.145 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? 129.69 47.36 0.0 OUTLIER 'General case' 0 C--N 1.351 0.656 0 O-C-N 126.912 2.632 . . . . 0.0 106.933 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.73 108.36 0.73 Allowed 'General case' 0 C--N 1.357 0.917 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -86.67 -82.64 0.2 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.267 -2.242 . . . . 0.0 104.972 -178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.5 pp -89.57 142.08 28.0 Favored 'General case' 0 C--N 1.35 0.601 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -127.45 144.66 36.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.658 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 -178.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 60.5 m -134.68 129.31 34.6 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 112.433 -2.167 . . . . 0.0 106.686 -179.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.587 HG23 HG12 ' A' ' 90' ' ' VAL . 92.5 t -99.96 137.04 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 CA-C-N 110.042 -3.254 . . . . 0.0 103.451 178.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.8 p -123.14 89.56 3.13 Favored 'General case' 0 CA--C 1.506 -0.719 0 N-CA-C 102.952 -2.981 . . . . 0.0 102.952 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 10.0 t -165.77 -172.62 2.43 Favored 'General case' 0 C--O 1.221 -0.416 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.05 42.68 3.03 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 81.29 96.02 0.05 OUTLIER 'General case' 0 C--N 1.356 0.873 0 CA-C-N 112.779 -2.01 . . . . 0.0 106.205 179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -165.33 19.85 0.11 Allowed Glycine 0 CA--C 1.538 1.515 0 CA-C-N 112.391 -2.186 . . . . 0.0 110.689 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -109.4 -0.81 18.81 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.71 160.18 13.18 Favored Glycine 0 C--N 1.355 1.61 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -81.56 6.87 13.61 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-N 113.455 -1.373 . . . . 0.0 108.263 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.57 -48.2 16.3 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.401 ' HA ' HE21 ' A' ' 43' ' ' GLN . 13.6 t70 -71.31 -25.14 62.29 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 52.7 t -67.46 -57.88 5.75 Favored 'General case' 0 C--N 1.352 0.71 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.15 25.55 2.14 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 124.879 1.362 . . . . 0.0 109.295 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.63 -32.72 4.08 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.264 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.421 ' CD2' HE22 ' A' ' 43' ' ' GLN . 52.1 mt -86.41 -26.71 24.6 Favored 'General case' 0 C--N 1.351 0.658 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.525 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.5 mmt85 -73.03 -33.38 65.7 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.074 -2.195 . . . . 0.0 105.074 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -79.69 -19.93 47.79 Favored 'General case' 0 C--N 1.359 1.017 0 CA-C-N 113.491 -1.686 . . . . 0.0 108.659 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 38.9 tttp -76.42 -20.33 57.19 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 66.5 m -90.15 -43.22 10.59 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-O 123.698 1.713 . . . . 0.0 107.434 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -76.45 1.09 17.46 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 108.932 -3.758 . . . . 0.0 108.478 178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -80.89 -54.69 5.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 104.154 -2.536 . . . . 0.0 104.154 177.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 64.08 39.37 7.81 Favored 'General case' 0 C--N 1.353 0.743 0 CA-C-N 110.686 -2.961 . . . . 0.0 107.114 -179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -49.22 0.04 OUTLIER Glycine 0 C--N 1.35 1.348 0 N-CA-C 107.736 -2.146 . . . . 0.0 107.736 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.43 120.28 27.6 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 102.969 -2.974 . . . . 0.0 102.969 177.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.98 122.0 28.59 Favored 'General case' 0 C--N 1.348 0.505 0 CA-C-N 113.716 -1.584 . . . . 0.0 107.13 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.6 81.73 0.04 OUTLIER Glycine 0 C--N 1.348 1.211 0 CA-C-N 112.339 -2.21 . . . . 0.0 109.995 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.5 tt -111.78 38.79 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.2 mmtm -145.48 114.17 6.81 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -140.25 98.76 3.5 Favored 'General case' 0 C--O 1.221 -0.403 0 N-CA-C 105.368 -2.086 . . . . 0.0 105.368 -179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -99.62 90.84 4.62 Favored 'General case' 0 C--N 1.349 0.57 0 N-CA-C 101.762 -3.421 . . . . 0.0 101.762 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.587 HG12 HG23 ' A' ' 60' ' ' VAL . 15.5 m -89.42 93.39 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 110.294 -3.139 . . . . 0.0 109.696 -175.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -70.43 118.43 7.84 Favored Glycine 0 CA--C 1.532 1.123 0 CA-C-N 110.181 -3.19 . . . . 0.0 113.912 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.9 -45.1 2.89 Favored Glycine 0 CA--C 1.543 1.794 0 CA-C-N 111.915 -2.143 . . . . 0.0 113.778 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -46.12 129.77 10.04 Favored 'General case' 0 C--N 1.355 0.826 0 C-N-CA 127.743 2.417 . . . . 0.0 107.184 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 60.33 72.36 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.439 ' O ' HG22 ' A' ' 96' ' ' VAL . 0.2 OUTLIER -78.16 -161.89 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-N 112.253 -2.249 . . . . 0.0 109.312 -178.274 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 95' ' ' VAL 0.279 17.2 m 61.46 118.85 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 127.831 2.453 . . . . 0.0 109.482 -179.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 74.46 160.07 7.1 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 113.223 -1.808 . . . . 0.0 110.181 -179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -152.07 109.57 3.6 Favored 'General case' 0 C--N 1.349 0.555 0 N-CA-C 103.826 -2.657 . . . . 0.0 103.826 179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 98.29 -53.01 0.0 OUTLIER 'General case' 0 C--N 1.355 0.832 0 N-CA-C 104.038 -2.578 . . . . 0.0 104.038 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -92.73 75.86 4.95 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.435 ' CH2' ' HB ' ' A' ' 116' ' ' VAL . 95.3 m95 -83.85 159.92 59.39 Favored Pre-proline 0 C--N 1.351 0.653 0 CA-C-N 112.652 -2.067 . . . . 0.0 105.808 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -69.34 -154.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.37 1.684 0 N-CA-C 108.139 -1.524 . . . . 0.0 108.139 178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -68.29 -21.2 64.79 Favored 'General case' 0 C--N 1.352 0.695 0 CA-C-N 112.949 -1.932 . . . . 0.0 108.724 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.557 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.7 p -59.87 -68.84 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.82 0 O-C-N 124.477 1.111 . . . . 0.0 111.282 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.557 ' H ' HG13 ' A' ' 104' ' ' VAL . 35.7 mt-10 -90.18 27.41 1.64 Allowed 'General case' 0 C--N 1.358 0.95 0 C-N-CA 117.986 -1.486 . . . . 0.0 108.967 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -80.51 -41.25 24.59 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 103.438 -2.801 . . . . 0.0 103.438 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -80.52 -31.87 37.01 Favored 'General case' 0 C--N 1.355 0.845 0 CA-C-N 112.3 -2.227 . . . . 0.0 106.468 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -91.3 15.11 12.67 Favored 'General case' 0 C--N 1.364 1.222 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -90.42 -40.41 12.07 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 104.106 -2.553 . . . . 0.0 104.106 176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.91 -36.2 78.66 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.404 -2.18 . . . . 0.0 107.316 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 37.6 mtp -77.56 -61.45 1.99 Allowed 'General case' 0 C--N 1.354 0.791 0 N-CA-C 103.647 -2.723 . . . . 0.0 103.647 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.52 27.13 0.09 OUTLIER Glycine 0 C--N 1.353 1.493 0 CA-C-N 112.177 -2.283 . . . . 0.0 118.085 177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -86.05 -2.7 58.57 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 177.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.22 128.75 53.57 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 102.937 -2.986 . . . . 0.0 102.937 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' HB ' ' CH2' ' A' ' 101' ' ' TRP . 42.5 t -140.01 151.66 21.86 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -99.63 148.06 34.22 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 102.95 -2.982 . . . . 0.0 102.95 179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -70.39 155.75 63.18 Favored 'Trans proline' 0 C--N 1.364 1.356 0 N-CA-C 106.017 -2.339 . . . . 0.0 106.017 179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -75.93 118.11 4.92 Favored 'Trans proline' 0 C--N 1.365 1.441 0 N-CA-C 105.08 -2.7 . . . . 0.0 105.08 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 74.46 56.56 5.03 Favored Glycine 0 C--N 1.352 1.436 0 CA-C-N 113.559 -1.655 . . . . 0.0 109.186 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.591 ' CG2' H112 ' A' ' 139' ' ' DBI . 13.8 t -88.35 179.1 6.4 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-O 125.151 2.405 . . . . 0.0 107.501 -178.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.331 21.4 p -75.87 170.68 14.73 Favored Pre-proline 0 N--CA 1.431 -1.4 1 CA-C-N 106.815 -4.72 . . . . 0.0 104.782 178.123 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.38 -3.19 3.82 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 N-CA-C 105.875 -2.394 . . . . 0.0 105.875 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -74.73 -12.05 60.32 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 125.927 1.691 . . . . 0.0 109.057 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.63 -28.0 58.64 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.474 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.9 p -87.78 -21.74 24.93 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 124.483 1.115 . . . . 0.0 110.701 -177.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.6 mt -69.92 -28.87 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 174.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.9 -3.19 58.61 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 112.123 -2.308 . . . . 0.0 109.16 178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.512 ' O ' HG23 ' A' ' 133' ' ' VAL . 7.7 t0 -63.53 -56.43 16.06 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.52 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -87.47 1.0 54.72 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 110.854 -2.885 . . . . 0.0 110.311 -177.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -84.37 -47.55 10.59 Favored 'General case' 0 C--N 1.352 0.694 0 C-N-CA 117.302 -1.759 . . . . 0.0 110.079 -178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -84.31 -40.49 17.9 Favored 'General case' 0 C--N 1.353 0.756 0 O-C-N 124.149 0.906 . . . . 0.0 111.467 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.5 t -68.78 -31.08 49.3 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 O-C-N 124.717 1.261 . . . . 0.0 112.973 -177.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 1' ' ' MET . 45.0 mt -90.11 -33.12 16.39 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -63.6 -93.03 0.02 OUTLIER Glycine 0 C--N 1.355 1.584 0 CA-C-N 114.243 -1.344 . . . . 0.0 113.03 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -169.37 160.22 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 113.319 -1.44 . . . . 0.0 108.36 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--N 1.349 0.566 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 179.628 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.591 H112 ' CG2' ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.445 -0.683 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -152.45 81.92 1.24 Allowed 'General case' 0 C--N 1.352 0.696 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -87.65 -159.26 0.51 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 113.124 -1.853 . . . . 0.0 106.195 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -153.59 63.16 0.74 Allowed 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 113.35 -1.75 . . . . 0.0 108.267 -178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.3 p -149.89 110.29 4.21 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 176.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -129.75 109.44 17.97 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 111.268 -2.696 . . . . 0.0 104.492 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 37' ' ' ILE . 0.0 OUTLIER -89.96 111.96 23.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.741 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 179.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 ' CG2' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -125.21 148.34 48.67 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 113.484 -1.689 . . . . 0.0 109.127 -177.086 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.41 -165.27 34.88 Favored Glycine 0 C--N 1.356 1.662 0 CA-C-N 111.629 -2.532 . . . . 0.0 110.408 177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . 0.636 12.4 p 110.68 -113.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 C-N-CA 127.705 2.402 . . . . 0.0 113.091 178.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.42 HD11 HG23 ' A' ' 18' ' ' VAL 0.279 3.0 tp 56.06 154.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 129.131 2.972 . . . . 0.0 110.753 -177.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -172.81 76.84 0.09 OUTLIER Glycine 0 C--N 1.356 1.684 0 CA-C-N 110.485 -3.052 . . . . 0.0 107.269 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 13.4 t -151.25 -111.5 0.05 Allowed 'General case' 0 C--N 1.351 0.637 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 -178.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -173.24 -142.67 0.03 OUTLIER 'General case' 0 C--N 1.357 0.915 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.5 m 72.16 -108.18 0.04 OUTLIER 'General case' 0 C--N 1.364 1.233 0 O-C-N 124.182 0.926 . . . . 0.0 108.54 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -133.81 41.69 3.0 Favored 'General case' 0 C--N 1.366 1.294 0 N-CA-C 105.49 -2.041 . . . . 0.0 105.49 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 59.44 45.01 14.23 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 -178.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.449 HG21 H5'2 ' A' ' 139' ' ' DBI . 1.6 t -23.25 120.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.56 1.352 0 O-C-N 126.279 2.237 . . . . 0.0 113.469 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.443 ' O ' ' HG ' ' A' ' 23' ' ' LEU . . . 105.36 -62.45 0.34 Allowed Glycine 0 C--N 1.353 1.499 0 CA-C-N 114.12 -1.4 . . . . 0.0 110.019 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -54.71 -27.37 40.14 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-N 113.413 -1.393 . . . . 0.0 107.333 178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -39.48 71.08 0.0 OUTLIER 'General case' 0 C--N 1.373 1.59 1 C-N-CA 140.923 7.689 . . . . 0.0 105.376 175.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.82 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.266 0.2 OUTLIER 47.77 44.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.119 2 CA-C-N 103.287 -6.324 . . . . 0.0 109.448 179.104 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.446 ' CB ' HD23 ' A' ' 8' ' ' LEU . 1.1 mt -69.4 -20.39 63.8 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 103.203 -2.888 . . . . 0.0 103.203 172.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -66.09 -18.91 65.65 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 176.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.82 ' HB2' HG22 ' A' ' 22' ' ' ILE . 4.8 t60 -71.86 -27.46 62.88 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 23.9 p -55.96 -39.52 71.89 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 125.264 1.602 . . . . 0.0 110.55 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.665 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -59.56 -41.27 89.79 Favored 'General case' 0 C--O 1.222 -0.378 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.316 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.88 -21.55 54.77 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 111.606 -2.543 . . . . 0.0 112.431 -176.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -83.67 -3.57 57.87 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 112.842 -1.981 . . . . 0.0 108.938 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.428 ' HB3' ' SD ' ' A' ' 130' ' ' MET . . . -126.14 -7.39 6.53 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 66.73 22.19 71.64 Favored Glycine 0 CA--C 1.54 1.647 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 m-30 -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.359 1.022 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -141.74 143.52 33.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.5 p -99.64 173.95 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.915 0 CA-C-N 111.977 -2.374 . . . . 0.0 107.039 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.08 93.07 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 111.188 -2.733 . . . . 0.0 105.088 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -68.45 117.29 10.02 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.477 -179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.617 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 32.3 mt -90.1 -41.4 13.58 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 CA-C-N 113.117 -1.856 . . . . 0.0 106.247 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 130.64 -129.21 5.75 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.0 m -130.41 44.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 113.249 -1.476 . . . . 0.0 109.626 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.4 tp -163.06 109.52 1.17 Allowed 'General case' 0 C--N 1.352 0.708 0 N-CA-C 104.76 -2.311 . . . . 0.0 104.76 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 5.2 t -85.23 95.27 9.12 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -90.3 138.49 31.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 112.055 -2.339 . . . . 0.0 105.803 179.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.41 -90.67 0.06 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.856 -178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -62.26 -11.17 13.47 Favored 'General case' 0 C--N 1.351 0.658 0 O-C-N 124.973 1.42 . . . . 0.0 112.786 -175.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -89.18 -46.14 9.03 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 118.348 -1.341 . . . . 0.0 107.475 -179.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.617 ' CE2' ' HB ' ' A' ' 37' ' ' ILE . 11.5 m-85 -86.88 6.78 30.21 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 117.964 -1.494 . . . . 0.0 108.568 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -90.28 -29.06 4.92 Favored 'Isoleucine or valine' 0 C--N 1.359 1.01 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 175.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -74.95 -24.5 58.48 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 -4.2 55.42 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.0 -12.51 38.43 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -87.94 -38.33 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -59.41 -65.27 0.7 Allowed 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 111.823 -2.444 . . . . 0.0 110.356 -178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.403 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.6 OUTLIER -79.94 -47.5 14.92 Favored 'General case' 0 C--N 1.362 1.11 0 C-N-CA 119.727 -0.789 . . . . 0.0 109.118 -176.011 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' CB ' ' O ' ' A' ' 53' ' ' THR . 3.7 ttmp? 109.8 42.79 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 126.543 2.402 . . . . 0.0 108.357 178.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.84 120.6 5.46 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 124.485 1.116 . . . . 0.0 108.981 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -90.73 -66.1 0.96 Allowed 'General case' 0 C--N 1.352 0.708 0 CA-C-N 111.86 -2.427 . . . . 0.0 105.6 179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 pp -107.18 148.39 28.93 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-O 123.456 1.598 . . . . 0.0 109.35 -177.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' HB ' HD13 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -97.62 148.92 5.34 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 CA-C-N 109.818 -3.355 . . . . 0.0 104.82 178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.552 ' N ' HD12 ' A' ' 58' ' ' ILE . 60.9 m -141.73 105.0 4.63 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -99.69 131.95 46.1 Favored 'Isoleucine or valine' 0 C--N 1.35 0.629 0 N-CA-C 103.675 -2.713 . . . . 0.0 103.675 178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 m -110.38 45.35 1.13 Allowed 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 29.3 p -154.06 168.4 26.6 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.598 ' CD1' ' HB ' ' A' ' 95' ' ' VAL . 15.3 tp -74.39 -127.04 0.01 OUTLIER 'General case' 0 N--CA 1.426 -1.642 0 CA-C-N 111.251 -2.704 . . . . 0.0 103.823 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.476 ' HE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -93.53 50.67 1.5 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.95 21.13 47.68 Favored Glycine 0 C--N 1.357 1.702 0 CA-C-N 113.112 -1.858 . . . . 0.0 110.549 178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -124.09 -31.12 3.39 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 84.55 166.6 41.49 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 113.835 -1.529 . . . . 0.0 110.088 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -78.21 -1.35 32.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 113.581 -1.309 . . . . 0.0 108.499 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -83.29 -46.19 18.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 3.9 m-20 -74.25 -27.12 60.61 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-N 114.507 -1.224 . . . . 0.0 107.928 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 80.7 m -68.99 -50.69 46.71 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -89.53 21.79 3.26 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 124.569 1.168 . . . . 0.0 109.481 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -27.04 7.75 Favored Glycine 0 CA--C 1.53 0.975 0 N-CA-C 108.931 -1.668 . . . . 0.0 108.931 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 17.8 mt -89.99 -32.28 16.85 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 112.27 -1.965 . . . . 0.0 106.473 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 29.2 mtt85 -75.55 -22.1 57.34 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 177.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -76.89 -31.67 56.91 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -74.98 -11.69 60.17 Favored 'General case' 0 CA--C 1.553 1.089 0 O-C-N 124.497 1.123 . . . . 0.0 109.162 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 73.4 m -90.27 -48.05 7.39 Favored 'General case' 0 CA--C 1.501 -0.935 0 CA-C-O 123.239 1.495 . . . . 0.0 107.624 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.296 2.9 p30 -78.27 4.23 13.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 109.672 -3.422 . . . . 0.0 109.233 178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -81.96 -53.38 6.19 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.29 39.79 25.23 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.084 -2.78 . . . . 0.0 108.042 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.29 -48.58 0.05 OUTLIER Glycine 0 C--N 1.349 1.274 0 N-CA-C 107.543 -2.223 . . . . 0.0 107.543 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 85.5 mt -87.33 119.94 28.11 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 103.025 -2.954 . . . . 0.0 103.025 177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.03 128.96 34.9 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 113.49 -1.686 . . . . 0.0 106.506 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 154.02 59.27 0.01 OUTLIER Glycine 0 C--N 1.347 1.164 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.327 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -84.65 -8.79 11.32 Favored 'Isoleucine or valine' 0 C--N 1.352 0.716 0 CA-C-N 112.509 -1.846 . . . . 0.0 108.593 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -97.54 129.09 44.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 105.62 -1.993 . . . . 0.0 105.62 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.571 HD13 ' HB ' ' A' ' 58' ' ' ILE . 0.6 OUTLIER -139.97 140.68 36.35 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 179.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.27 92.37 2.53 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 178.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' VAL . 0.4 OUTLIER -89.46 93.97 4.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-O 125.118 2.389 . . . . 0.0 110.358 -176.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.43 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.48 119.92 8.01 Favored Glycine 0 CA--C 1.537 1.445 0 CA-C-N 109.895 -3.32 . . . . 0.0 112.453 178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.08 -84.04 1.01 Allowed Glycine 0 C--N 1.353 1.498 0 CA-C-N 112.104 -2.048 . . . . 0.0 108.095 -178.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.403 HD22 ' HA ' ' A' ' 93' ' ' ASN . 5.6 t-20 53.95 -111.54 0.63 Allowed 'General case' 0 C--N 1.353 0.758 0 CA-C-N 111.79 -2.205 . . . . 0.0 107.63 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.476 ' HB ' ' HE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -92.29 126.82 44.78 Favored 'Isoleucine or valine' 0 C--N 1.348 0.541 0 N-CA-C 104.394 -2.447 . . . . 0.0 104.394 179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 63' ' ' LEU . 10.8 p -73.79 157.44 6.3 Favored 'Isoleucine or valine' 0 C--N 1.35 0.613 0 CA-C-N 112.861 -1.972 . . . . 0.0 108.74 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 45.28 99.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.761 0 CA-C-N 112.358 -2.201 . . . . 0.0 112.918 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 152.58 152.92 6.11 Favored Glycine 0 C--N 1.349 1.272 0 CA-C-N 112.091 -2.322 . . . . 0.0 108.895 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -175.83 124.16 0.2 Allowed 'General case' 0 C--N 1.35 0.595 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 86.06 -67.37 0.03 OUTLIER 'General case' 0 C--N 1.357 0.905 0 O-C-N 126.004 2.065 . . . . 0.0 106.369 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -95.29 134.55 37.93 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -139.03 167.37 19.42 Favored Pre-proline 0 C--N 1.347 0.499 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -67.75 -145.21 0.02 OUTLIER 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 121.831 1.687 . . . . 0.0 108.549 178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -72.18 -25.06 61.53 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-N 113.841 -1.527 . . . . 0.0 108.519 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.488 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.7 p -54.13 -72.48 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 124.768 1.293 . . . . 0.0 111.219 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' H ' HG13 ' A' ' 104' ' ' VAL . 11.2 mt-10 -90.35 26.74 1.85 Allowed 'General case' 0 C--N 1.361 1.101 0 C-N-CA 117.505 -1.678 . . . . 0.0 109.416 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -73.03 -42.42 63.2 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 103.403 -2.814 . . . . 0.0 103.403 174.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -89.98 -24.68 21.18 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 111.676 -2.511 . . . . 0.0 108.411 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -85.77 -13.4 48.34 Favored 'General case' 0 C--N 1.364 1.209 0 C-N-CA 118.249 -1.38 . . . . 0.0 109.486 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -90.57 -20.28 22.79 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.72 -33.75 74.58 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 178.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 56.2 mtt -87.38 -52.01 5.61 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 45.97 26.24 1.98 Allowed Glycine 0 C--N 1.356 1.671 0 CA-C-N 112.769 -2.014 . . . . 0.0 117.644 178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.6 -4.91 58.98 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 106.822 -1.547 . . . . 0.0 106.822 177.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.08 119.54 39.3 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 104.745 -2.317 . . . . 0.0 104.745 178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 179.23 4.16 Favored 'General case' 0 C--N 1.347 0.489 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 90' ' ' VAL . 48.9 t -140.01 151.17 21.69 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.43 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 4.8 m-85 -99.63 153.03 37.98 Favored Pre-proline 0 C--N 1.355 0.837 0 N-CA-C 103.096 -2.928 . . . . 0.0 103.096 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -65.16 136.57 48.36 Favored 'Trans proline' 0 C--N 1.371 1.722 0 N-CA-C 107.907 -1.613 . . . . 0.0 107.907 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.71 110.62 2.97 Favored 'Trans proline' 0 C--N 1.371 1.721 0 N-CA-C 104.589 -2.889 . . . . 0.0 104.589 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.489 ' H ' ' H7 ' ' A' ' 139' ' ' DBI . . . 138.94 -103.61 0.4 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 111.647 -2.524 . . . . 0.0 107.561 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 2.9 p -90.27 167.59 12.56 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 105.469 -2.048 . . . . 0.0 105.469 178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.6 p -168.67 70.75 0.77 Allowed Pre-proline 0 C--N 1.349 0.559 0 CA-C-N 113.136 -1.847 . . . . 0.0 106.04 175.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -76.27 -84.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.37 1.689 0 C-N-CA 123.264 2.643 . . . . 0.0 109.473 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -57.25 -19.47 21.76 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 127.126 2.17 . . . . 0.0 110.683 -178.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.06 -25.43 62.63 Favored 'General case' 0 N--CA 1.444 -0.768 0 O-C-N 124.051 0.844 . . . . 0.0 109.694 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 0.7 OUTLIER -86.11 -23.4 26.66 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 117.419 -1.712 . . . . 0.0 109.579 -179.966 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.8 mt -66.83 -26.12 36.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.974 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 174.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -89.15 -6.46 56.95 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.042 -1.89 . . . . 0.0 109.011 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 133' ' ' VAL . 63.3 t0 -54.22 -66.6 0.37 Allowed 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.428 ' SD ' ' HB3' ' A' ' 30' ' ' ALA . 6.4 mtm -90.36 -6.17 55.34 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 111.343 -2.662 . . . . 0.0 111.755 -177.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -89.97 -45.33 9.27 Favored 'General case' 0 C--N 1.352 0.681 0 C-N-CA 117.209 -1.796 . . . . 0.0 107.659 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 63.9 tt0 -58.39 -45.8 87.62 Favored 'General case' 0 C--N 1.351 0.67 0 CA-C-O 121.817 0.818 . . . . 0.0 109.168 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 129' ' ' ASP . 84.6 t -82.24 -71.28 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 CA-C-N 112.901 -1.954 . . . . 0.0 112.234 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 62.5 mt -90.12 55.88 3.24 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 114.169 -1.378 . . . . 0.0 109.579 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -160.39 -70.78 0.02 OUTLIER Glycine 0 C--N 1.35 1.314 0 C-N-CA 119.655 -1.259 . . . . 0.0 110.651 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -171.38 153.38 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.566 0 CA-C-N 113.446 -1.377 . . . . 0.0 107.598 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 CA--C 1.543 0.699 0 CA-C-N 112.566 -2.106 . . . . 0.0 107.355 179.39 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.489 ' H7 ' ' H ' ' A' ' 120' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.4 ttp . . . . . 0 N--CA 1.447 -0.624 0 N-CA-C 105.057 -2.201 . . . . 0.0 105.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -131.1 74.67 1.61 Allowed 'General case' 0 C--N 1.352 0.694 0 N-CA-C 104.181 -2.525 . . . . 0.0 104.181 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.8 mttm -72.92 172.2 11.35 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 112.153 -2.294 . . . . 0.0 107.503 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 57.3 pttt -108.1 68.99 0.72 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 111.082 -2.781 . . . . 0.0 110.654 -175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 79.9 p -150.44 109.22 3.85 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.503 HD12 ' SD ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -123.57 136.24 60.74 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 102.372 -3.196 . . . . 0.0 102.372 -179.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -130.08 133.42 64.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 O-C-N 124.502 1.127 . . . . 0.0 108.736 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.1 pp -116.25 146.77 42.1 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 113.187 -1.824 . . . . 0.0 106.252 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.404 ' HA2' HG22 ' A' ' 37' ' ' ILE . . . -131.2 146.43 17.84 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-N 112.381 -2.19 . . . . 0.0 109.325 179.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.754 HG12 ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -120.25 126.49 75.33 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 O-C-N 124.96 1.035 . . . . 0.0 110.664 -179.201 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 2.1 tp -152.92 139.91 13.01 Favored 'Isoleucine or valine' 0 C--N 1.351 0.644 0 N-CA-C 104.096 -2.557 . . . . 0.0 104.096 177.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.07 84.69 0.2 Allowed Glycine 0 C--N 1.344 0.99 0 N-CA-C 105.691 -2.964 . . . . 0.0 105.691 -178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.4 m -98.21 47.67 1.0 Allowed 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 110.826 -2.687 . . . . 0.0 106.711 -176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -73.0 -40.43 65.21 Favored 'General case' 0 C--N 1.36 1.025 0 CA-C-N 112.928 -1.942 . . . . 0.0 106.687 178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.1 t -163.95 -43.9 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.907 0 CA-C-N 112.596 -2.093 . . . . 0.0 105.578 -179.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -149.98 134.44 17.4 Favored 'General case' 0 C--N 1.369 1.443 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -101.78 10.36 40.02 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 111.543 -2.571 . . . . 0.0 106.076 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -55.72 116.42 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.369 1.418 0 CA-C-O 121.957 0.884 . . . . 0.0 111.729 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -104.13 32.68 7.27 Favored Glycine 0 C--N 1.356 1.659 0 CA-C-N 113.085 -1.87 . . . . 0.0 111.154 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.443 ' C ' ' H ' ' A' ' 22' ' ' ILE . 6.5 t30 -41.32 -63.88 0.63 Allowed 'General case' 0 C--N 1.368 1.38 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 24.8 mmtp 12.25 32.68 0.0 OUTLIER 'General case' 0 C--N 1.38 1.913 2 C-N-CA 139.689 7.196 . . . . 0.0 109.855 176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.489 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.307 0.0 OUTLIER 38.82 47.23 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.777 1 C-N-CA 132.593 4.357 . . . . 0.0 105.786 -175.081 . . . . . . . . 5 4 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD11 H103 ' A' ' 139' ' ' DBI . 0.4 OUTLIER -77.63 -26.27 50.41 Favored 'General case' 0 C--N 1.376 1.721 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 176.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.31 -18.03 65.01 Favored 'General case' 0 CA--C 1.554 1.102 0 CA-C-N 113.39 -1.732 . . . . 0.0 106.584 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.489 ' HB2' HG22 ' A' ' 22' ' ' ILE . 0.5 OUTLIER -69.35 -30.77 68.87 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 179.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.5 m -45.31 -44.33 11.46 Favored 'General case' 0 C--N 1.36 1.036 0 O-C-N 124.856 1.348 . . . . 0.0 107.962 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -55.16 -47.97 74.41 Favored 'General case' 0 C--N 1.347 0.483 0 CA-C-N 111.649 -2.523 . . . . 0.0 109.402 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.02 -14.61 58.42 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 112.296 -2.229 . . . . 0.0 113.748 -176.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.408 HD21 ' CG ' ' A' ' 25' ' ' HIS . 7.5 m120 -75.49 -14.87 60.45 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 126.369 1.867 . . . . 0.0 109.781 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -152.94 19.42 0.59 Allowed 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 117.445 -1.702 . . . . 0.0 108.216 177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.2 28.4 54.35 Favored Glycine 0 C--N 1.355 1.638 0 O-C-N 124.182 0.926 . . . . 0.0 112.803 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -99.73 160.3 14.4 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.45 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 32.3 t30 -89.21 135.62 33.47 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 112.248 -2.251 . . . . 0.0 106.373 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.4 p -99.94 170.05 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.501 0 CA-C-N 111.309 -2.678 . . . . 0.0 106.973 177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.4 t -140.14 106.36 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.688 0 CA-C-N 111.557 -2.565 . . . . 0.0 105.446 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.7 m-20 -86.55 123.71 32.05 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.423 HD11 ' CG ' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -89.84 -30.08 5.08 Favored 'Isoleucine or valine' 0 C--N 1.357 0.927 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 179.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 99.78 -129.24 9.83 Favored Glycine 0 C--N 1.355 1.627 0 N-CA-C 107.828 -2.109 . . . . 0.0 107.828 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' HG12 ' A' ' 10' ' ' VAL . 2.8 m -98.18 -12.69 8.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 113.353 -1.423 . . . . 0.0 110.002 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.75 86.91 6.8 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -91.44 58.08 3.5 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 112.869 -1.968 . . . . 0.0 105.909 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.5 p -90.03 116.37 28.01 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 101.385 -3.561 . . . . 0.0 101.385 177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.538 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.5 tp-100 -89.96 -54.09 4.2 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.21 -1.359 . . . . 0.0 108.866 -176.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pp20? -62.36 -32.68 73.5 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 125.143 1.527 . . . . 0.0 110.449 -177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -79.36 -26.46 42.07 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 2.7 t80 -86.94 4.15 42.79 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.541 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -78.69 -37.35 20.52 Favored 'Isoleucine or valine' 0 C--N 1.36 1.064 0 N-CA-C 102.475 -3.158 . . . . 0.0 102.475 175.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -73.93 -28.68 61.64 Favored 'General case' 0 C--N 1.363 1.172 0 CA-C-N 112.482 -2.145 . . . . 0.0 106.997 178.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -89.82 0.54 56.96 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 118.485 -1.286 . . . . 0.0 108.031 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.04 -7.67 53.35 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 3.9 mt -84.09 -39.83 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 N-CA-C 103.492 -2.781 . . . . 0.0 103.492 174.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.95 -75.54 0.08 Allowed 'General case' 0 C--N 1.356 0.852 0 CA-C-N 112.189 -2.278 . . . . 0.0 110.746 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.5 p -74.07 -19.28 60.66 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 123.961 0.788 . . . . 0.0 110.471 -175.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.7 tptt 72.47 50.83 0.18 Allowed 'General case' 0 C--N 1.349 0.578 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.99 130.93 35.2 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 125.251 1.594 . . . . 0.0 107.537 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -104.22 -77.12 0.58 Allowed 'General case' 0 C--N 1.364 1.228 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.432 HD11 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -87.4 147.66 25.35 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 125.016 1.448 . . . . 0.0 108.072 -176.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.572 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -134.15 165.51 31.46 Favored 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 111.458 -2.61 . . . . 0.0 105.78 -178.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 1.9 p -161.94 158.78 25.73 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 p -127.62 168.95 19.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.056 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.4 m -123.86 69.21 1.05 Allowed 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 102.985 -2.969 . . . . 0.0 102.985 179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 3.2 p -174.32 168.48 3.94 Favored 'General case' 0 C--N 1.354 0.804 0 CA-C-N 111.912 -2.404 . . . . 0.0 106.243 -179.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.413 ' H ' ' H51' ' A' ' 138' ' ' FOP . 65.3 mt -79.73 -105.58 0.02 OUTLIER 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 110.732 -2.94 . . . . 0.0 103.203 177.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -102.68 27.08 7.26 Favored 'General case' 0 N--CA 1.432 -1.355 0 CA-C-N 112.808 -1.996 . . . . 0.0 106.498 179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -75.74 -9.68 84.92 Favored Glycine 0 C--N 1.359 1.839 0 CA-C-N 114.759 -1.11 . . . . 0.0 111.305 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.6 pt20 -80.01 -34.66 38.26 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.3 -178.32 49.18 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 113.002 -1.908 . . . . 0.0 112.226 178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -77.92 -12.19 59.96 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.152 -2.024 . . . . 0.0 108.644 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -77.68 -49.47 21.98 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 -178.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -72.37 -29.44 63.78 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 113.847 -1.524 . . . . 0.0 108.853 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -57.04 8.83 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.0 mtmm -88.27 27.46 1.23 Allowed 'General case' 0 C--N 1.358 0.961 0 O-C-N 125.316 1.635 . . . . 0.0 109.944 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.21 -30.41 7.03 Favored Glycine 0 CA--C 1.534 1.264 0 N-CA-C 106.959 -2.457 . . . . 0.0 106.959 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.538 HD21 ' CD ' ' A' ' 43' ' ' GLN . 8.0 mt -90.03 -33.84 16.19 Favored 'General case' 0 C--N 1.356 0.856 0 CA-C-N 111.644 -2.278 . . . . 0.0 107.788 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.61 -24.37 61.06 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -80.77 -31.42 35.82 Favored 'General case' 0 C--N 1.358 0.943 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.5 tttp -76.51 -15.09 59.97 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 124.139 0.899 . . . . 0.0 109.479 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 43.0 t -90.32 -47.04 8.01 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 123.94 1.829 . . . . 0.0 107.293 -178.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -72.43 -3.58 25.07 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 108.531 -3.94 . . . . 0.0 109.041 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -81.24 -56.65 3.93 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.49 -2.411 . . . . 0.0 104.49 177.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.35 48.93 7.41 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 110.931 -2.85 . . . . 0.0 106.82 -179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -157.96 -42.15 0.02 OUTLIER Glycine 0 C--N 1.35 1.335 0 CA-C-N 112.894 -1.957 . . . . 0.0 110.017 -179.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 29.7 mt -78.78 124.95 28.73 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.96 117.08 15.33 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 149.73 107.04 0.4 Allowed Glycine 0 C--N 1.348 1.247 0 CA-C-N 112.777 -2.011 . . . . 0.0 109.557 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.3 tt -157.01 46.72 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.398 0 N-CA-C 104.832 -2.284 . . . . 0.0 104.832 179.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -151.24 119.65 6.42 Favored 'General case' 0 C--N 1.348 0.522 0 N-CA-C 102.86 -3.015 . . . . 0.0 102.86 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.572 HD11 HD13 ' A' ' 58' ' ' ILE . 3.2 mm? -139.3 149.09 43.83 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 105.75 -1.945 . . . . 0.0 105.75 -178.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -140.33 94.59 2.76 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 102.374 -3.195 . . . . 0.0 102.374 177.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.508 HG23 ' HB2' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -89.87 100.07 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 CA-C-N 111.209 -2.723 . . . . 0.0 109.732 -175.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -70.44 81.61 0.38 Allowed Glycine 0 CA--C 1.533 1.178 0 CA-C-N 108.434 -3.985 . . . . 0.0 112.745 177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 134.4 -85.68 0.26 Allowed Glycine 0 C--N 1.351 1.412 0 CA-C-N 112.714 -1.743 . . . . 0.0 109.376 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.508 ' HB2' HG23 ' A' ' 90' ' ' VAL . 65.6 t30 65.29 -116.15 0.34 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.901 -1.649 . . . . 0.0 106.932 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 16.5 mt -104.4 129.34 56.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.607 0 N-CA-C 103.983 -2.599 . . . . 0.0 103.983 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -81.42 169.06 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.756 -2.02 . . . . 0.0 107.893 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.9 p 45.63 48.85 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.812 0 CA-C-N 112.713 -2.039 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 178.83 139.03 3.39 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 112.282 -2.236 . . . . 0.0 108.767 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -161.17 111.52 1.71 Allowed 'General case' 0 C--N 1.349 0.571 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 96.96 -45.34 0.01 OUTLIER 'General case' 0 C--N 1.357 0.893 0 CA-C-N 112.548 -2.115 . . . . 0.0 105.83 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -90.17 126.54 35.84 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 73.8 m95 -138.03 160.11 65.72 Favored Pre-proline 0 C--N 1.353 0.746 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -178.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.59 -148.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.78 0 N-CA-C 107.759 -1.669 . . . . 0.0 107.759 178.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -75.48 -20.43 58.79 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.665 -178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.406 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -60.12 -64.47 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.744 0 O-C-N 124.433 1.083 . . . . 0.0 111.429 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.406 ' H ' HG13 ' A' ' 104' ' ' VAL . 9.6 mm-40 -89.4 18.67 5.04 Favored 'General case' 0 C--N 1.358 0.968 0 C-N-CA 117.009 -1.876 . . . . 0.0 107.965 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -72.79 -39.08 66.99 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -80.78 -32.16 35.54 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.691 -2.049 . . . . 0.0 106.826 178.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -91.74 15.03 13.63 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 118.703 -1.199 . . . . 0.0 108.737 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.7 -41.36 11.33 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 104.112 -2.551 . . . . 0.0 104.112 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.07 -35.04 74.29 Favored 'General case' 0 C--N 1.359 1.005 0 CA-C-N 112.21 -2.268 . . . . 0.0 107.418 179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.3 mtp -82.35 -57.99 3.13 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 103.504 -2.776 . . . . 0.0 103.504 178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 27.61 43.32 0.03 OUTLIER Glycine 0 C--N 1.357 1.741 0 C-N-CA 127.401 2.429 . . . . 0.0 117.355 177.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -87.8 -2.76 58.82 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.108 -1.442 . . . . 0.0 107.108 177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -105.01 131.22 52.81 Favored 'General case' 0 C--N 1.354 0.785 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.485 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.07 169.74 8.53 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 101.287 -3.597 . . . . 0.0 101.287 178.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 2.8 t -136.92 159.41 36.96 Favored 'Isoleucine or valine' 0 C--N 1.344 0.363 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.601 ' CD2' H111 ' A' ' 139' ' ' DBI . 11.5 m-85 -99.46 161.39 24.74 Favored Pre-proline 0 N--CA 1.447 -0.615 0 N-CA-C 104.801 -2.296 . . . . 0.0 104.801 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -67.53 158.1 58.67 Favored 'Trans proline' 0 C--N 1.368 1.559 0 N-CA-C 106.873 -2.01 . . . . 0.0 106.873 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.37 122.35 9.13 Favored 'Trans proline' 0 C--N 1.37 1.706 0 N-CA-C 104.81 -2.804 . . . . 0.0 104.81 179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 100.76 140.88 11.57 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 105.905 -2.878 . . . . 0.0 105.905 -177.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 10.4 t -75.34 162.05 28.74 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-O 125.422 2.535 . . . . 0.0 108.164 -178.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.3 p -167.78 113.4 0.62 Allowed Pre-proline 0 N--CA 1.427 -1.595 1 CA-C-N 106.12 -5.036 . . . . 0.0 101.019 -179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -79.01 -1.22 11.42 Favored 'Trans proline' 0 C--N 1.358 1.076 0 C-N-CA 121.234 1.289 . . . . 0.0 109.358 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -70.2 -30.28 67.35 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.15 -16.66 54.41 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.541 -178.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.47 ' C ' ' H ' ' A' ' 129' ' ' ASP . 24.1 p -79.04 -25.34 43.2 Favored 'General case' 0 C--N 1.366 1.314 0 C-N-CA 116.67 -2.012 . . . . 0.0 109.372 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.6 mt -66.52 -26.56 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 N-CA-C 104.307 -2.479 . . . . 0.0 104.307 176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.91 -3.18 56.31 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.04 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.47 ' H ' ' C ' ' A' ' 126' ' ' THR . 38.4 t0 -62.07 -52.76 62.64 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.503 ' SD ' HD12 ' A' ' 6' ' ' ILE . 36.2 mmt -87.77 -22.85 24.31 Favored 'General case' 0 C--N 1.345 0.407 0 CA-C-N 112.36 -2.2 . . . . 0.0 110.725 -177.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -86.92 -12.96 46.12 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 118.6 -1.24 . . . . 0.0 110.098 -176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -90.11 -52.9 4.72 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.485 ' HA ' HH21 ' A' ' 115' ' ' ARG . 23.1 t -69.74 -58.88 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 111.564 -2.562 . . . . 0.0 113.364 -177.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.04 -14.32 34.12 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 124.431 1.082 . . . . 0.0 109.861 -177.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -88.71 -72.59 1.28 Allowed Glycine 0 C--N 1.357 1.721 0 C-N-CA 118.542 -1.789 . . . . 0.0 111.461 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -174.12 152.01 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.677 0 CA-C-N 113.624 -1.288 . . . . 0.0 107.885 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 -179.693 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . 0.413 ' H51' ' H ' ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.601 H111 ' CD2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.694 0 N-CA-C 105.171 -2.159 . . . . 0.0 105.171 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -92.77 79.78 4.73 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 105.091 -2.189 . . . . 0.0 105.091 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -89.61 177.33 6.57 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 112.681 -2.054 . . . . 0.0 107.777 -178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.577 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -105.5 103.58 13.13 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 110.018 -3.265 . . . . 0.0 109.435 -176.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 172.3 113.87 0.01 OUTLIER 'General case' 0 C--N 1.361 1.108 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.445 ' HB ' ' CE ' ' A' ' 130' ' ' MET . 0.0 OUTLIER -148.03 110.81 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.075 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.5 p -89.88 131.23 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.031 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.833 ' CD2' ' HG ' ' A' ' 23' ' ' LEU . 1.5 tm? -125.84 130.25 51.0 Favored 'General case' 0 C--N 1.357 0.916 0 C-N-CA 117.718 -1.593 . . . . 0.0 108.174 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.31 171.39 23.72 Favored Glycine 0 C--N 1.36 1.876 0 CA-C-N 113.183 -1.826 . . . . 0.0 110.932 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.4 p -149.28 136.94 13.95 Favored 'Isoleucine or valine' 0 C--N 1.358 0.97 0 CA-C-N 114.909 -0.645 . . . . 0.0 111.009 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 4.3 tp -155.01 88.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 115.448 -2.501 . . . . 0.0 110.06 -178.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 152.51 108.75 0.38 Allowed Glycine 0 C--N 1.352 1.439 0 N-CA-C 106.636 -2.585 . . . . 0.0 106.636 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 31.3 t -85.97 159.63 19.57 Favored 'General case' 0 C--N 1.359 0.995 0 CA-C-O 123.798 1.761 . . . . 0.0 109.52 -174.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -174.38 56.28 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 109.04 -3.709 . . . . 0.0 103.199 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.9 m 86.79 -56.25 0.05 Allowed 'General case' 0 C--N 1.363 1.17 0 CA-C-N 113.502 -1.681 . . . . 0.0 107.057 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -135.44 -36.27 0.79 Allowed 'General case' 0 C--N 1.357 0.929 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 101.05 -11.67 0.03 OUTLIER 'General case' 0 C--N 1.358 0.936 0 O-C-N 125.9 2.0 . . . . 0.0 107.045 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.921 ' HB ' ' HB ' ' A' ' 121' ' ' THR 0.312 3.3 m 68.18 16.16 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.422 0 O-C-N 124.311 1.007 . . . . 0.0 110.757 -178.17 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -91.53 -40.67 5.31 Favored Glycine 0 C--N 1.354 1.536 0 CA-C-O 123.076 1.375 . . . . 0.0 110.255 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -46.35 -54.52 8.85 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 111.479 -2.361 . . . . 0.0 106.03 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.411 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -14.83 57.78 0.0 OUTLIER 'General case' 0 C--N 1.38 1.914 2 C-N-CA 140.008 7.323 . . . . 0.0 108.515 177.987 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.286 0.0 OUTLIER 31.54 52.96 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.342 2 CA-C-N 105.157 -5.474 . . . . 0.0 108.155 -178.367 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.833 ' HG ' ' CD2' ' A' ' 8' ' ' LEU . 0.1 OUTLIER -72.27 -25.91 61.78 Favored 'General case' 0 CA--C 1.558 1.285 0 N-CA-C 103.019 -2.956 . . . . 0.0 103.019 173.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -67.93 -15.83 63.79 Favored 'General case' 0 CA--C 1.565 1.532 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 175.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.614 ' HB2' HG22 ' A' ' 22' ' ' ILE . 14.6 t-80 -72.88 -27.29 61.81 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 178.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 p -50.88 -44.16 59.72 Favored 'General case' 0 C--N 1.352 0.686 0 O-C-N 125.492 1.745 . . . . 0.0 109.422 -179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.7 -47.23 80.39 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 112.746 -2.024 . . . . 0.0 109.694 -179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -17.15 61.34 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 111.828 -2.442 . . . . 0.0 113.039 -176.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.3 -18.95 60.64 Favored 'General case' 0 N--CA 1.436 -1.128 0 C-N-CA 128.372 2.669 . . . . 0.0 109.773 -176.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.43 11.93 2.76 Favored 'General case' 0 N--CA 1.437 -1.12 0 O-C-N 124.598 1.186 . . . . 0.0 107.936 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.74 25.79 52.41 Favored Glycine 0 C--N 1.356 1.671 0 O-C-N 124.271 0.982 . . . . 0.0 112.922 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -99.78 145.49 27.64 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 29.9 m-20 -69.33 137.62 53.09 Favored 'General case' 0 C--N 1.349 0.567 0 CA-C-N 111.846 -2.434 . . . . 0.0 108.099 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.9 p -102.82 172.38 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.504 0 CA-C-N 112.117 -2.311 . . . . 0.0 108.886 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.5 t -139.97 73.83 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 CA-C-N 108.786 -3.825 . . . . 0.0 103.71 176.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -70.11 118.45 12.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 104.275 -2.491 . . . . 0.0 104.275 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.453 HG23 ' H ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -89.66 -90.14 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.713 0 N-CA-C 104.894 -2.262 . . . . 0.0 104.894 -177.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' H ' HG23 ' A' ' 37' ' ' ILE . . . 176.8 -112.26 0.38 Allowed Glycine 0 C--N 1.343 0.928 0 N-CA-C 108.117 -1.993 . . . . 0.0 108.117 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -54.59 7.67 Favored 'Isoleucine or valine' 0 C--N 1.349 0.578 0 CA-C-N 112.735 -1.733 . . . . 0.0 109.055 179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.0 mt -83.73 153.43 24.16 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 113.526 -1.67 . . . . 0.0 106.576 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.0 t -153.35 59.24 0.76 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 101.101 -3.666 . . . . 0.0 101.101 178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -49.84 158.53 0.48 Allowed 'General case' 0 C--N 1.359 0.99 0 CA-C-N 110.284 -3.144 . . . . 0.0 108.921 -177.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tp-100 -82.81 -89.24 0.09 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 112.107 -2.315 . . . . 0.0 108.645 -177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.78 -15.6 31.43 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 124.736 1.272 . . . . 0.0 112.247 -176.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -90.09 -39.15 13.07 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 118.178 -1.409 . . . . 0.0 107.342 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -81.69 -9.99 59.5 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 117.641 -1.624 . . . . 0.0 109.166 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -79.23 -28.11 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -75.66 -28.06 58.58 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.79 2.29 56.18 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.05 -15.94 30.76 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -80.22 -38.5 18.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 N-CA-C 104.324 -2.472 . . . . 0.0 104.324 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -62.58 -71.81 0.15 Allowed 'General case' 0 C--N 1.354 0.761 0 CA-C-N 112.24 -2.255 . . . . 0.0 111.087 -178.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.1 p -74.59 -38.63 62.57 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 123.845 0.716 . . . . 0.0 110.629 -175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.5 ttmp? 98.28 41.65 0.0 OUTLIER 'General case' 0 C--N 1.346 0.427 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -53.49 126.06 20.19 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 114.342 -1.299 . . . . 0.0 109.266 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -106.08 -79.5 0.56 Allowed 'General case' 0 C--N 1.359 0.989 0 O-C-N 125.337 1.648 . . . . 0.0 106.558 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 20.3 tp -81.45 114.21 20.04 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.894 -1.521 . . . . 0.0 106.894 -178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.9 mm -100.91 123.75 54.1 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 104.971 -2.233 . . . . 0.0 104.971 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 71.6 m -145.47 145.66 31.18 Favored 'General case' 0 C--N 1.359 1.004 0 CA-C-O 123.836 1.779 . . . . 0.0 107.932 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -140.28 178.31 3.42 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 110.343 -3.117 . . . . 0.0 105.042 177.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.465 ' HA ' ' H4 ' ' A' ' 139' ' ' DBI . 0.0 OUTLIER -140.32 103.75 4.64 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 117.218 -1.793 . . . . 0.0 107.298 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 m 177.78 173.95 0.54 Allowed 'General case' 0 C--N 1.359 1.017 0 O-C-N 126.412 2.32 . . . . 0.0 106.057 178.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 96.4 mt -81.09 -147.07 0.06 Allowed 'General case' 0 C--N 1.357 0.902 0 CA-C-N 111.637 -2.529 . . . . 0.0 104.782 178.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -83.42 92.91 7.67 Favored 'General case' 0 C--N 1.36 1.064 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -118.95 -29.43 1.82 Allowed Glycine 0 CA--C 1.535 1.321 0 CA-C-N 111.419 -2.628 . . . . 0.0 108.77 178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -86.24 -24.73 25.9 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-N 112.589 -1.806 . . . . 0.0 107.28 179.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 86.56 178.99 49.36 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-N 113.983 -1.462 . . . . 0.0 111.745 179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -80.04 -12.97 59.65 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 111.853 -2.174 . . . . 0.0 108.246 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 1.2 mm -76.6 -49.21 24.73 Favored 'Isoleucine or valine' 0 C--N 1.354 0.783 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -72.82 -16.83 61.6 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 114.002 -1.454 . . . . 0.0 107.687 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . 0.466 ' HG ' ' HD2' ' A' ' 108' ' ' PHE . 8.8 t -72.14 -42.23 66.23 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 104.837 -2.283 . . . . 0.0 104.837 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.6 mtmm -90.09 20.07 4.55 Favored 'General case' 0 C--N 1.363 1.179 0 O-C-N 124.672 1.232 . . . . 0.0 108.953 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -97.03 -34.24 5.74 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.355 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 25.1 mt -89.28 -23.47 22.3 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 113.04 -1.58 . . . . 0.0 106.845 179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.25 -26.92 56.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 178.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -81.04 -24.12 38.08 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-N 113.968 -1.469 . . . . 0.0 107.512 179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.0 tttp -76.55 -17.77 59.04 Favored 'General case' 0 CA--C 1.551 1.016 0 O-C-N 124.113 0.883 . . . . 0.0 108.712 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 86' ' ' ILE . 68.1 m -90.23 -43.9 10.09 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 123.875 1.798 . . . . 0.0 107.345 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -75.45 -0.92 21.73 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 108.701 -3.863 . . . . 0.0 108.624 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -80.12 -53.6 6.54 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 104.005 -2.591 . . . . 0.0 104.005 177.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.65 41.7 11.86 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 110.855 -2.884 . . . . 0.0 107.303 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.44 -47.2 0.03 OUTLIER Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.453 -2.158 . . . . 0.0 107.795 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.7 mt -88.51 118.26 28.03 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.75 111.89 14.03 Favored 'General case' 0 C--N 1.346 0.431 0 CA-C-N 112.362 -2.199 . . . . 0.0 106.144 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 176.37 59.26 0.06 OUTLIER Glycine 0 C--N 1.348 1.22 0 CA-C-N 113.398 -1.728 . . . . 0.0 111.067 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.407 ' HA ' ' SG ' ' A' ' 78' ' ' CYS . 1.8 mt -91.15 0.75 8.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.665 0 CA-C-N 112.29 -1.955 . . . . 0.0 106.973 178.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -112.83 117.69 32.85 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.16 121.89 15.36 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 115' ' ' ARG . 0.1 OUTLIER -104.77 117.23 33.55 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 101.414 -3.55 . . . . 0.0 101.414 178.578 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 115' ' ' ARG . 88.1 t -89.73 89.32 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 CA-C-N 110.827 -2.897 . . . . 0.0 108.491 -175.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.509 ' HA3' H101 ' A' ' 139' ' ' DBI . . . -69.13 108.39 2.45 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 109.52 -3.491 . . . . 0.0 109.417 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 70.66 -122.74 10.71 Favored Glycine 0 C--N 1.354 1.531 0 N-CA-C 106.773 -2.531 . . . . 0.0 106.773 -178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 40.4 t30 68.97 145.99 0.05 Allowed 'General case' 0 C--N 1.353 0.742 0 O-C-N 125.397 1.293 . . . . 0.0 108.269 177.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 55.95 81.76 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.351 0.655 0 CA-C-N 112.31 -2.223 . . . . 0.0 107.614 177.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -64.54 155.64 6.13 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-N 112.537 -2.12 . . . . 0.0 108.538 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 8.3 p 46.07 51.8 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 CA-C-N 112.83 -1.987 . . . . 0.0 111.829 -179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -162.83 138.34 5.29 Favored Glycine 0 C--N 1.351 1.374 0 CA-C-N 112.101 -2.318 . . . . 0.0 109.163 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.9 ttpp -167.24 140.3 3.5 Favored 'General case' 0 C--N 1.35 0.62 0 N-CA-C 104.863 -2.273 . . . . 0.0 104.863 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 79.08 -81.47 0.03 OUTLIER 'General case' 0 C--N 1.355 0.846 0 O-C-N 125.966 2.041 . . . . 0.0 105.878 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -87.11 114.99 24.2 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 104.427 -2.434 . . . . 0.0 104.427 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.7 m95 -95.15 161.91 26.58 Favored Pre-proline 0 C--N 1.349 0.562 0 CA-C-N 112.861 -1.972 . . . . 0.0 105.738 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.79 -150.09 0.02 OUTLIER 'Trans proline' 0 C--N 1.37 1.682 0 C-N-CA 121.927 1.751 . . . . 0.0 108.904 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.66 -25.75 62.25 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 113.073 -1.876 . . . . 0.0 108.19 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.449 HG23 ' H ' ' A' ' 105' ' ' GLU 0.272 0.1 OUTLIER -54.8 -67.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 0 O-C-N 124.886 1.366 . . . . 0.0 110.457 -179.429 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.449 ' H ' HG23 ' A' ' 104' ' ' VAL . 3.5 mm-40 -90.24 20.31 4.48 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 117.951 -1.499 . . . . 0.0 109.149 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -66.39 -51.78 53.5 Favored 'General case' 0 C--N 1.351 0.671 0 N-CA-C 104.228 -2.508 . . . . 0.0 104.228 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -90.28 -15.59 30.97 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 111.842 -2.435 . . . . 0.0 110.092 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.466 ' HD2' ' HG ' ' A' ' 71' ' ' CYS . 4.1 m-30 -89.5 -45.42 9.43 Favored 'General case' 0 C--N 1.366 1.299 0 C-N-CA 117.802 -1.559 . . . . 0.0 108.714 -178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 18.8 mmtt -77.75 -2.11 34.65 Favored 'General case' 0 C--N 1.35 0.595 0 O-C-N 124.723 1.264 . . . . 0.0 107.783 179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.9 -36.53 77.18 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 5.1 mpp? -83.97 -53.95 5.2 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.26 -2.496 . . . . 0.0 104.26 176.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.97 40.51 58.2 Favored Glycine 0 C--N 1.362 1.996 0 O-C-N 124.677 1.236 . . . . 0.0 116.065 178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -6.92 59.43 Favored 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 177.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.09 137.8 42.28 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.065 -2.198 . . . . 0.0 105.065 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.442 ' O ' HG23 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -110.35 173.63 6.24 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 179.083 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.7 m -140.12 160.01 26.07 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -99.61 160.54 27.12 Favored Pre-proline 0 C--N 1.355 0.82 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -73.19 149.01 45.15 Favored 'Trans proline' 0 C--N 1.366 1.46 0 N-CA-C 104.412 -2.957 . . . . 0.0 104.412 179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -73.26 110.05 2.97 Favored 'Trans proline' 0 C--N 1.366 1.489 0 N-CA-C 104.812 -2.803 . . . . 0.0 104.812 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 141.41 158.65 7.62 Favored Glycine 0 C--N 1.345 1.082 0 CA-C-N 111.723 -2.489 . . . . 0.0 108.716 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.921 ' HB ' ' HB ' ' A' ' 18' ' ' VAL . 0.1 OUTLIER -73.63 143.44 46.31 Favored 'General case' 0 C--N 1.348 0.519 0 CA-C-N 112.743 -1.729 . . . . 0.0 106.718 -179.714 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 59.4 p 174.0 100.37 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.646 0 CA-C-N 110.763 -2.926 . . . . 0.0 106.41 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -76.29 -2.87 13.13 Favored 'Trans proline' 0 C--N 1.372 1.774 0 C-N-CA 121.861 1.707 . . . . 0.0 108.155 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -64.96 -37.9 89.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.352 1.861 . . . . 0.0 107.757 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.82 -21.42 57.32 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 113.438 -1.71 . . . . 0.0 107.928 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.486 ' C ' ' H ' ' A' ' 129' ' ' ASP . 2.3 p -80.65 -17.22 51.89 Favored 'General case' 0 C--N 1.365 1.258 0 C-N-CA 117.183 -1.807 . . . . 0.0 110.517 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.8 mt -67.9 -31.53 52.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 N-CA-C 103.592 -2.744 . . . . 0.0 103.592 176.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.12 2.66 55.05 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-N 112.413 -2.176 . . . . 0.0 108.763 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.574 ' O ' HG23 ' A' ' 133' ' ' VAL . 61.0 t0 -60.29 -61.69 2.42 Favored 'General case' 0 C--N 1.363 1.182 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.445 ' CE ' ' HB ' ' A' ' 6' ' ' ILE . 11.1 mmm -90.1 -15.5 31.55 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 110.999 -2.818 . . . . 0.0 111.57 -175.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -87.52 -13.32 43.35 Favored 'General case' 0 C--N 1.352 0.689 0 C-N-CA 118.026 -1.469 . . . . 0.0 108.801 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 67.6 tt0 -90.35 -56.59 3.15 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.574 HG23 ' O ' ' A' ' 129' ' ' ASP . 2.5 t -57.56 -51.58 68.07 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-N 112.077 -2.329 . . . . 0.0 114.0 -177.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.4 mp -89.66 -35.93 15.54 Favored 'General case' 0 C--N 1.35 0.606 0 O-C-N 124.343 1.027 . . . . 0.0 108.604 -177.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -66.67 -74.8 0.51 Allowed Glycine 0 C--N 1.354 1.575 0 C-N-CA 119.028 -1.558 . . . . 0.0 112.772 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -167.39 148.06 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.694 0 CA-C-O 122.425 1.107 . . . . 0.0 109.033 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 . . . . . 0 CA--C 1.545 0.759 0 CA-C-N 111.468 -2.606 . . . . 0.0 107.946 179.688 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.509 H101 ' HA3' ' A' ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.6 ttp . . . . . 0 N--CA 1.445 -0.676 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -127.26 79.95 1.92 Allowed 'General case' 0 C--N 1.352 0.678 0 N-CA-C 104.055 -2.572 . . . . 0.0 104.055 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -74.91 -176.9 3.08 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 111.862 -2.426 . . . . 0.0 107.969 -179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -120.43 63.81 0.84 Allowed 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 110.809 -2.905 . . . . 0.0 108.442 -178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 40.2 p -149.54 106.42 3.56 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 176.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.487 ' CD1' HD21 ' A' ' 57' ' ' LEU . 4.0 mm -121.87 125.72 73.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 109.772 -3.377 . . . . 0.0 102.641 -177.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.2 OUTLIER -127.86 134.05 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 124.766 1.291 . . . . 0.0 109.278 -179.108 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.18 138.74 54.13 Favored 'General case' 0 C--N 1.36 1.042 0 CA-C-N 113.237 -1.801 . . . . 0.0 107.489 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -128.13 164.5 21.41 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 111.322 -2.672 . . . . 0.0 107.844 178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -160.5 119.07 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 118.012 -1.475 . . . . 0.0 110.866 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 65' ' ' GLY . 1.9 tp -112.48 179.32 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.949 0 N-CA-C 102.151 -3.277 . . . . 0.0 102.151 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.572 ' H ' HD12 ' A' ' 11' ' ' ILE . . . 92.14 98.73 1.35 Allowed Glycine 0 C--N 1.35 1.32 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -179.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m -80.95 0.05 37.18 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 112.213 -1.993 . . . . 0.0 109.301 -177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -74.0 118.77 17.34 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 30.4 m 85.77 -70.81 0.03 OUTLIER 'General case' 0 C--N 1.359 0.99 0 O-C-N 125.585 1.803 . . . . 0.0 106.777 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -157.39 -69.75 0.1 Allowed 'General case' 0 C--N 1.365 1.276 0 C-N-CA 115.791 -2.363 . . . . 0.0 106.827 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 127.19 36.24 0.0 OUTLIER 'General case' 0 C--N 1.346 0.447 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.4 p -73.21 111.54 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-N 114.449 -1.25 . . . . 0.0 110.383 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.61 11.61 62.97 Favored Glycine 0 C--N 1.359 1.826 0 CA-C-O 123.425 1.57 . . . . 0.0 112.491 179.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' O ' ' N ' ' A' ' 22' ' ' ILE . 3.6 m-20 -44.95 -63.07 1.0 Allowed 'General case' 0 C--N 1.36 1.06 0 N-CA-C 103.721 -2.696 . . . . 0.0 103.721 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.6 mmtp 10.26 38.41 0.0 OUTLIER 'General case' 0 C--N 1.378 1.826 2 C-N-CA 138.349 6.66 . . . . 0.0 109.472 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.438 ' N ' ' O ' ' A' ' 20' ' ' ASN 0.412 42.0 pt 33.91 46.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.404 -2.753 1 C-N-CA 132.228 4.211 . . . . 0.0 107.976 -176.034 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.548 HD21 H103 ' A' ' 139' ' ' DBI . 4.7 mt -74.38 -42.27 59.56 Favored 'General case' 0 C--N 1.373 1.604 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 175.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -73.81 -0.58 16.27 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-N 112.191 -2.277 . . . . 0.0 108.44 178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 24.9 t60 -79.23 -43.72 23.23 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 117.679 -1.608 . . . . 0.0 107.885 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.3 t -67.41 -19.78 65.44 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.684 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.851 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -64.3 -43.98 93.05 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -70.3 -28.18 64.98 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 110.708 -2.951 . . . . 0.0 111.985 -176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -87.57 2.71 50.05 Favored 'General case' 0 N--CA 1.437 -1.095 0 CA-C-N 111.836 -2.438 . . . . 0.0 108.823 -177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.28 4.98 5.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.49 30.38 61.88 Favored Glycine 0 C--N 1.361 1.942 0 O-C-N 124.306 1.004 . . . . 0.0 112.251 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -103.36 -175.58 2.84 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -106.93 150.73 26.14 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.851 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 2.2 p -99.93 146.21 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 111.047 -2.797 . . . . 0.0 108.115 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 6' ' ' ILE . 86.9 t -140.04 82.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 CA-C-N 111.317 -2.674 . . . . 0.0 105.333 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -87.83 123.95 33.14 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 105.631 -1.988 . . . . 0.0 105.631 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.96 -93.67 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.806 0 CA-C-N 112.848 -1.978 . . . . 0.0 105.866 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.55 -120.76 0.58 Allowed Glycine 0 C--N 1.35 1.308 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.56 10.95 2.1 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 CA-C-N 113.277 -1.461 . . . . 0.0 110.405 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 61.1 tp -87.22 129.45 34.96 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -178.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.9 t -98.51 41.42 1.14 Allowed 'General case' 0 C--N 1.357 0.914 0 CA-C-N 113.072 -1.876 . . . . 0.0 107.415 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 60.9 p -90.11 80.21 6.35 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 103.294 -2.854 . . . . 0.0 103.294 178.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.423 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.5 tp-100 -78.32 -36.75 46.0 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 112.309 -2.223 . . . . 0.0 108.573 -177.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.34 -35.64 79.79 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.312 1.007 . . . . 0.0 108.619 -178.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -79.82 -24.8 41.13 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -81.2 -10.17 59.66 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.73 -33.93 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 N-CA-C 105.604 -1.999 . . . . 0.0 105.604 178.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -74.15 -31.52 62.76 Favored 'General case' 0 C--N 1.359 0.98 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.368 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.61 -0.5 57.33 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.12 -13.92 34.76 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.0 mt -79.88 -41.88 21.87 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 177.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -59.75 -60.49 3.75 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 112.263 -2.244 . . . . 0.0 108.229 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.418 ' CG2' HG21 ' A' ' 35' ' ' VAL . 16.7 m -60.32 -66.44 0.52 Allowed 'General case' 0 C--N 1.352 0.714 0 CA-C-N 113.454 -1.703 . . . . 0.0 107.819 -178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tptt 102.74 35.76 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 O-C-N 126.782 2.552 . . . . 0.0 104.294 -177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -44.8 107.88 0.1 Allowed 'General case' 0 C--N 1.364 1.207 0 C-N-CA 128.457 2.703 . . . . 0.0 109.222 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -88.88 -42.28 11.95 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.487 HD21 ' CD1' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -144.43 144.5 31.43 Favored 'General case' 0 C--N 1.358 0.975 0 C-N-CA 117.548 -1.661 . . . . 0.0 107.113 179.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -131.05 146.96 33.1 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 CA-C-N 110.71 -2.95 . . . . 0.0 105.254 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 9.0 t -150.5 125.88 10.11 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.612 -1.995 . . . . 0.0 105.612 -179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.3 p -99.85 -178.04 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.852 0 CA-C-N 114.671 -1.15 . . . . 0.0 108.037 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.74 97.12 3.57 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 112.765 -2.016 . . . . 0.0 106.043 178.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 5.6 p 155.93 152.6 0.01 OUTLIER 'General case' 0 C--N 1.356 0.876 0 CA-C-N 112.681 -2.054 . . . . 0.0 106.98 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 ' H ' ' H51' ' A' ' 138' ' ' FOP . 43.9 mt -65.84 -110.63 0.0 OUTLIER 'General case' 0 C--N 1.36 1.032 0 CA-C-N 111.884 -2.416 . . . . 0.0 105.105 178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -95.94 68.47 2.76 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.663 ' O ' ' HB ' ' A' ' 11' ' ' ILE . . . -131.73 55.68 0.76 Allowed Glycine 0 C--N 1.345 1.066 0 CA-C-N 109.63 -3.441 . . . . 0.0 105.016 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.431 ' H ' ' H ' ' A' ' 67' ' ' GLY . 20.0 pt20 -167.14 -28.12 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 111.044 -2.578 . . . . 0.0 106.977 -179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 74.54 -177.21 47.1 Favored Glycine 0 C--N 1.348 1.249 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.029 178.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -76.61 -3.41 37.55 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 111.35 -2.425 . . . . 0.0 108.376 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 69' ' ' ILE . 0.1 OUTLIER -71.55 -53.31 21.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.0 -22.13 59.72 Favored 'General case' 0 C--N 1.35 0.601 0 CA-C-N 112.561 -2.109 . . . . 0.0 109.111 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 72.5 m -68.67 -64.24 0.9 Allowed 'General case' 0 C--N 1.356 0.884 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 33.2 mtmm -90.15 27.99 1.51 Allowed 'General case' 0 C--N 1.355 0.807 0 O-C-N 124.717 1.26 . . . . 0.0 109.798 -178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.63 -40.68 3.81 Favored Glycine 0 C--N 1.34 0.752 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.423 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.7 mt -88.58 -22.77 23.35 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 111.92 -2.14 . . . . 0.0 108.517 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.9 mmt85 -78.71 -26.98 44.9 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -79.62 -26.74 41.1 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -75.98 -16.75 59.93 Favored 'General case' 0 C--N 1.358 0.957 0 O-C-N 124.123 0.889 . . . . 0.0 109.227 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 42.3 t -90.21 -46.26 8.55 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 123.948 1.832 . . . . 0.0 107.319 -178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -71.15 -4.94 28.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 108.536 -3.938 . . . . 0.0 109.002 178.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -80.22 -56.29 4.32 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 63.0 47.81 4.11 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 110.881 -2.872 . . . . 0.0 106.527 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.54 -42.14 0.02 OUTLIER Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.654 -2.067 . . . . 0.0 109.9 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 18.3 mt -80.34 122.94 27.55 Favored 'General case' 0 C--N 1.353 0.724 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.89 128.3 34.8 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.26 113.6 1.55 Allowed Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.221 -2.263 . . . . 0.0 108.835 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 tt -146.41 35.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 106.449 -1.685 . . . . 0.0 106.449 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mmtm -141.15 112.98 7.72 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 103.527 -2.768 . . . . 0.0 103.527 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.52 106.39 8.49 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.78 85.39 3.09 Favored 'General case' 0 C--N 1.347 0.5 0 N-CA-C 100.613 -3.847 . . . . 0.0 100.613 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.26 101.5 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-O 126.221 2.915 . . . . 0.0 110.085 -175.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.27 116.55 4.77 Favored Glycine 0 C--N 1.343 0.961 1 CA-C-N 108.239 -4.073 . . . . 0.0 108.489 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.64 -84.91 0.44 Allowed Glycine 0 C--N 1.347 1.159 0 N-CA-C 105.738 -2.945 . . . . 0.0 105.738 -176.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.7 t30 72.24 -84.34 0.03 OUTLIER 'General case' 0 C--N 1.357 0.935 0 CA-C-N 112.879 -1.66 . . . . 0.0 107.681 177.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.519 ' HB ' ' CE2' ' A' ' 64' ' ' TYR . 0.0 OUTLIER -140.37 135.05 35.7 Favored 'Isoleucine or valine' 0 C--N 1.347 0.492 0 N-CA-C 102.996 -2.964 . . . . 0.0 102.996 179.5 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 t -65.34 158.06 4.9 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 113.035 -1.893 . . . . 0.0 109.57 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 42.68 75.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.757 0 CA-C-N 112.172 -2.286 . . . . 0.0 112.47 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 173.2 135.14 1.94 Allowed Glycine 0 C--N 1.348 1.239 0 CA-C-N 112.119 -2.31 . . . . 0.0 109.196 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.6 ttpp -174.16 110.73 0.16 Allowed 'General case' 0 C--N 1.349 0.554 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 91.45 -61.27 0.01 OUTLIER 'General case' 0 C--N 1.355 0.841 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -94.14 135.73 35.19 Favored 'General case' 0 C--N 1.35 0.602 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -143.06 162.94 40.73 Favored Pre-proline 0 C--N 1.35 0.605 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -71.27 -150.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.843 0 N-CA-C 107.478 -1.778 . . . . 0.0 107.478 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -70.11 -22.26 63.03 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 113.59 -1.641 . . . . 0.0 109.216 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.533 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.3 p -58.13 -69.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.784 0 O-C-N 124.483 1.114 . . . . 0.0 111.214 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.533 ' H ' HG13 ' A' ' 104' ' ' VAL . 15.3 mm-40 -90.17 24.92 2.33 Favored 'General case' 0 C--N 1.353 0.751 0 C-N-CA 117.501 -1.68 . . . . 0.0 108.209 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -77.32 -41.03 42.13 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 104.616 -2.365 . . . . 0.0 104.616 176.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.2 ptm180 -79.43 -32.55 42.84 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 112.472 -2.149 . . . . 0.0 106.41 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -92.78 16.68 11.82 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 118.152 -1.419 . . . . 0.0 108.678 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -39.82 12.33 Favored 'General case' 0 C--N 1.361 1.096 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.46 -35.29 75.5 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 112.485 -2.143 . . . . 0.0 107.028 179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.8 mtp -78.96 -60.77 2.25 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.324 -2.843 . . . . 0.0 103.324 177.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 30.32 37.34 0.02 OUTLIER Glycine 0 C--N 1.356 1.643 0 C-N-CA 128.056 2.741 . . . . 0.0 117.642 177.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -89.73 -0.23 57.41 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.18 134.51 48.17 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.471 HH21 ' HA ' ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.23 176.54 5.01 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 104.129 -2.545 . . . . 0.0 104.129 178.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 17.3 m -140.01 161.61 25.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 114.548 -1.206 . . . . 0.0 109.792 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.609 ' CD2' H102 ' A' ' 139' ' ' DBI . 5.6 m-85 -99.88 154.9 37.0 Favored Pre-proline 0 C--N 1.355 0.842 0 CA-C-N 111.405 -2.634 . . . . 0.0 104.964 178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.49 162.21 38.53 Favored 'Trans proline' 0 C--N 1.368 1.604 0 N-CA-C 106.84 -2.023 . . . . 0.0 106.84 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -72.53 124.9 10.18 Favored 'Trans proline' 0 C--N 1.368 1.597 0 N-CA-C 105.201 -2.653 . . . . 0.0 105.201 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 102.13 137.05 9.46 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 106.548 -2.621 . . . . 0.0 106.548 -178.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 15.2 t -73.85 154.34 39.51 Favored 'General case' 0 C--N 1.357 0.901 0 CA-C-O 125.584 2.612 . . . . 0.0 107.492 -178.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 p -166.11 108.67 0.71 Allowed Pre-proline 0 N--CA 1.426 -1.642 1 CA-C-N 105.819 -5.173 . . . . 0.0 100.362 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -78.61 0.31 10.07 Favored 'Trans proline' 0 N--CA 1.449 -1.128 0 N-CA-C 108.918 -1.224 . . . . 0.0 108.918 -178.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -66.3 -38.35 87.53 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 125.945 1.698 . . . . 0.0 107.631 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.66 -24.29 59.96 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.985 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.7 p -84.64 -19.84 32.28 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 117.673 -1.611 . . . . 0.0 110.957 -177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.8 mt -64.69 -30.17 49.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.013 0 N-CA-C 104.595 -2.372 . . . . 0.0 104.595 177.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -81.49 -7.65 59.61 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 111.712 -2.495 . . . . 0.0 108.798 178.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 126' ' ' THR . 25.4 t0 -53.7 -72.34 0.06 Allowed 'General case' 0 C--N 1.356 0.855 0 CA-C-O 122.116 0.96 . . . . 0.0 108.72 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.403 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 4.9 mmt -86.67 -6.07 58.95 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 112.302 -2.226 . . . . 0.0 110.336 -176.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.14 -66.01 0.96 Allowed 'General case' 0 C--N 1.355 0.836 0 C-N-CA 118.84 -1.144 . . . . 0.0 108.834 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -48.02 -44.69 31.19 Favored 'General case' 0 C--N 1.356 0.861 0 C-N-CA 124.34 1.056 . . . . 0.0 111.021 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.502 HG12 HD23 ' A' ' 134' ' ' LEU . 25.6 t -65.37 -65.57 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 114.093 -1.412 . . . . 0.0 111.243 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.502 HD23 HG12 ' A' ' 133' ' ' VAL . 49.8 mt -90.52 55.76 3.11 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -158.65 -83.59 0.05 OUTLIER Glycine 0 C--N 1.35 1.318 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 178.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -164.24 152.94 2.51 Favored 'Isoleucine or valine' 0 C--N 1.349 0.577 0 CA-C-N 113.272 -1.464 . . . . 0.0 107.862 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 . . . . . 0 C--N 1.346 0.445 0 N-CA-C 105.352 -2.092 . . . . 0.0 105.352 -179.554 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . 0.443 ' H51' ' H ' ' A' ' 63' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.609 H102 ' CD2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 ttt . . . . . 0 N--CA 1.445 -0.699 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -90.49 77.01 6.55 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 -179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 5.2 tttm -73.05 -162.43 0.11 Allowed 'General case' 0 N--CA 1.435 -1.206 0 CA-C-N 111.689 -2.505 . . . . 0.0 107.505 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -149.69 99.74 2.9 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 113.188 -1.824 . . . . 0.0 106.253 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 175.62 100.33 0.01 OUTLIER 'General case' 0 C--N 1.355 0.845 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -123.8 116.43 48.07 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 178.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.677 HG23 HG12 ' A' ' 35' ' ' VAL . 5.8 p -107.43 112.25 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.97 0 CA-C-N 111.621 -2.536 . . . . 0.0 109.113 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.1 tp -109.16 134.44 51.72 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.449 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.86 168.03 31.18 Favored Glycine 0 C--N 1.353 1.488 0 CA-C-N 112.849 -1.978 . . . . 0.0 109.734 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.81 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 167.57 -121.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.374 1.662 0 N-CA-C 117.492 2.404 . . . . 0.0 117.492 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.704 HG22 HG22 ' A' ' 10' ' ' VAL . 0.7 OUTLIER -142.92 -168.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.384 2.094 0 CA-C-N 113.914 -1.494 . . . . 0.0 107.221 -177.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 176.82 162.34 27.2 Favored Glycine 0 C--N 1.364 2.103 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.156 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.4 p -105.97 -24.51 12.4 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 110.755 -2.722 . . . . 0.0 107.618 -178.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -134.56 156.4 48.74 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 72.7 m -99.66 58.06 1.04 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -173.36 131.92 0.47 Allowed 'General case' 0 C--N 1.365 1.243 0 C-N-CA 116.988 -1.885 . . . . 0.0 107.509 -177.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 22.11 63.36 0.03 OUTLIER 'General case' 0 C--N 1.354 0.796 0 C-N-CA 131.344 3.858 . . . . 0.0 111.278 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -114.4 66.5 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.628 177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.08 -34.57 3.21 Favored Glycine 0 CA--C 1.54 1.649 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.832 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 17.9 t30 -39.21 -48.33 1.75 Allowed 'General case' 0 C--N 1.361 1.078 0 CA-C-N 112.285 -1.958 . . . . 0.0 106.559 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.2 mtmm -5.81 50.11 0.0 OUTLIER 'General case' 0 C--N 1.392 2.423 2 C-N-CA 140.728 7.611 . . . . 0.0 108.365 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.521 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.328 0.0 OUTLIER 34.67 54.05 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.407 -2.605 1 CA-C-N 106.871 -4.695 . . . . 0.0 106.437 -175.847 . . . . . . . . 5 4 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.55 HD23 H103 ' A' ' 139' ' ' DBI . 0.2 OUTLIER -66.9 -21.78 65.99 Favored 'General case' 0 C--N 1.377 1.773 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 173.558 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.402 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.7 OUTLIER -67.57 -20.47 65.39 Favored 'General case' 0 CA--C 1.566 1.595 0 C-N-CA 116.514 -2.075 . . . . 0.0 107.299 176.284 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.521 ' HB2' HG22 ' A' ' 22' ' ' ILE . 7.9 t60 -66.02 -29.96 70.41 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.436 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 37.0 t -67.19 -18.38 65.23 Favored 'General case' 0 C--N 1.349 0.555 0 CA-C-N 113.289 -1.778 . . . . 0.0 109.608 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.99 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -56.73 -47.1 80.76 Favored 'General case' 0 C--N 1.361 1.069 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -31.07 69.11 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 110.482 -3.054 . . . . 0.0 112.763 -176.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -84.72 7.53 20.2 Favored 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 111.559 -2.564 . . . . 0.0 108.632 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -128.78 -0.99 5.39 Favored 'General case' 0 N--CA 1.431 -1.389 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 60.61 28.88 68.5 Favored Glycine 0 C--N 1.36 1.902 0 O-C-N 124.139 0.899 . . . . 0.0 111.377 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -105.38 -168.01 1.4 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 113.342 -1.429 . . . . 0.0 107.605 -178.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -93.56 149.69 21.02 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 112.695 -2.048 . . . . 0.0 108.093 -177.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.99 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.8 124.5 53.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 108.871 -3.786 . . . . 0.0 108.79 -179.168 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.677 HG12 HG23 ' A' ' 7' ' ' VAL . 2.8 t -140.33 132.93 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 CA-C-N 110.896 -2.865 . . . . 0.0 105.429 176.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -139.02 133.19 31.34 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.2 mt -109.55 -20.15 6.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 CA-C-N 113.714 -1.585 . . . . 0.0 108.567 -178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.68 -123.36 7.9 Favored Glycine 0 C--N 1.355 1.617 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 m -145.14 113.38 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.746 0 CA-C-O 122.324 1.059 . . . . 0.0 109.28 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.435 ' CG ' ' HB2' ' A' ' 42' ' ' SER . 3.7 tt -175.25 137.79 0.4 Allowed 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.736 -3.061 . . . . 0.0 102.736 179.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.6 t -94.54 39.55 1.09 Allowed 'General case' 0 C--N 1.354 0.776 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.435 ' HB2' ' CG ' ' A' ' 40' ' ' LEU . 0.3 OUTLIER -90.55 91.52 8.47 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 102.958 -2.978 . . . . 0.0 102.958 -179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -90.02 -58.54 2.47 Favored 'General case' 0 C--N 1.35 0.617 0 CA-C-N 114.655 -1.157 . . . . 0.0 108.61 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.7 pt-20 -59.93 -20.92 60.08 Favored 'General case' 0 CA--C 1.541 0.633 0 O-C-N 124.771 1.294 . . . . 0.0 112.04 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.95 -38.89 14.14 Favored 'General case' 0 C--N 1.347 0.471 0 C-N-CA 118.687 -1.205 . . . . 0.0 107.878 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.485 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 54.7 m-85 -89.15 12.65 15.2 Favored 'General case' 0 C--N 1.35 0.605 0 C-N-CA 118.671 -1.212 . . . . 0.0 108.907 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.6 OUTLIER -91.97 -34.3 6.09 Favored 'Isoleucine or valine' 0 C--N 1.358 0.967 0 N-CA-C 102.63 -3.1 . . . . 0.0 102.63 175.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -72.73 -27.93 62.34 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.485 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -84.41 -16.65 41.95 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -79.63 -7.6 58.65 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.2 -43.06 18.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 104.054 -2.573 . . . . 0.0 104.054 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -60.61 -64.0 1.1 Allowed 'General case' 0 C--N 1.354 0.802 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.492 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.01 -47.84 82.96 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -178.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.4 tttp 84.38 54.47 0.01 OUTLIER 'General case' 0 C--N 1.345 0.386 0 CA-C-N 112.022 -2.354 . . . . 0.0 105.02 -179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -68.43 124.51 23.75 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.112 -2.313 . . . . 0.0 107.489 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -84.99 -84.09 0.15 Allowed 'General case' 0 C--N 1.354 0.789 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.9 pp -98.82 145.62 26.78 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.62 142.37 43.86 Favored 'Isoleucine or valine' 0 C--N 1.351 0.649 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 51.1 m -129.56 131.92 46.69 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-N 112.18 -2.282 . . . . 0.0 105.815 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.757 HG22 HG23 ' A' ' 10' ' ' VAL . 13.1 p -116.32 133.17 63.73 Favored 'Isoleucine or valine' 0 C--N 1.351 0.664 0 CA-C-N 111.481 -2.6 . . . . 0.0 106.727 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.81 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.5 OUTLIER -110.32 90.77 3.42 Favored 'General case' 0 C--N 1.361 1.086 0 CA-C-O 123.979 1.847 . . . . 0.0 107.016 -179.45 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 31.2 t -131.12 176.93 7.84 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 111.257 -2.701 . . . . 0.0 106.544 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -148.07 52.55 1.02 Allowed 'General case' 0 N--CA 1.433 -1.324 0 CA-C-N 110.405 -3.089 . . . . 0.0 105.906 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CE2' ' HB ' ' A' ' 94' ' ' ILE . 0.1 OUTLIER 60.9 49.01 6.22 Favored 'General case' 0 C--N 1.355 0.843 0 CA-C-N 112.325 -2.216 . . . . 0.0 108.602 179.1 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.2 -0.07 5.96 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.868 178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -95.13 -2.86 49.06 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.67 177.56 8.58 Favored Glycine 0 C--N 1.356 1.658 0 O-C-N 124.35 1.031 . . . . 0.0 111.652 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -90.17 25.58 2.14 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 112.871 -1.665 . . . . 0.0 108.188 178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.93 -52.68 10.33 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.529 ' O ' HD22 ' A' ' 74' ' ' LEU . 12.6 m-20 -71.81 -26.86 62.57 Favored 'General case' 0 C--N 1.351 0.631 0 CA-C-N 112.703 -2.044 . . . . 0.0 107.26 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 17.5 t -67.78 -58.22 4.98 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 106.684 -1.599 . . . . 0.0 106.684 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.8 mtmt -90.07 30.13 1.13 Allowed 'General case' 0 C--N 1.359 0.999 0 O-C-N 124.48 1.112 . . . . 0.0 109.426 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -99.49 -37.79 3.91 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 179.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.529 HD22 ' O ' ' A' ' 70' ' ' ASP . 2.0 mm? -90.01 -23.77 21.4 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 112.692 -1.754 . . . . 0.0 107.625 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -76.36 -29.6 57.26 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 105.619 -1.993 . . . . 0.0 105.619 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -76.93 -28.21 55.15 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -74.96 -16.82 60.62 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 124.155 0.909 . . . . 0.0 109.368 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 39.8 t -90.24 -46.85 8.15 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-O 123.847 1.784 . . . . 0.0 107.518 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -75.41 2.34 11.65 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 108.715 -3.857 . . . . 0.0 109.11 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.72 -55.59 3.9 Favored 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 176.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 44.78 7.93 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 110.958 -2.837 . . . . 0.0 106.798 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.01 -43.7 0.02 OUTLIER Glycine 0 C--N 1.351 1.396 0 CA-C-N 112.788 -2.005 . . . . 0.0 109.392 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.4 mt -80.06 121.11 25.11 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.91 140.75 32.65 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 113.302 -1.772 . . . . 0.0 106.412 -179.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 121.74 71.16 0.28 Allowed Glycine 0 C--N 1.351 1.364 0 CA-C-N 112.633 -2.076 . . . . 0.0 110.24 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 tt -103.73 35.27 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.767 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 179.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -128.01 118.1 22.91 Favored 'General case' 0 C--N 1.349 0.576 0 N-CA-C 103.185 -2.894 . . . . 0.0 103.185 179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -140.29 151.93 45.47 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 112.592 -2.094 . . . . 0.0 105.73 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 106.24 5.17 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 100.654 -3.832 . . . . 0.0 100.654 177.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.87 93.58 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-O 125.114 2.388 . . . . 0.0 110.164 -175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.42 ' HA3' ' C10' ' A' ' 139' ' ' DBI . . . -63.69 118.47 13.5 Favored Glycine 0 CA--C 1.537 1.453 1 CA-C-N 107.975 -4.193 . . . . 0.0 111.137 176.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.82 -92.39 1.62 Allowed Glycine 0 C--N 1.353 1.482 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 72.75 -142.6 0.04 OUTLIER 'General case' 0 C--N 1.356 0.885 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.502 HG12 HG11 ' A' ' 104' ' ' VAL . 0.6 OUTLIER -91.68 148.71 4.44 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 N-CA-C 104.656 -2.35 . . . . 0.0 104.656 179.195 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -85.31 -164.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.557 0 CA-C-N 112.548 -2.115 . . . . 0.0 108.423 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.5 p 41.77 74.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 112.276 -2.238 . . . . 0.0 112.717 179.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 160.15 178.04 33.79 Favored Glycine 0 C--N 1.349 1.294 0 CA-C-N 112.068 -2.333 . . . . 0.0 110.009 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 65.7 tttp -159.93 -46.72 0.05 Allowed 'General case' 0 C--N 1.347 0.473 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -129.7 -44.27 1.21 Allowed 'General case' 0 C--N 1.349 0.549 0 N-CA-C 104.384 -2.45 . . . . 0.0 104.384 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -85.97 95.58 9.54 Favored 'General case' 0 C--N 1.352 0.697 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -103.0 164.24 15.93 Favored Pre-proline 0 C--N 1.35 0.624 0 CA-C-N 112.483 -2.144 . . . . 0.0 105.36 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.08 -152.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 121.784 1.656 . . . . 0.0 108.792 179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -69.33 -25.54 64.26 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 113.431 -1.713 . . . . 0.0 108.456 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.675 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.0 p -53.53 -74.66 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.88 0 O-C-N 124.912 1.382 . . . . 0.0 110.749 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.675 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.8 mt-10 -90.07 28.71 1.34 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 117.817 -1.553 . . . . 0.0 109.5 -178.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -76.62 -45.33 30.53 Favored 'General case' 0 C--N 1.356 0.852 0 N-CA-C 103.081 -2.933 . . . . 0.0 103.081 174.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.6 ptm180 -80.58 -31.38 36.79 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 111.495 -2.593 . . . . 0.0 107.381 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -89.3 10.7 21.31 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 118.584 -1.247 . . . . 0.0 109.125 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -37.31 14.12 Favored 'General case' 0 C--N 1.359 1.007 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 175.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.31 -33.93 74.39 Favored 'General case' 0 C--N 1.36 1.053 0 CA-C-N 113.182 -1.826 . . . . 0.0 107.652 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 55.7 mtp -81.29 -60.49 2.26 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 178.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 34.68 37.55 0.1 OUTLIER Glycine 0 C--N 1.354 1.531 0 CA-C-N 112.31 -2.223 . . . . 0.0 117.243 177.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -79.84 -15.47 57.33 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -101.63 138.8 38.14 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.556 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.422 ' HE ' HG22 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.31 178.79 4.28 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.081 -3.303 . . . . 0.0 102.081 177.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.19 156.89 24.94 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -99.53 114.24 65.46 Favored Pre-proline 0 CA--C 1.553 1.084 0 N-CA-C 101.785 -3.413 . . . . 0.0 101.785 178.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -55.34 157.89 13.54 Favored 'Trans proline' 0 C--N 1.376 2.022 0 C-N-CA 123.418 2.745 . . . . 0.0 110.459 -177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.96 121.03 8.17 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 105.918 -2.378 . . . . 0.0 105.918 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 95.89 65.91 0.96 Allowed Glycine 0 C--N 1.35 1.357 0 CA-C-N 112.388 -2.187 . . . . 0.0 107.901 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.559 HG21 H112 ' A' ' 139' ' ' DBI . 15.4 p -82.12 -151.99 0.1 Allowed 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 111.424 -2.388 . . . . 0.0 107.173 -178.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 p 176.97 166.33 0.47 Allowed Pre-proline 0 N--CA 1.439 -0.979 0 CA-C-N 110.805 -2.907 . . . . 0.0 104.243 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.61 -5.15 15.27 Favored 'Trans proline' 0 C--N 1.365 1.424 0 N-CA-C 107.271 -1.857 . . . . 0.0 107.271 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.48 -23.87 53.81 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.15 -17.82 58.32 Favored 'General case' 0 C--N 1.356 0.861 0 CA-C-N 114.317 -1.31 . . . . 0.0 107.753 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 3.0 p -87.19 -20.79 26.48 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 123.914 0.758 . . . . 0.0 110.613 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 3.4 mt -67.89 -27.2 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 175.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.66 -1.01 57.61 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 112.606 -2.088 . . . . 0.0 109.264 178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.554 ' O ' HG23 ' A' ' 133' ' ' VAL . 19.0 t0 -69.75 -68.03 0.44 Allowed 'General case' 0 C--N 1.361 1.106 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.436 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 1.9 mpt? -74.45 -13.65 60.73 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 112.852 -1.976 . . . . 0.0 110.803 -176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -90.04 -43.45 10.5 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 118.51 -1.276 . . . . 0.0 108.999 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -60.39 -31.74 70.65 Favored 'General case' 0 C--N 1.354 0.785 0 CA-C-O 121.053 0.454 . . . . 0.0 109.789 -178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 129' ' ' ASP . 53.8 t -90.09 -77.06 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.871 0 CA-C-N 113.82 -1.536 . . . . 0.0 110.327 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.421 HD23 HG12 ' A' ' 133' ' ' VAL . 27.2 mt -90.49 63.06 5.44 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 124.643 1.215 . . . . 0.0 108.839 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -168.97 -36.67 0.02 OUTLIER Glycine 0 CA--C 1.531 1.071 0 C-N-CA 119.632 -1.271 . . . . 0.0 111.329 178.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.7 t -149.75 162.22 4.31 Favored 'Isoleucine or valine' 0 C--N 1.348 0.503 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 CA--C 1.543 0.703 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.016 179.508 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.559 H112 HG21 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -121.63 16.6 11.17 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 124.924 1.39 . . . . 0.0 107.745 -179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.0 tttm -70.82 145.38 50.37 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -79.53 95.68 5.9 Favored 'General case' 0 C--N 1.346 0.452 0 CA-C-N 111.197 -2.729 . . . . 0.0 108.413 -177.336 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.41 112.45 0.01 OUTLIER 'General case' 0 C--N 1.353 0.76 0 N-CA-C 104.684 -2.339 . . . . 0.0 104.684 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -141.82 132.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.986 0 N-CA-C 102.377 -3.194 . . . . 0.0 102.377 179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 0.6 OUTLIER -125.7 141.05 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-N 110.974 -2.83 . . . . 0.0 110.202 -176.478 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.612 ' O ' HG22 ' A' ' 37' ' ' ILE . 2.9 pp -125.31 167.23 15.19 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 112.272 -2.24 . . . . 0.0 105.728 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.402 ' N ' HD12 ' A' ' 8' ' ' LEU . . . 178.25 -172.25 44.71 Favored Glycine 0 C--N 1.358 1.805 0 O-C-N 126.428 2.33 . . . . 0.0 113.42 177.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.96 HG11 HG13 ' A' ' 60' ' ' VAL 0.455 13.5 p 69.53 -125.29 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 CA-C-N 110.139 -3.031 . . . . 0.0 114.714 177.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.54 ' H ' HG13 ' A' ' 10' ' ' VAL . 4.2 tp 56.71 113.85 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.054 0 C-N-CA 128.744 2.817 . . . . 0.0 109.018 -178.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.52 78.23 0.16 Allowed Glycine 0 C--N 1.366 2.197 0 N-CA-C 108.031 -2.028 . . . . 0.0 108.031 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.404 ' OG ' ' H72' ' A' ' 138' ' ' FOP . 0.9 OUTLIER -129.06 -36.81 1.74 Allowed 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 110.773 -2.714 . . . . 0.0 106.836 -177.349 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.32 -156.0 0.56 Allowed 'General case' 0 C--N 1.354 0.793 0 N-CA-C 103.819 -2.66 . . . . 0.0 103.819 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.33 98.57 4.54 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 97.0 m-70 80.67 -89.1 0.02 OUTLIER 'General case' 0 C--N 1.354 0.771 0 N-CA-C 104.014 -2.587 . . . . 0.0 104.014 -177.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 93.34 33.52 0.01 OUTLIER 'General case' 0 C--N 1.354 0.776 0 C-N-CA 126.535 1.934 . . . . 0.0 106.819 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.1 t 59.07 113.6 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.592 0 CA-C-N 113.875 -1.511 . . . . 0.0 109.73 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' C ' ' H ' ' A' ' 21' ' ' LYS . . . -169.94 -78.17 0.04 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-N 113.255 -1.793 . . . . 0.0 108.786 179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -74.88 -0.13 17.49 Favored 'General case' 0 CA--C 1.556 1.207 0 CA-C-N 112.252 -1.974 . . . . 0.0 108.684 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.604 ' O ' HG22 ' A' ' 22' ' ' ILE . 7.1 tmtm? -82.54 73.45 9.57 Favored 'General case' 0 N--CA 1.437 -1.118 1 C-N-CA 133.556 4.742 . . . . 0.0 104.995 -177.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.604 HG22 ' O ' ' A' ' 21' ' ' LYS 0.318 38.7 mt 93.61 9.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.215 1 CA-C-N 107.101 -4.59 . . . . 0.0 112.325 175.518 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.474 ' HG ' ' CG2' ' A' ' 126' ' ' THR 0.259 0.2 OUTLIER -74.85 -30.46 61.36 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 114.472 -2.891 . . . . 0.0 106.378 176.32 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -77.17 -13.13 59.99 Favored 'General case' 0 C--N 1.363 1.164 0 C-N-CA 117.406 -1.717 . . . . 0.0 107.05 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -77.31 -31.89 54.97 Favored 'General case' 0 C--N 1.346 0.429 0 C-N-CA 117.378 -1.729 . . . . 0.0 107.976 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 m -74.33 -18.76 60.65 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 112.992 -1.913 . . . . 0.0 110.792 -177.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.4 OUTLIER -68.43 -39.44 81.56 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 118.139 -1.424 . . . . 0.0 107.472 179.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.6 -31.0 64.84 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 110.425 -3.08 . . . . 0.0 112.246 -176.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -88.05 0.29 56.14 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 112.077 -2.329 . . . . 0.0 109.989 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.33 -8.26 11.67 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.01 23.64 69.67 Favored Glycine 0 CA--C 1.541 1.666 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -176.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.6 m-30 -99.9 170.59 8.42 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -177.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 64.9 m-20 -80.86 151.12 28.81 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 111.232 -2.713 . . . . 0.0 105.399 179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 135.83 33.8 Favored 'Isoleucine or valine' 0 C--N 1.347 0.498 0 CA-C-N 111.703 -2.499 . . . . 0.0 107.469 -179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 60.0 t -136.66 92.91 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.489 0 CA-C-N 111.593 -2.549 . . . . 0.0 106.172 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.0 t30 -96.55 126.17 41.54 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 113.292 -1.776 . . . . 0.0 107.198 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 8' ' ' LEU . 15.8 mt -98.72 -24.59 4.19 Favored 'Isoleucine or valine' 0 C--N 1.361 1.092 0 O-C-N 124.778 1.299 . . . . 0.0 107.655 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.78 -151.33 19.51 Favored Glycine 0 C--N 1.355 1.624 0 N-CA-C 108.498 -1.841 . . . . 0.0 108.498 -178.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.3 m -85.64 14.1 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-N 114.423 -0.889 . . . . 0.0 111.441 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 37.0 mt -130.89 102.77 6.2 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 104.642 -2.355 . . . . 0.0 104.642 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.582 ' HA ' HG21 ' A' ' 37' ' ' ILE . 53.8 p -84.89 83.07 8.17 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.07 125.05 22.51 Favored 'General case' 0 C--N 1.353 0.742 0 CA-C-N 109.809 -3.36 . . . . 0.0 106.969 -177.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -83.95 -93.59 0.07 Allowed 'General case' 0 C--N 1.351 0.656 0 CA-C-N 111.907 -2.406 . . . . 0.0 107.987 -177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.66 -18.45 53.76 Favored 'General case' 0 C--N 1.351 0.657 0 O-C-N 124.8 1.313 . . . . 0.0 111.462 -176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -86.63 -43.24 12.79 Favored 'General case' 0 C--N 1.35 0.626 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD2' HG12 ' A' ' 37' ' ' ILE . 1.3 t80 -86.52 4.48 39.74 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 116.862 -1.935 . . . . 0.0 108.982 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.22 -26.89 6.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -78.16 -30.21 49.04 Favored 'General case' 0 C--N 1.365 1.25 0 N-CA-C 105.856 -1.905 . . . . 0.0 105.856 177.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.26 10.16 33.11 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.13 -26.77 20.03 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -69.1 -37.31 76.58 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.31 -71.75 0.14 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 112.318 -2.219 . . . . 0.0 110.449 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -75.25 -61.54 1.86 Allowed 'General case' 0 C--N 1.362 1.134 0 O-C-N 123.512 0.508 . . . . 0.0 110.362 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? 99.87 68.9 0.0 OUTLIER 'General case' 0 C--N 1.348 0.509 0 O-C-N 126.248 2.217 . . . . 0.0 106.654 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -55.42 116.09 2.66 Favored 'General case' 0 C--N 1.354 0.789 0 CA-C-N 112.795 -2.002 . . . . 0.0 108.331 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.1 t0 -77.2 -48.55 17.3 Favored 'General case' 0 C--N 1.355 0.808 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 178.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pp -146.39 150.49 35.78 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.252 -1.758 . . . . 0.0 106.252 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.5 mt -114.96 170.63 5.01 Favored 'Isoleucine or valine' 0 C--N 1.355 0.81 0 N-CA-C 106.031 -1.84 . . . . 0.0 106.031 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 77.2 m -153.21 109.02 3.29 Favored 'General case' 0 C--N 1.353 0.724 0 CA-C-N 112.773 -2.012 . . . . 0.0 105.814 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.96 HG13 HG11 ' A' ' 10' ' ' VAL . 3.0 t -99.86 120.05 48.74 Favored 'Isoleucine or valine' 0 C--N 1.344 0.357 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 10' ' ' VAL . 0.0 OUTLIER -101.84 113.01 25.82 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 117.851 -1.54 . . . . 0.0 107.685 -176.783 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 27.1 t 150.74 162.83 0.0 OUTLIER 'General case' 0 C--N 1.351 0.635 0 N-CA-C 105.148 -2.168 . . . . 0.0 105.148 177.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.5 mp -90.76 74.4 6.59 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 111.517 -2.583 . . . . 0.0 106.682 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 72.66 49.65 0.18 Allowed 'General case' 0 C--N 1.353 0.754 0 CA-C-N 112.558 -2.11 . . . . 0.0 107.805 178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -93.22 2.99 72.16 Favored Glycine 0 CA--C 1.541 1.67 0 CA-C-N 114.445 -1.252 . . . . 0.0 111.996 178.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.627 ' HB3' HG11 ' A' ' 60' ' ' VAL . 12.2 pt20 -88.13 -20.49 25.57 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 113.661 -1.27 . . . . 0.0 109.463 -178.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 77.04 174.35 40.25 Favored Glycine 0 CA--C 1.533 1.192 0 N-CA-C 108.513 -1.835 . . . . 0.0 108.513 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -78.58 6.29 9.04 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.85 -178.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -90.01 -67.93 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.576 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 29.4 t70 -71.13 -20.7 62.28 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 113.364 -1.744 . . . . 0.0 109.553 -177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 19.4 t -72.94 -56.26 5.41 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.81 -1.181 . . . . 0.0 107.81 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mttm -90.07 21.08 3.87 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.617 -177.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.44 -27.07 6.6 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-N 113.407 -1.724 . . . . 0.0 109.867 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.576 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 20.6 mt -85.67 -27.67 25.2 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.567 ' HG3' HH11 ' A' ' 75' ' ' ARG . 3.0 mmt85 -72.02 -32.38 67.09 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -78.28 -23.54 47.19 Favored 'General case' 0 C--N 1.359 1.001 0 CA-C-N 113.624 -1.626 . . . . 0.0 108.391 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.2 tttp -77.11 -16.5 59.16 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 83.7 m -90.24 -42.98 10.69 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 123.831 1.777 . . . . 0.0 107.282 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.65 -1.06 22.88 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 108.679 -3.873 . . . . 0.0 108.654 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -80.27 -54.5 5.67 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 104.032 -2.581 . . . . 0.0 104.032 177.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 59.94 40.88 18.47 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 110.882 -2.872 . . . . 0.0 107.541 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.78 -51.25 0.04 OUTLIER Glycine 0 C--N 1.35 1.308 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 93.9 mt -92.34 120.19 32.63 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 103.889 -2.634 . . . . 0.0 103.889 178.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 126.59 31.14 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 113.153 -1.84 . . . . 0.0 106.29 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 170.61 56.19 0.04 OUTLIER Glycine 0 C--N 1.345 1.062 0 CA-C-N 112.235 -2.257 . . . . 0.0 109.195 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.2 tt -99.94 32.27 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 CA-C-N 112.203 -1.998 . . . . 0.0 106.691 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -144.36 112.56 6.42 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 102.541 -3.133 . . . . 0.0 102.541 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.01 97.35 3.23 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.552 -2.758 . . . . 0.0 103.552 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -99.67 85.25 3.08 Favored 'General case' 0 C--N 1.348 0.52 0 N-CA-C 101.632 -3.47 . . . . 0.0 101.632 -179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.492 HG23 ' CB ' ' A' ' 93' ' ' ASN . 4.4 m -89.45 98.45 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 CA-C-N 109.881 -3.327 . . . . 0.0 110.397 -175.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -63.31 132.92 42.25 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 109.116 -3.675 . . . . 0.0 113.348 178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.96 -74.21 0.95 Allowed Glycine 0 C--N 1.353 1.521 0 CA-C-N 111.869 -2.165 . . . . 0.0 109.765 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.492 ' CB ' HG23 ' A' ' 90' ' ' VAL . 15.7 t-20 18.75 103.67 0.0 OUTLIER 'General case' 0 C--N 1.354 0.769 1 C-N-CA 131.763 4.025 . . . . 0.0 111.06 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER 58.44 120.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.83 0 CA-C-N 112.334 -2.212 . . . . 0.0 108.478 178.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.49 162.5 4.41 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 CA-C-N 112.102 -2.317 . . . . 0.0 108.58 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 6.0 p 41.3 69.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.353 0.748 0 CA-C-N 112.432 -2.167 . . . . 0.0 112.715 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.36 128.96 1.06 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 112.343 -2.208 . . . . 0.0 109.365 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -157.61 100.0 1.76 Allowed 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.234 -2.876 . . . . 0.0 103.234 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 96.49 -51.77 0.01 OUTLIER 'General case' 0 C--N 1.356 0.89 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 -178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -85.68 99.13 11.1 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 104.208 -2.516 . . . . 0.0 104.208 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.508 ' HH2' HG21 ' A' ' 116' ' ' VAL . 88.6 m95 -113.5 160.47 31.48 Favored Pre-proline 0 C--N 1.351 0.646 0 CA-C-N 112.694 -2.048 . . . . 0.0 106.122 -179.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -72.58 -155.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.371 1.747 0 N-CA-C 106.456 -2.171 . . . . 0.0 106.456 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -70.38 -20.91 62.92 Favored 'General case' 0 C--N 1.35 0.625 0 CA-C-N 113.732 -1.576 . . . . 0.0 108.688 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.522 HG13 ' H ' ' A' ' 105' ' ' GLU . 2.6 p -60.01 -69.66 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.776 0 O-C-N 124.437 1.086 . . . . 0.0 111.621 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.522 ' H ' HG13 ' A' ' 104' ' ' VAL . 29.5 mt-10 -90.15 27.01 1.72 Allowed 'General case' 0 C--N 1.358 0.962 0 C-N-CA 117.688 -1.605 . . . . 0.0 109.3 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -79.92 -42.36 24.25 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 103.562 -2.755 . . . . 0.0 103.562 174.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -79.48 -31.79 42.39 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 112.314 -2.221 . . . . 0.0 106.683 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -90.87 14.29 14.1 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.214 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -90.41 -37.37 14.01 Favored 'General case' 0 C--N 1.361 1.094 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.5 -33.78 75.55 Favored 'General case' 0 C--N 1.361 1.088 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.84 178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 29.9 mtp -76.9 -63.51 1.34 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 35.5 31.29 0.02 OUTLIER Glycine 0 C--N 1.355 1.635 0 C-N-CA 127.135 2.302 . . . . 0.0 117.496 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.94 -7.19 59.26 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 178.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -105.25 128.63 53.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 176.91 4.87 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 103.626 -2.731 . . . . 0.0 103.626 178.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.508 HG21 ' HH2' ' A' ' 101' ' ' TRP . 4.8 m -138.23 158.47 32.16 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.17 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.412 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 0.5 OUTLIER -99.9 152.62 37.87 Favored Pre-proline 0 C--N 1.358 0.946 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -66.43 147.89 83.26 Favored 'Trans proline' 0 C--N 1.369 1.654 0 N-CA-C 107.064 -1.937 . . . . 0.0 107.064 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -79.78 114.5 3.2 Favored 'Trans proline' 0 C--N 1.364 1.373 0 N-CA-C 104.011 -3.111 . . . . 0.0 104.011 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 87.29 42.77 6.1 Favored Glycine 0 C--N 1.349 1.305 0 CA-C-N 113.499 -1.682 . . . . 0.0 110.389 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.564 HG23 H112 ' A' ' 139' ' ' DBI . 7.5 t -90.17 -179.08 5.57 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-O 125.174 2.416 . . . . 0.0 106.457 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.357 19.7 p -82.39 170.78 13.63 Favored Pre-proline 0 N--CA 1.426 -1.668 1 CA-C-N 106.806 -4.725 . . . . 0.0 106.031 179.078 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -92.06 -0.06 4.23 Favored 'Trans proline' 0 CA--C 1.554 1.499 0 N-CA-C 104.586 -2.89 . . . . 0.0 104.586 174.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.404 ' HA ' HG13 ' A' ' 127' ' ' ILE . 38.6 tt0 -74.97 -16.1 60.65 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 124.679 1.192 . . . . 0.0 108.284 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -27.75 55.57 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.495 ' C ' ' H ' ' A' ' 129' ' ' ASP . 35.6 p -79.83 -23.21 42.17 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 118.012 -1.475 . . . . 0.0 109.817 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.404 HG13 ' HA ' ' A' ' 124' ' ' GLU . 5.8 mt -68.55 -30.34 47.03 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 N-CA-C 103.768 -2.679 . . . . 0.0 103.768 176.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -82.68 -5.14 58.7 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 112.134 -2.303 . . . . 0.0 108.796 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' H ' ' C ' ' A' ' 126' ' ' THR . 50.4 t0 -59.85 -58.56 8.03 Favored 'General case' 0 C--N 1.367 1.347 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -88.29 1.61 54.2 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 112.362 -2.199 . . . . 0.0 110.156 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -81.04 -48.35 12.32 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 117.151 -1.82 . . . . 0.0 109.866 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -87.76 -31.49 19.61 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 124.235 0.96 . . . . 0.0 111.928 -175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 129' ' ' ASP . 16.9 t -73.25 -26.02 22.14 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 O-C-N 124.105 0.878 . . . . 0.0 112.379 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -89.21 -36.85 15.41 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.83 -95.42 0.06 OUTLIER Glycine 0 C--N 1.356 1.641 0 CA-C-N 114.124 -1.398 . . . . 0.0 111.033 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -169.31 154.27 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.633 0 CA-C-N 113.548 -1.326 . . . . 0.0 108.635 179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 C--N 1.347 0.486 0 N-CA-C 104.268 -2.493 . . . . 0.0 104.268 179.558 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . 0.404 ' H72' ' OG ' ' A' ' 13' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.564 H112 HG23 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ttt . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.71 13.45 19.85 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 125.296 1.622 . . . . 0.0 107.543 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 tttm -70.93 145.94 49.82 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-O 122.938 1.351 . . . . 0.0 107.76 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.3 OUTLIER -80.61 95.85 6.67 Favored 'General case' 0 C--N 1.347 0.489 0 CA-C-N 110.938 -2.847 . . . . 0.0 108.313 -177.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 172.29 111.51 0.01 OUTLIER 'General case' 0 C--N 1.352 0.686 0 N-CA-C 103.81 -2.663 . . . . 0.0 103.81 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -141.08 122.07 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 102.42 -3.178 . . . . 0.0 102.42 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 99.3 t -108.3 147.16 13.34 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.539 0 CA-C-N 110.546 -3.025 . . . . 0.0 110.163 -177.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.436 ' O ' HG22 ' A' ' 37' ' ' ILE . 1.2 tm? -125.13 149.21 48.1 Favored 'General case' 0 C--N 1.353 0.74 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.1 155.41 26.15 Favored Glycine 0 C--N 1.357 1.729 0 O-C-N 125.762 1.914 . . . . 0.0 112.554 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 11' ' ' ILE 0.704 13.6 p 84.94 -127.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.678 0 C-N-CA 130.406 3.483 . . . . 0.0 117.03 177.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.592 HG22 ' O ' ' A' ' 10' ' ' VAL 0.316 2.0 tp 72.78 115.0 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 1.002 0 C-N-CA 128.443 2.697 . . . . 0.0 106.382 -175.964 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -165.5 73.6 0.17 Allowed Glycine 0 C--N 1.367 2.286 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 -179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -123.6 -44.59 2.1 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 110.058 -3.071 . . . . 0.0 104.816 -177.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -159.01 -131.15 0.03 OUTLIER 'General case' 0 C--N 1.354 0.773 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.6 p -89.08 77.25 7.63 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 102.632 -3.099 . . . . 0.0 102.632 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 75.9 -142.66 0.02 OUTLIER 'General case' 0 C--N 1.355 0.815 0 N-CA-C 103.048 -2.945 . . . . 0.0 103.048 -176.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 164.93 46.81 0.0 OUTLIER 'General case' 0 C--N 1.351 0.641 0 N-CA-C 105.063 -2.199 . . . . 0.0 105.063 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.6 m 61.19 179.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.965 0 CA-C-N 113.58 -1.646 . . . . 0.0 110.708 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.71 -70.74 1.13 Allowed Glycine 0 C--N 1.352 1.458 0 CA-C-N 113.123 -1.853 . . . . 0.0 111.674 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HA ' ' HG ' ' A' ' 8' ' ' LEU . 4.1 p-10 -56.59 -25.97 54.2 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-N 112.525 -1.838 . . . . 0.0 110.945 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -60.96 -66.79 0.48 Allowed 'General case' 0 C--N 1.345 0.381 0 CA-C-O 122.961 1.362 . . . . 0.0 107.68 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.69 3.35 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 111.502 -2.59 . . . . 0.0 111.357 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.796 ' HG ' ' CG2' ' A' ' 126' ' ' THR . 0.2 OUTLIER -85.69 -38.58 18.16 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 116.573 -2.051 . . . . 0.0 107.664 -179.741 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -78.98 -11.24 60.0 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 117.489 -1.685 . . . . 0.0 106.478 177.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -80.78 -38.56 28.3 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.5 m -71.0 -14.84 62.49 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 112.242 -2.254 . . . . 0.0 109.903 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.481 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -70.11 -42.03 73.21 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 179.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.89 -31.61 66.59 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 110.188 -3.187 . . . . 0.0 112.462 -176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 -87.63 -1.76 58.17 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 111.971 -2.377 . . . . 0.0 110.016 -177.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -110.72 -10.32 14.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 65.86 23.1 70.76 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -176.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 4.3 m-30 -99.88 168.47 9.86 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 -177.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 58.3 m-20 -78.22 148.74 33.85 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 111.178 -2.737 . . . . 0.0 105.766 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.88 132.37 45.54 Favored 'Isoleucine or valine' 0 C--N 1.347 0.499 0 CA-C-N 111.792 -2.458 . . . . 0.0 107.579 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.4 t -128.85 74.18 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 111.481 -2.599 . . . . 0.0 105.444 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.09 122.98 31.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.472 -2.149 . . . . 0.0 107.622 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.436 HG22 ' O ' ' A' ' 8' ' ' LEU . 53.3 mt -98.39 -27.6 3.67 Favored 'Isoleucine or valine' 0 C--N 1.359 1.003 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 178.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.71 -141.51 15.58 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.691 -1.764 . . . . 0.0 108.691 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 15.3 m -86.99 -13.67 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-N 114.237 -0.982 . . . . 0.0 110.278 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 84.8 mt -91.3 98.89 11.99 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.0 p -82.68 80.76 8.7 Favored 'General case' 0 C--N 1.35 0.614 0 N-CA-C 104.069 -2.567 . . . . 0.0 104.069 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.36 118.15 16.99 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 110.883 -2.872 . . . . 0.0 105.387 -178.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.412 HE21 ' HA ' ' A' ' 70' ' ' ASP . 6.7 tp-100 -89.86 -87.37 0.18 Allowed 'General case' 0 C--N 1.352 0.702 0 CA-C-N 112.477 -2.147 . . . . 0.0 107.585 -178.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -63.11 -18.63 63.63 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 124.63 1.206 . . . . 0.0 110.563 -177.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.52 -41.8 14.99 Favored 'General case' 0 C--N 1.35 0.605 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -86.47 4.88 37.82 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 116.898 -1.921 . . . . 0.0 108.877 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.37 -26.6 6.54 Favored 'Isoleucine or valine' 0 C--N 1.356 0.885 0 N-CA-C 103.683 -2.71 . . . . 0.0 103.683 176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -78.65 -31.17 46.68 Favored 'General case' 0 C--N 1.365 1.279 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.88 10.79 29.61 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.11 -28.0 19.27 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 mt -67.55 -37.12 78.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 N-CA-C 105.016 -2.216 . . . . 0.0 105.016 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -60.87 -71.73 0.13 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 112.387 -2.188 . . . . 0.0 110.234 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.57 -63.96 1.13 Allowed 'General case' 0 C--N 1.362 1.148 0 O-C-N 123.491 0.494 . . . . 0.0 110.193 -175.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? 101.25 71.14 0.0 OUTLIER 'General case' 0 C--N 1.346 0.444 0 O-C-N 126.4 2.312 . . . . 0.0 106.467 -179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -56.39 122.0 10.87 Favored 'General case' 0 C--N 1.355 0.838 0 CA-C-N 112.296 -2.229 . . . . 0.0 107.433 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -95.19 -59.41 1.9 Allowed 'General case' 0 C--N 1.351 0.634 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.79 124.83 40.59 Favored 'General case' 0 C--N 1.351 0.664 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 -178.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.459 HG21 HD13 ' A' ' 74' ' ' LEU . 39.6 mt -95.79 167.9 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 86.2 m -148.98 120.82 8.14 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 111.918 -2.401 . . . . 0.0 106.056 178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.593 HG23 HG12 ' A' ' 90' ' ' VAL . 23.5 t -99.88 133.38 43.0 Favored 'Isoleucine or valine' 0 C--N 1.346 0.423 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 176.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 p -119.66 96.47 5.21 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 30.4 t 147.57 161.72 0.0 OUTLIER 'General case' 0 C--N 1.354 0.789 0 O-C-N 126.293 2.246 . . . . 0.0 106.031 177.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.37 77.57 8.88 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 111.279 -2.691 . . . . 0.0 106.527 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 64.67 50.66 2.05 Favored 'General case' 0 C--N 1.355 0.813 0 CA-C-N 112.819 -1.992 . . . . 0.0 107.607 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.74 57.69 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 114.262 -1.335 . . . . 0.0 112.897 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -92.57 4.32 53.81 Favored 'General case' 0 C--N 1.349 0.578 0 CA-C-N 113.444 -1.378 . . . . 0.0 109.357 -178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 66.31 -167.53 35.95 Favored Glycine 0 C--N 1.352 1.443 0 C-N-CA 120.31 -0.948 . . . . 0.0 111.721 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -90.11 21.08 3.9 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 112.498 -1.851 . . . . 0.0 108.072 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.08 -75.06 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.717 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -178.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.511 ' O ' ' HG ' ' A' ' 74' ' ' LEU . 20.8 t70 -71.25 -24.49 62.19 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 112.472 -2.149 . . . . 0.0 108.904 -177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 53.7 t -74.48 -49.4 22.36 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.6 mttt -90.02 16.11 8.9 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.961 -1.096 . . . . 0.0 109.554 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.77 -23.61 11.72 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-N 113.819 -1.537 . . . . 0.0 110.149 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 70' ' ' ASP . 29.5 mt -89.94 -25.41 20.93 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.513 ' HG3' HH11 ' A' ' 75' ' ' ARG . 2.3 mmt85 -71.81 -30.49 65.57 Favored 'General case' 0 CA--C 1.547 0.857 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -79.51 -23.67 42.77 Favored 'General case' 0 C--N 1.359 1.016 0 CA-C-N 113.763 -1.562 . . . . 0.0 108.187 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -77.64 -12.8 60.0 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.801 0.84 . . . . 0.0 108.904 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 76.0 m -90.24 -42.91 10.74 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 123.923 1.82 . . . . 0.0 106.661 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -74.43 -3.56 31.31 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 108.527 -3.942 . . . . 0.0 108.741 177.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -79.5 -54.58 5.77 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 104.538 -2.393 . . . . 0.0 104.538 177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 58.71 40.43 23.25 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 111.125 -2.761 . . . . 0.0 107.688 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.75 -52.35 0.05 OUTLIER Glycine 0 C--N 1.35 1.328 0 N-CA-C 107.956 -2.058 . . . . 0.0 107.956 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.8 mt -94.46 122.55 37.14 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 103.8 -2.667 . . . . 0.0 103.8 178.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.57 134.89 38.14 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 164.13 54.97 0.02 OUTLIER Glycine 0 C--N 1.347 1.14 0 CA-C-N 112.36 -2.2 . . . . 0.0 109.208 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.5 -33.41 11.06 Favored 'Isoleucine or valine' 0 C--N 1.352 0.709 0 CA-C-N 112.42 -1.89 . . . . 0.0 107.389 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 33.4 mmtm -80.92 117.53 21.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 104.998 -2.223 . . . . 0.0 104.998 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.09 100.22 3.86 Favored 'General case' 0 C--N 1.347 0.47 0 N-CA-C 104.225 -2.509 . . . . 0.0 104.225 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -99.66 92.76 5.49 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 101.044 -3.688 . . . . 0.0 101.044 -179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.593 HG12 HG23 ' A' ' 60' ' ' VAL . 27.3 m -89.21 97.21 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 110.298 -3.137 . . . . 0.0 110.64 -174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -67.57 134.74 30.63 Favored Glycine 0 C--N 1.348 1.234 0 CA-C-N 110.027 -3.261 . . . . 0.0 113.02 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.59 -80.67 1.37 Allowed Glycine 0 C--N 1.354 1.546 0 CA-C-N 111.691 -2.255 . . . . 0.0 108.492 -179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.49 ' CB ' HG23 ' A' ' 90' ' ' VAL . 11.1 t-20 21.56 94.06 0.01 OUTLIER 'General case' 0 C--N 1.354 0.767 0 C-N-CA 131.399 3.88 . . . . 0.0 110.171 179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 3.2 mt 76.19 131.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.801 0 CA-C-N 113.783 -1.553 . . . . 0.0 106.94 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.03 159.18 3.39 Favored 'Isoleucine or valine' 0 C--N 1.352 0.708 0 CA-C-N 112.313 -2.221 . . . . 0.0 108.103 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 4.9 p 35.22 63.82 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.773 0 CA-C-N 112.241 -2.254 . . . . 0.0 112.71 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -165.36 147.55 12.61 Favored Glycine 0 C--N 1.347 1.185 0 CA-C-N 112.48 -2.145 . . . . 0.0 109.643 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.9 mtpp -175.27 107.99 0.1 Allowed 'General case' 0 C--N 1.349 0.545 0 N-CA-C 103.546 -2.761 . . . . 0.0 103.546 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? 93.42 -55.97 0.01 OUTLIER 'General case' 0 C--N 1.356 0.888 0 O-C-N 126.137 2.148 . . . . 0.0 105.429 -179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -87.69 107.51 18.66 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 104.958 -2.238 . . . . 0.0 104.958 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -116.47 163.34 22.45 Favored Pre-proline 0 C--N 1.351 0.651 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.16 -151.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.732 0 C-N-CA 121.763 1.642 . . . . 0.0 107.976 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -76.07 -20.13 57.99 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 114.093 -1.412 . . . . 0.0 108.523 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -61.9 -67.69 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.606 0 CA-C-N 114.238 -1.346 . . . . 0.0 110.721 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -90.23 25.86 2.08 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 117.199 -1.8 . . . . 0.0 109.41 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.07 -41.23 26.02 Favored 'General case' 0 C--N 1.361 1.072 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -78.32 -31.79 48.94 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-N 112.512 -2.131 . . . . 0.0 106.256 178.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -92.85 17.02 11.18 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.087 -1.045 . . . . 0.0 108.294 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -90.36 -38.97 12.97 Favored 'General case' 0 C--N 1.359 1.013 0 N-CA-C 103.648 -2.723 . . . . 0.0 103.648 175.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.19 80.1 Favored 'General case' 0 C--N 1.362 1.121 0 CA-C-N 112.282 -2.235 . . . . 0.0 106.915 179.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 12.3 mtp -74.22 -65.29 0.86 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 176.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 39.49 27.57 0.09 OUTLIER Glycine 0 C--N 1.354 1.561 0 CA-C-N 112.127 -2.306 . . . . 0.0 117.295 177.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -82.32 -5.24 58.46 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 176.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -105.12 132.59 51.15 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 105.246 -2.131 . . . . 0.0 105.246 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.28 172.75 6.68 Favored 'General case' 0 C--N 1.348 0.514 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 42.8 t -137.08 157.58 35.54 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.429 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 0.7 OUTLIER -99.44 147.68 33.66 Favored Pre-proline 0 C--N 1.359 0.982 0 N-CA-C 104.046 -2.576 . . . . 0.0 104.046 -178.745 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.56 145.06 81.14 Favored 'Trans proline' 0 C--N 1.371 1.723 0 N-CA-C 107.451 -1.788 . . . . 0.0 107.451 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -79.97 111.97 2.78 Favored 'Trans proline' 0 C--N 1.364 1.35 0 N-CA-C 103.552 -3.288 . . . . 0.0 103.552 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.16 42.14 5.04 Favored Glycine 0 C--N 1.349 1.297 0 CA-C-N 113.47 -1.695 . . . . 0.0 110.478 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.591 HG23 H112 ' A' ' 139' ' ' DBI . 12.5 t -90.12 -179.15 5.6 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-O 124.875 2.274 . . . . 0.0 106.644 -179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . 0.335 22.3 p -78.73 173.43 7.71 Favored Pre-proline 0 N--CA 1.431 -1.394 1 CA-C-N 107.297 -4.501 . . . . 0.0 105.666 178.797 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -93.75 -4.6 2.82 Favored 'Trans proline' 0 CA--C 1.551 1.355 0 N-CA-C 105.198 -2.655 . . . . 0.0 105.198 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -73.33 -10.68 60.0 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 125.717 1.607 . . . . 0.0 108.3 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.27 -30.55 60.49 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.796 ' CG2' ' HG ' ' A' ' 23' ' ' LEU . 36.3 p -83.66 -25.66 30.54 Favored 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.46 1.1 . . . . 0.0 110.069 -178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 6.4 mt -69.8 -28.61 37.64 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 N-CA-C 103.242 -2.874 . . . . 0.0 103.242 175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.35 58.39 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-N 112.145 -2.298 . . . . 0.0 108.609 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 133' ' ' VAL . 54.7 t0 -61.74 -53.75 51.76 Favored 'General case' 0 C--N 1.366 1.325 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -87.43 -2.61 58.74 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 111.956 -2.384 . . . . 0.0 110.168 -177.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -81.32 -49.69 10.41 Favored 'General case' 0 C--N 1.35 0.602 0 C-N-CA 117.15 -1.82 . . . . 0.0 110.223 -178.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -85.16 -36.36 21.11 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 124.161 0.913 . . . . 0.0 112.148 -175.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.8 t -70.59 -29.71 39.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 C-N-CA 119.249 -0.98 . . . . 0.0 112.767 -178.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 76.6 mt -84.09 -39.91 18.95 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -67.09 -91.39 0.05 OUTLIER Glycine 0 C--N 1.354 1.571 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.292 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -164.71 150.97 2.46 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 CA-C-N 113.564 -1.318 . . . . 0.0 108.608 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 . . . . . 0 C--N 1.347 0.471 0 CA-C-N 111.29 -2.687 . . . . 0.0 104.162 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.591 H112 HG23 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 ttt . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 105.117 -2.179 . . . . 0.0 105.117 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -94.3 77.88 3.95 Favored 'General case' 0 C--N 1.352 0.706 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.4 156.58 16.42 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-O 124.429 2.061 . . . . 0.0 108.404 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -61.96 94.19 0.05 OUTLIER 'General case' 0 N--CA 1.449 -0.506 1 CA-C-N 107.999 -4.182 . . . . 0.0 108.757 -178.483 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 177.26 106.53 0.02 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.623 ' HB ' HD21 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -145.65 111.25 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.289 -2.486 . . . . 0.0 104.289 178.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.597 ' HB ' HG22 ' A' ' 37' ' ' ILE . 7.6 m -89.72 145.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.353 0.72 0 CA-C-O 123.198 1.475 . . . . 0.0 109.385 -178.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.4 pp -125.34 111.43 15.17 Favored 'General case' 0 C--N 1.349 0.562 0 CA-C-N 110.081 -3.236 . . . . 0.0 104.034 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 60' ' ' VAL . . . -160.83 141.61 7.5 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-N 113.486 -1.688 . . . . 0.0 109.854 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.734 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.7 p 171.26 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.36 1.034 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 0.3 OUTLIER 118.97 170.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.375 1.688 0 O-C-N 125.916 2.01 . . . . 0.0 105.879 -178.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -160.7 -104.11 0.19 Allowed Glycine 0 C--N 1.353 1.509 0 CA-C-N 113.425 -1.716 . . . . 0.0 110.541 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -147.35 87.44 1.66 Allowed 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.3 t0 174.9 134.79 0.04 OUTLIER 'General case' 0 C--N 1.346 0.44 0 N-CA-C 103.05 -2.944 . . . . 0.0 103.05 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.1 t -84.64 83.69 7.93 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-N 113.608 -1.633 . . . . 0.0 106.652 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 8.0 t60 152.31 -49.2 0.01 OUTLIER 'General case' 0 C--N 1.355 0.823 0 N-CA-C 101.387 -3.56 . . . . 0.0 101.387 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 65.79 24.64 11.39 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 110.248 -3.16 . . . . 0.0 107.789 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.9 m 53.78 -151.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.373 1.592 0 C-N-CA 118.153 -1.419 . . . . 0.0 109.719 -178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.29 -40.25 3.09 Favored Glycine 0 C--N 1.357 1.698 0 O-C-N 123.649 0.593 . . . . 0.0 113.237 178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 22' ' ' ILE . 9.7 t30 -46.27 -52.13 13.17 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -14.87 55.94 0.0 OUTLIER 'General case' 0 C--N 1.369 1.442 2 C-N-CA 140.133 7.373 . . . . 0.0 109.348 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.507 HG13 ' HB3' ' A' ' 25' ' ' HIS 0.433 0.1 OUTLIER 45.12 39.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.652 1 CA-C-N 107.405 -4.452 . . . . 0.0 110.181 178.463 . . . . . . . . 5 4 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.443 HD21 H103 ' A' ' 139' ' ' DBI . 0.1 OUTLIER -74.43 -37.18 63.38 Favored 'General case' 0 C--N 1.37 1.463 0 N-CA-C 103.864 -2.643 . . . . 0.0 103.864 174.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -70.74 -9.76 57.98 Favored 'General case' 0 CA--C 1.551 0.993 0 CA-C-N 112.019 -2.355 . . . . 0.0 107.268 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HB3' HG13 ' A' ' 22' ' ' ILE . 16.9 t-80 -87.11 -7.68 57.79 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 107.324 -1.362 . . . . 0.0 107.324 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 69.3 m -59.58 -41.33 90.01 Favored 'General case' 0 C--N 1.362 1.15 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -60.95 -42.69 98.73 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 110.013 -3.267 . . . . 0.0 109.137 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.2 m -82.38 -9.53 59.42 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 114.114 -1.403 . . . . 0.0 112.82 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.536 ' HB3' ' SD ' ' A' ' 130' ' ' MET . 0.6 OUTLIER -68.2 -42.03 80.48 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 124.556 1.142 . . . . 0.0 108.664 -177.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -165.82 39.43 0.06 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 117.818 -1.553 . . . . 0.0 109.0 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.7 27.78 64.51 Favored Glycine 0 CA--C 1.538 1.473 0 CA-C-N 115.122 -0.944 . . . . 0.0 114.571 178.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -99.87 92.01 5.09 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 59.7 m-20 -35.57 141.33 0.08 Allowed 'General case' 0 C--N 1.356 0.876 0 C-N-CA 129.757 3.223 . . . . 0.0 109.213 -178.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.499 ' HB ' ' O ' ' A' ' 6' ' ' ILE . 2.6 m -121.45 136.42 58.44 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 CA-C-N 111.898 -2.41 . . . . 0.0 106.643 179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 32.3 t -102.31 102.7 13.93 Favored 'Isoleucine or valine' 0 C--N 1.347 0.481 0 CA-C-N 112.282 -2.235 . . . . 0.0 107.004 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -77.71 114.62 16.74 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.597 HG22 ' HB ' ' A' ' 7' ' ' VAL . 1.1 tt -98.82 -3.25 9.67 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 CA-C-N 112.085 -2.325 . . . . 0.0 108.161 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.01 -100.61 2.23 Favored Glycine 0 C--N 1.354 1.57 0 O-C-N 123.924 0.765 . . . . 0.0 113.75 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.505 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 16.3 m -127.08 -31.82 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.759 0 CA-C-N 113.223 -1.489 . . . . 0.0 111.876 -177.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 60.5 mt -91.83 111.85 23.54 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 -179.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.7 p -101.5 80.26 2.05 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.6 140.84 58.56 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 110.877 -2.874 . . . . 0.0 107.928 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -90.23 -82.6 0.27 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 113.597 -1.638 . . . . 0.0 108.359 -179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -60.05 -21.18 61.07 Favored 'General case' 0 C--N 1.351 0.634 0 CA-C-N 114.144 -1.389 . . . . 0.0 111.543 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -92.25 -34.78 14.13 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 118.617 -1.233 . . . . 0.0 108.525 -178.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -85.01 -8.54 58.67 Favored 'General case' 0 C--N 1.36 1.044 0 C-N-CA 116.864 -1.934 . . . . 0.0 109.686 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.614 ' HB ' HD13 ' A' ' 83' ' ' LEU . 1.1 mp -82.75 -26.84 8.3 Favored 'Isoleucine or valine' 0 C--N 1.349 0.584 0 N-CA-C 105.453 -2.055 . . . . 0.0 105.453 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -76.67 -29.77 56.5 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -90.55 2.04 56.16 Favored 'General case' 0 C--N 1.357 0.908 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.122 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -87.64 -20.32 26.51 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 2.1 mt -74.3 -39.91 49.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.686 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -61.77 -68.03 0.36 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.471 -2.149 . . . . 0.0 110.144 -179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.04 -63.78 1.01 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 123.779 0.674 . . . . 0.0 109.713 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 45.2 tttp 111.62 50.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.372 0 N-CA-C 103.664 -2.717 . . . . 0.0 103.664 -177.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.61 109.76 0.34 Allowed 'General case' 0 C--N 1.356 0.851 0 CA-C-N 112.177 -2.283 . . . . 0.0 108.782 -178.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -81.38 -42.95 19.71 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.623 HD21 ' HB ' ' A' ' 6' ' ' ILE . 0.9 OUTLIER -151.65 160.35 43.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 117.383 -1.727 . . . . 0.0 107.682 -179.327 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.4 mm -122.93 139.73 48.82 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 CA-C-N 111.308 -2.678 . . . . 0.0 106.179 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.42 ' SG ' ' CD1' ' A' ' 57' ' ' LEU . 71.5 m -136.85 124.15 21.89 Favored 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.51 -2.132 . . . . 0.0 105.386 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 9' ' ' GLY . 34.6 m -112.14 135.24 52.08 Favored 'Isoleucine or valine' 0 C--N 1.352 0.674 0 CA-C-N 112.592 -2.095 . . . . 0.0 105.532 177.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.734 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -107.95 106.54 16.84 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 117.37 -1.732 . . . . 0.0 109.662 -177.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.3 m 131.42 -177.0 0.0 OUTLIER 'General case' 0 C--N 1.352 0.674 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.3 mt -65.85 -163.38 0.02 OUTLIER 'General case' 0 C--N 1.352 0.706 0 CA-C-N 112.723 -2.035 . . . . 0.0 108.648 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -66.0 97.67 0.38 Allowed 'General case' 0 C--N 1.36 1.046 0 CA-C-N 113.749 -1.568 . . . . 0.0 107.187 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -113.04 -28.27 3.42 Favored Glycine 0 CA--C 1.535 1.284 0 CA-C-N 111.12 -2.764 . . . . 0.0 107.411 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -84.62 -32.02 23.94 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 111.67 -2.265 . . . . 0.0 106.432 178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 88.46 178.76 46.75 Favored Glycine 0 CA--C 1.533 1.215 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.115 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -80.45 -9.18 59.76 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 113.081 -1.56 . . . . 0.0 108.529 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.0 mm -80.09 -48.56 20.14 Favored 'Isoleucine or valine' 0 C--N 1.355 0.806 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -71.97 -20.63 61.71 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-N 114.118 -1.401 . . . . 0.0 107.677 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 9.9 t -70.61 -45.26 65.6 Favored 'General case' 0 C--N 1.358 0.945 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -90.06 18.0 6.31 Favored 'General case' 0 C--N 1.361 1.098 0 O-C-N 124.464 1.102 . . . . 0.0 109.461 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.63 -31.69 5.68 Favored Glycine 0 CA--C 1.53 0.988 0 CA-C-N 114.241 -1.345 . . . . 0.0 110.325 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD13 HD12 ' A' ' 88' ' ' LEU . 12.6 mt -89.22 -25.35 21.79 Favored 'General case' 0 C--N 1.351 0.671 0 CA-C-N 112.998 -1.601 . . . . 0.0 106.783 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -75.0 -29.12 60.8 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 105.342 -2.095 . . . . 0.0 105.342 177.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -79.13 -24.81 43.09 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-N 113.838 -1.528 . . . . 0.0 107.653 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -76.57 -15.62 59.81 Favored 'General case' 0 CA--C 1.552 1.021 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . 0.426 ' SG ' HG12 ' A' ' 86' ' ' ILE . 62.2 m -90.35 -44.84 9.41 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 123.885 1.802 . . . . 0.0 107.195 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -74.65 -1.72 22.98 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 108.589 -3.914 . . . . 0.0 108.857 178.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -80.81 -54.03 5.96 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 60.77 43.59 12.01 Favored 'General case' 0 C--N 1.352 0.698 0 CA-C-N 111.037 -2.801 . . . . 0.0 107.41 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.34 -47.36 0.03 OUTLIER Glycine 0 C--N 1.348 1.212 0 CA-C-N 112.542 -2.117 . . . . 0.0 107.923 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.614 HD13 ' HB ' ' A' ' 47' ' ' ILE . 88.1 mt -89.04 121.14 31.09 Favored 'General case' 0 C--N 1.351 0.645 0 N-CA-C 103.519 -2.771 . . . . 0.0 103.519 178.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.39 119.45 23.11 Favored 'General case' 0 C--N 1.349 0.584 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.88 75.84 0.04 OUTLIER Glycine 0 C--N 1.348 1.245 0 CA-C-N 113.087 -1.869 . . . . 0.0 109.711 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.426 HG12 ' SG ' ' A' ' 78' ' ' CYS . 0.6 OUTLIER -115.41 30.7 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.616 0 CA-C-N 112.122 -2.039 . . . . 0.0 106.292 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.473 ' HB3' HH22 ' A' ' 115' ' ' ARG . 72.9 mmtt -142.63 119.0 10.88 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 104.699 -2.334 . . . . 0.0 104.699 -178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.467 HD12 HD13 ' A' ' 74' ' ' LEU . 0.3 OUTLIER -140.3 112.22 7.57 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -107.83 83.84 1.86 Allowed 'General case' 0 C--N 1.356 0.874 0 N-CA-C 102.443 -3.169 . . . . 0.0 102.443 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -89.6 99.17 8.97 Favored 'Isoleucine or valine' 0 C--N 1.348 0.522 0 CA-C-N 111.453 -2.612 . . . . 0.0 111.044 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -73.25 122.77 8.11 Favored Glycine 0 CA--C 1.534 1.235 0 CA-C-N 110.184 -3.189 . . . . 0.0 110.299 177.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.6 -98.39 2.42 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 106.793 -2.523 . . . . 0.0 106.793 -177.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 58.3 t30 64.89 -97.13 0.05 Allowed 'General case' 0 C--N 1.352 0.682 0 CA-C-N 112.48 -1.86 . . . . 0.0 107.616 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.628 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -85.07 111.89 21.27 Favored 'Isoleucine or valine' 0 C--N 1.346 0.456 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.8 t -79.28 168.58 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.628 0 CA-C-N 111.078 -2.783 . . . . 0.0 108.251 -179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.6 p 40.32 57.35 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.602 -2.09 . . . . 0.0 112.46 179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -173.25 151.34 13.5 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-N 112.16 -2.291 . . . . 0.0 109.508 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -173.6 131.83 0.45 Allowed 'General case' 0 C--N 1.348 0.541 0 N-CA-C 104.28 -2.489 . . . . 0.0 104.28 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 87.9 -71.6 0.02 OUTLIER 'General case' 0 C--N 1.356 0.848 0 O-C-N 126.113 2.133 . . . . 0.0 105.534 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -92.61 145.43 24.43 Favored 'General case' 0 C--N 1.349 0.554 0 N-CA-C 104.54 -2.393 . . . . 0.0 104.54 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.488 ' CZ3' HD13 ' A' ' 94' ' ' ILE . 87.3 m95 -129.39 160.29 64.98 Favored Pre-proline 0 C--N 1.351 0.655 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -70.41 -150.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.372 1.766 0 N-CA-C 108.03 -1.565 . . . . 0.0 108.03 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.02 -26.68 63.22 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 113.499 -1.682 . . . . 0.0 108.352 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.527 HG23 ' H ' ' A' ' 105' ' ' GLU . 0.0 OUTLIER -52.85 -72.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 124.881 1.363 . . . . 0.0 110.362 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.527 ' H ' HG23 ' A' ' 104' ' ' VAL . 19.7 mt-10 -90.39 24.72 2.48 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 117.807 -1.557 . . . . 0.0 109.635 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -68.9 -47.72 65.11 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 103.495 -2.779 . . . . 0.0 103.495 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -90.13 -20.08 23.54 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 111.575 -2.557 . . . . 0.0 109.716 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.1 m-30 -84.17 -45.93 12.43 Favored 'General case' 0 C--N 1.364 1.237 0 C-N-CA 117.977 -1.489 . . . . 0.0 108.879 -178.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 23.0 mmtt -80.33 -0.38 36.52 Favored 'General case' 0 C--N 1.348 0.542 0 O-C-N 124.949 1.406 . . . . 0.0 108.252 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -36.42 79.81 Favored 'General case' 0 C--N 1.366 1.315 0 N-CA-C 105.128 -2.175 . . . . 0.0 105.128 175.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 4.8 mpp? -87.77 -50.85 6.2 Favored 'General case' 0 C--N 1.358 0.941 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 52.67 37.08 50.3 Favored Glycine 0 C--N 1.363 2.04 0 N-CA-C 116.384 1.313 . . . . 0.0 116.384 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -79.17 -7.44 58.21 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 176.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.01 133.09 50.39 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 104.79 -2.3 . . . . 0.0 104.79 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.473 HH22 ' HB3' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -110.04 169.97 8.38 Favored 'General case' 0 C--N 1.346 0.454 0 N-CA-C 102.511 -3.144 . . . . 0.0 102.511 177.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 27.6 m -140.13 166.66 19.79 Favored 'Isoleucine or valine' 0 C--N 1.343 0.302 0 CA-C-N 113.67 -1.604 . . . . 0.0 107.284 178.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.596 ' CE2' H102 ' A' ' 139' ' ' DBI . 1.2 m-85 -99.62 150.69 37.02 Favored Pre-proline 0 C--N 1.35 0.616 0 N-CA-C 103.369 -2.826 . . . . 0.0 103.369 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -65.47 160.02 44.93 Favored 'Trans proline' 0 C--N 1.368 1.561 0 C-N-CA 122.095 1.863 . . . . 0.0 108.708 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -70.81 122.02 8.45 Favored 'Trans proline' 0 C--N 1.371 1.762 0 N-CA-C 105.219 -2.646 . . . . 0.0 105.219 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.8 -170.27 13.26 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 106.866 -2.494 . . . . 0.0 106.866 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 7.4 p -69.77 146.03 51.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 104.945 -2.243 . . . . 0.0 104.945 178.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.16 76.17 8.69 Favored Pre-proline 0 N--CA 1.438 -1.025 0 N-CA-C 104.386 -2.45 . . . . 0.0 104.386 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.57 -20.72 13.63 Favored 'Trans proline' 0 C--N 1.369 1.655 0 O-C-N 123.422 1.222 . . . . 0.0 110.222 -178.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.92 -32.81 51.88 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.422 -1.263 . . . . 0.0 109.374 -177.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 1.7 m -77.73 -11.38 59.87 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 114.097 -1.411 . . . . 0.0 109.036 -177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 129' ' ' ASP . 30.9 p -89.3 -20.93 23.47 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 118.387 -1.325 . . . . 0.0 109.127 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.0 mt -66.69 -26.55 37.54 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.082 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 175.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.29 -2.99 57.27 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.459 -2.155 . . . . 0.0 108.578 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.631 ' O ' HG23 ' A' ' 133' ' ' VAL . 48.3 t0 -53.06 -60.58 3.1 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.158 1.456 . . . . 0.0 107.261 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.639 ' HG2' HD13 ' A' ' 134' ' ' LEU . 3.0 ttp -90.02 -22.45 21.87 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 110.643 -2.98 . . . . 0.0 111.034 -176.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -86.48 -13.37 46.28 Favored 'General case' 0 C--N 1.352 0.705 0 C-N-CA 118.108 -1.437 . . . . 0.0 110.921 -175.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -90.21 -55.6 3.54 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-O 122.439 1.114 . . . . 0.0 108.366 -178.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 129' ' ' ASP . 88.1 t -63.65 -53.07 49.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 112.361 -2.2 . . . . 0.0 114.197 -176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.639 HD13 ' HG2' ' A' ' 130' ' ' MET . 3.8 mp -89.16 -12.12 41.91 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 124.37 1.044 . . . . 0.0 109.646 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -90.54 -78.34 1.35 Allowed Glycine 0 C--N 1.357 1.704 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.22 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 t -163.21 149.01 3.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 CA-C-N 113.64 -1.28 . . . . 0.0 108.69 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 . . . . . 0 CA--C 1.546 0.82 0 CA-C-N 111.876 -2.42 . . . . 0.0 107.959 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.596 H102 ' CE2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.447 -0.608 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -131.74 37.97 3.6 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -79.72 143.24 34.71 Favored 'General case' 0 N--CA 1.436 -1.156 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER -79.24 95.21 5.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 110.786 -2.916 . . . . 0.0 108.817 -177.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.39 115.18 0.01 OUTLIER 'General case' 0 C--N 1.357 0.929 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.0 119.48 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.8 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.77 126.52 49.47 Favored 'Isoleucine or valine' 0 C--N 1.351 0.653 0 CA-C-N 112.285 -2.234 . . . . 0.0 108.385 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.43 HD11 ' HG ' ' A' ' 23' ' ' LEU . 56.9 tp -125.15 140.96 52.41 Favored 'General case' 0 C--N 1.357 0.929 0 CA-C-N 113.911 -1.495 . . . . 0.0 107.182 -178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 155.57 173.96 24.86 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 113.488 -1.687 . . . . 0.0 109.289 179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.997 HG23 HG22 ' A' ' 60' ' ' VAL . 2.2 p 164.98 -120.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.227 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 -179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -175.27 -145.47 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.514 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -178.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 96.49 83.49 1.67 Allowed Glycine 0 C--N 1.361 1.948 0 N-CA-C 106.808 -2.517 . . . . 0.0 106.808 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 16.2 t -90.41 74.61 6.89 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 113.594 -1.303 . . . . 0.0 107.968 -177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -83.14 -30.95 27.47 Favored 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 104.483 -2.414 . . . . 0.0 104.483 176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.5 p -157.37 -40.89 0.07 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 128.449 2.699 . . . . 0.0 104.595 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -166.98 -65.63 0.03 OUTLIER 'General case' 0 C--N 1.369 1.432 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 133.54 100.87 0.0 OUTLIER 'General case' 0 C--N 1.353 0.741 0 O-C-N 127.018 2.699 . . . . 0.0 105.34 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.7 p -85.64 65.94 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 CA-C-N 113.626 -1.624 . . . . 0.0 108.636 175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.548 ' O ' HD23 ' A' ' 23' ' ' LEU . . . -91.37 -19.16 42.79 Favored Glycine 0 C--N 1.354 1.575 0 CA-C-N 113.66 -1.609 . . . . 0.0 111.202 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.416 ' O ' ' N ' ' A' ' 22' ' ' ILE . 52.6 m-80 -45.04 -54.07 7.1 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 111.57 -2.315 . . . . 0.0 105.13 178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -6.68 50.17 0.0 OUTLIER 'General case' 0 C--N 1.38 1.907 2 C-N-CA 140.32 7.448 . . . . 0.0 109.445 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.356 0.0 OUTLIER 36.94 48.36 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.633 2 CA-C-N 106.731 -4.759 . . . . 0.0 108.557 -178.925 . . . . . . . . 5 4 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.574 HD12 ' SG ' ' A' ' 59' ' ' CYS . 1.7 mm? -68.35 -33.31 74.06 Favored 'General case' 0 CA--C 1.581 2.148 0 N-CA-C 102.547 -3.131 . . . . 0.0 102.547 173.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.49 6.49 4.6 Favored 'General case' 0 C--N 1.363 1.171 0 CA-C-N 110.971 -2.831 . . . . 0.0 107.817 176.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 22' ' ' ILE . 2.0 t60 -76.0 -41.72 50.29 Favored 'General case' 0 C--N 1.356 0.879 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -51.8 -44.83 63.62 Favored 'General case' 0 C--N 1.349 0.586 0 CA-C-N 111.318 -2.673 . . . . 0.0 109.601 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER -54.12 -41.35 68.24 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.363 -178.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 -21.67 44.58 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 112.666 -2.061 . . . . 0.0 113.581 -175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -78.82 -5.41 53.38 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 112.758 -2.019 . . . . 0.0 110.751 -176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -149.36 10.02 0.75 Allowed 'General case' 0 C--N 1.355 0.814 0 C-N-CA 115.984 -2.286 . . . . 0.0 109.215 178.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.64 40.32 97.43 Favored Glycine 0 C--N 1.352 1.424 0 C-N-CA 118.672 -1.727 . . . . 0.0 110.658 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.2 m-30 -99.31 151.45 21.05 Favored 'General case' 0 C--N 1.349 0.586 0 N-CA-C 104.562 -2.385 . . . . 0.0 104.562 -179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 21.8 t30 -76.98 136.64 38.75 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 111.479 -2.6 . . . . 0.0 105.932 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.96 148.0 7.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.49 0 CA-C-N 112.304 -2.225 . . . . 0.0 107.011 178.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.11 67.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 111.172 -2.74 . . . . 0.0 106.982 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -70.81 115.3 9.8 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 113.304 -1.771 . . . . 0.0 106.58 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 6.4 tt -94.38 -2.35 10.68 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 112.344 -2.207 . . . . 0.0 108.636 -179.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 -115.11 3.99 Favored Glycine 0 C--N 1.357 1.713 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.402 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.434 ' HA ' ' H ' ' A' ' 10' ' ' VAL . 0.8 OUTLIER -143.94 51.86 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.66 0 CA-C-N 113.568 -1.316 . . . . 0.0 109.507 -179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.3 mt -115.27 150.51 36.09 Favored 'General case' 0 C--N 1.351 0.664 0 CA-C-N 112.828 -1.987 . . . . 0.0 105.644 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.5 t -112.13 31.31 6.35 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-N 113.059 -1.882 . . . . 0.0 106.043 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 69.3 p -82.35 97.58 8.4 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 178.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -90.05 -56.55 3.18 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 112.471 -2.15 . . . . 0.0 108.85 -176.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.73 -24.84 67.69 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 124.749 1.281 . . . . 0.0 110.889 -177.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -88.0 -32.83 18.63 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -88.16 2.91 51.06 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 117.94 -1.504 . . . . 0.0 109.027 -179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -84.01 -31.17 7.79 Favored 'Isoleucine or valine' 0 C--N 1.356 0.852 0 N-CA-C 103.263 -2.865 . . . . 0.0 103.263 176.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -72.9 -27.4 61.86 Favored 'General case' 0 C--N 1.366 1.284 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 177.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.48 -4.43 55.53 Favored 'General case' 0 C--N 1.362 1.124 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -86.89 -8.61 57.11 Favored 'General case' 0 C--N 1.354 0.802 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.99 -40.32 13.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.65 -64.08 1.07 Allowed 'General case' 0 C--N 1.355 0.81 0 CA-C-N 112.388 -2.187 . . . . 0.0 109.46 -179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.46 -62.0 1.57 Allowed 'General case' 0 C--N 1.359 0.991 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? 112.32 45.78 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.497 0 O-C-N 127.052 2.72 . . . . 0.0 104.85 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -52.46 112.1 0.76 Allowed 'General case' 0 C--N 1.358 0.953 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 -178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -91.85 -81.69 0.33 Allowed 'General case' 0 C--N 1.358 0.94 0 CA-C-N 113.423 -1.717 . . . . 0.0 106.711 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.52 130.77 37.3 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 124.737 1.273 . . . . 0.0 108.333 -177.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -92.6 162.46 2.4 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 CA-C-N 112.84 -1.982 . . . . 0.0 106.297 179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . 0.574 ' SG ' HD12 ' A' ' 23' ' ' LEU . 21.5 t -156.99 104.65 2.11 Favored 'General case' 0 C--N 1.351 0.642 0 CA-C-N 112.643 -2.071 . . . . 0.0 105.702 179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.997 HG22 HG23 ' A' ' 10' ' ' VAL . 2.1 p -110.35 129.9 64.6 Favored 'Isoleucine or valine' 0 C--N 1.355 0.825 0 N-CA-C 105.173 -2.158 . . . . 0.0 105.173 179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.731 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.0 OUTLIER -116.99 111.32 19.42 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 117.426 -1.71 . . . . 0.0 108.767 -177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.4 t 145.36 173.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.638 0 CA-C-N 111.27 -2.695 . . . . 0.0 104.52 177.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.5 mt -73.04 -129.08 0.0 OUTLIER 'General case' 0 C--N 1.353 0.757 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -82.38 80.81 8.45 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 104.722 -2.325 . . . . 0.0 104.722 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -129.21 53.95 0.79 Allowed Glycine 0 C--N 1.348 1.197 0 CA-C-N 111.572 -2.558 . . . . 0.0 107.33 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' H ' ' H ' ' A' ' 67' ' ' GLY . 12.9 pt20 -165.52 -20.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 111.689 -2.256 . . . . 0.0 107.654 -179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.434 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 81.82 177.19 51.66 Favored Glycine 0 C--N 1.349 1.3 0 CA-C-N 114.523 -1.217 . . . . 0.0 110.339 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -86.92 9.41 19.43 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.222 -1.489 . . . . 0.0 108.101 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -84.68 -51.54 13.66 Favored 'Isoleucine or valine' 0 C--N 1.354 0.796 0 N-CA-C 104.575 -2.38 . . . . 0.0 104.575 179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -72.51 -27.79 62.47 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 112.284 -2.234 . . . . 0.0 108.502 -178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 10.7 t -68.49 -57.19 6.2 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.4 mtmm -90.18 27.81 1.56 Allowed 'General case' 0 C--N 1.359 1.021 0 O-C-N 124.754 1.284 . . . . 0.0 109.025 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -100.67 -30.23 6.24 Favored Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 12.4 mt -90.12 -30.02 17.93 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-N 112.637 -1.781 . . . . 0.0 107.211 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.509 ' HG3' HH11 ' A' ' 75' ' ' ARG . 1.4 mmt85 -71.31 -31.89 67.96 Favored 'General case' 0 C--N 1.352 0.695 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -75.21 -31.89 61.03 Favored 'General case' 0 C--N 1.358 0.967 0 CA-C-N 113.503 -1.68 . . . . 0.0 108.03 178.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -71.52 -16.09 62.32 Favored 'General case' 0 CA--C 1.549 0.936 0 O-C-N 124.298 0.999 . . . . 0.0 109.763 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 50.8 t -90.25 -48.06 7.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 123.169 1.461 . . . . 0.0 108.237 -177.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . 0.307 2.4 p30 -76.63 3.58 11.26 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 109.727 -3.397 . . . . 0.0 109.389 178.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -81.24 -54.89 5.12 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 176.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.97 40.34 12.43 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.841 -2.89 . . . . 0.0 107.409 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.07 -48.08 0.04 OUTLIER Glycine 0 C--N 1.35 1.309 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.5 mt -86.58 121.18 28.75 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.687 -3.079 . . . . 0.0 102.687 177.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.29 121.98 33.51 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.94 -177.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.32 78.46 0.04 OUTLIER Glycine 0 C--N 1.351 1.385 0 CA-C-N 112.444 -2.162 . . . . 0.0 109.966 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -106.52 33.95 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.673 -1.763 . . . . 0.0 106.672 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.09 113.08 4.22 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 103.633 -2.728 . . . . 0.0 103.633 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -135.96 111.19 9.01 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -99.61 87.61 3.62 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 -179.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.479 HG22 HG12 ' A' ' 116' ' ' VAL . 33.9 m -89.43 96.32 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 111.184 -2.735 . . . . 0.0 110.119 -176.094 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' HA2' ' H ' ' A' ' 117' ' ' TYR . . . -71.78 101.24 0.99 Allowed Glycine 0 CA--C 1.531 1.088 0 CA-C-N 108.94 -3.755 . . . . 0.0 110.366 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.78 -108.42 3.09 Favored Glycine 0 C--N 1.351 1.4 0 CA-C-N 112.37 -1.915 . . . . 0.0 109.766 -179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.5 t30 68.96 -110.79 0.09 Allowed 'General case' 0 C--N 1.357 0.902 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.491 ' H ' HD12 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -79.18 129.59 37.36 Favored 'Isoleucine or valine' 0 C--N 1.348 0.542 0 N-CA-C 104.419 -2.437 . . . . 0.0 104.419 178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.89 174.8 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 112.521 -2.127 . . . . 0.0 108.487 -179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p 41.58 80.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.85 0 CA-C-N 112.038 -2.346 . . . . 0.0 112.623 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 165.08 156.13 8.91 Favored Glycine 0 C--N 1.347 1.17 0 CA-C-N 111.972 -2.377 . . . . 0.0 109.086 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -168.78 93.35 0.31 Allowed 'General case' 0 C--N 1.348 0.526 0 N-CA-C 103.852 -2.647 . . . . 0.0 103.852 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 95.56 -47.98 0.01 OUTLIER 'General case' 0 C--N 1.355 0.828 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -89.37 122.76 32.91 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 96.3 m95 -135.64 160.84 66.15 Favored Pre-proline 0 C--N 1.349 0.581 0 N-CA-C 105.603 -1.999 . . . . 0.0 105.603 -179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.8 -149.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 121.773 1.649 . . . . 0.0 108.239 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.86 -21.2 60.98 Favored 'General case' 0 C--N 1.352 0.711 0 CA-C-N 113.781 -1.554 . . . . 0.0 108.642 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.556 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.8 p -57.32 -70.76 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.78 0 O-C-N 124.619 1.199 . . . . 0.0 111.236 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.556 ' H ' HG13 ' A' ' 104' ' ' VAL . 12.2 mm-40 -88.35 21.49 2.84 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 117.33 -1.748 . . . . 0.0 108.393 -179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -73.12 -43.07 62.2 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 176.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -79.95 -32.05 39.94 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.115 -2.311 . . . . 0.0 107.216 179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -91.04 13.45 16.73 Favored 'General case' 0 C--N 1.362 1.137 0 C-N-CA 118.447 -1.301 . . . . 0.0 109.027 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.49 -38.8 12.99 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 175.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.18 -33.46 73.48 Favored 'General case' 0 C--N 1.36 1.051 0 CA-C-N 112.716 -2.038 . . . . 0.0 107.214 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 46.2 mtp -80.04 -61.5 1.97 Allowed 'General case' 0 C--N 1.355 0.823 0 N-CA-C 103.328 -2.841 . . . . 0.0 103.328 177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.22 35.66 0.02 OUTLIER Glycine 0 C--N 1.355 1.611 0 C-N-CA 127.379 2.419 . . . . 0.0 117.431 178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -89.69 -1.39 58.0 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -105.18 137.21 43.32 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 104.838 -2.282 . . . . 0.0 104.838 178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.13 173.39 6.35 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 103.006 -2.961 . . . . 0.0 103.006 178.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.479 HG12 HG22 ' A' ' 90' ' ' VAL . 18.9 m -140.09 156.4 24.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.71 0 O-C-N 124.499 1.124 . . . . 0.0 109.198 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.639 ' CD2' H102 ' A' ' 139' ' ' DBI . 2.0 m-85 -99.72 150.14 36.55 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 177.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.24 166.36 5.96 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.123 2.549 . . . . 0.0 109.045 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 -92.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.372 1.798 0 N-CA-C 104.436 -2.948 . . . . 0.0 104.436 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -47.38 131.64 14.98 Favored Glycine 0 C--N 1.359 1.854 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 12.6 t -64.84 162.92 15.27 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-O 125.494 2.569 . . . . 0.0 109.189 -176.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -170.73 114.35 0.45 Allowed Pre-proline 0 N--CA 1.431 -1.415 1 CA-C-N 106.235 -4.984 . . . . 0.0 100.941 -178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.68 -4.03 13.82 Favored 'Trans proline' 0 C--N 1.363 1.317 0 O-C-N 122.41 0.689 . . . . 0.0 111.335 -178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -66.99 -23.05 65.89 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.958 1.303 . . . . 0.0 108.96 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.59 -28.05 51.5 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.17 -177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.481 ' C ' ' H ' ' A' ' 129' ' ' ASP . 77.9 p -80.65 -18.68 47.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 116.872 -1.931 . . . . 0.0 109.968 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 2.7 mt -66.56 -25.55 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.12 -4.01 46.97 Favored 'General case' 0 N--CA 1.434 -1.238 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.387 178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.486 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.7 t0 -52.73 -62.36 1.7 Allowed 'General case' 0 C--N 1.369 1.421 0 CA-C-O 123.781 1.753 . . . . 0.0 106.832 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 45.9 ttm -90.12 -25.8 20.54 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 109.574 -3.467 . . . . 0.0 111.383 -176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -78.52 -13.0 60.04 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 117.709 -1.596 . . . . 0.0 110.316 -176.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -88.98 -56.23 3.37 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 129' ' ' ASP . 45.3 t -63.18 -34.49 67.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 CA-C-N 113.068 -1.878 . . . . 0.0 113.611 -177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 12.6 mt -81.93 -33.02 30.55 Favored 'General case' 0 C--N 1.353 0.758 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -70.63 -86.04 0.15 Allowed Glycine 0 C--N 1.352 1.463 0 O-C-N 124.55 1.156 . . . . 0.0 111.483 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.3 t -92.23 164.42 2.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.502 0 CA-C-N 112.527 -1.836 . . . . 0.0 108.698 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--N 1.352 0.702 0 CA-C-N 112.709 -2.041 . . . . 0.0 107.715 178.687 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.639 H102 ' CD2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.0 ttp . . . . . 0 N--CA 1.445 -0.686 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -119.82 68.75 0.83 Allowed 'General case' 0 C--N 1.352 0.696 0 N-CA-C 104.293 -2.484 . . . . 0.0 104.293 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -79.07 169.28 18.44 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 112.708 -2.042 . . . . 0.0 108.601 -178.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -103.84 104.79 14.83 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 109.065 -3.698 . . . . 0.0 108.589 -177.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 172.32 99.38 0.01 OUTLIER 'General case' 0 C--N 1.355 0.804 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -129.85 109.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.186 0 N-CA-C 103.628 -2.73 . . . . 0.0 103.628 -176.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.52 127.8 58.6 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 CA-C-N 112.344 -2.207 . . . . 0.0 110.775 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.458 ' HB3' HD12 ' A' ' 23' ' ' LEU . 2.0 pp -125.28 136.19 53.26 Favored 'General case' 0 C--N 1.352 0.684 0 CA-C-N 112.515 -2.129 . . . . 0.0 105.721 178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.29 171.11 44.27 Favored Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.405 -2.634 . . . . 0.0 108.343 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.931 ' HB ' ' H ' ' A' ' 61' ' ' SER . 2.9 p 164.42 -122.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.37 1.464 0 N-CA-C 115.937 1.829 . . . . 0.0 115.937 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.515 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.2 tp -168.68 -149.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.379 1.884 0 N-CA-C 105.997 -1.853 . . . . 0.0 105.997 -179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 174.82 -142.11 6.15 Favored Glycine 0 C--N 1.357 1.711 0 C-N-CA 118.76 -1.686 . . . . 0.0 110.234 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.5 -60.83 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -79.82 151.5 30.24 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 113.053 -1.885 . . . . 0.0 106.987 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.4 t 68.49 -108.83 0.09 Allowed 'General case' 0 C--N 1.362 1.114 0 O-C-N 125.272 1.608 . . . . 0.0 107.232 178.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 73.5 t60 -164.16 44.14 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 -178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.23 43.68 13.57 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 113.912 -1.494 . . . . 0.0 107.871 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.55 106.97 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.081 0 O-C-N 124.642 1.214 . . . . 0.0 110.922 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -98.76 -21.97 14.97 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 112.619 -2.082 . . . . 0.0 110.256 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.421 ' O ' ' N ' ' A' ' 22' ' ' ILE . 85.8 m-20 -41.83 -53.15 3.82 Favored 'General case' 0 C--N 1.365 1.274 0 CA-C-N 111.671 -2.265 . . . . 0.0 104.969 178.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -9.12 54.05 0.0 OUTLIER 'General case' 0 C--N 1.373 1.62 2 C-N-CA 140.354 7.462 . . . . 0.0 108.265 175.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.336 0.2 OUTLIER 31.05 42.1 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.411 -2.39 2 CA-C-N 106.898 -4.683 . . . . 0.0 109.149 -177.897 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 8' ' ' LEU . 0.2 OUTLIER -81.12 -35.18 31.91 Favored 'General case' 0 C--N 1.359 1.014 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 176.739 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -78.2 -0.85 30.09 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 113.286 -1.779 . . . . 0.0 107.163 177.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.6 t-160 -78.18 -35.07 49.2 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 27.7 p -56.58 -44.31 80.91 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 112.486 -2.143 . . . . 0.0 111.072 -178.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.824 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.55 -43.5 75.9 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 113.739 -1.573 . . . . 0.0 108.889 -178.342 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.96 -26.82 62.41 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 111.865 -2.425 . . . . 0.0 112.648 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -79.68 0.49 30.15 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 112.072 -2.331 . . . . 0.0 109.149 -178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -141.6 11.3 2.08 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 118.199 -1.4 . . . . 0.0 108.031 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.6 34.44 55.72 Favored Glycine 0 C--N 1.357 1.723 0 O-C-N 124.289 0.993 . . . . 0.0 112.882 179.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -99.67 -177.43 3.57 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.098 -1.816 . . . . 0.0 106.098 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -89.39 145.21 25.5 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.365 -2.198 . . . . 0.0 106.55 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.824 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.3 OUTLIER -99.93 135.41 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 110.777 -2.92 . . . . 0.0 107.262 179.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.25 76.41 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.419 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.636 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -88.91 120.75 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -92.29 -92.98 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.689 0 CA-C-N 111.985 -2.37 . . . . 0.0 104.924 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 173.12 -140.42 5.63 Favored Glycine 0 C--N 1.349 1.302 0 N-CA-C 108.907 -1.677 . . . . 0.0 108.907 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.5 m -91.41 4.03 6.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 113.121 -1.54 . . . . 0.0 110.671 179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 95.1 mt -87.06 99.54 11.98 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 103.563 -2.755 . . . . 0.0 103.563 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.0 t -97.5 54.6 1.2 Allowed 'General case' 0 C--N 1.353 0.718 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 -179.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 56.9 p -90.08 85.35 6.28 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 102.846 -3.02 . . . . 0.0 102.846 178.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.464 ' CD ' HD21 ' A' ' 74' ' ' LEU . 6.1 tp-100 -68.27 -47.65 67.15 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 113.122 -1.853 . . . . 0.0 109.836 -176.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -36.53 84.56 Favored 'General case' 0 C--N 1.353 0.718 0 O-C-N 124.636 1.21 . . . . 0.0 109.529 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -77.9 -21.94 50.45 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -85.47 -2.23 57.91 Favored 'General case' 0 C--N 1.36 1.037 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.46 -35.69 33.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -75.6 -33.01 60.53 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 113.008 -1.905 . . . . 0.0 107.826 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.57 7.09 43.06 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 119.163 -1.015 . . . . 0.0 108.903 -179.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.428 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.21 -21.73 22.01 Favored 'General case' 0 C--N 1.355 0.817 0 N-CA-C 105.535 -2.024 . . . . 0.0 105.535 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -74.47 -38.46 46.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 N-CA-C 104.795 -2.298 . . . . 0.0 104.795 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -59.7 -69.05 0.23 Allowed 'General case' 0 C--N 1.354 0.787 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.029 -179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.407 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -72.37 -57.97 3.77 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.158 -176.573 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.407 ' CB ' ' O ' ' A' ' 53' ' ' THR . 63.7 tttt 120.47 48.15 0.0 OUTLIER 'General case' 0 C--N 1.355 0.835 0 O-C-N 126.672 2.483 . . . . 0.0 107.705 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.428 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -49.36 106.62 0.11 Allowed 'General case' 0 C--N 1.355 0.819 0 CA-C-O 122.061 0.934 . . . . 0.0 110.027 -178.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -79.87 -38.95 31.6 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 177.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.641 ' CD2' HD11 ' A' ' 134' ' ' LEU . 2.6 pp -151.1 167.52 27.46 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 177.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.552 HD13 HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -142.04 150.75 18.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.915 0 CA-C-N 112.081 -2.327 . . . . 0.0 105.839 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.2 t -145.69 134.78 22.72 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.38 135.28 40.2 Favored 'Isoleucine or valine' 0 C--N 1.358 0.937 0 CA-C-N 112.855 -1.975 . . . . 0.0 106.806 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.931 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.14 91.12 3.54 Favored 'General case' 0 CA--C 1.557 1.235 0 N-CA-C 106.284 -1.747 . . . . 0.0 106.284 179.112 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 6.5 t 150.62 165.92 0.0 OUTLIER 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.0 mt -69.8 -127.84 0.0 OUTLIER 'General case' 0 C--N 1.359 1.007 0 CA-C-N 113.52 -1.673 . . . . 0.0 107.308 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.82 86.4 7.36 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 -179.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -139.84 42.56 1.21 Allowed Glycine 0 C--N 1.344 1.015 0 CA-C-N 110.92 -2.855 . . . . 0.0 106.928 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.413 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -147.08 -32.61 0.3 Allowed 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 111.143 -2.528 . . . . 0.0 106.841 -178.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.49 167.84 43.35 Favored Glycine 0 C--N 1.343 0.938 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -77.51 1.55 19.0 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 113.614 -1.293 . . . . 0.0 108.992 -178.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.86 -47.07 17.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.849 0 N-CA-C 105.985 -1.858 . . . . 0.0 105.985 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -72.27 -27.06 62.24 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 114.303 -1.317 . . . . 0.0 107.66 -179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 93.3 m -68.29 -47.7 66.94 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 178.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -90.12 26.6 1.83 Allowed 'General case' 0 C--N 1.362 1.122 0 O-C-N 124.909 1.381 . . . . 0.0 108.829 179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -95.7 -34.96 5.79 Favored Glycine 0 CA--C 1.528 0.864 0 N-CA-C 108.54 -1.824 . . . . 0.0 108.54 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.464 HD21 ' CD ' ' A' ' 43' ' ' GLN . 1.6 mt -88.84 -28.14 20.59 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 112.032 -2.084 . . . . 0.0 107.712 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.06 -24.43 58.23 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -82.04 -29.08 32.13 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 52.8 tttp -76.6 -15.66 59.78 Favored 'General case' 0 CA--C 1.551 0.982 0 O-C-N 124.31 1.006 . . . . 0.0 109.189 -179.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 20.7 t -90.29 -47.71 7.59 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-O 123.982 1.849 . . . . 0.0 107.115 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.91 -3.61 23.5 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-N 108.478 -3.965 . . . . 0.0 109.158 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -82.01 -56.08 4.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 177.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.01 47.65 5.69 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 110.932 -2.849 . . . . 0.0 106.616 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -155.95 -44.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.328 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.73 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 23.0 mt -79.81 120.9 24.7 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.55 134.14 34.42 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 136.47 56.96 0.06 OUTLIER Glycine 0 C--N 1.349 1.284 0 CA-C-N 112.733 -2.03 . . . . 0.0 110.266 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 tt -104.7 47.55 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.745 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -142.51 118.17 10.42 Favored 'General case' 0 C--N 1.347 0.472 0 N-CA-C 102.258 -3.238 . . . . 0.0 102.258 178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.552 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -140.04 151.84 45.74 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 112.898 -1.955 . . . . 0.0 106.205 -177.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.34 91.41 2.44 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 101.7 -3.444 . . . . 0.0 101.7 177.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.4 m -89.35 99.11 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 126.039 2.828 . . . . 0.0 110.339 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.08 109.08 2.71 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 108.498 -3.955 . . . . 0.0 109.358 177.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.8 -101.65 2.23 Favored Glycine 0 C--N 1.349 1.262 0 CA-C-N 112.244 -1.978 . . . . 0.0 109.353 -178.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 50.5 t30 64.65 -104.84 0.12 Allowed 'General case' 0 C--N 1.356 0.862 0 N-CA-C 105.442 -2.058 . . . . 0.0 105.442 -179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.14 124.88 56.32 Favored 'Isoleucine or valine' 0 C--N 1.347 0.471 0 N-CA-C 103.722 -2.696 . . . . 0.0 103.722 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.35 176.95 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 CA-C-N 112.858 -1.974 . . . . 0.0 108.505 -179.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.51 56.17 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.838 0 CA-C-N 112.722 -2.036 . . . . 0.0 112.462 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.77 141.35 5.15 Favored Glycine 0 C--N 1.349 1.259 0 CA-C-N 112.284 -2.235 . . . . 0.0 109.142 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.3 106.22 0.24 Allowed 'General case' 0 C--N 1.35 0.608 0 N-CA-C 104.048 -2.575 . . . . 0.0 104.048 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.17 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.355 0.829 0 O-C-N 126.032 2.083 . . . . 0.0 105.608 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -89.49 130.69 35.79 Favored 'General case' 0 C--N 1.352 0.684 0 N-CA-C 103.614 -2.735 . . . . 0.0 103.614 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -142.99 158.84 58.18 Favored Pre-proline 0 C--N 1.352 0.697 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -71.77 -148.98 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.853 0 N-CA-C 107.442 -1.792 . . . . 0.0 107.442 177.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.97 -22.34 60.71 Favored 'General case' 0 C--N 1.353 0.739 0 CA-C-N 114.004 -1.453 . . . . 0.0 109.0 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.486 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.35 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.804 0 O-C-N 124.519 1.137 . . . . 0.0 111.309 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.486 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.3 mm-40 -89.85 22.95 2.91 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 117.391 -1.723 . . . . 0.0 108.338 -179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -74.35 -42.13 59.88 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 104.666 -2.346 . . . . 0.0 104.666 176.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -79.65 -32.07 41.57 Favored 'General case' 0 C--N 1.351 0.669 0 CA-C-N 112.104 -2.316 . . . . 0.0 106.877 178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -92.72 15.97 13.32 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 118.348 -1.341 . . . . 0.0 108.841 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.47 -40.56 11.94 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 103.723 -2.695 . . . . 0.0 103.723 176.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.27 -35.15 74.86 Favored 'General case' 0 C--N 1.36 1.023 0 CA-C-N 112.355 -2.202 . . . . 0.0 107.473 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 48.4 mtp -80.78 -58.69 2.98 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 103.875 -2.639 . . . . 0.0 103.875 178.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 32.11 40.67 0.08 OUTLIER Glycine 0 C--N 1.353 1.515 0 C-N-CA 127.347 2.403 . . . . 0.0 117.32 177.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.5 p90 -84.62 -6.29 59.36 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -103.62 132.08 50.19 Favored 'General case' 0 C--N 1.353 0.731 0 N-CA-C 105.427 -2.064 . . . . 0.0 105.427 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.06 -178.26 3.47 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 102.01 -3.33 . . . . 0.0 102.01 178.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 25.9 m -140.07 161.09 26.04 Favored 'Isoleucine or valine' 0 C--N 1.352 0.679 0 C-N-CA 117.729 -1.588 . . . . 0.0 110.227 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.489 ' CE2' H102 ' A' ' 139' ' ' DBI . 5.6 m-85 -99.36 154.35 37.33 Favored Pre-proline 0 C--N 1.352 0.705 0 CA-C-N 110.532 -3.031 . . . . 0.0 103.679 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.26 159.73 43.32 Favored 'Trans proline' 0 C--N 1.368 1.554 0 N-CA-C 107.173 -1.895 . . . . 0.0 107.173 -178.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.02 116.46 4.66 Favored 'Trans proline' 0 C--N 1.369 1.649 0 N-CA-C 103.763 -3.206 . . . . 0.0 103.763 178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.81 132.79 5.57 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 105.838 -2.905 . . . . 0.0 105.838 -177.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 14.4 t -73.62 159.61 32.82 Favored 'General case' 0 C--N 1.355 0.836 0 CA-C-O 125.25 2.452 . . . . 0.0 107.67 -178.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 10.5 p -173.4 119.57 0.39 Allowed Pre-proline 0 N--CA 1.427 -1.607 1 CA-C-N 106.484 -4.871 . . . . 0.0 101.537 -178.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 71.5 Cg_endo -78.93 -4.53 14.02 Favored 'Trans proline' 0 C--N 1.358 1.041 0 N-CA-C 108.698 -1.309 . . . . 0.0 108.698 -179.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -64.29 -37.38 87.29 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 126.462 1.905 . . . . 0.0 107.619 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.87 -23.71 59.63 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 113.615 -1.629 . . . . 0.0 108.148 -178.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.4 p -81.79 -25.57 35.15 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 116.948 -1.901 . . . . 0.0 109.909 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.4 mt -67.72 -24.87 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 N-CA-C 104.42 -2.437 . . . . 0.0 104.42 176.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.44 -6.48 58.4 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-N 112.969 -1.923 . . . . 0.0 108.714 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.544 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.3 t0 -61.89 -58.03 9.48 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 36.0 mmt -88.15 -10.78 48.87 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 113.069 -1.878 . . . . 0.0 110.874 -177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 39.8 ttpt -90.21 -49.81 6.35 Favored 'General case' 0 C--N 1.351 0.667 0 C-N-CA 117.864 -1.534 . . . . 0.0 109.013 -178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -53.92 -50.27 66.78 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 124.214 0.946 . . . . 0.0 109.868 -177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 129' ' ' ASP . 51.1 t -69.45 -61.36 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 CA-C-N 113.035 -1.893 . . . . 0.0 111.86 -179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.641 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.1 mp -90.38 52.61 2.27 Favored 'General case' 0 C--N 1.351 0.661 0 O-C-N 124.768 1.293 . . . . 0.0 109.876 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -165.75 -77.7 0.03 OUTLIER Glycine 0 C--N 1.351 1.367 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -165.22 149.96 2.2 Favored 'Isoleucine or valine' 0 C--N 1.35 0.627 0 CA-C-N 113.703 -1.248 . . . . 0.0 108.148 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 . . . . . 0 CA--C 1.536 0.405 0 CA-C-N 112.508 -2.133 . . . . 0.0 105.392 -178.883 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.489 H102 ' CE2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.3 ttp . . . . . 0 N--CA 1.445 -0.709 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -95.39 80.26 3.5 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -79.12 161.16 26.68 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 111.891 -2.413 . . . . 0.0 107.802 -178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.464 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 21.2 pttp -119.6 108.91 15.06 Favored 'General case' 0 C--N 1.351 0.663 0 CA-C-N 110.927 -2.851 . . . . 0.0 108.123 -177.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 174.41 85.48 0.0 OUTLIER 'General case' 0 C--N 1.35 0.63 0 N-CA-C 102.029 -3.323 . . . . 0.0 102.029 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.579 ' HB ' ' SD ' ' A' ' 130' ' ' MET . 0.8 OUTLIER -109.86 107.25 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.451 0 CA-C-N 110.721 -2.945 . . . . 0.0 103.751 -176.268 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.706 HG23 HG12 ' A' ' 35' ' ' VAL . 0.8 OUTLIER -113.68 126.35 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.932 0 CA-C-N 111.563 -2.562 . . . . 0.0 111.483 -177.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.27 153.13 43.69 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 112.4 -2.182 . . . . 0.0 106.679 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 176.23 174.07 42.42 Favored Glycine 0 C--N 1.351 1.386 0 CA-C-N 111.137 -2.756 . . . . 0.0 108.171 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.933 ' HB ' ' H ' ' A' ' 61' ' ' SER . 3.0 p 164.48 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.371 1.541 0 N-CA-C 116.12 1.896 . . . . 0.0 116.12 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.521 ' N ' HG13 ' A' ' 10' ' ' VAL . 2.3 tp -168.29 -150.22 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.38 1.904 0 N-CA-C 105.758 -1.942 . . . . 0.0 105.758 -179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.17 -142.17 6.11 Favored Glycine 0 C--N 1.356 1.671 0 C-N-CA 118.681 -1.723 . . . . 0.0 110.327 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -165.87 -61.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 -178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.05 151.8 29.73 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.965 -179.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t 68.91 -109.09 0.09 Allowed 'General case' 0 C--N 1.362 1.139 0 O-C-N 125.116 1.51 . . . . 0.0 107.252 178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -163.93 43.14 0.1 Allowed 'General case' 0 C--N 1.361 1.104 0 C-N-CA 117.218 -1.793 . . . . 0.0 106.308 -178.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 60.17 42.44 15.41 Favored 'General case' 0 C--N 1.356 0.86 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.034 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.4 p -59.15 107.68 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.079 0 O-C-N 124.647 1.217 . . . . 0.0 110.997 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -97.96 -22.13 16.44 Favored Glycine 0 CA--C 1.538 1.512 0 CA-C-N 112.707 -2.042 . . . . 0.0 110.133 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' O ' ' N ' ' A' ' 22' ' ' ILE . 86.1 m-20 -42.33 -52.36 4.56 Favored 'General case' 0 C--N 1.365 1.268 0 CA-C-N 111.639 -2.28 . . . . 0.0 105.034 178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' C ' HD13 ' A' ' 22' ' ' ILE . 88.7 tttt -11.39 56.86 0.0 OUTLIER 'General case' 0 C--N 1.373 1.592 2 C-N-CA 140.014 7.325 . . . . 0.0 107.906 175.548 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.466 ' CG1' ' HB3' ' A' ' 123' ' ' PRO 0.348 0.2 OUTLIER 29.65 42.63 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.332 2 CA-C-N 106.614 -4.812 . . . . 0.0 109.522 -178.213 . . . . . . . . 5 4 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.18 -35.53 25.42 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 176.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.401 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 2.1 p30 -76.95 -2.95 36.35 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-N 113.694 -1.594 . . . . 0.0 106.868 176.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -77.36 -34.97 55.0 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 51.7 p -56.79 -43.53 80.99 Favored 'General case' 0 C--N 1.35 0.592 0 CA-C-N 112.671 -2.059 . . . . 0.0 111.28 -178.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.748 ' CZ ' ' HB ' ' A' ' 34' ' ' VAL . 0.2 OUTLIER -55.28 -44.07 75.35 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.793 -1.549 . . . . 0.0 108.928 -178.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.86 -27.33 62.8 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 111.545 -2.57 . . . . 0.0 112.782 -176.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -78.74 -0.53 30.65 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 112.087 -2.324 . . . . 0.0 109.201 -177.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.28 9.21 2.49 Favored 'General case' 0 N--CA 1.435 -1.205 0 C-N-CA 118.511 -1.275 . . . . 0.0 107.908 178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 55.35 33.58 58.57 Favored Glycine 0 C--N 1.358 1.758 0 O-C-N 124.243 0.964 . . . . 0.0 112.627 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -99.61 -179.47 4.2 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 -179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' H ' ' HB2' ' A' ' 4' ' ' LYS . 28.2 t-20 -76.85 144.5 38.99 Favored 'General case' 0 C--N 1.355 0.829 0 CA-C-N 112.219 -2.264 . . . . 0.0 106.873 -178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.748 ' HB ' ' CZ ' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.92 127.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.347 0.497 0 CA-C-N 110.669 -2.969 . . . . 0.0 107.469 179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 7' ' ' VAL . 5.8 t -140.19 128.75 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 111.561 -2.563 . . . . 0.0 105.6 177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -144.2 132.49 21.91 Favored 'General case' 0 C--N 1.343 0.322 0 N-CA-C 104.746 -2.316 . . . . 0.0 104.746 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -97.08 -87.9 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.605 0 CA-C-N 111.85 -2.432 . . . . 0.0 104.886 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 170.05 -137.99 4.77 Favored Glycine 0 C--N 1.349 1.287 0 N-CA-C 108.855 -1.698 . . . . 0.0 108.855 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.2 m -92.6 2.28 8.65 Favored 'Isoleucine or valine' 0 C--N 1.352 0.695 0 CA-C-N 113.201 -1.499 . . . . 0.0 110.716 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 96.5 mt -87.27 98.31 11.26 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 103.363 -2.829 . . . . 0.0 103.363 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.402 ' HB2' ' HA ' ' A' ' 10' ' ' VAL . 47.6 t -97.9 55.34 1.18 Allowed 'General case' 0 C--N 1.352 0.681 0 CA-C-N 113.106 -1.861 . . . . 0.0 106.386 -178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.8 p -90.14 86.51 6.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.413 ' CD ' HD21 ' A' ' 74' ' ' LEU . 5.7 tp-100 -66.81 -46.31 75.6 Favored 'General case' 0 C--N 1.35 0.605 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.144 -176.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.95 -37.71 88.54 Favored 'General case' 0 C--N 1.352 0.711 0 O-C-N 124.482 1.113 . . . . 0.0 109.61 -177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -77.72 -21.01 52.57 Favored 'General case' 0 C--N 1.352 0.691 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -85.88 -2.24 58.06 Favored 'General case' 0 C--N 1.358 0.972 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 mp -75.7 -35.88 32.28 Favored 'Isoleucine or valine' 0 C--N 1.355 0.835 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -75.04 -32.21 61.5 Favored 'General case' 0 C--N 1.36 1.045 0 CA-C-N 112.971 -1.922 . . . . 0.0 107.958 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.98 5.69 49.15 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 119.433 -0.907 . . . . 0.0 108.988 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 55' ' ' ALA . . . -90.25 -19.04 24.6 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 177.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.8 mt -77.15 -38.48 27.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 104.429 -2.434 . . . . 0.0 104.429 176.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -59.51 -69.13 0.22 Allowed 'General case' 0 C--N 1.355 0.837 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.988 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.414 ' O ' ' CB ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -70.85 -54.74 10.42 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.722 -176.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' CB ' ' O ' ' A' ' 53' ' ' THR . 64.0 tttt 117.65 47.23 0.0 OUTLIER 'General case' 0 C--N 1.356 0.852 0 O-C-N 126.705 2.503 . . . . 0.0 107.55 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . . . -48.85 106.46 0.1 Allowed 'General case' 0 C--N 1.355 0.839 0 CA-C-O 122.499 1.142 . . . . 0.0 110.279 -178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -79.63 -38.15 34.46 Favored 'General case' 0 C--N 1.35 0.594 0 CA-C-N 111.584 -2.553 . . . . 0.0 104.163 177.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.521 ' CD2' HD11 ' A' ' 134' ' ' LEU . 1.9 pp -154.39 165.05 37.61 Favored 'General case' 0 C--N 1.357 0.903 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 177.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.55 HD13 HD11 ' A' ' 88' ' ' LEU . 0.1 OUTLIER -138.61 142.79 33.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 CA-C-N 111.722 -2.49 . . . . 0.0 106.169 -179.837 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 44.8 t -137.79 133.67 34.31 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 135.82 37.1 Favored 'Isoleucine or valine' 0 C--N 1.359 0.998 0 CA-C-N 113.246 -1.797 . . . . 0.0 107.138 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.933 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 0.3 OUTLIER -111.42 91.85 3.82 Favored 'General case' 0 CA--C 1.556 1.188 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 178.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.3 t 150.09 166.26 0.0 OUTLIER 'General case' 0 C--N 1.36 1.056 0 N-CA-C 105.484 -2.043 . . . . 0.0 105.484 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 91.7 mt -69.75 -127.24 0.0 OUTLIER 'General case' 0 C--N 1.358 0.959 0 CA-C-N 113.595 -1.638 . . . . 0.0 107.277 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.61 85.16 7.43 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -137.48 42.87 1.26 Allowed Glycine 0 C--N 1.345 1.058 0 CA-C-N 110.881 -2.872 . . . . 0.0 107.089 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.407 ' H ' ' H ' ' A' ' 67' ' ' GLY . 29.7 pt20 -148.38 -32.42 0.25 Allowed 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 111.181 -2.509 . . . . 0.0 106.857 -178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 66' ' ' GLN . . . 84.08 167.73 42.79 Favored Glycine 0 C--N 1.343 0.944 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -77.39 1.38 19.17 Favored 'General case' 0 CA--C 1.548 0.889 0 CA-C-N 113.582 -1.309 . . . . 0.0 109.044 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -84.32 -46.51 17.85 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 105.98 -1.859 . . . . 0.0 105.98 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -72.6 -27.38 62.13 Favored 'General case' 0 C--N 1.354 0.779 0 CA-C-N 114.241 -1.345 . . . . 0.0 107.781 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 89.4 m -68.47 -47.28 67.52 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 36.4 mtmm -90.07 25.43 2.15 Favored 'General case' 0 C--N 1.362 1.13 0 O-C-N 124.815 1.322 . . . . 0.0 108.988 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -96.35 -33.31 6.27 Favored Glycine 0 CA--C 1.529 0.911 0 N-CA-C 108.618 -1.793 . . . . 0.0 108.618 178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 HD21 ' CD ' ' A' ' 43' ' ' GLN . 4.3 mt -88.27 -29.67 20.23 Favored 'General case' 0 C--N 1.352 0.701 0 CA-C-N 111.939 -2.131 . . . . 0.0 107.678 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -74.75 -24.23 58.67 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -82.1 -29.25 31.84 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 178.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -76.49 -15.1 59.97 Favored 'General case' 0 CA--C 1.55 0.97 0 O-C-N 124.235 0.959 . . . . 0.0 109.238 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 12.5 t -90.35 -48.12 7.33 Favored 'General case' 0 CA--C 1.505 -0.762 0 CA-C-O 124.014 1.864 . . . . 0.0 107.059 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -71.61 -3.67 22.83 Favored 'General case' 0 N--CA 1.44 -0.932 0 CA-C-N 108.43 -3.986 . . . . 0.0 109.207 179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -82.45 -56.36 3.93 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 104.626 -2.361 . . . . 0.0 104.626 177.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 61.75 48.02 5.81 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 110.964 -2.835 . . . . 0.0 106.641 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -156.75 -43.62 0.02 OUTLIER Glycine 0 C--N 1.351 1.384 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.905 -179.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 22.7 mt -79.35 120.57 23.98 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 104.757 -2.312 . . . . 0.0 104.757 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.52 136.12 33.95 Favored 'General case' 0 C--N 1.351 0.662 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 131.72 53.96 0.09 OUTLIER Glycine 0 C--N 1.35 1.307 0 CA-C-N 112.734 -2.03 . . . . 0.0 110.117 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 7.5 tt -104.86 55.09 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 105.567 -2.012 . . . . 0.0 105.567 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -148.35 118.67 7.33 Favored 'General case' 0 C--N 1.346 0.445 0 N-CA-C 101.965 -3.346 . . . . 0.0 101.965 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.55 HD11 HD13 ' A' ' 58' ' ' ILE . 2.0 mm? -139.98 151.84 45.82 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 112.862 -1.972 . . . . 0.0 106.121 -177.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.37 90.99 2.4 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 101.598 -3.482 . . . . 0.0 101.598 177.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.1 m -89.33 98.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.346 0.454 0 CA-C-O 126.106 2.86 . . . . 0.0 110.307 -176.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -77.24 109.54 2.82 Favored Glycine 0 CA--C 1.527 0.822 0 CA-C-N 108.456 -3.975 . . . . 0.0 109.367 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 101.87 -101.14 2.14 Favored Glycine 0 C--N 1.348 1.232 0 CA-C-N 112.219 -1.99 . . . . 0.0 109.195 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 52.3 t30 64.38 -104.94 0.12 Allowed 'General case' 0 C--N 1.356 0.889 0 N-CA-C 105.553 -2.018 . . . . 0.0 105.553 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.34 125.28 56.61 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 103.706 -2.701 . . . . 0.0 103.706 179.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -77.44 177.32 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.663 0 CA-C-N 112.824 -1.989 . . . . 0.0 108.449 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.3 p 42.57 55.75 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.87 0 CA-C-N 112.654 -2.067 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -177.92 141.34 5.1 Favored Glycine 0 C--N 1.349 1.253 0 CA-C-N 112.336 -2.211 . . . . 0.0 109.227 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -171.27 105.51 0.23 Allowed 'General case' 0 C--N 1.35 0.605 0 N-CA-C 103.952 -2.61 . . . . 0.0 103.952 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 94.36 -51.88 0.01 OUTLIER 'General case' 0 C--N 1.356 0.856 0 O-C-N 126.056 2.097 . . . . 0.0 105.526 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -89.22 130.09 35.69 Favored 'General case' 0 C--N 1.351 0.643 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -142.91 158.82 58.45 Favored Pre-proline 0 C--N 1.352 0.675 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.73 -148.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.374 1.872 0 N-CA-C 107.433 -1.795 . . . . 0.0 107.433 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.96 -22.32 60.72 Favored 'General case' 0 C--N 1.353 0.729 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.969 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -57.21 -69.41 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 O-C-N 124.495 1.122 . . . . 0.0 111.282 -179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.49 ' H ' HG13 ' A' ' 104' ' ' VAL . 13.0 mm-40 -89.99 23.11 2.9 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.403 -1.719 . . . . 0.0 108.41 -179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.0 tt0 -74.43 -42.41 59.18 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 104.587 -2.375 . . . . 0.0 104.587 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.2 ptm180 -79.57 -31.82 41.97 Favored 'General case' 0 C--N 1.351 0.64 0 CA-C-N 112.065 -2.334 . . . . 0.0 106.869 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -93.19 16.43 13.06 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 118.309 -1.356 . . . . 0.0 108.914 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -40.71 11.83 Favored 'General case' 0 C--N 1.36 1.044 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.38 -35.25 75.28 Favored 'General case' 0 C--N 1.36 1.033 0 CA-C-N 112.212 -2.267 . . . . 0.0 107.408 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 49.1 mtp -80.78 -58.51 3.06 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 31.52 41.04 0.07 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.399 2.428 . . . . 0.0 117.373 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -84.69 -6.09 59.34 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -103.4 132.14 49.91 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 105.369 -2.085 . . . . 0.0 105.369 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.11 -178.97 3.66 Favored 'General case' 0 C--N 1.351 0.641 0 N-CA-C 102.095 -3.298 . . . . 0.0 102.095 178.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 29.4 m -140.02 161.03 26.23 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 C-N-CA 117.793 -1.563 . . . . 0.0 110.255 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.506 ' CE2' H102 ' A' ' 139' ' ' DBI . 5.9 m-85 -99.39 154.41 37.3 Favored Pre-proline 0 C--N 1.352 0.715 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.815 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.08 160.66 42.42 Favored 'Trans proline' 0 C--N 1.368 1.579 0 N-CA-C 107.21 -1.881 . . . . 0.0 107.21 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -73.9 116.43 4.66 Favored 'Trans proline' 0 C--N 1.368 1.599 0 N-CA-C 103.823 -3.183 . . . . 0.0 103.823 178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.11 133.86 5.94 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 13.9 t -73.84 159.61 32.62 Favored 'General case' 0 C--N 1.356 0.852 0 CA-C-O 125.144 2.402 . . . . 0.0 107.52 -178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.7 p -173.17 120.57 0.41 Allowed Pre-proline 0 N--CA 1.427 -1.606 1 CA-C-N 106.583 -4.826 . . . . 0.0 101.648 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.466 ' HB3' ' CG1' ' A' ' 22' ' ' ILE . 80.1 Cg_endo -78.8 -5.45 14.68 Favored 'Trans proline' 0 C--N 1.357 0.999 0 N-CA-C 108.685 -1.313 . . . . 0.0 108.685 -179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -63.84 -37.92 89.17 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 126.547 1.939 . . . . 0.0 107.744 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.17 -23.42 59.24 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-N 113.668 -1.606 . . . . 0.0 108.256 -178.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.453 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.3 p -82.09 -25.44 34.51 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 116.94 -1.904 . . . . 0.0 109.983 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 1.3 mt -67.65 -24.78 31.54 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.77 -6.3 58.23 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 112.955 -1.93 . . . . 0.0 108.77 178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.541 ' O ' HG23 ' A' ' 133' ' ' VAL . 36.1 t0 -61.91 -58.37 8.19 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.579 ' SD ' ' HB ' ' A' ' 6' ' ' ILE . 35.1 mmt -87.09 -11.93 48.7 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.82 -177.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -90.13 -48.55 7.1 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 117.93 -1.508 . . . . 0.0 109.201 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -54.13 -47.99 71.27 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 124.131 0.894 . . . . 0.0 109.921 -177.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 129' ' ' ASP . 52.3 t -71.42 -61.19 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 CA-C-N 113.246 -1.797 . . . . 0.0 111.638 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 57' ' ' LEU . 3.9 mp -90.37 53.97 2.62 Favored 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.842 1.339 . . . . 0.0 109.635 -178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -167.26 -78.08 0.04 OUTLIER Glycine 0 C--N 1.349 1.29 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -166.07 151.28 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.638 0 CA-C-N 113.74 -1.23 . . . . 0.0 108.241 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 CA--C 1.536 0.437 0 CA-C-N 112.387 -2.188 . . . . 0.0 105.211 -179.141 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.506 H102 ' CE2' ' A' ' 117' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 ttt . . . . . 0 N--CA 1.446 -0.63 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -101.39 43.74 1.05 Allowed 'General case' 0 C--N 1.353 0.755 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.212 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -63.04 144.06 57.23 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 113.579 -1.646 . . . . 0.0 107.404 -179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -97.24 102.44 14.22 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 111.786 -2.461 . . . . 0.0 107.505 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 179.03 105.75 0.03 OUTLIER 'General case' 0 C--N 1.357 0.919 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -133.73 112.7 17.31 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 N-CA-C 104.906 -2.257 . . . . 0.0 104.906 178.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.746 HG23 HG12 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -101.8 117.92 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-N 111.779 -2.464 . . . . 0.0 108.293 179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.64 HD13 HD22 ' A' ' 23' ' ' LEU . 16.2 tp -90.14 159.89 16.54 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 112.912 -1.949 . . . . 0.0 108.262 -177.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.52 159.48 29.84 Favored Glycine 0 C--N 1.348 1.233 0 CA-C-N 111.422 -2.626 . . . . 0.0 107.844 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.5 p -156.36 131.75 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.811 0 CA-C-O 122.312 1.053 . . . . 0.0 112.087 -179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -134.54 133.07 54.85 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 101.961 -3.348 . . . . 0.0 101.961 176.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.31 175.71 36.19 Favored Glycine 0 C--N 1.357 1.719 0 C-N-CA 117.818 -2.134 . . . . 0.0 113.192 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.307 13.7 p -114.45 20.56 15.32 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 108.25 -3.975 . . . . 0.0 107.258 -178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -165.09 132.84 3.12 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.5 p -81.56 115.91 21.07 Favored 'General case' 0 C--N 1.363 1.179 0 N-CA-C 104.842 -2.281 . . . . 0.0 104.842 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 61.0 t60 79.04 142.02 0.08 Allowed 'General case' 0 C--N 1.36 1.048 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 67.17 73.33 0.34 Allowed 'General case' 0 C--N 1.356 0.88 0 CA-C-N 112.938 -1.937 . . . . 0.0 106.26 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -161.84 41.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 CA-C-N 112.709 -2.042 . . . . 0.0 111.06 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.21 -28.32 15.26 Favored Glycine 0 C--N 1.359 1.81 0 CA-C-O 122.157 0.865 . . . . 0.0 113.857 179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -41.85 -47.31 4.18 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -11.49 57.2 0.0 OUTLIER 'General case' 0 C--N 1.382 2.001 3 C-N-CA 140.77 7.628 . . . . 0.0 107.833 175.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.515 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.355 0.2 OUTLIER 30.09 54.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.41 -2.434 1 CA-C-N 106.242 -4.981 . . . . 0.0 107.922 -177.371 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.64 HD22 HD13 ' A' ' 8' ' ' LEU . 6.8 tt -70.91 -25.54 62.81 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 102.11 -3.292 . . . . 0.0 102.11 173.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 -66.32 -17.44 64.76 Favored 'General case' 0 C--N 1.368 1.386 0 C-N-CA 116.744 -1.982 . . . . 0.0 107.221 174.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.515 ' HB2' HG22 ' A' ' 22' ' ' ILE . 13.0 t-80 -69.4 -24.5 63.86 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.461 ' OG ' ' SD ' ' A' ' 130' ' ' MET . 7.4 p -56.78 -37.82 71.63 Favored 'General case' 0 C--N 1.352 0.695 0 O-C-N 125.024 1.453 . . . . 0.0 108.739 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.953 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.0 OUTLIER -54.64 -49.42 70.58 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 112.777 -2.01 . . . . 0.0 108.029 179.199 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -22.78 61.5 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 112.114 -2.312 . . . . 0.0 112.904 -176.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -81.33 0.07 38.82 Favored 'General case' 0 N--CA 1.436 -1.172 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.688 -178.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -144.93 12.9 1.45 Allowed 'General case' 0 N--CA 1.433 -1.275 0 C-N-CA 118.001 -1.48 . . . . 0.0 107.906 178.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.06 37.74 46.2 Favored Glycine 0 C--N 1.36 1.869 0 O-C-N 124.229 0.955 . . . . 0.0 113.056 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -99.71 -168.11 1.56 Allowed 'General case' 0 C--N 1.352 0.69 0 CA-C-N 113.303 -1.449 . . . . 0.0 107.519 -178.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -93.8 140.04 30.14 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-N 112.892 -1.958 . . . . 0.0 107.705 -177.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.953 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.2 OUTLIER -99.74 127.25 52.78 Favored 'Isoleucine or valine' 0 C--N 1.349 0.56 0 CA-C-N 109.995 -3.275 . . . . 0.0 108.927 -179.644 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.746 HG12 HG23 ' A' ' 7' ' ' VAL . 3.7 t -140.31 144.48 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.733 0 CA-C-N 109.909 -3.314 . . . . 0.0 104.432 176.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.13 135.79 8.34 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mt -89.96 -67.99 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.613 0 N-CA-C 104.332 -2.47 . . . . 0.0 104.332 179.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 139.36 -145.63 16.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-N 112.144 -2.298 . . . . 0.0 108.374 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -87.52 88.7 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.951 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.744 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 1.2 tp -164.68 119.72 1.41 Allowed 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.4 t -98.31 37.11 1.49 Allowed 'General case' 0 C--N 1.358 0.974 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.478 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.744 ' OG ' ' HG ' ' A' ' 40' ' ' LEU . 72.9 p -90.17 98.15 11.6 Favored 'General case' 0 C--N 1.35 0.628 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -83.16 -55.45 4.34 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 113.343 -1.753 . . . . 0.0 108.985 -176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' ILE . 12.9 pt-20 -64.78 -20.44 66.37 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 124.65 1.219 . . . . 0.0 111.597 -177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -87.34 -37.26 17.27 Favored 'General case' 0 C--N 1.35 0.589 0 C-N-CA 118.389 -1.324 . . . . 0.0 108.239 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -90.04 10.16 25.24 Favored 'General case' 0 C--N 1.351 0.658 0 C-N-CA 118.027 -1.469 . . . . 0.0 108.629 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -86.04 -32.46 6.89 Favored 'Isoleucine or valine' 0 C--N 1.359 1.022 0 N-CA-C 102.27 -3.234 . . . . 0.0 102.27 174.427 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -73.68 -26.1 60.57 Favored 'General case' 0 C--N 1.368 1.393 0 N-CA-C 106.46 -1.681 . . . . 0.0 106.46 177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -89.27 -6.79 56.5 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.68 -9.64 51.34 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.7 mt -83.87 -41.64 16.69 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 N-CA-C 104.043 -2.577 . . . . 0.0 104.043 176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -61.22 -57.52 12.08 Favored 'General case' 0 C--N 1.355 0.831 0 CA-C-N 112.146 -2.297 . . . . 0.0 108.835 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.582 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.21 -55.06 20.68 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 -178.372 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 51.6 tttp 90.21 53.19 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 110.691 -2.959 . . . . 0.0 103.114 -177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -63.57 126.52 27.79 Favored 'General case' 0 C--N 1.358 0.954 0 CA-C-N 111.2 -2.727 . . . . 0.0 107.335 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -88.21 -31.92 18.83 Favored 'General case' 0 C--N 1.349 0.569 0 CA-C-N 112.825 -1.988 . . . . 0.0 107.214 -179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.8 pp -157.76 154.34 28.02 Favored 'General case' 0 C--N 1.353 0.733 0 N-CA-C 106.055 -1.832 . . . . 0.0 106.055 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 88' ' ' LEU . 2.7 mt -114.73 165.91 9.27 Favored 'Isoleucine or valine' 0 C--N 1.352 0.7 0 CA-C-N 111.908 -2.405 . . . . 0.0 105.489 179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 89.0 m -153.14 100.56 2.48 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 111.333 -2.667 . . . . 0.0 103.989 179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 28.3 m -105.92 137.39 36.2 Favored 'Isoleucine or valine' 0 C--N 1.348 0.508 0 N-CA-C 102.756 -3.053 . . . . 0.0 102.756 177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.493 ' HA ' ' H4 ' ' A' ' 139' ' ' DBI . 3.6 m -99.71 125.8 45.65 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 -177.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 18.1 t -157.99 175.4 13.87 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 114.639 -2.824 . . . . 0.0 107.519 -178.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -151.67 48.38 0.8 Allowed 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 110.814 -2.903 . . . . 0.0 106.454 -178.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER 72.78 32.76 1.39 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-N 113.734 -1.576 . . . . 0.0 107.305 179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -114.53 -3.01 22.62 Favored Glycine 0 CA--C 1.541 1.669 0 CA-C-N 113.801 -1.545 . . . . 0.0 110.367 178.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -87.63 -17.75 31.19 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 78.72 177.44 49.12 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 113.743 -1.571 . . . . 0.0 110.341 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -90.07 18.9 5.36 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 113.6 -1.3 . . . . 0.0 108.048 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.05 -53.21 9.52 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.488 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 m-20 -71.19 -26.17 62.84 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 112.684 -2.053 . . . . 0.0 107.413 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 26.9 t -66.67 -56.18 11.78 Favored 'General case' 0 C--N 1.356 0.89 0 N-CA-C 106.149 -1.797 . . . . 0.0 106.149 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -90.1 30.1 1.14 Allowed 'General case' 0 C--N 1.359 1.0 0 O-C-N 124.684 1.24 . . . . 0.0 109.36 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -98.14 -38.83 3.94 Favored Glycine 0 CA--C 1.529 0.945 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 70' ' ' ASP . 1.7 mm? -90.03 -23.13 21.55 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 112.705 -1.747 . . . . 0.0 107.771 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.42 -29.94 59.9 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -77.36 -26.56 52.09 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 114.235 -1.348 . . . . 0.0 107.69 178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 48.0 tttp -74.71 -17.62 60.63 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 124.005 0.816 . . . . 0.0 109.261 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 36.5 t -90.22 -46.47 8.41 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.919 1.819 . . . . 0.0 107.524 -178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 64.2 m-20 -74.17 0.76 12.98 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 108.67 -3.877 . . . . 0.0 109.095 178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -84.03 -55.97 3.93 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.27 45.56 6.7 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-N 110.84 -2.891 . . . . 0.0 106.68 -179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.07 -43.62 0.02 OUTLIER Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.681 -2.054 . . . . 0.0 109.492 -179.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.9 mt -79.62 120.87 24.56 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 104.5 -2.407 . . . . 0.0 104.5 178.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 136.57 35.91 Favored 'General case' 0 C--N 1.351 0.665 0 N-CA-C 106.177 -1.786 . . . . 0.0 106.177 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.21 122.42 2.68 Favored Glycine 0 C--N 1.35 1.326 0 CA-C-N 112.17 -2.286 . . . . 0.0 107.459 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 tt -149.56 34.0 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -138.4 118.18 13.19 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 102.415 -3.18 . . . . 0.0 102.415 179.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -138.79 112.87 8.6 Favored 'General case' 0 C--N 1.345 0.407 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 -176.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.49 89.77 4.06 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 104.55 -2.389 . . . . 0.0 104.55 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 4.2 t -89.84 91.19 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 CA-C-N 111.076 -2.784 . . . . 0.0 110.351 -177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.645 ' HA3' H102 ' A' ' 139' ' ' DBI . . . -69.71 142.17 36.22 Favored Glycine 0 CA--C 1.536 1.364 0 CA-C-N 110.218 -3.174 . . . . 0.0 110.393 175.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 83.84 -83.67 1.61 Allowed Glycine 0 C--N 1.351 1.377 0 CA-C-N 111.406 -2.397 . . . . 0.0 107.229 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 61.5 -108.05 0.3 Allowed 'General case' 0 C--N 1.355 0.835 0 CA-C-N 112.56 -1.82 . . . . 0.0 107.053 178.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 14.3 mt -118.09 149.71 20.41 Favored 'Isoleucine or valine' 0 C--N 1.349 0.558 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -87.43 -172.38 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.667 0 CA-C-N 112.728 -2.033 . . . . 0.0 108.73 -179.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 5.9 p 39.24 68.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.834 0 CA-C-N 112.486 -2.143 . . . . 0.0 112.881 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 169.9 171.13 35.13 Favored Glycine 0 C--N 1.348 1.197 0 CA-C-N 112.316 -2.22 . . . . 0.0 109.878 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -157.03 -49.25 0.07 Allowed 'General case' 0 C--N 1.347 0.5 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -127.21 -38.14 2.0 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.5 p-10 -89.76 111.44 22.45 Favored 'General case' 0 C--N 1.353 0.73 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 95.2 m95 -119.09 166.09 15.28 Favored Pre-proline 0 C--N 1.35 0.619 0 N-CA-C 105.418 -2.068 . . . . 0.0 105.418 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_exo -69.48 -151.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.373 1.865 0 N-CA-C 108.1 -1.539 . . . . 0.0 108.1 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -71.91 -24.45 61.64 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 113.844 -1.526 . . . . 0.0 108.41 -178.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.4 p -55.78 -72.85 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 O-C-N 124.739 1.275 . . . . 0.0 111.323 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.57 ' H ' HG13 ' A' ' 104' ' ' VAL . 26.1 mt-10 -88.78 25.94 1.64 Allowed 'General case' 0 C--N 1.356 0.855 0 C-N-CA 117.875 -1.53 . . . . 0.0 109.65 -178.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -75.78 -45.37 36.6 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -80.57 -30.04 36.98 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 111.541 -2.572 . . . . 0.0 107.531 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -91.51 12.65 20.1 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 118.864 -1.134 . . . . 0.0 108.878 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.31 -38.46 13.36 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.93 -31.9 73.08 Favored 'General case' 0 C--N 1.36 1.039 0 CA-C-N 112.726 -2.034 . . . . 0.0 107.729 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 47.9 mtp -81.79 -61.53 1.9 Allowed 'General case' 0 C--N 1.354 0.786 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.0 39.87 0.01 OUTLIER Glycine 0 C--N 1.356 1.641 0 C-N-CA 127.698 2.571 . . . . 0.0 117.432 177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -87.79 -6.19 58.27 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -105.07 137.66 42.48 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 103.922 -2.622 . . . . 0.0 103.922 178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.16 170.45 8.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 102.496 -3.15 . . . . 0.0 102.496 178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 19.7 m -139.88 156.47 25.49 Favored 'Isoleucine or valine' 0 C--N 1.344 0.347 0 CA-C-N 113.982 -1.463 . . . . 0.0 107.212 178.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.49 ' H ' ' HA2' ' A' ' 91' ' ' GLY . 1.6 m-85 -99.59 128.66 30.81 Favored Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 103.179 -2.897 . . . . 0.0 103.179 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -60.92 160.27 26.19 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 122.324 2.016 . . . . 0.0 109.322 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.24 121.27 7.64 Favored 'Trans proline' 0 C--N 1.369 1.646 0 N-CA-C 104.684 -2.852 . . . . 0.0 104.684 179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 96.92 67.18 0.94 Allowed Glycine 0 C--N 1.348 1.245 0 N-CA-C 107.418 -2.273 . . . . 0.0 107.418 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.502 HG22 ' H ' ' A' ' 122' ' ' SER . 0.2 OUTLIER -89.85 -165.77 1.43 Allowed 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 110.466 -2.867 . . . . 0.0 106.775 -178.004 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.502 ' H ' HG22 ' A' ' 121' ' ' THR . 3.5 p -168.26 168.35 5.83 Favored Pre-proline 0 N--CA 1.437 -1.119 0 CA-C-N 111.566 -2.561 . . . . 0.0 104.447 -178.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -77.19 -8.15 17.41 Favored 'Trans proline' 0 C--N 1.367 1.543 0 N-CA-C 107.865 -1.629 . . . . 0.0 107.865 178.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -70.33 -29.21 65.86 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.02 -20.41 49.08 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 113.822 -1.536 . . . . 0.0 108.006 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 129' ' ' ASP . 4.5 p -82.7 -16.81 46.7 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 118.048 -1.461 . . . . 0.0 110.264 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 4.9 mt -69.0 -29.38 43.04 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 N-CA-C 103.406 -2.812 . . . . 0.0 103.406 176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 -1.33 57.75 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 112.427 -2.169 . . . . 0.0 108.728 178.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.636 ' O ' HG23 ' A' ' 133' ' ' VAL . 53.4 t0 -64.5 -63.59 1.09 Allowed 'General case' 0 C--N 1.359 1.01 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.461 ' SD ' ' OG ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -83.23 -10.49 58.54 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 112.431 -2.168 . . . . 0.0 110.299 -176.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.18 -46.06 8.69 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.91 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -59.45 -37.28 77.72 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 123.591 0.557 . . . . 0.0 109.957 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.636 HG23 ' O ' ' A' ' 129' ' ' ASP . 74.1 t -88.51 -73.98 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.016 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.493 HD23 HG12 ' A' ' 133' ' ' VAL . 95.9 mt -90.41 57.11 3.56 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 124.644 1.215 . . . . 0.0 109.423 -178.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -163.49 -36.64 0.02 OUTLIER Glycine 0 C--N 1.346 1.129 0 C-N-CA 119.626 -1.273 . . . . 0.0 111.26 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.25 159.21 11.2 Favored 'Isoleucine or valine' 0 C--N 1.35 0.598 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 . . . . . 0 CA--C 1.543 0.674 0 CA-C-N 113.175 -1.829 . . . . 0.0 107.042 179.531 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.645 H102 ' HA3' ' A' ' 91' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 ttt . . . . . 0 N--CA 1.445 -0.717 0 N-CA-C 105.197 -2.149 . . . . 0.0 105.197 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -105.92 36.15 2.66 Favored 'General case' 0 C--N 1.352 0.689 0 CA-C-N 112.962 -1.927 . . . . 0.0 106.188 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -59.24 141.3 54.66 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 123.197 1.475 . . . . 0.0 108.617 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -84.29 95.64 8.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 110.548 -3.023 . . . . 0.0 107.894 -177.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -176.65 111.55 0.09 Allowed 'General case' 0 C--N 1.355 0.807 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 179.929 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.27 111.94 9.93 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.74 138.82 18.56 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 O-C-N 125.866 1.979 . . . . 0.0 105.689 177.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.654 HD13 HD22 ' A' ' 23' ' ' LEU . 16.6 tp -113.45 149.36 34.34 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 123.114 1.435 . . . . 0.0 108.81 -177.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.28 149.87 21.4 Favored Glycine 0 C--N 1.349 1.261 0 CA-C-N 110.866 -2.879 . . . . 0.0 106.577 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -160.32 98.28 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.352 0.714 0 CA-C-O 122.328 1.061 . . . . 0.0 110.587 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -101.3 156.69 4.42 Favored 'Isoleucine or valine' 0 C--N 1.349 0.562 0 N-CA-C 103.453 -2.795 . . . . 0.0 103.453 176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -174.73 175.41 46.92 Favored Glycine 0 C--N 1.359 1.817 0 C-N-CA 115.574 -3.203 . . . . 0.0 113.597 -178.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . 0.288 25.2 p -115.26 22.68 13.08 Favored 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 108.2 -4.0 . . . . 0.0 106.344 -179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -161.92 132.76 5.07 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -79.0 103.65 9.09 Favored 'General case' 0 C--N 1.364 1.239 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.7 t60 77.27 149.84 0.11 Allowed 'General case' 0 C--N 1.359 0.986 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 71.49 73.1 0.18 Allowed 'General case' 0 C--N 1.354 0.799 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -159.47 -12.77 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 111.784 -2.462 . . . . 0.0 111.198 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.51 -23.58 0.1 Allowed Glycine 0 C--N 1.354 1.569 0 C-N-CA 119.954 -1.117 . . . . 0.0 113.004 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -40.92 -49.61 3.24 Favored 'General case' 0 C--N 1.362 1.119 0 N-CA-C 105.625 -1.991 . . . . 0.0 105.625 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -12.96 58.84 0.0 OUTLIER 'General case' 0 C--N 1.381 1.941 2 C-N-CA 139.927 7.291 . . . . 0.0 107.757 176.016 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 HG22 ' HB2' ' A' ' 25' ' ' HIS 0.383 0.3 OUTLIER 26.61 54.88 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.408 -2.571 2 CA-C-N 105.222 -5.445 . . . . 0.0 108.263 -177.142 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.654 HD22 HD13 ' A' ' 8' ' ' LEU . 7.1 tt -74.17 -24.84 59.45 Favored 'General case' 0 CA--C 1.558 1.265 0 N-CA-C 102.386 -3.19 . . . . 0.0 102.386 173.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.447 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 35.4 m-20 -71.9 -8.99 57.63 Favored 'General case' 0 CA--C 1.559 1.312 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 174.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.516 ' HB2' HG22 ' A' ' 22' ' ' ILE . 10.2 t-160 -74.51 -30.09 61.66 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.3 p -53.29 -44.36 68.23 Favored 'General case' 0 C--N 1.353 0.727 0 O-C-N 125.647 1.842 . . . . 0.0 110.349 -178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.838 ' CE2' ' HB ' ' A' ' 34' ' ' VAL . 0.3 OUTLIER -60.07 -41.71 93.01 Favored 'General case' 0 C--N 1.351 0.639 0 CA-C-N 113.63 -1.623 . . . . 0.0 108.87 -179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -73.7 -24.57 59.95 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 112.668 -2.06 . . . . 0.0 112.689 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -81.87 -1.19 46.84 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 112.224 -2.262 . . . . 0.0 108.926 -178.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.59 3.7 2.32 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 58.75 32.06 68.97 Favored Glycine 0 C--N 1.358 1.795 0 O-C-N 123.952 0.783 . . . . 0.0 111.674 -179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.9 m-30 -99.7 -175.3 2.94 Favored 'General case' 0 C--N 1.354 0.786 0 CA-C-N 113.206 -1.497 . . . . 0.0 107.542 -178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -86.26 138.63 31.71 Favored 'General case' 0 C--N 1.358 0.936 0 CA-C-N 112.291 -2.231 . . . . 0.0 108.271 -176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.838 ' HB ' ' CE2' ' A' ' 27' ' ' PHE . 0.1 OUTLIER -99.62 127.57 52.3 Favored 'Isoleucine or valine' 0 C--N 1.348 0.534 0 CA-C-N 109.824 -3.353 . . . . 0.0 107.807 -179.452 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 53' ' ' THR . 10.9 t -140.1 125.04 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 CA-C-N 110.036 -3.256 . . . . 0.0 104.662 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -142.77 128.6 19.4 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 mt -90.03 -75.67 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.707 0 N-CA-C 104.282 -2.488 . . . . 0.0 104.282 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 148.34 -151.18 23.42 Favored Glycine 0 C--N 1.351 1.394 0 CA-C-N 113.444 -1.707 . . . . 0.0 109.638 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 63.7 t -87.79 84.05 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.96 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.732 ' HG ' ' OG ' ' A' ' 42' ' ' SER . 9.8 tp -162.49 117.5 1.84 Allowed 'General case' 0 C--N 1.348 0.506 0 N-CA-C 103.717 -2.698 . . . . 0.0 103.717 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.1 t -93.53 48.34 1.29 Allowed 'General case' 0 C--N 1.356 0.889 0 CA-C-N 112.564 -2.107 . . . . 0.0 107.281 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.732 ' OG ' ' HG ' ' A' ' 40' ' ' LEU 0.257 8.8 p -90.5 95.45 10.17 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 103.767 -2.679 . . . . 0.0 103.767 177.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -90.13 -57.83 2.71 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 118.03 -1.468 . . . . 0.0 108.322 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.1 -18.46 63.44 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 124.828 1.33 . . . . 0.0 111.382 -177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -91.35 -37.11 13.44 Favored 'General case' 0 C--N 1.35 0.595 0 C-N-CA 118.495 -1.282 . . . . 0.0 107.65 -178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.496 ' HA ' ' HB3' ' A' ' 49' ' ' ALA . 23.3 m-85 -90.06 10.05 25.74 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 118.734 -1.186 . . . . 0.0 108.924 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -89.22 -33.69 6.35 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 174.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -73.37 -25.02 60.41 Favored 'General case' 0 C--N 1.367 1.335 0 N-CA-C 106.033 -1.84 . . . . 0.0 106.033 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 46' ' ' PHE . . . -92.05 -2.33 56.73 Favored 'General case' 0 C--N 1.363 1.178 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 178.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -90.01 -9.45 48.61 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.6 mt -86.2 -41.6 15.24 Favored 'Isoleucine or valine' 0 C--N 1.352 0.701 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -59.62 -58.69 7.51 Favored 'General case' 0 C--N 1.356 0.859 0 CA-C-N 112.129 -2.305 . . . . 0.0 108.404 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.657 HG21 HG11 ' A' ' 35' ' ' VAL . 0.2 OUTLIER -65.89 -56.21 12.96 Favored 'General case' 0 C--N 1.356 0.866 0 O-C-N 124.68 1.237 . . . . 0.0 107.821 -178.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 tttp 95.64 47.49 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-N 110.362 -3.108 . . . . 0.0 102.722 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -60.33 117.62 5.43 Favored 'General case' 0 C--N 1.362 1.142 0 CA-C-N 111.851 -2.431 . . . . 0.0 106.819 -178.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 5' ' ' THR . 24.6 t0 -80.48 -36.44 33.39 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 111.706 -2.497 . . . . 0.0 106.555 -178.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.2 pp -150.41 158.39 44.1 Favored 'General case' 0 C--N 1.354 0.763 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.21 141.32 46.89 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 CA-C-N 111.797 -2.456 . . . . 0.0 104.957 -179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' CYS . . . . . . . . . . . . . 78.8 m -131.97 109.16 9.85 Favored 'General case' 0 C--N 1.353 0.739 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 85.4 t -102.32 133.66 45.31 Favored 'Isoleucine or valine' 0 C--N 1.353 0.758 0 N-CA-C 103.078 -2.934 . . . . 0.0 103.078 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.404 ' HA ' ' H4 ' ' A' ' 139' ' ' DBI . 1.2 m -100.94 117.55 35.22 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.258 -2.867 . . . . 0.0 103.258 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 15.9 t -157.76 177.83 10.93 Favored 'General case' 0 C--N 1.348 0.504 0 C-N-CA 115.623 -2.431 . . . . 0.0 108.133 -176.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.6 46.19 0.72 Allowed 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 111.405 -2.634 . . . . 0.0 106.947 -178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 77.32 30.1 0.53 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.802 -1.545 . . . . 0.0 107.197 179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.68 -2.02 27.33 Favored Glycine 0 CA--C 1.54 1.65 0 CA-C-N 113.779 -1.555 . . . . 0.0 110.092 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -91.97 -8.95 44.72 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 68.44 177.38 13.19 Favored Glycine 0 C--N 1.355 1.608 0 O-C-N 124.524 1.14 . . . . 0.0 110.558 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -90.24 25.5 2.18 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 113.807 -1.196 . . . . 0.0 108.028 178.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -90.01 -54.16 8.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -72.21 -26.37 62.02 Favored 'General case' 0 C--N 1.351 0.665 0 CA-C-N 112.699 -2.046 . . . . 0.0 107.954 -179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' CYS . . . . . . . . . . . . . 27.8 t -68.71 -58.51 4.12 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -90.1 27.88 1.52 Allowed 'General case' 0 C--N 1.359 0.99 0 O-C-N 124.751 1.282 . . . . 0.0 110.145 -178.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -103.03 -30.15 5.53 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 109.259 -1.537 . . . . 0.0 109.259 178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.446 HD22 ' CD1' ' A' ' 88' ' ' LEU . 31.0 mt -90.07 -28.28 19.12 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 112.332 -1.934 . . . . 0.0 107.484 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.78 -29.79 58.88 Favored 'General case' 0 C--N 1.351 0.666 0 N-CA-C 105.278 -2.119 . . . . 0.0 105.278 178.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -76.09 -27.87 57.33 Favored 'General case' 0 C--N 1.357 0.898 0 CA-C-N 114.162 -1.381 . . . . 0.0 107.484 178.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.6 tttp -73.58 -19.54 60.85 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 123.92 0.762 . . . . 0.0 109.651 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' CYS . . . . . . . . . . . . . 44.8 t -90.25 -46.3 8.5 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-O 123.806 1.765 . . . . 0.0 107.902 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -73.98 0.95 11.97 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 108.788 -3.824 . . . . 0.0 109.167 179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -84.24 -56.29 3.73 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 104.216 -2.512 . . . . 0.0 104.216 176.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 62.83 45.66 5.54 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 110.73 -2.941 . . . . 0.0 106.494 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.48 -42.1 0.02 OUTLIER Glycine 0 C--N 1.352 1.423 0 CA-C-N 112.749 -2.023 . . . . 0.0 109.841 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.7 mt -78.8 122.78 26.48 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -179.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 123.49 117.58 2.35 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-N 112.229 -2.259 . . . . 0.0 108.554 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 4.2 tt -143.36 40.65 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.538 0 N-CA-C 105.952 -1.87 . . . . 0.0 105.952 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -140.66 117.26 10.88 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 102.563 -3.125 . . . . 0.0 102.563 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.446 ' CD1' HD22 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -140.09 108.3 5.79 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 105.492 -2.04 . . . . 0.0 105.492 -178.685 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -100.19 86.84 3.3 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 102.027 -3.323 . . . . 0.0 102.027 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 9.0 t -89.35 95.98 5.83 Favored 'Isoleucine or valine' 0 C--N 1.348 0.54 0 CA-C-N 111.338 -2.664 . . . . 0.0 109.65 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.476 ' HA2' ' CD1' ' A' ' 117' ' ' TYR . . . -60.31 128.44 45.78 Favored Glycine 0 CA--C 1.529 0.966 0 CA-C-N 109.259 -3.61 . . . . 0.0 111.82 177.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.88 -83.12 1.55 Allowed Glycine 0 C--N 1.352 1.471 0 CA-C-N 111.539 -2.331 . . . . 0.0 107.372 -177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 71.22 -88.35 0.03 OUTLIER 'General case' 0 C--N 1.357 0.931 0 CA-C-N 112.505 -1.847 . . . . 0.0 106.827 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . . . . . . . . . 22.6 mt -135.33 149.72 28.86 Favored 'Isoleucine or valine' 0 C--N 1.348 0.543 0 N-CA-C 103.957 -2.608 . . . . 0.0 103.957 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.41 -175.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.601 0 CA-C-N 112.835 -1.984 . . . . 0.0 108.864 -179.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.1 p 45.7 84.96 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.354 0.791 0 CA-C-N 112.007 -2.361 . . . . 0.0 112.595 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 151.47 -178.42 28.81 Favored Glycine 0 C--N 1.35 1.348 0 CA-C-N 112.239 -2.255 . . . . 0.0 110.608 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 63.1 tttp -159.33 -44.73 0.05 Allowed 'General case' 0 C--N 1.346 0.438 0 CA-C-N 111.523 -2.338 . . . . 0.0 104.839 179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -136.18 -37.16 0.72 Allowed 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -87.13 89.84 8.14 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -101.99 169.26 7.86 Favored Pre-proline 0 C--N 1.35 0.615 0 N-CA-C 105.032 -2.211 . . . . 0.0 105.032 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.05 -152.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.371 1.752 0 N-CA-C 108.092 -1.541 . . . . 0.0 108.092 179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.45 -24.15 61.97 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 113.911 -1.495 . . . . 0.0 108.459 -178.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.545 HG13 ' H ' ' A' ' 105' ' ' GLU . 1.5 p -56.69 -72.53 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.843 0 O-C-N 124.764 1.29 . . . . 0.0 111.544 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.545 ' H ' HG13 ' A' ' 104' ' ' VAL . 25.7 mt-10 -89.03 26.25 1.62 Allowed 'General case' 0 C--N 1.357 0.904 0 C-N-CA 117.773 -1.571 . . . . 0.0 109.846 -178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -76.66 -45.77 28.48 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 103.093 -2.929 . . . . 0.0 103.093 174.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -80.24 -29.0 38.38 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 111.46 -2.609 . . . . 0.0 107.509 179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -92.72 12.77 22.24 Favored 'General case' 0 C--N 1.364 1.218 0 C-N-CA 119.036 -1.066 . . . . 0.0 108.897 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.37 -37.12 14.22 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 103.327 -2.842 . . . . 0.0 103.327 174.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.4 -33.25 75.14 Favored 'General case' 0 C--N 1.361 1.084 0 CA-C-N 112.845 -1.979 . . . . 0.0 107.494 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' MET . . . . . . . . . . . . . 44.7 mtp -80.2 -61.21 2.05 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 177.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 28.95 38.57 0.01 OUTLIER Glycine 0 C--N 1.355 1.595 0 C-N-CA 127.91 2.671 . . . . 0.0 117.708 177.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -84.84 -6.84 59.35 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -105.14 135.97 45.51 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.437 HH21 HG13 ' A' ' 133' ' ' VAL . 0.0 OUTLIER -110.19 170.42 8.09 Favored 'General case' 0 C--N 1.348 0.523 0 N-CA-C 102.51 -3.144 . . . . 0.0 102.51 177.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 33.7 m -140.15 163.01 24.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.476 ' CD1' ' HA2' ' A' ' 91' ' ' GLY . 1.0 OUTLIER -99.58 153.45 37.77 Favored Pre-proline 0 C--N 1.355 0.811 0 N-CA-C 103.017 -2.957 . . . . 0.0 103.017 -179.933 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.42 164.92 25.94 Favored 'Trans proline' 0 C--N 1.365 1.447 0 C-N-CA 121.826 1.684 . . . . 0.0 108.056 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -79.23 118.01 3.91 Favored 'Trans proline' 0 C--N 1.367 1.542 0 N-CA-C 102.377 -3.74 . . . . 0.0 102.377 177.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 93.71 68.98 1.09 Allowed Glycine 0 C--N 1.348 1.201 0 N-CA-C 107.263 -2.335 . . . . 0.0 107.263 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 122' ' ' SER 0.273 0.2 OUTLIER -90.25 -158.08 0.51 Allowed 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 109.496 -3.352 . . . . 0.0 107.336 -177.848 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.512 ' H ' HG22 ' A' ' 121' ' ' THR . 10.4 p -174.22 164.14 2.74 Favored Pre-proline 0 N--CA 1.434 -1.274 0 CA-C-N 110.47 -3.059 . . . . 0.0 103.936 -178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -77.25 -5.4 15.67 Favored 'Trans proline' 0 C--N 1.365 1.401 0 N-CA-C 107.665 -1.706 . . . . 0.0 107.665 177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -71.56 -29.5 64.8 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.29 -20.8 56.98 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.209 -1.359 . . . . 0.0 107.647 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.504 ' C ' ' H ' ' A' ' 129' ' ' ASP . 1.0 OUTLIER -85.34 -14.78 45.39 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 118.764 -1.175 . . . . 0.0 110.06 -179.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 8.8 mt -69.61 -28.62 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 N-CA-C 103.175 -2.898 . . . . 0.0 103.175 174.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -85.13 -2.49 58.06 Favored 'General case' 0 N--CA 1.435 -1.2 0 CA-C-N 112.41 -2.177 . . . . 0.0 108.498 178.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.588 ' O ' HG23 ' A' ' 133' ' ' VAL . 44.1 t0 -61.33 -62.4 1.86 Allowed 'General case' 0 C--N 1.362 1.12 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -82.31 -7.72 59.63 Favored 'General case' 0 C--N 1.347 0.459 0 CA-C-N 112.282 -2.235 . . . . 0.0 110.444 -176.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -90.1 -54.25 4.12 Favored 'General case' 0 C--N 1.354 0.794 0 C-N-CA 117.792 -1.563 . . . . 0.0 108.443 -179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.92 -39.5 71.75 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.752 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.661 HG12 HD23 ' A' ' 134' ' ' LEU . 80.6 t -89.99 -68.99 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 O-C-N 125.193 1.558 . . . . 0.0 111.778 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.661 HD23 HG12 ' A' ' 133' ' ' VAL . 89.1 mt -90.31 54.25 2.71 Favored 'General case' 0 C--N 1.353 0.734 0 O-C-N 124.377 1.048 . . . . 0.0 109.746 -178.5 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -162.67 -37.22 0.02 OUTLIER Glycine 0 C--N 1.346 1.088 0 C-N-CA 120.029 -1.081 . . . . 0.0 110.736 178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.5 t -143.23 161.98 17.05 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.8 mm-40 . . . . . 0 CA--C 1.543 0.711 0 CA-C-N 113.394 -1.73 . . . . 0.0 107.268 179.219 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' FOP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' DBI . . . . . 0.448 H112 HG21 ' A' ' 121' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_